import{_ as d,o as a,c as o,a as t,m,t as c,C as y,M as g,U as b,f as l,F as w,p as v,e as x,q as T}from"./chunks/framework.B1z0IdBH.js";const q={name:"PoemCard",props:{poem:{type:Object,required:!0}}},A={class:"poem-container"},k={class:"review"},S={class:"review-title"},P={class:"review-content"};function C(i,e,h,u,n,s){return a(),o("div",A,[t("div",k,[t("div",S,[e[0]||(e[0]=t("span",{class:"icon"},"question:",-1)),m(c(h.poem.instruction),1)]),e[2]||(e[2]=t("div",{class:"divider"},null,-1)),t("p",P,[e[1]||(e[1]=t("span",{class:"icon"},"answer:",-1)),m(c(h.poem.output),1)])])])}const H=d(q,[["render",C],["__scopeId","data-v-9088896e"]]),M=JSON.parse(`[{"instruction":"What are the symptoms of Laryngeal cleft ?","output":"What are the signs and symptoms of Laryngeal cleft? The symptoms of laryngeal clefts range from mild stridor to significant difficulties with breathing and swallowing. Severity of symptoms depends on the severity of the cleft. Swallowing problems, a husky cry and feeding difficulties are common. Feeding often causes stridor, coughing, choking, gagging, cyanosis, regurgitation, and frequent respiratory infections. Many individuals with laryngeal clefts develop chronic lung disease. The Human Phenotype Ontology provides the following list of signs and symptoms for Laryngeal cleft. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Laryngomalacia 90% Abnormality of the voice - Aspiration - Cyanosis - Laryngeal stridor - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Laryngeal cleft ?","output":"What causes laryngeal cleft? During fetal development, the trachea and esophagus begin as one tube. They later separate when a wall of tissue known as the tracheoesophageal septum forms, dividing the original tube into the trachea and esophagus. If the tracheoesophageal septum fails to form, the trachea and esophagus may remain open to each other or abnormally shaped, causing abnormalities such as a laryngeal cleft, tracheoesophageal fistula, or esophageal atresia. Exactly why these abnormalities occur is unknown."},{"instruction":"What are the treatments for Laryngeal cleft ?","output":"How might laryngeal cleft be treated? Medical and feeding therapies are often the first treatments for patients with laryngeal cleft (particularly type I and type II).[4126] Prevention of gastroesophageal reflux is also important in all types of clefts. Type I clefts often correct themselves over time with growth. During infancy, nursing in the upright position or thickening of formula may be necessary. If these treatments are not enough, surgery may be recommended. Different surgical approaches have been proposed for the management of laryngeal cleft. The timing and approach of surgery may differ depending upon the severity of symptoms, associated abnormalities, and type of cleft."},{"instruction":"What are the symptoms of PPMX syndrome ?","output":"What are the signs and symptoms of PPM-X syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for PPM-X syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Behavioral abnormality 90% Cognitive impairment 90% Hypertonia 90% Macroorchidism 90% EEG abnormality 50% Gait disturbance 50% Macrotia 50% Seizures 50% Abnormality of the cardiovascular system 7.5% Developmental regression 7.5% Scoliosis 7.5% Abnormality of the teeth - Ataxia - Babinski sign - Bruxism - Choreoathetosis - Delayed speech and language development - Drooling - Excessive salivation - Facial hypotonia - High palate - Hyperreflexia - Intellectual disability, mild - Microcephaly - Parkinsonism - Pes cavus - Psychosis - Short neck - Shuffling gait - Slow progression - Spastic gait - Tremor - X-linked recessive inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Multicentric reticulohistiocytosis ?","output":"Multicentric reticulohistiocytosis is a disease that is characterized by the presence of papules and nodules and associated with arthritis mutilans. The disease can involve the skin, the bones, the tendons, the muscles, the joints, and nearly any other organ (e.g., eyes, larynx, thyroid, salivary glands, bone marrow, heart, lung, kidney, liver, gastrointestinal tract). In the majority of cases, the cause of multicentric reticulohistiocytosis is unknown; however, it has been associated with an underlying cancer in about one fourth of cases, suggesting that it may be a paraneoplastic syndrome."},{"instruction":"What are the symptoms of Multicentric reticulohistiocytosis ?","output":"What are the signs and symptoms of Multicentric reticulohistiocytosis? The main symptoms of multicentric reticulohistiocytosis are arthritis and red to purple skin nodules varying in size from 1 to 10 mm. The nodules can be found on any part of the body but tend to concentrate on the face and hands and decrease in number from head to toe. The arthritis is most often symmetrical and polyarticular (affecting many joints). Unlike adult rheumatoid arthritis, it does not spare the joints closest to the fingertips. It can be severely destructive, and in one third of cases it progresses to arthritis multilans. Further history reveals that approximately one third of patients complain of symptoms such as fever, weight loss, and malaise; less often, pericarditis and myositis are present. The clinical presentation of multicentric reticulohistiocytosis is insidious in onset and begins with arthritic complaints in approximately two thirds of patients. It is potentially one of the most rapidly destructive forms of arthritis. Joint involvement remits and relapses, gradually worsening into a debilitating and permanent arthritis multilans. The severity of the damage has been reported to be related to the age of onset; therefore, the earlier one has symptoms, the more severe the symptoms tend to be. Like the associated arthritis, skin lesions tend to wax and wane until the disease spontaneously resolves, but may leave permanent disfigurement. The Human Phenotype Ontology provides the following list of signs and symptoms for Multicentric reticulohistiocytosis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the oral cavity 90% Abnormality of the skin 90% Arthritis 90% Abnormality of temperature regulation 7.5% Decreased body weight 7.5% Muscle weakness 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the treatments for Multicentric reticulohistiocytosis ?","output":"How might multicentric reticulohistiocytosis be treated? Dermatologists and rheumatologists are often the types of specialists that oversee the treatment of patients with multicentric reticulohistiocytosis. Although no specific therapy has consistently been shown to improve multicentric reticulohistiocytosis, many different drugs have been used. For instance, therapy with non-steroidal anti-inflammatory agents (e.g., aspirin or ibuprofen) may help the arthritis. Systemic corticosteroids and/or cytotoxic agents, particularly cyclophosphamide, chlorambucil, or methotrexate, may affect the inflammatory response, prevent further joint destruction, and cause skin lesions to regress. Antimalarials (e.g., hydroxychloroquine and mefloquine) have also been used. Alendronate and other bisphosphonates have been reported to be effective in at least one patient and etanercept and infliximab have been effective in some."},{"instruction":"What is (are) Type 1 plasminogen deficiency ?","output":"Type 1 plasminogen deficiency is a genetic condition associated with chronic lesions in the pseudomembrane (tough, thick material) of the mucosa of the eye, mouth, nasopharynx, trachea, and female genital tract; decreased serum plasminogen activity; and decreased plasminogen antigen level. The lesions may be triggered by local injury and/or infection and often recur after removal of the lesion; they are caused by the deposition of fibrin (a protein involved in blood clotting) and by inflammation. The most common clinical finding is ligenous ('wood-like') conjunctivitis, a condition marked by redness and subsequent formation of pseudomembranes of part of the eye that progresses to white, yellow-white or red thick masses with a wood-like consistency that replace the normal mucosa. Hydrocephalus may be present at birth in a small number of individuals."},{"instruction":"What are the symptoms of Type 1 plasminogen deficiency ?","output":"What are the signs and symptoms of Type 1 plasminogen deficiency? Type 1 plasminogen deficiency causes reduced levels of functional plasminogen. The rare inflammatory disease mainly affects the mucous membrances in different body sites. Although the symptoms and their severity may vary from person to person, the most common clinical manifestation is ligneous conjunctivitis, characterized by development of fibrin-rich, woodlike ('ligneous') pseudomembranous lesions. Involvement of the cornea may result in blindness. Other, less common manifestations are ligenous gingivitis, otitis media, ligneous bronchitis and pneumonia, involvement of the gastrointestinal or female genital tract, juvenile colloid milium of the skin (condition in which clear papules develop on sun-exposed areas of the skin), and congenital hydrocephalus. Although the condition is known to cause thrombotic events in mice, no reports of venous thrombosis in humans with the condition have been documented.[826] The Human Phenotype Ontology provides the following list of signs and symptoms for Type 1 plasminogen deficiency. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the eye 90% Abnormality of the oral cavity 50% Abnormality of the intestine 7.5% Abnormality of the middle ear 7.5% Abnormality of the respiratory system 7.5% Dandy-Walker malformation 7.5% Hydrocephalus 7.5% Nephrolithiasis 7.5% Polycystic ovaries 7.5% Nephritis 5% Abnormality of metabolism/homeostasis - Abnormality of the cardiovascular system - Abnormality of the ear - Abnormality of the larynx - Abnormality of the skin - Autosomal recessive inheritance - Blindness - Cerebellar hypoplasia - Conjunctivitis - Duodenal ulcer - Gingival overgrowth - Gingivitis - Infantile onset - Macrocephaly - Periodontitis - Recurrent upper respiratory tract infections - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Type 1 plasminogen deficiency ?","output":"What causes plasminogen deficiency, type 1? Plasminogen deficiency, type 1 is caused by a mutation in a gene encoding plasminogen, an enzyme whose function is to dissolve fibrin clots. Fibrin clots form scabs at a wound site."},{"instruction":"Type 1 plasminogen deficiency inherited ?","output":"Is plasminogen deficiency, type 1 inherited? If so, in what manner? Plasminogen deficiency, type 1 is inherited in an autosomal recessive fashion, which means that an individual must inherit two disease-causing mutated copies of the plasminogen gene in order to have the condition and exhibit symptoms."},{"instruction":"What are the treatments for Type 1 plasminogen deficiency ?","output":"How might type 1 plasminogen deficiency be treated? The treatment options available for type 1 plasminogen deficiency are few. However, some researchers have shown that the ligneous lesions can be reversed by plasminogen infusion, with changes occurring within 3 days and restored to normal after 2 weeks of treatment. Recurrence has been prevented by daily injections with plasminogen sufficient to achieve plasma concentrations to approximately 40% of the normal amount of plasminogen. Treatment with topical plasminogen has also been successful and resulted in dramatic improvement and complete resolution of the membranes. In some women, treatment with oral contraceptives have resulted in an increase in the levels of plasminogen and some resolution of the pseudomembrane."},{"instruction":"What is (are) Pyruvate dehydrogenase deficiency ?","output":"Pyruvate dehydrogenase deficiency is metabolic disorder associated with abnormal function of the mitochondria in cells, thus depriving the body of energy. Progressive neurological symptoms usually start in infancy but may be evident at birth, or in later childhood; these symptoms may include developmental delay, intermittent ataxia, poor muscle tone (hypotonia), abnormal eye movements, or seizures. Severe lethargy, poor feeding, and tachypnea (rapid breathing) commonly occur, especially during times of illness, stress, or high carbohydrate intake. Childhood-onset forms of the condition are often associated with intermittent periods of illness but normal neurological development. Prognosis is difficult to predict due to the many causes of the condition, but in most cases of neonatal and infantile onset, prognosis is described as poor. The most common form of pyruvate dehydrogenase deficiency is caused by mutations in the E1 alpha gene, and is inherited in an X-linked dominant manner; all other forms are caused by various genes and are inherited in an autosomal recessive manner. In addition to directly treating acidosis and providing alternative energy for the body, treatment typically includes dietary supplementation with thiamine, carnitine, and lipoic acids, although not all individuals respond to this therapy."},{"instruction":"What are the symptoms of Pyruvate dehydrogenase deficiency ?","output":"What are the signs and symptoms of Pyruvate dehydrogenase deficiency? Pyruvate dehydrogenase (PDH) deficiency can have a significant effect on fetal development, which may become apparent during late pregnancy with poor fetal weight gain and decreasing levels of estriol in the urine of the mother during pregnancy. Delivery may be complicated, and babies may have low Apgar scores. A low birth weight is common. It has been suggested that there is a characteristic abnormal appearance associated with PDH deficiency, which may include a narrow head, prominent forehead (frontal bossing), wide nasal bridge, long philtrum and flared nostrils; however, these are not seen in all individuals and these features may occur with other disorders as well. Other abnormalities that have been reported include a simian crease, short neck, slight shortening of the limbs, flexion contractures (bent fingers), pes cavus (high arched foot), club foot, ventricular septal defect, and hydronephrosis. Individuals with PDH deficiency typically develop symptoms soon after birth. In general, there are two major types of onset: metabolic and neurological. The metabolic type presents as severe lactic acidosis (too much lactate in the bloodstream). This often does not respond to treatment, thus many of the individuals with this type of onset die during the newborn period (in very few cases, the lactic acidosis has been reported to respond to high doses of thiamine). Some individuals with severe lactic acidosis have also had severe hyperammonemia (high levels of ammonia in the blood). Individuals with the neurological type typically have hypotonia (poor muscle tone), poor feeding, and lethargy, and they later develop seizures. This type typically progresses to severe mental retardation, microcephaly (small head), blindness, and spasticity with secondary contractures (damage to muscles and tendons). However, long term survival is possible and several individuals with this type have reportedly reached their teens. Between these two extremes, there is a continuous range of intermediate forms. When the metabolic abnormalities (lactic acidosis and hyperammonemia) are less severe, the onset may be delayed until later in infancy, and these individuals may have intermittent episodes of lactic acidosis, which often is brought on by an illness and is associated with cerebellar ataxia (abnormal muscle movement). Some of the individuals with primarily neurological symptoms are said to have Leigh's disease. Although PDH deficiency occurs in males and females equally, the presentation of the disease differs between them. The metabolic type, especially the severe neonatal lactic acidosis, is much more common in males; the chronic, neurological form is much more common in females. The Human Phenotype Ontology provides the following list of signs and symptoms for Pyruvate dehydrogenase deficiency. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Feeding difficulties in infancy 90% Muscular hypotonia 90% Reduced consciousness/confusion 90% Abnormal pattern of respiration 50% Abnormal pyramidal signs 50% Abnormality of eye movement 50% Aplasia/Hypoplasia of the corpus callosum 50% Chorea 50% Cognitive impairment 50% Gait disturbance 50% Hypertonia 50% Incoordination 50% Intrauterine growth retardation 50% Microcephaly 50% Neurological speech impairment 50% Seizures 50% Tremor 50% Abnormal facial shape 35% Abnormality of the nose 7.5% Abnormality of the palate 7.5% Cerebral palsy 7.5% Epicanthus 7.5% Frontal bossing 7.5% Hypertelorism 7.5% Long philtrum 7.5% Multiple lipomas 7.5% Narrow face 7.5% Pectus excavatum 7.5% Respiratory insufficiency 7.5% Trigonocephaly 7.5% Upslanted palpebral fissure 7.5% Ventriculomegaly 7.5% Agenesis of corpus callosum - Anteverted nares - Apneic episodes precipitated by illness, fatigue, stress - Basal ganglia cysts - Cerebral atrophy - Choreoathetosis - Chronic lactic acidosis - Decreased activity of the pyruvate dehydrogenase (PDH) complex - Dystonia - Episodic ataxia - Flared nostrils - Hyperalaninemia - Increased CSF lactate - Increased serum lactate - Infantile onset - Intellectual disability - Lethargy - Phenotypic variability - Ptosis - Severe lactic acidosis - Small for gestational age - Wide nasal bridge - X-linked dominant inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Pyruvate dehydrogenase deficiency ?","output":"What causes pyruvate dehydrogenase deficiency? Pyruvate dehydrogenase (PDH) deficiency is usually caused by a deficiency of one or more enzymes or cofactors (such as thiamine) that are needed for an important chemical reaction in the cells of the body. These enzymes or cofactors are part of the pyruvate dehydrogenase complex and normally convert (or aid in converting) a chemical called pyruvate to another chemical called acetyl-coenzyme A (CoA), which is one of two important chemicals the body needs to make citrate for the cells. Because pyruvate cannot be converted to acetyl-CoA, there is too much pyruvate in the cells, which then gets used to produce more lactic acid (which is toxic in large amounts) and alanine; there is also not enough citrate being made by the body. Citrate is the first step in another important group of chemical reactions called the citric acid cycle, which then cannot proceed. The body tries to make alternate pathways to produce more acetyl-CoA, but there is still not enough energy made in the body, especially in the central nervous system (CNS). The amount of energy that is deficient depends on the amount of the enzyme that is deficient. The condition is sometimes referred to as pyruvate dehydrogenase complex (PDHC) deficiency because there is a \\"complex\\" of three enzymes normally used in the reaction; when any one or more of the enzymes needed for the above-described reaction are deficient, the condition results. The most common form of pyruvate dehydrogenase deficiency is caused by mutations in the X-linked dominant E1 alpha gene; all other causes are thought to be due to mutations in recessive genes."},{"instruction":"Pyruvate dehydrogenase deficiency inherited ?","output":"How is pyruvate dehydrogenase deficiency inherited? Pyruvate dehydrogenase deficiency is most commonly caused by mutations in the E1 alpha gene, which is located on the X chromosome (one of the sex chromosomes) and is typically inherited in an X-linked dominant manner. Dominant inheritance occurs when an abnormal gene from one parent is capable of causing disease, even though a matching gene from the other parent is normal. The abnormal gene \\"dominates\\" the gene pair. Females have two X chromosomes (one from each parent) and males have one X chromosome from the mother and one Y chromosome from the father. For an X-linked dominant disorder, because one mutated gene is enough to cause the condition, both males and females can have the condition. Because males have no other copy of the X chromosome with a working gene, affected males usually have more severe disease than affected females (who have another X chromosome with a working gene). If the father carries the abnormal X gene, all of his daughters will inherit the disease and none of his sons will have the disease. If the mother carries the abnormal X gene, there is a 50% (1 in 2) chance for each child (whether male or female) to inherit the disease. The condition may also be caused by a new mutation that first appears in an affected individual, without either parent carrying an abnormal gene for the condition. The other genes that are thought to cause pyruvate dehydrogenase deficiency appear to be inherited in an autosomal recessive manner and are not on the sex chromosomes. This means that two non-working copies of the gene that is causing the condition must be present for an individual to have the condition. When an individual has an autosomal recessive condition, each of that person's parents have a non-working copy of the gene and are referred to as \\"carriers.\\" When 2 carriers for the same condition are having children, there is a 25% (1 in 4) chance for each child to have the condition, a 50% (1 in 2) chance for each child to be a carrier like each of the parents, and a 25% chance for each child to not have the condition and not be a carrier."},{"instruction":"w to diagnose Pyruvate dehydrogenase deficiency ?","output":"Is genetic testing available for pyruvate dehydrogenase deficiency? Genetic testing is available for pyruvate dehydrogenase deficiency. GeneTests lists the names of laboratories that are performing genetic testing for pyruvate dehydrogenase deficiency. To view the contact information for the clinical laboratories conducting testing click here. Please note: Most of the laboratories listed through GeneTests do not accept direct contact from patients and their families; therefore, if you are interested in learning more, you will need to work with a health care provider or a genetics professional. How is pyruvate dehydrogenase deficiency diagnosed? The diagnosis of pyruvate dehydrogenase (PDH) deficiency may be considered in any individual with early-onset neurological disease, especially if it appears to be associated with structural abnormalities in the brain and unexplained lactic acidosis. When lactic acid (also called lactate) and pyruvate in the blood do not seem to be significantly high, an important clue to the diagnosis may be high concentrations of lactate and/or pyruvate in the cerebrospinal fluid (the fluid that surrounds the brain and spinal cord). Additionally, magnetic resonance spectroscopy (MRS) of the brain may show concentrations of lactate in the central nervous system. Analysis of serum and urine amino acids usually shows hyperalaninemia (high levels of the amino acid alanine). When lactic acidosis is present, other disorders involving pyruvate abnormalities are part of the differential diagnosis. However, in all of these conditions, the diagnosis is based on specific laboratory tests. Specific enzyme tests have been designed which measure both the individual's overall PDH activity, as well as each separate component of the complex (because any defect in the complex may cause the condition). The vast majority of individuals with PDH deficiency are found to be deficient in the El enzyme, but abnormalities have also been detected in other components."},{"instruction":"What are the treatments for Pyruvate dehydrogenase deficiency ?","output":"How might pyruvate dehydrogenase deficiency be treated? Treatment of pyruvate dehydrogenase (PDH) deficiency rarely influences the course of the disease, but goals include stimulating the pyruvate dehydrogenase complex (PDHC), providing alternative sources of energy, and preventing immediate, acute worsening of the condition. However, even with treatment, damage to the central nervous system is common. Lactic acid accumulation may be lessened by giving a high fat/low carbohydrate (ketogenic) diet, but this does not alleviate the neurological symptoms, because structural damage in the brain is typically present from before birth. There is some evidence that a medication called dichloroacetate may reduce the metabolic issues in some patients. The standard of care is to supplement cofactors, which are substances in the body that help the chemical reactions in the cells to occur; these include thiamine, carnitine, and lipoic acid. The individuals with PDH deficiency that respond to these cofactors (especially thiamine) usually have a better outcome. However, giving all of these cofactors to all patients with PDH deficiency is typical in order to optimize pyruvate dehydrogenase complex function. Oral citrate is often used to treat acidosis."},{"instruction":"What are the symptoms of Grubben de Cock Borghgraef syndrome ?","output":"What are the signs and symptoms of Grubben de Cock Borghgraef syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Grubben de Cock Borghgraef syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of eye movement 90% Blue sclerae 90% Cognitive impairment 90% Deviation of finger 90% Dry skin 90% Eczema 90% Muscular hypotonia 90% Round face 90% Seizures 90% Short neck 90% Short palm 90% Autosomal recessive inheritance - Delayed speech and language development - Intrauterine growth retardation - Microdontia - Partial agenesis of the corpus callosum - Postnatal growth retardation - Widely spaced teeth - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Fumarase deficiency ?","output":"Fumarase deficiency is an inherited condition that primarily affects the nervous system, especially the brain. Affected infants may have microcephaly, abnormal brain structure, severe developmental delay, weak muscle tone (hypotonia), failure to thrive, seizures, and/or distinctive facial features. Other signs and symptoms may include hepatosplenomegaly, an excess of red blood cells (polycythemia), and/or or deficiency of white blood cells (leukopenia). Affected individuals usually survive only a few months, but a few have lived into early adulthood. This condition is caused by mutations in the FH gene and is inherited in an autosomal recessive manner. No effective treatment is currently available."},{"instruction":"What are the symptoms of Fumarase deficiency ?","output":"What are the signs and symptoms of Fumarase deficiency? Most newborns with fumarase deficiency show severe neurologic abnormalities, including poor feeding, failure to thrive, and poor muscle tone (hypotonia). Early-onset infantile encephalopathy (altered brain structure or function), seizures, and severe developmental delay with microcephaly are also common. Other signs and symptoms may include infantile spasms, abnormal posturing of the limbs, and autistic features. Distinctive facial features have been reported in some affected individuals and have included an unusually prominent forehead (frontal bossing); low-set ears; a small jaw (micrognathia); widely-spaced eyes (ocular hypertelorism); depressed nasal bridge; and high-arched palate. Other findings in affected individuals can include neonatal polycythemia (an excess of red blood cells); leukopenia (deficiency of white blood cells); neutropenia; enlarged liver and spleen (hepatosplenomegaly); and pancreatitis. Many children with this condition do not survive infancy or childhood. Those surviving beyond childhood have severe psychomotor deficits. The Human Phenotype Ontology provides the following list of signs and symptoms for Fumarase deficiency. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Agenesis of corpus callosum - Aminoaciduria - Anteverted nares - Autosomal recessive inheritance - Cerebral atrophy - Cholestasis - Choroid plexus cyst - Cutaneous leiomyoma - Decreased subcutaneous fat - Depressed nasal bridge - Failure to thrive - Frontal bossing - Hepatic failure - High palate - Hypertelorism - Hypoplasia of the brainstem - Intellectual disability, profound - Lactic acidosis - Metabolic acidosis - Microcephaly - Muscular hypotonia - Neurological speech impairment - Open operculum - Optic atrophy - Pallor - Polycythemia - Polymicrogyria - Relative macrocephaly - Status epilepticus - Visual impairment - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Fumarase deficiency ?","output":"What causes fumarase deficiency? Mutations in the FH gene cause fumarase deficiency. The FH gene provides instructions for making an enzyme called fumarase, which participates in a series of reactions allowing cells to use oxygen and generate energy. Mutations in the FH gene disrupt the enzyme's ability to do its job. Disruption of the process that generates energy for cells is particularly harmful to cells in the developing brain, thus resulting in the signs and symptoms of fumarase deficiency."},{"instruction":"What are the treatments for Fumarase deficiency ?","output":"How might fumarase deficiency be treated? There is currently no effective treatment for fumarase deficiency. Nutritional intervention may be appropriate for children with feeding difficulties. Physical therapy and wheelchairs can also be useful for some individuals."},{"instruction":"What are the symptoms of ThakkerDonnai syndrome ?","output":"What are the signs and symptoms of Thakker-Donnai syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Thakker-Donnai syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Anteverted nares 90% Downturned corners of mouth 90% Hypertelorism 90% Long palpebral fissure 90% Low-set, posteriorly rotated ears 90% Muscular hypotonia 90% Narrow mouth 90% Short neck 90% Upslanted palpebral fissure 90% Vertebral segmentation defect 90% Webbed neck 90% Abnormality of the upper urinary tract 50% Aplasia/Hypoplasia of the corpus callosum 50% Communicating hydrocephalus 50% Congenital diaphragmatic hernia 50% Intrauterine growth retardation 50% Macrotia 50% Tetralogy of Fallot 50% Tracheoesophageal fistula 50% Transposition of the great arteries 50% Ventricular septal defect 50% Abnormal facial shape - Abnormalities of placenta or umbilical cord - Agenesis of corpus callosum - Anal atresia - Autosomal recessive inheritance - Bulbous nose - Hemivertebrae - Hydrocephalus - Hydronephrosis - Long ear - Low posterior hairline - Posteriorly rotated ears - Rectovaginal fistula - Short nose - Wide nasal bridge - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) DowlingDegos disease ?","output":"Dowling-Degos disease is a skin condition characterized by a lacy or net-like (reticulate) pattern of abnormally dark skin coloring (hyperpigmentation), particularly in the body's folds and creases. Other features may include dark lesions on the face and back that resemble blackheads, red bumps around the mouth that resemble acne, depressed or pitted scars on the face similar to acne scars but with no history of acne, cysts within hair follicles (pilar cysts) on the scalp, and rarely, patches of skin that are unusually light in color (hypopigmented). Symptoms typically develop in late childhood or in adolescence and progress over time. While the skin changes caused by Dowling-Degos disease can be bothersome, they typically don't cause health problems. Dowling-Degos disease is caused by mutations in the KRT5 gene. This condition is inherited in an autosomal dominant pattern."},{"instruction":"What are the symptoms of DowlingDegos disease ?","output":"What are the signs and symptoms of Dowling-Degos disease? Dowling-Degos disease is characterized by a lacy or net-like (reticulate) pattern of abnormally dark skin coloring (hyperpigmentation), particularly in the body's folds and creases. These skin changes typically first appear in the armpits and groin area and can later spread to other skin folds such as the crook of the elbow and back of the knee. Less commonly, pigmentation changes can also occur on the wrist, back of the hand, face, scalp, scrotum (in males), and vulva (in females). These areas of hyperpigmentation are not affected by exposure to sunlight. Individuals with Dowling-Degos disease may also have dark lesions on the face and back that resemble blackheads, red bumps around the mouth that resemble acne, or depressed or pitted scars on the face similar to acne scars but with no history of acne. Cysts within the hair follicle (pilar cysts) may develop, most commonly on the scalp. Rarely, affected individuals have patches of skin that are unusually light in color (hypopigmented). The pigmentation changes characteristic of Dowling-Degos disease typically begin in late childhood or in adolescence, although in some individuals, features of the condition do not appear until adulthood. New areas of hyperpigmentation tend to develop over time, and the other skin lesions tend to increase in number as well. While the skin changes caused by Dowling-Degos disease can be bothersome, they typically cause no health problems. The Human Phenotype Ontology provides the following list of signs and symptoms for Dowling-Degos disease. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal dominant inheritance - Progressive reticulate hyperpigmentation - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the treatments for DowlingDegos disease ?","output":"Is there a medicine that can cure Dowling-Degos disease? There is no cure for Dowling-Degos disease. Many different treatments have been tried for this condition, but none has proven effective in eliminating the symptoms for all patients. Topical retinoic acids, topical steroids, hydroquinone, tretinoin, and systemic retinoids have been used without success. Limited reports indicate at least temporary therapeutic benefit with topical adapalene. Various laser systems (CO2 and erbiumYAG) have also shown some promise. Additional articles that address this topic can be accessed below: Altomare G, Capella GL, Fracchiolla C, Frigerio E. Effectiveness of topical adapalene in Dowling-Degos disease. Dermatology. 1999;198(2):176-7."},{"instruction":"What is (are) Freeman Sheldon syndrome ?","output":"Freeman Sheldon syndrome is an inherited disorder characterized by multiple contractures (i.e., restricted movement around two or more body areas) at birth (congenital), abnormalities of the head and face (craniofacial) area, defects of the hands and feet, and skeletal malformations. Freeman-Sheldon syndrome can be inherited as an autosomal dominant or autosomal recessive genetic trait. However, most cases occur randomly with no apparent cause (sporadically)."},{"instruction":"What are the symptoms of Freeman Sheldon syndrome ?","output":"What are the signs and symptoms of Freeman Sheldon syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Freeman Sheldon syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the teeth 90% Camptodactyly of finger 90% Chin dimple 90% Hypertelorism 90% Limitation of joint mobility 90% Narrow mouth 90% Scoliosis 90% Talipes 90% Trismus 90% Ulnar deviation of finger 90% Underdeveloped nasal alae 90% Wide nasal bridge 90% Abnormality of the nares 50% Cryptorchidism 50% Deeply set eye 50% Hearing impairment 50% Long philtrum 50% Malignant hyperthermia 50% Neurological speech impairment 50% Prenatal movement abnormality 50% Ptosis 50% Short stature 50% Strabismus 50% Intellectual disability 31% Absent palmar crease 7.5% Hernia 7.5% Oligohydramnios 7.5% Polyhydramnios 7.5% Abnormal auditory evoked potentials - Abnormality of the skin - Adducted thumb - Autosomal dominant inheritance - Autosomal recessive inheritance - Blepharophimosis - Breech presentation - Camptodactyly - Cerebellar atrophy - Chin with H-shaped crease - Epicanthus - Failure to thrive - Fever - Flat face - Flexion contracture of toe - High palate - Hip contracture - Hip dislocation - Hypoplasia of the brainstem - Inguinal hernia - Joint contracture of the hand - Knee flexion contracture - Kyphoscoliosis - Malar flattening - Mandibular prognathia - Mask-like facies - Microcephaly - Muscle weakness - Nasal speech - Postnatal growth retardation - Prominent forehead - Rocker bottom foot - Seizures - Short neck - Short nose - Shoulder flexion contracture - Small for gestational age - Spina bifida occulta - Talipes equinovarus - Telecanthus - Ulnar deviation of the hand or of fingers of the hand - Whistling appearance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"w to diagnose Freeman Sheldon syndrome ?","output":"How is Freeman Sheldon syndrome diagnosed? Freeman Sheldon syndrome may be suspected based on medical history and physical examination which reveal characteristic features such as a small mouth, flat mask-like face, club feet, joint contractures, and under-development of the cartilage of the nose. A definitive diagnosis can be made through clinical genetic testing. GeneTests lists laboratories offering clinical genetic testing for this condition. Clinical genetic tests are ordered to help diagnose a person or family and to aid in decisions regarding medical care or reproductive issues. Talk to your health care provider or a genetic professional to learn more about your testing options."},{"instruction":"What is (are) Hypoplastic left heart syndrome ?","output":"Hypoplastic left heart syndrome (HLHS) is a problem with the hearts structure that is present at birth (congenital). It occurs when parts of the left side of the heart (mitral valve, left ventricle, aortic valve, and aorta) do not develop completely. The underdeveloped left side of the heart is unable to provide enough blood flow to the body, which decreases the oxygen-rich blood supply. Babies with HLHS might look normal at birth, but will develop symptoms of HLHS within a few days. These symptoms might include: poor feeding, problems breathing, pounding heart, weak pulse, and ashen or bluish skin color. The cause of HLHs is presently unknown."},{"instruction":"What are the symptoms of Hypoplastic left heart syndrome ?","output":"What are the signs and symptoms of Hypoplastic left heart syndrome? Normally, oxygen-poor blood is pumped through the right side of the heart to the lungs, where it gains oxygen and returns to the left side of the heart. The oxygen-rich blood is then pumped from the left side of the heart to the rest of the body. At birth, all babies also have two connections, or shunts, between the two sides of the heart; however, within a few days of birth these connections close. In those with HLHS, the underdeveloped left side of the heart is unable to provide enough blood flow to the body. The normal shunts present at birth help to direct blood to the body; when these connections close the oxygen-rich blood supply decreases. At first, a newborn with HLHS may appear normal. Symptoms usually occur in the first few hours of life, although it may take up to a few days to develop symptoms. These symptoms may include: Bluish (cyanosis) or poor skin color Cold hands and feet (extremities) Lethargy Poor pulse Poor suckling and feeding Pounding heart Rapid breathing Shortness of breath In healthy newborns, bluish color in the hands and feet is a response to cold (this reaction is called peripheral cyanosis). However, a bluish color in the chest or abdomen, lips, and tongue is abnormal (called central cyanosis). It is a sign that there is not enough oxygen in the blood. Central cyanosis often increases with crying. The Human Phenotype Ontology provides the following list of signs and symptoms for Hypoplastic left heart syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Hypoplastic left heart 90% Abnormality of the aorta 50% Abnormality of chromosome segregation 7.5% Abnormality of the mitral valve 7.5% Atria septal defect 7.5% Maternal diabetes 7.5% Patent ductus arteriosus 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the treatments for Hypoplastic left heart syndrome ?","output":"How might hypoplastic left heart syndrome (HLHS) be treated? Once the diagnosis of HLHS is made, the baby will be admitted to the neonatal intensive care unit. A breathing machine (ventilator) may be needed to help the baby breathe. A medicine called prostaglandin E1 is used to keep blood circulating to the body by keeping the ductus arteriosus open. These measures do not solve the problem and ultimately, the baby will require surgery. The first surgery, called the Norwood operation, occurs within the baby's first few days of life. Stage I of the Norwood procedure consists of building a new aorta by: Using the pulmonary valve and artery Connecting the hypoplastic old aorta and coronary arteries to the new aorta Removing the wall between the atria (atrial septum) Making an artificial connection from either the right ventricle or a body-wide artery to the pulmonary artery to maintain blood flow to the lungs (called a shunt) Afterwards, the baby usually goes home. The child will need to take daily medicines and be closely followed by a pediatric cardiologist, who will determine when the second stage of surgery should be done. Stage II of the operation is called the Glenn shunt or hemi-Fontan procedure. This procedure connects the major vein carrying blue blood from the top half of the body (the superior vena cava) directly to blood vessels to the lungs (pulmonary arteries) to get oxygen. The surgery is usually done when the child is 4 to 6 months of age. During stages I and II, the child may still appear somewhat blue (cyanotic).Stage III, the final step, is called the Fontan procedure. The rest of the veins that carry blue blood from the body (the inferior vena cava) are connected directly to the blood vessels to the lungs. The right ventricle now serves only as the pumping chamber for the body (no longer the lungs and the body). This surgery is usually performed when the baby is 18 months - 3 years old. After this final step, the baby is no longer blue. Some patients may need more surgeries in their 20s or 30s if they develop hard to control arrhythmias or other complications of the Fontan procedure. In some hospitals, heart transplantation is considered a better choice than the three-step surgery process. However, there are few donated hearts available for small infants."},{"instruction":"What are the symptoms of Familial partial lipodystrophy associated with PPARG mutations ?","output":"What are the signs and symptoms of Familial partial lipodystrophy associated with PPARG mutations? The Human Phenotype Ontology provides the following list of signs and symptoms for Familial partial lipodystrophy associated with PPARG mutations. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of lipid metabolism 90% Abnormality of the menstrual cycle 90% Diabetes mellitus 90% Hypertension 90% Insulin resistance 90% Acanthosis nigricans 50% Hepatic steatosis 50% Hyperuricemia 50% Cirrhosis 7.5% Coronary artery disease 7.5% Hypertrichosis 7.5% Polycystic ovaries 7.5% Toxemia of pregnancy 7.5% Abnormality of the face - Abnormality of the musculature - Abnormality of the neck - Autosomal dominant inheritance - Decreased subcutaneous fat - Hirsutism - Hyperglycemia - Hyperinsulinemia - Hypertriglyceridemia - Hypoalphalipoproteinemia - Insulin-resistant diabetes mellitus - Lipodystrophy - Loss of gluteal subcutaneous adipose tissue - Loss of subcutaneous adipose tissue in limbs - Maternal diabetes - Oligomenorrhea - Preeclampsia - Primary amenorrhea - Prominent superficial veins - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Brachydactyly type A4 ?","output":"What are the signs and symptoms of Brachydactyly type A4? The Human Phenotype Ontology provides the following list of signs and symptoms for Brachydactyly type A4. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Short toe 90% Short stature 50% Symphalangism affecting the phalanges of the hand 50% Aplasia of the middle phalanges of the toes - Autosomal dominant inheritance - Congenital talipes calcaneovalgus - Short middle phalanx of the 2nd finger - Short middle phalanx of the 5th finger - Type A brachydactyly - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Ameloonychohypohidrotic syndrome ?","output":"What are the signs and symptoms of Ameloonychohypohidrotic syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Ameloonychohypohidrotic syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of dental color 90% Abnormality of dental enamel 90% Abnormality of the fingernails 90% Hyperkeratosis 90% Hypohidrosis 90% Hypoplastic toenails 90% Onycholysis 90% Abnormality of dental morphology 50% Advanced eruption of teeth 50% Delayed eruption of teeth 50% Dry skin 50% Fine hair 50% Reduced number of teeth 50% Abnormality of the hair - Autosomal dominant inheritance - Marked delay in eruption of permanent teeth - Seborrheic dermatitis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Long QT syndrome ?","output":"Long QT syndrome is a disorder of the hearts electrical activity that can cause sudden, uncontrollable, and irregular heartbeats (arrhythmia), which may lead to sudden death. Long QT syndrome can be detected by electrocardiogram (EKG). It can be caused by a variety of different gene mutations (changes). It can also be acquired (noninherited) and may be brought on by certain medicines and other medical conditions."},{"instruction":"What are the symptoms of Long QT syndrome ?","output":"What are the signs and symptoms of Long QT syndrome? Signs and symptoms of the arrhythmias experienced by people with long QT syndrome includes unexplained fainting, seizures, drowning or near drowning, and sudden cardiac arrest or death. You can read more about these and other symptoms of long QT syndrome on the National Heart Lung and Blood Institute's Web site by clicking here. The Human Phenotype Ontology provides the following list of signs and symptoms for Long QT syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Arrhythmia 90% Sensorineural hearing impairment 90% Abdominal situs inversus 7.5% Anemia 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Long QT syndrome ?","output":"What causes long QT syndrome? Acquired long QT syndrome can be caused by certain medicines and medical conditions. Some medications that cause long QT syndrome include antihistamines and decongestants, antibiotics, antidepressants, and cholesterol-lowering medicines. Examples of medical conditions that can cause long QT syndrome include excessive diarrhea or vomiting and certain thyroid disorders. Inherited forms of long QT syndrome are caused by changes in genes that control the heart muscles electrical activity. Inherited long QT syndrome may be isolated (occur alone without other associated symptoms) or be due to a genetic syndrome, such as Romano-Ward syndrome, Jervell Lang-Nielsen syndrome, Anderson-Tawil syndrome, and Timothy syndrome."},{"instruction":"w to diagnose Long QT syndrome ?","output":"How is long QT syndrome diagnosed? Long QT syndrome is diagnosed on the basis of electrocardiographic (EKG) findings, clinical findings such as congenital deafness or unexplained fainting, and family history of long QT syndrome or sudden cardiac death. Genetic testing is often performed in families in whom the diagnosis of long QT syndrome has been made or is suspected on clinical grounds."},{"instruction":"What are the symptoms of Chiari malformation type 3 ?","output":"What are the signs and symptoms of Chiari malformation type 3? The Human Phenotype Ontology provides the following list of signs and symptoms for Chiari malformation type 3. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Areflexia of upper limbs - Arnold-Chiari type I malformation - Autosomal dominant inheritance - Babinski sign - Basilar impression - Diplopia - Dysarthria - Dysphagia - Gait ataxia - Headache - Hearing impairment - Hyperacusis - Limb muscle weakness - Lower limb hyperreflexia - Lower limb spasticity - Nystagmus - Paresthesia - Photophobia - Scoliosis - Small flat posterior fossa - Syringomyelia - Tinnitus - Unsteady gait - Urinary incontinence - Vertigo - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Glutaric acidemia type III ?","output":"Glutaric acidemia type III is a rare metabolic condition characterized by persistent, isolated accumulation or excretion of glutaric acid. No specific phenotype has been described, as symptoms vary and some individuals remain symptom-free. Unlike other types of glutaric acidemia, this type is caused by a peroxisomal rather than a mitochondrial dysfunction. Mutations in the C7ORF10 gene on chromosome 7p14 have been identified in some people with glutaric acidemia type III and the condition follows an autosomal recessive pattern of inheritance. Treatment with riboflavin has been helpful in some patients."},{"instruction":"What are the symptoms of Glutaric acidemia type III ?","output":"What are the signs and symptoms of Glutaric acidemia type III? The Human Phenotype Ontology provides the following list of signs and symptoms for Glutaric acidemia type III. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Goiter 5% Hyperthyroidism 5% Autosomal recessive inheritance - Diarrhea - Failure to thrive - Glutaric aciduria - Hypertension - Vomiting - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Aquagenic pruritus ?","output":"Aquagenic pruritus is a condition in which contact with water of any temperature causes intense itching without any visible skin changes. The symptoms may begin immediately after contact with water and can last for an hour or more. The cause of aquagenic pruritus is unknown; however, familial cases have been described. The symptoms of the condition are similar to those seen in patients with other conditions; therefore, a thorough evaluation should be performed to rule out other more serious conditions. Overall, treatment is a challenge. Antihistamines, UVB phototherapy, PUVA therapy and various medications have been tried with varying success."},{"instruction":"What are the symptoms of Aquagenic pruritus ?","output":"What symptoms are observed in patients who have aquagenic pruritus? Aquagenic pruritus causes intense itching in the parts of the body that come in contact with water without an associated rash. The head, palms, soles, and mucosa are usually not affected."},{"instruction":"What causes Aquagenic pruritus ?","output":"What causes aquagenic pruritus? The exact cause of aquagenic pruritus is unknown, but increased mast cell degranulation (release of granules rich in histamine and other compounds into the body by mast cells, a special type of cell that plays a role in the immune system), increased circulating histamine, release of acetylcholine (a chemical in the body which sends signals from nerves to muscles and between nerves in the brain), and increased skin fibrinolytic activity (activity that controls clot size by promoting the breakdown of clots) have all been named as possible causes of the condition. In some cases, it appears to be a symptom of polycythemia vera."},{"instruction":"w to diagnose Aquagenic pruritus ?","output":"How is aquagenic pruritus diagnosed? Criteria for diagnosis include : Severe itching, prickling, stinging, or burning that consistently develops after skin contact with water, regardless of water temperature or salinity; Lack of visible skin manifestations; Reaction within minutes of exposure and lasting anywhere between 10 minutes to 2 hours; Lack of a other skin disease, internal condition, or medication to account for the reaction; and Exclusion of all other physical urticarias, symptomatic dermographism, and polycythemia vera."},{"instruction":"What are the treatments for Aquagenic pruritus ?","output":"What treatment has been attempted in patients who have aquagenic pruritus? The underlying cause of aquagenic pruritus is not well understood which complicates the decision about what therapy might be best for treatment. Various options have been tried with varying success. Antihistamines are the mainstay of treatment. Other therapies that have been tried include adding adding sodium bicarbonate to bath water, topical capsaicin, selective serotonin reuptake inhibitors, UVB phototherapy, PUVA therapy, naltrexone, propranolol, and atenolol."},{"instruction":"What are the symptoms of Short ribpolydactyly syndrome type 3 ?","output":"What are the signs and symptoms of Short rib-polydactyly syndrome type 3? The Human Phenotype Ontology provides the following list of signs and symptoms for Short rib-polydactyly syndrome type 3. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of pelvic girdle bone morphology 90% Abnormality of the metaphyses 90% Abnormality of the ribs 90% Brachydactyly syndrome 90% Limb undergrowth 90% Narrow chest 90% Respiratory insufficiency 90% Short thorax 90% Short toe 90% Skeletal dysplasia 90% Abnormal form of the vertebral bodies 50% Congenital hepatic fibrosis 50% Depressed nasal bridge 50% Displacement of the external urethral meatus 50% Epicanthus 50% Frontal bossing 50% Hydrops fetalis 50% Long philtrum 50% Macrocephaly 50% Median cleft lip 50% Postaxial hand polydactyly 50% Aplasia/Hypoplasia of the corpus callosum 7.5% Cataract 7.5% Ectopic anus 7.5% Midline facial cleft 7.5% Omphalocele 7.5% Polycystic kidney dysplasia 7.5% Preaxial hand polydactyly 7.5% Ventriculomegaly 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Meleda disease ?","output":"What are the signs and symptoms of Meleda disease? The Human Phenotype Ontology provides the following list of signs and symptoms for Meleda disease. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Lichenification 90% Palmoplantar keratoderma 90% Abnormality of the palate 50% Finger syndactyly 50% Hyperhidrosis 50% Hypertrichosis 50% Ichthyosis 50% Skin ulcer 50% Osteolysis 7.5% Abnormality of the mouth - Autosomal recessive inheritance - Brachydactyly syndrome - Congenital symmetrical palmoplantar keratosis - Erythema - Fragile nails - Infantile onset - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of BurnMckeown syndrome ?","output":"What are the signs and symptoms of Burn-Mckeown syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Burn-Mckeown syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Blepharophimosis 90% Choanal atresia 90% Hypertelorism 90% Abnormality of the cardiac septa 50% Prominent nasal bridge 50% Abnormality of the palate 7.5% Short nose 7.5% Short stature 7.5% 2-3 toe syndactyly - Abnormality of metabolism/homeostasis - Atria septal defect - Autosomal recessive inheritance - Bifid uvula - Bilateral choanal atresia/stenosis - Cleft palate - Cleft upper lip - Conductive hearing impairment - Feeding difficulties in infancy - Hypomimic face - Lower eyelid coloboma - Mandibular prognathia - Narrow mouth - Preauricular skin tag - Protruding ear - Renal hypoplasia - Short palpebral fissure - Short philtrum - Thin vermilion border - Underdeveloped nasal alae - Ventricular septal defect - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of White sponge nevus of cannon ?","output":"What are the signs and symptoms of White sponge nevus of cannon? The Human Phenotype Ontology provides the following list of signs and symptoms for White sponge nevus of cannon. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of metabolism/homeostasis - Autosomal dominant inheritance - Oral leukoplakia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Spinocerebellar degeneration and corneal dystrophy ?","output":"What are the signs and symptoms of Spinocerebellar degeneration and corneal dystrophy? The Human Phenotype Ontology provides the following list of signs and symptoms for Spinocerebellar degeneration and corneal dystrophy. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Cognitive impairment 90% EEG abnormality 90% Hemiplegia/hemiparesis 90% Incoordination 90% Opacification of the corneal stroma 90% Visual impairment 90% Abnormality of movement 50% Hyperlordosis 50% Hypertonia 50% Low-set, posteriorly rotated ears 50% Ptosis 50% Scoliosis 50% Triangular face 50% Abnormality of metabolism/homeostasis - Ataxia - Autosomal recessive inheritance - Corneal dystrophy - Intellectual disability - Severe visual impairment - Spinocerebellar tract degeneration - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Liposarcoma ?","output":"Liposarcoma is a tumor that arises from fat tissue. This tumor often occurs in the thigh, behind the knee, or in the abdomen, but it can be found in other parts of the body. Because a liposarcoma may grow into surrounding tissues or organs, it is considered a malignant tumor."},{"instruction":"What are the treatments for Liposarcoma ?","output":"How might liposarcoma be treated? The treatment for liposarcoma depends on the type, size, and location of the tumor. Surgery to remove the tumor is often the first treatment. When the tumor is in the abdomen, it may be difficult to remove completely, especially if the tumor is growing near important organs that cannot be removed. If the entire tumor cannot be removed during surgery, radiation therapy may be used after surgery to kill any cancer cells that remain to reduce the chance of the tumor coming back (a recurrence). Chemotherapy is another treatment that can kill remaining cancer cells following surgery, though it is not usually used to treat low-grade sarcomas. Sometimes radiation therapy or chemotherapy may be done prior to surgery to shrink the tumor; this may increase the chance of removing the whole tumor during surgery while limiting the impact to other organs."},{"instruction":"What are the symptoms of Fructosuria ?","output":"What are the signs and symptoms of Fructosuria? The Human Phenotype Ontology provides the following list of signs and symptoms for Fructosuria. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal recessive inheritance - Impairment of fructose metabolism - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) HaileyHailey disease ?","output":"Hailey-Hailey disease is a hereditary blistering skin disease. Signs and symptoms include a painful rash and blistering in skin folds such as the armpits, groin, neck, under the breasts, and between the buttocks. Secondary bacterial infections are not uncommon. Symptoms are often worse in summer months due to heat, sweating and friction. Hailey-Hailey disease is caused by mutations in the ATP2C1 gene and is inherited in an autosomal dominant manner. Treatment focuses on reducing symptoms and preventing flares."},{"instruction":"What are the symptoms of HaileyHailey disease ?","output":"What are the signs and symptoms of Hailey-Hailey disease? The Human Phenotype Ontology provides the following list of signs and symptoms for Hailey-Hailey disease. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal blistering of the skin 90% Abnormality of the oral cavity 90% Acantholysis 90% Hyperkeratosis 90% Skin ulcer 90% Autosomal dominant inheritance - Erythema - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"HaileyHailey disease inherited ?","output":"How is Hailey-Hailey disease inherited? Hailey-Hailey disease is inherited in an autosomal dominant manner. This means that having only one mutated copy of the disease-causing gene in each cell is enough to cause signs or symptoms of the condition. Some people with Hailey-Hailey disease inherit the condition from an affected parent. Other cases are due to a new mutation in the gene and occur in people with no history of the condition in their family. When a person with an autosomal dominant condition has children, each child has a 50% (1 in 2) risk to inherit the mutated copy of the gene."},{"instruction":"w to diagnose HaileyHailey disease ?","output":"Is genetic testing available for Hailey-Hailey disease? Yes. ATP2C1 is the only gene known to be associated with Hailey-Hailey disease. Genetic testing is available to analyze the ATP2C1 gene for mutations.Genetic testing for at-risk relatives and prenatal testing are also possible if the disease-causing mutation in the family is known. How is Hailey-Hailey disease diagnosed? Diagnosis of Hailey-Hailey disease is usually made based on symptoms and family history. As it can be mistaken for other blistering skin conditions, a skin biopsy might be required. Genetic testing is available to confirm the diagnosis of Hailey-Hailey disease, but is not required."},{"instruction":"What are the treatments for HaileyHailey disease ?","output":"How might Hailey-Hailey disease be treated? There is no specific treatment for Hailey-Hailey disease and management generally focuses on the specific symptoms and severity in each person. Affected people are encouraged to avoid \\"triggers\\" such as sunburn, sweating, and friction, and to keep the affected areas dry. Sunscreen, loose clothing, moisturizing creams, and avoiding excessive heat may help prevent outbreaks. Trying to prevent bacterial, viral, and fungal infections in the affected areas is also important, and drugs used to treat or prevent these infections are commonly used. Topical medications (such as mild corticosteroid creams and topical antibiotics) may improve symptoms in milder forms. Cool compresses and dressings may also help. More severe cases may require systemic antibiotics and/or stronger corticosteroid creams. Carbon dioxide laser treatment may be effective for severe forms. In very severe cases, surgery can be performed to remove the affected skin, but skin grafts are usually necessary to repair the wounds."},{"instruction":"What are the symptoms of Scalp ear nipple syndrome ?","output":"What are the signs and symptoms of Scalp ear nipple syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Scalp ear nipple syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal hair quantity 90% Abnormality of the antihelix 90% Abnormality of the antitragus 90% Abnormality of the tragus 90% Aplasia/Hypoplasia of the earlobes 90% Aplasia/Hypoplasia of the nipples 90% Abnormality of the fingernails 50% Cataract 50% Delayed eruption of teeth 50% Hypertension 50% Recurrent urinary tract infections 50% Telecanthus 50% Type I diabetes mellitus 50% Abnormality of the kidney 7.5% Abnormality of the ureter 7.5% Cleft eyelid 7.5% Hypohidrosis 7.5% Anteverted nares 5% Blepharophimosis 5% Congenital cataract 5% Epicanthus 5% Hypotelorism 5% Iris coloboma 5% Mandibular prognathia 5% Pyelonephritis 5% Renal agenesis 5% Renal hypoplasia 5% Renal insufficiency 5% Short columella 5% Sparse hair 5% 2-3 toe syndactyly - 3-4 finger cutaneous syndactyly - Abnormality of the endocrine system - Abnormality of the thorax - Agenesis of permanent teeth - Autosomal dominant inheritance - Breast aplasia - Cupped ear - Depressed nasal bridge - Low-set ears - Microtia - Nail dysplasia - Palpebral edema - Protruding ear - Small earlobe - Underdeveloped antitragus - Underdeveloped tragus - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of BardetBiedl syndrome 2 ?","output":"What are the signs and symptoms of Bardet-Biedl syndrome 2? The Human Phenotype Ontology provides the following list of signs and symptoms for Bardet-Biedl syndrome 2. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the kidney 95% Abnormal electroretinogram 90% Abnormality of retinal pigmentation 90% Cognitive impairment 90% Multicystic kidney dysplasia 90% Obesity 90% Postaxial hand polydactyly 90% Micropenis 88% Myopia 75% Astigmatism 63% Hypertension 50% Hypoplasia of penis 50% Nystagmus 50% Polycystic ovaries 50% Short stature 50% Cataract 30% Glaucoma 22% Rod-cone dystrophy 8% Abnormality of the ovary 7.5% Cryptorchidism 7.5% Finger syndactyly 7.5% Hearing impairment 7.5% Hepatic failure 7.5% Hypertrichosis 7.5% Low-set, posteriorly rotated ears 7.5% Macrocephaly 7.5% Medial flaring of the eyebrow 7.5% Nephrotic syndrome 7.5% Neurological speech impairment 7.5% Prominent nasal bridge 7.5% Short neck 7.5% Vaginal atresia 7.5% Aganglionic megacolon 5% Asthma - Ataxia - Autosomal recessive inheritance - Biliary tract abnormality - Brachydactyly syndrome - Broad foot - Congenital primary aphakia - Decreased testicular size - Delayed speech and language development - Dental crowding - Diabetes mellitus - Foot polydactyly - Gait imbalance - Hepatic fibrosis - High palate - Hirsutism - Hypodontia - Hypogonadism - Intellectual disability - Left ventricular hypertrophy - Nephrogenic diabetes insipidus - Poor coordination - Radial deviation of finger - Retinal degeneration - Short foot - Specific learning disability - Strabismus - Syndactyly - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Craniosynostosismental retardation syndrome of Lin and Gettig ?","output":"What are the signs and symptoms of Craniosynostosis-mental retardation syndrome of Lin and Gettig? The Human Phenotype Ontology provides the following list of signs and symptoms for Craniosynostosis-mental retardation syndrome of Lin and Gettig. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Agenesis of corpus callosum - Ambiguous genitalia, male - Arnold-Chiari type I malformation - Autosomal recessive inheritance - Blepharophimosis - Camptodactyly - Cleft palate - Craniosynostosis - Cryptorchidism - Decreased palmar creases - Dolichocephaly - Epicanthus - Feeding difficulties in infancy - Glabellar hemangioma - Hand clenching - Hydronephrosis - Hypertelorism - Hypertonia - Hypoplasia of midface - Hypoplastic philtrum - Hypospadias - Hypotelorism - Inguinal hernia - Intellectual disability, progressive - Intellectual disability, severe - Intestinal malrotation - Joint contracture of the hand - Long philtrum - Low-set ears - Malar flattening - Micropenis - Microtia - Multiple joint contractures - Multiple small bowel atresias - Narrow chest - Omphalocele - Pectus carinatum - Pectus excavatum - Ptosis - Sensorineural hearing impairment - Short columella - Short nose - Slender finger - Smooth philtrum - Stenosis of the external auditory canal - Strabismus - Supernumerary nipple - Thin vermilion border - Trigonocephaly - Turricephaly - Umbilical hernia - Upslanted palpebral fissure - Ventricular septal defect - Vesicoureteral reflux - Wide intermamillary distance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Autosomal dominant intermediate CharcotMarieTooth disease type F ?","output":"What are the signs and symptoms of Autosomal dominant intermediate Charcot-Marie-Tooth disease type F? The Human Phenotype Ontology provides the following list of signs and symptoms for Autosomal dominant intermediate Charcot-Marie-Tooth disease type F. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal dominant inheritance - Axonal regeneration - Distal sensory impairment - Hammertoe - Hyporeflexia - Onion bulb formation - Pes cavus - Slow progression - Steppage gait - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Renal tubulopathy, diabetes mellitus, and cerebellar ataxia due to duplication of mitochondrial DNA ?","output":"What are the signs and symptoms of Renal tubulopathy, diabetes mellitus, and cerebellar ataxia due to duplication of mitochondrial DNA? The Human Phenotype Ontology provides the following list of signs and symptoms for Renal tubulopathy, diabetes mellitus, and cerebellar ataxia due to duplication of mitochondrial DNA. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the renal tubule 90% Constipation 90% Irregular hyperpigmentation 90% Short stature 90% Cerebral cortical atrophy 50% Hearing impairment 50% Incoordination 50% Muscular hypotonia 50% Ptosis 50% Reduced bone mineral density 50% Type I diabetes mellitus 50% Abnormal electroretinogram 7.5% Visual impairment 7.5% Ataxia - Blindness - Blotching pigmentation of the skin - Dehydration - Developmental regression - Diarrhea - Failure to thrive - Hepatomegaly - Mitochondrial inheritance - Mottled pigmentation of photoexposed areas - Myoclonus - Ophthalmoparesis - Osteoporosis - Pigmentary retinal deposits - Polyuria - Proximal tubulopathy - Rickets - Undetectable electroretinogram - Vomiting - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of 17alphahydroxylase deficiency ?","output":"What are the signs and symptoms of 17-alpha-hydroxylase deficiency? The Human Phenotype Ontology provides the following list of signs and symptoms for 17-alpha-hydroxylase deficiency. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Adrenal hyperplasia - Adrenogenital syndrome - Autosomal recessive inheritance - Gynecomastia - Hypertension - Hypokalemic alkalosis - Male pseudohermaphroditism - Primary amenorrhea - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Growth hormone deficiency ?","output":"Growth hormone deficiency is characterized by abnormally short height due to lack (or shortage) of growth hormone. It can be congenital (present at birth) or acquired. Most of the time, no single clear cause can be identified. Most cases are identified in children. Although it is uncommon, growth hormone deficiency may also be diagnosed in adults. Too little growth hormone can cause short stature in children, and changes in muscle mass, cholesterol levels, and bone strength in adults. In adolescents, puberty may be delayed or absent. Treatment involves growth hormone injections."},{"instruction":"What are the symptoms of Spastic paraplegia 17 ?","output":"What are the signs and symptoms of Spastic paraplegia 17? The Human Phenotype Ontology provides the following list of signs and symptoms for Spastic paraplegia 17. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal dominant inheritance - Babinski sign - First dorsal interossei muscle atrophy - First dorsal interossei muscle weakness - Hyperreflexia - Impaired vibration sensation in the lower limbs - Lower limb muscle weakness - Lower limb spasticity - Pes cavus - Slow progression - Spastic gait - Spastic paraplegia - Thenar muscle atrophy - Thenar muscle weakness - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Blue cone monochromatism ?","output":"Blue cone monochromatism is an inherited X-linked vision disorder. In this condition both red and green cone sensitivities are absent, however rod function and blue cone sensitivities are present. Signs and symptoms include severely reduced visual acuity (clearnes), eccentric fixation, infantile nystagmus that decreases with age, no obvious retinal abnormalities, and poor or no color discrimination."},{"instruction":"What are the symptoms of Blue cone monochromatism ?","output":"What are the signs and symptoms of Blue cone monochromatism? The Human Phenotype Ontology provides the following list of signs and symptoms for Blue cone monochromatism. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Nystagmus 75% Abnormal electroretinogram 7.5% Abnormality of color vision 7.5% Abnormality of macular pigmentation 7.5% Abnormality of retinal pigmentation 7.5% Corneal dystrophy 7.5% Photophobia 7.5% Visual impairment 7.5% Blue cone monochromacy - Myopia - Reduced visual acuity - X-linked recessive inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Pontocerebellar hypoplasia type 3 ?","output":"What are the signs and symptoms of Pontocerebellar hypoplasia type 3? The Human Phenotype Ontology provides the following list of signs and symptoms for Pontocerebellar hypoplasia type 3. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal recessive inheritance - Brachycephaly - Cerebellar atrophy - Cerebellar hypoplasia - Cerebral atrophy - Congenital onset - Decreased body weight - Depressed nasal bridge - Downturned corners of mouth - Full cheeks - Hearing impairment - High palate - Hyperreflexia - Hypoplasia of the brainstem - Hypoplasia of the corpus callosum - Hypoplasia of the pons - Long palpebral fissure - Long philtrum - Low-set ears - Macrotia - Muscular hypotonia of the trunk - Neonatal hypotonia - Optic atrophy - Poor head control - Progressive - Progressive microcephaly - Proptosis - Seizures - Short stature - Spasticity - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Hyperlipidemia type 3 ?","output":"What are the signs and symptoms of Hyperlipidemia type 3? The Human Phenotype Ontology provides the following list of signs and symptoms for Hyperlipidemia type 3. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal glucose tolerance - Angina pectoris - Hypercholesterolemia - Hypertriglyceridemia - Obesity - Peripheral arterial disease - Xanthomatosis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Long QT syndrome 3 ?","output":"What are the signs and symptoms of Long QT syndrome 3? The Human Phenotype Ontology provides the following list of signs and symptoms for Long QT syndrome 3. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal dominant inheritance - Prolonged QT interval - Sudden cardiac death - Syncope - Torsade de pointes - Ventricular fibrillation - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Xlinked dominant scapuloperoneal myopathy ?","output":"X-linked scapuloperoneal myopathy is an inherited muscular dystrophy characterized by weakness and wasting of the muscles in the lower legs and the area of the shoulder blades. In some individuals, facial muscles may also be affected. While the progression varies from case to case, it tends to be relatively slow. Some cases of scapuloperoneal myopathy are caused by mutations in the FHL1 gene. These cases are inherited in an X-linked dominant manner. Treatment is symptomatic and supportive."},{"instruction":"What are the symptoms of Xlinked dominant scapuloperoneal myopathy ?","output":"What are the signs and symptoms of X-linked dominant scapuloperoneal myopathy? The Human Phenotype Ontology provides the following list of signs and symptoms for X-linked dominant scapuloperoneal myopathy. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Adult onset - Arrhythmia - Autosomal dominant inheritance - Elevated serum creatine phosphokinase - EMG: myopathic abnormalities - Flexion contracture - Foot dorsiflexor weakness - Hyporeflexia - Lower limb muscle weakness - Myofibrillar myopathy - Scapular winging - Scapuloperoneal myopathy - Skeletal muscle atrophy - Slow progression - Steppage gait - Waddling gait - Weakness of facial musculature - X-linked dominant inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Xlinked dominant scapuloperoneal myopathy ?","output":"What causes X-linked dominant scapuloperoneal myopathy? X-linked dominant scapuloperoneal myopathy is caused by mutations in the FHL1 gene. The FHL1 gene is located on chromosome Xq26. This gene may be involved in muscle development or hypertrophy."},{"instruction":"What are the treatments for Xlinked dominant scapuloperoneal myopathy ?","output":"How might scapuloperoneal myopathy be treated? There is no standard course of treatment for scapuloperoneal myopathy. Some patients may benefit from physical therapy or other therapeutic exercises."},{"instruction":"What is (are) Spinocerebellar ataxia 3 ?","output":"Spinocerebellar ataxia 3 is a rare movement disorder that is characterized by ataxia, clumsiness and weakness in the arms and legs, spasticity, a staggering lurching walk easily mistaken for drunkenness, difficulty with speech and swallowing, and involuntary eye movements sometimes accompanied by double vision, and bulging eyes. Some patients have dystonia or symptoms similar to those of Parkinson's disease. Others have twitching of the face or tongue, neuropathy, or problems with urination and the autonomic nervous system. Symptoms can begin any time between childhood and about 70 years of age. Spinocerebellar ataxia 3 is a progressive disease, meaning that symptoms get worse with time. Life expectancy ranges from the mid-thirties for those with severe forms of the disorder to a normal life expectancy for those with mild forms. Spinocerebellar ataxia is inherited in an autosomal dominant pattern and is caused by a trinucleotide repeat expansion in the ataxin-3 gene (ATXN3)."},{"instruction":"What are the symptoms of Spinocerebellar ataxia 3 ?","output":"What are the signs and symptoms of Spinocerebellar ataxia 3? The Human Phenotype Ontology provides the following list of signs and symptoms for Spinocerebellar ataxia 3. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Dysautonomia 7.5% Ataxia 57/57 Gaze-evoked nystagmus 15/20 External ophthalmoplegia 34/57 Dysarthria 30/57 Spasticity 62/139 Dystonia 17/57 Fasciculations 12/57 Parkinsonism 3/57 Absent Achilles reflex - Autosomal dominant inheritance - Babinski sign - Bradykinesia - Cerebellar atrophy - Chronic pain - Dementia - Dilated fourth ventricle - Diplopia - Distal amyotrophy - Dysmetric saccades - Dysphagia - Facial-lingual fasciculations - Genetic anticipation - Gliosis - Impaired horizontal smooth pursuit - Limb ataxia - Muscle cramps - Postural instability - Progressive - Progressive cerebellar ataxia - Proptosis - Ptosis - Rigidity - Spinocerebellar tract degeneration - Supranuclear ophthalmoplegia - Truncal ataxia - Urinary bladder sphincter dysfunction - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Craniofacial dyssynostosis ?","output":"What are the signs and symptoms of Craniofacial dyssynostosis? The Human Phenotype Ontology provides the following list of signs and symptoms for Craniofacial dyssynostosis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Cognitive impairment 90% Craniosynostosis 90% Dolichocephaly 90% Frontal bossing 90% Hypertelorism 90% Low-set, posteriorly rotated ears 90% Macrocephaly 90% Atresia of the external auditory canal 50% Clinodactyly of the 5th finger 50% Hydrocephalus 50% Open mouth 50% Short philtrum 50% Short stature 50% Strabismus 50% Umbilical hernia 50% Underdeveloped nasal alae 50% Underdeveloped supraorbital ridges 50% Abnormality of the oral cavity 7.5% Aplasia/Hypoplasia of the corpus callosum 7.5% Epicanthus 7.5% Facial asymmetry 7.5% Nystagmus 7.5% Patent ductus arteriosus 7.5% Sacral dimple 7.5% Short neck 7.5% Abnormal location of ears - Abnormal shape of the occiput - Agenesis of corpus callosum - Arnold-Chiari type I malformation - Brachyturricephaly - Cryptorchidism - Esotropia - Flat midface - Generalized hypotonia - Horseshoe kidney - Hypoplasia of midface - Hypoplasia of the corpus callosum - Hypospadias - Intellectual disability - Malar flattening - Narrow forehead - Pyloric stenosis - Seizures - Ventricular septal defect - Ventriculomegaly - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Macrodactyly of the hand ?","output":"Macrodactyly of the hand is a rare condition in which a person's fingers are abnormally large due to the overgrowth of the underlying bone and soft tissue. This condition is congenital, meaning that babies are born with it. Although babies are born with the condition, macrodactyly is usually not inherited. Most of the time, only one hand is affected, but usually more than one finger is involved. Macrodactyly may also coexist with syndactyly, a condition in which two fingers are fused together. Although it is a benign condition, macrodactyly is deforming and can look cosmetically displeasing. Surgery, usually involving multiple procedures, can help the problem."},{"instruction":"What is (are) Steatocystoma multiplex ?","output":"Steatocystoma multiplex is a condition characterized by numerous skin cysts that tend to develop during puberty. Cysts most often develop on the chest, upper arms and face, but may develop all over the body in some cases. The cysts may become inflamed and cause scarring when they heal. The condition is thought to be caused by mutations in the KRT17 gene and appears to be inherited in an autosomal dominant manner. Some researchers have suggested that the condition may be a mild variant of pachyonychia congenita type 2. Treatment may include minor surgery to remove cysts and oral antibiotics or oral isotretinoin to reduce inflammation."},{"instruction":"What are the symptoms of Steatocystoma multiplex ?","output":"What are the signs and symptoms of Steatocystoma multiplex? Signs and symptoms of steatocystoma multiplex include multiple cysts on the skin. The cysts are often 1 to 2 centimeter wide. They frequently occur on the trunk of the body, upper arms, legs, and face; however, they can develop on other parts of the body as well.The cysts are typically filled with a yellowish to white, oily fluid, and occasionally have hair within them. The cysts can become infected and may cause pain and scarring. The Human Phenotype Ontology provides the following list of signs and symptoms for Steatocystoma multiplex. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Adenoma sebaceum 90% Nephrolithiasis 7.5% Autosomal dominant inheritance - Steatocystoma multiplex - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Steatocystoma multiplex ?","output":"What causes steatocystoma multiplex? Mutations in a gene called keratin 17 (KRT17) have been identified in some individuals with inherited steatocystoma multiplex. In these families the condition is inherited in an autosomal dominant fashion. In other cases the condition occurs sporadically. This may mean that it is due to a gene mutation that was not inherited, but occurred for the first time in the affected individual. A sporadic condition may also be non-genetic and occur by chance, in which case it is not likely to recur in a family. In many sporadic cases of steatocystoma multiplex, mutations in the KRT17 gene have not been identified. Cases of steatocystoma multiplex have also been reported in association with pachyonychia congenita, acrokeratosis verruciformis, hypertrophic lichen planus, hypohidrosis, hidradenitis suppurativa, and natal teeth."},{"instruction":"What are the treatments for Steatocystoma multiplex ?","output":"How might steatocystoma multiplex be treated? Treatment options for steatocystoma multiplex are limited and have had varying degrees of success. The most effective treatment method is thought to be removal of cysts by surgery. However, cosmetic concerns, time, cost, and pain need to be considered because affected individuals often have multiple cysts. In many cases, small incisions (cuts into the skin) allow the cyst and its contents to be removed through the opening. Other treatment options include medications such as oral isotretinoin to temporarily shrink the cysts and reduce inflammation or oral antibiotics to reduce redness and swelling. Other procedures may include draining cysts through a procedure called aspiration, liquid nitrogen cryotherapy, dermabrasion, and carbon dioxide laser therapy. In a recently published case study, the authors present a case in which an individual with steatocystomas on the abdomen and lower chest showed substantial clearance of cysts after two laser treatment sessions. Future studies with a larger patient population will be helpful to evaluate this noninvasive treatment option and determine ideal treatment settings, number of treatments, and interval between treatments. This may prove to be an option for individuals with numerous cysts, in whom removal and drainage is not a realistic choice and other treatments have failed to improve the condition."},{"instruction":"What is (are) Hereditary multiple osteochondromas ?","output":"Hereditary multiple osteochondromas (HMO) (formerly called hereditary multiple exostoses) is a genetic condition in which people develop multiple benign (noncancerous) bone tumors that are covered by cartilage (called osteochondromas). The number and location of osteochondromas varies greatly among affected individuals. These tumors are not present at birth, but almost all affected people develop multiple osteochondromas by the time they are 12 years old. Once the bones stop growing, the development of new osteochondromas also usually stops. Osteochondromas can cause abnormal growth of the arms, hands, and legs, which can lead to uneven limb lengths (limb length discrepancy) and short stature. These tumors may cause pain, limit joint movement, and exert pressure on nerves, blood vessels, and surrounding tissues. Osteochondromas are typically benign; however, researchers estimate that people with HMO have about a 1% lifetime risk of these tumors becoming a cancerous osteochondrosarcoma. HMO is caused by mutations in the EXT1 and EXT2 genes and is inherited in an autosomal dominant pattern."},{"instruction":"What are the symptoms of Hereditary multiple osteochondromas ?","output":"What are the signs and symptoms of Hereditary multiple osteochondromas? The Human Phenotype Ontology provides the following list of signs and symptoms for Hereditary multiple osteochondromas. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the humerus 90% Abnormality of the tibia 90% Abnormality of the femur 50% Abnormality of the metaphyses 50% Abnormality of the teeth 50% Abnormality of the ulna 50% Anteverted nares 50% Aplasia/Hypoplasia of the radius 50% Aseptic necrosis 50% Bone pain 50% Chondrocalcinosis 50% Cranial nerve paralysis 50% Exostoses 50% Genu valgum 50% Madelung deformity 50% Micromelia 50% Muscle weakness 50% Short stature 50% Abnormal pyramidal signs 7.5% Abnormality of pelvic girdle bone morphology 7.5% Abnormality of the pericardium 7.5% Aneurysm 7.5% Elbow dislocation 7.5% Hemiplegia/hemiparesis 7.5% Osteoarthritis 7.5% Osteolysis 7.5% Recurrent fractures 7.5% Scoliosis 7.5% Synostosis of joints 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"Hereditary multiple osteochondromas inherited ?","output":"How is hereditary multiple osteochondromas inherited? HMO is caused by mutations in the EXT1 and EXT2 genes. It is inherited in an autosomal dominant pattern, which means that one copy of the altered gene in each cell is sufficient to cause this condition. In most cases, an affected individual inherits the mutation from one affected parent. Other cases result from new mutations in the gene and occur in people with no history of the condition in their family. Most affected individuals (96%) that have inherited a gene mutation from their parent show signs and symptoms of this condition. However, the family history may appear negative because of the failure to recognize the disorder in family members and/or reduced penetrance. Reports have suggested that some females may not show clinical features of HMO but still have the gene mutation that causes this condition."},{"instruction":"w to diagnose Hereditary multiple osteochondromas ?","output":"Is genetic testing available for hereditary multiple osteochondromas? GeneTests lists the names of laboratories that are performing genetic testing for hereditary multiple osteochondromas. To view the contact information for the clinical laboratories conducting testing for the EXT1 gene, click here. To view the contact information for the clinical laboratories conducting testing for the EXT2 gene, click here. Please note: Most of the laboratories listed through GeneTests do not accept direct contact from patients and their families; therefore, if you are interested in learning more, you will need to work with a health care provider or a genetics professional. Below, we provide a list of online resources that can assist you in locating a genetics professional near you. How might malignant transformation in hereditary multiple exostoses (HME) be diagnosed? Surface irregularities and unorganized chalk deposits with light areas in the middle of the tumor and cartilage cap may be seen on a bone scan, ultrasound or preferably an MRI. However the diagnosis of chondrosarcoma can only be confirmed by a bone biopsy. What are the signs and symptoms of malignant transformation in hereditary multiple exostoses (HME)? A doctor may become suspicious of a malignant transformation if there is an increase in the size of the tumor in adults when bone growth is already complete. In addition, cancer should be suspected if the thickness of the cartilaginous cap of the osteochondroma is over 1-2 centimeters (normally, after bone growth is complete, the cap is only a few millimeters thick). Other signs of a malignant transformation may include bone pain, temporary loss of sensory or motor function due to compression of a nerve (neurapraxia) or pressure related symptoms in nearby organs. Is screening recommended for malignant transformation in hereditary multiple exostoses (HME)? At present, medical researchers agree that more studies need to be performed to determine the best screening protocols for those with HME, including the study of benefit/cost/risk. However a compelling study was published in 2014 by Czajka and DiCaprio which compares the screening of malignant transformation in people with HME to the screening of breast and cervical cancer in women. The authors conclude that screening should be offered to individuals with HME over the age of 16 (or when bone growth has been completed). They propose screening should include a thorough clinical examination and a full body MRI every two years. If an MRI is not possible than a bone scan be performed, followed by an ultrasound of the cartilage cap of any suspicious findings. The Czajka and DiCaprio further recommend that individuals with HME should be made aware of warning signs of malignant transformation and taught self examination techniques."},{"instruction":"What are the treatments for Hereditary multiple osteochondromas ?","output":"How might hereditary multiple osteochondromas (HMO) be treated? Currently, there is no known medical treatment for HMO. Osteochondromas are not usually removed because they stop growing around age 12. Another consideration is how close the tumor is to the affected bone's growth plate, because surgery can affect how the bone grows. Surgery may be considered, however, if an osteochondroma is causing pain, bone fracture, nerve irritation, or if the tumor continues to grow after the person's bones have stopped growing. The surgical treatment of choice is complete removal of the tumor. Depending on the location of the osteochondroma, this may be relatively simple. However, if an osteochondroma is close to nerves and blood vessels, this may make surgery difficult and risky. Surgery may also be necessary to correct painful limb abnormalities that are caused by multiple osteochondromas. Surgery may be needed to cut and realign the bones that have become deformed, which is known as osteotomy. If the legs are not equal in length, treatment may include a procedure to slow down the growth of the longer leg. Surgery may also be needed to correct the forearm deformity seen in this condition. Adults with this condition who have untreated forearm deformities usually do not have significant functional limitations. Although rare, an osteochondroma can become cancerous (malignant), which usually takes the form of a low grade chondrosarcoma. This type of malignant tumor is unlikely to spread elsewhere in the body. Higher grades of cancer can occur, but this is even more uncommon. In that case, other therapies, such as chemotherapy and radiation, may be used in treatment. GeneReviews provides more information about treatment for hereditary multiple osteochondromas. How might a malignant transformation in hereditary multiple exostoses (HME) be treated? Chondrosarcomas in a person with HME tend to be well differentiated and low grade tumors. The tumors usually grow slowly and do not readily metastasize. Surgical removal is the recommended treatment as the condrosarcomas do not respond to radiation or chemotherapy. The prognosis or long term outlook after surgical removal of the chondrosarcoma for a person with HME is good as long as the tumor has not metastasized."},{"instruction":"What is (are) Spondylocarpotarsal synostosis syndrome ?","output":"Spondylocarpotarsal synostosis (SCT) syndrome is an inherited syndrome characterized by disproportionate short stature, abnormalities of the vertebrae in the spine, scoliosis and lordosis, carpal and tarsal fusion (fusion of the bones in the hands and feet), clubfoot, and facial abnormalities such as round face, large forehead, and up-turned nostrils. Other features can include cleft palate, deafness, loose joints, and poor formation of tooth enamel. SCT syndrome has been associated with retinal anomalies and cataracts. However, these eye problems are usually not severe enough to impair vision. This condition is caused by mutations in the FLNB gene. It is inherited in an autosomal recessive manner in families, which means that parents are usually unaffected and children have to have inherited a gene mutation from each parent."},{"instruction":"What are the symptoms of Spondylocarpotarsal synostosis syndrome ?","output":"What are the signs and symptoms of Spondylocarpotarsal synostosis syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Spondylocarpotarsal synostosis syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal form of the vertebral bodies 90% Hyperlordosis 90% Limitation of joint mobility 90% Short thorax 90% Synostosis of carpal bones 90% Vertebral segmentation defect 90% Cleft palate 7.5% Conductive hearing impairment 7.5% Pectus excavatum 7.5% Polycystic kidney dysplasia 7.5% Sensorineural hearing impairment 7.5% Abnormality of pelvic girdle bone morphology - Autosomal recessive inheritance - Block vertebrae - Broad face - Broad nasal tip - C2-C3 subluxation - Carpal synostosis - Cataract - Clinodactyly of the 5th finger - Delayed skeletal maturation - Disproportionate short-trunk short stature - Epiphyseal dysplasia - Hypertelorism - Hypoplasia of dental enamel - Hypoplasia of the odontoid process - Mixed hearing impairment - Pes planus - Preauricular skin tag - Rarefaction of retinal pigmentation - Renal cyst - Restrictive lung disease - Scoliosis - Short neck - Short nose - Tarsal synostosis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Neuronal ceroid lipofuscinosis 10 ?","output":"Neuronal ceroid lipofuscinosis 10 (CLN10-NCL) is a rare condition that affects the nervous system. Signs and symptoms of the condition can develop any time from birth to adulthood and may include progressive dementia, seizures, lack of muscle coordination, and vision loss. CLN10-NCL is caused by changes (mutations) in the CTSD gene and is inherited in an autosomal recessive manner. Treatment options are limited to therapies that can help relieve some of the symptoms."},{"instruction":"What are the symptoms of Neuronal ceroid lipofuscinosis 10 ?","output":"What are the signs and symptoms of Neuronal ceroid lipofuscinosis 10 ? The Human Phenotype Ontology provides the following list of signs and symptoms for Neuronal ceroid lipofuscinosis 10 . If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Microcephaly 90% Respiratory insufficiency 90% Seizures 90% Abnormality of metabolism/homeostasis - Apnea - Ataxia - Autosomal recessive inheritance - Cerebellar atrophy - Cerebral atrophy - Congenital onset - Increased neuronal autofluorescent lipopigment - Intellectual disability, progressive - Intellectual disability, severe - Low-set ears - Neuronal loss in central nervous system - Premature closure of fontanelles - Respiratory failure - Retinal atrophy - Rigidity - Rod-cone dystrophy - Sloping forehead - Spasticity - Status epilepticus - Visual loss - Wide nasal bridge - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Neuronal ceroid lipofuscinosis 5 ?","output":"Neuronal ceroid lipofuscinosis 5 (CLN5-NCL) is a rare condition that affects the nervous system. Signs and symptoms of the condition generally develop between ages 4.5 and 7 years, although later onset cases have been reported. Affected people may experience loss of muscle coordination (ataxia), seizures that do not respond to medications, muscle twitches (myoclonus), visual impairment, and cognitive/motor decline. It occurs predominantly in the Finnish population. CLN5-NCL is caused by changes (mutations) in the CLN5 gene and is inherited in an autosomal recessive manner. Treatment options are limited to therapies that can help relieve some of the symptoms."},{"instruction":"What are the symptoms of Neuronal ceroid lipofuscinosis 5 ?","output":"What are the signs and symptoms of Neuronal ceroid lipofuscinosis 5? The Human Phenotype Ontology provides the following list of signs and symptoms for Neuronal ceroid lipofuscinosis 5. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Cerebellar atrophy 5% Dysarthria 5% Dysdiadochokinesis 5% Dysmetria 5% Nystagmus 5% Abnormal nervous system electrophysiology - Autosomal recessive inheritance - Clumsiness - Curvilinear intracellular accumulation of autofluorescent lipopigment storage material - Developmental regression - Fingerprint intracellular accumulation of autofluorescent lipopigment storage material - Increased neuronal autofluorescent lipopigment - Intellectual disability - Motor deterioration - Myoclonus - Progressive visual loss - Rectilinear intracellular accumulation of autofluorescent lipopigment storage material - Retinal degeneration - Seizures - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Encephalocraniocutaneous lipomatosis ?","output":"What are the signs and symptoms of Encephalocraniocutaneous lipomatosis? The Human Phenotype Ontology provides the following list of signs and symptoms for Encephalocraniocutaneous lipomatosis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Alopecia 90% Cognitive impairment 90% Multiple lipomas 90% Retinopathy 90% Seizures 90% Abnormality of the tricuspid valve 50% Aplasia/Hypoplasia of the corpus callosum 50% Bone cyst 50% Cerebral calcification 50% Cerebral cortical atrophy 50% Craniofacial hyperostosis 50% Hypertonia 50% Iris coloboma 50% Macrocephaly 50% Neoplasm of the skeletal system 50% Neurological speech impairment 50% Opacification of the corneal stroma 50% Osteolysis 50% Pulmonary hypertension 50% Ventriculomegaly 50% Visceral angiomatosis 50% Abnormality of the aorta 7.5% Hemiplegia/hemiparesis 7.5% Neoplasm of the nervous system 7.5% Skeletal dysplasia 7.5% Abnormality of the anterior chamber - Agenesis of corpus callosum - Arachnoid cyst - Atria septal defect - Cerebellar hypoplasia - Cleft eyelid - Cortical dysplasia - Cryptorchidism - Dandy-Walker malformation - Epibulbar dermoid - Hydrocephalus - Hydronephrosis - Hypoplasia of the corpus callosum - Hypoplasia of the iris - Linear hyperpigmentation - Lipoma - Lipomas of the central neryous system - Microphthalmia - Pelvic kidney - Peripheral pulmonary artery stenosis - Sclerocornea - Subaortic stenosis - Subcutaneous lipoma - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Myopathy congenital ?","output":"What are the signs and symptoms of Myopathy congenital? The Human Phenotype Ontology provides the following list of signs and symptoms for Myopathy congenital. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the nervous system - Autosomal recessive inheritance - Myopathy - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Mitral valve prolapse, familial, Xlinked ?","output":"What are the signs and symptoms of Mitral valve prolapse, familial, X-linked? The Human Phenotype Ontology provides the following list of signs and symptoms for Mitral valve prolapse, familial, X-linked. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal dominant inheritance - Disproportionate tall stature - High palate - Mitral regurgitation - Mitral valve prolapse - Pectus excavatum - Reversed usual vertebral column curves - Striae distensae - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Ebstein's anomaly ?","output":"Ebstein's anomaly is a rare heart defect in which parts of the tricuspid valve (which separates the right ventricle from the right atrium) are abnormal. The abnormality causes the tricuspid valve to leak blood backwards into the right atrium. The backup of blood flow can lead to heart swelling and fluid buildup in the lungs or liver. Sometimes, not enough blood gets out of the heart into the lungs and the person may appear blue. Symptoms range from mild to very severe. Treatment depends on the severity of the defect and may include medications, oxygen therapy, or surgery."},{"instruction":"What are the symptoms of Ebstein's anomaly ?","output":"What are the signs and symptoms of Ebstein's anomaly? The Human Phenotype Ontology provides the following list of signs and symptoms for Ebstein's anomaly. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the tricuspid valve 90% Atria septal defect 90% Premature birth 90% Respiratory insufficiency 90% Chest pain 50% Patent ductus arteriosus 50% Abnormality of the endocardium 7.5% Arterial thrombosis 7.5% Cerebral ischemia 7.5% Congestive heart failure 7.5% Sudden cardiac death 7.5% Autosomal recessive inheritance - Ebstein's anomaly of the tricuspid valve - Right bundle branch block - Ventricular preexcitation - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Marden Walker like syndrome ?","output":"What are the signs and symptoms of Marden Walker like syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Marden Walker like syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the eyebrow 90% Abnormality of the ribs 90% Arachnodactyly 90% Blepharophimosis 90% Camptodactyly of finger 90% Clinodactyly of the 5th finger 90% Convex nasal ridge 90% Depressed nasal bridge 90% Disproportionate tall stature 90% Hallux valgus 90% Hypoplasia of the zygomatic bone 90% Long toe 90% Macrotia 90% Narrow nasal bridge 90% Abnormality of dental morphology 50% Bowing of the long bones 50% Delayed skeletal maturation 50% Elbow dislocation 50% Hypertelorism 50% Limitation of joint mobility 50% Slender long bone 50% Triphalangeal thumb 50% Underdeveloped nasal alae 50% Aplasia/Hypoplasia of the cerebellum 7.5% Cleft palate 7.5% Laryngomalacia 7.5% Talipes 7.5% Sclerocornea 5% Autosomal recessive inheritance - Camptodactyly of toe - Craniosynostosis - Dental crowding - Dislocated radial head - Distal ulnar hypoplasia - Elbow flexion contracture - Femoral bowing - Glenoid fossa hypoplasia - High palate - Hypoplasia of the maxilla - Joint contracture of the hand - Knee flexion contracture - Lateral clavicle hook - Long hallux - Long metacarpals - Malar flattening - Narrow foot - Narrow nose - Pectus excavatum - Protruding ear - Single umbilical artery - Slender metacarpals - Stridor - Talipes equinovarus - Thin ribs - Ulnar bowing - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Lethal chondrodysplasia Moerman type ?","output":"What are the signs and symptoms of Lethal chondrodysplasia Moerman type? The Human Phenotype Ontology provides the following list of signs and symptoms for Lethal chondrodysplasia Moerman type. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of epiphysis morphology 90% Abnormality of female internal genitalia 90% Abnormality of the cranial nerves 90% Abnormality of the metaphyses 90% Abnormality of the pulmonary artery 90% Abnormality of the ribs 90% Abnormality of the thumb 90% Aplasia/Hypoplasia of the lungs 90% Blue sclerae 90% Brachydactyly syndrome 90% Cleft palate 90% Dandy-Walker malformation 90% Intestinal malrotation 90% Kyphosis 90% Macrocephaly 90% Micromelia 90% Narrow chest 90% Polyhydramnios 90% Renal hypoplasia/aplasia 90% Scoliosis 90% Short stature 90% Ventricular septal defect 90% Vertebral segmentation defect 90% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Colpocephaly ?","output":"Colpocephaly is a congenital brain abnormality in which the occipital horns - the posterior or rear portion of the lateral ventricles (cavities) of the brain - are larger than normal because white matter in the posterior cerebrum has failed to develop or thicken."},{"instruction":"What are the symptoms of Colpocephaly ?","output":"What are the symptoms of colpocephaly? Colpocephaly is characterized by a small head circumference and in many cases, intellectual disability. Other signs and symptoms may include movement abnormalities, muscle spasms, and seizures. Poor vision, speech and language difficulties, deafness, and chorioretinitis have been described in individual cases. Cases of people with colpocephaly and normal neurological and motor development have also been described."},{"instruction":"What causes Colpocephaly ?","output":"What causes colpocephaly? Researchers believe that the disorder results from some kind of disturbance in the fetal environment that occurs between the second and sixth months of pregnancy. The underlying causes of colpocephaly are multiple and diverse. Causes include chromosomal anomalies such as trisomy-8 mosaicism and trisomy-9 mosaicism; intrauterine infection such as toxoplasmosis; perinatal anoxic-ischemic encephalopathy; and maternal drug ingestion during early pregnancy, such as corticosteroids, salbutamol, and theophylline. In addition, a familial occurrence of colpocephaly has been noted in three reports. A genetic origin with an autosomal recessive or X-linked recessive inheritance was suggested in these familial cases."},{"instruction":"What are the treatments for Colpocephaly ?","output":"How might colpocephaly be treated? There is no definitive treatment for colpocephaly. Anticonvulsant medications are often prescribed to prevent seizures, and doctors rely on exercise therapies and orthopedic appliances to reduce shrinkage or shortening of muscles."},{"instruction":"What is (are) Dentinogenesis imperfecta ?","output":"Dentinogenesis imperfecta is a condition that results in issues with tooth development, causing the teeth to be translucent and discolored (most often a blue-gray or yellow-brown in color). Individuals with this disorder tend to have teeth that are weaker than normal which leads to increased wear, breakage, and loss of the teeth. This can affect both primary (baby) and permanent teeth. Dentinogenesis imperfecta is caused by mutations in the DSPP gene and is inherited in an autosomal dominant manner. There are three types of dentinogenesis imperfecta. Type I: occurs in people who have osteogenesis imperfecta, a genetic condition in which bones are brittle, causing them to break easily. Type II and type III: usually occur in people without another inherited disorder. Some families with type II also have progressive hearing loss. Type III was first identified in a population in Brandywine, Maryland. Some researchers believe that dentinogenesis imperfecta type II and type III, along with a similar condition called dentin dysplasia type II, are actually just different forms of a single disorder."},{"instruction":"What causes Dentinogenesis imperfecta ?","output":"What causes dentinogenesis imperfecta? Mutations in the DSPP gene cause dentinogenesis imperfecta. The DSPP gene provides instructions for making three proteins that are essential for normal tooth development. These proteins are involved in the formation of dentin, which is a bone-like substance that makes up the protective middle layer of each tooth. DSPP mutations alter the proteins made from the gene, leading to the production of abnormally soft dentin. Teeth with defective dentin are discolored, weak, and more likely to decay and break. It is unclear how DSPP mutations are related to hearing loss in some families with dentinogenesis imperfecta type II."},{"instruction":"Dentinogenesis imperfecta inherited ?","output":"How do people inherit dentinogenesis imperfecta? Dentinogenesis imperfecta is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. In most cases, an affected person has one parent with the condition."},{"instruction":"What are the treatments for Dentinogenesis imperfecta ?","output":"How might dentinogenesis imperfecta be treated? The aims of treatment are to remove sources of infection or pain, restore aesthetics and protect posterior teeth from wear. Treatment varies according to the age of the patient, severity of the problem and the presenting complaint. Crowns, caps or other forms of dental care are the most commonly used treatments. Dentures or dental implants may be necessary if the majority of teeth are lost. More detailed information regarding the treatment of dentinogenesis imperfecta can be found by visiting the following web links: https://www.dentistry.unc.edu/dentalprofessionals/resources/defects/di/ http://www.ojrd.com/content/3/1/31"},{"instruction":"What are the symptoms of CLOVES syndrome ?","output":"What are the signs and symptoms of CLOVES syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for CLOVES syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Hemihypertrophy 100% Lipoma 75% Lower limb asymmetry 5% Renal hypoplasia/aplasia 5% Scoliosis 5% Spinal dysraphism 5% Tethered cord 5% Abnormality of cardiovascular system morphology - Cranial hyperostosis - Facial asymmetry - Overgrowth - Sandal gap - Splenomegaly - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of ITCH E3 ubiquitin ligase deficiency ?","output":"What are the signs and symptoms of ITCH E3 ubiquitin ligase deficiency? The Human Phenotype Ontology provides the following list of signs and symptoms for ITCH E3 ubiquitin ligase deficiency. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Chronic diarrhea 5% Abnormal facial shape - Autoimmunity - Autosomal recessive inheritance - Camptodactyly - Clinodactyly - Dolichocephaly - Frontal bossing - Hepatomegaly - Low-set ears - Posteriorly rotated ears - Prominent occiput - Proptosis - Relative macrocephaly - Short chin - Splenomegaly - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Glucose6phosphate dehydrogenase deficiency ?","output":"Glucose 6 phosphate dehydrogenase (G6PD) deficiency is a hereditary condition in which red blood cells break down (hemolysis) when the body is exposed to certain foods, drugs, infections or stress. This condition occurs when a person is missing or doesn't have enough glucose-6-phosphate dehydrogenase, an enzyme which helps red blood cells work properly. G6PD deficiency is more likely to occur in males, particularly African Americans, and those from certain parts of Africa, Asia, and the Mediterranean. This condition is inherited in an X-linked recessive manner and is caused by mutations in the G6PD gene. Treatment may involve medicines to treat an infection, stopping drugs that are causing red blood cell destruction, and/or transfusions, in some cases."},{"instruction":"What are the symptoms of Glucose6phosphate dehydrogenase deficiency ?","output":"What are the signs and symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency? People with G6PD deficiency do not have signs of the disease unless their red blood cells are exposed to certain chemicals in food or medicine, certain bacterial or viral infections, or to stress. Many people with this condition never experience symptoms. The most common medical problem associated with G6PD deficiency is hemolytic anemia, which occurs when red blood cells are destroyed faster than the body can replace them. This type of anemia leads to paleness, yellowing of the skin and whites of the eyes (jaundice), dark urine, fatigue, shortness of breath, enlarged spleen, and a rapid heart rate. Researchers believe that carriers of a mutation in the G6PD gene may be partially protected against malaria, an infectious disease carried by a certain type of mosquito. A reduction in the amount of functional glucose-6-dehydrogenase appears to make it more difficult for this parasite to invade red blood cells. G6PD deficiency occurs more frequently in areas of the world where malaria is common."},{"instruction":"What causes Glucose6phosphate dehydrogenase deficiency ?","output":"What causes glucose-6-phosphate dehydrogenase (G6PD) deficiency? Glucose-6-phosphate dehydrogenase (G6PD) deficiency is caused by mutations in the G6PD gene. This gene gives the body instructions to make an enzyme called G6PD, which is involved in processing carbohydrates. This enzyme also protects red blood cells from potentially harmful molecules called reactive oxygen species. Chemical reactions involving G6PD produce compounds that prevent reactive oxygen species from building up to toxic levels within red blood cells. Mutations in the G6PD gene lower the amount of G6PD or alter its structure, lessening its ability to play its protective role. As a result, reactive oxygen species can accumulate and damage red blood cells. Factors such as infections, certain drugs, or eating fava beans can increase the levels of reactive oxygen species, causing red blood cells to be destroyed faster than the body can replace them. This reduction of red blood cells causes the signs and symptoms of hemolytic anemia in people with G6PD deficiency."},{"instruction":"Glucose6phosphate dehydrogenase deficiency inherited ?","output":"How is glucose-6-phosphate dehydrogenase (G6PD) deficiency inherited? G6PD deficiency is inherited in an X-linked recessive manner. The gene associated with this condition is located on the X chromosome, which is one of the two sex chromosomes. In males (who have only one X chromosome), one changed (mutated) copy of the gene in each cell is enough to cause the condition because they don't have another X chromosome with a normal copy of the gene. In females (who have two X chromosomes), a mutation would have to occur in both copies of the gene to cause the disorder. Because it is unlikely that females will have two mutated copies of this gene, males are affected by X-linked recessive disorders much more frequently than females. Fathers cannot pass X-linked traits to their sons."},{"instruction":"What are the treatments for Glucose6phosphate dehydrogenase deficiency ?","output":"How might glucose-6-phosphate dehydrogenase (G6PD) deficiency be treated? The most important aspect of management for G6PD deficiency is to avoid agents that might trigger an attack. In cases of acute hemolytic anemia, a blood transfusion or even an exchange transfusion may be required. The G6PD Deficiency Association, which is an advocacy group that provides information and supportive resources to individuals and families affected by G6PD deficiency, provides a list of drugs and food ingredients that individuals with this condition should avoid. They also maintain a list of low risk drugs that are generally safe to take in low doses."},{"instruction":"What are the symptoms of MarinescoSjogren syndrome ?","output":"What are the signs and symptoms of Marinesco-Sjogren syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Marinesco-Sjogren syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the genital system 90% Aplasia/Hypoplasia of the cerebellum 90% Cataract 90% Cognitive impairment 90% Incoordination 90% Muscular hypotonia 90% Myopathy 90% Neurological speech impairment 90% Short stature 90% Strabismus 90% Abnormality of movement 50% Abnormality of the hip bone 50% Abnormality of the metacarpal bones 50% Brachydactyly syndrome 50% Hypertonia 50% Muscle weakness 50% Nystagmus 50% Pectus carinatum 50% Scoliosis 50% Skeletal muscle atrophy 50% Talipes 50% Microcephaly 7.5% Optic atrophy 7.5% Peripheral neuropathy 7.5% Autosomal recessive inheritance - Centrally nucleated skeletal muscle fibers - Cerebellar cortical atrophy - Congenital cataract - Coxa valga - Cubitus valgus - Dysarthria - Elevated serum creatine phosphokinase - Failure to thrive - Flexion contracture - Gait ataxia - Hypergonadotropic hypogonadism - Infantile onset - Intellectual disability - Kyphosis - Limb ataxia - Pes planus - Progressive muscle weakness - Short metacarpal - Short metatarsal - Spasticity - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Hashimoto's syndrome ?","output":"Hashimotos syndrome is a form of chronic inflammation that can damage the thyroid, reducing its ability to produce hormones (hypothyroidism). An early sign of the condition may be enlargement of the thyroid (called a goiter), which can potentially interfere with breathing or swallowing. Other signs and symptoms may include tiredness, weight gain, thin and dry hair, joint or muscle pain, constipation, cold intolerance, and/or a slowed heart rate. Affected women may have irregular menstrual periods or difficulty becoming pregnant. Hashimotos syndrome is the most common cause of hypothyroidism in the United States. It is more common in women than in men, and it usually appears in mid-adulthood. The exact cause is unknown but it is thought to result from a combination of genetic and environmental factors. Treatment is not always needed, but may include taking synthetic thyroid hormone."},{"instruction":"What are the symptoms of Hashimoto's syndrome ?","output":"What are the signs and symptoms of Hashimoto's syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Hashimoto's syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autoimmune antibody positivity - Autosomal dominant inheritance - Hashimoto thyroiditis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Hashimoto's syndrome ?","output":"What causes Hashimotos syndrome? Hashimoto's syndrome is an autoimmune disorder thought to result from a combination of genetic and environmental factors. Some of these factors have been identified, but many remain unknown. People with Hashimotos syndrome have antibodies to various thyroid antigens. The antibodies \\"attack\\" the thyroid, resulting in damage to the gland. Most of the genes associated with Hashimotos syndrome are part of a gene family called the human leukocyte antigen (HLA) complex, which helps the immune system distinguish the body's own proteins from proteins made by viruses and bacteria or other agents. However, the genetic factors have only a small effect on a person's overall risk of developing this condition. Non-genetic factors that may trigger the condition in people at risk may include changes in sex hormones (particularly in women), viral infections, certain medications, exposure to ionizing radiation, and excess consumption of iodine (a substance involved in thyroid hormone production)."},{"instruction":"Hashimoto's syndrome inherited ?","output":"Is Hashimoto's syndrome inherited? The inheritance pattern of Hashimoto's syndrome is unclear because many genetic and environmental factors appear to be involved. However, the condition can cluster in families, and having a close relative with Hashimoto's syndrome or another autoimmune disorder likely increases a person's risk of developing the condition."},{"instruction":"What are the symptoms of Keratosis follicularis dwarfism and cerebral atrophy ?","output":"What are the signs and symptoms of Keratosis follicularis dwarfism and cerebral atrophy? The Human Phenotype Ontology provides the following list of signs and symptoms for Keratosis follicularis dwarfism and cerebral atrophy. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Alopecia 90% Cerebral cortical atrophy 90% Hyperkeratosis 90% Microcephaly 90% Short stature 90% Abnormality of the eyelashes 50% Aplasia/Hypoplasia of the eyebrow 50% Absent eyebrow - Absent eyelashes - Cerebral atrophy - Death in childhood - Generalized keratosis follicularis - Severe short stature - X-linked inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of BardetBiedl syndrome 8 ?","output":"What are the signs and symptoms of Bardet-Biedl syndrome 8? The Human Phenotype Ontology provides the following list of signs and symptoms for Bardet-Biedl syndrome 8. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the kidney 95% Micropenis 88% Myopia 75% Astigmatism 63% Cataract 30% Glaucoma 22% Rod-cone dystrophy 8% Abnormality of the ovary 7.5% Hearing impairment 7.5% Macrocephaly 7.5% Vaginal atresia 7.5% Aganglionic megacolon 5% Asthma - Ataxia - Autosomal recessive inheritance - Biliary tract abnormality - Brachydactyly syndrome - Broad foot - Congenital primary aphakia - Decreased testicular size - Delayed speech and language development - Dental crowding - Diabetes mellitus - Foot polydactyly - Gait imbalance - Hepatic fibrosis - High palate - Hirsutism - Hypertension - Hypodontia - Hypogonadism - Intellectual disability - Left ventricular hypertrophy - Nephrogenic diabetes insipidus - Neurological speech impairment - Nystagmus - Obesity - Poor coordination - Postaxial hand polydactyly - Radial deviation of finger - Retinal degeneration - Short foot - Specific learning disability - Strabismus - Syndactyly - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Limbgirdle muscular dystrophy type 2H ?","output":"What are the signs and symptoms of Limb-girdle muscular dystrophy type 2H? The Human Phenotype Ontology provides the following list of signs and symptoms for Limb-girdle muscular dystrophy type 2H. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) EMG abnormality 90% Gait disturbance 90% Mask-like facies 90% Myopathy 90% Tall stature 50% Areflexia - Autosomal recessive inheritance - Calf muscle pseudohypertrophy - Centrally nucleated skeletal muscle fibers - Elevated serum creatine phosphokinase - EMG: myopathic abnormalities - Exercise-induced myalgia - Facial palsy - Gowers sign - Hyporeflexia - Increased variability in muscle fiber diameter - Muscular dystrophy - Neck flexor weakness - Pelvic girdle muscle atrophy - Pelvic girdle muscle weakness - Phenotypic variability - Quadriceps muscle weakness - Shoulder girdle muscle atrophy - Shoulder girdle muscle weakness - Slow progression - Waddling gait - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Gardner syndrome ?","output":"Gardner syndrome is a form of familial adenomatous polyposis (FAP) that is characterized by multiple colorectal polyps and various types of tumors, both benign (noncancerous) and malignant (cancerous). People affected by Gardner syndrome have a high risk of developing colorectal cancer at an early age. They are also at an increased risk of developing other FAP-related cancers, such as those of the small bowel, stomach, pancreas, thyroid, central nervous system, liver, bile ducts, and/or adrenal gland. Other signs and symptoms of Gardner syndrome include dental abnormalities; osteomas (benign bone growths); various skin abnormalities such as epidermoid cysts, fibromas (a benign tumor of the connective tissue), and lipomas; and desmoid tumors. It is caused by changes (mutations) in the APC gene and inherited in an autosomal dominant manner. Although there is no cure for Gardner syndrome, management options are available to reduce the risk of cancer. These may include high risk screening, prophylactic surgeries and/or certain types of medications."},{"instruction":"What are the symptoms of Gardner syndrome ?","output":"What are the signs and symptoms of Gardner syndrome? The signs and symptoms of Gardner syndrome vary from person to person. It is a form of familial adenomatous polyposis (FAP), which is characterized primarily by hundreds to thousands of noncancerous (benign) polyps in the colon that begin to appear at an average age of 16 years. Unless the colon is removed, these polyps will become malignant (cancerous), leading to early-onset colorectal cancer at an average age of 39 years. Other features of Gardner syndrome may include: Dental abnormalities Fundic gland or adenomatous polyps of the stomach Adenomatous polyps of the small intestines Osteomas (benign bone growths) Congenital hypertrophy of the retinal pigment epithelium (a flat, pigmented spot within the outer layer of the retina) Benign skin abnormalities such as epidermoid cysts, fibromas (a benign tumor of the connective tissue), and lipomas Adrenal masses Desmoid tumors Other types of cancer (small bowel, stomach, pancreas, thyroid, central nervous system, liver, bile ducts, and/or adrenal gland) The Human Phenotype Ontology provides the following list of signs and symptoms for Gardner syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Adenomatous colonic polyposis 90% Intestinal polyposis 90% Duodenal polyposis 50% Neoplasm of the colon 50% Colon cancer 33% Multiple gastric polyps 33% Adrenocortical adenoma 13% Carious teeth 7.5% Congenital hypertrophy of retinal pigment epithelium 7.5% Delayed eruption of teeth 7.5% Epidermoid cyst 7.5% Fibroadenoma of the breast 7.5% Increased number of teeth 7.5% Irregular hyperpigmentation 7.5% Multiple lipomas 7.5% Neoplasm of the nervous system 7.5% Odontogenic neoplasm 7.5% Osteoma 7.5% Sarcoma 7.5% Unerupted tooth 7.5% Hepatoblastoma 1.6% Medulloblastoma 1% Duodenal adenocarcinoma % Papillary thyroid carcinoma % Adrenocortical carcinoma - Astrocytoma - Autosomal dominant inheritance - Hyperpigmentation of the skin - Keloids - Odontoma - Small intestine carcinoid - Variable expressivity - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Gardner syndrome ?","output":"What causes Gardner syndrome? Gardner syndrome is caused by changes (mutations) in the APC gene, which is called a \\"tumor suppressor.\\" Tumor suppressor genes encode proteins that are part of the system that controls cell growth and division. These proteins ensure that cells do not grow and divide too quickly or in an abnormal manner. Mutations in the APC gene lead to uncontrolled cell growth which results in the development of the polyps, tumors and cancers that can be associated with Gardner syndrome. The symptoms found in each person and the severity of the condition depend on which part of the APC gene is mutated."},{"instruction":"Gardner syndrome inherited ?","output":"How is Gardner syndrome inherited? Gardner syndrome is inherited in an autosomal dominant manner. This means that to be affected, a person only needs a change (mutation) in one copy of the responsible gene in each cell. In some cases, an affected person inherits the mutation from an affected parent. Other cases may result from new (de novo) mutations in the gene. These cases occur in people with no history of the disorder in their family. A person with Gardner syndrome has a 50% chance with each pregnancy of passing along the altered gene to his or her child."},{"instruction":"w to diagnose Gardner syndrome ?","output":"Is genetic testing available for Gardner syndrome? Yes, genetic testing is available for APC, the gene known to cause Gardner syndrome. Carrier testing for at-risk relatives and prenatal testing are possible if the disease-causing mutation in the family is known. Because colon screening for those at risk for Gardner syndrome begins as early as age ten years, genetic testing is generally offered to children by this age. The Genetic Testing Registry (GTR) is a centralized online resource for information about genetic tests. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional. How is Gardner syndrome diagnosed? Gardner syndrome is diagnosed based on the following features: At least 100 colorectal polyps OR fewer than 100 polyps and a family member with Familial Adenomatous Polyposis or Gardner syndrome Osteomas (bony growths) Soft tissue tumors such as epidermoid cysts, fibromas, and desmoid tumors These symptoms are usually identified using a combination of physical examination, colonoscopy, and X-rays of the long bones and/or jaw bone. The presence of other signs and symptoms such as stomach or small intestinal polyps; congenital hypertrophy of the retinal pigment epithelium (a flat, pigmented spot within the outer layer of the retina); and/or associated cancers, supports the diagnosis. A diagnosis of Gardner syndrome can be confirmed by the identification of a disease-causing change (mutation) in the APC gene."},{"instruction":"What are the treatments for Gardner syndrome ?","output":"How might Gardner syndrome be treated? Although there is no cure for Gardner syndrome, treatment and management options are available to reduce the risk of cancer. For example, affected people typically undergo regular screening for the various polyps and tumors associated with Gardner syndrome to permit early diagnosis and treatment. This screening regimen may include: Sigmoidoscopy or colonoscopy every one to two years, beginning at age ten to 12 years. Once polyps are detected, colonoscopy is recommended annually until colectomy (removal of colon). EGD (esophagogastroduodenoscopy) beginning by age 25 and repeated every one to three years. Annual physical examination, including a thorough thyroid evaluation beginning in the late teenage years. Screening for desmoid tumors and hepatoblastoma (a specific type of liver cancer that is diagnosed in young children) may also be recommended in some people. A colectomy is usually recommended when more than 20 or 30 polyps and/or multiple advanced polyps are identified. Sulindac, a nonsteroidal anti-inflammatory drug (NSAIDs), is sometimes prescribed in people with Gardner syndrome who have had a colectomy to treat polyps in the remaining rectum. Treatment for desmoid tumors varies depending on the size and location of the tumor, but may include watchful waiting, surgery, NSAIDS, anti-estrogen medications, chemotherapy and/or radiation therapy. Osteomas (bony growths) may be removed for cosmetic reasons. Treatment of epidermoid cysts in Gardner syndrome is similar to that used for ordinary cysts and involves excision. For more information on the treatment and management of Gardner syndrome, please click here."},{"instruction":"What is (are) Apert syndrome ?","output":"Apert syndrome is a disorder mainly characterized by craniosynostosis (premature fusion of skull bones, causing abnormalities in the shape of the head and face) and syndactyly (fusion or webbing or fingers and/or toes). Other signs and symptoms may include distinctive facial features (bulging and wide-set eyes; a beaked nose; an underdeveloped upper jaw leading to crowded teeth and other dental problems; and shallow eye sockets which can cause vision problems); polydactyly; hearing loss; hyperhidrosis (increased sweating); and other symptoms. Cognitive abilities in affected individuals range from normal to mild or moderate intellectual disability. It is caused by mutations in the FGFR2 gene and is inherited in an autosomal dominant manner. Management typically includes various surgical procedures that are tailored to the affected individual's needs."},{"instruction":"What are the symptoms of Apert syndrome ?","output":"What are the signs and symptoms of Apert syndrome? Apert syndrome is characterized by the premature fusion of certain skull bones (craniosynostosis). This early fusion prevents the skull from growing normally and affects the shape of the head and face, effectively resulting in a cone or tower shaped skull. In addition, a varied number of fingers and toes are fused together (syndactyly). Many of the characteristic facial features of Apert syndrome result from the premature fusion of the skull bones. The head is unable to grow normally, which leads to a sunken appearance in the middle of the face, bulging and wide-set eyes, a beaked nose, and an underdeveloped upper jaw leading to crowded teeth and other dental problems. Shallow eye sockets can cause vision problems. Early fusion of the skull bones also affects the development of the brain, which can disrupt intellectual development. Cognitive abilities in people with Apert syndrome range from normal to mild or moderate intellectual disability. Individuals with Apert syndrome have webbed or fused fingers and toes (syndactyly). The severity of the fusion varies. Less commonly, people with this condition have extra fingers or toes (polydactyly). Additional signs and symptoms of Apert syndrome may include hearing loss, unusually heavy sweating (hyperhidrosis), oily skin with severe acne, patches of missing hair in the eyebrows, fusion of spinal bones in the neck (cervical vertebrae), and recurrent ear infections that may be associated with an opening in the roof of the mouth (a cleft palate). The Human Phenotype Ontology provides the following list of signs and symptoms for Apert syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Conductive hearing impairment 90% Depressed nasal bridge 90% Frontal bossing 90% Malar flattening 90% Proptosis 90% Toe syndactyly 90% Abnormality of the fontanelles or cranial sutures 50% Aplasia/Hypoplasia of the corpus callosum 50% Aplasia/Hypoplasia of the thumb 50% Cognitive impairment 50% Convex nasal ridge 50% Delayed eruption of teeth 50% Facial asymmetry 50% Hypertelorism 50% Hypertension 50% Mandibular prognathia 50% Strabismus 50% Vertebral segmentation defect 50% Arnold-Chiari malformation 7.5% Choanal atresia 7.5% Cleft palate 7.5% Cloverleaf skull 7.5% Corneal erosion 7.5% Ectopic anus 7.5% Hydrocephalus 7.5% Limb undergrowth 7.5% Optic atrophy 7.5% Ovarian neoplasm 7.5% Respiratory insufficiency 7.5% Sensorineural hearing impairment 7.5% Ventriculomegaly 7.5% Visual impairment 7.5% Postaxial hand polydactyly 5% Preaxial hand polydactyly 5% Absent septum pellucidum - Acne - Acrobrachycephaly - Agenesis of corpus callosum - Anomalous tracheal cartilage - Arachnoid cyst - Arnold-Chiari type I malformation - Autosomal dominant inheritance - Bifid uvula - Brachyturricephaly - Broad distal hallux - Broad distal phalanx of the thumb - Broad forehead - Cervical vertebrae fusion (C5/C6) - Choanal stenosis - Chronic otitis media - Coronal craniosynostosis - Cryptorchidism - Cutaneous finger syndactyly - Delayed cranial suture closure - Dental malocclusion - Esophageal atresia - Flat face - Growth abnormality - Hearing impairment - High forehead - Humeroradial synostosis - Hydronephrosis - Hypoplasia of midface - Intellectual disability - Large fontanelles - Limbic malformations - Megalencephaly - Narrow palate - Overriding aorta - Posterior fossa cyst - Pyloric stenosis - Shallow orbits - Synostosis of carpal bones - Vaginal atresia - Ventricular septal defect - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"w to diagnose Apert syndrome ?","output":"How is Apert syndrome diagnosed? Is genetic testing needed to confirm the diagnosis? Apert syndrome and the other conditions associated with FGFR-related craniosynostosis were clinically defined long before the molecular basis of this group of disorders was discovered. Apert syndrome can be diagnosed primarily based on the following clinical findings: Turribrachycephalic skull shape (cone-shaped or towering skull) which is observable clinically and can be confirmed by skull radiograph or head CT examination; Characteristic facial features including moderate-to-severe underdevelopment of the midface, bulging and wide-set eyes, beaked nose, underdeveloped jaw and shallow eye sockets; Variable hand and foot findings such as syndactyly of the fingers and toes and polydactyly. While clinical findings are suggestive of Apert syndrome, molecular genetic testing can help to confirm the diagnosis. Fibroblast growth factor receptor type 2 (FGFR2) sequence analysis is highly sensitive for Apert syndrome. More than 98% of cases are caused by a specific mutation in the 7th exon of the gene encoding FGFR2. The remaining cases are due to another specific mutation in or near exon 9 of FGFR2. GeneTests lists laboratories offering clinical genetic testing for this condition. Clinical genetic tests are ordered to help diagnose a person or family and to aid in decisions regarding medical care or reproductive issues. Talk to your health care provider or a genetic professional to learn more about your testing options."},{"instruction":"What is (are) Progressive transformation of germinal centers ?","output":"Progressive transformation of germinal centers is a condition in which a lymph node becomes very enlarged (lymphadenopathy). Typically, only one lymph node is affected, though PTGC can involve multiple lymph nodes. The neck is the most common location of affected lymph nodes, but PTGC may also affect lymph nodes in the groin and armpits. Adults are more frequently affected than children, but children have a higher chance of developing PTGC multiple times (recurrence). PTGC is not considered a precancerous condition, though it has been associated with Hodgkin lymphoma."},{"instruction":"What causes Progressive transformation of germinal centers ?","output":"What causes progressive transformation of germinal centers? Is it genetic? The cause of progressive transformation of germinal centers (PTGC) is currently unknown. Also, there is no evidence in the medical literature that PTGC is a genetic condition."},{"instruction":"What are the treatments for Progressive transformation of germinal centers ?","output":"What treatment is available for progressive transformation of germinal centers? Because progressive transformation of germinal centers (PTGC) is considered a benign condition and usually has no symptoms other than the enlarged lymph node, no treatment is necessary. The enlarged lymph node may stay the same size or shrink over time. Affected individuals should have regular follow-up visits with their physician; a biopsy should be taken of any new enlarged lymph node because PTGC is associated with Hodgkin lymphoma in some individuals."},{"instruction":"What is (are) Scurvy ?","output":"Scurvy is a condition that develops in people who do not consume an adequate amount of vitamin C in their diet. Although scurvy is relatively rare in the United States, it continues to be a problem in malnourished populations around the world (such as impoverished, underdeveloped third world countries). Early features of the condition include general weakness, fatigue and aching limbs. If left untreated, more serious problems can develop such as anemia, gum disease, and skin hemorrhages. Symptoms generally develop after at least 3 months of severe or total vitamin C deficiency. Treatment consists of vitamin C supplements taken by mouth."},{"instruction":"What are the symptoms of Scurvy ?","output":"What are the signs and symptoms of Scurvy? The Human Phenotype Ontology provides the following list of signs and symptoms for Scurvy. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of metabolism/homeostasis - Autosomal recessive inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Exstrophyepispadias complex ?","output":"Exstrophy-epispadias complex (EEC) comprises a spectrum of congenital abnormalities that includes epispadias, classical bladder exstrophy and exstrophy of the cloaca and several variants. EEC is characterized by a visible defect of the lower abdominal wall and other problems. The defect occurs due to a rupture of a fetal tissue known as the cloacal membrane during the first trimester of pregnancy. This results in the abnormal development of the abdominal wall of the fetus. The exact timing of the rupture determines whether the child is born with isolated epispadias, classic bladder exstrophy or cloacal exstrophy. Therefore, depending on severity, EEC may involve the urinary system, musculoskeletal system, pelvis, pelvic floor, abdominal wall, genitalia, and sometimes the spine and anus. There is no known cause for this condition. Treatment may involve several surgeries to repair the abdominal wall and any associated malformation. The University of Michigan has a webpage about the development of the embryo and its parts, including the formation of the cloaca."},{"instruction":"What are the symptoms of Cardioauditory syndrome of Sanchez Cascos ?","output":"What are the signs and symptoms of Cardioauditory syndrome of Sanchez Cascos? The Human Phenotype Ontology provides the following list of signs and symptoms for Cardioauditory syndrome of Sanchez Cascos. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal recessive inheritance - Hearing impairment - Increased dermatoglyphic whorls - Ventricular hypertrophy - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Johnson Munson syndrome ?","output":"What are the signs and symptoms of Johnson Munson syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Johnson Munson syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Adactyly 90% Split foot 90% Vertebral segmentation defect 90% Abnormality of female external genitalia 50% Abnormality of pelvic girdle bone morphology 50% Abnormality of the metacarpal bones 50% Anonychia 50% Aplasia/Hypoplasia of the lungs 50% Asymmetry of the thorax 50% Elbow dislocation 50% Finger syndactyly 50% Oligohydramnios 50% Patent ductus arteriosus 50% Renal hypoplasia/aplasia 50% Toe syndactyly 50% Vaginal fistula 50% Aphalangy of hands and feet - Aphalangy of the hands - Aplasia of the phalanges of the toes - Autosomal recessive inheritance - Hemivertebrae - Pulmonary hypoplasia - Ventricular septal defect - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Autosomal recessive axonal neuropathy with neuromyotonia ?","output":"What are the signs and symptoms of Autosomal recessive axonal neuropathy with neuromyotonia? The Human Phenotype Ontology provides the following list of signs and symptoms for Autosomal recessive axonal neuropathy with neuromyotonia. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the foot - Autosomal recessive inheritance - Elevated serum creatine phosphokinase - Fasciculations - Foot dorsiflexor weakness - Hyperhidrosis - Muscle cramps - Muscle stiffness - Myokymia - Myotonia - Progressive - Sensory axonal neuropathy - Skeletal muscle atrophy - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Omodysplasia 2 ?","output":"What are the signs and symptoms of Omodysplasia 2? The Human Phenotype Ontology provides the following list of signs and symptoms for Omodysplasia 2. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the metacarpal bones 90% Cryptorchidism 90% Elbow dislocation 90% Limb undergrowth 90% Depressed nasal bridge 50% Frontal bossing 50% Hypertelorism 50% Hypoplasia of penis 50% Long philtrum 50% Malar flattening 50% Scrotal hypoplasia 50% Short nose 50% Abnormality of female internal genitalia 7.5% Brachydactyly syndrome 7.5% Patellar dislocation 7.5% Autosomal dominant inheritance - Bifid nasal tip - Dislocated radial head - Hypoplastic distal humeri - Hypospadias - Limited elbow flexion/extension - Micropenis - Rhizomelic arm shortening - Short 1st metacarpal - Short humerus - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Barber Say syndrome ?","output":"Barber Say syndrome is a very rare condition characterized by the association of excessive hair growth (hypertrichosis), papery thin and fragile (atrophic) skin, outward turned eyelids (ectropion) and a large mouth (macrostomia). It has been described in less than 20 patients in the medical literature. Barber Say syndrome has a variable presentation, with reports of both mild and severe cases. Inheritance has been debated, with qualities suggestive of autosomal dominant and autosomal recessive. A recent study suggests that at least some cases of Barber Say syndrome are caused by dominant mutations in the TWIST2 gene. Treatment remains a challenge for both patients and doctors, and requires a multidisciplinary approach."},{"instruction":"What are the symptoms of Barber Say syndrome ?","output":"What are the signs and symptoms of Barber Say syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Barber Say syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the eyelashes 90% Anteverted nares 90% Aplasia/Hypoplasia of the eyebrow 90% Cutis laxa 90% Delayed eruption of teeth 90% Hearing abnormality 90% Hypertelorism 90% Hypertrichosis 90% Telecanthus 90% Wide mouth 90% Aplasia/Hypoplasia of the nipples 50% Breast aplasia 50% Hyperextensible skin 50% Atresia of the external auditory canal 7.5% External ear malformation 7.5% Shawl scrotum 7.5% High palate 5% Intellectual disability 5% Abnormality of female external genitalia - Abnormality of male external genitalia - Abnormality of the pinna - Autosomal dominant inheritance - Bulbous nose - Dermal atrophy - Dry skin - Ectropion - Hearing impairment - Hypoplastic nipples - Low-set ears - Mandibular prognathia - Redundant skin - Sparse eyebrow - Thin vermilion border - Underdeveloped nasal alae - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Revesz syndrome ?","output":"What are the signs and symptoms of Revesz syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Revesz syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal hair quantity 90% Abnormality of neutrophils 90% Abnormality of the nail 90% Abnormality of the oral cavity 90% Abnormality of the retinal vasculature 90% Anemia 90% Aplasia/Hypoplasia of the cerebellum 90% Fine hair 90% Intrauterine growth retardation 90% Microcephaly 90% Premature birth 90% Retinal detachment 90% Subcutaneous hemorrhage 90% Thrombocytopenia 90% Abnormality of metabolism/homeostasis - Aplastic anemia - Ataxia - Autosomal dominant inheritance - Bone marrow hypocellularity - Cerebellar hypoplasia - Cerebral calcification - Exudative retinopathy - Fine, reticulate skin pigmentation - Hypertonia - Leukocoria - Megalocornea - Nail dystrophy - Nail pits - Nystagmus - Oral leukoplakia - Progressive neurologic deterioration - Ridged fingernail - Sparse hair - Sporadic - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Scholte syndrome ?","output":"What are the signs and symptoms of Scholte syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Scholte syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal hair quantity 90% Abnormality of the genital system 90% Blepharophimosis 90% Broad forehead 90% Cognitive impairment 90% Decreased body weight 90% Deeply set eye 90% High forehead 90% Midline defect of the nose 90% Muscular hypotonia 90% Short foot 90% Short palm 90% Short philtrum 90% Skeletal muscle atrophy 90% Thin vermilion border 90% Abnormality of calvarial morphology 50% Abnormality of the antihelix 50% Abnormality of the palate 50% Delayed eruption of teeth 50% Epicanthus 50% Hyperlordosis 50% Joint hypermobility 50% Kyphosis 50% Limitation of joint mobility 50% Neurological speech impairment 50% Patellar aplasia 50% Patellar dislocation 50% Pes cavus 50% Sandal gap 50% Seizures 50% Short nose 50% Toe syndactyly 50% Truncal obesity 50% Upslanted palpebral fissure 50% Wide mouth 50% Abnormal facial shape - Abnormal joint morphology - Autosomal dominant inheritance - Early balding - Hypogonadism - Intellectual disability - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Radial hypoplasia, triphalangeal thumbs and hypospadias ?","output":"What are the signs and symptoms of Radial hypoplasia, triphalangeal thumbs and hypospadias? The Human Phenotype Ontology provides the following list of signs and symptoms for Radial hypoplasia, triphalangeal thumbs and hypospadias. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal dermatoglyphics 90% Aplasia/Hypoplasia of the radius 90% Mandibular prognathia 90% Micromelia 90% Triphalangeal thumb 90% Autosomal dominant inheritance - Diastema - Hypoplasia of the radius - Hypospadias - Nonopposable triphalangeal thumb - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Interstitial cystitis ?","output":"Interstitial cystitis (IC) is a condition that causes discomfort or pain in the bladder and abdomen. Symptoms may vary, but often include an urgent or frequent need to urinate. Many of the individuals affected by IC are women. Because IC varies so much in symptoms and severity, most researchers believe it is not one, but several diseases. In recent years, scientists have started to use the terms bladder pain syndrome (BPS) or painful bladder syndrome (PBS) to describe cases with painful urinary symptoms that may not meet the strictest definition of IC. While there is no cure for IC/PBS, in many cases, the symptoms can be managed. Treatments include dietary and lifestyle changes; distending, or inflating, the bladder; bathing the inside of the bladder with a medicine solution; oral medicines and in rare cases, surgery."},{"instruction":"What is (are) Jones syndrome ?","output":"Jones syndrome is a very rare condition characterized by gingival fibromatosis (enlargement and overgrowth of the gums) and progressive, sensorineural hearing loss. The onset of gingival fibromatosis usually occurs with the eruption of the permanent teeth. Excessive growth of the gums may cause displacement of teeth, over-retention of primary teeth, and increased spacing. Jones syndrome is inherited in an autosomal dominant manner, but the underlying genetic cause is not yet known. Only a few families with Jones syndrome have been reported."},{"instruction":"What are the symptoms of Jones syndrome ?","output":"What are the signs and symptoms of Jones syndrome? Jones syndrome is primarily characterized by gingival fibromatosis (slowly progressive enlargement of the gums) and progressive, sensorineural hearing loss. Enlargement of the gingival tissue usually begins at the time the permanent teeth are erupting, although it may occur before. Excessive growth of the gums may cause displacement of teeth, over-retention of primary teeth, increased spacing, speech problems, and painful chewing. Absence of teeth (oligodontia) and extra (supernumerary) teeth have also been reported in people with Jones syndrome. Hearing loss has been reported to begin in the second or third decade of life and is bilateral (in both ears). Overlapping of symptoms with other syndromes associated with hereditary gingival fibromatosis (HGF) has been reported, including Zimmermann-Laband syndrome and gingival fibromatosis-hypertrichosis syndrome (HGF with excessive hair growth). It has been proposed that the overlapping features reported may represent a spectrum of a single disorder, rather than separate syndromes. The Human Phenotype Ontology provides the following list of signs and symptoms for Jones syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Delayed eruption of teeth 90% Gingival overgrowth 90% Sensorineural hearing impairment 90% Autosomal dominant inheritance - Gingival fibromatosis - Progressive sensorineural hearing impairment - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Jones syndrome ?","output":"What causes Jones syndrome? The exact, underlying genetic cause of Jones syndrome is not yet known."},{"instruction":"Jones syndrome inherited ?","output":"How is Jones syndrome inherited? Jones syndrome is inherited in an autosomal dominant manner. This means that having only one changed (mutated) copy of the responsible gene in each cell is enough to cause signs or symptoms of the condition. When a person with an autosomal dominant condition has children, each child has a 50% (1 in 2) risk to inherit the mutated copy of the gene from the affected parent."},{"instruction":"What are the treatments for Jones syndrome ?","output":"How might Jones syndrome be treated? Due to the rarity of Jones syndrome, there are no treatment guidelines available in the medical literature. However, there is information about how the features associated with Jones syndrome might be treated. Treatment for gingival fibromatosis varies depending on the severity. Maintaining good oral hygiene is very important. Surgery to remove the enlarged gum tissue in the mouth (gingivectomy) may be needed for functional and/or cosmetic reasons. Enlargement may recur to various extents, and repeated surgeries may be needed to reshape the gums. It has been recommended that whenever possible, this treatment should be performed after the complete eruption of permanent teeth. The goal of treatment for sensorineural hearing loss is to improve hearing. People with sensorineural hearing loss may use hearing aids; telephone amplifiers and other assistive devices; sign language (for those with severe hearing loss); and/or speech reading (such as lip reading and using visual cues to aid communication). A cochlear implant may be recommended for some people with severe hearing loss."},{"instruction":"What are the symptoms of Orofaciodigital syndrome 8 ?","output":"What are the signs and symptoms of Orofaciodigital syndrome 8? The Human Phenotype Ontology provides the following list of signs and symptoms for Orofaciodigital syndrome 8. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of calvarial morphology 90% Abnormality of the eyelashes 90% Abnormality of the palate 90% Abnormality of the voice 90% Anteverted nares 90% Bifid tongue 90% Blepharophimosis 90% Brachydactyly syndrome 90% Camptodactyly of finger 90% Chorioretinal coloboma 90% Clinodactyly of the 5th finger 90% Cognitive impairment 90% EEG abnormality 90% Finger syndactyly 90% Hearing abnormality 90% Increased number of teeth 90% Lip pit 90% Microcephaly 90% Non-midline cleft lip 90% Nystagmus 90% Polyhydramnios 90% Postaxial hand polydactyly 90% Prominent nasal bridge 90% Short philtrum 90% Short stature 90% Synophrys 90% Tapered finger 90% Telecanthus 90% Upslanted palpebral fissure 90% Ventriculomegaly 90% Wide nasal bridge 90% Bifid nasal tip - Broad nasal tip - Cleft palate - High palate - Hypertelorism - Hypoplasia of the epiglottis - Median cleft lip - Milia - Polydactyly - Recurrent aspiration pneumonia - Short tibia - Strabismus - Syndactyly - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Nephropathic cystinosis ?","output":"Cystinosis is an inherited condition in which the body accumulates the amino acid cystine (a building block of proteins) within the cells. Excess cystine forms crystals that can build up and damage cells. These crystals can negatively affect many systems in the body, especially the kidneys and eyes. There are three distinct types of cystinosis: nephropathic cystinosis, intermediate cystinosis, and non-nephropathic or ocular cystinosis. All three types of cystinosis are caused by mutations in the CTNS gene and inherited in an autosomal recessive pattern.[1]"},{"instruction":"What are the symptoms of Nephropathic cystinosis ?","output":"What are the signs and symptoms of Nephropathic cystinosis? The Human Phenotype Ontology provides the following list of signs and symptoms for Nephropathic cystinosis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the voice - Autosomal recessive inheritance - Cerebral atrophy - Corneal crystals - Decreased plasma carnitine - Dehydration - Delayed puberty - Delayed skeletal maturation - Diabetes mellitus - Dysphagia - Elevated intracellular cystine - Episodic metabolic acidosis - Exocrine pancreatic insufficiency - Failure to thrive in infancy - Frontal bossing - Generalized aminoaciduria - Genu valgum - Glycosuria - Hepatomegaly - Hypohidrosis - Hyponatremia - Hypophosphatemic rickets - Hypopigmentation of hair - Hypopigmentation of the skin - Male infertility - Metaphyseal widening - Microscopic hematuria - Myopathy - Nephrolithiasis - Photophobia - Pigmentary retinopathy - Polydipsia - Polyuria - Primary hypothyroidism - Progressive neurologic deterioration - Proteinuria - Rachitic rosary - Recurrent corneal erosions - Reduced visual acuity - Renal Fanconi syndrome - Renal insufficiency - Retinal pigment epithelial mottling - Short stature - Skeletal muscle atrophy - Splenomegaly - Visual impairment - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Sacrococcygeal Teratoma ?","output":"A sacrococcygeal teratoma is a tumor that grows at the base of the spine in a developing fetus. It occurs in one in 40,000 newborns and girls are four times more likely to be affected than boys. Though it is usually benign, there is a possibility that the teratoma could become malignant. As such, the recommended treatment of a teratoma is complete removal of the tumor by surgery, performed soon after the birth. If not all of the tumor is removed during the initial surgery, the teratoma may grow back (recur) and additional surgeries may be needed. Studies have found that sacrococcygeal teratomas recur in up to 22% of cases."},{"instruction":"What are the treatments for Sacrococcygeal Teratoma ?","output":"How might a sacrococcygeal teratoma be treated? The treatment for sacrococcygeal teratoma (SCT) typically involves surgery to remove the tumor. Surgery occurs either in the prenatal period or shortly after delivery. The timing is dependent on the size of the tumor and the associated symptoms. To learn more about both prenatal and postnatal surgery for SCT, visit the following links from The Children's Hospital of Philadelphia (CHOP) http://www.chop.edu/treatments/fetal-surgery-sacrococcygeal-teratoma-sct/about#.VqGW_PkrJD8 http://www.chop.edu/treatments/postnatal-surgery-sacrococcygeal-teratoma-sct#.VqGX7vkrJD8"},{"instruction":"What are the symptoms of Chang Davidson Carlson syndrome ?","output":"What are the signs and symptoms of Chang Davidson Carlson syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Chang Davidson Carlson syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the kidney 95% Abnormality of retinal pigmentation 90% Abnormality of the genital system 90% Anterior hypopituitarism 90% Micropenis 88% Myopia 75% Astigmatism 63% Cataract 30% Glaucoma 22% Rod-cone dystrophy 8% Abnormality of the ovary 7.5% Hearing impairment 7.5% Macrocephaly 7.5% Vaginal atresia 7.5% Aganglionic megacolon 5% Asthma - Ataxia - Autosomal recessive inheritance - Biliary tract abnormality - Brachydactyly syndrome - Broad foot - Congenital primary aphakia - Decreased testicular size - Delayed speech and language development - Dental crowding - Diabetes mellitus - Foot polydactyly - Gait imbalance - Hepatic fibrosis - High palate - Hirsutism - Hypertension - Hypodontia - Hypogonadism - Intellectual disability - Left ventricular hypertrophy - Nephrogenic diabetes insipidus - Neurological speech impairment - Nystagmus - Obesity - Poor coordination - Postaxial hand polydactyly - Radial deviation of finger - Retinal degeneration - Short foot - Specific learning disability - Strabismus - Syndactyly - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Microphthalmia syndromic 7 ?","output":"What are the signs and symptoms of Microphthalmia syndromic 7? The Human Phenotype Ontology provides the following list of signs and symptoms for Microphthalmia syndromic 7. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Aplasia/Hypoplasia affecting the eye 90% Aplasia/Hypoplasia of the skin 90% Congenital diaphragmatic hernia 90% Irregular hyperpigmentation 90% Malar flattening 90% Opacification of the corneal stroma 90% Sclerocornea 90% Abnormal facial shape 50% Abnormality of retinal pigmentation 50% Abnormality of the cardiac septa 50% Abnormality of the nose 50% Abnormality of the vitreous humor 50% Arrhythmia 50% Hypertrophic cardiomyopathy 50% Hypopigmented skin patches 50% Short stature 50% Intellectual disability, progressive 24% Abnormality of dental enamel 7.5% Abnormality of female internal genitalia 7.5% Abnormality of the gastrointestinal tract 7.5% Abnormality of the mitral valve 7.5% Abnormality of the nail 7.5% Abnormality of the testis 7.5% Abnormality of the tricuspid valve 7.5% Anterior creases of earlobe 7.5% Aplasia/Hypoplasia of the corpus callosum 7.5% Chorioretinal abnormality 7.5% Cognitive impairment 7.5% Displacement of the external urethral meatus 7.5% Female pseudohermaphroditism 7.5% Glaucoma 7.5% Hearing impairment 7.5% Hydrocephalus 7.5% Male pseudohermaphroditism 7.5% Microcephaly 7.5% Neurological speech impairment 7.5% Posterior embryotoxon 7.5% Respiratory insufficiency 7.5% Sacral dimple 7.5% Seizures 7.5% Visual impairment 7.5% Abnormality of metabolism/homeostasis - Absent septum pellucidum - Agenesis of corpus callosum - Anal atresia - Anteriorly placed anus - Asymmetric, linear skin defects - Atria septal defect - Cataract - Chordee - Clitoral hypertrophy - Colpocephaly - Hypoplasia of the uterus - Hypospadias - Iris coloboma - Micropenis - Microphthalmia - Oncocytic cardiomyopathy - Overriding aorta - Ovotestis - Pigmentary retinopathy - Ventricular septal defect - X-linked dominant inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Polycystic ovarian syndrome ?","output":"Polycystic ovarian syndrome (PCOS) is a health problem that can affect a woman's menstrual cycle, ability to have children, hormones, heart, blood vessels, and appearance. Women with this condition typically have high levels of hormones called androgens, missed or irregular periods, and many small cysts in their ovaries. The cause of PCOS is unknown, but probably involves a combination of genetic and environmental factors. Treatment for PCOS may involve birth control pills and medications for diabetes and infertility. Medicines called anti-androgens are also used to speed the growth of hair and clear acne."},{"instruction":"What are the symptoms of Polycystic ovarian syndrome ?","output":"What are the signs and symptoms of Polycystic ovarian syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Polycystic ovarian syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of metabolism/homeostasis - Amenorrhea - Autosomal dominant inheritance - Enlarged polycystic ovaries - Hirsutism - Obesity - Oligomenorrhea - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Acanthoma ?","output":"An acanthoma is a small, reddish bump that usually develops on the skin of an older adult. There are several types of acanthoma, including \\"acantholytic\\", \\"epidermolytic\\", \\"clear cell\\", and \\"melanoacanthoma\\". Though most individuals have only one acanthoma, there have been rare reports of individuals who have developed many. The exact cause of acanthoma is not known; it is sometimes called a benign tumor, and sometimes described as the result of inflammation. Acanthomas are not considered dangerous and do not require treatment, but they may be removed for cosmetic reasons or to relieve any associated symptoms."},{"instruction":"What are the treatments for Acanthoma ?","output":"How might an acanthoma be treated? Acanthomas are considered benign, but treatment may be done for cosmetic reasons or to relieve any associated symptoms. Because acanthomas are quite rare, there are no established guidelines for treatment. Treatment may depend on the type, number, and location of acanthomas. For example, a single acanthoma may be removed by surgery, whereas multiple acanthomas may be treated with cryosurgery or the use of the medication fluorouracil cream."},{"instruction":"What are the symptoms of Negative rheumatoid factor polyarthritis ?","output":"What are the signs and symptoms of Negative rheumatoid factor polyarthritis? The Human Phenotype Ontology provides the following list of signs and symptoms for Negative rheumatoid factor polyarthritis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autoimmune antibody positivity - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Progressive myoclonic epilepsy ?","output":"Progressive myoclonus epilepsy (PME) refers to a group of inherited conditions involving the central nervous system and representing more than a dozen different diseases. These diseases share certain features, including a worsening of symptoms over time and the presence of both muscle contractions (myoclonus) and seizures (epilepsy). PME is different from myoclonic epilepsy. Other features include dementia, dystonia, and trouble walking or speaking. These rare disorders often get worse over time and sometimes are fatal. Many of these PME diseases begin in childhood or adolescence."},{"instruction":"What is (are) Children's interstitial lung disease ?","output":"Children's interstitial and diffuse lung disease (chILD) is not a single condition, but a group of rare lung diseases found in infants, children and adolescents that can range from mild to severe. All types of chILD decrease a child's ability to supply oxygen to their body. These diseases make it difficult for the lungs to exchange oxygen and carbon dioxide and can cause fluid and other materials to collect in the lungs. Early diagnosis and treatment is important for any type of chILD. See the Children's Interstitial Lung Disease Foundation to see a list of different ILDs and to find more information about diagnosis, treatment and help finding a specialist."},{"instruction":"What are the treatments for Children's interstitial lung disease ?","output":"How might chILD be treated? There is no single treatment for interstitial lung diseases in children. Different forms of chILD require different treatments and support depending on the condition. The goals of treatment for chILD is to relieve symptoms, provide support to maximize growth and development, and to prevent exposure to preventable illnesses that could make the chILD worse. See the Children's Interstitial and Diffuse Lung Disease Foundation for more detailed information about treatment."},{"instruction":"What is (are) Richter syndrome ?","output":"Richter syndrome is a rare condition in which chronic lymphocytic leukemia (CLL) changes into a fast-growing type of lymphoma. Symptoms of Richter syndrome can include fever, loss of weight and muscle mass, abdominal pain, and enlargement of the lymph nodes, liver, and spleen. Laboratory results may show anemia and low platelet counts (which can lead to easy bleeding and bruising)."},{"instruction":"What are the treatments for Richter syndrome ?","output":"Are there any recent advancements in the treatment of Richter syndrome? Monoclonal antibodies (MABs) are a type of biological therapy. They are man-made proteins that target specific proteins on cancer cells. MABs are a fairly new treatment for cancer. Doctors often use the MAB drug called rituximab along with chemotherapy and steroids to treat Richter syndrome. Researchers in a trial called the CHOP-OR study are studying whether a new biological therapy similar to rituximab can make CHOP chemotherapy work better. The new biological therapy drug is called ofatumumab (Arzerra). People who have been recently diagnosed with Richter syndrome can participate in this study. The study has two parts. First, patients have ofatumumab with CHOP chemotherapy to eliminate the lymphoma (this is called induction treatment). They then have more ofatumumab on its own to try to stop the lymphoma from coming back (this is called maintenance treatment). CLICK HERE to learn more about this study. Stem cell transplant is another way of treating Richter syndrome. While only a few people have undergone stem cell transplant for treatment of this disease, so far it has appeared to work quite well. The disease was controlled for longer than in people having normal dose chemotherapy. However, because stem cell transplants have serious side effects and complications, they are only suitable for a small group of people. More research is needed before we can truly find out how well stem cell treatment works for people with Richter syndrome. A recent study showed that a chemotherapy regimen called OFAR (a combination of oxaliplatin, fludarabine, cytarabine, and rituximab) had significant antileukemic activity in patients with Richter syndrome and relapsed/refractory CLL. Patients who underwent stem cell therapy as post-remission therapy had even more favorable outcomes."},{"instruction":"What is (are) Stenotrophomonas maltophilia infection ?","output":"Stenotrophomonas maltophilia (S. maltophilia) infection is a healthcare-associated bacterial infection caused by S. maltophilia bacteria. These bacteria typically colonize (live in or on) areas of the body without causing infection. However, people who are hospitalized and receiving treatment for other conditions may be susceptible to infection, especially those with severely impaired immune systems. Factors that increase the risk for S. maltophilia infection include admission to an intensive care unit, prolonged hospitalization, HIV infection, cancer, cystic fibrosis, neutropenia, recent surgery, trauma, mechanical ventilation, and previous therapy with broad-spectrum antibiotics (medications that target a wide range of bacteria). S. maltophilia bacteria are resistant to many types of antibiotics; however, most strains can be treated with trimethoprim-sulfamethoxazole treatment."},{"instruction":"What are the symptoms of Stenotrophomonas maltophilia infection ?","output":"What are the signs and symptoms of Stenotrophomonas maltophilia infection? S. maltophilia bacteria usually colonize (live in or on) areas of the body without causing infection. In these cases, people have no signs or symptoms of a bacterial infection. When present, the features of Stenotrophomonas maltophilia (S. maltophilia) infections are generally related to the organ system(s) involved. The most common manifestations are pneumonia and bacteremia. Less commonly, people infected by S. maltophilia may experience endocarditis, mastoiditis, peritonitis, meningitis, soft tissue infections, wound infections, urinary tract infections, and/or eye infections."},{"instruction":"What causes Stenotrophomonas maltophilia infection ?","output":"What causes Stenotrophomonas maltophilia infection? Stenotrophomonas maltophilia (S. maltophilia) infections are caused by the S. maltophilia bacteria. These bacteria live in various aquatic (water-based) environments. In a hospital setting, they are able to survive and multiply in fluids such as respiratory secretions, urine, and intravenous (IV) fluids. Most healthy people do not get S. maltophilia infections. However, people who are hospitalized and receiving treatment for other conditions may be susceptible to these infections, especially those with severely impaired immune systems. Factors that increase the risk for S. maltophilia infection include admission to an intensive care unit, prolonged hospitalization, HIV infection, cancer, cystic fibrosis, neutropenia, recent surgery, trauma, mechanical ventilation, and previous therapy with broad-spectrum antibiotics (medications that target a wide range of bacteria)."},{"instruction":"w to diagnose Stenotrophomonas maltophilia infection ?","output":"How is Stenotrophomonas maltophilia infection diagnosed? Stenotrophomonas maltophilia (S. maltophilia) infection is usually diagnosed by examining a small sample of blood, mucus, and/or urine. When an infection is suspected, possible sites of infection including wounds, intravenous (vein) catheters, urinary catheters, and breathing machines should also be tested for the presence of S. maltophilia bacteria."},{"instruction":"What are the treatments for Stenotrophomonas maltophilia infection ?","output":"How might Stenotrophomonas maltophilia infection be treated? Stenotrophomonas maltophilia (S. maltophilia) bacteria are usually resistant to many antibiotics. The recommended therapy is trimethoprim-sulfamethoxazole (also called co-trimoxazole, or TMP-SMX). If this medication can not be used, a variety of other antibiotics may be considered. Combination therapy may be necessary in life-threatening cases. The duration of therapy largely depends on the site of infection. More detailed information about medications used to treat S. maltophilia infection is available in Medscape Reference and can be viewed by clicking here. This information is intended for informational purposes only. People seeking treatment for S. maltophilia infection should consult with their health care provider."},{"instruction":"What is (are) Tarsal carpal coalition syndrome ?","output":"Tarsal carpal coalition syndrome is a genetic condition characterized by fusion of the bones in the wrist (carpals), feet (tarsals), and the fingers and toes (phalanges). Other bone abnormalities in the hands and feet may be present. Approximately 10 affected families have been described. Tarsal carpal coalition syndrome is caused by mutations in the NOD gene, and it is inherited in an autosomal dominant pattern."},{"instruction":"What are the symptoms of Tarsal carpal coalition syndrome ?","output":"What are the signs and symptoms of Tarsal carpal coalition syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Tarsal carpal coalition syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the ankles 90% Short stature 90% Tarsal synostosis 90% Carpal synostosis 75% Proximal symphalangism (hands) 75% Radial deviation of finger 75% Short 1st metacarpal 75% Cubitus valgus 7.5% Distal symphalangism (hands) 7.5% Humeroradial synostosis 7.5% Autosomal dominant inheritance - Brachydactyly syndrome - Clinodactyly - Progressive fusion 2nd-5th pip joints - Short finger - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Testicular cancer ?","output":"What are the signs and symptoms of Testicular cancer? The Human Phenotype Ontology provides the following list of signs and symptoms for Testicular cancer. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of metabolism/homeostasis - Cryptorchidism - Gonadal dysgenesis - Sporadic - Teratoma - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Maple syrup urine disease type 1B ?","output":"What are the signs and symptoms of Maple syrup urine disease type 1B? The Human Phenotype Ontology provides the following list of signs and symptoms for Maple syrup urine disease type 1B. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Ataxia - Autosomal recessive inheritance - Cerebral edema - Coma - Elevated plasma branched chain amino acids - Feeding difficulties in infancy - Growth abnormality - Hypertonia - Hypoglycemia - Intellectual disability - Ketosis - Lactic acidosis - Lethargy - Vomiting - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Achondrogenesis type 1A ?","output":"Achondrogenesis is a group of severe disorders that are present from birth and affect the development of cartilage and bone. Infants with achondrogenesis usually have a small body, short arms and legs, and other skeletal abnormalities that cause life-threatening complications. There are at least three forms of achondrogenesis, type 1A, type 1B and type 2, which are distinguished by signs and symptoms, pattern of inheritance, and the results of imaging studies such as x-rays (radiology), tissue analysis (histology), and genetic testing. Type 1A and 1B achondrogenesis are both inherited in an autosomal recessive pattern. Type 1B may be caused by mutations in the SLC26A2 gene. Type 2 achondrogenesis is inherited in an autosomal dominant pattern and is caused by new (de novo) mutations in the COL2A1 gene."},{"instruction":"What are the symptoms of Achondrogenesis type 1A ?","output":"What are the signs and symptoms of Achondrogenesis type 1A? The Human Phenotype Ontology provides the following list of signs and symptoms for Achondrogenesis type 1A. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of bone mineral density 90% Anteverted nares 90% Aplasia/Hypoplasia of the lungs 90% Frontal bossing 90% Hydrops fetalis 90% Long philtrum 90% Macrocephaly 90% Malar flattening 90% Micromelia 90% Narrow chest 90% Short neck 90% Short nose 90% Short thorax 90% Skeletal dysplasia 90% Thickened nuchal skin fold 90% Brachydactyly syndrome 50% Polyhydramnios 50% Recurrent fractures 50% Short toe 50% Umbilical hernia 50% Cystic hygroma 7.5% Abnormal foot bone ossification - Abnormal hand bone ossification - Abnormality of the femoral metaphysis - Autosomal recessive inheritance - Barrel-shaped chest - Beaded ribs - Broad clavicles - Decreased skull ossification - Depressed nasal bridge - Disproportionate short-trunk short stature - Hypoplasia of the radius - Hypoplastic ischia - Hypoplastic scapulae - Protuberant abdomen - Short clavicles - Short ribs - Stillbirth - Unossified vertebral bodies - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Papillary thyroid carcinoma ?","output":"What are the signs and symptoms of Papillary thyroid carcinoma? The Human Phenotype Ontology provides the following list of signs and symptoms for Papillary thyroid carcinoma. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal dominant inheritance - Papillary thyroid carcinoma - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Fallopian tube cancer ?","output":"Fallopian tube cancer develops in the tubes that connect a woman's ovaries and uterus. It is very rare and accounts for only 1-2% of all gynecologic cancers. Fallopian tube cancer occurs when normal cells in one or both tubes change and grow in an uncontrolled way, forming a mass called a tumor. Cancer can begin in any of the different cell types that make up the fallopian tubes. The most common type is called adenocarcinoma (a cancer of cells from glands). Leiomyosarcoma (a cancer of smooth muscle cells) and transitional cell carcinoma (a cancer of the cells lining the fallopian tubes) are more rare. While some fallopian tube cancers actually begin in the tubes themselves, fallopian tube cancer is more often the result of cancer spreading from other parts of the body to the tubes. For example, the fallopian tubes are a common site of metastasis (spread) of cancers that started in the ovaries, uterus, endometrium, (the tissue lining the uterus) appendix, or colon. Women with fallopian tube cancer may experience symptoms, although some affected women may have no symptoms at all. The signs of fallopian tube cancer are often non-specific, meaning that they can also be signs of other medical conditions that are not cancer. Signs and symptoms of fallopian tube cancer can include: irregular or heavy vaginal bleeding (especially after menopause); occasional abdominal or pelvic pain or feeling of pressure; vaginal discharge that may be clear, white, or tinged with blood; and a pelvic mass or lump. Doctors use many tests to diagnose cancer of the fallopian tubes. Some of these tests may include: pelvic examination, transvaginal ultrasound, a blood test that measures the tumor marker CA-125, computed tomography (CT or CAT) scan, and magnetic resonance imaging (MRI). Fallopian tube cancer can be best treated when detected early. If the cancer has spread to the walls of the tubes or outside of the tubes, then there is a lower chance that the disease can be treated successfully. The stage of the cancer determines the type of treatment needed. Most women will need surgery and some will go on to have chemotherapy and/or radiation therapy. [1] [2]"},{"instruction":"What is (are) Severe combined immunodeficiency ?","output":"Severe combined immunodeficiencies (SCID) are inherited immune system disorders characterized by abnormalities with responses of both T cells and B cells (specific types of white blood cells needed for immune system function). Common signs and symptoms include an increased susceptibility to infections including ear infections; pneumonia or bronchitis; oral thrush; and diarrhea. Due to recurrent infections, affected children do not grow and gain weight as expected (failure to thrive). SCID may be caused by mutations in any of several genes and can be inherited in an X-linked recessive (most commonly) or autosomal recessive manner. The most effective treatment is transplantation of blood-forming stem cells from the bone marrow of a healthy person. Without treatment, affected children rarely live past the age of two."},{"instruction":"Severe combined immunodeficiency inherited ?","output":"How is severe combined immunodeficiency inherited? Severe combined immunodeficiency (SCID) can be inherited in an X-linked recessive or autosomal recessive manner depending on the genetic cause of the condition. X-linked SCID is the most common type of SCID and is inherited in an X-linked recessive manner. A condition is X-linked if the changed (mutated) gene responsible for the condition is located on the X chromosome. The X chromosome is one of the two sex chromosomes; females have two X chromosomes and males have one X chromosome and one Y chromosome. In males, one mutated copy of the responsible gene causes signs and symptoms of the condition because they don't have another X chromosome with a working copy of the gene. In females, having one mutated copy of the gene would make them an unaffected carrier; a mutation would have to occur in both copies of the gene to cause the condition. This is why X-linked recessive disorders, including X-linked SCID, occur much more frequently in males. Because fathers only pass their Y chromosome on to their sons, fathers cannot pass X-linked conditions on to their sons. The other, less common causes of SCID are inherited in an autosomal recessive manner. These types are due to mutations in responsible genes on other chromosomes (not the sex chromosomes). In autosomal recessive conditions, a person must have mutations in both copies of the responsible gene in order to have signs or symptoms of the condition. In most cases, the affected person inherits one mutated copy of the gene from each of the parents, who are typically unaffected carriers."},{"instruction":"w to diagnose Severe combined immunodeficiency ?","output":"How is severe combined immunodeficiency (SCID) diagnosed? A diagnosis of severe combined immunodeficiency (SCID) may be suspected if a baby shows any of the following persistent symptoms within the first year of life: Eight or more ear infections Two or more cases of pneumonia Infections that do not resolve with antibiotic treatment for two or more months Failure to gain weight or grow normally Infections that require intravenous antibiotic treatment Deep-seated infections, such as pneumonia that affects an entire lung or an abscess in the liver Persistent thrush in the mouth or throat A family history of immune deficiency or infant deaths due to infections Diagnosis can be confirmed by blood tests. Blood tests show significantly lower-than-normal levels of T cells and antibodies. For further details on diagnosis see the following Web pages: The Primary Immunodeficiency Resource Center provides further details regarding diagnosis of SCID. Click on the embedded link to view the page. An article from Medscape Reference provides detailed information on the diagnosis of SCID. Click on eMedicine Journal to view the page. You may need to register to view the article, but registration is free."},{"instruction":"What are the symptoms of Scheie syndrome ?","output":"What are the signs and symptoms of Scheie syndrome ? The Human Phenotype Ontology provides the following list of signs and symptoms for Scheie syndrome . If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the aortic valve 90% Cerebral palsy 90% Decreased nerve conduction velocity 90% Glaucoma 90% Limitation of joint mobility 90% Mucopolysacchariduria 90% Opacification of the corneal stroma 90% Coarse facial features 50% Hepatomegaly 50% Splenomegaly 50% Thick lower lip vermilion 50% Hemiplegia/hemiparesis 7.5% Hypertonia 7.5% Sensorineural hearing impairment 7.5% Sinusitis 7.5% Wide mouth 7.5% Retinal degeneration 5% Aortic regurgitation - Aortic valve stenosis - Autosomal recessive inheritance - Broad face - Corneal opacity - Depressed nasal bridge - Full cheeks - Genu valgum - Mandibular prognathia - Obstructive sleep apnea - Pes cavus - Short neck - Wide nose - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Juvenile idiopathic arthritis ?","output":"What are the signs and symptoms of Juvenile idiopathic arthritis? The Human Phenotype Ontology provides the following list of signs and symptoms for Juvenile idiopathic arthritis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of temperature regulation 90% Arthralgia 90% Arthritis 90% Autoimmunity 90% Joint swelling 90% Skin rash 90% Mediastinal lymphadenopathy 50% Abdominal pain 7.5% Abnormality of the pericardium 7.5% Abnormality of the pleura 7.5% Hepatomegaly 7.5% Splenomegaly 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial ?","output":"What are the signs and symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial? The Human Phenotype Ontology provides the following list of signs and symptoms for Infantile convulsions and paroxysmal choreoathetosis, familial. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Chorea 90% EEG abnormality 90% Seizures 90% Incoordination 50% Migraine 50% Stereotypic behavior 7.5% Anxiety - Autosomal dominant inheritance - Focal seizures, afebril - Generalized seizures - Normal interictal EEG - Paroxysmal choreoathetosis - Paroxysmal dystonia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Epidermolysis bullosa, lethal acantholytic ?","output":"What are the signs and symptoms of Epidermolysis bullosa, lethal acantholytic? The Human Phenotype Ontology provides the following list of signs and symptoms for Epidermolysis bullosa, lethal acantholytic. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal blistering of the skin 90% Advanced eruption of teeth 90% Alopecia 90% Anonychia 90% Skin ulcer 90% Abnormality of the gastric mucosa 7.5% Hypertrophic cardiomyopathy 7.5% Acantholysis - Autosomal recessive inheritance - Mitten deformity - Natal tooth - Neonatal death - Phimosis - Sandal gap - Skin erosion - Tapered distal phalanges of finger - Widely spaced toes - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Cholestasis, progressive familial intrahepatic 4 ?","output":"What are the signs and symptoms of Cholestasis, progressive familial intrahepatic 4? The Human Phenotype Ontology provides the following list of signs and symptoms for Cholestasis, progressive familial intrahepatic 4. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Elevated hepatic transaminases 90% Hepatomegaly 90% Abnormality of coagulation 50% Gastrointestinal hemorrhage 50% Splenomegaly 50% Cirrhosis 7.5% Nyctalopia 7.5% Peripheral neuropathy 7.5% Pruritus 7.5% Reduced bone mineral density 7.5% Abnormality of the coagulation cascade - Acholic stools - Autosomal recessive inheritance - Diarrhea - Failure to thrive - Giant cell hepatitis - Hepatic failure - Hyperbilirubinemia - Hypocholesterolemia - Intrahepatic cholestasis - Jaundice - Neonatal onset - Steatorrhea - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Refsum disease, infantile form ?","output":"Infantile Refsum disease is the mildest of a group of disorders known as peroxisome biogenesis disorders, Zellweger syndrome spectrum (PBD-ZSS). PBD-ZSS is a group of inherited genetic disorders that damage the white matter of the brain and affect motor movements. Peroxisome biogenesis disorders, in turn, are part of a larger group of disorders called leukodystrophies. IRD can cause low muscle tone (hypotonia), retinitis pigmentosa (a visual impairment that can lead to blindness), developmental delay, sensorineural hearing loss, and liver dysfunction. IRD usually presents at birth or in infancy. Most individuals with IRD can achieve motor milestones, though they may be delayed, and most individuals can communicate with a few words or signs. Leukodystrophy with loss of acquired skills can occur at any age and may stabilize or progress. Peroxisome biogenesis disorders are caused by mutations in one of the PEX genes and are inherited in an autosomal recessive manner. Life expectancy, medical complications, and the degree of neurological impairment can vary. Survival into adulthood is possible. Adult Refsum disease and infantile refsum disease are separate disorders caused by different genetic defects."},{"instruction":"What are the symptoms of Refsum disease, infantile form ?","output":"What are the signs and symptoms of Refsum disease, infantile form? The Human Phenotype Ontology provides the following list of signs and symptoms for Refsum disease, infantile form. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of metabolism/homeostasis 90% Abnormality of retinal pigmentation 90% Cognitive impairment 90% Hepatomegaly 90% Nyctalopia 90% Short stature 90% Skeletal muscle atrophy 90% Visual impairment 90% Behavioral abnormality 50% Hypertonia 50% Incoordination 50% Muscular hypotonia 50% Nystagmus 50% Sensorineural hearing impairment 50% Abnormality of epiphysis morphology 7.5% Arrhythmia 7.5% Cataract 7.5% Facial palsy 7.5% Hypertrophic cardiomyopathy 7.5% Ichthyosis 7.5% Optic atrophy 7.5% Seizures 7.5% Abnormal bleeding - Abnormal electroretinogram - Abnormal facial shape - Autosomal recessive inheritance - Congenital onset - Depressed nasal ridge - Failure to thrive - Flat face - Hypocholesterolemia - Hyporeflexia - Intellectual disability - Malar flattening - Osteoporosis - Polyneuropathy - Rod-cone dystrophy - Single transverse palmar crease - Steatorrhea - Very long chain fatty acid accumulation - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Premature aging Okamoto type ?","output":"What are the signs and symptoms of Premature aging Okamoto type? The Human Phenotype Ontology provides the following list of signs and symptoms for Premature aging Okamoto type. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of blood and blood-forming tissues - Abnormality of the hair - Abnormality of the pinna - Cataract - Depressed nasal bridge - Diabetes mellitus - Growth abnormality - Low-set ears - Microcephaly - Neoplasm - Osteoporosis - Osteosarcoma - Round face - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Pili torti onychodysplasia ?","output":"What are the signs and symptoms of Pili torti onychodysplasia? The Human Phenotype Ontology provides the following list of signs and symptoms for Pili torti onychodysplasia. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Sparse body hair 5% Absent eyebrow - Absent eyelashes - Alopecia - Autosomal dominant inheritance - Autosomal recessive inheritance - Brittle hair - Congenital onychodystrophy - Hair-nail ectodermal dysplasia - Nail dystrophy - Onycholysis - Pili torti - Temporal hypotrichosis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Wellesley Carmen French syndrome ?","output":"What are the signs and symptoms of Wellesley Carmen French syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Wellesley Carmen French syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the oral cavity 50% Cataract 50% Cavernous hemangioma 50% Epicanthus 50% Hypermetropia 50% Low-set, posteriorly rotated ears 50% Ptosis 50% Short stature 50% Umbilical hernia 50% Accessory oral frenulum - Anteverted nares - Autosomal dominant inheritance - Blepharophimosis - Curly hair - Posterior polar cataract - Posteriorly rotated ears - Short nose - Short palpebral fissure - Upslanted palpebral fissure - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Craniometaphyseal dysplasia, autosomal dominant ?","output":"Autosomal dominant craniometaphyseal dysplasia is a genetic skeletal condition characterized by progressive thickening of bones in the skull (cranium) and abnormalities at the ends of long bones in the limbs (metaphyseal dysplasia). The overgrowth of bones in the head can lead to distinctive facial features and delayed tooth eruption, as well as compression of the cranial nerves. If untreated, compression of the cranial nerves can be disabling. The condition is caused by mutations in the ANKH gene. As the name suggests, it is inherited in an autosomal dominant manner. Treatment may include surgery to reduce compression of cranial nerves and recontouring of the facial bones."},{"instruction":"What are the symptoms of Craniometaphyseal dysplasia, autosomal dominant ?","output":"What are the signs and symptoms of Craniometaphyseal dysplasia, autosomal dominant? Bone overgrowth in the head causes many of the signs and symptoms of craniometaphyseal dysplasia. Affected individuals typically have distinctive facial features such as a wide nasal bridge, a prominent forehead, wide-set eyes (hypertelorism), and a prominent jaw. Excessive new bone formation (hyperostosis) in the jaw can delay teething (dentition) or result in absent teeth. Infants with this condition may have breathing or feeding problems caused by narrow nasal passages. In severe cases, abnormal bone growth can compress the nerves that emerge from the brain and extend to various areas of the head and neck (cranial nerves). Compression of the cranial nerves can lead to paralyzed facial muscles (facial nerve palsy), blindness, or deafness. The x-rays of individuals with craniometaphyseal dysplasia show unusually shaped long bones, particularly the large bones in the legs. The ends of these bones (metaphyses) are wider and appear less dense in people with this condition. The symptoms seen in autosomal recessive craniometaphyseal dysplasia are typically more severe than those seen in the autosomal dominant form. The Human Phenotype Ontology provides the following list of signs and symptoms for Craniometaphyseal dysplasia, autosomal dominant. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the metaphyses 90% Craniofacial hyperostosis 90% Depressed nasal bridge 90% Hypertelorism 90% Increased bone mineral density 90% Wide nasal bridge 90% Skeletal dysplasia 50% Telecanthus 50% Conductive hearing impairment 7.5% Facial palsy 7.5% Sensorineural hearing impairment 7.5% Visual impairment 7.5% Abnormality of pelvic girdle bone morphology - Abnormality of the nasopharynx - Abnormality of the vertebral column - Autosomal dominant inheritance - Bony paranasal bossing - Calvarial osteosclerosis - Club-shaped distal femur - Erlenmeyer flask deformity of the femurs - Macrocephaly - Mandibular prognathia - Metaphyseal widening - Misalignment of teeth - Mixed hearing impairment - Nasal obstruction - Sclerosis of skull base - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Craniometaphyseal dysplasia, autosomal dominant ?","output":"What causes autosomal dominant craniometaphyseal dysplasia? Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the ANKH gene. The ANKH gene provides instructions for making a protein that is present in bone and transports a molecule called pyrophosphate out of cells. Pyrophosphate helps regulate bone formation by preventing mineralization, the process by which minerals such as calcium and phosphorus are deposited in developing bones. The ANKH protein may have other, unknown functions. Mutations in the ANKH gene that cause autosomal dominant craniometaphyseal dysplasia may decrease the ANKH protein's ability to transport pyrophosphate out of cells. Reduced levels of pyrophosphate can increase bone mineralization, contributing to the bone overgrowth seen in craniometaphyseal dysplasia. Why long bones are shaped differently and only the skull bones become thicker in people with this condition remains unclear."},{"instruction":"Craniometaphyseal dysplasia, autosomal dominant inherited ?","output":"How is autosomal dominant craniometaphyseal dysplasia inherited? Autosomal dominant craniometaphyseal dysplasia is inherited in an autosomal dominant pattern, which means one altered copy of the ANKH gene in each cell is sufficient to cause the disorder. Individuals with autosomal dominant craniometaphyseal dysplasia typically have one parent who also has the condition. Less often, cases result from new mutations in the gene and occur in people with no history of the disorder in their family."},{"instruction":"What are the treatments for Craniometaphyseal dysplasia, autosomal dominant ?","output":"How might craniometaphyseal dysplasia be treated? Treatment consists primarily of surgery to reduce compression of cranial nerves and the brain stem/spinal cord at the level of the foramen magnum. Severely overgrown facial bones can be contoured; however, surgical procedures can be technically difficult and bone regrowth is common. Individuals with craniometaphyseal dysplasia should have regular neurologic evaluations, hearing assessments, and ophthalmologic examinations. The frequency of these evaluations and assessments should be determined by the individual's history and severity of skeletal changes."},{"instruction":"What are the symptoms of Dennis Fairhurst Moore syndrome ?","output":"What are the signs and symptoms of Dennis Fairhurst Moore syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Dennis Fairhurst Moore syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the clavicle 90% Abnormality of the ribs 90% Alopecia 90% Aplasia/Hypoplasia affecting the eye 90% Aplasia/Hypoplasia of the skin 90% Cataract 90% Convex nasal ridge 90% Frontal bossing 90% Reduced bone mineral density 90% Short stature 90% Abnormality of hair texture 50% Abnormality of the fontanelles or cranial sutures 50% Abnormality of the nares 50% Abnormality of the palate 50% Advanced eruption of teeth 50% Glossoptosis 50% Hypoplasia of the zygomatic bone 50% Increased number of teeth 50% Narrow mouth 50% Recurrent fractures 50% Telecanthus 50% Visual impairment 50% Intellectual disability 15% Abdominal situs inversus 7.5% Aplasia/Hypoplasia of the cerebellum 7.5% Choanal atresia 7.5% Clinodactyly of the 5th finger 7.5% Cognitive impairment 7.5% Congestive heart failure 7.5% Cryptorchidism 7.5% Glaucoma 7.5% Hypothyroidism 7.5% Inflammatory abnormality of the eye 7.5% Microcephaly 7.5% Myopia 7.5% Nystagmus 7.5% Respiratory insufficiency 7.5% Short foot 7.5% Short palm 7.5% Strabismus 7.5% Tracheomalacia 7.5% Abnormality of the hand - Abnormality of the nasopharynx - Blue sclerae - Brachycephaly - Choreoathetosis - Chorioretinal coloboma - Decreased number of sternal ossification centers - Dental malocclusion - Dermal atrophy - Dolichocephaly - Dry skin - Fine hair - Generalized tonic-clonic seizures - High palate - Hyperactivity - Hyperlordosis - Hypotrichosis of the scalp - Iris coloboma - Joint hypermobility - Low-set ears - Malar flattening - Metaphyseal widening - Microphthalmia - Narrow nose - Narrow palate - Natal tooth - Obstructive sleep apnea - Optic nerve coloboma - Parietal bossing - Pectus excavatum - Platybasia - Proportionate short stature - Pulmonary hypertension - Recurrent pneumonia - Recurrent respiratory infections - Scoliosis - Selective tooth agenesis - Slender long bone - Small for gestational age - Sparse eyebrow - Sparse eyelashes - Sparse hair - Spina bifida - Sporadic - Telangiectasia - Thin calvarium - Thin ribs - Thin vermilion border - Underdeveloped nasal alae - Wormian bones - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Osteopetrosis autosomal recessive 3 ?","output":"Osteopetrosis is a bone disease that makes bones abnormally dense and prone to breakage (fracture). Researchers have described several major types of osteopetrosis, which are usually distinguished by their pattern of inheritance: autosomal dominant, autosomal recessive, or X-linked. The different types of the disorder can also be distinguished by the severity of their signs and symptoms. Mutations in at least nine genes cause the various types of osteopetrosis."},{"instruction":"What are the symptoms of Osteopetrosis autosomal recessive 3 ?","output":"What are the signs and symptoms of Osteopetrosis autosomal recessive 3? The Human Phenotype Ontology provides the following list of signs and symptoms for Osteopetrosis autosomal recessive 3. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of epiphysis morphology 90% Abnormality of the renal tubule 90% Anemia 90% Aseptic necrosis 90% Bone pain 90% Cognitive impairment 90% Genu valgum 90% Hepatomegaly 90% Increased bone mineral density 90% Recurrent fractures 90% Reduced bone mineral density 90% Splenomegaly 90% Abnormality of dental morphology 50% Carious teeth 50% Cerebral calcification 50% Mandibular prognathia 50% Peripheral neuropathy 50% Thrombocytopenia 50% Optic atrophy 7.5% Visual impairment 7.5% Autosomal recessive inheritance - Basal ganglia calcification - Cranial hyperostosis - Dental malocclusion - Diaphyseal sclerosis - Distal renal tubular acidosis - Elevated serum acid phosphatase - Extramedullary hematopoiesis - Hepatosplenomegaly - Intellectual disability - Optic nerve compression - Osteopetrosis - Periodic hypokalemic paresis - Short stature - Visual loss - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Kleefstra syndrome ?","output":"What are the signs and symptoms of Kleefstra syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Kleefstra syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Anteverted nares 90% Cognitive impairment 90% Hypertelorism 90% Intellectual disability 90% Malar flattening 90% Muscular hypotonia 90% Neurological speech impairment 90% Short nose 90% Tented upper lip vermilion 90% Abnormality of the aorta 50% Abnormality of the aortic valve 50% Arrhythmia 50% Autism 50% Brachycephaly 50% Broad forehead 50% Coarse facial features 50% Constipation 50% Delayed speech and language development 50% Hearing impairment 50% Highly arched eyebrow 50% Macroglossia 50% Mandibular prognathia 50% Microcephaly 50% Obesity 50% Otitis media 50% Protruding tongue 50% Sleep disturbance 50% Synophrys 50% Thickened helices 50% Upslanted palpebral fissure 50% U-Shaped upper lip vermilion 50% Ventricular septal defect 50% Aggressive behavior 33% Cryptorchidism 33% Hypospadias 33% Micropenis 33% Recurrent respiratory infections 33% Stereotypic behavior 33% Seizures 30% Abnormality of the pulmonary artery 7.5% Aplasia/Hypoplasia of the corpus callosum 7.5% Bowel incontinence 7.5% Cerebral cortical atrophy 7.5% Delayed eruption of teeth 7.5% Developmental regression 7.5% Downturned corners of mouth 7.5% Facial asymmetry 7.5% Hernia 7.5% Limitation of joint mobility 7.5% Natal tooth 7.5% Persistence of primary teeth 7.5% Pyloric stenosis 7.5% Renal cyst 7.5% Renal insufficiency 7.5% Respiratory insufficiency 7.5% Scoliosis 7.5% Self-injurious behavior 7.5% Short stature 7.5% Supernumerary nipple 7.5% Talipes equinovarus 7.5% Tetralogy of Fallot 7.5% Ventriculomegaly 7.5% Vesicoureteral reflux 7.5% Gastroesophageal reflux 5% Apathy 1% Tracheobronchomalacia 1% Microcephaly 8/22 Hearing impairment 3/22 Autosomal dominant inheritance - Brachydactyly syndrome - Flat face - Hypoplasia of midface - Intellectual disability, severe - Obsessive-compulsive behavior - Single transverse palmar crease - Sporadic - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Large granular lymphocyte leukemia ?","output":"Large granular lymphocyte (LGL) leukemia is a rare cancer of a type of white blood cells called lymphocytes. LGL leukemia causes a slow increase in white blood cells called T lymphocytes, or T cells, which originate in the lymph system and bone marrow and help to fight infection. This disease usually affects people in their sixties. Symptoms include anemia; low levels of platelets (thrombocytopenia) and infection-fighting neutrophils (neutropenia) in the blood; and an enlarged spleen. About one-third of patients are asymptomatic at the time of diagnosis. The exact cause of LGL leukemia is unknown. Doctors can diagnose this disease through a bone marrow biopsy, or by using a specialized technique in which various types of blood or bone marrow cells are separated, identified, and counted."},{"instruction":"What are the symptoms of BardetBiedl syndrome 9 ?","output":"What are the signs and symptoms of Bardet-Biedl syndrome 9? The Human Phenotype Ontology provides the following list of signs and symptoms for Bardet-Biedl syndrome 9. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the kidney 95% Micropenis 88% Myopia 75% Astigmatism 63% Cataract 30% Glaucoma 22% Rod-cone dystrophy 8% Abnormality of the ovary 7.5% Hearing impairment 7.5% Macrocephaly 7.5% Vaginal atresia 7.5% Aganglionic megacolon 5% Asthma - Ataxia - Autosomal recessive inheritance - Biliary tract abnormality - Brachydactyly syndrome - Broad foot - Congenital primary aphakia - Decreased testicular size - Delayed speech and language development - Dental crowding - Diabetes mellitus - Foot polydactyly - Gait imbalance - Hepatic fibrosis - High palate - Hirsutism - Hypertension - Hypodontia - Hypogonadism - Intellectual disability - Left ventricular hypertrophy - Nephrogenic diabetes insipidus - Neurological speech impairment - Nystagmus - Obesity - Poor coordination - Postaxial hand polydactyly - Radial deviation of finger - Retinal degeneration - Short foot - Specific learning disability - Strabismus - Syndactyly - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Torsion dystonia with onset in infancy ?","output":"What are the signs and symptoms of Torsion dystonia with onset in infancy? The Human Phenotype Ontology provides the following list of signs and symptoms for Torsion dystonia with onset in infancy. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal dominant inheritance - Infantile onset - Torsion dystonia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Gray zone lymphoma ?","output":"Gray zone lymphoma is a cancer of the immune system. The name of this lymphoma refers to the fact that cancer cells in this condition are in a \\"gray zone\\" (an uncertain category) because they appear similar to that of two other types of lymphoma, classical Hodgkin lymphoma and mediastinal large B-cell lymphoma. Because features of gray zone lymphoma overlap with these two other types of lymphoma, diagnosing this condition can be difficult. Gray zone lymphoma is most often diagnosed in young adults when an unusual lump (mass) is found in the chest in the space between the lungs (mediastinum). This condition affects men and women equally."},{"instruction":"What are the treatments for Gray zone lymphoma ?","output":"How might gray zone lymphoma be treated? Gray zone lymphoma shares features with two other types of lymphoma, classical Hodgkin lymphoma (cHL) and mediastinal large B-cell lymphoma (MLBCL). Because MLBCL and cHL are treated differently, it is unclear how gray zone lymphoma should be treated. At this time, there are no guidelines for the best treatment of gray zone lymphoma; treatment is determined based on each individual's diagnosis. Treatment usually begins with chemotherapy, which may be followed by radiation therapy in some cases."},{"instruction":"What are the symptoms of Mesomelic dysplasia Kantaputra type ?","output":"What are the signs and symptoms of Mesomelic dysplasia Kantaputra type? The Human Phenotype Ontology provides the following list of signs and symptoms for Mesomelic dysplasia Kantaputra type. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the ankles 90% Abnormality of the fibula 90% Abnormality of the humerus 90% Camptodactyly of finger 90% Micromelia 90% Short stature 90% Tarsal synostosis 90% Clinodactyly of the 5th finger 50% Synostosis of carpal bones 50% Ulnar deviation of finger 50% Abnormality of the ribs 7.5% Cubitus valgus 7.5% Talipes 7.5% Vertebral segmentation defect 7.5% Autosomal dominant inheritance - Carpal synostosis - Mesomelia - Radial bowing - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Empty sella syndrome ?","output":"Empty sella syndrome (ESS) is a condition that involves the sella turcica, a bony structure at the base of the brain that protects the pituitary gland. There is a primary and secondary form of the condition. The primary form occurs when a structural defect above the pituitary gland increases pressure in the sella turcica and causes the gland to flatten. The secondary form occurs when the pituitary gland is damaged due to injury, a tumor, surgery or radiation therapy. Some people with ESS have no symptoms. People with secondary ESS may have symptoms of decreased pituitary function such as absence of menstruation, infertility, fatigue, and intolerance to stress and infection. In children, ESS may be associated with early onset of puberty, growth hormone deficiency, pituitary tumors, or pituitary gland dysfunction. Treatment focuses on the symptoms present in each person."},{"instruction":"What are the symptoms of Empty sella syndrome ?","output":"What are the signs and symptoms of Empty sella syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Empty sella syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Atresia of the external auditory canal 90% Conductive hearing impairment 90% Dolichocephaly 90% Dural ectasia 90% Hypoplasia of the zygomatic bone 90% Low-set, posteriorly rotated ears 90% Meningocele 90% Narrow face 90% Ptosis 90% Wormian bones 90% Abnormal form of the vertebral bodies 50% Abnormality of the teeth 50% Craniofacial hyperostosis 50% Joint hypermobility 50% Low posterior hairline 50% Pectus excavatum 50% Prominent metopic ridge 50% Scoliosis 50% Short neck 50% Short stature 50% Umbilical hernia 50% Arnold-Chiari malformation 7.5% Cleft palate 7.5% Cognitive impairment 7.5% Cryptorchidism 7.5% Epicanthus 7.5% Hyperlordosis 7.5% Hypertelorism 7.5% Iris coloboma 7.5% Kyphosis 7.5% Muscular hypotonia 7.5% Proptosis 7.5% Sensorineural hearing impairment 7.5% Syringomyelia 7.5% Ventricular septal defect 7.5% Abnormality of the middle ear ossicles - Abnormality of the rib cage - Abnormality of the skin - Arachnoid cyst - Arnold-Chiari type I malformation - Autosomal dominant inheritance - Biconcave vertebral bodies - Dental crowding - High palate - Inguinal hernia - Long philtrum - Low-set ears - Malar flattening - Patent ductus arteriosus - Platybasia - Posteriorly rotated ears - Sclerosis of skull base - Short nasal bridge - Smooth philtrum - Vertebral fusion - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"Empty sella syndrome inherited ?","output":"Is empty sella syndrome inherited? Empty sella syndrome (ESS) is typically not inherited. We are aware of one report of familial ESS, occurring in a father and two children. Some researchers believe that a defect present at birth may play a role in the development of the condition, but are unsure whether the defect directly causes ESS or is only a predisposing factor."},{"instruction":"What is (are) Polyhydramnios, megalencephaly, and symptomatic epilepsy syndrome ?","output":"Polyhydramnios, megalencephaly, and symptomatic epilepsy syndrome (PMSE syndrome) is characterized by excessive accumulation of amniotic fluid that surrounds the baby in the uterus during pregnancy (polyhydramnios), abnormally large, heavy, and usually malfunctioning brain (megalencephaly), seizures and intellectual disability. Some patients also have heart problems, diabetes insipidus, kidney problems and leukemia. It is caused by a mutation in the LYK5 gene. Seizures are difficult to treat and there is ongoing research for more effective medication."},{"instruction":"What are the symptoms of Polyhydramnios, megalencephaly, and symptomatic epilepsy syndrome ?","output":"What are the signs and symptoms of Polyhydramnios, megalencephaly, and symptomatic epilepsy syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Polyhydramnios, megalencephaly, and symptomatic epilepsy syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Hyperplasia of midface 16/16 Hypertelorism 16/16 Large forehead 16/16 Long face 16/16 Muscular hypotonia 16/16 Polyhydramnios 16/16 Thick lower lip vermilion 16/16 Thick upper lip vermilion 16/16 Wide mouth 16/16 Wide nasal bridge 16/16 Macrocephaly 15/16 Premature birth 15/16 Atria septal defect 4/16 Diabetes insipidus 2/16 Nephrocalcinosis 2/16 Autosomal recessive inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Isolated ectopia lentis ?","output":"Isolated ectopia lentis (IEL) is a genetic disorder that affects the positioning of the lens in the eyes. In individuals with IEL, the lens in one or both of the eyes is off-center. Symptoms of IOL usually present in childhood and may include vision problems such as nearsightedness (myopia), blurred vision (astigmatism), clouding of the lenses (cataracts), and increased pressure in the eyes (glaucoma). In some individuals, IEL can progress to retinal detachment (tearing of the back lining of the eye). IEL is caused by mutations in either the FBN1 or ADAMTSL4 gene. When caused by a mutation in the FBN1 gene, IEL is inherited in an autosomal dominant manner. When caused by a mutation in the ADAMTSL4 gene, IEL is inherited in an autosomal recessive manner. The primary goal of treatment is preventing amblyopia (lazy eye) through early correction of astigmatism. Surgical intervention including lensectomy (removal of the lens) may be considered in cases where vision is significantly affected."},{"instruction":"What are the symptoms of Isolated ectopia lentis ?","output":"What are the signs and symptoms of Isolated ectopia lentis? The Human Phenotype Ontology provides the following list of signs and symptoms for Isolated ectopia lentis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Corneal dystrophy 90% Ectopia lentis 90% Flat cornea 90% Astigmatism 50% Glaucoma 50% Abnormality of the pupil 7.5% Aplasia/Hypoplasia of the lens 7.5% Disproportionate tall stature 7.5% Hypermetropia 7.5% Lens coloboma 7.5% Limitation of joint mobility 7.5% Retinal detachment 7.5% Visual impairment 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Pityriasis lichenoides ?","output":"Pityriasis lichenoides is a skin disorder of unknown cause. There are two types of pityriasis lichenoides; a more severe form with a sudden onset that tends to be short-lived (acute) which is usually found in children, known as pityriasis lichenoides et varioliformis acuta and a more mild but long-lasting (chronic) form known as pityriasis lichenoides chronica. Pityriasis lichenoides chronica may clear up in a few weeks or persist for years."},{"instruction":"What are the treatments for Pityriasis lichenoides ?","output":"What treatment is available for pityriasis lichenoides? The different forms of treatment for pityriasis lichenoides that have been used range from natural sunlight exposure to chemotherapeutic agents. Treatment may not be necessary if the rash is not causing symptoms. When itching is severe, topical corticosteroids, tar preparations, and antihistamines may provide relief without changing the course of the disease. In adult patients, administration of methotrexate and oral tetracycline has led to good results; however, these medications are inappropriate for first-line treatment in young children. In addition to tetracycline, erythromycin is another antibiotic that is commonly used to treat pityriasis lichenoides. Sunlight is helpful, and excellent therapeutic responses to UVB phototherapy are documented. UVB therapy is more difficult in young children, and there is little data regarding the long-term risks of phototherapy in the pediatric population. It is difficult to interpret the results of formal therapy evaluations because of the frequency of spontaneous remissions."},{"instruction":"What are the symptoms of Methylmalonic acidemia with homocystinuria, type cblJ ?","output":"What are the signs and symptoms of Methylmalonic acidemia with homocystinuria, type cblJ? The Human Phenotype Ontology provides the following list of signs and symptoms for Methylmalonic acidemia with homocystinuria, type cblJ. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Atria septal defect 5% Cerebral atrophy 5% Coarctation of aorta 5% Cryptorchidism 5% Decreased methionine synthase activity 5% Decreased methylcobalamin 5% Gastroesophageal reflux 5% Hypertelorism 5% Pulmonary hypertension 5% Wide intermamillary distance 5% Abnormal posturing - Anemia - Autosomal recessive inheritance - Congenital onset - Decreased adenosylcobalamin - Feeding difficulties - Growth delay - Homocystinuria - Hyperhomocystinemia - Inguinal hernia - Lethargy - Methylmalonic acidemia - Methylmalonic aciduria - Muscular hypotonia - Neutropenia - Tachypnea - Thrombocytopenia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Ichthyosis cheek eyebrow syndrome ?","output":"What are the signs and symptoms of Ichthyosis cheek eyebrow syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Ichthyosis cheek eyebrow syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the palate 90% Asymmetry of the thorax 90% Full cheeks 90% Ichthyosis 90% Pectus excavatum 90% Scoliosis 90% Sparse lateral eyebrow 90% Kyphosis 7.5% Abnormality of the thorax - Autosomal dominant inheritance - High palate - Kyphoscoliosis - Pes planus - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Muscular dystrophy, congenital, megaconial type ?","output":"What are the signs and symptoms of Muscular dystrophy, congenital, megaconial type? The Human Phenotype Ontology provides the following list of signs and symptoms for Muscular dystrophy, congenital, megaconial type. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Dilated cardiomyopathy 50% Autosomal recessive inheritance - Congenital muscular dystrophy - Congenital onset - Delayed speech and language development - Elevated serum creatine phosphokinase - Facial palsy - Gowers sign - Ichthyosis - Intellectual disability - Microcephaly - Mitochondrial inheritance - Motor delay - Myopathy - Neonatal hypotonia - Poor speech - Seizures - Slow progression - Waddling gait - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Tiglic acidemia ?","output":"What are the signs and symptoms of Tiglic acidemia? The Human Phenotype Ontology provides the following list of signs and symptoms for Tiglic acidemia. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Acidosis - Aminoaciduria - Autosomal recessive inheritance - Episodic abdominal pain - Ketosis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Baylisascaris infection ?","output":"Baylisascaris roundworms are intestinal parasites found in many different animals. Baylisascaris infection in humans is uncommon but can be severe. While Baylisascaris can infect different types of animals, Baylisascaris procyonis, carried by raccoons, is thought to pose the greatest risk to humans because raccoons often live in close proximity to humans. Humans can acquire the parasite by ingesting the eggs of infected raccoons. Young children are at greatest risk for Baylisascaris infection because they are more likely to put contaminated soil in their mouths. Though rare, human infections can be severe if the parasite invades the eye (ocular larva migrans), organs (visceral larva migrans), or the brain (neural larva migrans). Symptoms of a Baylisascaris infection may include nausea, fatigue, an enlarged liver, loss of coordination, lack of muscle control, blindness, and coma. Baylisascaris infections cannot be spread from one person to another. No drug has been found to be completely effective against Baylisascaris infections in humans though albendazole has been used in some cases."},{"instruction":"What are the treatments for Baylisascaris infection ?","output":"How might Baylisascaris infection be treated? No drug has been found to be completely effective in treating Baylisascaris infections in humans. Albendazole is currently considered to be the drug of choice. Corticosteroids may also be given to reduce inflammation. In many cases, significant damage has already occurred by the time treatment has started. Early diagnosis and treatment provide the best chance of recovery."},{"instruction":"What are the symptoms of Tuberous sclerosis, type 1 ?","output":"What are the signs and symptoms of Tuberous sclerosis, type 1? The Human Phenotype Ontology provides the following list of signs and symptoms for Tuberous sclerosis, type 1. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Intellectual disability 30% Abnormality of the respiratory system - Achromatic retinal patches - Astrocytoma - Attention deficit hyperactivity disorder - Autism - Autosomal dominant inheritance - Cafe-au-lait spot - Cerebral calcification - Chordoma - Dental enamel pits - Ependymoma - Gingival fibromatosis - Hypomelanotic macule - Hypothyroidism - Infantile spasms - Optic glioma - Phenotypic variability - Precocious puberty - Premature chromatid separation - Projection of scalp hair onto lateral cheek - Renal angiomyolipoma - Renal cell carcinoma - Renal cyst - Shagreen patch - Specific learning disability - Subcutaneous nodule - Subependymal nodules - Subungual fibromas - Wolff-Parkinson-White syndrome - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Fanconi renotubular syndrome ?","output":"Fanconi syndrome is a condition in which the kidneys do not absorb certain substances into the body. These substances, such as cysteine, fructose, galactose, or glycogen, are lost in the urine. Fanconi syndrome is thought to be caused by genetic and environmental factors, and it may be diagnosed at any age. Symptoms of Fanconi syndrome include increased urine production (which may cause dehydration), weakness, and abnormalities of the bones."},{"instruction":"What are the symptoms of Fanconi renotubular syndrome ?","output":"What are the signs and symptoms of Fanconi renotubular syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Fanconi renotubular syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal dominant inheritance - Glycosuria - Hypokalemia - Hypophosphatemia - Lacticaciduria - Muscle weakness - Osteomalacia - Proteinuria - Renal insufficiency - Renal tubular dysfunction - Rickets - Short stature - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Simosa cranio facial syndrome ?","output":"What are the signs and symptoms of Simosa cranio facial syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Simosa cranio facial syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the antihelix 90% Abnormality of the antitragus 90% Abnormality of the palate 90% Abnormality of the tragus 90% Abnormality of the voice 90% Aplasia/Hypoplasia of the earlobes 90% Aplasia/Hypoplasia of the eyebrow 90% Blepharophimosis 90% Broad forehead 90% Chin dimple 90% Downturned corners of mouth 90% High forehead 90% Highly arched eyebrow 90% Hypoplasia of the zygomatic bone 90% Long face 90% Long philtrum 90% Macrotia 90% Malar flattening 90% Narrow mouth 90% Telecanthus 90% Underdeveloped nasal alae 90% Wide nasal bridge 90% Cryptorchidism 50% Hernia of the abdominal wall 50% Low-set, posteriorly rotated ears 50% Scoliosis 50% Scrotal hypoplasia 50% Camptodactyly of finger 7.5% Abnormality of the pinna 2/2 Abnormality of the skin 2/2 Blepharophimosis 2/2 Broad forehead 2/2 Depressed nasal tip 2/2 High, narrow palate 2/2 Highly arched eyebrow 2/2 Inguinal hernia 2/2 Long face 2/2 Long nose 2/2 Long philtrum 2/2 Low-set ears 2/2 Malar flattening 2/2 Narrow mouth 2/2 Nasal speech 2/2 Posteriorly rotated ears 2/2 Sparse eyebrow 2/2 Telecanthus 2/2 Underdeveloped nasal alae 2/2 Wide nasal bridge 2/2 Autosomal dominant inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Pulmonary alveolar microlithiasis ?","output":"Pulmonary alveolar microlithiasis is a disorder in which tiny fragments (microliths) of calcium phosphate gradually accumulate in the small air sacs (alveoli) of the lungs. These deposits eventually cause widespread damage to the alveoli and surrounding lung tissue (interstitial lung disease). People with this disorder may also develop a persistent cough and difficulty breathing (dyspnea), especially during physical exertion. Chest pain that worsens when coughing, sneezing, or taking deep breaths is another common feature. People with pulmonary alveolar microlithiasis may also develop calcium phosphate deposits in other organs and tissue of the body. Though the course of the disease can be variable, many cases slowly progress to lung fibrosis, respiratory failure, or cor pulmonale. The only effective therapy is lung transplantation. In some cases, pulmonary alveolar microlithiasis is caused by mutations in the SLC34A2 gene and inherited in an autosomal recessive manner."},{"instruction":"What are the symptoms of Pulmonary alveolar microlithiasis ?","output":"What are the signs and symptoms of Pulmonary alveolar microlithiasis? The Human Phenotype Ontology provides the following list of signs and symptoms for Pulmonary alveolar microlithiasis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal recessive inheritance - Intraalveolar nodular calcifications - Onset - Progressive pulmonary function impairment - Restrictive respiratory insufficiency - Slow progression - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Hypertrophic neuropathy of DejerineSottas ?","output":"Hypertrophic neuropathy of Dejerine-Sottas (Dejerine-Sottas syndrome) is a term sometimes used to describe a severe, early childhood form of Charcot-Marie-Tooth disease (sometimes called type 3) that is characterized by sensory loss with ataxia in the limbs furthest from the body and pes cavus with progression towards the limbs closest to the body. Depending on the specific gene that is altered, this severe, early onset form of the disorder may also be classified as type 1 or type 4. Dejerine-Sottas syndrome has been associated with mutations in the MPZ, PMP22, EGR2, and PRX genes. Autosomal dominant and autosomal recessive inheritance have been described."},{"instruction":"What are the symptoms of Hypertrophic neuropathy of DejerineSottas ?","output":"What are the signs and symptoms of Hypertrophic neuropathy of Dejerine-Sottas? The Human Phenotype Ontology provides the following list of signs and symptoms for Hypertrophic neuropathy of Dejerine-Sottas. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Nystagmus 5% Areflexia - Autosomal dominant inheritance - Autosomal recessive inheritance - Decreased motor nerve conduction velocity - Decreased number of peripheral myelinated nerve fibers - Distal amyotrophy - Distal sensory impairment - Foot dorsiflexor weakness - Hammertoe - Heterogeneous - Hypertrophic nerve changes - Hyporeflexia - Increased CSF protein - Infantile onset - Kyphoscoliosis - Motor delay - Muscular hypotonia - Onion bulb formation - Pes cavus - Segmental peripheral demyelination/remyelination - Sensory ataxia - Steppage gait - Ulnar claw - Variable expressivity - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Martsolf syndrome ?","output":"What are the signs and symptoms of Martsolf syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Martsolf syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal dermatoglyphics 90% Cataract 90% Cognitive impairment 90% Furrowed tongue 90% Hypoplasia of the zygomatic bone 90% Low posterior hairline 90% Malar flattening 90% Microcephaly 90% Prematurely aged appearance 90% Short philtrum 90% Short stature 90% Abnormality of calvarial morphology 50% Abnormality of the distal phalanx of finger 50% Abnormality of the palate 50% Abnormality of the teeth 50% Abnormality of the toenails 50% Cryptorchidism 50% Depressed nasal bridge 50% Hyperlordosis 50% Hypotelorism 50% Low-set, posteriorly rotated ears 50% Ulnar deviation of finger 50% Abnormality of the antihelix 7.5% Cerebral cortical atrophy 7.5% Scoliosis 7.5% Autosomal recessive inheritance - Brachycephaly - Broad fingertip - Broad nasal tip - Cardiomyopathy - Congestive heart failure - Epicanthus - Feeding difficulties in infancy - High palate - Hypogonadotrophic hypogonadism - Hypoplasia of the maxilla - Intellectual disability, progressive - Intellectual disability, severe - Lumbar hyperlordosis - Micropenis - Misalignment of teeth - Pectus carinatum - Pectus excavatum - Posteriorly rotated ears - Prominent antitragus - Prominent nipples - Recurrent respiratory infections - Short metacarpal - Short palm - Short phalanx of finger - Short toe - Slender ulna - Talipes equinovarus - Talipes valgus - Tracheomalacia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Atelosteogenesis type 1 ?","output":"What are the signs and symptoms of Atelosteogenesis type 1? The Human Phenotype Ontology provides the following list of signs and symptoms for Atelosteogenesis type 1. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) 11 pairs of ribs - Aplasia/Hypoplasia of the ulna - Brachydactyly syndrome - Cleft palate - Clubbing - Club-shaped proximal femur - Coronal cleft vertebrae - Cryptorchidism - Depressed nasal bridge - Distal tapering femur - Elbow dislocation - Encephalocele - Fibular aplasia - Frontal bossing - Fused cervical vertebrae - Hypoplasia of midface - Laryngeal stenosis - Malar flattening - Multinucleated giant chondrocytes in epiphyseal cartilage - Narrow chest - Neonatal death - Polyhydramnios - Premature birth - Proptosis - Radial bowing - Rhizomelia - Short femur - Short humerus - Short metacarpal - Short metatarsal - Short neck - Short nose - Sporadic - Stillbirth - Talipes equinovarus - Thoracic platyspondyly - Tibial bowing - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Hemifacial hyperplasia strabismus ?","output":"What are the signs and symptoms of Hemifacial hyperplasia strabismus? The Human Phenotype Ontology provides the following list of signs and symptoms for Hemifacial hyperplasia strabismus. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Facial asymmetry 90% Cleft palate 50% Dental malocclusion 50% Strabismus 50% Telecanthus 50% Upslanted palpebral fissure 50% Visual impairment 50% Amblyopia - Autosomal dominant inheritance - Hemifacial hypertrophy - Submucous cleft hard palate - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Pycnodysostosis ?","output":"Pycnodysostosis is a rare condition characterized by moderate short stature (1.35m to 1.5m), increased density of the bones (osteosclerosis/osteopetrosis), underdevelopment of the tips of the fingers with absent or small nails, an abnomal collarbone (clavicle), distinctive facial features including a large head with a small face and chin, underdeveloped facial bones, a high forehead and dental abnormalities. Pycnodysostosis is an autosomal recessive genetic condition. The gene has been mapped to the same location as the gene for cathepsin K on chromosome 1q21. The diagnosis of pycnodysostosis is based on physical features and X-ray findings. Molecular genetic testing is available. Management is symptomatic. Individuals need orthopedic monitoring, treatment of fractures, appropriate dental care, and craniofacial surgery may be needed."},{"instruction":"What are the symptoms of Pycnodysostosis ?","output":"What are the signs and symptoms of Pycnodysostosis? The Human Phenotype Ontology provides the following list of signs and symptoms for Pycnodysostosis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of epiphysis morphology 90% Abnormality of the clavicle 90% Abnormality of the fingernails 90% Abnormality of the palate 90% Brachydactyly syndrome 90% Delayed eruption of teeth 90% Frontal bossing 90% High forehead 90% Malar flattening 90% Osteolysis 90% Recurrent fractures 90% Short distal phalanx of finger 90% Short stature 90% Short toe 90% Skeletal dysplasia 90% Abnormality of dental morphology 50% Anonychia 50% Blue sclerae 50% Bone pain 50% Proptosis 50% Wormian bones 50% Abnormal pattern of respiration 7.5% Abnormality of pelvic girdle bone morphology 7.5% Anemia 7.5% Cognitive impairment 7.5% Hepatomegaly 7.5% Hydrocephalus 7.5% Hyperlordosis 7.5% Kyphosis 7.5% Narrow chest 7.5% Osteomyelitis 7.5% Splenomegaly 7.5% Abnormality of the thorax - Absent frontal sinuses - Autosomal recessive inheritance - Carious teeth - Delayed eruption of permanent teeth - Delayed eruption of primary teeth - Hypodontia - Increased bone mineral density - Narrow palate - Osteolytic defects of the distal phalanges of the hand - Persistence of primary teeth - Persistent open anterior fontanelle - Prominent nose - Prominent occiput - Ridged nail - Scoliosis - Spondylolisthesis - Spondylolysis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Subaortic stenosis short stature syndrome ?","output":"What are the signs and symptoms of Subaortic stenosis short stature syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Subaortic stenosis short stature syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the aorta 90% Abnormality of the voice 90% Anteverted nares 90% Arrhythmia 90% Short stature 90% Hernia of the abdominal wall 50% Kyphosis 50% Obesity 50% Respiratory insufficiency 50% Scoliosis 50% Abnormality of lipid metabolism 7.5% Acne 7.5% Aplasia/Hypoplasia affecting the eye 7.5% Biliary tract abnormality 7.5% Cognitive impairment 7.5% Epicanthus 7.5% Low-set, posteriorly rotated ears 7.5% Microdontia 7.5% Nystagmus 7.5% Short neck 7.5% Single transverse palmar crease 7.5% Synostosis of carpal bones 7.5% Type II diabetes mellitus 7.5% Autosomal recessive inheritance - Barrel-shaped chest - Broad finger - Broad toe - Diastema - Flat face - Glaucoma - Growth delay - Hypoplasia of midface - Hypoplasia of the maxilla - Intellectual disability - Low-set ears - Malar flattening - Membranous subvalvular aortic stenosis - Microcornea - Microphthalmia - Narrow mouth - Opacification of the corneal stroma - Pectus excavatum - Round face - Shield chest - Short foot - Short nose - Short palm - Short phalanx of finger - Short toe - Short upper lip - Small hand - Strabismus - Subaortic stenosis - Wide intermamillary distance - Wide nasal bridge - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Fabry disease ?","output":"Fabry disease is an inherited disorder that results from the buildup of a particular type of fat in the body's cells, called globotriaosylceramide or GL-3. Fabry disease affects many parts of the body. Signs and symptoms may include episodes of pain, particularly in the hands and feet (acroparesthesias); clusters of small, dark red spots on the skin called angiokeratomas; a decreased ability to sweat (hypohidrosis); cloudiness of the front part of the eye (corneal opacity); and hearing loss. Potentially severe complications can include progressive kidney damage, heart attack, and stroke. Milder forms of the disorder may appear later in life and affect only the heart or kidneys. Fabry disease is caused by mutations in the GLA gene and is inherited in an X-linked manner. Treatment may include enzyme replacement therapy (ERT); pain medications, ACE inhibitors; and chronic hemodialysis or renal transplantation for end stage renal disease."},{"instruction":"What are the symptoms of Fabry disease ?","output":"What are the signs and symptoms of Fabry disease? The Human Phenotype Ontology provides the following list of signs and symptoms for Fabry disease. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abdominal pain 90% Anemia 90% Arthralgia 90% Arthritis 90% Cerebral ischemia 90% Congestive heart failure 90% Conjunctival telangiectasia 90% Corneal dystrophy 90% Hematuria 90% Hyperkeratosis 90% Hypohidrosis 90% Malabsorption 90% Myalgia 90% Nephrotic syndrome 90% Opacification of the corneal stroma 90% Paresthesia 90% Renal insufficiency 90% Telangiectasia of the skin 90% Abnormality of lipid metabolism 50% Abnormality of the aortic valve 50% Abnormality of the genital system 50% Abnormality of the mitral valve 50% Abnormality of the renal tubule 50% Anorexia 50% Arrhythmia 50% Behavioral abnormality 50% Cataract 50% Coarse facial features 50% Cognitive impairment 50% Emphysema 50% Nausea and vomiting 50% Nephropathy 50% Optic atrophy 50% Proteinuria 50% Short stature 50% Thick lower lip vermilion 50% Abnormality of temperature regulation 7.5% Abnormality of the endocardium 7.5% Abnormality of the femur 7.5% Chronic obstructive pulmonary disease 7.5% Coronary artery disease 7.5% Developmental regression 7.5% Diabetes insipidus 7.5% Glomerulopathy 7.5% Hypertension 7.5% Hypertrophic cardiomyopathy 7.5% Lymphedema 7.5% Reduced bone mineral density 7.5% Respiratory insufficiency 7.5% Seizures 7.5% Sensorineural hearing impairment 7.5% Vertigo 7.5% Abnormality of the hand - Angina pectoris - Angiokeratoma - Delayed puberty - Diarrhea - Dysautonomia - Fasciculations - Juvenile onset - Left ventricular hypertrophy - Left ventricular septal hypertrophy - Muscle cramps - Myocardial infarction - Nausea - Obstructive lung disease - Tenesmus - Transient ischemic attack - Vomiting - X-linked recessive inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"Fabry disease inherited ?","output":"How is Fabry disease inherited? Fabry disease is inherited in an X-linked pattern, which means that the gene that causes the condition is located on the X chromosome. In males (who have only one X chromosome), one mutated copy of the gene is enough to cause symptoms of the condition. Because females have two copies of the X chromosome, one mutated copy of the gene in each cell usually leads to less severe symptoms in females than in males, or may cause no symptoms at all."},{"instruction":"What are the treatments for Fabry disease ?","output":"How might Fabry disease be treated? Management for Fabry disease may include treatment of specific signs and symptoms as well as prevention of secondary complications. Treatment for acroparesthesias (pain in the extremities) may include diphenylhydantoin and/or carbamazepine to reduce the frequency and severity of pain crises; or gabapentin, which has also been shown to improve pain. Renal insufficiency may be treated with ACE inhibitors. Experts recommend ACE inhibitors for all individuals with evidence of kidney involvement, especially to reduce protein in the urine (proteinuria). Chronic hemodialysis and/or renal transplantation have become lifesaving procedures for affected individuals. The transplanted kidney remains free of the harmful fatty substance (glycosphingolipid) deposition. Therefore, successful renal transplantation corrects the renal function. Transplantation of kidneys from carriers for Fabry disease should be avoided because these kidneys may already be affected. All potential donors that are relatives of the affected individual should be evaluated for their genetic status to make sure they are not affected or a carrier. Enzyme replacement therapy (ERT) is generally used to improve some of the the signs and symptoms associated with Fabry disease and to stabilize organ function. Experts have recommended that ERT be started as early as possible in all males with Fabry disease (including children and those with end stage renal disease (ESRD) undergoing dialysis and renal transplantation) and in female carriers that are significantly affected. All of these individuals are at high risk for cardiac, cerebrovascular (interruption of blood supply to the brain), and neurologic complications, such as transient ischemic attacks and strokes. The role of ERT in the long-term prevention of renal, cardiac, and central nervous system (CNS) involvement is unproven; however, because ERT can stabilize organ function in individuals with more advanced disease, some have suggested starting ERT in early disease stages. This might include starting ERT when an individual is asymptomatic. Prevention of complications such as renovascular disease (conditions affecting the blood vessels of the kidneys), ischemic heart disease, and cerebrovascular disease in affected individuals is generally the same as for the general population. Measures taken may include ACE inhibitors and/or ARB drugs for proteinuria or albuminemia (high levels of albumin in the blood); blood pressure control; and cholesterol control. Aspirin and other medications may be recommended for the prevention of stroke. Surveillance may include yearly or more frequent renal function studies, yearly cardiology evaluation, and yearly hearing evaluation."},{"instruction":"What are the symptoms of Ulna and fibula, hypoplasia of ?","output":"What are the signs and symptoms of Ulna and fibula, hypoplasia of? The Human Phenotype Ontology provides the following list of signs and symptoms for Ulna and fibula, hypoplasia of. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the fibula 90% Abnormality of the tibia 90% Abnormality of the ulna 90% Aplasia/Hypoplasia of the radius 90% Elbow dislocation 90% Micromelia 90% Sacrococcygeal pilonidal abnormality 90% Ulnar deviation of finger 90% Synostosis of carpal bones 50% Myopia 7.5% Strabismus 7.5% Autosomal dominant inheritance - Fibular hypoplasia - Hypoplasia of the ulna - Neonatal short-limb short stature - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Trichodentoosseous syndrome ?","output":"What are the signs and symptoms of Tricho-dento-osseous syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Tricho-dento-osseous syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of dental color 90% Abnormality of dental enamel 90% Craniofacial hyperostosis 90% Frontal bossing 90% Increased bone mineral density 90% Taurodontia 90% Woolly hair 90% Abnormality of frontal sinus 50% Abnormality of the fingernails 50% Abnormality of the ulna 50% Aplasia/Hypoplasia of the radius 50% Carious teeth 50% Delayed eruption of teeth 50% Delayed skeletal maturation 50% Dolichocephaly 50% Malar prominence 50% Round face 50% Abnormality of the hair - Abnormality of the mastoid - Autosomal dominant inheritance - Fragile nails - Microdontia - Widely spaced teeth - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Pseudohypoparathyroidism type 1A ?","output":"Pseudohypoparathyroidism type 1A is a type of pseudohypoparathyroidism. Pseudohypoparathyroidism is when your body is unable to respond to parathyroid hormone, which is a hormone that controls the levels of calcium, phosphorous, and vitamin D in the blood. The symptoms are very similar to hypoparathyroidism (when parathyroid hormone levels are too low). The main symptoms are low calcium levels and high phosphate levels in the blood. This results in cataracts, dental problems, seizures, numbness, and tetany (muscle twitches and hand and foot spasms). Symptoms are generally first seen in childhood. People with this disorder are also resistant to other hormones, such as thyroid-stimulating hormone and gonadotropins. Type 1A is also associated with a group of symptoms referred to as Albright's hereditary osteodystrophy, which includes short stature, a round face, obesity, and short hand bones. Pseudohypoparathyroidism type 1A is caused by a spelling mistake (mutation) in the GNAS gene and is inherited in an autosomal dominant manner."},{"instruction":"What are the symptoms of Pseudohypoparathyroidism type 1A ?","output":"What are the signs and symptoms of Pseudohypoparathyroidism type 1A? The Human Phenotype Ontology provides the following list of signs and symptoms for Pseudohypoparathyroidism type 1A. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal dominant inheritance - Basal ganglia calcification - Brachydactyly syndrome - Cataract - Choroid plexus calcification - Cognitive impairment - Delayed eruption of teeth - Depressed nasal bridge - Elevated circulating parathyroid hormone (PTH) level - Full cheeks - Hyperphosphatemia - Hypocalcemic tetany - Hypogonadism - Hypoplasia of dental enamel - Hypothyroidism - Intellectual disability - Low urinary cyclic AMP response to PTH administration - Nystagmus - Obesity - Osteoporosis - Phenotypic variability - Pseudohypoparathyroidism - Round face - Seizures - Short finger - Short metacarpal - Short metatarsal - Short neck - Short stature - Short toe - Thickened calvaria - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of RochLeri mesosomatous lipomatosis ?","output":"What are the signs and symptoms of Roch-Leri mesosomatous lipomatosis? The Human Phenotype Ontology provides the following list of signs and symptoms for Roch-Leri mesosomatous lipomatosis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the skin 90% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Hereditary endotheliopathy, retinopathy, nephropathy, and stroke ?","output":"Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS) is a rare genetic condition that affects the vascular endothelium (the inner lining of the arteries and blood vessels). Specifically, the small blood vessels of the brain (microangiopathy); retina (vascular retinopathy); and kidneys are affected. Signs and symptoms may include progressive adult onset vision loss, psychiatric disturbances, stroke-like episodes, neurologic decline, and kidney disease. HERNS is inherited in an autosomal dominant manner. The term retinal vasculopathy with cerebral leukodystrophy (RVCL) has recently been adopted to include HERNS; cerebroretinal vasculopathy (CRV); and hereditary vascular retinopathy (HVR); historically, these 3 conditions have been considered distinct. Genetic studies have shown that these 3 conditions are likely variations of RVCL and are caused by mutations in the TREX1 gene."},{"instruction":"What are the symptoms of Hereditary endotheliopathy, retinopathy, nephropathy, and stroke ?","output":"What are the signs and symptoms of Hereditary endotheliopathy, retinopathy, nephropathy, and stroke? Very few cases of hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS) have been reported. Based upon these reports, it appears that symptoms often begin in the 30s or 40s. Early symptoms, which may differ among individuals, may include depression, anxiety, paranoia, decreased central vision, and/or blind spots. Within the next 4 to 10 years affected individuals reportedly experience focal neurologic deficits that may have a sudden stroke-like onset. The stroke-like episodes may last several days. Headache and seizures may also occur. As the condition progresses, symptoms may include speech impairment, partial paralysis, and/or apraxia. Other symptoms of advanced disease include loss of vision as well as physical and mental skills. Kidney failure, hematuria (blood in the urine) and proteinuria has been described in some affected individuals. Common to all affected individuals is the presence of cerebral microvasculopathic lesions. Some individuals go on to develop mass lesions, predominantly involving the right frontal lobe. These lesions are often mistaken for tumors. The Human Phenotype Ontology provides the following list of signs and symptoms for Hereditary endotheliopathy, retinopathy, nephropathy, and stroke. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the retinal vasculature 90% Visual impairment 90% Abnormality of movement 50% Behavioral abnormality 50% Cerebral ischemia 50% Developmental regression 50% Hematuria 50% Hemiplegia/hemiparesis 50% Migraine 50% Nephropathy 50% Neurological speech impairment 50% Proteinuria 50% Retinopathy 50% Seizures 50% Cataract 7.5% Glaucoma 7.5% Incoordination 7.5% Micronodular cirrhosis 5% Abnormality of the musculature of the lower limbs - Abnormality of the periventricular white matter - Adult onset - Apraxia - Autosomal dominant inheritance - Central nervous system degeneration - Dementia - Dysarthria - Elevated erythrocyte sedimentation rate - Elevated hepatic transaminases - Hemiparesis - Limb pain - Lower limb hyperreflexia - Macular edema - Pigmentary retinal degeneration - Progressive - Progressive forgetfulness - Progressive visual loss - Punctate vasculitis skin lesions - Retinal exudate - Retinal hemorrhage - Stroke - Telangiectasia - Vasculitis in the skin - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"Hereditary endotheliopathy, retinopathy, nephropathy, and stroke inherited ?","output":"How is hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS) inherited? Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS) is inherited in an autosomal dominant manner. This means that having a mutation in only one copy of the gene responsible for the condition is sufficient to cause signs and symptoms of HERNS. When an individual with HERNS has children, each child has a 50% (1 in 2) chance to inherit the mutated gene. The term retinal vasculopathy with cerebral leukodystrophy (RVCL) has recently been adopted to include HERNS; cerebroretinal vasculopathy (CRV); and hereditary vascular retinopathy (HVR); historically, these 3 conditions have been considered distinct. However, recent genetic studies have shown that these 3 conditions are likely variations of RVCL and are now known to be caused by mutations in the TREX1 gene."},{"instruction":"What are the treatments for Hereditary endotheliopathy, retinopathy, nephropathy, and stroke ?","output":"How might hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS) be treated? At this time there is no effective treatment for hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS). Treatment of HERNS is largely palliative, which means that it is aimed at decreasing pain and suffering by providing treatments for relief of symptoms along with comfort and support. In some cases, aspirin may be recommended. Laser treatment to prevent retinal hemorrhage may be beneficial to some affected individuals. A continuous maintenance dose of corticosteroids may be prescribed to manage cerebral edema (swelling in the brain)."},{"instruction":"What are the symptoms of Cleft palate short stature vertebral anomalies ?","output":"What are the signs and symptoms of Cleft palate short stature vertebral anomalies? The Human Phenotype Ontology provides the following list of signs and symptoms for Cleft palate short stature vertebral anomalies. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal form of the vertebral bodies 90% Abnormality of the metacarpal bones 90% Aganglionic megacolon 90% Brachydactyly syndrome 90% Carious teeth 90% Cleft palate 90% Cognitive impairment 90% Delayed skeletal maturation 90% Epicanthus 90% Genu recurvatum 90% Low-set, posteriorly rotated ears 90% Scoliosis 90% Short neck 90% Short nose 90% Short stature 90% Vertebral segmentation defect 90% Abnormality of bone mineral density 50% Abnormality of the hip bone 50% Abnormality of the ureter 50% Anteverted nares 50% Congenital diaphragmatic hernia 50% Facial asymmetry 50% Joint hypermobility 50% Laryngomalacia 50% Limitation of joint mobility 50% Muscular hypotonia 50% Thin vermilion border 50% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) La Crosse encephalitis ?","output":"La Crosse (LAC) encephalitis is a mosquito-borne virus that was first described in La Crosse, Wisconsin in 1963. Since then, it has been reported in several Midwestern and Mid-Atlantic states. The LAC virus is one of many mosquito-transmitted viruses that can cause an inflammation of the brain (encephalitis). About 80-100 cases of this condition are reported each year in the United States. Most cases occur in children younger than age 16. While most people who become infected have no symptoms, those who do become ill may have fever, headache, vomiting and lethargy (tiredness). Severe cases develop encephalitis accompanied by seizures. Coma and paralysis occur in some cases. There is no specific treatment for LAC encephalitis. Supportive therapy is provided to those who develop severe cases of the disease."},{"instruction":"What are the symptoms of La Crosse encephalitis ?","output":"What are the symptoms of La Crosse (LAC) encephalitis? Most people infected with LAC encephalitis do not have symptoms. Those that do become ill may initially have fever, headache, vomiting and lethargy (tiredness). Severe cases may develop encephalitis, an inflammation of the brain, which is often accompanied by seizures. Coma and paralysis may also occur. Most cases that develop symptoms occur in children under the age of 16 Symptoms, if present, typically develop 5 to 15 days after the bite of an infected mosquito. Most cases occur during the summer months."},{"instruction":"What are the treatments for La Crosse encephalitis ?","output":"How might La Crosse (LAC) encephalitis be treated? There is no specific treatment for LAC encephalitis. Severe cases are treated with supportive therapy which may include hospitalization, respiratory support, IV fluids and prevention of other infections.[9633]"},{"instruction":"What is (are) Felty's syndrome ?","output":"Felty's syndrome is a rare, potentially serious disorder that is defined by the presence of three conditions: rheumatoid arthritis (RA), an enlarged spleen (splenomegaly) and a decreased white blood cell count (neutropenia), which causes repeated infections. Although some individuals with Felty's syndrome are asymptomatic, others can develop serious and life-threatening infections. Symptoms of Felty's syndrome, in addition to those associated with the three conditions stated above, may include fatigue, fever, weight loss, discoloration of patches of skin, mild hepatomegaly (enlarged liver), lymphadenopathy (swelling of lymph nodes), Sjgren syndrome, vasculitis, lower-extremity ulcers, and other findings. The exact cause is unknown, but several risk factors have been proposed, including autoimmunity. A few familial cases of the condition have been reported. Treatment typically focuses on controlling the underlying RA; immunosuppressive therapy for RA may improve neutropenia and splenomegaly."},{"instruction":"What are the symptoms of Felty's syndrome ?","output":"What are the signs and symptoms of Felty's syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Felty's syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of neutrophils 90% Arthralgia 90% Arthritis 90% Autoimmunity 90% Limitation of joint mobility 90% Osteolysis 90% Abnormality of lymphocytes 50% Anemia 50% Lymphadenopathy 50% Otitis media 50% Recurrent pharyngitis 50% Sinusitis 50% Splenomegaly 50% Weight loss 50% Abnormality of the pericardium 7.5% Abnormality of the pleura 7.5% Bone marrow hypocellularity 7.5% Cellulitis 7.5% Generalized hyperpigmentation 7.5% Hepatomegaly 7.5% Inflammatory abnormality of the eye 7.5% Irregular hyperpigmentation 7.5% Lymphoma 7.5% Peripheral neuropathy 7.5% Pulmonary fibrosis 7.5% Recurrent urinary tract infections 7.5% Sepsis 7.5% Skin ulcer 7.5% Thrombocytopenia 7.5% Autosomal dominant inheritance - Neutropenia - Rheumatoid arthritis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Felty's syndrome ?","output":"What causes Felty's syndrome? The exact cause of Felty's syndrome is unknown, although several causes and risk factors have been proposed. Some experts believe it may be an autoimmune disorder, and that it may sometimes be inherited in an autosomal dominant manner. Other proposed risk factors have included: RF (rheumatoid factor) positivity - being positive for a test used to help diagnose rheumatoid arthritis Long-term rheumatoid arthritis Aggressive and erosive synovitis (inflammation of the tissue that lines the joints) HLA-DR4 positivity (having a specific gene for the immune system that is associated with RA) and DR4 homozygosity (having 2 identical copies of this gene) Extra-articular RA manifestations (symptoms that are not joint-related)"},{"instruction":"Felty's syndrome inherited ?","output":"Is Felty's syndrome inherited? It has not been concluded that Felty's syndrome is an inherited condition; most individuals with Felty's syndrome have not had a history of the condition in their family. However, there have been a few reports of the condition appearing to be familial. Furthermore, although the condition itself may not be inherited, some of the risk factors associated with Felty's syndrome may have genetic components. One study found that a family history of rheumatoid arthritis was more common in patients with Felty's syndrome and that there was a strong association with HLA-DR4 (an immune system gene common in individuals with RA). The authors also stated that there was an increased frequency of another gene as well, suggesting that certain other immune system genes may interact with HLA-DR4 and contribute to individuals developing Felty's syndrome. In another report, the authors described a family in which 3 siblings had Felty's syndrome. All of the siblings shared a specific haplotype (a group of immune system genes that may be inherited together). The authors stated that they believe this supports the theory that multiple genetic factors are involved in family members being predisposed to Felty's syndrome. An earlier article described a family in which the mother and 2 of her 5 children had Felty's syndrome, which suggested autosomal dominant inheritance (which has not otherwise been reported)."},{"instruction":"What is (are) Arginase deficiency ?","output":"Arginase deficiency is an inherited metabolic condition in which the body is unable to process the amino acid (a building block of protein), arginine. Consequently, people affected by the condition have high levels of arginine in the blood and may also experience episodes of hyperammonemia (an accumulation of ammonia in the blood). Although most affected people appear healthy at birth, features of arginase deficiency generally develop between ages one and three years. Signs and symptoms may include growth deficiency, spasticity (abnormal tensing of the muscles), developmental delay, loss of developmental milestones, intellectual disability, seizures, and microcephaly. Arginase deficiency is caused by changes (mutations) in the ARG1 gene and is inherited in an autosomal recessive manner. Management is generally focused on lowering arginine levels and preventing hyperammonemia. This may be accomplished through restriction of dietary protein and use of certain medications (called nitrogen-scavenging drugs) under the supervision of a medical team with experience treating metabolic conditions."},{"instruction":"What are the symptoms of Arginase deficiency ?","output":"What are the signs and symptoms of Arginase deficiency? The Human Phenotype Ontology provides the following list of signs and symptoms for Arginase deficiency. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Aminoaciduria 90% Behavioral abnormality 90% Cognitive impairment 90% Neurological speech impairment 90% EEG abnormality 50% Hemiplegia/hemiparesis 50% Hyperammonemia 50% Seizures 50% Anorexia - Autosomal recessive inheritance - Diaminoaciduria - Hyperactivity - Intellectual disability - Irritability - Oroticaciduria - Postnatal growth retardation - Progressive spastic quadriplegia - Vomiting - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the treatments for Arginase deficiency ?","output":"How might arginase deficiency be treated? The treatment and management of arginase deficiency is generally focused on lowering arginine levels and preventing hyperammonemia (an accumulation of ammonia in the blood). This may be accomplished through dietary modifications and the use of certain medications (called nitrogen-scavenging drugs) under the supervision of a medical team with experience treating metabolic conditions. More specifically, people affected by arginase deficiency must restrict dietary protein and arginine. This is often achieved with the use of specialized formulas, which may account for half or more of protein intake. Although people with arginase deficiency are less prone to episodes of severe hyperammonemia than people affected by other urea cycle disorders, special treatment is needed should these episodes occur. During an episode, affected people are generally treated in the hospital and may require dialysis, nitrogen-scavenging medications, intravenous (IV) fluids/feeds and/or other treatments. These treatments are administered with the goal of rapidly reducing blood ammonia levels and preventing neurological damage. GeneReviews offers more specific information on the treatment of arginase deficiency and urea cycle disorders, in general. Please click on the links to access these resources."},{"instruction":"What is (are) Earlyonset, autosomal dominant Alzheimer disease ?","output":"Early-onset, autosomal dominant Alzheimer disease is a form of Alzheimer disease (AD) that develops before the age of 65. In general, AD is a degenerative disease of the brain that causes gradual loss of memory, judgement, and the ability to function socially. The early-onset, autosomal dominant form of AD is caused by changes (mutations) one of three different genes: APP, PSEN1, and PSEN2. The condition is inherited in an autosomal dominant manner. There is no cure for AD. Treatment is supportive and based on the signs and symptoms present in each person."},{"instruction":"Earlyonset, autosomal dominant Alzheimer disease inherited ?","output":"How is early-onset, autosomal dominant Alzheimer disease inherited? Early-onset, autosomal dominant Alzheimer disease is inherited in an autosomal dominant manner. This means that to be affected, a person only needs a change (mutation) in one copy of the responsible gene in each cell. In some cases, an affected person inherits the mutation from an affected parent. Other cases may result from new (de novo) mutations in the gene. These cases occur in people with no history of the disorder in their family. A person with this condition has a 50% chance with each pregnancy of passing along the altered gene to his or her child."},{"instruction":"What are the symptoms of Madokoro Ohdo Sonoda syndrome ?","output":"What are the signs and symptoms of Madokoro Ohdo Sonoda syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Madokoro Ohdo Sonoda syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of metabolism/homeostasis - Absent lacrimal punctum - Autosomal recessive inheritance - Bulbous nose - Constipation - Cryptorchidism - Downturned corners of mouth - Ectodermal dysplasia - High, narrow palate - Hypoplastic lacrimal duct - Hypotrichosis - Intellectual disability - Preauricular pit - Sacral dimple - Tetraamelia - Umbilical hernia - Upslanted palpebral fissure - Wide mouth - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Perniosis ?","output":"Perniosis are itchy and/or tender red or purple bumps that occur as a reaction to cold. In severe cases, blistering, pustules, scabs and ulceration may also develop. Occasionally, the lesions may be ring-shaped. They may become thickened and persist for months. Perniosis is a form of vasculitis. Signs and symptoms occur hours after cold exposure. Risk factors for perniosis include having poor blood circulation (such as due to diabetes or smoking), a family history of perniosis, poor nutrition, and low body weight. Perniosis may occur alone or in association with an autoimmune condition (e.g., lupus, scleroderma), bone marrow disorder, or cancer. Treatment aims to relieve symptoms and prevent infection. Lifestyle/adaptive changes may also be recommended to prevent future symptoms."},{"instruction":"What is (are) DICER1related pleuropulmonary blastoma cancer predisposition syndrome ?","output":"DICER1-related pleuropulmonary blastoma cancer predisposition syndrome causes a moderately increased risk for certain cancers and tumors. The lungs, kidneys, ovaries, and thyroid are the most commonly involved sites. Pleuropulmonary blastoma is the most commonly associated tumor and often occurs in infants and young children. Cysts in the kidneys (cystic nephroma) are also associated with DICER1 syndrome. These cysts typically develop in childhood, but do not usually cause any health problems. Women with DICER1 syndrome are at an increased risk for Sertoli-Leydig tumors of the ovaries. DICER1 syndrome is also associated with goiter (multiple fluid-filled or solid tumors in the thyroid gland). These goiters typically occur in adulthood and most often do not cause symptoms. This syndrome is caused by mutations in the DICER1 gene. It is passed through families in an autosomal dominant fashion. Affected members in the same family can be very differently affected."},{"instruction":"What are the symptoms of DICER1related pleuropulmonary blastoma cancer predisposition syndrome ?","output":"What are the signs and symptoms of DICER1-related pleuropulmonary blastoma cancer predisposition syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for DICER1-related pleuropulmonary blastoma cancer predisposition syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of metabolism/homeostasis - Autosomal dominant inheritance - Familial predisposition - Medulloblastoma - Pleuropulmonary blastoma - Rhabdomyosarcoma - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) L2hydroxyglutaric aciduria ?","output":"L-2-hydroxyglutaric aciduria is an inherited metabolic condition that is associated with progressive brain damage. Signs and symptoms of this condition typically begin during infancy or early childhood and may include developmental delay, seizures, speech difficulties, macrocephaly and abnormalities in a part of the brain called the cerebellum, which is involved in coordinating movement (i.e. balance and muscle coordination). L-2-hydroxyglutaric aciduria is caused by changes (mutations) in the L2HGDH gene and is inherited in an autosomal recessive manner. Treatment is focused on alleviating the signs and symptoms of the condition, such as medications to control seizures."},{"instruction":"What are the symptoms of L2hydroxyglutaric aciduria ?","output":"What are the signs and symptoms of L-2-hydroxyglutaric aciduria? The Human Phenotype Ontology provides the following list of signs and symptoms for L-2-hydroxyglutaric aciduria. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Cognitive impairment 90% Encephalitis 90% Seizures 90% Abnormality of extrapyramidal motor function 50% Aplasia/Hypoplasia of the cerebellum 50% Behavioral abnormality 50% Hypertonia 50% Macrocephaly 50% Muscular hypotonia 50% Neoplasm of the nervous system 50% Neurological speech impairment 7.5% Abnormal pyramidal signs - Autosomal recessive inheritance - Cerebellar atrophy - Corpus callosum atrophy - Developmental regression - Dysphasia - Gliosis - Global brain atrophy - Hearing impairment - Infantile onset - Intellectual disability, progressive - Intellectual disability, severe - L-2-hydroxyglutaric acidemia - L-2-hydroxyglutaric aciduria - Leukoencephalopathy - Morphological abnormality of the pyramidal tract - Nystagmus - Optic atrophy - Severe demyelination of the white matter - Spastic tetraparesis - Strabismus - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Osteogenesis imperfecta type III ?","output":"Osteogenesis imperfecta type III (OI type III) is a form of osteogenesis imperfecta, a group of genetic conditions that primarily affect the bones. In OI type III, specifically, a diagnosis can often be made shortly after birth as fractures (broken bones) during the newborn period simply from handling the infant are common. Other signs and symptoms vary significantly from person to person but may include severe bone fragility, bone malformations, short stature, dental problems (dentinogenesis imperfect), macrocephaly (unusually large head), hearing loss, and blue sclerae (whites of the eyes). Most affected people are unable to walk without assistance. OI type III is caused by changes (mutations) in the COL1A1 or COL1A2 genes and is inherited in an autosomal dominant manner. Treatment is based on the signs and symptoms present in each person."},{"instruction":"What are the symptoms of Osteogenesis imperfecta type III ?","output":"What are the signs and symptoms of Osteogenesis imperfecta type III? The Human Phenotype Ontology provides the following list of signs and symptoms for Osteogenesis imperfecta type III. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the nervous system - Abnormality of the thorax - Autosomal dominant inheritance - Autosomal recessive inheritance - Basilar impression - Biconcave vertebral bodies - Blue sclerae - Bowing of limbs due to multiple fractures - Decreased calvarial ossification - Dentinogenesis imperfecta - Frontal bossing - Hearing impairment - Kyphosis - Multiple prenatal fractures - Neonatal short-limb short stature - Platybasia - Protrusio acetabuli - Pulmonary hypertension - Recurrent fractures - Scoliosis - Severe generalized osteoporosis - Slender long bone - Tibial bowing - Triangular face - Wide anterior fontanel - Wormian bones - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Dicarboxylic aminoaciduria ?","output":"Dicarboxylic aminoaciduria is a rare metabolic disorder characterized by the excessive loss of aspartate and glutamate in urine. Symptoms have varied greatly among the few reported cases. Dicarboxylic aminoaciduria is caused by mutations in the SLC1A1 gene. It is inherited in an autosomal recessive fashion."},{"instruction":"What are the symptoms of Dicarboxylic aminoaciduria ?","output":"What are the signs and symptoms of Dicarboxylic aminoaciduria? There are no common signs or symptoms of dicarboxylic aminoaciduria. Hypoglycemia, developmental and neurological abnormalities, and obsessive compulsive tendencies were described in individual cases. Others that have been diagnosed had virtually no signs or symptoms. The Human Phenotype Ontology provides the following list of signs and symptoms for Dicarboxylic aminoaciduria. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Aminoaciduria - Autosomal recessive inheritance - Fasting hypoglycemia - Intellectual disability - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Microgastria limb reduction defect ?","output":"Microgastria limb reduction defect is a rare disorder with less than 60 previously reported cases. Children born with this condition have a small stomach (microgastria) and limb abnormalities. Symptoms may include vomiting, aspiration pneumonia and growth problems. Abnormalities involving the heart, lungs, kidney and gastrointestinal system are also symptoms of this condition. This condition is caused by an error that occurs during the development of the embryo. Treatment may involve reconstructive surgery (Hunt-Lawrence pouch) to help improve the child's feeding abilities."},{"instruction":"What are the symptoms of Microgastria limb reduction defect ?","output":"What are the signs and symptoms of Microgastria limb reduction defect? The Human Phenotype Ontology provides the following list of signs and symptoms for Microgastria limb reduction defect. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the spleen 90% Aplasia/Hypoplasia of the radius 90% Aplasia/Hypoplasia of the thumb 90% Microgastria 90% Abnormality of the humerus 50% Abnormality of the metacarpal bones 50% Abnormality of the ulna 50% Congenital muscular torticollis 50% Frontal bossing 50% Multicystic kidney dysplasia 50% Plagiocephaly 50% Abnormal localization of kidney 7.5% Abnormal lung lobation 7.5% Abnormality of neuronal migration 7.5% Abnormality of the clavicle 7.5% Absent hand 7.5% Amelia 7.5% Aplasia/Hypoplasia affecting the eye 7.5% Aplasia/Hypoplasia of the corpus callosum 7.5% Atria septal defect 7.5% Elbow dislocation 7.5% Hepatomegaly 7.5% Holoprosencephaly 7.5% Intestinal malrotation 7.5% Phocomelia 7.5% Renal hypoplasia/aplasia 7.5% Split hand 7.5% Tracheoesophageal fistula 7.5% Truncus arteriosus 7.5% Urogenital fistula 7.5% Absent gallbladder - Absent thumb - Aganglionic megacolon - Agenesis of corpus callosum - Anophthalmia - Arrhinencephaly - Asplenia - Bicornuate uterus - Biliary tract abnormality - Cryptorchidism - Cystic renal dysplasia - Failure to thrive - Fusion of the left and right thalami - Gastroesophageal reflux - Horseshoe kidney - Hypoplasia of the radius - Hypoplasia of the ulna - Oligodactyly (hands) - Pelvic kidney - Polymicrogyria - Secundum atrial septal defect - Sporadic - Type I truncus arteriosus - Unilateral renal agenesis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Spondyloepimetaphyseal dysplasia, Aggrecan type ?","output":"What are the signs and symptoms of Spondyloepimetaphyseal dysplasia, Aggrecan type? The Human Phenotype Ontology provides the following list of signs and symptoms for Spondyloepimetaphyseal dysplasia, Aggrecan type. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Absent nasal bridge 3/3 Barrel-shaped chest 3/3 Broad thumb 3/3 Joint laxity 3/3 Low-set ears 3/3 Lumbar hyperlordosis 3/3 Malar flattening 3/3 Mandibular prognathia 3/3 Mesomelia 3/3 Posteriorly rotated ears 3/3 Relative macrocephaly 3/3 Rhizomelia 3/3 Short finger 3/3 Short neck 3/3 Hoarse voice 2/3 Autosomal recessive inheritance - Spondyloepimetaphyseal dysplasia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Autosomal dominant compelling helio ophthalmic outburst syndrome ?","output":"What are the signs and symptoms of Autosomal dominant compelling helio ophthalmic outburst syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Autosomal dominant compelling helio ophthalmic outburst syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the nervous system - Autosomal dominant inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Punctate palmoplantar keratoderma type I ?","output":"Punctate palmoplantar keratoderma type I, also known as keratosis palmoplantaris papulosa (KPPP) or Brauer-Buschke-Fisher Syndrome is is a rare condition that affects the skin. It is a type of punctate palmoplantar keratoderma. Signs and symptoms begin in early adolescence or later and include hard, round bumps of thickened skin on the palms of the hands and soles of the feet. It is is usually inherited in an autosomal dominant manner and can be caused by mutations in the AAGAB gene. Treatment options may include chemical or mechanical keratolysis as well as systemic acitretin. Some affected individuals have used surgical approaches consisting of excision and skin grafting."},{"instruction":"What are the symptoms of Punctate palmoplantar keratoderma type I ?","output":"What are the signs and symptoms of Punctate palmoplantar keratoderma type I? Signs and symptoms of punctate palmoplantar keratoderma type 1 tend to become evident between the ages of 10 to 30 years. Symptoms include multiple, tiny, hard rounded bumps of thickened skin on the palms of the hands and soles of the feet. The bumps may join to form calluses on pressure points. The legions may cause pain, making walking difficult and impairing hand/finger movement. Symptoms tend to worsen with time and may be aggravated by manual work or injury. In some families, punctate palmoplantar keratoderma type 1 appears to be associated with an increased risk for several types of cancer. The Human Phenotype Ontology provides the following list of signs and symptoms for Punctate palmoplantar keratoderma type I. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Palmoplantar keratoderma 90% Lymphoma 50% Neoplasm of the breast 50% Neoplasm of the colon 50% Neoplasm of the pancreas 50% Renal neoplasm 50% Abnormality of the nail 7.5% Abnormality of the skin - Autosomal dominant inheritance - Heterogeneous - Late onset - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Punctate palmoplantar keratoderma type I ?","output":"What causes palmoplantar keratoderma type 1? Punctate palmoplantar keratoderma type 1 is a condition that is usually inherited in an autosomal dominant manner. It has recently been shown to be caused by mutations in the AAGAB gene in several families. Although the exact function of the AAGAB gene is currently unknown, the gene is thought to play an important role in skin integrity."},{"instruction":"Punctate palmoplantar keratoderma type I inherited ?","output":"How is punctate palmoplantar keratoderma type I inherited? Punctate palmoplantar keratoderma type I is usually inherited in an autosomal dominant manner. Autosomal dominant inheritance is when only one mutated copy of a disease-causing gene in each cell is sufficient for a person to be affected. An autosomal dominant condition may occur for the first time in an affected individual due to a new mutation, or may be inherited from an affected parent. When a person with an autosomal dominant disorder has a child, there is a 50% chance that his/her child will inherit the condition. Keratosis palmoplantaris papulosa shows age dependent penetrance and possibly variable penetrance as well. Age dependant penetrance means that the older the person is, the more likely they are to develop symptoms if they have inherited the disease causing gene mutation. Variable penetrance means that not everyone who inherits the gene mutation that causes keratosis palmoplantaris papulosa develops the signs and symptoms of the condition. However this person would still be at risk of passing the disease-causing mutation to their offspring."},{"instruction":"w to diagnose Punctate palmoplantar keratoderma type I ?","output":"How is punctate palmoplantar keratoderma type I diagnosed? Features that support the diagnosis of punctate palmoplantar keratoderma type I include a positive family history (i.e., other affected family members), the presence of multiple tiny hard rounded bumps of thickened skin on the hands and feet, and certain cell histology (i.e., appearance of skin samples when viewed under a microscope)."},{"instruction":"What are the treatments for Punctate palmoplantar keratoderma type I ?","output":"How might punctate palmoplantar keratoderma type 1 be treated? Treatment options for this condition generally include topical salicylic acid, mechanical debridement, excision, and systemic retinoids. These therapies can lead to a temporary decrease in skin thickness and softening of the skin. Unfortunately, in many cases, medical and surgical treatment for punctate keratodermas do not provide consistent or long-lasting results. In general, there has been some reported success using keratolytics such as corticosteroids, urea, salicylic acid, lactic acid, or Vitamin A. Systemic therapy using vitamin D analogues, aromatic retinoids, and 5-fluorouracil has also been used. However, individuals with successful resolution of lesions often relapse unless they are maintained on chronic low-dose therapy. These topical and systemic treatments carry a variety of side effects. Surgery (including excision and skin grafting) for punctate keratodermas has been used on lesions resistant to medical treatment, but healing after surgical treatment can be difficult. CO2 laser ablation has also been attempted and reportedly produces good results for limited areas of hyperkeratosis of the palms."},{"instruction":"What is (are) 2q37 deletion syndrome ?","output":"2q37 deletion syndrome is a rare chromosome condition that can affect many parts of the body. Approximately 100 cases have been reported worldwide. This condition is characterized by weak muscle tone (hypotonia) in infancy, mild to severe intellectual disability and developmental delay, behavioral problems, characteristic facial features, and other physical abnormalities. 2q37 deletion syndrome is caused by a deletion of the genetic material from a specific region in the long (q) arm of chromosome 2. Most cases are not inherited."},{"instruction":"What are the symptoms of 2q37 deletion syndrome ?","output":"What are the signs and symptoms of 2q37 deletion syndrome? Most babies with 2q37 deletion syndrome are born with hypotonia, which usually improves with age. About 25 percent of those with this condition have autism, a developmental condition that affects communication and social interaction. The characteristic facial features include a prominent forehead, highly arched eyebrows, deep-set eyes, a flat nasal bridge, a thin upper lip, and minor ear abnormalities. Other features can include short stature, obesity, unusually short fingers and toes (brachymetaphalangy), sparse hair, heart defects, seizures, and an inflammatory skin disorder called eczema. A few people with 2q37 deletion syndrome have a rare form of kidney cancer called Wilms tumor. Some affected individuals can also have malformations of the brain, gastrointestinal system, kidneys, and/or genitalia. Unique is a source of information and support to families and individuals affected by rare chromosome disorders. On their Web site, they have a pamphlet that provides additional information on the signs and symptoms of 2q37 deletion syndrome. Click on the link below to view this information. http://www.rarechromo.org/information/Chromosome%20%202/2q37%20deletions%20FTNW.pdf The Human Phenotype Ontology provides the following list of signs and symptoms for 2q37 deletion syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Cognitive impairment 90% Malar flattening 90% Muscular hypotonia 90% Round face 90% Abnormal hair quantity 50% Abnormality of the metacarpal bones 50% Abnormality of the palate 50% Anteverted nares 50% Aplasia/Hypoplasia of the eyebrow 50% Brachydactyly syndrome 50% Broad columella 50% Clinodactyly of the 5th finger 50% Deeply set eye 50% Depressed nasal bridge 50% Downturned corners of mouth 50% Eczema 50% Finger syndactyly 50% Frontal bossing 50% Highly arched eyebrow 50% Joint hypermobility 50% Microcephaly 50% Obesity 50% Seizures 50% Short foot 50% Short palm 50% Short stature 50% Single transverse palmar crease 50% Supernumerary nipple 50% Thin vermilion border 50% Toe syndactyly 50% Umbilical hernia 50% Underdeveloped nasal alae 50% Upslanted palpebral fissure 50% Abnormality of the aorta 7.5% Attention deficit hyperactivity disorder 7.5% Autism 7.5% Conductive hearing impairment 7.5% Congenital diaphragmatic hernia 7.5% Laryngomalacia 7.5% Macrocephaly 7.5% Multicystic kidney dysplasia 7.5% Nephroblastoma (Wilms tumor) 7.5% Obsessive-compulsive behavior 7.5% Pyloric stenosis 7.5% Short neck 7.5% Sleep disturbance 7.5% Stereotypic behavior 7.5% Tracheomalacia 7.5% Arrhythmia 5% Sensorineural hearing impairment 5% Subaortic stenosis 5% Aggressive behavior - Brachycephaly - Broad face - Broad nasal tip - Congenital onset - Hyperactivity - Hypoplasia of midface - Hyporeflexia - Intellectual disability - Pain insensitivity - Self-injurious behavior - Short metacarpal - Short metatarsal - Short phalanx of finger - Short toe - Somatic mutation - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes 2q37 deletion syndrome ?","output":"What causes 2q37 deletion syndrome? 2q37 deletion syndrome is caused by a deletion of genetic material from a specific region in the long (q) arm of chromosome 2. The deletion occurs near the end of the chromosome at a location designated 2q37. The size of the deletion varies among affected individuals. The signs and symptoms of this disorder are probably related to the loss of multiple genes in this region."},{"instruction":"2q37 deletion syndrome inherited ?","output":"How is 2q37 deletion syndrome inherited? Can it be a hidden trait? Most cases of 2q37 deletion syndrome are not inherited. They result from a chromosomal deletion that occurs as a random event during the formation of reproductive cells (eggs or sperm) or in early fetal development. Affected people typically have no history of the disorder in their family. Rarely, affected individuals inherit a copy of chromosome 2 with a deleted segment from an unaffected parent. In these cases, one of the parents carries a chromosomal rearrangement between chromosome 2 and another chromosome. This rearrangement is called a balanced translocation. No genetic material is gained or lost in a balanced translocation, so these chromosomal changes usually do not cause any health problems. However, translocations can become unbalanced as they are passed to the next generation. Children who inherit an unbalanced translocation can have a chromosomal rearrangement with extra or missing genetic material. Some individuals with 2q37 deletion syndrome inherit an unbalanced translocation that deletes genetic material near the end of the long arm of chromosome 2, which results in birth defects and other health problems characteristic of this disorder."},{"instruction":"What is (are) Preauricular sinus ?","output":"Preauricular sinus is a common birth defect that may be seen during a routine exam of a newborn. It generally appears as a tiny skin-lined hole or pit, often just in front of the upper ear where the cartilage of the ear rim meets the face. It may occur on one side (unilateral) or both sides (bilateral) of the ear. Affected people usually do not have any additional symptoms unless it becomes infected. Preauricular sinus may occur sporadically during the development of an embryo or it may be inherited in an autosomal dominant manner with reduced penetrance. Less often, it occurs as a feature of another condition or syndrome. Treatment may include antibiotics for infection and/or surgery to remove the sinus."},{"instruction":"What are the symptoms of Preauricular sinus ?","output":"What are the signs and symptoms of Preauricular sinus? The Human Phenotype Ontology provides the following list of signs and symptoms for Preauricular sinus. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal dominant inheritance - Preauricular pit - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the treatments for Preauricular sinus ?","output":"How might a preauricular sinus be treated? The majority of preauricular sinuses do not cause symptoms or problems unless they become infected. Common signs of infection include swelling, redness, fluid drainage, and pain. In these cases, treatment typically includes systemic antibiotics. If an abscess is present, it will likely need to be incised and drained. There are differing opinions in the medical literature about the indications for surgical removal of preauricular sinuses. Some believe that even asymptomatic sinuses should be removed. Others believe that surgery is indicated if infection or other complications arise."},{"instruction":"What are the symptoms of Radial ray hypoplasia choanal atresia ?","output":"What are the signs and symptoms of Radial ray hypoplasia choanal atresia? The Human Phenotype Ontology provides the following list of signs and symptoms for Radial ray hypoplasia choanal atresia. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the metacarpal bones 90% Aplasia/Hypoplasia of the thumb 90% Depressed nasal bridge 90% Strabismus 90% Triphalangeal thumb 90% Abnormality of the skin 50% Abnormality of the wrist 50% Brachydactyly syndrome 50% Choanal atresia 50% Autosomal dominant inheritance - Choanal stenosis - Distally placed thumb - Esotropia - Hypoplasia of the radius - Short thumb - Small thenar eminence - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Cataract microcornea syndrome ?","output":"What are the signs and symptoms of Cataract microcornea syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Cataract microcornea syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Cataract 90% Microcornea 90% Myopia 50% Corneal dystrophy 7.5% Iris coloboma 7.5% Nystagmus 7.5% Opacification of the corneal stroma 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Intellectual disability athetosis microphthalmia ?","output":"What are the signs and symptoms of Intellectual disability - athetosis - microphthalmia? The Human Phenotype Ontology provides the following list of signs and symptoms for Intellectual disability - athetosis - microphthalmia. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of movement 90% Abnormality of thumb phalanx 90% Broad forehead 90% Chin dimple 90% Cognitive impairment 90% Facial cleft 90% Frontal bossing 90% Hypertelorism 90% Hypertonia 90% Hypoplasia of the ear cartilage 90% Large earlobe 90% Malar flattening 90% Microcephaly 90% Reduced number of teeth 90% Scoliosis 90% Single transverse palmar crease 90% Supernumerary nipple 90% Telecanthus 90% Abnormality of the palate 50% Abnormality of the thorax 50% Aplasia/Hypoplasia affecting the eye 50% Blue sclerae 50% Camptodactyly of finger 50% Facial asymmetry 50% Iris coloboma 50% Lip pit 50% Mandibular prognathia 50% Preauricular skin tag 50% Seizures 50% Strabismus 50% Tapered finger 50% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of LoeysDietz syndrome type 2 ?","output":"What are the signs and symptoms of Loeys-Dietz syndrome type 2? The Human Phenotype Ontology provides the following list of signs and symptoms for Loeys-Dietz syndrome type 2. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Absent distal phalanges 5% Arnold-Chiari malformation 5% Atria septal defect 5% Bicuspid aortic valve 5% Bicuspid pulmonary valve 5% Cerebral aneurysm 5% Cleft palate 5% Craniosynostosis 5% Descending aortic aneurysm 5% Disproportionate tall stature 5% Hydrocephalus 5% Inguinal hernia 5% Intellectual disability 5% Mitral valve prolapse 5% Osteoporosis 5% Postaxial polydactyly 5% Syndactyly 5% Umbilical hernia 5% Abnormality of the sternum - Arachnodactyly - Ascending aortic aneurysm - Ascending aortic dissection - Autosomal dominant inheritance - Bifid uvula - Blue sclerae - Brachydactyly syndrome - Camptodactyly - Dermal translucency - Exotropia - Generalized arterial tortuosity - Hypertelorism - Joint contracture of the hand - Joint laxity - Malar flattening - Patent ductus arteriosus - Proptosis - Pulmonary artery aneurysm - Retrognathia - Scoliosis - Talipes equinovarus - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Pulmonary venous return anomaly ?","output":"What are the signs and symptoms of Pulmonary venous return anomaly? The Human Phenotype Ontology provides the following list of signs and symptoms for Pulmonary venous return anomaly. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the cardiac septa 90% Anomalous pulmonary venous return 90% Respiratory insufficiency 7.5% Tapered distal phalanges of finger 5% Aplasia/Hypoplasia of the nails - Autosomal dominant inheritance - Pulmonary hypertension - Recurrent respiratory infections - Total anomalous pulmonary venous return - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Ichthyosismental retardation syndrome with large keratohyalin granules in the skin ?","output":"What are the signs and symptoms of Ichthyosis-mental retardation syndrome with large keratohyalin granules in the skin? The Human Phenotype Ontology provides the following list of signs and symptoms for Ichthyosis-mental retardation syndrome with large keratohyalin granules in the skin. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal recessive inheritance - Generalized ichthyosis - Intellectual disability - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Platyspondylic lethal skeletal dysplasia Torrance type ?","output":"What are the signs and symptoms of Platyspondylic lethal skeletal dysplasia Torrance type? The Human Phenotype Ontology provides the following list of signs and symptoms for Platyspondylic lethal skeletal dysplasia Torrance type. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of epiphysis morphology 90% Abnormality of pelvic girdle bone morphology 90% Abnormality of the metacarpal bones 90% Abnormality of the metaphyses 90% Brachydactyly syndrome 90% Micromelia 90% Narrow chest 90% Platyspondyly 90% Short distal phalanx of finger 90% Short stature 90% Short thorax 90% Short toe 90% Aplasia/Hypoplasia of the lungs 50% Depressed nasal bridge 50% Genu varum 50% Hydrops fetalis 50% Low-set, posteriorly rotated ears 50% Malar flattening 50% Polyhydramnios 50% Sprengel anomaly 50% Cleft palate 7.5% Abnormality of the abdominal wall - Autosomal dominant inheritance - Coarse facial features - Decreased cranial base ossification - Disc-like vertebral bodies - Flat acetabular roof - Hypoplastic ilia - Hypoplastic ischia - Hypoplastic pubic bone - Lethal skeletal dysplasia - Macrocephaly - Metaphyseal cupping - Neonatal short-limb short stature - Protuberant abdomen - Severe limb shortening - Severe platyspondyly - Short long bone - Short neck - Short ribs - Thin ribs - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Dykes Markes Harper syndrome ?","output":"What are the signs and symptoms of Dykes Markes Harper syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Dykes Markes Harper syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Developmental regression 90% Gait disturbance 90% Hepatomegaly 90% Ichthyosis 90% Incoordination 90% Neurological speech impairment 90% Splenomegaly 90% Ataxia - Autosomal recessive inheritance - Dysarthria - Hepatosplenomegaly - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Mosaic trisomy 8 ?","output":"Mosaic trisomy 8 is a chromosome disorder defined by the presence of three copies of chromosome 8 in some cells of the body. It is characterized by distinctive facial features; mild intellectual disability; and joint, kidney, cardiac, and skeletal abnormalities. Males are more frequently affected than females. In the absence of serious problems, life expectancy is normal. Complete trisomy 8 is lethal and often results in miscarriage during the first trimester. Mosaic trisomy 8 is the result of a random error in the egg or sperm. Diagnosis is based on karyotype analysis. Mosaic trisomy 8 almost always occurs in individuals with no family history of the condition."},{"instruction":"What are the symptoms of Mosaic trisomy 8 ?","output":"What are the signs and symptoms of Mosaic trisomy 8? The facial features are usually mild and can include elongation of the skull (scaphocephaly), prominent forehead, widely-spaced eyes, deeply set eyes, broad upturned nose, micrognathia, and ear abnormalities. Additional features can include: agenesis of the corpus callosum, highly arched or cleft palate, short and large neck, high stature, elongated thin trunk, and narrow shoulders and pelvis. Kidney and cardiac abnormalities are frequent. Camptodactyly, stiff joints, absent malformed kneecap, vertebral malformations such as scoliosis, as well as eye abnormalities also commonly observed. Most affected individuals have moderate intellectual disabilities (IQ between 50 and 75), with some people having a normal intelligence. There is no correlation between the percentage of trisomic cells and the severity of the intellectual deficit. Mosaic trisomy 8 also seems to predispose to Wilms tumors, myelodysplasias, and myeloid leukemia. The Human Phenotype Ontology provides the following list of signs and symptoms for Mosaic trisomy 8. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of chromosome segregation 90% Cognitive impairment 90% Abnormality of pelvic girdle bone morphology 50% Abnormality of the antihelix 50% Abnormality of the ribs 50% Abnormality of the shoulder 50% Anteverted nares 50% Camptodactyly of finger 50% Deep palmar crease 50% Deep plantar creases 50% Deeply set eye 50% Dolichocephaly 50% Frontal bossing 50% Hypertelorism 50% Large earlobe 50% Limitation of joint mobility 50% Long face 50% Low-set, posteriorly rotated ears 50% Narrow chest 50% Opacification of the corneal stroma 50% Patellar aplasia 50% Scoliosis 50% Strabismus 50% Vertebral segmentation defect 50% Vesicoureteral reflux 50% Aplasia/Hypoplasia of the corpus callosum 7.5% Cleft palate 7.5% Cryptorchidism 7.5% Deviation of finger 7.5% Hearing impairment 7.5% Hypopigmented skin patches 7.5% Irregular hyperpigmentation 7.5% Short neck 7.5% Short stature 7.5% Tall stature 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Monoclonal gammopathy of undetermined significance ?","output":"Monoclonal gammopathy of undetermined significance (MGUS) is a condition in which an abnormal protein called monoclonal protein is detected in the blood. MGUS typically does not cause any problems, although some affected people may experience numbness, tingling or weakness. In some cases, MGUS may progress over time to certain forms of blood cancer (such as multiple myeloma, macroglobulinemia, or B-cell lymphoma). MGUS is thought to be a multifactorial condition that is likely associated with the effects of multiple genes in combination with lifestyle and environmental factors. People with MGUS are usually monitored closely to ensure that the levels of monoclonal protein do not rise and other problems do not develop. Those with stable levels of monoclonal protein typically do not require treatment."},{"instruction":"What are the symptoms of Auriculocondylar syndrome ?","output":"What are the signs and symptoms of Auriculo-condylar syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Auriculo-condylar syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Narrow mouth 52% Glossoptosis 46% Stenosis of the external auditory canal 30% Anterior open-bite malocclusion - Apnea - Autosomal dominant inheritance - Chewing difficulties - Cleft at the superior portion of the pinna - Cleft palate - Cupped ear - Dental crowding - Dental malocclusion - Hypoplastic superior helix - Low-set ears - Macrocephaly - Mandibular condyle aplasia - Mandibular condyle hypoplasia - Overfolding of the superior helices - Postauricular skin tag - Posteriorly rotated ears - Preauricular skin tag - Round face - Speech articulation difficulties - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Cockayne syndrome ?","output":"Cockayne syndrome is a rare condition which causes short stature, premature aging (progeria), severe photosensitivity, and moderate to severe learning delay. This syndrome also includes failure to thrive in the newborn, microcephaly, and impaired nervous system development. Other symptoms may include hearing loss, tooth decay, and eye and bone abnormalities. Cockayne syndrome type 1 (type A) is sometimes called classic or \\"moderate\\" Cockayne syndrome and is diagnosed during early childhood. Cockayne syndrome type 2 (type B) is sometimes referred to as the severe or \\"early-onset\\" type. This more severe form presents with growth and developmental abnormalities at birth. The third type, Cockayne syndrome type 3 (type C) is a milder form of the disorder. Cockayne syndrome is caused by mutations in either the ERCC8 (CSA) or ERCC6 (CSB) genes and is inherited in an autosomal recessive pattern. The typical lifespan for individuals with Cockayne syndrome type 1 is ten to twenty years. Individuals with type 2 usually do not survive past childhood. Those with type 3 live into middle adulthood."},{"instruction":"What are the symptoms of Cockayne syndrome ?","output":"What are the signs and symptoms of Cockayne syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Cockayne syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal blistering of the skin 90% Abnormality of the nose 90% Carious teeth 90% Cognitive impairment 90% Cutaneous photosensitivity 90% Deeply set eye 90% Hyperreflexia 90% Hypertonia 90% Incoordination 90% Macrotia 90% Microcephaly 90% Peripheral neuropathy 90% Prematurely aged appearance 90% Retinopathy 90% Sensorineural hearing impairment 90% Short stature 90% Abnormal hair quantity 50% Abnormality of the foot 50% Aplasia/Hypoplasia of the skin 50% Atypical scarring of skin 50% Cerebral calcification 50% Cerebral cortical atrophy 50% Chorioretinal abnormality 50% Decreased nerve conduction velocity 50% Dental malocclusion 50% Disproportionate tall stature 50% EEG abnormality 50% Fine hair 50% Generalized hyperpigmentation 50% Hypertension 50% Kyphosis 50% Large hands 50% Limitation of joint mobility 50% Strabismus 50% Tremor 50% Abnormality of pelvic girdle bone morphology 7.5% Abnormality of retinal pigmentation 7.5% Abnormality of the palate 7.5% Aplasia/Hypoplasia affecting the eye 7.5% Breast aplasia 7.5% Cataract 7.5% Cryptorchidism 7.5% Delayed eruption of teeth 7.5% Glomerulopathy 7.5% Hypertrophic cardiomyopathy 7.5% Nephrotic syndrome 7.5% Optic atrophy 7.5% Oral cleft 7.5% Platyspondyly 7.5% Seizures 7.5% Telangiectasia of the skin 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Tubulointerstitial nephritis and uveitis ?","output":"What are the signs and symptoms of Tubulointerstitial nephritis and uveitis? The Human Phenotype Ontology provides the following list of signs and symptoms for Tubulointerstitial nephritis and uveitis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Panuveitis 5% Abnormality of the mouth - Acute tubulointerstitial nephritis - Circulating immune complexes - Elevated serum creatinine - Glomerulonephritis - Non-caseating epithelioid cell granulomatosis - Reversible renal failure - Sporadic - Uveitis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Congenital lipoid adrenal hyperplasia ?","output":"What are the signs and symptoms of Congenital lipoid adrenal hyperplasia? The Human Phenotype Ontology provides the following list of signs and symptoms for Congenital lipoid adrenal hyperplasia. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Adrenogenital syndrome - Autosomal recessive inheritance - Congenital adrenal hyperplasia - Hypospadias - Renal salt wasting - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Autosomal dominant neuronal ceroid lipofuscinosis 4B ?","output":"Autosomal dominant neuronal ceroid lipofuscinosis 4B is a form of adult neuronal ceroid lipofuscinosis, which is a rare condition that affects the nervous system. Signs and symptoms usually begin around age 30, but they can develop anytime between adolescence and late adulthood. Affected people generally experience behavioral abnormalities, dementia; difficulties with muscle coordination (ataxia); and involuntary movements such as tremors or tics. It can be caused by changes (mutations) in the DNAJC5 or CTSF gene and is inherited in an autosomal dominant manner. Treatment options are limited to therapies that can help relieve some of the symptoms."},{"instruction":"What are the symptoms of Autosomal dominant neuronal ceroid lipofuscinosis 4B ?","output":"What are the signs and symptoms of Autosomal dominant neuronal ceroid lipofuscinosis 4B? The Human Phenotype Ontology provides the following list of signs and symptoms for Autosomal dominant neuronal ceroid lipofuscinosis 4B. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Adult onset - Ataxia - Auditory hallucinations - Autosomal dominant inheritance - Curvilinear intracellular accumulation of autofluorescent lipopigment storage material - Dementia - Depression - Fingerprint intracellular accumulation of autofluorescent lipopigment storage material - Granular osmiophilic deposits (GROD) in cells - Increased neuronal autofluorescent lipopigment - Myoclonus - Parkinsonism - Rapidly progressive - Rectilinear intracellular accumulation of autofluorescent lipopigment storage material - Seizures - Visual hallucinations - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Paroxysmal extreme pain disorder ?","output":"Paroxysmal extreme pain disorder is a form of peripheral neuropathy characterized by skin redness and warmth (flushing) and attacks of severe pain in various parts of the body. Early in life, the pain is often concentrated in the lower part of the body and may be triggered by a bowel movement. As a person ages, the location of the pain may change, with attacks affecting the head and face. Triggers of these pain attacks include changes in temperature, emotional distress or eating spicy foods and drinking cold beverages. Paroxysmal extreme pain disorder is caused by mutations in the SCN9A gene. This condition is inherited in an autosomal dominant pattern. Treatment may include medications used to manage chronic neuropathic pain (anticonvulsants) such as the sodium channel blocker carbamazepine."},{"instruction":"What are the symptoms of Paroxysmal extreme pain disorder ?","output":"What are the signs and symptoms of Paroxysmal extreme pain disorder? The Human Phenotype Ontology provides the following list of signs and symptoms for Paroxysmal extreme pain disorder. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Constipation 50% Autosomal dominant inheritance - Bradycardia - Impaired pain sensation - Lacrimation abnormality - Mandibular pain - Neonatal onset - Ocular pain - Tachycardia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Anonychia congenita ?","output":"Anonychia congenita is an extremely rare nail disorder characterized by the complete absence (anonychia) or abnormally developed fingernails and toenails. Affected individuals usually do not have hair, teeth, or bone abnormalities. Signs and symptoms are variable, even among affected members of the same family. Less than 20 individuals with anonychia congenita have been identified. This condition is thought to be caused by mutations in the RSPO4 gene and inherited in an autosomal recessive fashion."},{"instruction":"What are the symptoms of Anonychia congenita ?","output":"What are the signs and symptoms of Anonychia congenita? The Human Phenotype Ontology provides the following list of signs and symptoms for Anonychia congenita. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Anonychia - Autosomal recessive inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the treatments for Anonychia congenita ?","output":"How might anonychia congenita be treated? There is limited information regarding anonychia congenita because it is very rare. After a careful review of the medical literature, we did not find any information about treatment for this condition."},{"instruction":"What are the symptoms of Microcephaly cervical spine fusion anomalies ?","output":"What are the signs and symptoms of Microcephaly cervical spine fusion anomalies? The Human Phenotype Ontology provides the following list of signs and symptoms for Microcephaly cervical spine fusion anomalies. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the ribs 90% Cognitive impairment 90% Convex nasal ridge 90% Hyperlordosis 90% Hypoplasia of the zygomatic bone 90% Kyphosis 90% Low-set, posteriorly rotated ears 90% Malar prominence 90% Microcephaly 90% Pectus excavatum 90% Proptosis 90% Short stature 90% Sloping forehead 90% Vertebral segmentation defect 90% Abnormality of dental morphology 50% Abnormality of the clavicle 50% Abnormality of the hip bone 50% Abnormality of the ureter 50% Displacement of the external urethral meatus 50% Hyperreflexia 50% Neurological speech impairment 50% Ptosis 50% Short neck 50% Autosomal recessive inheritance - Intellectual disability - Spinal cord compression - Spinal instability - Vertebral fusion - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Genochondromatosis ?","output":"What are the signs and symptoms of Genochondromatosis? The Human Phenotype Ontology provides the following list of signs and symptoms for Genochondromatosis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the clavicle 90% Abnormality of the knees 90% Multiple enchondromatosis 90% Abnormality of the skeletal system - Autosomal dominant inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Camurati Engelmann disease, type 2 ?","output":"Camurati-Engelmann disease is a genetic condition that mainly affects the bones. People with this disease have increased bone density, particularly affecting the long bones of the arms and legs. In some cases, the skull and hip bones are also affected. The thickened bones can lead to pain in the arms and legs, a waddling walk, muscle weakness, and extreme tiredness. The age at which affected individuals first experience symptoms varies greatly; however, most people with this condition develop pain or weakness by adolescence. Camurati-Engelmann disease is caused by a mutation in the TGFB1 gene which is inherited in an autosomal dominant fashion. In some instances, people have the gene mutation that causes Camurati-Engelmann disease but never develop the characteristic features of this condition. In others, features are present, but a mutation cannot be identified. These cases are referred to as Camurati-Engelmann disease type II. Treatment for Camurati-Engelman disease depends on many factors including the signs and symptoms present in each person and the severity of the condition."},{"instruction":"What are the symptoms of Epidermolysa bullosa simplex with muscular dystrophy ?","output":"What are the signs and symptoms of Epidermolysa bullosa simplex with muscular dystrophy? The Human Phenotype Ontology provides the following list of signs and symptoms for Epidermolysa bullosa simplex with muscular dystrophy. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal blistering of the skin 90% Abnormality of the fingernails 90% Alopecia 90% Myopathy 90% Neurological speech impairment 90% Ophthalmoparesis 90% Abnormality of dental enamel 50% Aplasia/Hypoplasia of the skin 50% Ptosis 50% Fatigable weakness 7.5% Anemia - Autosomal recessive inheritance - Carious teeth - Hypoplasia of dental enamel - Increased connective tissue - Keratitis - Milia - Muscular dystrophy - Nail dysplasia - Nail dystrophy - Neonatal respiratory distress - Palmoplantar hyperkeratosis - Punctate keratitis - Scarring alopecia of scalp - Short stature - Urethral stricture - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Histidinuria renal tubular defect ?","output":"What are the signs and symptoms of Histidinuria renal tubular defect? The Human Phenotype Ontology provides the following list of signs and symptoms for Histidinuria renal tubular defect. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Aminoaciduria 90% Cerebral cortical atrophy 90% Cognitive impairment 90% Delayed skeletal maturation 90% Hypoglycemia 90% Hypoplastic toenails 90% Long philtrum 90% Macrotia 90% Sensorineural hearing impairment 90% Ventriculomegaly 90% Wide nasal bridge 90% Autosomal recessive inheritance - Generalized myoclonic seizures - Histidinuria - Impaired histidine renal tubular absorption - Intellectual disability - Rounded middle phalanx of finger - Short middle phalanx of finger - Smooth philtrum - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Epithelioid sarcoma ?","output":"Epithelioid sarcoma is a rare cancer that most often occurs in the soft tissue of the fingers, hands and forearms of young adults. It may also be found in the legs, trunk, head or neck regions. It is rare in young children and adults, and it occurs more frequently in men. Epithelioid sarcoma begins as a painless, firm growth or bump that may be accompanied by an open wound (ulceration) in the skin covering the growth. It is considered an aggressive cancer because it has a high chance of regrowing after treatment (a recurrence), or spreading to surrounding tissues or more distant parts of the body (a metastasis). Epithelioid sarcoma is first treated with surgery to remove all the cancer cells (wide local excision). Amputation of part of the affected limb may be needed in severe cases. Radiation therapy or chemotherapy may also be used to destroy any cancer cells not removed during surgery."},{"instruction":"What are the symptoms of Salcedo syndrome ?","output":"What are the signs and symptoms of Salcedo syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Salcedo syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Glomerulopathy 90% Hematuria 90% Hypertension 90% Proteinuria 90% Renal insufficiency 90% Short stature 90% Abnormality of the skeletal system - Autosomal recessive inheritance - Nephropathy - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Selective IgM deficiency ?","output":"Selective IgM deficiency or \\"Selective Immunoglobulin M deficiency (SIgMD) is a rare immune disorder that has been reported in association with serious infections, such as bacteremia. The disorder can occur in babies, children, and adults. It is characterized by isolated absence or deficiency of IgM, normal levels of other immunoglobulins and recurrent infections (especially by Staphylococcus aureus, Streptococcus pneumoniae, Hemophilus influenza). The cause is still unclear. The diagnosis includes the isolated deficiency of IgM in the blood and no other immunodeficiency or secondary cause of low IgM. Patients with SIgMD and recurrent infections are managed like other antibody defects and deficiencies. It is suggested to have pneumococcal and meningococcal vaccines, prophylactic antibiotics to patients who have recurrent infections and immune globulin replacement."},{"instruction":"What is (are) Dent disease 1 ?","output":"Dent disease type 1 is a kidney disease seen mostly in males. The most frequent sign of Dent disease is the presence of an abnormally large amount of protein in the urine (proteinuria). Other common signs of the disorder include excess calcium in the urine (hypercalciuria), calcium deposits in the kidney (nephrocalcinosis), and kidney stones (nephrolithiasis). In many males with Dent disease, progressive kidney problems lead to end-stage renal disease (ESRD) in early to mid-adulthood. ESRD ia a failure of kidney function that occurs when the kidneys are no longer able to effectively filter fluids and waste products from the body. Disease severity can vary even among members of the same family. Dent disease type 1 is inherited in an X-linked recessive manner. Approximately 60% of individuals with Dent disease 1 have a mutation in the CLCN5 gene which is located on the X chromosome. Due to random X-chromosome inactivation, some female carriers may manifest hypercalciuria and, rarely, proteinuria."},{"instruction":"What are the symptoms of Dent disease 1 ?","output":"What are the signs and symptoms of Dent disease 1? The Human Phenotype Ontology provides the following list of signs and symptoms for Dent disease 1. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Aminoaciduria - Bone pain - Bowing of the legs - Bulging epiphyses - Chronic kidney disease - Delayed epiphyseal ossification - Enlargement of the ankles - Enlargement of the wrists - Femoral bowing - Fibular bowing - Glycosuria - Hypercalciuria - Hyperphosphaturia - Hypophosphatemia - Increased serum 1,25-dihydroxyvitamin D3 - Low-molecular-weight proteinuria - Metaphyseal irregularity - Microscopic hematuria - Nephrocalcinosis - Nephrolithiasis - Osteomalacia - Phenotypic variability - Proximal tubulopathy - Recurrent fractures - Renal phosphate wasting - Rickets - Short stature - Sparse bone trabeculae - Thin bony cortex - Tibial bowing - X-linked recessive inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) 47, XYY syndrome ?","output":"47, XYY syndrome is a condition in males characterized by features that occur due to having an extra copy of the Y chromosome in each cell. Signs and symptoms can vary and range from barely noticeable to more severe; many men with the extra Y chromosome are completely unaware of its presence. Appearance and intelligence are usually normal, but learning disabilities may be present. Other signs and symptoms may include autism spectrum disorder (usually on the milder end); speech or motor delay; low muscle tone; asthma; tall stature; impaired social skills; ADHD; and/or anxiety or mood disorders. While sexual development and infertility is usually normal, some adolescents and adults have testicular failure. 47, XYY syndrome usually is not inherited, occurring due to a random event in the formation of a sperm cell prior to conception. Management depends on the symptoms in each person and may include intervention or therapies for developmental delays, behavior or mood disorders; and/or special education."},{"instruction":"What causes 47, XYY syndrome ?","output":"What causes 47, XYY syndrome? 47,XYY syndrome is caused by the presence of an extra copy of the Y chromosome in each of a male's cells. This is typically due to a random event during the formation of a sperm cell in the father, usually before conception (fertilization of the egg). In this case, the father's two Y chromosomes do not separate when sperm cells are being made. If two Y chromosomes are present in a sperm that fertilizes an egg (with an X chromosome), the resulting embryo will be a male with an extra Y chromosome. It is also possible that a similar random event could occur very early in an embryo's development. It is not fully understood why an extra copy of the Y chromosome leads to an increased risk for the features associated with 47, XYY syndrome in some males. Importantly, there is nothing either parent can do (or not do) to cause or prevent 47, XYY syndrome."},{"instruction":"47, XYY syndrome inherited ?","output":"Is 47, XYY syndrome inherited? 47, XYY syndrome is usually not inherited. It is typically due to a random event during the formation of a sperm cell. Recurrence of 47, XYY syndrome in a family is rare. The recurrence risk for siblings and other family members is not thought to be increased. Additionally, men with 47, XYY are not reported to have an increased risk for a child with a chromosome variation. People with personal questions about recurrence risks are encouraged to speak with a genetic counselor or other genetic professional."},{"instruction":"What are the symptoms of Fryns Hofkens Fabry syndrome ?","output":"What are the signs and symptoms of Fryns Hofkens Fabry syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Fryns Hofkens Fabry syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Ulnar deviation of finger 90% Autosomal dominant inheritance - Distal ulnar hypoplasia - Dysplastic radii - Hypoplasia of the radius - Mesomelic arm shortening - Radial bowing - Ulnar deviation of the hand - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of ThymicRenalAnalLung dysplasia ?","output":"What are the signs and symptoms of Thymic-Renal-Anal-Lung dysplasia? The Human Phenotype Ontology provides the following list of signs and symptoms for Thymic-Renal-Anal-Lung dysplasia. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal lung lobation 90% Abnormality of female internal genitalia 90% Abnormality of the fingernails 90% Abnormality of the nose 90% Abnormality of the parathyroid gland 90% Aplasia/Hypoplasia of the lungs 90% Aplasia/Hypoplasia of the thymus 90% Hypoplasia of the ear cartilage 90% Hypoplastic toenails 90% Intestinal malrotation 90% Intrauterine growth retardation 90% Low-set, posteriorly rotated ears 90% Malar flattening 90% Multicystic kidney dysplasia 90% Oligohydramnios 90% Urogenital fistula 90% Abnormality of metabolism/homeostasis - Abnormality of the endocrine system - Abnormality of the respiratory system - Anal atresia - Autosomal recessive inheritance - Renal agenesis - Ureteral agenesis - Ureteral dysgenesis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Prieto Xlinked mental retardation syndrome ?","output":"What are the signs and symptoms of Prieto X-linked mental retardation syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Prieto X-linked mental retardation syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the nose 90% Clinodactyly of the 5th finger 90% Cognitive impairment 90% Gait disturbance 90% Low-set, posteriorly rotated ears 90% Ventriculomegaly 90% Abnormal dermatoglyphics 50% Abnormality of the hip bone 50% Aplasia/Hypoplasia of the earlobes 50% Cryptorchidism 50% High forehead 50% Hypertelorism 50% Increased number of teeth 50% Muscular hypotonia 50% Neurological speech impairment 50% Optic atrophy 50% Patellar dislocation 50% Sacral dimple 50% Seizures 50% Abnormality of the pupil 7.5% Abnormality of the ribs 7.5% Delayed skeletal maturation 7.5% Epicanthus 7.5% Hernia of the abdominal wall 7.5% Nystagmus 7.5% Ptosis 7.5% Reduced bone mineral density 7.5% Strabismus 7.5% 11 pairs of ribs - Abnormality of the skin - Abnormality of the teeth - Cerebral atrophy - Clinodactyly - Coxa valga - Inguinal hernia - Intellectual disability - Low-set ears - Osteoporosis - Patellar subluxation - Prominent nose - Radial deviation of finger - Retrognathia - Talipes equinovarus - X-linked recessive inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Maple syrup urine disease type 1A ?","output":"What are the signs and symptoms of Maple syrup urine disease type 1A? The Human Phenotype Ontology provides the following list of signs and symptoms for Maple syrup urine disease type 1A. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Ataxia - Autosomal recessive inheritance - Cerebral edema - Coma - Elevated plasma branched chain amino acids - Feeding difficulties in infancy - Growth abnormality - Hypertonia - Hypoglycemia - Intellectual disability - Ketosis - Lactic acidosis - Lethargy - Vomiting - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Hypomelia mullerian duct anomalies ?","output":"What are the signs and symptoms of Hypomelia mullerian duct anomalies? The Human Phenotype Ontology provides the following list of signs and symptoms for Hypomelia mullerian duct anomalies. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal dermatoglyphics 50% Abnormality of female internal genitalia 50% Abnormality of the elbow 50% Abnormality of the humerus 50% Abnormality of the ulna 50% Abnormality of the wrist 50% Hypoplasia of penis 50% Microcephaly 50% Micromelia 50% Short stature 50% Split hand 50% Hypothyroidism 7.5% Postaxial hand polydactyly 7.5% Strabismus 7.5% Autosomal dominant inheritance - Longitudinal vaginal septum - Uterus didelphys - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Reticuloendotheliosis ?","output":"What are the signs and symptoms of Reticuloendotheliosis? The Human Phenotype Ontology provides the following list of signs and symptoms for Reticuloendotheliosis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Anemia - Hepatosplenomegaly - Infantile onset - Jaundice - Lymphadenopathy - X-linked inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Myoclonic epilepsy with ragged red fibers ?","output":"Myoclonic epilepsy with ragged red fibers (MERRF) is a multisystem disorder characterized by myoclonus, which is often the first symptom, followed by generalized epilepsy, ataxia, weakness, and dementia. Symptoms usually first appear in childhood or adolescence after normal early development. The features of MERRF vary widely from individual to individual, even within families. Other common findings include hearing loss, short stature, optic atrophy, and cardiomyopathy with Wolff-Parkinson-White (WPW) syndrome. The diagnosis is based on clinical features and a muscle biopsy finding of ragged red fibers (RRF). In over 80% of cases, MERRF is caused by mutations in the mitochondrial gene called MT-TK. Several other mitochondrial genes have also been reported to cause MERRF, but many of the individuals with mutations in these other genes have additional signs and symptoms. Seizures associated with MERRF are generally treated with conventional anticonvulsant therapy. Coenzyme Q10 and L-carnitine are often used with the hope of improving mitochondrial function."},{"instruction":"What are the symptoms of Myoclonic epilepsy with ragged red fibers ?","output":"What are the signs and symptoms of Myoclonic epilepsy with ragged red fibers? Because muscle cells and nerve cells have especially high energy needs, muscular and neurological problems are common features of diseases that affect the mitochondria. MERRF is a progressive multi-system syndrome with symptoms that begin during childhood, but onset may occur in adulthood. The rate of progression varies widely. Onset and extent of symptoms can differ widely from individual to individual and among affected siblings. The classic features of MERRF include: Myoclonus (brief, sudden, twitching muscle spasms) the most characteristic symptom Epileptic seizures Ataxia (impaired coordination) Ragged-red fibers (a characteristic microscopic abnormality observed in muscle biopsy of patients with MERRF and other mitochondrial disorders) Additional symptoms may include: hearing loss, lactic acidosis (elevated lactic acid level in the blood), short stature, exercise intolerance, dementia, cardiac defects, eye abnormalities, and speech impairment. However, the exact symptoms aren't the same for everyone, because a person with mitochondrial disease can have a unique mixture of healthy and non-working mitochondria, with a unique distribution in the body. Despite their many potential effects, mitochondrial diseases sometimes cause little disability. Sometimes, a person has enough healthy mitochondria to compensate for the defective ones. The Human Phenotype Ontology provides the following list of signs and symptoms for Myoclonic epilepsy with ragged red fibers. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of movement 90% EMG abnormality 90% Incoordination 90% Multiple lipomas 90% Myopathy 90% Sensorineural hearing impairment 90% Cognitive impairment 50% Short stature 50% Optic atrophy 7.5% Ataxia - Generalized myoclonic seizures - Increased serum lactate - Increased serum pyruvate - Mitochondrial inheritance - Muscle weakness - Myoclonus - Ragged-red muscle fibers - Seizures - Spasticity - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"Myoclonic epilepsy with ragged red fibers inherited ?","output":"Is myoclonic epilepsy associated with ragged red fibers genetic? If so, how is it inherited? MERRF is caused by mutations in the mitochondrial DNA and is transmitted by maternal inheritance. It is called maternal inheritance because a child inherits the great majority of their mitochondria from their mother through the egg. The Centre for Genetics Education provides a detail description of maternal inheritance. The mother of an individual with MERRF usually has a mitochondrial mutation and may or may not have symptoms. Or, an individual with MERRF may have a mitochondrial mutation that just occurred in them, called a de novo mutation. If the mother has the mitochondrial mutation, all of her children will inherit the mutation and may or may not have symptoms. All of her daughters children will also inherit the mitochondrial mutation. Her son's children are not at risk of inheriting the mutation."},{"instruction":"What is (are) BarraquerSimons syndrome ?","output":"Barraquer-Simons syndrome, or acquired partial lipodystrophy, is characterized by the loss of fat from the face, neck, shoulders, arms, forearms, chest and abdomen. Occasionally the groin or thighs are also affected. Onset usually begins in childhood following a viral illness. It affects females more often than males. The fat loss usually has a 18 month course, but can come and go over the course of several years. Following puberty, affected women may experience a disproportionate accumulation of fat in the hips and lower limbs. Around 1 in 5 people with this syndrome develop membranoproliferative glomerulonephritis. This kidney condition usually develops more than 10 years after the lipodystrophy's onset. Autoimmune disorders may also occur in association with this syndrome."},{"instruction":"What are the symptoms of BarraquerSimons syndrome ?","output":"What are the signs and symptoms of Barraquer-Simons syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Barraquer-Simons syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Lipoatrophy 90% Abnormality of complement system 50% Autoimmunity 50% Cognitive impairment 50% Glomerulopathy 50% Hearing impairment 50% Hematuria 50% Lymphocytosis 50% Myopathy 50% Prematurely aged appearance 50% Proteinuria 50% Seizures 50% Arthralgia 7.5% Hepatic steatosis 7.5% Hypertrichosis 7.5% Insulin resistance 7.5% Abnormality of lipid metabolism - Autosomal dominant inheritance - Decreased serum complement C3 - Diabetes mellitus - Hirsutism - Juvenile onset - Loss of subcutaneous adipose tissue from upper limbs - Loss of truncal subcutaneous adipose tissue - Membranoproliferative glomerulonephritis - Nephrotic syndrome - Phenotypic variability - Polycystic ovaries - Progressive loss of facial adipose tissue - Recurrent infections - Sporadic - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the treatments for BarraquerSimons syndrome ?","output":"How might Barraquer-Simons syndrome be treated? Surgery may be used to improve a person's appearance, but is not needed for medical reasons. Facial reconstruction techniques may be used with varying success. These techniques may include transplantation of fat tissue, silicone implants, movement of facial muscles, or other techniques. No specific diet is recommended for people with Barraquer-Simons syndrome and weight gain should be avoided. Regular exercise is recommended to improve a person's metabolic status. If a person with Barraquer-Simons syndrome has kidney problems, then they may also need to be managed. Treatment may involving a special diet or medications. Dialysis or a kidney transplant may be needed if the condition progresses to kidney failure."},{"instruction":"What are the symptoms of Mental retardation syndrome, Belgian type ?","output":"What are the signs and symptoms of Mental retardation syndrome, Belgian type? The Human Phenotype Ontology provides the following list of signs and symptoms for Mental retardation syndrome, Belgian type. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal nasal morphology 90% Abnormality of the testis 90% Cognitive impairment 90% Deeply set eye 90% Eunuchoid habitus 90% Long face 90% Long thorax 90% Mandibular prognathia 90% Narrow chest 90% Narrow nasal bridge 90% Type I diabetes mellitus 90% Muscular hypotonia 50% Seizures 50% Skeletal muscle atrophy 50% Autosomal recessive inheritance - Cleft ala nasi - Diabetes mellitus - Hypergonadotropic hypogonadism - Intellectual disability, moderate - Wide nose - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Craniosynostosis, anal anomalies, and porokeratosis ?","output":"What are the signs and symptoms of Craniosynostosis, anal anomalies, and porokeratosis? The Human Phenotype Ontology provides the following list of signs and symptoms for Craniosynostosis, anal anomalies, and porokeratosis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the clavicle 90% Abnormality of the eyelashes 90% Aplasia/Hypoplasia of the eyebrow 90% Displacement of the external urethral meatus 90% Frontal bossing 90% Hyperkeratosis 90% Urogenital fistula 90% Cognitive impairment 50% Ectopic anus 50% Hearing impairment 50% Malar flattening 50% Proptosis 50% Thick lower lip vermilion 50% Wide mouth 50% Cleft palate 7.5% Kyphosis 7.5% Anal atresia - Autosomal recessive inheritance - Brachycephaly - Coronal craniosynostosis - Delayed cranial suture closure - Ectropion - Hypoplasia of midface - Hypospadias - Lambdoidal craniosynostosis - Parietal foramina - Porokeratosis - Ptosis - Rectovaginal fistula - Sagittal craniosynostosis - Sensorineural hearing impairment - Short clavicles - Short ribs - Sparse eyebrow - Sparse eyelashes - Sparse scalp hair - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) TAR syndrome ?","output":"TAR syndrome is characterized by the absence of a bone called the radius in each forearm, short stature, and thrombocytopenia. The thrombocytopenia often appears first in infancy but becomes less severe or returns to normal over time. Infants and young children are particularly vulnerable to episodes of severe bleeding which may occur in the brain and other organs. Children who survive this period and do not have damaging bleeding in the brain usually have a normal life expectancy and normal intellectual development. Other signs and symptoms vary but may include heart defects, kidney defects, and other skeletal abnormalities. About half of people with TAR syndrome also have difficulty digesting cow's milk. TAR syndrome is thought be caused by a deletion of genes on chromosome 1q21.1 in concert with another genetic change that has yet to be identified. Click here to see a diagram of chromosome 1."},{"instruction":"What are the symptoms of TAR syndrome ?","output":"What are the signs and symptoms of TAR syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for TAR syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Bilateral radial aplasia 100% Abnormality of coagulation 90% Aplasia/Hypoplasia of the ulna 90% Thrombocytopenia 90% Clinodactyly of the 5th finger 75% Cow milk allergy 75% Coxa valga 75% Eosinophilia 75% Genu varum 75% Hip dislocation 75% Patellar aplasia 75% Abnormality of the intestine 50% Adducted thumb 50% Aplasia/hypoplasia of the humerus 50% Broad forehead 50% Broad thumb 50% High forehead 50% Low-set, posteriorly rotated ears 50% Patellar dislocation 50% Death in infancy 40% Anemia 33% Abnormal localization of kidney 7.5% Abnormality of the cardiac septa 7.5% Abnormality of the shoulder 7.5% Carpal bone hypoplasia 7.5% Cavum septum pellucidum 7.5% Cerebellar hypoplasia 7.5% Cleft palate 7.5% Delayed CNS myelination 7.5% Edema of the dorsum of feet 7.5% Edema of the dorsum of hands 7.5% Finger syndactyly 7.5% Hepatosplenomegaly 7.5% Lateral clavicle hook 7.5% Malar flattening 7.5% Nevus flammeus of the forehead 7.5% Phocomelia 7.5% Ptosis 7.5% Scoliosis 7.5% Sensorineural hearing impairment 7.5% Short phalanx of finger 7.5% Strabismus 7.5% Talipes equinovarus 7.5% Tetralogy of Fallot 7.5% Tibial torsion 7.5% Short stature 7% Aplasia of the uterus 5% Axial malrotation of the kidney 5% Cervical ribs 5% Coarctation of aorta 5% Fibular aplasia 5% Fused cervical vertebrae 5% Anteverted nares - Atria septal defect - Autosomal recessive inheritance - Brachycephaly - Carpal synostosis - Decreased antibody level in blood - Horseshoe kidney - Meckel diverticulum - Motor delay - Pancreatic cysts - Seborrheic dermatitis - Seizures - Shoulder muscle hypoplasia - Spina bifida - Ventricular septal defect - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) 48,XXYY syndrome ?","output":"48,XXYY syndrome is a chromosomal condition, characterized by the presence of an extra X and Y chromosome in males, that causes medical and behavioral problems. 48,XXYY can be considered a variant of Klinefelter syndrome. Individuals with 48,XXYY are usually considerably tall with small testes that do not function normally leading to infertility. In addition, affected individuals have behavioral problems such as anxiety, aggressiveness, problems communicating, hyperactivity, depression, as well as general learning disabilities and intellectual impairment. Other medical probelms can include congenital heart defects, bone abnormalities, tremor, obesity, type 2 diabetes and/or respiratory problems. Patients have an essentially normal life expectancy but require regular medical follow-up."},{"instruction":"What are the symptoms of 48,XXYY syndrome ?","output":"What are signs and symptoms of 48,XXYY syndrome? 48,XXYY affects various body systems including disruption of male sexual development. Adolescent and adult males with this condition typically have small testes that do not produce enough testosterone, which is the hormone that directs male sexual development. A shortage of testosterone during puberty can lead to reduced facial and body hair, poor muscle development, low energy levels, and an increased risk for breast enlargement (gynecomastia). Because their testes do not function normally, males with 48, XXYY syndrome have an inability to father children (infertility). 48,XXYY syndrome can affect other parts of the body as well. Males with 48,XXYY syndrome are often taller than other males their age. They tend to develop a tremor that typically starts as a young adult and worsens with age. Dental problems are frequently seen with this condition; they include delayed appearance of the primary (baby) or secondary (adult) teeth, thin tooth enamel, crowded and/or misaligned teeth, and multiple cavities. As affected males get older, they may develop a narrowing of the blood vessels in the legs, called peripheral vascular disease. Peripheral vascular disease can cause skin ulcers to form. Affected males are also at risk for developing a type of clot called a deep vein thrombosis (DVT) that occurs in the deep veins of the legs. Additionally, males with 48,XXYY syndrome may have flat feet (pes planus), elbow abnormalities, allergies, asthma, type 2 diabetes, seizures, and congenital heart defects. Most males with 48,XXYY syndrome have some degree of difficulty with speech and language development. Learning disabilities, especially reading problems, are very common in males with this disorder. Affected males seem to perform better at tasks focused on math, visual-spatial skills such as puzzles, and memorization of locations or directions. Some boys with 48,XXYY syndrome have delayed development of motor skills such as sitting, standing, and walking that can lead to poor coordination. Affected males have higher than average rates of behavioral disorders, such as attention deficit hyperactivity disorder (ADHD); mood disorders, including anxiety and bipolar disorder; and/or autism spectrum disorders, which affect communication and social interaction."},{"instruction":"What causes 48,XXYY syndrome ?","output":"What causes 48,XXYY? 48,XXYY syndrome is a condition related to the X and Y chromosomes (the sex chromosomes). People normally have 46 chromosomes in each cell. Two of the 46 chromosomes, known as X and Y, are called sex chromosomes because they help determine whether a person will develop male or female sex characteristics. Females typically have two X chromosomes (46,XX), and males have one X chromosome and one Y chromosome (46,XY). 48,XXYY syndrome results from the presence of an extra copy of both sex chromosomes in each of a male's cells (48,XXYY). Extra copies of genes on the X chromosome interfere with male sexual development, preventing the testes from functioning normally and reducing the levels of testosterone. Many genes are found only on the X or Y chromosome, but genes in areas known as the pseudoautosomal regions are present on both sex chromosomes. Extra copies of genes from the pseudoautosomal regions of the extra X and Y chromosome contribute to the signs and symptoms of 48,XXYY syndrome; however, the specific genes have not been identified.[5209]"},{"instruction":"48,XXYY syndrome inherited ?","output":"Can 48,XXYY syndrome be inherited?"},{"instruction":"What is (are) AicardiGoutieres syndrome type 1 ?","output":"Aicardi-Goutieres syndrome is an inherited condition that mainly affects the brain, immune system, and skin. It is characterized by early-onset severe brain dysfunction (encephalopathy) that usually results in severe intellectual and physical disability. Additional symptoms may include epilepsy, painful, itchy skin lesion (chilblains), vision problems, and joint stiffness. Symptoms usually progress over several months before the disease course stabilizes. There are six different types of Aicardi-Goutieres syndrome, which are distinguished by the gene that causes the condition: TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR genes. Most cases are inherited in an autosomal recessive pattern, although rare autosomal dominant cases have been reported. Treatment is symptomatic and supportive."},{"instruction":"What are the symptoms of AicardiGoutieres syndrome type 1 ?","output":"What are the signs and symptoms of Aicardi-Goutieres syndrome type 1? The Human Phenotype Ontology provides the following list of signs and symptoms for Aicardi-Goutieres syndrome type 1. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Hepatomegaly 5% Splenomegaly 5% Abnormality of extrapyramidal motor function - Acrocyanosis - Autosomal dominant inheritance - Autosomal recessive inheritance - Cerebral atrophy - Chilblain lesions - Chronic CSF lymphocytosis - Deep white matter hypodensities - Dystonia - Elevated hepatic transaminases - Feeding difficulties in infancy - Fever - Hepatosplenomegaly - Increased CSF interferon alpha - Intellectual disability, profound - Leukoencephalopathy - Morphological abnormality of the pyramidal tract - Multiple gastric polyps - Muscular hypotonia of the trunk - Nystagmus - Petechiae - Poor head control - Progressive encephalopathy - Progressive microcephaly - Prolonged neonatal jaundice - Purpura - Seizures - Spasticity - Strabismus - Thrombocytopenia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Restless legs syndrome ?","output":"Restless legs syndrome is a neurological condition that causes an irresistible urge to move the legs. The movement is triggered by strange or uncomfortable feelings, which occur mostly while the affected person is sitting or lying down and are worse at night. Movement (i.e. kicking, stretching, rubbing, or pacing) makes the discomfort go away, at least temporarily. Many people with restless legs syndrome also experience uncontrollable, repetitive leg movements that occur while they are sleeping or while relaxed or drowsy. Researchers have described early-onset and late-onset forms of restless legs syndrome. The early-onset form begins before age 45 and progresses slowly. The late-onset form begins after age 45, and its signs and symptoms tend to worsen more rapidly. Restless legs syndrome likely results from a combination of genetic, environmental, and lifestyle factors, many of which are unknown. Treatment is based on the signs and symptoms present in each person."},{"instruction":"What is (are) Prolactinoma, familial ?","output":"A prolactinoma is a tumor of the pituitary gland, which controls production of many hormones. A prolactinoma causes increased levels of the hormone prolactin. The symptoms of prolactinoma may include unusual milk production (galactorrhea) or no menstrual cycles (amenorrhea) in women or decreased sex drive in men. Most prolactinomas occur by chance (sporadically); in a small number of cases, prolactinoma may be associated with an inherited condition such as Multiple Endocrine Neoplasia type 1 (MEN1) or other genetic factor."},{"instruction":"What are the symptoms of Spastic paraplegia 4 ?","output":"What are the signs and symptoms of Spastic paraplegia 4? The Human Phenotype Ontology provides the following list of signs and symptoms for Spastic paraplegia 4. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Aggressive behavior - Agitation - Apathy - Autosomal dominant inheritance - Babinski sign - Degeneration of the lateral corticospinal tracts - Dementia - Depression - Disinhibition - Genetic anticipation - Hyperreflexia - Impaired vibration sensation in the lower limbs - Insidious onset - Intellectual disability - Low back pain - Lower limb muscle weakness - Memory impairment - Nystagmus - Paraplegia - Progressive - Spastic gait - Spastic paraplegia - Urinary bladder sphincter dysfunction - Urinary incontinence - Urinary urgency - Variable expressivity - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Mastocytic enterocolitis ?","output":"Mastocytic enterocolitis is a term describing the condition of chronic, intractable diarrhea in people with normal colon or duodenum biopsy results, but with an increased number of mast cells in the colonic mucosa (the innermost layer of the colon). The increase in mast cells is not associated with systemic or cutaneous mastocytosis. It is unclear whether the accumulation of mast cells is a response to, or cause of, the mucosal inflammation that causes the symptoms of the condition. Most individuals with this condition respond well to drugs affecting mast cell function."},{"instruction":"What are the symptoms of Mastocytic enterocolitis ?","output":"What are the signs and symptoms of mastocytic enterocolitis? According to the medical literature, signs and symptoms of mastocytic enterocolitis primarily include chronic, intractable diarrhea and abdominal pain. Other symptoms that have occasionally been reported include constipation, nausea, and/or vomiting. Although other signs and symptoms appear to have been reported by individuals on various online forums and support Web sites, we were unable to locate additional information about symptoms of the condition in the available medical literature. At this time, literature about mastocytic enterocolitis is scarce."},{"instruction":"w to diagnose Mastocytic enterocolitis ?","output":"How is mastocytic enterocolits diagnosed? Mastocytic enterocolitis is diagnosed after an endoscopic procedure in which the doctor takes samples of tissues (biopsies) from the lining of the intestines. The tissue is then sent to a pathologist who looks at it under the microscope. Mast cells may be hard to see on biopsies without a special stain for tryptase, an enzyme present in mast cells. Mastocytic enterocolitis is diagnosed when excess mast cells are present in the small bowel or the colon."},{"instruction":"What are the treatments for Mastocytic enterocolitis ?","output":"How might mastocytic enterocolitis be treated? There is very limited information in the medical literature about the treatment of mastocytic enterocolitis. Options that have been suggested include antihistamines and/or medications that alter mast cell mediator release and function, or mast cell stabilizers. Symptoms of chronic diarrhea may be relieved by staying well-hydrated and avoiding dehydration; maintaining a well-balanced diet; and avoiding alcohol and beverages that contain caffeine. People with a diagnosis of mastocytic enterocolitis who are looking for specific treatment options should speak with their healthcare provider."},{"instruction":"What is (are) Buerger disease ?","output":"Buerger disease is a disease of the arteries and veins in the arms and legs. The arteries and veins become inflamed which can lead to narrowed and blocked vessels. This reduces blood flow resulting in pain and eventually damage to affected tissues. Buerger disease nearly always occurs in association with cigarette or other tobacco use. Quitting all forms of tobacco is an essential part of treatment."},{"instruction":"What are the symptoms of Buerger disease ?","output":"What are the signs and symptoms of Buerger disease? The Human Phenotype Ontology provides the following list of signs and symptoms for Buerger disease. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Arterial thrombosis 90% Gangrene 90% Skin ulcer 90% Vasculitis 90% Acrocyanosis 50% Arthralgia 50% Paresthesia 50% Hyperhidrosis 7.5% Insomnia 7.5% Autosomal recessive inheritance - Limb pain - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Buerger disease ?","output":"What causes Buerger disease? Buerger disease has a strong relationship to cigarette smoking. This association may be due to direct poisioning of cells from some component of tobacco, or by hypersensitivity to the same components. Many people with Buerger disease will show hypersensitivities to injection of tobacco extracts into their skin. There may be a genetic component to susceptibility to Buerger disease as well. It is possible that these genetic influences account for the higher prevalence of Buerger disease in people of Israeli, Indian subcontinent, and Japanese descent. Certain HLA (human leukocyte antigen) haplotypes have also been found in association with Buerger disease."},{"instruction":"What are the treatments for Buerger disease ?","output":"How is Buerger disease treated? Currently there is not a cure for Buerger disease, however there are treatments that can help control it. The most essential part of treatment is to avoid all tobacco and nicotine products. Even one cigarette a day can worsen the disease. A doctor can help a person with Buerger disease learn about safe medications and programs to combat smoking/nicotine addiction. Continued smoking is associated with an overall amputation rate of 40 to 50 percent. The following treatments may also be helpful, but do not replace smoking/nicotine cessation: Medications to dilate blood vessels and improve blood flow (e.g., intravenous Iloprost) Medications to dissolve blood clots Treatment with calcium channel blockers Walking exercises Intermittent compression of the arms and legs to increase blood flow to your extremities Surgical sympathectomy (a controversial surgery to cut the nerves to the affected area to control pain and increase blood flow) Therapeutic angiogenesis (medications to stimulate growth of new blood vessels) Spinal cord stimulation Amputation, if infection or gangrene occurs"},{"instruction":"What is (are) Marshall syndrome ?","output":"Marshall syndrome is an inherited condition characterized by a distinctive facial appearance, eye abnormalities, hearing loss, and early-onset arthritis. Those with Marshall syndrome can also have short stature. Some researchers have argued that Marshall syndrome represents a variant form of Stickler syndrome; but this remains controversial. Marshall syndrome is caused by mutations in the COL11A1 gene and is inherited in an autosomal dominant fashion."},{"instruction":"What are the symptoms of Marshall syndrome ?","output":"What are the signs and symptoms of Marshall syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Marshall syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Anteverted nares 90% Aplasia/Hypoplasia involving the nose 90% Arthralgia 90% Depressed nasal bridge 90% Hypertelorism 90% Hypoplasia of the zygomatic bone 90% Long philtrum 90% Malar flattening 90% Myopia 90% Sensorineural hearing impairment 90% Short stature 90% Thick lower lip vermilion 90% Abnormal hair quantity 50% Abnormality of the vitreous humor 50% Cleft palate 50% Craniofacial hyperostosis 50% Genu valgum 50% Glaucoma 50% Hypohidrosis 50% Osteoarthritis 50% Proptosis 50% Retinal detachment 50% Visual impairment 50% Aplasia/Hypoplasia of the eyebrow 7.5% Frontal bossing 7.5% Nystagmus 7.5% Absent frontal sinuses - Autosomal dominant inheritance - Calcification of falx cerebri - Congenital cataract - Coxa valga - Epicanthus - Esotropia - Flat midface - Hypoplastic ilia - Irregular distal femoral epiphysis - Irregular proximal tibial epiphyses - Lens luxation - Low-set ears - Macrodontia of permanent maxillary central incisor - Meningeal calcification - Pierre-Robin sequence - Platyspondyly - Radial bowing - Short nose - Small distal femoral epiphysis - Small proximal tibial epiphyses - Thick upper lip vermilion - Thickened calvaria - Ulnar bowing - Vitreoretinal degeneration - Wide tufts of distal phalanges - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Craniodiaphyseal dysplasia ?","output":"What are the signs and symptoms of Craniodiaphyseal dysplasia? The Human Phenotype Ontology provides the following list of signs and symptoms for Craniodiaphyseal dysplasia. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the mandible 90% Abnormality of the ribs 90% Coarse facial features 90% Cognitive impairment 90% Craniofacial hyperostosis 90% Depressed nasal bridge 90% Frontal bossing 90% Macrocephaly 90% Short stature 90% Atresia of the external auditory canal 50% Conductive hearing impairment 50% Optic atrophy 7.5% Autosomal recessive inheritance - Diaphyseal dysplasia - Diaphyseal sclerosis - Facial hyperostosis - Intellectual disability - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Oculo skeletal renal syndrome ?","output":"What are the signs and symptoms of Oculo skeletal renal syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Oculo skeletal renal syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of pelvic girdle bone morphology 90% Abnormality of retinal pigmentation 90% Abnormality of the humeroulnar joint 90% Abnormality of the metacarpal bones 90% Abnormality of the renal tubule 90% Abnormality of the toenails 90% Astigmatism 90% Brachydactyly syndrome 90% Conductive hearing impairment 90% Deviation of finger 90% Dolichocephaly 90% Hypertension 90% Madelung deformity 90% Micromelia 90% Myopia 90% Proteinuria 90% Renal insufficiency 90% Short stature 90% Upslanted palpebral fissure 90% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Lafora disease ?","output":"Lafora disease is an inherited, severe form of progressive myoclonus epilepsy. The condition most commonly begins with epileptic seizures in late childhood or adolescence. Other signs and symptoms include difficulty walking, muscle spasms (myoclonus) and dementia. Affected people also experience rapid cognitive deterioration that begins around the same time as the seizures. The condition is often fatal within 10 years of onset. Most cases are caused by changes (mutations) in either the EPM2A gene or the NHLRC1 gene and are inherited in an autosomal recessive manner. Treatment is based on the signs and symptoms present in each person."},{"instruction":"What are the symptoms of Lafora disease ?","output":"What are the signs and symptoms of Lafora disease? The signs and symptoms of Lafora disease generally appear during late childhood or adolescence. Prior to the onset of symptoms, affected children appear to have normal development although some may have isolated febrile or nonfebrile convulsions in infancy or early childhood. The most common feature of Lafora disease is recurrent seizures. Several different types of seizures have been reported including generalized tonic-clonic seizures, occipital seizures (which can cause temporary blindness and visual hallucinations) and myoclonic seizures. These seizures are considered \\"progressive\\" because they generally become worse and more difficult to treat over time. With the onset of seizures, people with Lafora disease often begin showing signs of cognitive decline. This may include behavioral changes, depression, confusion, ataxia (difficulty controlling muscles), dysarthria, and eventually, dementia. By the mid-twenties, most affected people lose the ability to perform the activities of daily living; have continuous myoclonus; and require tube feeding and comprehensive care. The Human Phenotype Ontology provides the following list of signs and symptoms for Lafora disease. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of metabolism/homeostasis - Absence seizures - Apraxia - Autosomal recessive inheritance - Bilateral convulsive seizures - Cutaneous photosensitivity - Dementia - Gait disturbance - Generalized myoclonic seizures - Generalized tonic-clonic seizures - Hepatic failure - Heterogeneous - Myoclonus - Progressive neurologic deterioration - Psychosis - Rapidly progressive - Visual auras - Visual hallucinations - Visual loss - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Lafora disease ?","output":"What causes Lafora disease? Most cases of Lafora disease are caused by changes (mutations) in either the EPM2A gene or the NHLRC1 gene. These genes encode proteins that play a critical role in the survival of nerve cells (neurons) in the brain. Although the proteins are thought to have many functions in the body, one important role is to help regulate the production of a complex sugar called glycogen (an important source of stored energy in the body). Mutations in the EPM2A gene or the NHLRC1 gene interfere with the production of functional proteins, leading to the formation of Lafora bodies (clumps of abnormal glycogen that cannot be broken down and used for fuel) within cells. A build up of Lafora bodies appears to be especially toxic to the cells of the nervous system and leads to the signs and symptoms of Lafora disease."},{"instruction":"Lafora disease inherited ?","output":"Is Lafora disease inherited? Lafora disease is inherited in an autosomal recessive manner. This means that to be affected, a person must have a mutation in both copies of the responsible gene in each cell. The parents of an affected person usually each carry one mutated copy of the gene and are referred to as carriers. Carriers typically do not show signs or symptoms of the condition. When two carriers of an autosomal recessive condition have children, each child has a 25% (1 in 4) risk to have the condition, a 50% (1 in 2) risk to be a carrier like each of the parents, and a 25% chance to not have the condition and not be a carrier."},{"instruction":"w to diagnose Lafora disease ?","output":"How is Lafora disease diagnosed? A diagnosis of Lafora disease is often suspected based on the presence of characteristic signs and symptoms. Additional testing can then be ordered to confirm the diagnosis and rule out other conditions that may cause similar features. For example, a skin biopsy may be performed to detect \\"Lafora bodies\\" (clumps of abnormal glycogen that cannot be broken down and used for fuel) which are found in most people with the condition. Genetic testing for changes (mutations) in either the EPM2A gene or the NHLRC1 gene may be used to confirm the diagnosis in some cases. An EEG and an MRI of the brain are generally recommended in all people with recurrent seizures and are useful in investigating other conditions in the differential diagnosis. GeneReview's Web site offers more specific information regarding the diagnosis of Lafora disease. Please click on the link to access this resource."},{"instruction":"What are the treatments for Lafora disease ?","output":"How might Lafora disease be treated? Unfortunately, there is currently no cure for Lafora disease or way to slow the progression of the condition. Treatment is based on the signs and symptoms present in each person. For example, certain medications may be recommended to managed generalized seizures. In the advanced stages of the condition, a gastrostomy tube may be placed for feeding. Drugs that are known to worsen myoclonus (i.e. phenytoin) are generally avoided. GeneReview's Web site offers more specific information regarding the treatment and management of Lafora disease. Please click on the link to access this resource."},{"instruction":"What is (are) Granulomatous Amebic Encephalitis ?","output":"Granulomatous amebic encephalitis is a life-threatening infection of the brain caused by the free-living amoebae Acanthamoeba spp., Balamuthia mandrillaris and Sappinia pedata. Acanthamoeba species, are commonly found in lakes, swimming pools, tap water, and heating and air conditioning units. The disease affects immunocompromised peple and is very serious. Symptoms include mental status changes, loss of coordination, fever, muscular weakness or partial paralysis affecting one side of the body, double vision, sensitivity to light and other neurologic problems. The diagnosis is difficult and is often made at advanced stages. Tests useful in the diagnosis include brain scans, biopsies, or spinal taps and in disseminated disease, biopsy of the involved sites and testing by the laboratory experts. Early diagnosis is important for the prognosis. No single drug is effective; hence multiple antibiotics are needed for successful treatment. A combination of surgical and medical interventions involving multiple specialty experts is required to prevent death and morbidity in survivors."},{"instruction":"What is (are) Hypocomplementemic urticarial vasculitis syndrome ?","output":"Hypocomplementemic urticarial vasculitis (HUV) is a rare form of cutaneous small-vessel vasculitis characterized by recurrent episodes of urticaria and painful, tender, burning or itchy skin lesions, often associated with extracutaneous involvement but usually with no significant peripheral nerve damage. Patients with this condition are likely to have systemic involvement, including angioedema, arthralgias, pulmonary disease, abdominal or chest pain, fever, renal disease, and episcleritis. Hypocomplementemic urticarial vasculitis is thought be an autoimmune response involving a specific region of complement 1 (C1). It can present as or precede a syndrome that includes obstructive pulmonary disease , uveitis, systemic lupus erythematous (SLE), Sjgren's syndrome, or cryoglobulinemia (which is closely linked with hepatitis B or hepatitis C virus infection). Some cases of hypocomplementemic urticarial vasculitis respond to therapies commonly used for the treatment of SLE, including low-dose prednisone, hydroxychloroquine, dapsone, or other immunomodulatory agents."},{"instruction":"w to diagnose Hypocomplementemic urticarial vasculitis syndrome ?","output":"How is hypocomplementemic urticarial vasculitis (HUV) diagnosed? What kind of tests are required? A diagnosis of hypocomplementemic urticarial vasculitis (HUV) syndrome is supported by findings from varied tests, such as skin biopsy, blood tests, physical and eye examinations, and urinalysis and kidney imaging studies (when glomerulonephritis is suspected). People with HUV syndrome have hives (urticaria) for at least six months and low levels of proteins (complement) in the blood. Complement levels can be determined through a blood test. Click here to visit the American Association for Clinical Chemistry's Web site Lab Tests Online to learn more about this test. In addition to these major criteria, people with HUV syndrome must also have at least two of the following minor criteria: Inflammation in the small veins of the dermis (diagnosed by biopsy) Joint pain or arthritis Mild glomerulonephritis Inflammation in the eye (uvea or episclera) Recurrent abdominal pain The presence of anti-C1q antibodies (this test is not widely available) Some people have urticarial vasculitis and low complement levels (hypocomplementemia), but do not meet diagnostic criteria for HUV syndrome. These individuals may be diagnosed as having HUV (where symptoms are limited to the skin), versus HUV syndrome. Differential diagnoses for HUV syndrome include, Schnitzler's syndrome, Cogan's syndrome, and Muckle-Wells syndrome."},{"instruction":"What is (are) Hemochromatosis ?","output":"Hemochromatosis is a condition in which too much iron builds up in the body (iron overload). Accumulation of iron in the organs is toxic and can result in organ failure. While many organs can be affected, it may especially affect the liver, heart, and pancreas. Symptoms of hemochromatosis tend to develop gradually and often don't appear until middle age or later. The condition may not be diagnosed until iron accumulation is excessive. Early symptoms may be vague, such as fatigue or weakness. Other symptoms or features may include joint pain, abdominal pain, loss of sex drive, arthritis, liver disease, diabetes, heart problems, and skin discoloration. Hemochromatosis may be hereditary or acquired (secondary) due to another condition such as anemia, chronic liver disease, or an infection. There is also a neonatal form. Hereditary hemochromatosis is classified by type based on age of onset, genetic cause and mode of inheritance: Hemochromotosis type 1 Hemochromatosis type 2 Hemochromatosis type 3 Hemochromatosis type 4 Treatment usually involves removing blood (phlebotomy), which prevents additional organ damage but does not reverse existing damage."},{"instruction":"What are the symptoms of Hemochromatosis ?","output":"What are the signs and symptoms of Hemochromatosis? The Human Phenotype Ontology provides the following list of signs and symptoms for Hemochromatosis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal glucose tolerance - Alopecia - Amenorrhea - Arrhythmia - Arthropathy - Ascites - Autosomal recessive inheritance - Azoospermia - Cardiomegaly - Cardiomyopathy - Cirrhosis - Congestive heart failure - Diabetes mellitus - Elevated hepatic transaminases - Hepatocellular carcinoma - Hepatomegaly - Hyperpigmentation of the skin - Hypogonadotrophic hypogonadism - Impotence - Increased serum ferritin - Increased serum iron - Osteoporosis - Pleural effusion - Splenomegaly - Telangiectasia - Testicular atrophy - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Hemochromatosis ?","output":"What causes hemochromatosis? The underlying cause of hemochromatosis depends on whether a person has a hereditary form, an acquired form, or the neonatal form. Hereditary hemochromatosis is caused by mutations in any of several genes: type 1 hemochromatosis - the HFE gene type 2 hemochromatosis - either the HFE2 or HAMP gene type 3 hemochromatosis - the TFR2 gene type 4 hemochromatosis - the SLC40A1 gene These genes give the body instructions to make proteins that help regulate how iron is absorbed, transported, and stored. Mutations in these genes impair how iron is absorbed during digestion and alter the distribution of iron throughout the body. This causes iron to accumulate in tissues and organs. Acquired hemochromatosis (or secondary hemochromatosis) is usually due to other blood-related disorders, such as thalassemia or certain anemias, or having many blood transfusions. Sometimes it occurs as a result of long-term alcoholism or other health conditions. The cause of neonatal hemochromatosis is not fully understood. However, a woman with an affected child has approximately an 80% chance to have another affected child. This likelihood of recurrence is not explained by normal inheritance patterns. Therefore, this form appears to be familial, but not inherited."},{"instruction":"Hemochromatosis inherited ?","output":"Is hemochromatosis inherited? Hereditary hemochromatosis is inherited in an autosomal recessive or autosomal dominant manner, depending on the type a person has. Types 1, 2, and 3 are inherited in an autosomal recessive manner. This means that to be affected, a person must have a mutation in both copies of the responsible gene in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a carrier. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a 25% (1 in 4) chance to be affected, a 50% (1 in 2) chance to be an unaffected carrier like each parent, and a 25% chance to be unaffected and not be a carrier. Type 4 is inherited in an autosomal dominant manner. This means having only one mutated copy of the responsible gene in each cell is enough to cause the condition. When a person with an autosomal dominant condition has children, each child has a 50% chance to inherit the mutated copy of the gene. In most cases, a person with type 4 hemochromatosis has one affected parent. Acquired hemochromatosis is not inherited. Neonatal hemochromatosis is also not inherited, but it does appear to be familial. A woman with an affected child has approximately an 80% chance to have another affected child. However, this likelihood of recurrence is not explained by normal inheritance patterns. The underlying cause of this type is not fully understood."},{"instruction":"What are the symptoms of Retinopathy pigmentary mental retardation ?","output":"What are the signs and symptoms of Retinopathy pigmentary mental retardation? The Human Phenotype Ontology provides the following list of signs and symptoms for Retinopathy pigmentary mental retardation. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Arachnodactyly - Autosomal recessive inheritance - Cataract - Hypogonadism - Intellectual disability, progressive - Intellectual disability, severe - Joint hypermobility - Microcephaly - Moderately short stature - Myopia - Narrow palm - Pigmentary retinal degeneration - Reduced visual acuity - Retinopathy - Scoliosis - Truncal obesity - Visual impairment - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Polyneuropathy mental retardation acromicria premature menopause ?","output":"What are the signs and symptoms of Polyneuropathy mental retardation acromicria premature menopause? The Human Phenotype Ontology provides the following list of signs and symptoms for Polyneuropathy mental retardation acromicria premature menopause. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Brachydactyly syndrome 90% Cognitive impairment 90% Decreased nerve conduction velocity 90% EMG abnormality 90% Gait disturbance 90% Micromelia 90% Secondary amenorrhea 90% Short stature 90% Skeletal muscle atrophy 90% Camptodactyly of finger 50% Truncal obesity 50% Ulnar deviation of finger 50% Abnormality of pelvic girdle bone morphology 7.5% Arrhythmia 7.5% Furrowed tongue 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Aniridia absent patella ?","output":"What are the signs and symptoms of Aniridia absent patella? The Human Phenotype Ontology provides the following list of signs and symptoms for Aniridia absent patella. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Aplasia/Hypoplasia of the iris 90% Patellar aplasia 90% Cataract 50% Cryptorchidism 50% Glaucoma 50% Hernia of the abdominal wall 50% Muscular hypotonia 50% Ptosis 50% Aniridia - Aplasia/Hypoplasia of the patella - Autosomal dominant inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Cerebellar degeneration ?","output":"Cerebellar degeneration refers to the deterioration of neurons in the cerebellum (the area of the brain that controls muscle coordination and balance). Conditions that cause cerebellar degeneration may also affect other areas of the central nervous system, such as the spinal cord, the cerebral cortex, and the brain stem. Signs and symptoms of cerebellar degeneration may include a wide-based, uncoordinated walk; a back and forth tremor in the trunk of the body; uncoordinated movements of the arms and legs; slow and slurred speech; and nystagmus. Cerebellar degeneration can be caused by a variety of factors including inherited gene changes (mutations), chronic alcohol abuse, and paraneoplastic disorders. Treatment for cerebellar degeneration varies depending on the underlying cause."},{"instruction":"What are the symptoms of Cerebellar degeneration ?","output":"What are the signs and symptoms of cerebellar degeneration? Cerebellar degeneration is primarily characterized by a wide-legged, unsteady, lurching walk that is usually accompanied by a back and forth tremor in the trunk of the body. Other signs and symptoms may include slow, unsteady and jerky movement of the arms or legs; slowed and slurred speech; and nystagmus. Although cerebellar disorders usually strike adults in middle age, the age of symptomatic onset varies depending on the underlying cause of the degeneration. Studies have shown that many patients with movement disorders caused by damage to the cerebellum also have psychiatric symptoms. These studies suggest that patients with cerebellar diseases may benefit from screening and treatment of psychiatric disorders."},{"instruction":"What causes Cerebellar degeneration ?","output":"What causes cerebellar degeneration? Cerebellar degeneration can be caused by a variety of different conditions. Neurological diseases that can lead to cerebellar degeneration include: Acute and hemorrhagic stroke can result in a lack of blood flow or oxygen to the brain, leading to the death of neurons in the cerebellum and other brain structures. Cerebellar cortical atrophy, multisystem atrophy and olivopontocerebellar degeneration are progressive degenerative disorders that affect various parts of the nervous system, including the cerebellum. Spinocerebellar ataxias, including Friedreich ataxia, are caused by inherited changes (mutations) in many different genes and are characterized by cell death in the cerebellum, brain stem, and spinal cord. Transmissible spongiform encephalopathies (such as 'Mad Cow Disease' and Creutzfeldt-Jakob disease) are associated with inflammation of the brain, particularly in the cerebellum, that is caused by abnormal proteins. Multiple sclerosis occurs when the insulating membrane (myelin) that wraps around and protects nerve cells (including those of the cerebellum) become damaged. Other conditions that can lead to temporary or permanent cerebellar damage include chronic alcohol abuse and paraneoplastic disorders."},{"instruction":"Cerebellar degeneration inherited ?","output":"Is cerebellar degeneration inherited? Cerebellar degeneration is associated with a variety of inherited and non-inherited conditions. One example of an inherited form of cerebellar degeneration is spinocerebellar ataxia (SCA), which refers to a group of conditions characterized by degenerative changes of the cerebellum, brain stem, and spinal cord. Depending on the type, SCA can be inherited in an autosomal dominant, autosomal recessive, or X-linked manner. Other complex conditions such as multiple sclerosis and multisystem atrophy are also associated with cerebellar degeneration. These conditions are likely caused by the interaction of multiple genetic and environmental factors. Although complex conditions are not passed directly from parent to child, reports of familial forms exist. This suggests that a genetic susceptibility to these conditions can run in families. Many causes of cerebellar degeneration are acquired (non-genetic and non-inherited) including strokes, transmissible spongiform encephalopathies, chronic alcohol abuse and paraneoplastic disorders."},{"instruction":"w to diagnose Cerebellar degeneration ?","output":"How is cerebellar degeneration diagnosed? A diagnosis of cerebellar degeneration is often suspected when concerning signs and symptoms, such as a poorly coordinated gait (walk) and uncoordinated hand/finger movements, are present. For hereditary forms of cerebellar degeneration, genetic testing may be used to confirm the diagnosis. However, this is only an option if the disease-causing gene for that particular condition is known. In cerebellar degeneration caused by acquired (non-genetic and non-inherited) conditions or conditions with an unknown genetic cause, imaging studies such as computed tomography (CT scan) and/or magnetic resonance imaging (MRI scan) may be necessary to establish a diagnosis. A CT scan is an imaging method that uses x-rays to create pictures of cross-sections of the body, while an MRI scan uses powerful magnets and radio waves to create pictures of the brain and surrounding nerve tissues. Both of these imaging methods can be used to identify brain abnormalities found in people with cerebellar degeneration. Is genetic testing available for cerebellar degeneration? Genetic testing is only available for cerebellar degeneration that is caused by an inherited change (mutation) in a disease-causing gene. For example, genetic testing is available for many different genes known to cause spinocerebellar ataxia (SCA) which is one cause of inherited cerebellar degeneration. For more information on genetic testing for SCA, please click here. For many conditions known to cause cerebellar ataxia, the genetic cause is unknown or the condition is acquired (non-genetic and non-inherited). Genetic testing is not an option for people with these conditions."},{"instruction":"What are the treatments for Cerebellar degeneration ?","output":"How might cerebellar degeneration be treated? There is currently no cure for hereditary forms of cerebellar degeneration. In these cases, treatment is usually supportive and based on the signs and symptoms present in each person. For example, a variety of drugs may be used to treat gait abnormalities. Physical therapy can strengthen muscles, while special devices or appliances can assist in walking and other activities of daily life. In acquired (non-genetic and non-inherited) forms of cerebellar degeneration, some signs and symptoms may be reversible with treatment of the underlying cause. For example, paraneoplastic cerebellar degeneration may improve after successful treatment of the underlying cancer. For alcoholic/nutritional cerebellar degeneration, symptoms are often relieved with discontinuation of alcohol abuse, a normal diet and dietary supplementation with thiamine and other B vitamins."},{"instruction":"What is (are) Brachydactyly type B ?","output":"Brachydactyly type B is a very rare genetic condition characterized by disproportionately short fingers and toes. The ends of the second and fifth fingers are usually underdeveloped with complete absence of the fingernails. The thumb bones are always intact but are frequently flattened and/or split. The feet are usually similarly affected, but less severely. Other features that may be present include webbed fingers (syndactyly) and fusion of the joints (symphalangism) and bones in the hands and feet. Only a few cases have been reported in the literature. This condition is caused by mutations in the ROR2 gene. Most cases have been shown to be inherited in an autosomal dominant fashion."},{"instruction":"What are the symptoms of Brachydactyly type B ?","output":"What are the signs and symptoms of Brachydactyly type B? The Human Phenotype Ontology provides the following list of signs and symptoms for Brachydactyly type B. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the metacarpal bones 90% Anonychia 90% Aplasia/Hypoplasia of the distal phalanges of the toes 90% Short distal phalanx of finger 90% Short toe 90% Abnormality of thumb phalanx 7.5% Preaxial foot polydactyly 7.5% Symphalangism affecting the phalanges of the hand 7.5% Synostosis of carpal bones 7.5% Cutaneous finger syndactyly 5% Abnormality of the foot - Aplasia/Hypoplasia of the distal phalanges of the hand - Autosomal dominant inheritance - Broad thumb - Camptodactyly - Delayed cranial suture closure - Delayed eruption of permanent teeth - Hemivertebrae - Hypoplastic sacrum - Joint contracture of the hand - Micropenis - Short long bone - Short middle phalanx of finger - Syndactyly - Thoracolumbar scoliosis - Type B brachydactyly - Ventricular septal defect - Vertebral fusion - Wide anterior fontanel - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"Brachydactyly type B inherited ?","output":"How is brachydactyly type B inherited? Brachydactyly type B is caused by mutations in the ROR2 gene. It is inherited in an autosomal dominant fashion, which means one copy of the altered gene in each cell is sufficient to cause the disorder. Individuals with brachydactyly type B have a 50% chance of passing on this condition to their children."},{"instruction":"What are the symptoms of Holzgreve syndrome ?","output":"What are the signs and symptoms of Holzgreve syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Holzgreve syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Aplasia/Hypoplasia of the lungs 90% Cleft palate 90% Hand polydactyly 90% Intrauterine growth retardation 90% Oligohydramnios 90% Renal hypoplasia/aplasia 90% Abnormal vertebral ossification 50% Abnormality of calvarial morphology 50% Abnormality of the mesentery 50% Abnormality of the metacarpal bones 50% Abnormality of the ribs 50% Abnormality of the ulna 50% Aplasia/Hypoplasia of the corpus callosum 50% Aplasia/Hypoplasia of the tongue 50% Bifid tongue 50% Limitation of joint mobility 50% Low-set, posteriorly rotated ears 50% Macrotia 50% Single umbilical artery 50% Webbed neck 50% Autosomal recessive inheritance - Cleft upper lip - Hypoplastic left heart - Renal agenesis - Renal hypoplasia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Persistence of mullerian derivatives with lymphangiectasia and postaxial polydactyly ?","output":"What are the signs and symptoms of Persistence of mullerian derivatives with lymphangiectasia and postaxial polydactyly? The Human Phenotype Ontology provides the following list of signs and symptoms for Persistence of mullerian derivatives with lymphangiectasia and postaxial polydactyly. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Cryptorchidism 90% Hepatic failure 90% Abnormality of the palate 50% Hypocalcemia 50% Long philtrum 50% Low-set, posteriorly rotated ears 50% Polyhydramnios 50% Short neck 50% Thickened nuchal skin fold 50% Underdeveloped supraorbital ridges 50% Abnormality of the intestine 7.5% Adducted thumb 7.5% Anteverted nares 7.5% Epicanthus 7.5% Hernia of the abdominal wall 7.5% Hypoplasia of penis 7.5% Kyphosis 7.5% Prominent metopic ridge 7.5% Renal hypoplasia/aplasia 7.5% Ventriculomegaly 7.5% Abdominal distention - Alveolar ridge overgrowth - Ascites - Autosomal recessive inheritance - Cleft palate - Death in infancy - Flat midface - Flat occiput - Hepatomegaly - High palate - Hydronephrosis - Hypertelorism - Hypertrichosis - Hypoproteinemia - Inguinal hernia - Low-set ears - Lymphedema - Malar flattening - Micropenis - Muscular hypotonia - Narrow chest - Pancreatic lymphangiectasis - Postaxial hand polydactyly - Proptosis - Protein-losing enteropathy - Pulmonary lymphangiectasia - Redundant neck skin - Smooth philtrum - Splenomegaly - Thyroid lymphangiectasia - Ventricular septal defect - Wide nasal bridge - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Dihydrolipoamide dehydrogenase deficiency ?","output":"Dihydrolipoamide dehydrogenase (DLD) deficiency is a very rare condition that can vary in age of onset, symptoms and severity. The condition may be characterized by early-onset lactic acidosis and delayed development (most commonly); later-onset neurological dysfunction; or adult-onset isolated liver disease. Signs and symptoms may include lactic acidosis shortly after birth; hypotonia and lethargy in infancy; feeding difficulties; seizures; and various other health issues. Liver problems can range from hepatomegaly to life-threatening liver failure. Symptoms often occur in episodes that may be triggered by illness or other stresses on the body. Many affected infants do not survive the first few years of life; those who survive through early childhood often have growth delay and intellectual disability. Some with onset later in childhood may have neurological dysfunction with normal cognitive development. DLD deficiency is caused by mutations in the DLD gene and is inherited in an autosomal recessive manner."},{"instruction":"What are the symptoms of Dihydrolipoamide dehydrogenase deficiency ?","output":"What are the signs and symptoms of Dihydrolipoamide dehydrogenase deficiency? The signs and symptoms of dihydrolipoamide dehydrogenase (DLD) deficiency can vary widely among affected people. Early-onset DLD deficiency typically appears in early infancy with decreased muscle tone (hypotonia), lethargy, and lactic acidosis. Lactic acidosis can cause nausea, vomiting, severe breathing problems, and an abnormal heartbeat. Symptoms typically occur in episodes that may be triggered by illness, injury, or other stresses on the body. Affected infants often do not survive their initial episode or may die within the first few years of life during a recurrent episode. Children who live beyond the first two to three years often have growth delays and neurological problems such as intellectual disability, spasticity, ataxia, and seizures. However, normal intellect has been reported in a few people with the early-onset form of DLD deficiency. Isolated liver involvement, which can range from hepatomegaly (enlarged liver) to life-threatening liver failure, can also occur in the newborn period, or as late as the 3rd decade of life. A few people with DLD deficiency have become affected later in childhood with ataxia and dystonia, with normal cognitive development. Rarely, affected people have muscle weakness (particularly during exercise) or a weakened heart muscle (cardiomyopathy). The Human Phenotype Ontology provides the following list of signs and symptoms for Dihydrolipoamide dehydrogenase deficiency. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Aminoaciduria 90% Cognitive impairment 50% Gait disturbance 50% Hepatomegaly 50% Microcephaly 50% Muscular hypotonia 50% Hepatic failure 7.5% Hypoglycemia 7.5% Decreased liver function 5% Elevated hepatic transaminases 5% Ataxia - Autosomal recessive inheritance - Dystonia - Encephalopathy - Feeding difficulties - Hypertrophic cardiomyopathy - Lactic acidosis - Lethargy - Metabolic acidosis - Seizures - Variable expressivity - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Dihydrolipoamide dehydrogenase deficiency ?","output":"What causes dihydrolipoamide dehydrogenase deficiency? Dihydrolipoamide dehydrogenase (DLD) deficiency is caused by changes (mutations) in the DLD gene. This gene gives the body instructions to make an enzyme called dihydrolipoamide dehydrogenase (DLD). DLD is one part of 3 different groups of enzymes that work together (enzyme complexes). These enzyme complexes are involved in breaking down amino acids commonly found in protein-rich foods, and in other reactions that help to convert energy from food into a form that our cells can use. Mutations in the DLD gene impair the function of DLD, preventing the 3 enzyme complexes from functioning properly. This causes a build-up of molecules that are normally broken down, which in turn leads to tissue damage, lactic acidosis and other chemical imbalances. The brain is especially sensitive to the buildup of molecules and lack of cellular energy, which is why there are neurological problems associated with DLD deficiency."},{"instruction":"Dihydrolipoamide dehydrogenase deficiency inherited ?","output":"How is dihydrolipoamide dehydrogenase deficiency inherited? Dihydrolipoamide dehydrogenase (DLD) deficiency is inherited in an autosomal recessive manner. This means that a person must have a mutation in both copies of the responsible gene in each cell to be affected. The parents of an affected person usually each carry one mutated copy of the gene and are referred to as carriers. Carriers typically do not have any signs or symptoms of the condition. When two carriers of an autosomal recessive condition have children, each child has a 25% (1 in 4) risk to be affected, a 50% (1 in 2) risk to be a carrier like each of the parents, and a 25% to be unaffected and not be a carrier."},{"instruction":"What are the treatments for Dihydrolipoamide dehydrogenase deficiency ?","output":"How might dihydrolipoamide dehydrogenase deficiency be treated? There are currently no consensus recommendations for the management of dihydrolipoamide dehydrogenase (DLD) deficiency. Management can be hard because various metabolic pathways are affected and 3 enzyme complexes are involved. Deficiencies in enzyme pathways vary depending on the specific mutation(s) each affected person has. Unfortunately, the treatments that have been attempted in children with the early-onset neurologic form do not appear to significantly alter the course of the disease. Even with treatment, children often do not survive infancy or have varying degrees of chronic neurologic impairment if they survive the initial episode. Depending on individual enzyme complex deficiencies, treatment may involve certain dietary restrictions or certain diets; use of medical foods; and/or supplementation of specific amino acids or other substances. There is limited data for the chronic management of people with the primarily hepatic (liver-related) form of the disease. Management typically involves supportive therapy during times of acute liver injury or failure, and may include nutritional support; IV glucose for hypoglycemia; correction of metabolic acidosis; correction of coagulopathy; and avoidance of liver-toxic medications. More detailed information about the management of DLD deficiency can be viewed on the GeneReviews Web site. GeneReviews is intended for use by genetics professionals. Those not familiar with the principles discussed on the GeneReviews Web site are encouraged to speak with a genetics professional or other healthcare provider regarding information of interest."},{"instruction":"What is (are) Nephrogenic diabetes insipidus ?","output":"Nephrogenic diabetes insipidus is a disorder in which a defect in the small tubes (tubules) in the kidneys causes a person to pass a large amount of urine. Nephrogenic diabetes insipidus occurs when the kidney tubules, which allow water to be removed from the body or reabsorbed, do not respond to a chemical in the body called antidiuretic hormone (ADH) or vasopressin. ADH normally tells the kidneys to make the urine more concentrated. As a result of the defect, the kidneys release an excessive amount of water into the urine, producing a large quantity of very dilute urine. Nephrogenic diabetes insipidus can be either acquired or hereditary. The acquired form is brought on by certain drugs and chronic diseases and can occur at any time during life. The hereditary form is caused by genetic mutations, and its signs and symptoms usually become apparent within the first few months of life."},{"instruction":"What are the symptoms of Nephrogenic diabetes insipidus ?","output":"What are the signs and symptoms of Nephrogenic diabetes insipidus? The Human Phenotype Ontology provides the following list of signs and symptoms for Nephrogenic diabetes insipidus. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Constipation - Diabetes insipidus - Failure to thrive - Feeding difficulties in infancy - Hypernatremia - Hypertonic dehydration - Intellectual disability - Irritability - Megacystis - Neonatal onset - Polydipsia - Polyuria - Seizures - Short stature - Unexplained fevers - Vomiting - X-linked recessive inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Nephrogenic diabetes insipidus ?","output":"What causes nephrogenic diabetes insipidus? Nephrogenic diabetes insipidus can be either acquired or hereditary. The acquired form can result from chronic kidney disease, certain medications (such as lithium), low levels of potassium in the blood (hypokalemia), high levels of calcium in the blood (hypercalcemia), or an obstruction of the urinary tract. Acquired nephrogenic diabetes insipidus can occur at any time during life. The hereditary form of nephrogenic diabetes insipidus is caused by genetic mutations, and its signs and symptoms usually become apparent within the first few months of life."},{"instruction":"Nephrogenic diabetes insipidus inherited ?","output":"How is nephrogenic diabetes insipidus inherited? When nephrogenic diabetes insipidus results from mutations in the AVPR2 gene, the condition has an X-linked recessive pattern of inheritance. The AVPR2 gene is located on the X chromosome, which is one of the two sex chromosomes. In males (who have only one X chromosome), one altered copy of the gene in each cell is sufficient to cause the condition. In females (who have two X chromosomes), a mutation usually has to occur in both copies of the gene to cause the disorder. However, some females who carry a single mutated copy of the AVPR2 gene have features of nephrogenic diabetes insipidus, including polyuria and polydipsia. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons."},{"instruction":"w to diagnose Nephrogenic diabetes insipidus ?","output":"Is genetic testing available for nephrogenic diabetes insipidus? Yes. GeneTests lists laboratories offering clinical genetic testing for both X-linked and autosomal types of nephrogenic diabetes insipidus. Clinical genetic tests are ordered to help diagnose a person or family and to aid in decisions regarding medical care or reproductive issues. Talk to your health care provider or a genetic professional to learn more about your testing options."},{"instruction":"What are the treatments for Nephrogenic diabetes insipidus ?","output":"How might nephrogenic diabetes insipidus be treated? Management is usually best accomplished by a team of physicians and other healthcare professionals. The team may include a nutritionist, a pediatric (or adult) nephrologist or endocrinologist, and a clinical geneticist. The basis of management involves free access to drinking water and toilet facilities. Polyuria and polydipsia can be reduced up to 50% without disrupting appropriate levels of sodium in the blood through the use of thiazide diuretics hydrochlorothiazide, chlorothiazide) and/or other diuretics (i.e., potassium-sparing diuretic amiloride), dietary restriction of sodium, and nonsteroidal anti-inflammatory drugs (NSAIDs) such as indomethacin, which can potentially improve the ability of the body to concentrate urine and reduce urine output."},{"instruction":"What are the symptoms of Lethal congenital contracture syndrome 2 ?","output":"What are the signs and symptoms of Lethal congenital contracture syndrome 2? The Human Phenotype Ontology provides the following list of signs and symptoms for Lethal congenital contracture syndrome 2. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Dilated cardiomyopathy 7.5% Ventricular septal defect 7.5% Akinesia - Autosomal recessive inheritance - Decreased fetal movement - Degenerative vitreoretinopathy - Edema - Hydronephrosis - Polyhydramnios - Respiratory failure - Severe Myopia - Skeletal muscle atrophy - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Dystonia 7, torsion ?","output":"What are the signs and symptoms of Dystonia 7, torsion? The Human Phenotype Ontology provides the following list of signs and symptoms for Dystonia 7, torsion. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal dominant inheritance - Blepharospasm - Clumsiness - Dysphonia - Hand tremor - Oromandibular dystonia - Skeletal muscle hypertrophy - Torsion dystonia - Torticollis - Writer's cramp - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Optic atrophy polyneuropathy deafness ?","output":"What are the signs and symptoms of Optic atrophy polyneuropathy deafness? The Human Phenotype Ontology provides the following list of signs and symptoms for Optic atrophy polyneuropathy deafness. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Areflexia - Autosomal recessive inheritance - Broad-based gait - Distal muscle weakness - Distal sensory impairment - Distal upper limb amyotrophy - Gait ataxia - Joint contracture of the hand - Optic atrophy - Pectus excavatum - Peripheral demyelination - Positive Romberg sign - Progressive sensorineural hearing impairment - Short thumb - Thoracic scoliosis - Ulnar deviation of the hand - Variable expressivity - Visual impairment - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Tetraploidy ?","output":"What are the signs and symptoms of Tetraploidy? The Human Phenotype Ontology provides the following list of signs and symptoms for Tetraploidy. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of chromosome segregation 90% Convex nasal ridge 90% Intrauterine growth retardation 90% Microcephaly 90% Narrow forehead 90% Hypoplasia of the ear cartilage 50% Radial club hand 50% Short philtrum 50% Aplasia/Hypoplasia affecting the eye 7.5% Aplasia/Hypoplasia of the lungs 7.5% Aplasia/Hypoplasia of the thymus 7.5% Arnold-Chiari malformation 7.5% Cleft palate 7.5% Preauricular skin tag 7.5% Renal hypoplasia/aplasia 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Chilaiditi syndrome ?","output":"Chilaiditi syndrome is a medical condition in which a portion of the colon is abnormally positioned between the liver and the diaphragm. Symptoms vary, but may include abdominal pain, nausea, vomiting, and small bowel obstruction. In many cases, there are no symptoms and the interposition is an incidental finding. When no symptoms are present, the clinical finding is called Chilaiditi's sign.. The underlying cause of Chilaiditi syndrome is unknown. Treatment is symptomatic and supportive."},{"instruction":"What are the symptoms of Chilaiditi syndrome ?","output":"What are the signs and symptoms of Chilaiditi syndrome? The symptoms of Chilaiditi syndrome vary. Chronic recurrent abdominal pain is a common finding. Other symptoms might include nausea, vomiting, constipation, indigestion, difficulty swallowing, and abdominal tenderness, especially in the upper, central area. In some cases, breathing problems may develop."},{"instruction":"What causes Chilaiditi syndrome ?","output":"What causes Chilaiditi syndrome? The exact cause of Chilaiditi syndrome is unknown. The condition appears to occur with higher frequency among individuals with chronic lung disease, scarring of the liver (cirrhosis), and in those with an accumulation of ascites in the abdomen. Other risk factors may include reduced liver volume, paralysis of the motor nerve to the diaphragm (phrenic nerve palsy), and obesity. In some cases, the condition is present from birth (congenital)."},{"instruction":"What are the treatments for Chilaiditi syndrome ?","output":"How might Chilaiditi syndrome be treated? Treatment of Chilaiditi syndrome is directed at the individual symptoms present. In some cases, treatment is not needed. Reducing (or removing) the pressure within the abdomen may help alleviate symptoms. This may be achieved through conservative measure that address constipation, pain and distention. Surgical intervention may include removal of a portion of the color or the anchoring of the liver to the abdominal wall."},{"instruction":"What are the symptoms of Osteogenesis imperfecta type V ?","output":"What are the signs and symptoms of Osteogenesis imperfecta type V? The Human Phenotype Ontology provides the following list of signs and symptoms for Osteogenesis imperfecta type V. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Blue sclerae 5% Dentinogenesis imperfecta 5% Joint hypermobility 5% Abnormality of metabolism/homeostasis - Abnormality of pelvic girdle bone morphology - Anterior radial head dislocation - Autosomal dominant inheritance - Biconcave vertebral bodies - Hyperplastic callus formation - Limited pronation/supination of forearm - Osteopenia - Platyspondyly - Recurrent fractures - Short stature - Triangular face - Vertebral wedging - Wormian bones - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Spastic diplegia infantile type ?","output":"What are the signs and symptoms of Spastic diplegia infantile type? The Human Phenotype Ontology provides the following list of signs and symptoms for Spastic diplegia infantile type. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the palate 90% Cognitive impairment 90% Hemiplegia/hemiparesis 90% Hyperreflexia 90% Muscular hypotonia 90% Autosomal recessive inheritance - Infantile onset - Intellectual disability - Spastic diplegia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Lemierre syndrome ?","output":"Lemierre syndrome is a rare and potentially life-threatening illness. The bacterium responsible for this disease is typically Fusobacterium necrophorum, although a wide variety of bacteria have been reported as causing the disease. The bacterial infection begins in the oropharynx then spreads through the lymphatic vessels. Following this primary infection, thrombophlebitis of the internal jugular vein (IJV) develops. The final phase of the disease occurs when septic emboli (pus-containing tissue) migrate from their original location in the body to various organs. The lungs are most commonly involved, however other sites may include the joints, muscle, skin and soft tissue, liver, and spleen. The symptoms of Lemierre syndrome include fever, sore throat, neck swelling, pulmonary involvement and joint pain. It is an uncommon disease that occurs in about one person per million per year. The disease primarily affects healthy young people before age 40. Diagnosis of Lemierre syndrome rests on the presence of a blood clot (or clots) in the IJV and blood cultures that show the presence of Fusobacterium necrophorum. Intravenous antibiotics are the mainstay of treatment."},{"instruction":"What are the symptoms of Lemierre syndrome ?","output":"What are the symptoms reported in children who have Lemierre syndrome? In children and adolescents, Lemierre syndrome usually begins with a severe sore throat, persistent fever, and possibly chills. Some cases begin with acute otitis media. As the syndrome progresses, there is neck pain and tender swelling along the internal jugular vein.[ If undiagnosed, the next stage is the \\"metastasis\\" of septic emboli to the lungs, abdominal organs, brain or heart. Lung involvement typically results in a productive cough (a cough that brings up mucus or phlegm) and chest pain. Girls may report abdominal pain and have enlargement of the liver (hepatomegaly) and jaundice, all of which indicate involvement of the liver."},{"instruction":"What causes Lemierre syndrome ?","output":"What causes Lemierre syndrome? In about 90% of cases, Lemierre syndrome is caused by Fusobacterium necrophorum; however, the syndrome has also been reported with other bacteria, including Stapylococcus aureus, Bacteroides, Eikenella, Porphyromonas, Prevotella, Proteus, Peptostreptococcus and Streptococcus pyogenes."},{"instruction":"w to diagnose Lemierre syndrome ?","output":"How is Lemierre syndrome diagnosed? After performing blood cultures and complete blood counts, contrast computed tomography (CT) of the neck provides the definitive diagnosis. Ultrasound can also confirm internal jugular vein thrombosis."},{"instruction":"What are the treatments for Lemierre syndrome ?","output":"How is Lemierre syndrome treated? Most cases of internal jugular thrombophlebitis can be managed medically without the need for surgery of the infected vein. Prolonged courses of intravenous antibiotics (3 to 6 weeks) is usually required. Anticoagulants have sometimes been used, but efficacy is unconfirmed. Surgery of the internal jugular vein may be required only in the rare patient who fails to respond to antibiotic treatment alone."},{"instruction":"What are the symptoms of Pachygyria, frontotemporal ?","output":"What are the signs and symptoms of Pachygyria, frontotemporal? The Human Phenotype Ontology provides the following list of signs and symptoms for Pachygyria, frontotemporal. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal recessive inheritance - Esotropia - Hypertelorism - Intellectual disability, moderate - Pachygyria - Seizures - Telecanthus - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) 3Hydroxyisobutyric aciduria ?","output":"3-Hydroxyisobutyric aciduria is a rare metabolic condition in which the body is unable to breakdown certain amino acids (the building blocks of protein). This leads to a toxic buildup of particular acids known as organic acids in the blood (organic acidemia), tissues and urine (organic aciduria). Signs and symptoms of 3-hydroxyisobutyric aciduria include developmental delay, characteristic facial features and brain abnormalities. The exact underlying cause is not well understood; however, researchers believe some cases are caused by changes (mutations) in the ALDH6A1 gene and inherited in an autosomal recessive manner. Because it is so rare, there is limited evidence to support the effectiveness of treatment, but a protein-restricted diet and carnitine supplementation have been tried with varying degrees of success."},{"instruction":"What are the symptoms of 3Hydroxyisobutyric aciduria ?","output":"What are the signs and symptoms of 3-Hydroxyisobutyric aciduria? The signs and symptoms of 3-hydroxyisobutyric aciduria vary but may include: Developmental delay Intellectual disability Failure to thrive Characteristic facial features including a long philtrum and small, low-set ears Unusually small head (microcephaly) Congenital brain abnormalities Nausea Diarrhea Dehydration Lethargy The severity of the condition can also vary significantly from person to person. Some affected people may only experience mild attacks of vomiting with normal development, while others experience failure to thrive with severe intellectual disability and early death. The Human Phenotype Ontology provides the following list of signs and symptoms for 3-Hydroxyisobutyric aciduria. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Aminoaciduria 90% Abnormality of the outer ear 50% Long philtrum 50% Triangular face 50% Aplasia/Hypoplasia of the cerebellum 7.5% Aplasia/Hypoplasia of the corpus callosum 7.5% Cerebral calcification 7.5% Cerebral cortical atrophy 7.5% Intrauterine growth retardation 7.5% Microcephaly 7.5% Seizures 7.5% Sloping forehead 7.5% Ventriculomegaly 7.5% Abnormal facial shape - Abnormality of neuronal migration - Autosomal recessive inheritance - Congenital intracerebral calcification - Episodic ketoacidosis - Failure to thrive - Lactic acidosis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes 3Hydroxyisobutyric aciduria ?","output":"What causes 3-hydroxyisobutyric aciduria? In many affected people, the exact underlying cause of 3-hydroxyisobutyric aciduria is poorly understood. Scientists believe that some cases are caused by changes (mutations) in the ALDH6A1 gene. This gene encodes an enzyme called methylmalonate semialdehyde dehydrogenase, which helps the body break down certain amino acids (the building blocks of protein) found in food. If this gene isn't working properly, the body is unable to break down the amino acids valine and thymine which leads to a build-up of toxic substances in the body and the many signs and symptoms of 3-hydroxyisobutyric aciduria."},{"instruction":"3Hydroxyisobutyric aciduria inherited ?","output":"Is 3-hydroxyisobutyric aciduria inherited? Cases of 3-hydroxyisobutyric aciduria thought to be caused by changes (mutations) in the ALDH6A1 gene are inherited in an autosomal recessive manner. This means that to be affected, a person must have a mutation in both copies of the responsible gene in each cell. The parents of an affected person usually each carry one mutated copy of the gene and are referred to as carriers. Carriers typically do not show signs or symptoms of the condition. When two carriers of an autosomal recessive condition have children, each child has a 25% (1 in 4) risk to have the condition, a 50% (1 in 2) risk to be a carrier like each of the parents, and a 25% chance to not have the condition and not be a carrier."},{"instruction":"What are the treatments for 3Hydroxyisobutyric aciduria ?","output":"How might 3-hydroxyisobutyric aciduria be treated? There is no cure for 3-hydroxyisobutyric aciduria. Because it is so rare, there is limited evidence to support the effectiveness of treatment. However, affected people have been treated with a protein-restricted diet and carnitine supplementation with varying degrees of success."},{"instruction":"What is (are) Kienbock's disease ?","output":"Kienbock's disease is a condition characterized by interruption of blood supply to one of the small bones of the hand near the wrist (the lunate). If blood supply to a bone stops, the bone can die; this is known as osteonecrosis. Affected people may first think they have a sprained wrist and may have experienced trauma to the wrist, which can disrupt the blood flow to the lunate. As the disease progresses, signs and symptoms may include a painful and/or swollen wrist; stiffness; decreased grip strength; tenderness directly over the bone; and pain or difficulty in turning the hand upward. The underlying cause of Kienbock's disease is unknown. Treatment aims to relieve the pressure on the bone and restore blood flow within the bone. Surgery may be recommended."},{"instruction":"What are the symptoms of Kienbock's disease ?","output":"What are the signs and symptoms of Kienbock's disease? Kienbock's disease most commonly affects men between the ages of 20 and 40 years, but it affects women as well. Most affected people report a history of trauma to the wrist. Symptoms can vary depending on the stage of the condition, but usually include pain that is localized to the affected area, decreased motion, swelling, and weakness in the affected hand. Rarely, the condition may occur in both hands. The Human Phenotype Ontology provides the following list of signs and symptoms for Kienbock's disease. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the wrist 90% Arthralgia 90% Aseptic necrosis 90% Bone pain 90% Limitation of joint mobility 90% Osteoarthritis 50% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"Kienbock's disease inherited ?","output":"Is Kienbock's disease inherited? There is currently no evidence that Kienbock's disease is inherited. However, the cause of Kienbock's disease is not known. It is possible that unidentified genetic factors contribute to the development of the condition."},{"instruction":"What are the treatments for Kienbock's disease ?","output":"What nonsurgical options are available for the treatment of Kienbock's disease? The primary means of nonsurgical treatment of Kienbock's disease involve immobilization and anti-inflammatory medications. The wrist may be immobilized through splinting or casting over a period of two to three weeks. Anti-inflammatory medications, such as aspirin or ibuprofen, can help to relieve pain and reduce swelling. If the pain continues after these conservative treatments, your physician may refer you to an orthopaedic or hand surgeon for further evaluation."},{"instruction":"What is (are) Tyrosinemia type 3 ?","output":"Tyrosinemia type 3 is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. This condition is caused by a deficiency of the enzyme 4-hydroxyphenylpyruvate dioxygenase, one of the enzymes required for the multi-step process that breaks down tyrosine. This enzyme shortage is caused by mutations in the HPD gene. Characteristic features include intellectual disability, seizures, and periodic loss of balance and coordination (intermittent ataxia). Tyrosinemia type 3 is inherited in an autosomal recessive manner."},{"instruction":"What are the symptoms of Tyrosinemia type 3 ?","output":"What are the signs and symptoms of Tyrosinemia type 3? The Human Phenotype Ontology provides the following list of signs and symptoms for Tyrosinemia type 3. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) 4-Hydroxyphenylacetic aciduria - 4-Hydroxyphenylpyruvic aciduria - Abnormality of the liver - Autosomal recessive inheritance - Hypertyrosinemia - Intellectual disability, mild - Seizures - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Neutral lipid storage disease with myopathy ?","output":"Neutral lipid storage disease with myopathy is a condition in which fats (lipids) are stored abnormally in organs and tissues throughout the body. The accumulation of fats in muscle tissue leads to muscle weakness (myopathy). This condition is caused by mutations in the PNPLA2 gene. It is inherited in an autosomal recessive pattern. There is currently no treatment to correct the underlying metabolic problem."},{"instruction":"What are the symptoms of Neutral lipid storage disease with myopathy ?","output":"What are the signs and symptoms of Neutral lipid storage disease with myopathy? The Human Phenotype Ontology provides the following list of signs and symptoms for Neutral lipid storage disease with myopathy. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Areflexia 5% Cardiomyopathy 5% Diabetes mellitus 5% Hypertriglyceridemia 5% Neck muscle weakness 5% Sensorineural hearing impairment 5% Short stature 5% Adult onset - Autosomal recessive inheritance - Difficulty running - Difficulty walking - Easy fatigability - Elevated hepatic transaminases - Elevated serum creatine phosphokinase - Exercise intolerance - Fasciculations - Gowers sign - Hepatic steatosis - Hepatomegaly - Increased muscle lipid content - Muscular hypotonia - Myalgia - Myopathy - Proximal muscle weakness - Slow progression - Variable expressivity - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Neutral lipid storage disease with myopathy ?","output":"What causes neutral lipid storage disease with myopathy? Neutral lipid storage disease with myopathy is caused by mutations in the PNPLA2 gene. This gene provides instructions for making an enzyme called adipose triglyceride lipase (ATGL). The ATGL enzyme plays a role in breaking down fats called triglycerides. Triglycerides are an important source of stored energy in cells. These fats must be broken down into simpler molecules called fatty acids before they can be used for energy. PNPLA2 gene mutations impair the ATGL enzyme's ability to break down triglycerides, allowing them to accumulate in muscle and tissues throughout the body. This results in the signs and symptoms seen in people with neutral lipid storage disease with myopathy."},{"instruction":"Neutral lipid storage disease with myopathy inherited ?","output":"How is neutral lipid storage disease with myopathy inherited? This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition."},{"instruction":"What are the treatments for Neutral lipid storage disease with myopathy ?","output":"How might neutral lipid storage disease with myopathy be treated? To date, there is no treatment for the underlying metabolic problem. Current therapies include adhering to strict dietary guidelines and utilizing treatments focused on the associated symptoms. A recent study suggests that people with this condition may benefit from bezafibrate (a medication used to treat high cholesterol) treatment, particularly with respect to lipid accumulation and fat oxidative capacity. Additional studies into this therapy are needed."},{"instruction":"What are the symptoms of Melanoma astrocytoma syndrome ?","output":"What are the signs and symptoms of Melanoma astrocytoma syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Melanoma astrocytoma syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Medulloblastoma 50% Meningioma 50% Astrocytoma - Autosomal dominant inheritance - Cutaneous melanoma - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Familial exudative vitreoretinopathy ?","output":"Familial exudative vitreoretinopathy (FEVR) is a hereditary disorder that can cause progressive vision loss. This condition affects the retina, the light-sensitive tissue that lines the back of the eye, by preventing blood vessels from forming at the edges of the retina. This reduces the blood supply to retina. The signs and symptoms include vision loss or blindness, retinal detachment, strabismus, and a visible whiteness (leukocoria) in the normally black pupil. The severity of FEVR varies widely, even within the same family. Many people with this condition do not experience any vision problems.FEVR has different inheritance patterns depending on the gene involved. Most individuals have the autosomal dominant form of this condition, caused by mutations in the FZD4 or LRP5 gene. FEVR caused by LRP5 gene mutations can also have an autosomal recessive inheritance. When this condition is caused by mutations in the NDP gene, it has an X-linked pattern of inheritance."},{"instruction":"Familial exudative vitreoretinopathy inherited ?","output":"How is familial exudative vitreoretinopathy inherited? FEVR has different inheritance patterns depending on the gene involved. Most individuals have the autosomal dominant form of this condition, caused by mutations in the FZD4 or LRP5 gene. FEVR caused by LRP5 gene mutations can also have an autosomal recessive inheritance. When this condition is caused by mutations in the NDP gene, it has an X-linked pattern of inheritance."},{"instruction":"What are the treatments for Familial exudative vitreoretinopathy ?","output":"How might familial exudative vitreoretinopathy be treated? Affected individuals with abnormal blood vessel formation in their retina can be treated with laser therapy. Surgery may also be necessary to correct retinal detachment."},{"instruction":"What is (are) Xlinked sideroblastic anemia ?","output":"X-linked sideroblastic anemia is an inherited disorder that prevents developing red blood cells (erythroblasts) from making enough hemoglobin. People with X-linked sideroblastic anemia have mature red blood cells that are smaller than normal (microcytic) and appear pale (hypochromic) because of the shortage of hemoglobin. This disorder also leads to an abnormal accumulation of iron in red blood cells. The iron-loaded erythroblasts, which are present in bone marrow, are called ring sideroblasts. These abnormal cells give the condition its name. The signs and symptoms of X-linked sideroblastic anemia result from a combination of reduced hemoglobin and an overload of iron. They range from mild to severe and most often appear in young adulthood. Common features include fatigue, dizziness, a rapid heartbeat, pale skin, and an enlarged liver and spleen (hepatosplenomegaly). Over time, severe medical problems such as heart disease and liver damage (cirrhosis) can result from the buildup of excess iron in these organs. X-linked sideroblastic anemia is caused by mutation in the ALAS2 gene. In rare cases, mutations are found in both the HFE gene and the ALAS2 gene, resulting in a more severe form of X-linked sideroblastic anemia. X-linked sideroblastic anemia is inherited in an X-linked recessive pattern."},{"instruction":"What are the symptoms of Xlinked sideroblastic anemia ?","output":"What are the signs and symptoms of X-linked sideroblastic anemia? The Human Phenotype Ontology provides the following list of signs and symptoms for X-linked sideroblastic anemia. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Anemia 90% Abnormality of the cardiovascular system 7.5% Abnormality of the spleen 7.5% Irregular hyperpigmentation 7.5% Respiratory insufficiency 7.5% Type II diabetes mellitus 7.5% Hypochromic microcytic anemia - Macrocytic anemia - Sideroblastic anemia - Variable expressivity - X-linked recessive inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Medulloblastoma ?","output":"What are the signs and symptoms of Medulloblastoma? The Human Phenotype Ontology provides the following list of signs and symptoms for Medulloblastoma. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal dominant inheritance - Medulloblastoma - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Desmosterolosis ?","output":"What are the signs and symptoms of Desmosterolosis? The Human Phenotype Ontology provides the following list of signs and symptoms for Desmosterolosis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Aplasia/Hypoplasia of the corpus callosum 90% Cleft palate 90% Cognitive impairment 90% Hypertonia 90% Intrauterine growth retardation 90% Microcephaly 90% Short stature 90% Abnormality of the ribs 50% Aplasia/Hypoplasia involving the nose 50% Depressed nasal bridge 50% Large earlobe 50% Low-set, posteriorly rotated ears 50% Narrow mouth 50% Nystagmus 50% Seizures 50% Strabismus 50% Ventriculomegaly 50% Abnormality of neuronal migration 7.5% Anomalous pulmonary venous return 7.5% Aplasia/Hypoplasia of the skin 7.5% Epicanthus 7.5% Frontal bossing 7.5% Hydrocephalus 7.5% Increased bone mineral density 7.5% Intestinal malrotation 7.5% Limb undergrowth 7.5% Macrocephaly 7.5% Patent ductus arteriosus 7.5% Renal hypoplasia/aplasia 7.5% Splenomegaly 7.5% Talipes 7.5% Abnormality of cholesterol metabolism 2/2 Aplasia/Hypoplasia of the corpus callosum 2/2 Cleft palate 2/2 Alveolar ridge overgrowth 1/2 Ambiguous genitalia, female 1/2 Ambiguous genitalia, male 1/2 Bilateral talipes equinovarus 1/2 Cupped ear 1/2 Epicanthus 1/2 Frontal bossing 1/2 Generalized osteosclerosis 1/2 Gingival fibromatosis 1/2 Hypoplastic nasal bridge 1/2 Joint contracture of the hand 1/2 Low-set ears 1/2 Macrocephaly 1/2 Microcephaly 1/2 Patent ductus arteriosus 1/2 Posteriorly rotated ears 1/2 Rhizomelia 1/2 Total anomalous pulmonary venous return 1/2 Anteverted nares - Autosomal recessive inheritance - Failure to thrive - Partial agenesis of the corpus callosum - Phenotypic variability - Relative macrocephaly - Short nose - Spasticity - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Nonseminomatous germ cell tumor ?","output":"Nonseminomatous germ cell tumors are cancerous tumors commonly found in the pineal gland in the brain, in the mediastinum, or in the abdomen. They originate from cells that were meant to form sex cells (i.e., sperm or eggs). They are often large and have a tendency to spread more quickly than the other type of germ cell tumor (i.e., seminoma type). Possible early signs of this cancer include chest pain and breathing problems."},{"instruction":"What is (are) Wildervanck syndrome ?","output":"Wildervanck syndrome is a condition that occurs almost exclusively in females and affects the bones in the neck, the eyes, and the ears. It is characterized by Klippel-Feil anomaly (in which the bones of the neck fuse together), Duane syndrome (an eye movement disorder that is present from birth), and hearing loss. The cause of Wildervanck syndrome is unknown. In most cases, affected individuals have no family history of the condition."},{"instruction":"What are the symptoms of Wildervanck syndrome ?","output":"What are the signs and symptoms of Wildervanck syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Wildervanck syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Sensorineural hearing impairment 90% Short neck 90% Vertebral segmentation defect 90% Ectopia lentis 7.5% Facial asymmetry 7.5% Facial palsy 7.5% Low posterior hairline 7.5% Meningocele 7.5% Optic atrophy 7.5% Webbed neck 7.5% Abnormality of the outer ear - Fused cervical vertebrae - Hearing impairment - Preauricular skin tag - Pseudopapilledema - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Wildervanck syndrome ?","output":"What causes Wildervanck syndrome? The exact cause of Wildervanck syndrome is not known. It is suspected to be a polygenic condition, meaning that many genetic factors may be involved."},{"instruction":"Wildervanck syndrome inherited ?","output":"How is Wildervanck syndrome inherited? Wildervanck syndrome does not have a clear pattern of inheritance. In most cases, only one person in a family is affected. These cases are called isolated or sporadic because there is no family history of Wildervanck syndrome. Because this syndrome occurs mostly in females, it is possible that this condition has X-linked dominant inheritance. The lack of males with Wildervanck syndrome suggests that affected males have more severe features and do not survive to birth."},{"instruction":"What are the symptoms of Mandibuloacral dysplasia with type A lipodystrophy ?","output":"What are the signs and symptoms of Mandibuloacral dysplasia with type A lipodystrophy? The Human Phenotype Ontology provides the following list of signs and symptoms for Mandibuloacral dysplasia with type A lipodystrophy. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the clavicle 90% Abnormality of the teeth 90% Alopecia 90% Aplasia/Hypoplasia of the skin 90% Limitation of joint mobility 90% Osteolysis 90% Prematurely aged appearance 90% Short distal phalanx of finger 90% Short stature 90% Wormian bones 90% Abnormality of lipid metabolism 50% Abnormality of the eyebrow 50% Insulin resistance 50% Proptosis 50% Abnormality of skin pigmentation 7.5% Abnormality of the palate 7.5% Arthralgia 7.5% Breast aplasia 7.5% Cataract 7.5% Hearing impairment 7.5% Lack of skin elasticity 7.5% Muscular hypotonia 7.5% Acroosteolysis of distal phalanges (feet) - Autosomal recessive inheritance - Bird-like facies - Calcinosis - Decreased subcutaneous fat - Delayed cranial suture closure - Dental crowding - Dermal atrophy - Flexion contracture - Full cheeks - Glucose intolerance - Heterogeneous - High palate - Hyperglycemia - Hyperinsulinemia - Hyperlipidemia - Hypoplasia of teeth - Increased adipose tissue around the neck - Increased facial adipose tissue - Insulin-resistant diabetes mellitus - Joint stiffness - Juvenile onset - Lipodystrophy - Loss of subcutaneous adipose tissue in limbs - Mottled pigmentation - Narrow nasal ridge - Osteolytic defects of the distal phalanges of the hand - Postnatal growth retardation - Premature loss of teeth - Progressive clavicular acroosteolysis - Short clavicles - Sparse scalp hair - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Pyle disease ?","output":"Pyle disease is a bone disorder characterized by genu valgum (knock knees), Erlenmeyer flask deformity (where there is relative constriction of the diaphysis or shaft of the bone and flaring of the metaphysis or end of the bone), widening of the ribs and clavicles (collarbones), platyspondyly (flattening of the bones of the spine) and cortical thinning. Only about 30 cases have been reported in the literature. Cranial involvement is minimal with some showing mild hyperostosis (excessive new bone formation ) of the skull base and thickening of the frontal and occipital bones. Pyle disease is passed through families in an autosomal recessive manner."},{"instruction":"What are the symptoms of Pyle disease ?","output":"What are the signs and symptoms of Pyle disease? The Human Phenotype Ontology provides the following list of signs and symptoms for Pyle disease. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Genu valgum 90% Abnormality of pelvic girdle bone morphology 50% Abnormality of the clavicle 50% Abnormality of the elbow 50% Abnormality of the ribs 50% Craniofacial hyperostosis 50% Mandibular prognathia 50% Prominent supraorbital ridges 50% Recurrent fractures 50% Scoliosis 50% Abnormal form of the vertebral bodies 7.5% Carious teeth 7.5% Dental malocclusion 7.5% Abnormality of the thorax - Arthralgia - Autosomal recessive inheritance - Limited elbow extension - Metaphyseal dysplasia - Muscle weakness - Platyspondyly - Thickened calvaria - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"Pyle disease inherited ?","output":"Is Pyle disease inherited? Pyle disease in inherited in an autosomal recessive manner, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they often don't have any signs and symptoms of the condition. Some carriers (obligate heterozygotes) of Pyle disease show minor skeletal changes."},{"instruction":"What is (are) Prinzmetal's variant angina ?","output":"Prinzmetal's variant angina is characterized by recurrent episodes of chest pain that occur while an individual is at rest. This condition is a form of unstable angina because the episodes do not occur in a predictable pattern. Prinzmetal's variant angina may occur spontaneously, or it may be caused by exposure to cold, emotional stress, alcohol withdrawal, or vasoconstricting medications. The symptoms of this condition usually respond to treatment. Individuals with Prinzmetals' variant angina may have a higher risk for heart attack or arrhythmia."},{"instruction":"What are the symptoms of Prinzmetal's variant angina ?","output":"What are the symptoms of Prinzmetal's variant angina? The main symptom of Prinzmetal's variant angina is chest pain (angina) with the following characteristics: Occurs under the chest bone Described as squeezing, constricting, tightness, pressure, crushing Is usually severe and may radiate to the neck, jaw, shoulder, or arm Often occurs at rest Typically occurs at the same time each day, usually between midnight and 8am. Duration of pain is 5 to 30 minutes Pain is relieved by nitroglycerin Loss of consciousness"},{"instruction":"What causes Prinzmetal's variant angina ?","output":"What causes Prinzmetal's variant angina? Prinzmetal's variant angina is caused by coronary artery spasms. A coronary artery spasm is a temporary, abrupt, and focal (restricted to one location) contraction of the muscles in the wall of an artery in the heart. This spasm constricts the artery, slowing or stoping blood flow. A prolonged spasm can cause chest pain, or even a heart attack (myocardial infarction)."},{"instruction":"What are the treatments for Prinzmetal's variant angina ?","output":"What is the treatment for Prinzmetal's variant angina? The goal of treatment is to control chest pain and to prevent heart attack. Nitroglycerin or other nitrate medications may be prescribed to relieve chest pain. Calcium-channel blockers may be chronically needed. These medications widen the blood vessels to improve blood and oxygen flow. Medications may also include beta-blockers; however, in some individuals, beta-blockers may be harmful."},{"instruction":"What are the symptoms of Hurler syndrome ?","output":"What are the signs and symptoms of Hurler syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Hurler syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the tonsils 90% Anteverted nares 90% Cerebral palsy 90% Coarse facial features 90% Cognitive impairment 90% Depressed nasal bridge 90% Frontal bossing 90% Full cheeks 90% Hepatomegaly 90% Hernia 90% Hypertrichosis 90% Hypertrophic cardiomyopathy 90% Large face 90% Mucopolysacchariduria 90% Muscular hypotonia 90% Short neck 90% Sinusitis 90% Skeletal dysplasia 90% Splenomegaly 90% Thick eyebrow 90% Wide nasal bridge 90% Abnormality of epiphysis morphology 50% Abnormality of finger 50% Abnormality of the elbow 50% Abnormality of the ribs 50% Abnormality of the tongue 50% Dolichocephaly 50% Glaucoma 50% Hearing impairment 50% Hydrocephalus 50% Hypertension 50% Malabsorption 50% Opacification of the corneal stroma 50% Recurrent respiratory infections 50% Retinopathy 50% Scoliosis 50% Short stature 50% Sleep disturbance 50% Thick lower lip vermilion 50% C1-C2 subluxation 38% Abnormal pyramidal signs 7.5% Abnormality of skin pigmentation 7.5% Coronary artery disease 7.5% Decreased nerve conduction velocity 7.5% Hemiplegia/hemiparesis 7.5% Spinal canal stenosis 7.5% Retinal degeneration 5% Mitral regurgitation 10/12 Aortic regurgitation 4/12 Recurrent respiratory infections 4/12 Endocardial fibroelastosis 11/58 Abnormal CNS myelination - Autosomal recessive inheritance - Biconcave vertebral bodies - Broad nasal tip - Calvarial hyperostosis - Cardiomyopathy - Coxa valga - Diaphyseal thickening - Dysostosis multiplex - Flared iliac wings - Flexion contracture - Gingival overgrowth - Hepatosplenomegaly - Hirsutism - Hypoplasia of the femoral head - Hypoplasia of the odontoid process - Inguinal hernia - Intellectual disability - Joint stiffness - J-shaped sella turcica - Kyphosis - Macrocephaly - Microdontia - Neurodegeneration - Progressive neurologic deterioration - Short clavicles - Thick vermilion border - Umbilical hernia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Myxopapillary ependymoma ?","output":"Myxopapillary ependymoma (MEPN) is a slow-growing ependymoma (a type of glioma, which is a tumor that arises from the supportive tissue of the brain). They tend to occur in the lower part of the spinal column and are usually considered to be benign, low-grade or grade I tumors. The age of diagnosis ranges from 6 to 82 years. Symptoms of an ependymoma are related to the location and size of the tumor and may include nausea, vomiting, headache, pain, numbness, bowel or bladder symptoms, and various other signs and symptoms. The cause of ependymomas is unknown. They are known to recur locally (more commonly in individuals diagnosed in childhood). Treatment may vary depending on the location, grade, and whether the tumor has spread to the spine, but typically includes aggressive surgery. Management may also include chemotherapy and radiation therapy."},{"instruction":"What are the treatments for Myxopapillary ependymoma ?","output":"How might myxopapillary ependymoma be treated? Standard treatment of myxopapillary ependymoma is surgery with the aim of removing as much of the tumor as possible. This tumor type may be cured if all of the tumor is removed during surgery, which is referred to as total resection, and there is usually a favorable outlook in these cases. However, surgery is typically less curative in tumors that are large, multifocal or extend outside the spinal cord. These tumors have the potential to regrow after the initial diagnosis and surgery (recur), particularly in individuals diagnosed as children. Following surgery, radiation therapy may be considered to destroy any cancer cells that could remain in the body. The use of chemotherapy as another treatment of myxopapillary ependymoma remains controversial; chemotherapy has been widely used in pediatric individuals due to more aggressive disease. The usefulness of additional therapies following surgery is unclear for the subset of individuals with recurrence or in individuals in whom total resection cannot be achieved."},{"instruction":"What are the symptoms of Hyperlipoproteinemia type 4 ?","output":"What are the signs and symptoms of Hyperlipoproteinemia type 4? The Human Phenotype Ontology provides the following list of signs and symptoms for Hyperlipoproteinemia type 4. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal glucose tolerance - Atheroeruptive xanthoma - Autosomal dominant inheritance - Heterogeneous - Hypertriglyceridemia - Increased circulating very-low-density lipoprotein cholesterol - Precocious atherosclerosis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Familial hyperlipoproteinemia type 1 ?","output":"What are the signs and symptoms of Familial hyperlipo-proteinemia type 1? The Human Phenotype Ontology provides the following list of signs and symptoms for Familial hyperlipo-proteinemia type 1. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal recessive inheritance - Episodic abdominal pain - Eruptive xanthomas - Hepatosplenomegaly - Hypercholesterolemia - Hyperchylomicronemia - Hyperlipidemia - Jaundice - Lipemia retinalis - Nausea - Pancreatitis - Splenomegaly - Vomiting - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Cone dystrophy Xlinked with tapetallike sheen ?","output":"What are the signs and symptoms of Cone dystrophy X-linked with tapetal-like sheen? The Human Phenotype Ontology provides the following list of signs and symptoms for Cone dystrophy X-linked with tapetal-like sheen. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal light-adapted electroretinogram - Abnormality of metabolism/homeostasis - Adult onset - Cone/cone-rod dystrophy - Retinal detachment - Visual loss - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) EhlersDanlos syndrome, dermatosparaxis type ?","output":"Ehlers-Danlos syndrome (EDS), dermatosparaxis type is an inherited connective tissue disorder that is caused by defects in a protein called collagen. Common symptoms include soft, doughy skin that is extremely fragile; saggy, redundant skin, especially on the face; hernias; and mild to severe joint hypermobility. EDS, dermatosparaxis type is caused by changes (mutations) in the ADAMTS2 gene and is inherited in an autosomal recessive manner. Treatment and management is focused on preventing serious complications and relieving associated signs and symptoms."},{"instruction":"What are the symptoms of EhlersDanlos syndrome, dermatosparaxis type ?","output":"What are the signs and symptoms of Ehlers-Danlos syndrome, dermatosparaxis type? The signs and symptoms of Ehlers-Danlos syndrome (EDS), dermatosparaxis type vary but may include: Soft, doughy skin that is extremely fragile Severe bruising and scarring Saggy, redundant skin, especially on the face Hernias Short stature Delayed closure of the fontanelles Short fingers Characteristic facial appearance with puffy eyelids, blue sclerae (whites of the eyes), epicanthal folds, downslanting palpebral fissures (outside corners of the eyes that point downward) and micrognathia Rupture of the bladder or diaphragm Mild to severe joint hypermobility The Human Phenotype Ontology provides the following list of signs and symptoms for Ehlers-Danlos syndrome, dermatosparaxis type. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of coagulation 90% Abnormality of the hip bone 90% Atypical scarring of skin 90% Hyperextensible skin 90% Joint dislocation 90% Limitation of joint mobility 90% Muscular hypotonia 90% Neurological speech impairment 90% Reduced bone mineral density 90% Short stature 90% Thin skin 90% Umbilical hernia 90% Depressed nasal bridge 50% Epicanthus 50% Hypertelorism 50% Scoliosis 50% Abnormality of primary molar morphology - Autosomal recessive inheritance - Blepharochalasis - Blue sclerae - Bruising susceptibility - Delayed closure of the anterior fontanelle - Fragile skin - Frontal open bite - Gingival bleeding - Gingival hyperkeratosis - Gingival overgrowth - Hirsutism - Hypodontia - Inguinal hernia - Joint laxity - Micromelia - Motor delay - Myopia - Osteopenia - Premature birth - Premature rupture of membranes - Recurrent mandibular subluxations - Redundant skin - Short phalanx of finger - Short toe - Soft, doughy skin - Spontaneous neonatal pneumothorax - Thick vermilion border - Wide anterior fontanel - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes EhlersDanlos syndrome, dermatosparaxis type ?","output":"What causes Ehlers-Danlos syndrome, dermatosparaxis type? Ehlers-Danlos syndrome (EDS), dermatosparaxis type is caused by changes (mutations) in the ADAMTS2 gene. This gene encodes an enzyme that helps process several types of \\"procollagen molecules\\" (precursors of collagen). Collagen is a protein that provides structure and strength to connective tissues throughout the body. Mutations in ADAMTS2 lead to reduced levels of functional enzyme which interferes with the proper processing of procollagens. As a result, networks of collagen are not assembled properly. This weakens connective tissues and causes the many signs and symptoms associated with EDS, dermatosparaxis type."},{"instruction":"EhlersDanlos syndrome, dermatosparaxis type inherited ?","output":"Is Ehlers-Danlos syndrome, dermatosparaxis type inherited? Ehlers-Danlos syndrome, dermatosparaxis type is inherited in an autosomal recessive manner. This means that to be affected, a person must have a mutation in both copies of the responsible gene in each cell. The parents of an affected person usually each carry one mutated copy of the gene and are referred to as carriers. Carriers typically do not show signs or symptoms of the condition. When two carriers of an autosomal recessive condition have children, each child has a 25% (1 in 4) risk to have the condition, a 50% (1 in 2) risk to be a carrier like each of the parents, and a 25% chance to not have the condition and not be a carrier."},{"instruction":"w to diagnose EhlersDanlos syndrome, dermatosparaxis type ?","output":"How is Ehlers-Danlos syndrome, dermatosparaxis type diagnosed? A diagnosis of Ehlers-Danlos syndrome (EDS), dermatosparaxis type is typically based on the presence of characteristic signs and symptoms. Genetic testing for a change (mutation) in the ADAMTS2 gene and/or a skin biopsy can then be ordered to confirm the diagnosis."},{"instruction":"What are the treatments for EhlersDanlos syndrome, dermatosparaxis type ?","output":"How might Ehlers-Danlos syndrome, dermatosparaxis type be treated? The treatment of Ehlers-Danlos syndrome (EDS), dermatosparaxis type is focused on preventing serious complications and relieving associated signs and symptoms. For example, physical therapy may be recommended in children with moderate to severe joint hypermobility. Assistive devices such as braces, wheelchairs, or scooters may also be necessary depending on the severity of joint instability. Hernias may be treated with surgery. Because EDS, dermatosparaxis type is associated with extremely fragile skin, affected people, especially children, may need to use protective bandages or pads over exposed areas, such as the knees, shins, and forehead. Heavy exercise and contact sports may also need to be avoided due to skin fragility and easy bruising. Please speak to your healthcare provider if you have any questions about your personal medical management plan."},{"instruction":"What is (are) Hereditary sensory neuropathy type IE ?","output":"Hereditary sensory neuropathy type IE (HSNIE) is a progressive disorder of the central and peripheral nervous systems. Symptoms typically begin by age 20 to 35 and include sensory impairment of the lower legs and feet; loss of sweating in the hands and feet; sensorineural hearing loss; and gradual decline of mental ability (dementia). The severity of symptoms and age of onset vary, even within the same family. HSNIE is caused by a mutation in the DNMT1 gene and is inherited in an autosomal dominant manner. There is no effective treatment, but management may include injury prevention, the use of hearing aids, and sedative or antipsychotic medications for symptoms of dementia."},{"instruction":"What are the symptoms of Hereditary sensory neuropathy type IE ?","output":"What are the signs and symptoms of Hereditary sensory neuropathy type IE? The Human Phenotype Ontology provides the following list of signs and symptoms for Hereditary sensory neuropathy type IE. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Apathy - Autosomal dominant inheritance - Cerebral atrophy - Decreased number of peripheral myelinated nerve fibers - Dementia - Hyporeflexia - Impulsivity - Irritability - Memory impairment - Osteomyelitis - Progressive - Sensorineural hearing impairment - Sensory neuropathy - Somnolence - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"Hereditary sensory neuropathy type IE inherited ?","output":"How is hereditary sensory neuropathy type IE inherited? Hereditary sensory neuropathy type IE (HSNIE) is inherited in an autosomal dominant manner. This means that having only one changed (mutated) copy of the responsible gene in each cell is enough to cause features of the condition. When a person with a mutation that causes HSNIE has children, each child has a 50% (1/2) chance to inherit the mutated gene. A person who does not inherit the mutation from an affected parent is not at risk to pass the condition on to his/her children."},{"instruction":"What are the treatments for Hereditary sensory neuropathy type IE ?","output":"How might hereditary sensory neuropathy type IE be treated? There is currently no effective treatment for any type of hereditary sensory neuropathy. Management of symptoms may include: meticulous care of the distal limbs, which includes proper fit of shoes, prevention and treatment of callus formation, cleaning and protection of wounds, and avoidance of trauma to the hands and feet injury prevention when sensory impairment is significant the use of hearing aids and/or assistive communication methods as needed sedative or antipsychotic medications to help reduce the restlessness, roaming behavior, delusions, and hallucinations associated with dementia psychological support for caregivers"},{"instruction":"What is (are) Dihydropyrimidine dehydrogenase deficiency ?","output":"Dihydropyrimidine dehydrogenase (DPD) deficiency is a condition in which the body cannot break down the nucleotides thymine and uracil. DPD deficiency can have a wide range of severity; some individuals may have various neurological problems, while others have no signs and symptoms. Signs and symptoms in severely affected individuals begin in infancy and may include seizures, intellectual disability, microcephaly, increased muscle tone (hypertonia), delayed motor skills, and autistic behavior. All individuals with the condition, regardless of the presence or severity of symptoms, are at risk for severe, toxic reactions to drugs called fluoropyrimidines which are used to treat cancer. Individuals with no symptoms may be diagnosed only by laboratory testing or after exposure to fluoropyrimidines. DPD deficiency is caused by mutations in the DPYD gene and is inherited in an autosomal recessive manner."},{"instruction":"What are the symptoms of Dihydropyrimidine dehydrogenase deficiency ?","output":"What are the signs and symptoms of Dihydropyrimidine dehydrogenase deficiency? The Human Phenotype Ontology provides the following list of signs and symptoms for Dihydropyrimidine dehydrogenase deficiency. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Agenesis of corpus callosum 5% Autism - Autosomal recessive inheritance - Cerebral atrophy - Coloboma - Delayed speech and language development - Failure to thrive - Growth delay - Hyperactivity - Hypertonia - Intellectual disability - Lethargy - Microcephaly - Microphthalmia - Motor delay - Muscular hypotonia - Nystagmus - Optic atrophy - Phenotypic variability - Reduced dihydropyrimidine dehydrogenase activity - Seizures - Tetraplegia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Dihydropyrimidine dehydrogenase deficiency ?","output":"What causes dihydropyrimidine dehydrogenase (DPD) deficiency? DPD deficiency is caused by mutations in the DPYD gene. This gene provides instructions for making an enzyme called dihydropyrimidine dehydrogenase (DPD), which is involved in the breakdown of molecules called uracil and thymine. Uracil and thymine are building blocks of DNA, RNA, and molecules that serve as energy sources in cells. Mutations in the DPYD gene result in deficiencies (to various degrees) of functional DPD, interfering with the breakdown of uracil and thymine in cells. This results in excessive amounts of uracil and thymine in the blood, urine, and the fluid that surrounds the brain and spinal cord. It is currently poorly understood exactly how this cascade of events causes the signs and symptoms of the condition."},{"instruction":"Dihydropyrimidine dehydrogenase deficiency inherited ?","output":"How is dihydropyrimidine dehydrogenase deficiency inherited? Dihydropyrimidine dehydrogenase (DPD) deficiency is inherited in an autosomal recessive manner. This means that in affected individuals, both copies of the DPYD gene in each cell (one inherited from each parent) have mutations. The mutations that cause DPD deficiency vary widely in severity; therefore, some people with 2 mutated copies of the gene may have signs and symptoms of the condition, while others may be asymptomatic. However, all individuals with 2 mutations are at risk for toxic reactions to fluoropyrimidine drugs. Individuals who carry one mutated copy of the disease-causing gene (including most parents of affected individuals) are referred to as carriers. Carriers typically do not have signs and symptoms of the condition. However, people with one mutated copy of the DPYD gene may still experience toxic reactions to fluoropyrimidine drugs. When 2 carriers for the same autosomal recessive condition have children, each child has a 25% (1 in 4) risk to have the condition, a 50% (1 in 2) risk to be a carrier like each parent, and a 25% risk to not have the condition and not be a carrier. A child of one carrier parent has a 50% risk to also be a carrier."},{"instruction":"w to diagnose Dihydropyrimidine dehydrogenase deficiency ?","output":"How is dihydropyrimidine dehydrogenase (DPD) deficiency diagnosed? DPD deficiency may be diagnosed in various ways. In individuals with complete or profound DPD deficiency, laboratory testing can detect elevated levels of uracil and/or thymine in plasma or urine. Partial DPD deficiency is more difficult to detect, which has led to the development of a radioenzymatic test for the DPD enzyme. This test has remained the gold standard for diagnosing DPD deficiency even after the development of genetic testing for the condition, because of the complexity of the DPYD gene and the presence of multiple DNA sequence variations present in most affected individuals. Various types of cells and tissues can be examined this way. More recently, a rapid, noninvasive, and cost-effective breath test was developed. This test permits the evaluation of DPD activity (normal activity and partial or profound deficiency) before the administration of fluoropyrmidine drugs such as 5-FU."},{"instruction":"What are the treatments for Dihydropyrimidine dehydrogenase deficiency ?","output":"How might dihydropyrimidine dehydrogenase deficiency be treated in infants and children? Currently, no treatment or cure exists for the inborn error of metabolism form of DHD deficiency. Symptoms usually remain the same throughout the person's life."},{"instruction":"What is (are) Early Infantile Epileptic Encephalopathy ?","output":"Ohtahara syndrome is a neurological disorder characterized by seizures. The disorder affects newborns, usually within the first three months of life (most often within the first 10 days) in the form of epileptic seizures. Infants have primarily tonic seizures (which cause stiffening of muscles of the body, generally those in the back, legs, and arms), but may also experience partial seizures, and rarely, myoclonic seizures (which cause jerks or twitches of the upper body, arms, or legs). Ohtahara syndrome is most commonly caused by metabolic disorders or structural damage in the brain, although the cause or causes for many cases cant be determined. Most infants with the disorder show significant underdevelopment of part or all of the cerebral hemispheres. The EEGs of infants with Ohtahara syndrome reveal a characteristic pattern of high voltage spike wave discharge followed by little activity. This pattern is known as burst suppression. The seizures associated with Ohtahara syndrome are difficult to treat and the syndrome is severely progressive. Some children with this condition go on to develop other epileptic disorders such as West syndrome and Lennox-Gestaut syndrome."},{"instruction":"What are the symptoms of Coloboma, cleft lip/palate and mental retardation syndrome ?","output":"What are the signs and symptoms of Coloboma, cleft lip/palate and mental retardation syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Coloboma, cleft lip/palate and mental retardation syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Chorioretinal coloboma 90% Sensorineural hearing impairment 90% Aplasia/Hypoplasia affecting the eye 50% Cognitive impairment 50% Hematuria 50% Iris coloboma 50% Oral cleft 50% Cataract 7.5% Glaucoma 7.5% Nystagmus 7.5% Opacification of the corneal stroma 7.5% Optic atrophy 7.5% Posterior embryotoxon 7.5% Ptosis 7.5% Retinal detachment 7.5% Strabismus 7.5% Visual impairment 7.5% Cleft palate 5% Cleft upper lip 5% Intellectual disability 5% Microphthalmia 5% Autosomal dominant inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Kerion celsi ?","output":"What are the signs and symptoms of Kerion celsi? The Human Phenotype Ontology provides the following list of signs and symptoms for Kerion celsi. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of metabolism/homeostasis - Abnormality of the skin - Autosomal recessive inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Behcet's disease ?","output":"Behcet's disease is a chronic multisystem inflammatory disorder characterized by ulcers affecting the mouth and genitals, various skin lesions, and abnormalities affecting the eyes. In some people, the disease also results in arthritis (swollen, painful, stiff joints), skin problems, and inflammation of the digestive tract, brain, and spinal cord. Although it can happen at any age, symptoms generally begin when individuals are in their 20s or 30s. The disease is common in Japan, Turkey and Israel, and less common in the United States. The exact cause of Behcet's disease is still unknown. Treatment is symptomatic and supportive. Experience is evolving with the use of interferon-alpha and with agents which inhibit tumor necrosis factor (TNF) in the treatment of Behets disease. Behcet's disease is a lifelong disorder that comes and goes. Spontaneous remission over time is common for individuals with Behets disease but permanent remission of symptoms has not been reported."},{"instruction":"What are the symptoms of Behcet's disease ?","output":"What are the signs and symptoms of Behcet's disease? Symptoms of Behcet's disease include recurrent ulcers in the mouth (resembling canker sores) and on the genitals, and eye inflammation (uveitis). The disorder may also cause various types of skin lesions, arthritis, bowel inflammation, meningitis (inflammation of the membranes of the brain and spinal cord), and cranial nerve palsies. Behcet's is a multi-system disease; it may involve all organs and affect the central nervous system, causing memory loss and impaired speech, balance, and movement. The effects of the disease may include blindness, stroke, swelling of the spinal cord, and intestinal complications. The Human Phenotype Ontology provides the following list of signs and symptoms for Behcet's disease. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of temperature regulation 90% Arthritis 90% Meningitis 90% Migraine 90% Myalgia 90% Nausea and vomiting 90% Orchitis 90% Photophobia 90% Vasculitis 90% Abdominal pain 50% Abnormal blistering of the skin 50% Acne 50% Arthralgia 50% Gait disturbance 50% Gastrointestinal hemorrhage 50% Hemiplegia/hemiparesis 50% Immunologic hypersensitivity 50% Reduced consciousness/confusion 50% Thrombophlebitis 50% Abnormal pyramidal signs 7.5% Abnormality of the aortic valve 7.5% Abnormality of the endocardium 7.5% Abnormality of the mitral valve 7.5% Abnormality of the myocardium 7.5% Abnormality of the pericardium 7.5% Abnormality of the pleura 7.5% Anorexia 7.5% Arterial thrombosis 7.5% Aseptic necrosis 7.5% Cataract 7.5% Cerebral ischemia 7.5% Coronary artery disease 7.5% Cranial nerve paralysis 7.5% Developmental regression 7.5% Encephalitis 7.5% Gangrene 7.5% Glomerulopathy 7.5% Hemoptysis 7.5% Hyperreflexia 7.5% Incoordination 7.5% Increased intracranial pressure 7.5% Keratoconjunctivitis sicca 7.5% Lymphadenopathy 7.5% Malabsorption 7.5% Memory impairment 7.5% Myositis 7.5% Pancreatitis 7.5% Paresthesia 7.5% Polyneuropathy 7.5% Pulmonary embolism 7.5% Pulmonary infiltrates 7.5% Renal insufficiency 7.5% Retinopathy 7.5% Retrobulbar optic neuritis 7.5% Seizures 7.5% Splenomegaly 7.5% Vertigo 7.5% Visual impairment 7.5% Weight loss 7.5% Alopecia areata - Chorioretinitis - Epididymitis - Erythema - Genital ulcers - Iridocyclitis - Iritis - Irritability - Oral ulcer - Superficial thrombophlebitis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Behcet's disease ?","output":"What causes Behcet's disease? The exact cause of Behet's disease is unknown. Most symptoms of the disease are caused by inflammation of the blood vessels. Inflammation is a characteristic reaction of the body to injury or disease and is marked by four signs: swelling, redness, heat, and pain. Doctors think that an autoimmune reaction may cause the blood vessels to become inflamed, but they do not know what triggers this reaction. Under normal conditions, the immune system protects the body from diseases and infections by killing harmful \\"foreign\\" substances, such as germs, that enter the body. In an autoimmune reaction, the immune system mistakenly attacks and harms the body's own tissues. Behet's disease is not contagious; it is not spread from one person to another. Researchers think that two factors are important for a person to get Behet's disease. First, it is believed that abnormalities of the immune system make some people susceptible to the disease. Scientists think that this susceptibility may be inherited; that is, it may be due to one or more specific genes. Second, something in the environment, possibly a bacterium or virus, might trigger or activate the disease in susceptible people."},{"instruction":"What are the treatments for Behcet's disease ?","output":"How might Behcet's disease be treated? Although there is no cure for Behet's disease, people can usually control symptoms with proper medication, rest, exercise, and a healthy lifestyle. The goal of treatment is to reduce discomfort and prevent serious complications such as disability from arthritis or blindness. The type of medicine and the length of treatment depend on the person's symptoms and their severity. It is likely that a combination of treatments will be needed to relieve specific symptoms. Patients should tell each of their doctors about all of the medicines they are taking so that the doctors can coordinate treatment. Topical medicine is applied directly on the sores to relieve pain and discomfort. For example, doctors prescribe rinses, gels, or ointments. Creams are used to treat skin and genital sores. The medicine usually contains corticosteroids (which reduce inflammation), other anti-inflammatory drugs, or an anesthetic, which relieves pain. Doctors also prescribe medicines taken by mouth to reduce inflammation throughout the body, suppress the overactive immune system, and relieve symptoms. Doctors may prescribe one or more of the medicines listed below to treat the various symptoms of Behet's disease. Corticosteroids Immunosuppressive drugs (Azathioprine, Chlorambucil or Cyclophosphamide, Cyclosporine, Colchicine, or a combination of these treatments) Methotrexate"},{"instruction":"What are the symptoms of Lenz Majewski hyperostotic dwarfism ?","output":"What are the signs and symptoms of Lenz Majewski hyperostotic dwarfism? The Human Phenotype Ontology provides the following list of signs and symptoms for Lenz Majewski hyperostotic dwarfism. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal cortical bone morphology 90% Abnormality of dental enamel 90% Abnormality of the clavicle 90% Abnormality of the fontanelles or cranial sutures 90% Abnormality of the metaphyses 90% Abnormality of the ribs 90% Brachydactyly syndrome 90% Broad forehead 90% Choanal atresia 90% Cognitive impairment 90% Craniofacial hyperostosis 90% Cutis laxa 90% Delayed skeletal maturation 90% Finger syndactyly 90% Hypertelorism 90% Increased bone mineral density 90% Joint hypermobility 90% Macrocephaly 90% Macrotia 90% Mandibular prognathia 90% Prematurely aged appearance 90% Short stature 90% Symphalangism affecting the phalanges of the hand 90% Abnormality of the metacarpal bones 50% Cryptorchidism 50% Displacement of the external urethral meatus 50% Hernia of the abdominal wall 50% Humeroradial synostosis 50% Lacrimation abnormality 50% Thick lower lip vermilion 50% Wide mouth 50% Abnormality of the fingernails 7.5% Aplasia/Hypoplasia of the corpus callosum 7.5% Cleft palate 7.5% Facial palsy 7.5% Hydrocephalus 7.5% Kyphosis 7.5% Limitation of joint mobility 7.5% Muscular hypotonia 7.5% Scoliosis 7.5% Microcephaly 5% Abnormality of the teeth - Agenesis of corpus callosum - Anteriorly placed anus - Aplasia/Hypoplasia of the middle phalanges of the hand - Autosomal dominant inheritance - Broad clavicles - Broad ribs - Choanal stenosis - Chordee - Cutis marmorata - Delayed cranial suture closure - Diaphyseal thickening - Elbow flexion contracture - Failure to thrive - Flared metaphysis - Frontal bossing - Hyperextensibility of the finger joints - Hypospadias - Inguinal hernia - Intellectual disability - Intellectual disability, moderate - Intrauterine growth retardation - Knee flexion contracture - Lacrimal duct stenosis - Large fontanelles - Microglossia - Progressive sclerosis of skull base - Prominent forehead - Prominent scalp veins - Proximal symphalangism (hands) - Relative macrocephaly - Sensorineural hearing impairment - Sparse hair - Sporadic - Syndactyly - Thin skin - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Primary hyperoxaluria type 2 ?","output":"Primary hyperoxaluria type 2 is a rare condition characterized by the overproduction of a substance called oxalate (also called oxalic acid). In the kidneys, the excess oxalate combines with calcium to form calcium oxalate, a hard compound that is the main component of kidney stones. Deposits of calcium oxalate can lead to kidney damage, kidney failure, and injury to other organs. Primary hyperoxaluria type 2 is caused by the shortage (deficiency) of an enzyme called glyoxylate reductase/hydroxypyruvate reductase (GRHPR) that normally prevents the buildup of oxalate. This enzyme shortage is caused by mutations in the GRHPR gene. Primary hyperoxaluria type 2 is inherited in an autosomal recessive pattern."},{"instruction":"What are the symptoms of Primary hyperoxaluria type 2 ?","output":"What are the signs and symptoms of Primary hyperoxaluria type 2? Primary hyperoxaluria type 2 is characterized by recurrent nephrolithiasis (deposition of calcium oxalate in the kidney and urinary tract), nephrocalcinosis (deposition of calcium oxalate in the kidney tissue), and end-stage renal disease (ESRD). After ESRD, oxalosis (widespread tissue deposition of calcium oxalate) usually develops. Presenting symptoms are typically those associated with the presence of kidney stones, including hematuria, renal colic (a type of abdominal pain caused by kidney stones), or obstruction of the urinary tract. The symptoms of primary hyperoxaluria type 2 are typically less severe than primary hyperoxaluria type 1 and may be limited to kidney stone formation. Symptom onset may occur in childhood or adolescence. End stage renal disease is rarely observed in childhood. The Human Phenotype Ontology provides the following list of signs and symptoms for Primary hyperoxaluria type 2. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Renal insufficiency 5% Aminoaciduria - Autosomal recessive inheritance - Calcium oxalate nephrolithiasis - Hematuria - Hyperoxaluria - Nephrocalcinosis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Primary hyperoxaluria type 2 ?","output":"What causes primary hyperoxaluria type 2? Researchers have identified more than a dozen GRHPR mutations that cause this condition. These mutations either introduce signals that disrupt production of the glyoxylate reductase/hydroxypyruvate reductase enzyme or alter its structure. As a result, enzyme activity is absent or dramatically reduced. Glyoxylate builds up because of the enzyme shortage, and is converted to a compound called oxalate instead of glycolate. Oxalate, in turn, combines with calcium to form calcium oxalate, which the body cannot readily eliminate. Deposits of calcium oxalate can lead to the characteristic features of primary hyperoxaluria type 2."},{"instruction":"Primary hyperoxaluria type 2 inherited ?","output":"How is primary hyperoxaluria type 2 inherited? Primary hyperoxaluria type 2 is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition."},{"instruction":"What are the treatments for Primary hyperoxaluria type 2 ?","output":"How might primary hyperoxaluria type 2 be treated? The current management strategy includes high fluid intake, treatment with inhibitors of calcium oxalate crystallization, and temporary intensive dialysis for end-stage renal disease (ESRD) followed by kidney transplantation. Varying success has been reported following transplantation, with recurrence being a real possibility since hyperoxaluria and elevated L-glycerate levels persist. Careful management in the postoperative period, with attention to brisk urine output and use of calcium oxalate urinary inhibitors may help prevent complications. To date, liver-kidney transplantation has not been used in primary hyperoxaluria type 2. This strategy may be considered, however, as there is more enzyme in the liver than in other tissues. More studies are needed before liver transplantation can be recommended. Other treatment modalities needing further investigation include liver cell transplantation and recombinant gene therapy to replace the missing enzyme."},{"instruction":"What is (are) CharcotMarieTooth disease type 1E ?","output":"Charcot-Marie-Tooth disease type 1E (CMT1E) is a form of Charcot-Marie-Tooth disease, which is a group of rare conditions that affect the peripheral nerves. Signs and symptoms of CMT1E generally become apparent between age 5 and 25 years, although the age of onset and disease severity can vary significantly from person to person. In general, CMT1E is associated with the typical features of Charcot-Marie-Tooth disease type 1 (progressive weakness of the feet and/or ankles; foot drop; atrophy of muscles below the knee; absent tendon reflexes of upper and lower extremities; and a decreased sensitivity to touch, heat, and cold in the feet and/or lower legs) in addition to hearing loss. CMT1E is caused by certain changes (mutations) in the PMP22 gene and is inherited in an autosomal dominant manner. Treatment is based on the signs and symptoms present in each person."},{"instruction":"What are the symptoms of CharcotMarieTooth disease type 1E ?","output":"What are the signs and symptoms of Charcot-Marie-Tooth disease type 1E? The Human Phenotype Ontology provides the following list of signs and symptoms for Charcot-Marie-Tooth disease type 1E. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Areflexia - Autosomal dominant inheritance - Childhood onset - Decreased motor nerve conduction velocity - Distal muscle weakness - Distal sensory impairment - Foot dorsiflexor weakness - Hammertoe - Hyporeflexia - Juvenile onset - Pes cavus - Sensorineural hearing impairment - Split hand - Steppage gait - Talipes calcaneovalgus - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Split hand/foot malformation Xlinked ?","output":"Split hand foot malformation (SHFM) is a type of birth defect that consists of missing digits (fingers and/or toes), a deep cleft down the center of the hand or foot, and fusion of remaining digits. The severity of this condition varies widely among affected individuals. SHFM is sometimes called ectrodactyly; however, this is a nonspecific term used to describe missing digits. SHFM may occur by itself (isolated) or it may be part of a syndrome with abnormalities in other parts of the body. At least six different forms of isolated SHFM have been described. Each type is associated with a different underlying genetic cause. SHFM1 has been linked to chromosome 7, and SHFM2 is linked to the X chromosome. SHFM3 is caused by a duplication of chromosome 10 at position 10q24. Changes (mutations) in the TP63 gene cause SHFM4. SHFM5 is linked to chromosome 2, and SHFM6 is caused by mutations in the WNT10B gene. SHFM may be inherited in an autosomal dominant, autosomal recessive, or X-linked manner."},{"instruction":"What are the symptoms of Split hand/foot malformation Xlinked ?","output":"What are the signs and symptoms of Split hand/foot malformation X-linked? The Human Phenotype Ontology provides the following list of signs and symptoms for Split hand/foot malformation X-linked. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Finger syndactyly - Short metacarpal - Short phalanx of finger - Split foot - Split hand - X-linked inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Dihydropyrimidinase deficiency ?","output":"What are the signs and symptoms of Dihydropyrimidinase deficiency? The Human Phenotype Ontology provides the following list of signs and symptoms for Dihydropyrimidinase deficiency. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal pyramidal signs 5% Abnormal facial shape - Anal atresia - Autosomal recessive inheritance - Delayed speech and language development - Extrapyramidal dyskinesia - Feeding difficulties in infancy - Growth delay - Intellectual disability - Lethargy - Metabolic acidosis - Morphological abnormality of the pyramidal tract - Phenotypic variability - Plagiocephaly - Reduced dihydropyrimidine dehydrogenase activity - Seizures - Short phalanx of finger - Somnolence - Talipes equinovarus - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Cataract anterior polar dominant ?","output":"What are the signs and symptoms of Cataract anterior polar dominant? The Human Phenotype Ontology provides the following list of signs and symptoms for Cataract anterior polar dominant. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Anterior polar cataract - Autosomal dominant inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Diffuse mesangial sclerosis ?","output":"What are the signs and symptoms of Diffuse mesangial sclerosis? The Human Phenotype Ontology provides the following list of signs and symptoms for Diffuse mesangial sclerosis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Focal segmental glomerulosclerosis 5% Autosomal recessive inheritance - Childhood onset - Diffuse mesangial sclerosis - Nephroblastoma (Wilms tumor) - Nephrotic syndrome - Progressive - Renal insufficiency - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Leri Weill dyschondrosteosis ?","output":"Leri Weill dyschondrosteosis is a skeletal dysplasia characterized by short stature and an abnormality of the wrist bones called Madelung deformity. Short stature is present from birth due to shortening of the long bones in the legs. Madelung deformity typically develops during mid-to-late childhood and may progress during puberty. People with this condition often experience pain in their wrists or arms. The severity of Leri Weill dyschondrosteosis varies among affected individuals, although the signs and symptoms of this condition are generally more severe in females. Other features of Leri Weill dyschondrosteosis can include increased muscle size, bowing of a bone in the leg called the tibia, elbow abnormalities, scoliosis, and high-arched palate. Intelligence is not affected by this condition. Most cases of Leri Weill dyschondrosteosis are caused by mutations in or near the SHOX gene. The cause of the disorder remains unknown in those cases not related to the SHOX gene. Leri Weill dyschondrosteosis follows a pseudoautosomal dominant pattern of inheritance."},{"instruction":"What are the symptoms of Leri Weill dyschondrosteosis ?","output":"What are the signs and symptoms of Leri Weill dyschondrosteosis? The Human Phenotype Ontology provides the following list of signs and symptoms for Leri Weill dyschondrosteosis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the femur 90% Abnormality of the hip bone 90% Abnormality of the humeroulnar joint 90% Abnormality of the humerus 90% Abnormality of the metacarpal bones 90% Abnormality of the metaphyses 90% Abnormality of the tibia 90% Abnormality of the ulna 90% Anonychia 90% Aplasia/Hypoplasia of the radius 90% Aplastic/hypoplastic toenail 90% Arthralgia 90% Bone pain 90% Brachydactyly syndrome 90% Clinodactyly of the 5th finger 90% Cone-shaped epiphysis 90% Depressed nasal bridge 90% Exostoses 90% Genu varum 90% Limitation of joint mobility 90% Madelung deformity 90% Micromelia 90% Patellar aplasia 90% Short stature 90% Abnormality of calvarial morphology 50% Elbow dislocation 50% Genu valgum 50% Osteoarthritis 50% Scoliosis 50% Nephropathy 7.5% Abnormality of the carpal bones - Abnormality of the metatarsal bones - Autosomal dominant inheritance - Coxa valga - Disproportionate short-limb short stature - Dorsal subluxation of ulna - Fibular hypoplasia - High palate - Hypoplasia of the radius - Hypoplasia of the ulna - Increased carrying angle - Limited elbow movement - Limited wrist movement - Mesomelia - Multiple exostoses - Radial bowing - Short 4th metacarpal - Short tibia - Short toe - Skeletal muscle hypertrophy - Tibial bowing - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Harrod Doman Keele syndrome ?","output":"What are the signs and symptoms of Harrod Doman Keele syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Harrod Doman Keele syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal nasal morphology 90% Abnormality of the palate 90% Abnormality of the pinna 90% Abnormality of the teeth 90% Arachnodactyly 90% Cognitive impairment 90% Hypotelorism 90% Intrauterine growth retardation 90% Long face 90% Microcephaly 90% Narrow face 90% Narrow mouth 90% Pointed chin 90% Abnormality of pelvic girdle bone morphology 50% Abnormality of the shoulder 50% Cataract 50% Cerebral cortical atrophy 50% Cryptorchidism 50% Displacement of the external urethral meatus 50% Hypopigmented skin patches 50% Joint hypermobility 50% Kyphosis 50% Multicystic kidney dysplasia 50% Scoliosis 50% Seizures 50% Abnormal facial shape - Aganglionic megacolon - Dental malocclusion - External genital hypoplasia - Failure to thrive - High palate - Hypospadias - Intellectual disability - Long nose - Macrotia - Malrotation of small bowel - Pyloric stenosis - Renal cortical microcysts - Varicose veins - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Hypochondroplasia ?","output":"Hypochondroplasia is a form dwarfism that affects the conversion of cartilage into bone, particularly in the long bones of the arms and legs. Hypochondroplasia is similar to achondroplasia, but the features tend to be milder. People with this condtion usually have short arms and legs and broad, short hands and feet. Other features include a large head, limited range of motion in the elbows, lordosis, and bowed legs. Hypochondroplasia is caused by mutations in the FGFR3 gene and is inherited in an autosomal dominant fashion."},{"instruction":"What are the symptoms of Hypochondroplasia ?","output":"What are the signs and symptoms of Hypochondroplasia? The Human Phenotype Ontology provides the following list of signs and symptoms for Hypochondroplasia. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal form of the vertebral bodies 90% Brachydactyly syndrome 90% Micromelia 90% Short stature 90% Short toe 90% Skeletal dysplasia 90% Abnormality of pelvic girdle bone morphology 50% Abnormality of the elbow 50% Abnormality of the femur 50% Genu varum 50% Joint hypermobility 50% Apnea 7.5% Cognitive impairment 7.5% Hyperlordosis 7.5% Intellectual disability 7.5% Macrocephaly 7.5% Osteoarthritis 7.5% Scoliosis 7.5% Spinal canal stenosis 7.5% Aplasia/hypoplasia of the extremities - Autosomal dominant inheritance - Childhood onset short-limb short stature - Flared metaphysis - Frontal bossing - Limited elbow extension - Lumbar hyperlordosis - Malar flattening - Short long bone - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the treatments for Hypochondroplasia ?","output":"How might hypochondroplasia be treated? The evaluation of children with hypochondroplasia usually does not differ significantly from the evaluation of children with normal stature, except for genetic counseling issues (such as risk of recurrence) and dealing with parental concerns about short stature. Management of short stature may be influenced by the concerns and expectations of the parents. One reasonable approach is to address the parents' concerns about the height of their child rather than attempting to treat the child. Developmental intervention and special education may be appropriate, if it is indicated in the affected individual. If spinal stenosis (narrowing of the spine) is present, a procedure called a laminectomy may be considered. This is a type of surgery that can take pressure off the spinal nerves or spinal canal. However, one study found that about 70% of symptomatic individuals with achondroplasia experienced total relief of symptoms following decompression, without having a laminectomy. Decompression is a less invasive procedure. Support groups can help the affected individual and the family adapt to short stature through peer support, personal example, and social awareness programs. Support groups may offer information on employment, education, disability rights, adoption of children of short stature, medical issues, suitable clothing, adaptive devices, and parenting through local meetings, workshops and seminars. To see the contact information for several support groups for hypochondroplasia, click here. Sometimes, for individuals with hypochondroplasia who are more severely affected, the features may overlap with those of achondroplasia. In these cases, recommendations for the management of achondroplasia (outlined by the American Academy of Pediatrics Committee on Genetics) may be considered. The full report on these recommendations may be viewed here. For a more limited description of management of achondroplasia on our Web site, click here."},{"instruction":"What are the symptoms of Nasodigitoacoustic syndrome ?","output":"What are the signs and symptoms of Nasodigitoacoustic syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Nasodigitoacoustic syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of thumb phalanx 90% Anonychia 90% Aplasia/Hypoplasia of the distal phalanges of the toes 90% Broad forehead 90% Hypertelorism 90% Preaxial foot polydactyly 90% Prominent nasal bridge 90% Sensorineural hearing impairment 90% Short distal phalanx of finger 90% Short hallux 90% Abnormality of the voice 50% Aplastic/hypoplastic toenail 50% Clinodactyly of the 5th finger 50% Epicanthus 50% Exaggerated cupid's bow 50% Macrocephaly 50% Ptosis 50% Tented upper lip vermilion 50% Behavioral abnormality 7.5% Cognitive impairment 7.5% Short stature 7.5% Abnormality of the nail - Autosomal dominant inheritance - Broad distal phalanx of finger - Broad hallux - Broad thumb - Depressed nasal bridge - Enlarged epiphyses - Frontal bossing - High palate - Hoarse voice - Narrow palate - Prominent forehead - Pulmonic stenosis - Rounded epiphyses - Short 3rd metacarpal - Short phalanx of finger - Short toe - Thick upper lip vermilion - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Corneodermatoosseous syndrome ?","output":"What are the signs and symptoms of Corneodermatoosseous syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Corneodermatoosseous syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of dental enamel 90% Anonychia 90% Brachydactyly syndrome 90% Carious teeth 90% Corneal dystrophy 90% Palmoplantar keratoderma 90% Photophobia 90% Short stature 90% Abnormality of the fingernails 50% Abnormality of the metacarpal bones 50% Gingivitis 50% Premature birth 50% Hearing impairment 7.5% Nyctalopia 7.5% Abnormality of the teeth - Autosomal dominant inheritance - Erythroderma - Onycholysis - Palmoplantar hyperkeratosis - Short distal phalanx of finger - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Osteodysplasia familial Anderson type ?","output":"What are the signs and symptoms of Osteodysplasia familial Anderson type? The Human Phenotype Ontology provides the following list of signs and symptoms for Osteodysplasia familial Anderson type. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal cortical bone morphology 90% Abnormal nasal morphology 90% Abnormality of the clavicle 90% Abnormality of the femur 90% Depressed nasal ridge 90% Hypertension 90% Hyperuricemia 90% Hypoplasia of the zygomatic bone 90% Kyphosis 90% Large earlobe 90% Malar flattening 90% Mandibular prognathia 90% Pointed chin 90% Recurrent fractures 90% Scoliosis 90% Thick eyebrow 90% Abnormal form of the vertebral bodies 50% Abnormality of the ribs 50% Carious teeth 50% Clinodactyly of the 5th finger 50% Elbow dislocation 7.5% Seizures 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Total Hypotrichosis, Mari type ?","output":"What are the signs and symptoms of Total Hypotrichosis, Mari type? The Human Phenotype Ontology provides the following list of signs and symptoms for Total Hypotrichosis, Mari type. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Woolly hair 5% Autosomal recessive inheritance - Hypotrichosis - Sparse eyebrow - Sparse eyelashes - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of BardetBiedl syndrome 10 ?","output":"What are the signs and symptoms of Bardet-Biedl syndrome 10? The Human Phenotype Ontology provides the following list of signs and symptoms for Bardet-Biedl syndrome 10. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the kidney 95% Abnormal electroretinogram 90% Abnormality of retinal pigmentation 90% Cognitive impairment 90% Multicystic kidney dysplasia 90% Obesity 90% Postaxial hand polydactyly 90% Micropenis 88% Myopia 75% Astigmatism 63% Hypertension 50% Hypoplasia of penis 50% Nystagmus 50% Polycystic ovaries 50% Short stature 50% Cataract 30% Glaucoma 22% Rod-cone dystrophy 8% Abnormality of the ovary 7.5% Cryptorchidism 7.5% Finger syndactyly 7.5% Hearing impairment 7.5% Hepatic failure 7.5% Hypertrichosis 7.5% Low-set, posteriorly rotated ears 7.5% Macrocephaly 7.5% Medial flaring of the eyebrow 7.5% Nephrotic syndrome 7.5% Neurological speech impairment 7.5% Prominent nasal bridge 7.5% Short neck 7.5% Vaginal atresia 7.5% Aganglionic megacolon 5% Asthma - Ataxia - Autosomal recessive inheritance - Biliary tract abnormality - Brachydactyly syndrome - Broad foot - Congenital primary aphakia - Decreased testicular size - Delayed speech and language development - Dental crowding - Diabetes mellitus - Foot polydactyly - Gait imbalance - Hepatic fibrosis - High palate - Hirsutism - Hypodontia - Hypogonadism - Intellectual disability - Left ventricular hypertrophy - Nephrogenic diabetes insipidus - Poor coordination - Radial deviation of finger - Retinal degeneration - Short foot - Specific learning disability - Strabismus - Syndactyly - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Complete androgen insensitivity syndrome ?","output":"Complete androgen insensitivity syndrome is a condition that affects sexual development before birth and during puberty. People with this condition are genetically male (one X and one Y chromosome) but do not respond to male hormones at all. As a result, they generally have normal female external genitalia and female breasts. However, they do not have a uterus or cervix so are unable to menstruate or conceive children. Other signs and symptoms may include undescended testes and sparse to absent pubic hair. Gender identity is typically female. Complete androgen insensitivity syndrome is caused by changes (mutations) in the AR gene and is inherited in an X-linked manner. Treatment and gender assignment can be a very complex issue, and must be individualized with each affected person. In general, surgery may be required to remove testes that are located in unusual places and estrogen replacement therapy can be prescribed after puberty."},{"instruction":"What are the symptoms of Complete androgen insensitivity syndrome ?","output":"What are the signs and symptoms of Complete androgen insensitivity syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Complete androgen insensitivity syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal hair quantity 90% Cryptorchidism 90% Decreased fertility 90% Male pseudohermaphroditism 90% Primary amenorrhea 90% Tall stature 90% Hernia of the abdominal wall 50% Reduced bone mineral density 50% Flexion contracture 7.5% Gynecomastia 7.5% Testicular neoplasm 7.5% Tremor 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Chromosome 19p deletion ?","output":"Chromosome 19p deletion is a chromosome abnormality that occurs when there is a missing (deleted) copy of genetic material on the short arm (p) of chromosome 19. The severity of the condition and the signs and symptoms depend on the size and location of the deletion and which genes are involved. Features that often occur in people with chromosome 19p deletion include developmental delay, intellectual disability, behavioral problems and distinctive facial features. Chromosome testing of both parents can provide more information on whether or not the deletion was inherited. In most cases, parents do not have any chromosomal anomaly. However, sometimes one parent is found to have a balanced translocation, where a piece of a chromosome has broken off and attached to another one with no gain or loss of genetic material. The balanced translocation normally does not cause any signs or symptoms, but it increases the risk for having an affected child with a chromosomal anomaly like a deletion. Treatment is based on the signs and symptoms present in each person. This page is meant to provide general information about 19p deletions. You can contact GARD if you have questions about a specific deletion on chromosome 19. To learn more about chromosomal anomalies please visit our GARD webpage on FAQs about Chromosome Disorders."},{"instruction":"What is (are) Spinocerebellar ataxia 13 ?","output":"Spinocerebellar ataxia 13 (SCA13) is a rare sub-type of spinocerebellar ataxias, a group of neurological conditions characterized by degeneration of the brain and spinal cord. Signs and symptoms of SCA13 appear to vary among affected people and range from childhood-onset, slowly progressive gait ataxia and dysarthria (often with intellectual disability and occasional seizures) to adult-onset progressive ataxia. Life expectancy is normal. SCA13 is caused by mutations in the KCNC3 gene and is inherited in an autosomal dominant manner. Treatment may include anti-seizure medications; assistive devices (such as a canes and walkers); and/or speech therapy and communication devices."},{"instruction":"What are the symptoms of Spinocerebellar ataxia 13 ?","output":"What are the signs and symptoms of Spinocerebellar ataxia 13? The Human Phenotype Ontology provides the following list of signs and symptoms for Spinocerebellar ataxia 13. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal pyramidal signs - Autosomal dominant inheritance - Cerebellar atrophy - Dysarthria - Gait ataxia - Hyperreflexia - Intellectual disability - Limb ataxia - Limb dysmetria - Morphological abnormality of the pyramidal tract - Motor delay - Muscular hypotonia - Nystagmus - Progressive cerebellar ataxia - Slow progression - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Camptocormism ?","output":"Camptocormia, camptocormism or \\"bent spine syndrome,\\" (BSS) is an extreme forward flexion of the thoracolumbar spine, which often worsens during standing or walking, but completely resolves when laying down. The term itself is derived from the Greek \\"kamptos\\" (to bend) and \\"kormos\\" (trunk) BSS was initially considered, especially in wartime, as a result of a psychogenic disorder. It is now recognized that in it may also be related to a number of musculo-skeletal or neurological disorders. It seems that myopathy is the primary cause of camptocormia based on electromyography, magnetic resonance imaging/computed tomography (CT/MRI scans) of paraspinal muscles, and muscle biopsy. The majority of BSS of muscular origin is related to a primary idiopathic (with unknwon cause) axial myopathy of late onset, maybe a delayed-onset paraspinal myopathy, appearing in elderly patients. Causes of secondary BSS are numerous. The main causes are muscular disorders like inflammatory myopathies, muscular dystrophies of late onset, myotonic myopathies, endocrine and metabolic myopathies, and neurological disorders, principally Parkinsons disease. Diagnosis of axial myopathy is based upon CT/MRI scans demonstrating a lot of fatty infiltration of paravertebral muscles. General activity, walking with a cane, physiotherapy, and exercises should be encouraged. Treatment of secondary forms of BSS is dependent upon the cause."},{"instruction":"What are the symptoms of Zunich neuroectodermal syndrome ?","output":"What are the signs and symptoms of Zunich neuroectodermal syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Zunich neuroectodermal syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal dermatoglyphics 90% Abnormality of calvarial morphology 90% Aplasia/Hypoplasia of the nipples 90% Chorioretinal coloboma 90% Cognitive impairment 90% Depressed nasal ridge 90% Epicanthus 90% External ear malformation 90% Hearing impairment 90% Hypertelorism 90% Ichthyosis 90% Microdontia 90% Ptosis 90% Reduced number of teeth 90% Short philtrum 90% Strabismus 90% Tall stature 90% Thick lower lip vermilion 90% Abnormality of epiphysis morphology 50% Abnormality of the clavicle 50% Abnormality of the pulmonary valve 50% Adactyly 50% Brachydactyly syndrome 50% Cleft palate 50% Increased number of teeth 50% Opacification of the corneal stroma 50% Seizures 50% Short toe 50% Tetralogy of Fallot 50% Transposition of the great arteries 50% Upslanted palpebral fissure 50% Abnormal hair quantity 7.5% Abnormality of the hip bone 7.5% Abnormality of the kidney 7.5% Acute leukemia 7.5% Autism 7.5% Cerebral cortical atrophy 7.5% Clubbing of toes 7.5% Fine hair 7.5% Hyperkeratosis 7.5% Osteolysis 7.5% Skin ulcer 7.5% Ventricular septal defect 7.5% Acute lymphoblastic leukemia - Autosomal recessive inheritance - Brachycephaly - Broad-based gait - Cerebral atrophy - Clinodactyly of the 5th finger - Conductive hearing impairment - Duplicated collecting system - Frontal bossing - Hydronephrosis - Hypoplastic nipples - Intellectual disability - Joint contracture of the hand - Large for gestational age - Large hands - Long foot - Low-set nipples - Muscular hypotonia - Overfolded helix - Palmoplantar hyperkeratosis - Peripheral pulmonary artery stenosis - Prominent forehead - Retinal coloboma - Sparse hair - Ureteropelvic junction obstruction - Violent behavior - Webbed neck - Wide mouth - Wide nasal bridge - Widely spaced teeth - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Taurodontism, microdontia, and dens invaginatus ?","output":"What are the signs and symptoms of Taurodontism, microdontia, and dens invaginatus? The Human Phenotype Ontology provides the following list of signs and symptoms for Taurodontism, microdontia, and dens invaginatus. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Microdontia - Pulp stones - Taurodontia - X-linked recessive inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Spastic paraplegia 11 ?","output":"Spastic paraplegia 11 is a form of hereditary spastic paraplegia. People with spastic paraplegia 11 experience progressive muscle stiffness and eventual paralysis of the lower limbs, as well as a range of other neurologic symptoms. The tissue connecting the left and right halves of the brain (corpus callosum) is abnormally thin in individuals with this condition. Spastic paraplegia 11 is caused by mutations in the SPG11 gene and is passed through families in an autosomal recessive fashion."},{"instruction":"What are the symptoms of Spastic paraplegia 11 ?","output":"What are the signs and symptoms of Spastic paraplegia 11? Signs and symptoms of spastic paraplegia 11, include: Spasticity (progressive muscle stiffness) Paraplegia (eventual paralysis of the lower limbs) Numbness, tingling, or pain in the arms and legs Disturbance in the nerves used for muscle movement Intellectual disability Exaggerated reflexes of the lower limbs Speech difficulties Reduced bladder control Muscle wasting Less common features, include: Difficulty swallowing High-arched feet Scoliosis Involuntary movements of the eyes Age at time of symptom onset varies from infancy to early adulthood, with onset in infancy to adolescence being most common. Learning disability may begin in childhood. Most people experience a decline in intellectual ability and an increase in muscle weakness and nerve abnormalities over time. As the condition progresses, some people require wheelchair assistance (often 10 to 20 years after symptom onset). The Human Phenotype Ontology provides the following list of signs and symptoms for Spastic paraplegia 11. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Aplasia/Hypoplasia of the corpus callosum 90% Cerebral cortical atrophy 90% Gait disturbance 90% Incoordination 90% Neurological speech impairment 90% Seizures 90% Ventriculomegaly 90% Abnormality of the periventricular white matter - Adult onset - Agenesis of corpus callosum - Ankle clonus - Ataxia - Autosomal recessive inheritance - Babinski sign - Childhood onset - Decreased number of peripheral myelinated nerve fibers - Degeneration of the lateral corticospinal tracts - Distal peripheral sensory neuropathy - Dysarthria - Dysphagia - Gaze-evoked nystagmus - Hyperreflexia - Hypoplasia of the corpus callosum - Impaired vibration sensation in the lower limbs - Intellectual disability - Knee clonus - Lower limb muscle weakness - Lower limb spasticity - Macular degeneration - Mental deterioration - Motor polyneuropathy - Obesity - Pes cavus - Progressive - Retinal degeneration - Sensory neuropathy - Spastic gait - Spastic paraplegia - Specific learning disability - Thenar muscle atrophy - Tip-toe gait - Urinary bladder sphincter dysfunction - Urinary incontinence - Urinary urgency - Visual impairment - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Selig Benacerraf Greene syndrome ?","output":"What are the signs and symptoms of Selig Benacerraf Greene syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Selig Benacerraf Greene syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the foot - Autosomal dominant inheritance - Autosomal recessive inheritance - Bicornuate uterus - Congenital onset - Hypertelorism - Hypertension - Low-set ears - Oligohydramnios - Potter facies - Primary amenorrhea - Proteinuria - Pulmonary hypoplasia - Retrognathia - Talipes equinovarus - Vaginal atresia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Ataxia with Oculomotor Apraxia Type 2 ?","output":"What are the signs and symptoms of Ataxia with Oculomotor Apraxia Type 2? The Human Phenotype Ontology provides the following list of signs and symptoms for Ataxia with Oculomotor Apraxia Type 2. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Impaired distal tactile sensation 57% Tremor 57% Strabismus 30% Conjunctival telangiectasia 5% Areflexia 10/10 Cerebellar atrophy 8/8 Distal amyotrophy 10/10 Distal muscle weakness 10/10 Dysarthria 10/10 Dysphagia 10/10 Elevated alpha-fetoprotein 6/6 Gait ataxia 10/10 Impaired proprioception 10/10 Peripheral axonal neuropathy 8/8 Nystagmus 8/10 Pes cavus 12/18 Oculomotor apraxia 10/18 Scoliosis 7/18 Dystonia 5/18 Head tremor 5/19 Chorea 4/18 Hyporeflexia 4/18 Abnormal pyramidal signs - Autosomal recessive inheritance - Decreased motor nerve conduction velocity - Elevated serum creatine phosphokinase - Gaze-evoked nystagmus - Impaired distal vibration sensation - Increased antibody level in blood - Limb ataxia - Polyneuropathy - Pontocerebellar atrophy - Progressive - Progressive gait ataxia - Saccadic smooth pursuit - Variable expressivity - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Intestinal pseudoobstruction neuronal chronic idiopathic Xlinked ?","output":"Intestinal pseudo-obstruction is a condition characterized by impairment of the muscle contractions that move food through the digestive tract. The condition may arise from abnormalities of the gastrointestinal muscles themselves (myogenic) or from problems with the nerves that control the muscle contractions (neurogenic). When intestinal pseudo-obstruction occurs by itself, it is called primary or idiopathic (unknown cause) intestinal pseudo-obstruction. The disorder can also develop as a complication of another medical condition; in these cases, it is called secondary intestinal pseudo-obstruction. Individuals with this condition have symptoms that resemble those of an intestinal blockage (obstruction) but without any obstruction. It may be acute or chronic and is characterized by the presence of dilation of the bowel on imaging. The causes may be unknown or due to alterations (mutations) in the FLNA gene, other genes or are secondary to other conditions. It may be inherited in some cases. Intestinal pseudoobstruction neuronal chronic idiopathic X-linked is caused by alterations (mutations) in the FLNA gene which is located in the X chromosome. There is no specific treatment but several medications and procedures may be used to treat the symptoms."},{"instruction":"What are the symptoms of Intestinal pseudoobstruction neuronal chronic idiopathic Xlinked ?","output":"What are the signs and symptoms of Intestinal pseudoobstruction neuronal chronic idiopathic X-linked? The Human Phenotype Ontology provides the following list of signs and symptoms for Intestinal pseudoobstruction neuronal chronic idiopathic X-linked. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Hydronephrosis 5% Pyloric stenosis 5% Seizures 5% Spastic diplegia 5% Abdominal distention - Abnormal facial shape - Feeding difficulties in infancy - Hypertelorism - Increased mean platelet volume - Infantile onset - Intestinal malrotation - Intestinal pseudo-obstruction - Low-set ears - Patent ductus arteriosus - Smooth philtrum - Thrombocytopenia - Vomiting - X-linked recessive inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Friedreich ataxia ?","output":"Friedreich ataxia is an inherited condition that affects the nervous system and causes movement problems. People with this condition develop impaired muscle coordination (ataxia) that worsens over time. Other features include the gradual loss of strength and sensation in the arms and legs, muscle stiffness (spasticity), and impaired speech. Many individuals have a form of heart disease called hypertrophic cardiomyopathy. Some develop diabetes, impaired vision, hearing loss, or an abnormal curvature of the spine (scoliosis). Most people with Friedreich ataxia begin to experience the signs and symptoms around puberty. This condition is caused by mutations in the FXN gene and is inherited in an autosomal recessive pattern."},{"instruction":"What are the symptoms of Friedreich ataxia ?","output":"What are the signs and symptoms of Friedreich ataxia? Symptoms usually begin between the ages of 5 and 15 but can, on occasion, appear in adulthood or even as late as age 75. The first symptom to appear is usually difficulty in walking, or gait ataxia. The ataxia gradually worsens and slowly spreads to the arms and then the trunk. Over time, muscles begin to weaken and waste away, especially in the feet, lower legs, and hands, and deformities develop. Other symptoms include loss of tendon reflexes, especially in the knees and ankles. There is often a gradual loss of sensation in the extremities, which may spread to other parts of the body. Dysarthria (slowness and slurring of speech) develops, and the person is easily fatigued. Rapid, rhythmic, involuntary movements of the eye (nystagmus) are common. Most people with Friedreich's ataxia develop scoliosis (a curving of the spine to one side), which, if severe, may impair breathing. Other symptoms that may occur include chest pain, shortness of breath, and heart palpitations. These symptoms are the result of various forms of heart disease that often accompany Friedreich ataxia, such as cardiomyopathy (enlargement of the heart), myocardial fibrosis (formation of fiber-like material in the muscles of the heart), and cardiac failure. Heart rhythm abnormalities such as tachycardia (fast heart rate) and heart block (impaired conduction of cardiac impulses within the heart) are also common. About 20 percent of people with Friedreich ataxia develop carbohydrate intolerance and 10 percent develop diabetes mellitus. Some people lose hearing or eyesight. The rate of progression varies from person to person. Generally, within 10 to 20 years after the appearance of the first symptoms, the person is confined to a wheelchair, and in later stages of the disease individuals become completely incapacitated. Life expectancy may be affected, and many people with Friedreich ataxia die in adulthood from the associated heart disease, the most common cause of death. However, some people with less severe symptoms of Friedreich ataxia live much longer, sometimes into their sixties or seventies. The Human Phenotype Ontology provides the following list of signs and symptoms for Friedreich ataxia. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Reduced visual acuity 5% Visual impairment 5% Abnormal echocardiogram - Abnormal EKG - Abnormality of visual evoked potentials - Areflexia of lower limbs - Autosomal recessive inheritance - Babinski sign - Congestive heart failure - Decreased amplitude of sensory action potentials - Decreased pyruvate carboxylase activity - Decreased sensory nerve conduction velocity - Diabetes mellitus - Dysarthria - Gait ataxia - Hypertrophic cardiomyopathy - Impaired proprioception - Juvenile onset - Limb ataxia - Mitochondrial malic enzyme reduced - Nystagmus - Optic atrophy - Pes cavus - Scoliosis - Sensory neuropathy - Visual field defect - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Friedreich ataxia ?","output":"What causes Friedreich ataxia? Friedreich ataxia is caused by mutations in the FXN gene. This gene provides instructions for making a protein called frataxin. One region of the FXN gene contains a segment of DNA known as a GAA trinucleotide repeat. This segment is made up of a series of three DNA building blocks (one guanine and two adenines) that appear multiple times in a row. Normally, this segment is repeated 5 to 33 times within the FXN gene. In people with Friedreich ataxia, the GAA segment is repeated 66 to more than 1,000 times. The length of the GAA trinucleotide repeat appears to be related to the age at which the symptoms of Friedreich ataxia appear. The abnormally long GAA trinucleotide repeat disrupts the production of frataxin, which severely reduces the amount of this protein in cells. Certain nerve and muscle cells cannot function properly with a shortage of frataxin, leading to the characteristic signs and symptoms of Friedreich ataxia."},{"instruction":"Friedreich ataxia inherited ?","output":"How is Friedreich ataxia inherited? Friedreich ataxia is inherited in an autosomal recessive manner. This means that to be affected, a person must have a mutation in both copies of the responsible gene in each cell. The parents of an affected person usually each carry one mutated copy of the gene and are referred to as carriers. Carriers typically do not show signs or symptoms of the condition. When two carriers of an autosomal recessive condition have children, each child has a 25% (1 in 4) risk to have the condition, a 50% (1 in 2) risk to be a carrier like each of the parents, and a 25% chance to not have the condition and not be a carrier."},{"instruction":"What are the symptoms of Neutropenia chronic familial ?","output":"What are the signs and symptoms of Neutropenia chronic familial? The Human Phenotype Ontology provides the following list of signs and symptoms for Neutropenia chronic familial. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal dominant inheritance - Clubbing of fingers - Gingivitis - Increased antibody level in blood - Neutropenia - Periodontitis - Premature loss of teeth - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Chromosome Xp22 deletion syndrome ?","output":"What are the signs and symptoms of Chromosome Xp22 deletion syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Chromosome Xp22 deletion syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autistic behavior 100% Muscular hypotonia 5% Aggressive behavior - Attention deficit hyperactivity disorder - Impulsivity - Intellectual disability - Motor tics - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Desmoplastic infantile ganglioglioma ?","output":"Desmoplastic infantile gangliomas (DIGs) are rare brain tumors that are normally located in the frontal or parietal lobes of the brain. They are usually diagnosed before 18 months of age with most infants presenting with a short duration of symptoms. Although seizures are not commonly observed, a bulging fontanelle, rapid head growth, vomiting, and a sunset sign are usually noted. The standard treatment for DIGs is surgical resection (surgical procedure in which the portion of the brain with the tumor is removed)."},{"instruction":"What are the symptoms of Desmoplastic infantile ganglioglioma ?","output":"What signs and symptoms are associated with desmoplastic infantile gangliomas? Most infants with DIGs do not have seizures; however, they usually have a bulging fontanelle, rapid head growth, sunset sign, and vomiting."},{"instruction":"w to diagnose Desmoplastic infantile ganglioglioma ?","output":"How are desmoplastic infantile gangliomas diagnosed? In addition to detecting the signs and symptoms commonly seen in DIGs, head CT scans and MRIs may reveal the presence of this type of brain tumor."},{"instruction":"What are the treatments for Desmoplastic infantile ganglioglioma ?","output":"What treatment is available for desmoplastic infantile gangliomas? Surgical resection (removal of the area of the brain with the tumor) has been the standard treatment reported in the medical literature. The size of the resection is probably based on the size of the tumor, although the extent of the resection is not documented for all cases reported in the medical literature. Adjuvant therapy is generally not performed when a gross total resection can be performed. When total resection is not possible, some of suggested chemotherapy, as the effects of radiation on extremely young children may be harmful."},{"instruction":"What are the symptoms of Immotile cilia syndrome, due to defective radial spokes ?","output":"What are the signs and symptoms of Immotile cilia syndrome, due to defective radial spokes? The Human Phenotype Ontology provides the following list of signs and symptoms for Immotile cilia syndrome, due to defective radial spokes. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Absent respiratory ciliary axoneme radial spokes - Autosomal recessive inheritance - Chronic rhinitis - Ciliary dyskinesia - Immotile cilia - Nasal polyposis - Nonmotile sperm - Sinusitis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Red cell phospholipid defect with hemolysis ?","output":"What are the signs and symptoms of Red cell phospholipid defect with hemolysis? The Human Phenotype Ontology provides the following list of signs and symptoms for Red cell phospholipid defect with hemolysis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal dominant inheritance - Hyperbilirubinemia - Reticulocytosis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Tetrasomy X ?","output":"Tetrasomy X is a chromosome disorder that only affects females and is caused by having four copies of the X chromosome instead of two. Females with tetrasomy X have a total of 48 chromosomes in their cells, so this condition is sometimes written as 48, XXXX. The signs and symptoms of tetrasomy X vary, but can include mild to moderate speech and learning difficulties; developmental delay; distinctive facial features; dental abnormalities; hypotonia and joint laxity; radioulnar synostosis; heart defects; hip dysplasia; and problems with ovarian function. An increased risk of childhood infections has also been reported. Tetrasomy X is caused by a random error that occurs during the development of an egg cell and is not caused by anything a mother does during her pregnancy."},{"instruction":"What are the symptoms of Tetrasomy X ?","output":"What are the signs and symptoms of Tetrasomy X? The Human Phenotype Ontology provides the following list of signs and symptoms for Tetrasomy X. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of chromosome segregation 90% Abnormality of the teeth 50% Cognitive impairment 50% Epicanthus 50% Hypertelorism 50% Joint hypermobility 50% Muscular hypotonia 50% Radioulnar synostosis 50% Strabismus 50% Upslanted palpebral fissure 50% Abnormality of immune system physiology 7.5% Abnormality of the hip bone 7.5% Brachydactyly syndrome 7.5% Clinodactyly of the 5th finger 7.5% Secondary amenorrhea 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Tetrasomy X ?","output":"What causes tetrasomy X? Tetrasomy X is usually caused by a random error in the formation of an egg cell (before pregnancy). In some cases, it may be due to inheriting three X chromosomes from the mother and one X chromosome from the father. In other cases, it may be due to inheriting all four X chromosomes from the mother. During the normal formation of egg cells, each egg cell contains one X chromosome to pass on to offspring. However, errors in cell division can cause an egg cell to have three or four X chromosomes, instead of one. If an egg cell with the extra X chromosomes is fertilized by a sperm cell with one X chromosome, the resulting embryo will have these extra chromosomes. Rarely, tetrasomy X may be caused by an error in cell division that occurs after an egg is fertilized, or by the presence of extra X chromosomes in some of the mother's cells."},{"instruction":"What is (are) Tubular aggregate myopathy ?","output":"Tubular aggregate myopathy is a very rare muscle disease where the presence of tubular aggregates represent the major, if not sole, pathologic change in the muscle cell. It is often characterized by muscle weakness or stiffness, cramps, and exercise induced muscle fatigue. The exact cause of the condition is unknown. Sporadic and genetic forms have been reported. Some cases appear to be due to dominant mutations in the STIM1 gene."},{"instruction":"What are the symptoms of Tubular aggregate myopathy ?","output":"What are the signs and symptoms of Tubular aggregate myopathy? In general, many people with tubular aggregate myopathy have muscle weakness, muscle cramps, and exercise induced fatigue. Typically the facial muscles are not affected in tubular aggregate myopathy. The Human Phenotype Ontology provides the following list of signs and symptoms for Tubular aggregate myopathy. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the pupil 5% External ophthalmoplegia 5% Flexion contracture 5% Nyctalopia 5% Respiratory insufficiency 5% Adult onset - Areflexia of lower limbs - Autosomal dominant inheritance - Difficulty running - Easy fatigability - Elevated serum creatine phosphokinase - Exercise-induced myalgia - Frequent falls - Hyporeflexia of lower limbs - Increased variability in muscle fiber diameter - Muscle cramps - Muscle stiffness - Myopathy - Proximal amyotrophy - Proximal muscle weakness - Slow progression - Type 2 muscle fiber atrophy - Weakness of the intrinsic hand muscles - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common. Are there different types of tubular aggregate myopathy? Yes. Symptoms of tubular aggregate myopathy can be be grouped into at least three different types. The first type is characterized by exercise induced cramps with or without muscle pain associated or not with weakness in the proximal muscles. The second type of tubular aggregate myopathy is characterized by isolated, slowly progressive weakness of the proximal muscles. The third type is characterized by progressive proximal weakness and sometimes fatigability. In this type the serum creatine kinase levels are often elevated."},{"instruction":"What causes Tubular aggregate myopathy ?","output":"What causes tubular aggregate myopathy? Currently, the underlying cause of tubular aggregate myopathy is not known. Some cases appear to be due to dominant mutations in the STIM1 gene."},{"instruction":"Tubular aggregate myopathy inherited ?","output":"Is tubular aggregate myopathy genetic? It is evident from family history studies that the condition can be passed through families in either an autosomal dominant or autosomal recessive fashion. Some cases appear to be due to dominant mutations in the STIM1 gene. Sporadic cases of tubular aggregate myopathy have also been reported. Sporadic is used to denote either a genetic disorder that occurs for the first time in a family due to a new mutation or the chance occurrence of a non-genetic disorder or abnormality that is not likely to recur in a family."},{"instruction":"What are the treatments for Tubular aggregate myopathy ?","output":"How might tubular aggregate myopathy be treated?"},{"instruction":"What is (are) Hartnup disease ?","output":"Hartnup disease is a metabolic disorder characterized by abnormal transport of certain amino acids in the kidney and gastrointestinal system. It is a type of aminoaciduria. The condition may be diagnosed based on the results of newborn screening tests. Most people with the condition have no symptoms (asymptomatic). For those who do show symptoms, the onset of the disease is usually between the ages of 3 and 9; occasionally the disease may present in adulthood. Mental development is usually normal, though a few cases with intellectual impairment have been reported. The signs and symptoms of Hartnup disease incude skin photosensitivity, neurologic findings, psychiatric symptoms, and ocular (eye) findings. Hartnup disease is caused by mutations in the SLC6A19 gene and is inherited in an autosomal recessive manner.[1][2] People with Hartnup disease may benefit from a high-protein diet, protection from sunlight, vitamin supplementation, and avoidance of certain drugs/medications. In some cases, treatment with nicotinamide supplements and tryptophan ethyl ester may be indicated."},{"instruction":"What are the symptoms of Hartnup disease ?","output":"What are the signs and symptoms of Hartnup disease? The signs and symptoms of Hartnup disease may vary and include the following: Skin findings: sensitivity to sunlight Neurologic symptoms: ataxia, spasticity, headaches,and hypotonia Psychiatric symptoms: anxiety, emotional instability, mood changes Ocular findings: double vision, nystagmus, strabismus, photophobia Symptoms may be triggered by sunlight exposure, fever, drugs, and emotional or physical stress. The episodes of skin and neurologic findings may last for 1-4 weeks before spontaneous remission occurs. The Human Phenotype Ontology provides the following list of signs and symptoms for Hartnup disease. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Cutaneous photosensitivity 90% EEG abnormality 90% Hallucinations 90% Hyperreflexia 90% Incoordination 90% Migraine 90% Muscular hypotonia 90% Malabsorption 50% Nystagmus 50% Photophobia 50% Short stature 50% Skin rash 50% Strabismus 50% Abnormal blistering of the skin 7.5% Cognitive impairment 7.5% Encephalitis 7.5% Gingivitis 7.5% Glossitis 7.5% Hypopigmented skin patches 7.5% Irregular hyperpigmentation 7.5% Seizures 7.5% Autosomal recessive inheritance - Emotional lability - Episodic ataxia - Hypertonia - Neutral hyperaminoaciduria - Psychosis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Secondary adrenal insufficiency ?","output":"Adrenal insufficiency is an endocrine disorder that occurs when the adrenal glands do not produce enough of certain hormones. Secondary adrenal insufficiency occurs when the pituitary gland (a pea-sized gland at the base of the brain) fails to produce enough adrenocorticotropin (ACTH), a hormone that stimulates the adrenal glands to produce the hormone cortisol. The lack of these hormones in the body can be caused by reduction or cessation of corticosteroid medication, the surgical removal of pituitary tumors, or changes in the pituitary gland. Symptoms of secondary adrenal insufficiency may include severe fatigue, loss of appetite, weight loss, nausea, vomiting, diarrhea, muscle weakness, irritability, and depression. Treatment includes replacing the hormones that the adrenal glands are not making. The dose of each medication is adjusted to meet the needs of each affected individual."},{"instruction":"What are the symptoms of Transient erythroblastopenia of childhood ?","output":"What are the signs and symptoms of Transient erythroblastopenia of childhood? The Human Phenotype Ontology provides the following list of signs and symptoms for Transient erythroblastopenia of childhood. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal recessive inheritance - Transient erythroblastopenia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Lipidosis with triglycerid storage disease ?","output":"What are the signs and symptoms of Lipidosis with triglycerid storage disease? The Human Phenotype Ontology provides the following list of signs and symptoms for Lipidosis with triglycerid storage disease. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of lipid metabolism 90% Dry skin 90% Ichthyosis 90% Sensorineural hearing impairment 90% Abnormality of retinal pigmentation 50% Cognitive impairment 50% EMG abnormality 50% Hepatomegaly 50% Muscle weakness 50% Myopathy 50% Ptosis 50% Retinopathy 50% Short stature 50% Skeletal muscle atrophy 50% Abnormality of the aortic valve 7.5% Cataract 7.5% Cranial nerve paralysis 7.5% Diabetes mellitus 7.5% Incoordination 7.5% Nystagmus 7.5% Opacification of the corneal stroma 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Ectodermal dysplasia mental retardation syndactyly ?","output":"What are the signs and symptoms of Ectodermal dysplasia mental retardation syndactyly? The Human Phenotype Ontology provides the following list of signs and symptoms for Ectodermal dysplasia mental retardation syndactyly. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) 2-3 toe syndactyly - 3-4 finger syndactyly - Abnormal facial shape - Abnormality of the ear - Aplasia cutis congenita of scalp - Aqueductal stenosis - Autosomal recessive inheritance - Dental crowding - Dry skin - Ectodermal dysplasia - Headache - Hypohidrosis - Intellectual disability - Long palpebral fissure - Onychogryposis of toenails - Open mouth - Shovel-shaped maxillary central incisors - Sparse eyebrow - Sporadic - Subcapsular cataract - Ventriculomegaly - Wide nasal bridge - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Congenital toxoplasmosis ?","output":"What are the signs and symptoms of Congenital toxoplasmosis? The Human Phenotype Ontology provides the following list of signs and symptoms for Congenital toxoplasmosis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of retinal pigmentation 90% Premature birth 90% Visual impairment 50% Anemia 7.5% Aplasia/Hypoplasia affecting the eye 7.5% Ascites 7.5% Cardiomegaly 7.5% Cerebral calcification 7.5% Cognitive impairment 7.5% Diarrhea 7.5% Elevated hepatic transaminases 7.5% Hearing impairment 7.5% Hepatomegaly 7.5% Hydrocephalus 7.5% Hypermelanotic macule 7.5% Intrauterine growth retardation 7.5% Lymphadenopathy 7.5% Microcephaly 7.5% Muscular hypotonia 7.5% Nystagmus 7.5% Seizures 7.5% Thrombocytopenia 7.5% Ventriculomegaly 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Wyburn Mason's syndrome ?","output":"Wyburn Mason's syndrome is a condition in which blood vessels do not form correctly in both the retina of one eye and a part of the brain. These malformed blood vessels are called arteriovenous malformations (AVM). Wyburn Mason's syndrome is present from birth (congenital) and the cause is unknown. Individuals with this condition may have additional AVMs in other parts of the body, particularly the face. The symptoms of this condition are quite variable and depend on the size, location, and shape of the AVMs. Affected individuals may have no symptoms or may experience headaches, problems with vision, seizures, or partial paralysis (hemiparesis). Treatment usually consists of periodic visits to the doctor to see if the AVMs are changing over time."},{"instruction":"What are the symptoms of Wyburn Mason's syndrome ?","output":"What are the signs and symptoms of Wyburn Mason's syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Wyburn Mason's syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the retinal vasculature 90% Abnormality of the skin 90% Aneurysm 90% Peripheral arteriovenous fistula 90% Cerebral palsy 50% Cognitive impairment 50% Hemiplegia/hemiparesis 50% Migraine 50% Seizures 50% Visual impairment 50% Abnormality of eye movement 7.5% Abnormality of retinal pigmentation 7.5% Behavioral abnormality 7.5% Hearing impairment 7.5% Intracranial hemorrhage 7.5% Meningitis 7.5% Nausea and vomiting 7.5% Neurological speech impairment 7.5% Proptosis 7.5% Reduced consciousness/confusion 7.5% Tinnitus 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Pituitary hormone deficiency, combined 4 ?","output":"What are the signs and symptoms of Pituitary hormone deficiency, combined 4? The Human Phenotype Ontology provides the following list of signs and symptoms for Pituitary hormone deficiency, combined 4. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Small sella turcica 5% Adrenal insufficiency - Autosomal dominant inheritance - Autosomal recessive inheritance - Hypoglycemia - Hypothyroidism - Marked delay in bone age - Pituitary dwarfism - Severe postnatal growth retardation - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Adenylosuccinase deficiency ?","output":"Adenylosuccinase deficiency is a rare, inherited metabolic condition that results from a lack of the enzyme adenylosuccinate lyase. Signs and symptoms vary greatly from person to person. In general, affected individuals may have a mix of neurological symptoms, which usually includes abnormalities with cognition and movement, autistic features, epilepsy, muscle wasting, and feeding problems. Although less common, abnormal physical features can include severe growth failure, small head, abnormally shaped head, strabismus, small nose with upturned nostrils, thin upper lip, and low set ears. Adenylosuccinase deficiency is caused by mutations in the ADSL gene and is inherited in an autosomal recessive fashion."},{"instruction":"What are the symptoms of Adenylosuccinase deficiency ?","output":"What are the signs and symptoms of Adenylosuccinase deficiency? The signs and symptoms of adenylosuccinase deficiency vary greatly from person to person. Seizures are observed in 60 percent of affected individuals. Seizures may begin within the first month of life and, in many cases, are the first sign of the condition. Some of the neurological symptoms include floppiness (hypotonia) with severe tension of the hands and feet (hypertonia); muscle wasting; muscle twitchings of the tongue or hands and feet; and crossed eyes (strabismus). Almost all affected individuals experience delayed motor milestones ranging from mild to severe. In the first years of life, growth delay has been observed in 30 percent of affected individuals, mainly related to feeding problems. Autism has been found to be present in one-third of cases. Some children display unusual behavior such as stereotyped behavior, (hand washing movements, repetitive manipulation of toys, grimacing, clapping hands, rubbing feet, and inappropriate laughter), aggressive behavior, temper tantrums, impulsivity, hyperactivity, short attention span, and hypersensitivity to noise and lights. Many patients show severe intellectual disability, and language delay. The Human Phenotype Ontology provides the following list of signs and symptoms for Adenylosuccinase deficiency. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Happy demeanor 5% Microcephaly 5% Aggressive behavior - Anteverted nares - Autism - Autosomal recessive inheritance - Brachycephaly - Brisk reflexes - Cerebellar atrophy - Cerebral atrophy - Cerebral hypomyelination - CNS hypomyelination - Delayed speech and language development - Gait ataxia - Growth delay - Hyperactivity - Inability to walk - Inappropriate laughter - Infantile onset - Intellectual disability - Long philtrum - Low-set ears - Muscular hypotonia - Myoclonus - Nystagmus - Opisthotonus - Poor eye contact - Prominent metopic ridge - Seizures - Self-mutilation - Severe global developmental delay - Short nose - Skeletal muscle atrophy - Smooth philtrum - Strabismus - Wide mouth - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the treatments for Adenylosuccinase deficiency ?","output":"How might adenylosuccinase deficiency be treated? At the current time, there are no effective therapies for the treatment of adenylosuccinase deficiency. Treatment is supportive based on the specific features."},{"instruction":"What is (are) Pierson syndrome ?","output":"Pierson syndrome is a very rare condition that mainly affects the kidneys and eyes. Signs and symptoms include congenital nephrotic syndrome and distinct ocular (eye) abnormalities, including microcoria (small pupils that are not responsive to light). Most affected children have early-onset, chronic renal failure; neurodevelopmental problems; and blindness. Hypotonia (poor muscle tone) and movement disorders have also been reported. Pierson syndrome is caused by changes (mutations) in the LAMB2 gene and is inherited in an autosomal recessive manner. The long-term outlook is poor; affected infants may not survive past the first weeks or months of life."},{"instruction":"What are the symptoms of Pierson syndrome ?","output":"What are the signs and symptoms of Pierson syndrome? The features and severity of Pierson syndrome can vary among affected people. Affected infants are usually born with serious and progressive kidney disease due to congenital nephrotic syndrome, although some do not have kidney failure until adulthood. Most require a renal transplant for end-stage kidney disease within the first decade of life. Ocular (eye) abnormalities are another common feature of Pierson syndrome. Most affected infants are born with abnormally small pupils (microcoria). Other ocular abnormalities may include cataracts, glaucoma, retinal detachments, and blindness. Those that survive past infancy typically have neurological disabilities and developmental delays. Many children with Pierson syndrome don't achieve normal milestones such as sitting, standing, and talking. The Human Phenotype Ontology provides the following list of signs and symptoms for Pierson syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of movement 90% Cataract 90% EEG abnormality 90% Hematuria 90% Hemiplegia/hemiparesis 90% Hypertension 90% Muscular hypotonia 90% Nephrotic syndrome 90% Nystagmus 90% Proteinuria 90% Hypoplasia of penis 50% Areflexia - Autosomal recessive inheritance - Blindness - Diffuse mesangial sclerosis - Edema - Hypoplasia of the ciliary body - Hypoplasia of the iris - Hypoproteinemia - Neonatal onset - Posterior lenticonus - Stage 5 chronic kidney disease - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"Pierson syndrome inherited ?","output":"How is Pierson syndrome inherited? Pierson syndrome is inherited in an autosomal recessive manner. This means that to be affected, a person must have a mutation in both copies of the responsible gene in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a carrier. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a: 25% (1 in 4) chance to be affected 50% (1 in 2) chance to be an unaffected carrier like each parent 25% chance to be unaffected and not be a carrier"},{"instruction":"w to diagnose Pierson syndrome ?","output":"Is genetic testing available for Pierson syndrome? Yes. The Genetic Testing Registry (GTR) provides information about the genetic tests available for Pierson syndrome. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional. According to the GTR, genetic testing for Pierson syndrome may be available for diagnosis in a person suspected of having the condition, carrier testing, and prenatal testing."},{"instruction":"What are the symptoms of Galactose epimerase deficiency ?","output":"What are the signs and symptoms of Galactose epimerase deficiency? The Human Phenotype Ontology provides the following list of signs and symptoms for Galactose epimerase deficiency. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Aminoaciduria 90% Cataract 90% Cognitive impairment 90% Feeding difficulties in infancy 90% Hepatomegaly 90% Muscular hypotonia 90% Nausea and vomiting 90% Splenomegaly 90% Weight loss 90% Autosomal recessive inheritance - Delayed gross motor development - Delayed speech and language development - Failure to thrive - Galactosuria - Hypergalactosemia - Intellectual disability - Jaundice - Sensorineural hearing impairment - Vomiting - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia ?","output":"Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare condition in which cells called neuroendocrine cells spread and cluster in the small airways of the lungs. The majority of affected individuals are middled-aged women. Symptoms include shortness of breath and coughing. It is considered to be a precursor for pulmonary carcinoid tumors. Because so few cases have been reported in the medical literature, there is limited information on the prognosis and management of this condition."},{"instruction":"What are the symptoms of Peptidic growth factors deficiency ?","output":"What are the signs and symptoms of Peptidic growth factors deficiency? The Human Phenotype Ontology provides the following list of signs and symptoms for Peptidic growth factors deficiency. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of skin pigmentation 90% Convex nasal ridge 90% Flexion contracture 90% Lack of skin elasticity 90% Limitation of joint mobility 90% Lipoatrophy 90% Narrow mouth 90% Palmoplantar keratoderma 90% Pectus excavatum 90% Pes planus 90% Weight loss 90% Abnormal hair quantity 50% Abnormality of limb bone morphology 50% Abnormality of lipid metabolism 50% Atherosclerosis 50% Chondrocalcinosis 50% Premature graying of hair 50% Reduced bone mineral density 50% Type I diabetes mellitus 50% Autosomal recessive inheritance - Dermal atrophy - Insulin-resistant diabetes mellitus - Plantar hyperkeratosis - Reduced subcutaneous adipose tissue - Thin skin - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Greig cephalopolysyndactyly syndrome ?","output":"Greig cephalopolysyndactyly syndrome (GCPS) is a congenital disorder that affects development of the limbs, head, and face. Findings might include an extra finger or toe (polydactyly), fusion of the skin between the fingers or toes (syndactyly), widely spaced eyes (ocular hypertelorism), and an abnormally large head size (macrocephaly).The features of this syndrome are highly variable, ranging from polydactyly and syndactyly of the upper and/or lower limbs to seizure, hydrocephalus , and intellectual disability. Progression of GCPS is dependent on severity. Greig cephalopolysyndactyly syndrome is caused by mutations in the GLI3 gene. This condition is inherited in an autosomal dominant pattern. Treatment is symptomatic."},{"instruction":"What are the symptoms of Greig cephalopolysyndactyly syndrome ?","output":"What are the signs and symptoms of Greig cephalopolysyndactyly syndrome? The symptoms of Greig cephalopolysyndactyly syndrome (GCPS) are highly variable, ranging from mild to severe. People with this condition typically have limb anomalies, which may include one or more extra fingers or toes (polydactyly), an abnormally wide thumb or big toe (hallux), and the skin between the fingers and toes may be fused (cutaneous syndactyly). This disorder is also characterized by widely spaced eyes (ocular hypertelorism), an abnormally large head size (macrocephaly), and a high, prominent forehead. Rarely, affected individuals may have more serious medical problems including seizures, developmental delay, and intellectual disability. The Human Phenotype Ontology provides the following list of signs and symptoms for Greig cephalopolysyndactyly syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) 1-3 toe syndactyly 90% Macrocephaly 90% Postaxial hand polydactyly 90% Preaxial foot polydactyly 90% Broad hallux 89% Wide nasal bridge 79% High forehead 70% Frontal bossing 58% Abnormality of the nose 50% Accelerated skeletal maturation 50% Finger syndactyly 50% Hypertelorism 50% Telecanthus 50% Toe syndactyly 50% 3-4 finger syndactyly 33% Broad hallux phalanx 33% Broad thumb 33% Abnormal heart morphology 7.5% Abnormality of muscle fibers 7.5% Agenesis of corpus callosum 7.5% Aplasia/Hypoplasia of the corpus callosum 7.5% Camptodactyly of toe 7.5% Cognitive impairment 7.5% Congenital diaphragmatic hernia 7.5% Craniosynostosis 7.5% Cryptorchidism 7.5% Delayed cranial suture closure 7.5% Hirsutism 7.5% Hydrocephalus 7.5% Hyperglycemia 7.5% Hypospadias 7.5% Inguinal hernia 7.5% Intellectual disability, mild 7.5% Joint contracture of the hand 7.5% Postaxial foot polydactyly 7.5% Preaxial hand polydactyly 7.5% Seizures 7.5% Umbilical hernia 7.5% Metopic synostosis 5% Autosomal dominant inheritance - Dolichocephaly - Trigonocephaly - Variable expressivity - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Greig cephalopolysyndactyly syndrome ?","output":"What causes Greig cephalopolysyndactyly syndrome? Mutations in the GLI3 gene cause Greig cephalopolysyndactyly syndrome (GCPS). The GLI3 gene provides instructions for making a protein that controls gene expression, which is a process that regulates whether genes are turned on or off in particular cells. By interacting with certain genes at specific times during development, the GLI3 protein plays a role in the normal shaping (patterning) of many organs and tissues before birth. Different genetic changes involving the GLI3 gene can cause GCPS. In some cases, the condition results from a chromosome abnormalitysuch as a large deletion or rearrangement of genetic materialin the region of chromosome 7 that contains the GLI3 gene. In other cases, a mutation in the GLI3 gene itself is responsible for the disorder. Each of these genetic changes prevents one copy of the gene in each cell from producing any functional protein. It remains unclear how a reduced amount of this protein disrupts early development and causes the characteristic features of GCPS."},{"instruction":"Greig cephalopolysyndactyly syndrome inherited ?","output":"How is Greig cephalopolysyndactyly syndrome inherited? Greig cephalopolysyndactyly syndrome (GCPS) is often inherited in an autosomal dominant pattern. This means that to be affected, a person only needs a change (mutation) in one copy of the GLI3 gene in each cell. In some cases, an affected person inherits a gene mutation or chromosomal abnormality from one affected parent. Other cases occur in people with no history of the condition in their family. A person with GCPS syndrome has a 50% chance with each pregnancy of passing the altered gene to his or her child."},{"instruction":"w to diagnose Greig cephalopolysyndactyly syndrome ?","output":"Is genetic testing available for Greig cephalopolysyndactyly syndrome? Yes. GLI3 is the only gene known to be associated with Greig cephalopolysyndactyly syndrome (GCPS). Genetic testing is available to analyze the GLI3 gene for mutations. Mutations involving GLI3 can be identified in greater than 75% of people with GCPS. How is Greig cephalopolysyndactyly syndrome diagnosed? Greig cephalopolysyndactyly syndrome (GCPS) is diagnosed based on clinical findings and family history. Major findings of GCPS include: an abnormally large head size (macrocephaly) greater than the 97th percentile widely spaced eyes (ocular hypertelorism) limb anomalies including extra fingers or toes (polydactyly) fused skin between the fingers and toes (cutaneous syndactyly) A diagnosis is established in a first degree relative of a known affected individual if that person has polydactyly with or without syndactyly or craniofacial features (macrocephaly, widely spaced eyes). A diagnosis is additionally established in a person who has features of GCPS and a mutation in the GLI3 gene."},{"instruction":"What are the treatments for Greig cephalopolysyndactyly syndrome ?","output":"How might Greig cephalopolysyndactyly syndrome be treated? Treatment for Greig cephalopolysyndactyly syndrome (GCPS) is symptomatic. Treatment might include elective surgical repair of polydactyly. Evaluation and treatment of hydrocephalus might additionally occur if hydrocephalus is present. Hydrocephalus is a condition characterized by excessive accumulation of fluid in the brain. This fluid is cerebrospinal fluid (CSF) - a clear fluid that surrounds the brain and spinal cord. Excess CSF builds up when it cannot drain from the brain due to a blockage in a passage through which the fluid normally flows. This excess fluid causes an abnormal widening of spaces in the brain called ventricles; this can create harmful pressure on brain tissue. Treatment of hydrocephalus often includes surgical insertion of a shunt system-in which a catheters (tubes) are surgically placed behind both ears. A valve (fluid pump) is placed underneath the skin behind the ear and is connected to both catheters. When extra pressure builds up around the brain, the valve opens, and excess fluid drains through the catheter. This helps lower pressure within the skull (intracranial pressure)."},{"instruction":"What are the symptoms of Myelocerebellar disorder ?","output":"What are the signs and symptoms of Myelocerebellar disorder? The Human Phenotype Ontology provides the following list of signs and symptoms for Myelocerebellar disorder. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Aplasia/Hypoplasia of the cerebellum 90% Gait disturbance 90% Incoordination 90% Abnormality of macrophages 50% Abnormality of neutrophils 50% Acute leukemia 50% Anemia 50% Hyperreflexia 50% Neurological speech impairment 50% Nystagmus 50% Recurrent respiratory infections 50% Splenomegaly 50% Abnormality of thrombocytes 7.5% Decreased antibody level in blood 7.5% Microcephaly 7.5% Acute myelomonocytic leukemia - Ataxia - Autosomal dominant inheritance - Cerebellar atrophy - Decreased nerve conduction velocity - Dysmetria - Hyperactive deep tendon reflexes - Hypoplastic anemia - Impaired vibration sensation in the lower limbs - Pancytopenia - Unsteady gait - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Sideroblastic anemia ?","output":"Sideroblastic anemia is a heterogeneous group of blood disorders characterized by an impaired ability of the bone marrow to produce normal red blood cells. The iron inside red blood cells is inadequately used to make hemoglobin, despite adequate or increased amounts of iron. Abnormal red blood cells called sideroblasts are found in the blood of people with these anemias. Sideroblastic anemias are classified as hereditary, acquired, and reversible."},{"instruction":"What are the symptoms of Sideroblastic anemia ?","output":"What are the symptoms of sideroblastic anemia? The symptoms of sideroblastic anemia are the same as for any anemia and iron overload. These may include fatigue, weakness, palpitations, shortness of breath, headaches, irritability, and chest pain. Physical findings may include pallor, tachycardia, hepatosplenomegaly, S3 gallop, jugular vein distension, and rales."},{"instruction":"What causes Sideroblastic anemia ?","output":"What causes sideroblastic anemia? The exact cause of sideroblastic anemia in many patients remains unknown. Reversible sideroblastic anemia can be caused by alcohol, isoniazid, pyrazinamide, cycloserine (a prescription antibiotic that may cause anemia, peripheral neuritis, or seizures by acting as a pyridoxine antagonist or increasing excretion of pyridoxine), chloramphenicol, or copper deficiency. The hereditary forms may be passed through families in autosomal recessive, autosomal dominant, or X-linked patterns."},{"instruction":"w to diagnose Sideroblastic anemia ?","output":"How is sideroblastic anemia diagnosed? The principle feature of sideroblastic anemia is slowly progressive, mild, life-long anemia which often goes unnoticed. Symptoms of iron overload may lead to the discovery of this underlying disorder. The history and clinical findings, together with laboratory findings, usually permit accurate diagnosis of each type. Laboratory evaluation may include complete blood count, iron studies, free erythrocyte protoporphyrin levels, MRI, bone marrow aspiration and liver biopsy. Molecular defects can be identified in several hereditary forms and in some patients with acquired sideroblastic anemia."},{"instruction":"What are the treatments for Sideroblastic anemia ?","output":"How might sideroblastic anemia be treated? The treatment of sideroblastic anemia is directed at controlling symptoms of anemia and preventing organ damage from iron overload. Many patients see improvement with increased vitamin B6 intake - either through diet (potatoes, bananas, raisin bran cereal, lentils, liver, turkey, and tuna are good sources) or supplements - with red blood cell counts returning to near-normal values. Folic acid supplementation may also be beneficial. Those that do not respond to vitamin supplementation require blood transfusion. A few small studies have described the use of allogenic bone marrow or stem cell transplantation for hereditary and congenital forms of sideroblastic anemia. While these therapies may offer the possibility of a cure, the complications associated with transplantation surgery must be considered. All patients with sideroblastic anemia should be followed by a hematologist and avoid alcohol."},{"instruction":"What is (are) Leiomyosarcoma ?","output":"Leiomyosarcoma is a rare cancerous tumor that consists of smooth (involuntary) muscle cells. Leiomyosarcoma is a type of sarcoma. It spreads through the blood stream and can affect the lungs, liver, blood vessels, or any other soft tissue in the body. The exact cause of leiomyosarcoma is not known, although genetic and environmental factors appear to be involved. It is most often found in the uterus or abdomen."},{"instruction":"What are the treatments for Leiomyosarcoma ?","output":"How might leiomyosarcoma be treated? Treatment of leiomyosarcoma varies depending on the location and stage of the cancer. Surgery is typically the first choice for treatment, however, chemotherapy, targeted drugs, radiation therapy, and hormonal therapy may also be used to treat leiomyosarcoma. Additional information on the treatment of intestinal leiomyosarcoma is available from Medscape Reference. You may need to register to view this online medical resource, but registration is free"},{"instruction":"What is (are) Ovarian small cell carcinoma ?","output":"Ovarian small cell carcinoma is a rare cancer that typically occurs in young women. It is an aggressive tumor that can metastasize to other parts of the body. Ovarian small cell carcinoma is associated with hypercalcemia and is usually treated with platinum or etoposide-based chemotherapy."},{"instruction":"What are the treatments for Ovarian small cell carcinoma ?","output":"What treatments are available for ovarian small cell carcinoma? Ovarian small cell carcinoma is often treated with surgery and chemotherapy. Radiation therapy may also be used in some cases. Because this tumor is derived from the primitive germ cells (eggs) of the ovary, it is often treated with a chemotherapy regimen similar to what is used to treat ovarian germ cell tumors. Specifically, platinum and etoposide based chemotherapy is typically used to treat ovarian small cell carcinoma."},{"instruction":"What is (are) Familial osteochondritis dissecans ?","output":"Osteochondritis dissecans is a joint condition that occurs when a piece of cartilage and the thin layer of bone beneath it, separates from the end of the bone. If the piece of cartilage and bone remain close to where they detached, they may not cause any symptoms. However, affected people may experience pain, weakness and/or decreased range of motion in the affected joint if the cartilage and bone travel into the joint space. Although osteochondritis dissecans can affect people of all ages, it is most commonly diagnosed in people between the ages of 10 and 20 years. In most cases, the exact underlying cause is unknown. Rarely, the condition can affect more than one family member (called familial osteochondritis dissecans); in these cases, osteochondritis dissecans is caused by changes (mutations) in the ACAN gene and is inherited in an autosomal dominant manner. Treatment for the condition varies depending on many factors, including the age of the affected person and the severity of the symptoms, but may include rest; casting or splinting; surgery and/or physical therapy."},{"instruction":"What are the symptoms of Familial osteochondritis dissecans ?","output":"What are the signs and symptoms of Familial osteochondritis dissecans? The signs and symptoms of osteochondritis dissecans vary from person to person. If the piece of cartilage and bone remain close to where they detached, they may not cause any symptoms. However, affected people may experience the following if the cartilage and bone travel into the joint space: Pain, swelling and/or tenderness Joint popping Joint weakness Decreased range of motion Although osteochondritis dissecans can develop in any joint of the body, the knee, ankle and elbow are most commonly affected. Most people only develop the condition in a single joint. The Human Phenotype Ontology provides the following list of signs and symptoms for Familial osteochondritis dissecans. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal dominant inheritance - Exostoses - Growth abnormality - Osteoarthritis - Osteochondrosis dissecans - Short stature - Waddling gait - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Familial osteochondritis dissecans ?","output":"What causes osteochondritis dissecans? In most cases, the exact underlying cause of osteochondritis dissecans is not completely understood. Scientists suspect that it may be due to decreased blood flow to the end of the affected bone, which may occur when repetitive episodes of minor injury and/or stress damage a bone overtime. In some families, osteochondritis dissecans is caused by changes (mutations) in the ACAN gene. In these cases, which are referred to as familial osteochondritis dissecans, the condition generally affects multiple joints and is also associated with short stature and early-onset osteoarthritis. The ACAN gene encodes a protein that is important to the structure of cartilage. Mutations in this gene weaken cartilage, which leads to the various signs and symptoms of familial osteochondritis disssecans."},{"instruction":"w to diagnose Familial osteochondritis dissecans ?","output":"How is osteochondritis dissecans diagnosed? A diagnosis of osteochondritis dissecans is usually suspected based on the presence of characteristic signs and symptoms. Additional testing can then be ordered to confirm the diagnosis. These test may include x-rays, magnetic resonance imaging (MRI) and/or computed tomography (CT scan). For more information about the diagnosis of osteochondritis dissecans, please click here."},{"instruction":"What are the treatments for Familial osteochondritis dissecans ?","output":"How might osteochondritis dissecans be treated? The primary aim of treatment for osteochondritis dissecans is to restore normal function of the affected joint, relieve pain and prevent osteoarthritis. Treatment for the condition varies depending on many factors including the age of the affected person and the severity of the symptoms. In children and young teens, osteochondritis dissecans often heals overtime without surgical treatment. These cases are often managed with rest and in some cases, crutches and/or splinting to relieve pain and swelling. If non-surgical treatments are not successful or the case is particularly severe (i.e. the cartilage and bone are moving around within the joint space), surgery may be recommended. Following surgery, physical therapy is often necessary to improve the strength and range of motion of the affected joint."},{"instruction":"What is (are) Pediatric Crohn's disease ?","output":"Crohn's disease is a type of inflammatory bowel disease (IBD), the general name for conditions that cause inflammation in the gastrointestinal (GI) tract. Common signs and symptoms include abdominal pain and cramping, diarrhea, and weight loss. Other general symptoms include feeling tired, nausea and loss of appetite, fever, and anemia. Complications of Crohn's disease may include intestinal blockage, fistulas, anal fissures, ulcers, malnutrition, and inflammation in other areas of the body. Crohn's disease can occur in people of all age groups but is most often diagnosed in young adults. The exact cause is unknown, but is thought to involve both genetic and environmental factors. It appears to run in some families. Treatment is aimed at relieving symptoms and reducing inflammation, but some people require surgery."},{"instruction":"What are the symptoms of LaurinSandrow syndrome ?","output":"What are the signs and symptoms of Laurin-Sandrow syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Laurin-Sandrow syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the metacarpal bones 90% Aplasia/Hypoplasia of the thumb 90% Finger syndactyly 90% Preaxial foot polydactyly 90% Preaxial hand polydactyly 90% Tarsal synostosis 90% Toe syndactyly 90% Abnormality of the tibia 50% Abnormality of the wrist 50% Aplasia/Hypoplasia of the radius 50% Limb duplication 50% Limitation of joint mobility 50% Talipes 50% Underdeveloped nasal alae 50% Aplasia/Hypoplasia of the corpus callosum 7.5% Cognitive impairment 7.5% Cryptorchidism 7.5% Downturned corners of mouth 7.5% Hydrocephalus 7.5% Hypertelorism 7.5% Muscular hypotonia 7.5% Abnormality of the face - Absent radius - Absent tibia - Autosomal dominant inheritance - Broad foot - Fibular duplication - Hand polydactyly - Patellar aplasia - Short foot - Syndactyly - Triphalangeal thumb - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Glutathione synthetase deficiency ?","output":"Glutathione synthetase deficiency is type of organic acidemia that affects the production glutathione. Glutathione helps prevent cell damage, build DNA and proteins, and process medications and cancer-causing compounds. People can have mild, moderate, or severe disease. Mild disease may cause hemolytic anemia and 5-oxoprolinuria (excess excretion of 5-oxoproline in urine). Moderate disease may cause anemia, 5-oxoprolinuria, and metabolic acidosis in early infancy. Severe disease may cause anemia, 5-oxoprolinuria, metabolic acidosis, neurological symptoms (e.g., seizures, learning disability, loss of coordination), and recurrent infections. It is caused by mutations in the GSS gene and is inherited in an autosomal recessive fashion."},{"instruction":"What are the symptoms of Glutathione synthetase deficiency ?","output":"What are the signs and symptoms of Glutathione synthetase deficiency? The Human Phenotype Ontology provides the following list of signs and symptoms for Glutathione synthetase deficiency. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of immune system physiology 90% Abnormality of metabolism/homeostasis 90% Abnormality of the nervous system 90% Anemia 90% Ataxia - Autosomal recessive inheritance - Chronic metabolic acidosis - Dysarthria - Glutathione synthetase deficiency - Hemolytic anemia - Intellectual disability - Intention tremor - Neutropenia - Pigmentary retinopathy - Psychotic mentation - Seizures - Spastic tetraparesis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Brachydactyly type A5 ?","output":"What are the signs and symptoms of Brachydactyly type A5? The Human Phenotype Ontology provides the following list of signs and symptoms for Brachydactyly type A5. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the metacarpal bones 90% Anonychia 90% Aplasia/Hypoplasia of the distal phalanges of the toes 90% Brachydactyly syndrome 90% Proximal placement of thumb 90% Short distal phalanx of finger 90% Short toe 90% Abnormality of thumb phalanx 7.5% Finger syndactyly 7.5% Preaxial foot polydactyly 7.5% Symphalangism affecting the phalanges of the hand 7.5% Synostosis of carpal bones 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Ectopia pupillae ?","output":"What are the signs and symptoms of Ectopia pupillae? The Human Phenotype Ontology provides the following list of signs and symptoms for Ectopia pupillae. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal dominant inheritance - Ectopia pupillae - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Spondyloepiphyseal dysplasia congenita ?","output":"Spondyloepiphyseal dysplasia congenita is an inherited disorder of bone growth that affects the bones of the spine and ends of the long bones in the arms and legs. Features of this condition include short stature (dwarfism); a very short trunk and neck; abnormal curvature of the spine; barrel-shaped chest; shortened limbs; an abnormality of the hip joint; and problems with vision and hearing. Arthritis and decreased joint mobility often develop early in life. More than 175 cases have been reported in the scientific literature. This condition is caused by mutations in the COL2A1 gene and is inherited in an autosomal dominant pattern. Most cases result from new mutations in the gene and occur in people with no family history of the condition."},{"instruction":"What are the symptoms of Spondyloepiphyseal dysplasia congenita ?","output":"What are the signs and symptoms of Spondyloepiphyseal dysplasia congenita? The Human Phenotype Ontology provides the following list of signs and symptoms for Spondyloepiphyseal dysplasia congenita. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal form of the vertebral bodies 90% Abnormality of epiphysis morphology 90% Micromelia 90% Narrow chest 90% Short neck 90% Short stature 90% Short thorax 90% Skeletal dysplasia 90% Broad forehead 50% Cleft palate 50% Hyperlordosis 50% Hypertelorism 50% Malar flattening 50% Osteoarthritis 50% Talipes 50% Cataract 7.5% Glaucoma 7.5% Hearing impairment 7.5% Kyphosis 7.5% Myopia 7.5% Nystagmus 7.5% Retinal detachment 7.5% Scoliosis 7.5% Autosomal dominant inheritance - Barrel-shaped chest - Cervical myelopathy - Coxa vara - Delayed calcaneal ossification - Delayed pubic bone ossification - Flat face - Flattened epiphysis - Hip dislocation - Hypoplasia of the odontoid process - Limitation of knee mobility - Limited elbow movement - Limited hip movement - Lumbar hyperlordosis - Muscular hypotonia - Neonatal short-trunk short stature - Ovoid vertebral bodies - Pectus carinatum - Platyspondyly - Respiratory distress - Restrictive lung disease - Spondyloepiphyseal dysplasia - Talipes equinovarus - Vitreoretinal degeneration - Waddling gait - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"Spondyloepiphyseal dysplasia congenita inherited ?","output":"How is spondyloepiphyseal dysplasia congenita inherited? Spondyloepiphyseal dysplasia (SEDC) is typically inherited in an autosomal dominant manner. This means that one altered (mutated) gene in each cell is sufficient to cause the disorder. Most cases of SEDC do not result from inheriting it from a parent, however; the condition more commonly results from a random, new mutation in the gene occurring for the first time in an affected individual who does not have a history SEDC in the family. In most of these cases, the risk to have another child with the condition is comparable to the risk for an individual in the general population to have a child with the condition. A few cases of autosomal recessive forms of SEDC have been reported. Germline mosaicism has also been reported for this condition. In this case, the parent does not have the mutated gene in all the cells of the body (and is not affected), but only in some of the germ cells (sperm or egg cells). The recurrence risk for a parent with germline mosaicism to have another affected child is difficult to predict. For conditions with autosomal dominant inheritance, studies have demonstrated that the risk to have another affected child may be low (about 1%), moderate (about 6%), or higher (about 30%), depending on the proportion of germ cells with the mutation as well as the disorder itself."},{"instruction":"What are the symptoms of Leber congenital amaurosis 1 ?","output":"What are the signs and symptoms of Leber congenital amaurosis 1? The Human Phenotype Ontology provides the following list of signs and symptoms for Leber congenital amaurosis 1. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal recessive inheritance - Blindness - Cataract - Decreased light- and dark-adapted electroretinogram amplitude - Eye poking - Fundus atrophy - Growth delay - Hepatomegaly - Hyperthreoninemia - Hyperthreoninuria - Intellectual disability - Keratoconus - Nystagmus - Photophobia - Pigmentary retinopathy - Reduced visual acuity - Sensorineural hearing impairment - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Prekallikrein deficiency, congenital ?","output":"What are the signs and symptoms of Prekallikrein deficiency, congenital? The Human Phenotype Ontology provides the following list of signs and symptoms for Prekallikrein deficiency, congenital. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal recessive inheritance - Prolonged partial thromboplastin time - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Noonan syndrome 4 ?","output":"Noonan syndrome is a genetic disorder that causes abnormal development of multiple parts of the body. Features of Noonan syndrome may include a distinctive facial appearance, short stature, a broad or webbed neck, congenital heart defects, bleeding problems, skeletal malformations, and developmental delay. Noonan syndrome may be caused by mutations in any one of several genes including the PTPN11, KRAS, RAF1, SOS1, NRAS and BRAF genes. It is sometimes referred to as a specific subtype based on the responsible gene in an affected person. Noonan syndrome is typically inherited in an autosomal dominant manner but many cases are due to a new mutation and are not inherited from an affected parent."},{"instruction":"What are the symptoms of Noonan syndrome 4 ?","output":"What are the signs and symptoms of Noonan syndrome 4? The Human Phenotype Ontology provides the following list of signs and symptoms for Noonan syndrome 4. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Prolonged bleeding time 5% Autosomal dominant inheritance - Blue irides - Cryptorchidism - Cubitus valgus - Curly hair - Dental malocclusion - Depressed nasal bridge - Epicanthus - High anterior hairline - Hypertelorism - Hypertrophic cardiomyopathy - Low-set, posteriorly rotated ears - Macrocephaly - Pectus excavatum of inferior sternum - Ptosis - Pulmonic stenosis - Scoliosis - Short neck - Short stature - Sparse eyebrow - Thick lower lip vermilion - Ventricular septal defect - Webbed neck - Wide intermamillary distance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the treatments for Noonan syndrome 4 ?","output":"How might Noonan syndrome be treated? Management generally focuses on the specific signs and symptoms present in each person. Treatments for the complications of Noonan syndrome (such as cardiovascular abnormalities) are generally standard and do not differ from treatment in the general population. Developmental disabilities are addressed by early intervention programs and individualized education strategies. Treatment for serious bleeding depends upon the specific factor deficiency or platelet abnormality. Growth hormone treatment increases growth velocity. More detailed information about treatment for Noonan syndrome can be viewed on the GeneReviews Web site."},{"instruction":"What is (are) Distal chromosome 18q deletion syndrome ?","output":"Distal chromosome 18q deletion syndrome is a chromosome abnormality that occurs when there is a missing (deleted) copy of genetic material at the end of the long arm (q) of chromosome 18. The severity of the condition and the signs and symptoms depend on the size and location of the deletion and which genes are involved. Features that often occur in people with distal chromosome 18q deletion syndrome include developmental delay, intellectual disability, behavioral problems and distinctive facial features. Chromosome testing of both parents can provide more information on whether or not the deletion was inherited. In most cases, parents do not have any chromosomal anomaly. However, sometimes one parent is found to have a balanced translocation, where a piece of a chromosome has broken off and attached to another one with no gain or loss of genetic material. The balanced translocation normally does not cause any signs or symptoms, but it increases the risk for having an affected child with a chromosomal anomaly like a deletion. Treatment is based on the signs and symptoms present in each person. This page is meant to provide general information about distal 18q deletions. You can contact GARD if you have questions about a specific deletion on chromosome 18. To learn more about chromosomal anomalies please visit our GARD webpage on FAQs about Chromosome Disorders."},{"instruction":"What are the symptoms of Distal chromosome 18q deletion syndrome ?","output":"What are the signs and symptoms of Distal chromosome 18q deletion syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Distal chromosome 18q deletion syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Absence of the pulmonary valve - Aortic valve stenosis - Asthma - Atopic dermatitis - Atresia of the external auditory canal - Atria septal defect - Autosomal dominant inheritance - Bifid uvula - Blepharophimosis - Broad-based gait - Cerebellar hypoplasia - Choanal stenosis - Chorea - Cleft palate - Cleft upper lip - Conductive hearing impairment - Congestive heart failure - Cryptorchidism - Delayed CNS myelination - Depressed nasal bridge - Dilatation of the ascending aorta - Downturned corners of mouth - Dysplastic aortic valve - Dysplastic pulmonary valve - Epicanthus - Failure to thrive in infancy - Flat midface - Growth hormone deficiency - Hypertelorism - Hypoplasia of midface - Hypospadias - Inguinal hernia - Intellectual disability - Joint laxity - Low anterior hairline - Macrotia - Malar flattening - Mandibular prognathia - Microcephaly - Micropenis - Motor delay - Muscular hypotonia - Nystagmus - Optic atrophy - Overlapping toe - Patent ductus arteriosus - Pes cavus - Pes planus - Phenotypic variability - Poor coordination - Prominent nose - Proximal placement of thumb - Recurrent respiratory infections - Rocker bottom foot - Scoliosis - Secretory IgA deficiency - Seizures - Sensorineural hearing impairment - Short neck - Short palpebral fissure - Short philtrum - Short stature - Sporadic - Stenosis of the external auditory canal - Strabismus - Talipes equinovarus - Tapetoretinal degeneration - Toe syndactyly - Tremor - Umbilical hernia - U-Shaped upper lip vermilion - Ventricular septal defect - Ventriculomegaly - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1 ?","output":"Blepharophimosis, ptosis and epicanthus inversus syndrome type 1 (BPES I) is a condition, present at birth, that mainly effects the development of the eyelids. People with this condition have narrowing of the eye opening (blepharophimosis), droopy eyelids (ptosis), an upward fold of the skin of the lower eyelid near the inner corner of the eye (epicanthus inversus), and an increased distance between the inner corners of the eyes (telecanthus). Because of these eyelid malformations, the eyelids cannot open fully, and vision may be limited. Blepharophimosis syndrome type 1 also causes premature ovarian failure (POF). This condition is caused by mutations in the FOXL2 gene and is inherited in an autosomal dominant pattern."},{"instruction":"What are the symptoms of Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1 ?","output":"What are the signs and symptoms of Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1? The Human Phenotype Ontology provides the following list of signs and symptoms for Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Blepharophimosis 90% Depressed nasal bridge 90% Epicanthus 90% Ptosis 90% Decreased fertility 50% Lacrimation abnormality 50% Myopia 50% Nystagmus 7.5% Strabismus 7.5% Synophrys 7.5% Abnormality of the breast - Abnormality of the hair - Amenorrhea - Autosomal dominant inheritance - Cupped ear - Epicanthus inversus - Female infertility - High palate - Hypermetropia - Increased circulating gonadotropin level - Microcornea - Microphthalmia - Premature ovarian failure - Telecanthus - Wide nasal bridge - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1 inherited ?","output":"If my daughter inherits BPES from me, will she definitely have the same type as me, or could she have the other type? More than 130 mutations (changes) in the FOXL2 gene have been found to cause BPES. It has been reported that mutations that lead to a significantly shortened FOXL2 protein often cause BPES type I (characterized by eyelid malformations and premature ovarian failure (POF)), while mutations that result in an extra long FOXL2 protein may cause BPES type II (which involves only eyelid malformations). However, in a study published in 2003 in the American Journal of Human Genetics, the authors discussed how their study was the first to demonstrate intra- and interfamilial phenotypic variability (i.e. both BPES types caused by the same mutation). They discuss how assigning an affected family a diagnosis of either BPES type I or II is not always possible because of this. The article also discusses a previous report of menstrual abnormalities and reduced female fertility in two families with BPES type II, suggesting overlap between both BPES types, as well as a report of a family with BPES type I in which the first generations of affected females are infertile while three affected young women in the youngest generation appear to have normal pelvic ultrasound and hormone levels. They do caution that in this family, the early age of the affected women may preclude an accurate prediction of whether they will have POF, since the onset of POF usually occurs at a later age. Approximately 12 percent of people with BPES do not have an identified FOXL2 gene mutation; the cause of the condition in these people is unknown, and therefore there is no information on whether there may be variation within families for these affected individuals."},{"instruction":"What are the treatments for Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1 ?","output":"How might Blepharophimosis syndrome type 1 be treated? Management of blepharophimosis syndrome type 1 requires the input of several specialists including a clinical geneticist, pediatric ophthalmologist, eye plastic (oculoplastic) surgeon, endocrinologist, reproductive endocrinologist, and gynecologist. Eyelid surgery should be discussed with an oculoplastic surgeon to decide on the method and timing that is best suited for the patient. Traditionally, surgical correction of the blepharophimosis, epicanthus inversus, and telecanthus (canthoplasty) is performed at ages three to five years, followed about a year later by ptosis correction (usually requiring a brow suspension procedure). If the epicanthal folds are small, a \\"Y-V canthoplasty\\" is traditionally used; if the epicanthal folds are severe, a \\"double Z-plasty\\" is used. Unpublished reports have indicated that advanced understanding of the lower eyelid position has allowed for more targeted surgery that results in a more natural appearance. For a general explanation of these procedures and to locate an eye-care professional visit the Foundation of the American Academy of Ophthalmology and the National Eye Institute websites. To locate a surgeon through the American Society of Ophthalmic Plastic & Reconstructive Surgery click here. Generally, premature ovarian failure (POF) is treated with hormone replacement therapy. There is no specific treatment for POF caused by blepharophimosis syndrome type 1. Hormone replacement therapy is generally estrogen and progesterone and sometimes also includes testosterone. Birth control pills are sometimes substituted for hormone replacement therapy. Although health care providers can suggest treatments for some of the symptoms of POF, currently there is no scientifically established treatment to restore fertility for women diagnosed with POF. Women with POF are encouraged to speak to a health care professional. If you wish to obtain more information and support, you can visit the International Premature Ovarian Failure Association."},{"instruction":"What is (are) Oculofaciocardiodental syndrome ?","output":"Oculofaciocardiodental syndrome is a genetic syndrome that affects the eyes, heart, face, and teeth. Common signs and symptoms include abnormally small deep-set eyes, cataracts, long narrow face, a broad nasal tip that is divided by a cleft, heart defects, and teeth with very large roots. Other signs and symptoms include glaucoma, cleft palate, delayed loss of baby teeth, missing or abnormally small teeth, misaligned teeth, and defective tooth enamel. Eye symptoms may involve one or both eyes.Oculofaciocardiodental syndrome is caused by mutations in the BCOR gene and is inherited in an X-linked dominant fashion."},{"instruction":"What are the symptoms of Oculofaciocardiodental syndrome ?","output":"What are the signs and symptoms of Oculofaciocardiodental syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Oculofaciocardiodental syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the cardiac septa 90% Aplasia/Hypoplasia affecting the eye 90% Cataract 90% Delayed eruption of teeth 90% Microcornea 90% Midline defect of the nose 90% Camptodactyly of toe 50% Cleft palate 50% Long philtrum 50% Narrow face 50% Prominent nasal bridge 50% Radioulnar synostosis 50% Reduced number of teeth 50% Toe syndactyly 50% Abnormality of the mitral valve 7.5% Abnormality of the pulmonary valve 7.5% Aplasia/Hypoplasia of the thumb 7.5% Clinodactyly of the 5th finger 7.5% Cognitive impairment 7.5% Cubitus valgus 7.5% Ectopia lentis 7.5% Feeding difficulties in infancy 7.5% Genu valgum 7.5% Glaucoma 7.5% Highly arched eyebrow 7.5% Intestinal malrotation 7.5% Iris coloboma 7.5% Patent ductus arteriosus 7.5% Ptosis 7.5% Retinal detachment 7.5% Scoliosis 7.5% Sensorineural hearing impairment 7.5% Adrenal insufficiency 5% Decreased body weight 5% Dextrocardia 5% Double outlet right ventricle 5% Flexion contracture 5% Hand clenching 5% Hypoplasia of the corpus callosum 5% Hypospadias 5% Hypothyroidism 5% Phthisis bulbi 5% Seizures 5% Spastic paraparesis 5% Talipes equinovarus 5% Umbilical hernia 5% 2-3 toe syndactyly - Anophthalmia - Aortic valve stenosis - Asymmetry of the ears - Atria septal defect - Bifid nasal tip - Bifid uvula - Blepharophimosis - Broad nasal tip - Congenital cataract - Cryptorchidism - Dental malocclusion - Exotropia - Fused teeth - Hammertoe - Increased number of teeth - Intellectual disability, mild - Laterally curved eyebrow - Long face - Microcephaly - Microphthalmia - Mitral valve prolapse - Motor delay - Oligodontia - Persistence of primary teeth - Persistent hyperplastic primary vitreous - Posteriorly rotated ears - Pulmonic stenosis - Septate vagina - Short stature - Submucous cleft hard palate - Thick eyebrow - Ventricular septal defect - Visual loss - X-linked dominant inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Diffuse cutaneous mastocytosis ?","output":"What are the signs and symptoms of Diffuse cutaneous mastocytosis? The Human Phenotype Ontology provides the following list of signs and symptoms for Diffuse cutaneous mastocytosis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal blistering of the skin 90% Mastocytosis 90% Abnormality of skin pigmentation 50% Hypotension 50% Impaired temperature sensation 50% Pruritus 50% Subcutaneous hemorrhage 50% Thickened skin 50% Urticaria 50% Gastrointestinal hemorrhage 7.5% Hepatomegaly 7.5% Immunologic hypersensitivity 7.5% Leukemia 7.5% Malabsorption 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Adult neuronal ceroid lipofuscinosis ?","output":"Adult neuronal ceroid lipofuscinosis is a rare condition that affects the nervous system. Signs and symptoms usually begin around age 30, but they can develop anytime between adolescence and late adulthood. There are two forms of adult neuronal ceroid lipofuscinosis that are differentiated by their underlying genetic cause, mode of inheritance and certain symptoms: Type A is characterized by a combination of seizures and uncontrollable muscle jerks (myoclonic epilepsy); dementia; difficulties with muscle coordination (ataxia); involuntary movements such as tremors or tics; and dysarthria. It is caused by changes (mutations) in the CLN6 or PPT1 gene and is inherited in an autosomal recessive manner. Type B shares many features with type A; however, affected people also experience behavioral abnormalities and do not develop myoclonic epilepsy or dysarthria. It can be caused by mutations in the DNAJC5 or CTSF gene and is inherited in an autosomal dominant manner. Treatment options for adult neuronal ceroid lipofuscinosis are limited to therapies that can help relieve some of the symptoms."},{"instruction":"What are the symptoms of Adult neuronal ceroid lipofuscinosis ?","output":"What are the signs and symptoms of Adult neuronal ceroid lipofuscinosis? The Human Phenotype Ontology provides the following list of signs and symptoms for Adult neuronal ceroid lipofuscinosis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal pyramidal signs 90% Abnormality of extrapyramidal motor function 90% Behavioral abnormality 90% Developmental regression 90% Incoordination 90% Involuntary movements 90% Seizures 90% Retinopathy 7.5% Visual impairment 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Kaplan Plauchu Fitch syndrome ?","output":"What are the signs and symptoms of Kaplan Plauchu Fitch syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Kaplan Plauchu Fitch syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal form of the vertebral bodies 90% Abnormality of periauricular region 90% Abnormality of the fingernails 90% Abnormality of the metacarpal bones 90% Abnormality of the toenails 90% Anteverted nares 90% Cleft palate 90% Low-set, posteriorly rotated ears 90% Prominent nasal bridge 90% Proptosis 90% Ptosis 90% Short distal phalanx of finger 90% Short philtrum 90% Short stature 90% Tapered finger 90% Telecanthus 90% Triphalangeal thumb 90% Abnormality of the hip bone 50% Advanced eruption of teeth 50% Choanal atresia 50% Conductive hearing impairment 50% Craniosynostosis 50% Genu valgum 50% Hypertelorism 50% Lacrimation abnormality 50% Microcephaly 50% Myopia 50% Pectus excavatum 50% Sensorineural hearing impairment 50% Sloping forehead 50% Spina bifida occulta 50% Ulnar deviation of finger 50% Abnormal auditory evoked potentials - Abnormality of the vertebral column - Autosomal recessive inheritance - Hypotelorism - Oxycephaly - Preauricular pit - Short 1st metacarpal - Short first metatarsal - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Chudley Rozdilsky syndrome ?","output":"What are the signs and symptoms of Chudley Rozdilsky syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Chudley Rozdilsky syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal hair quantity 90% Abnormality of the palate 90% Clinodactyly of the 5th finger 90% Cognitive impairment 90% Craniofacial hyperostosis 90% Delayed skeletal maturation 90% Disproportionate tall stature 90% Facial palsy 90% Hyperlordosis 90% Hypertelorism 90% Hypoplasia of penis 90% Myopia 90% Ophthalmoparesis 90% Ptosis 90% Short stature 90% Skeletal muscle atrophy 90% Abnormality of the hip bone 50% Abnormality of the pinna 50% Limitation of joint mobility 50% Microcephaly 50% Prominent nasal bridge 50% Abnormality of the ribs 7.5% Facial asymmetry 7.5% Pectus carinatum 7.5% Tracheoesophageal fistula 7.5% Abnormality of metabolism/homeostasis - Autosomal recessive inheritance - Hypogonadotrophic hypogonadism - Intellectual disability, progressive - Intellectual disability, severe - Lumbar hyperlordosis - Myopathy - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Chromosome 15q deletion ?","output":"Chromosome 15q deletion is a chromosome abnormality that occurs when there is a missing copy of the genetic material located on the long arm (q) of chromosome 15. The severity of the condition and the signs and symptoms depend on the size and location of the deletion and which genes are involved. Features that often occur in people with chromosome 15q deletion include developmental delay, intellectual disability, behavioral problems, and distinctive facial features. Most cases are not inherited, but people can pass the deletion on to their children. Treatment is based on the signs and symptoms present in each person."},{"instruction":"What is (are) Congenital laryngeal palsy ?","output":"Congenital laryngeal palsy is also known as congenital vocal cord paralysis. It represents 15%-20% of all cases of congenital anomalies of the larynx. It may be bilateral or unilateral. The cause of bilateral paralysis of the vocal cords is often unknown (idiopathic). In some cases, paralysis may be secondary to the immaturity of the nerve or muscle (neuromuscular) or due to central nervous system damage (including the Arnold-Chiari malformation, cerebral palsy, hydrocephalus, myelomeningocele, spina bifida, hypoxia (lack of oxygen in the blood), or bleeding). Birth trauma that causes excessive tension in the neck can cause transient bilateral vocal cord paralysis that can last 6-9 months. Unilateral paralysis is usually idiopathic but can be secondary to problems with the vagus nerve or recurrent laryngeal nerve. Bilateral vocal fold paralysis signals and symptoms may include making a noise when breathing (inspiratory stridor) that worsens upon exercise, progressive obstruction of the respiratory airway, aspiration, recurrent chest infections, cyanosis, nose flaring and signs of cranial nerve deficits during the head and neck exam. Flexible endoscopy usually elucidates the diagnosis by demonstrating vocal fold paralysis and no other abnormality. Treatment may include medication, operations and speech therapy."},{"instruction":"What are the symptoms of Congenital laryngeal palsy ?","output":"What are the signs and symptoms associated with congenital laryngeal paralysis? The following online resources provide information on the signs and symptoms of congenital laryngeal paralysis: National Institute on Deafness and Other Communication Disorders- Vocal Fold Paralysis Medscape Reference - Congenital Malformations of the Larynx"},{"instruction":"What causes Congenital laryngeal palsy ?","output":"What is the cause of congenital laryngeal paralysis? The cause is often unknown (idiopathic). Congenital bilateral vocal cord paralysis may occur as a result of the immaturity of the nerve or muscle (neuromuscular) or as a result of central nervous system problems, such as Arnold-Chiari syndrome, cerebral palsy, hydrocephalus, myelomeningocele, spine bifida, hypoxia (lack of oxygen in the blood), or bleeding. In other cases the vocal cords' paralysis is acquired. For example, a birth trauma may cause tension in the neck and lead to bilateral vocal cord paralyses that can last 6-9 months. Other causes may include: Surgical Trauma Malignancies Delayed endotracheal intubation Neurological diseases Strokes Choking Diseases that result in inflammation of the vocal cords or the laryngeal cartilage (Wegener's granulomatosis, sarcoidosis or polychondritis, gout, syphilis and tuberculosis (resulting in mechanical attachment of the vocal cords) Diabetes mellitus, which may lead to a neuropathy resulting in vocal cord paralysis Gastroesophageal reflux (GER). The unilateral paralysis is usually idiopathic but may also be secondary to mediastinal lesions, such as tumors or vascular malformations or iatrogenic (caused by damage to the left recurrent laryngeal nerve during surgery in this area, such as heart surgery). It may also result from problems of the mechanical structures of the larynx as the cricoarytenoid joint. The following online resources provide more information on the cause of congenital laryngeal paralysis: American Academy of Otolaringology Medscape Reference - Congenital Malformations of the Larynx"},{"instruction":"w to diagnose Congenital laryngeal palsy ?","output":"How is congenital laryngeal paralysis diagnosed? The following online resources provide information on the diagnosis of congenital laryngeal paralysis: National Institute on Deafness and Other Communication Disorders- Vocal Fold Paralysis American Speech-Language-Hearing Association (ASHA) - Vocal Cord Paralysis Medscape Reference - Congenital Malformations of the Larynx"},{"instruction":"What are the treatments for Congenital laryngeal palsy ?","output":"What treatment is available for congenital laryngeal paralysis? The most common treatments for vocal fold paralysis are voice therapy and surgery. Some people's voices will naturally recover sometime during the first year after diagnosis, which is why doctors often delay surgery for at least a year. During this time, a speech-language pathologist may be needed for voice therapy, which may involve exercises to strengthen the vocal folds or improve breath control while speaking. Patients may also learn how to use the voice differently, for example, by speaking more slowly or opening the mouth wider when speaking. Treatment may include: Corticosteroids: When there is an associated disease such as Wegener's granulomatosis, sarcoidosis or polychondritis. Medical treatment of the disease that lead to an inflammation of the cricoarytenoid joint ( gout) or the laryngeal mucosa such as syphilis and tuberculosis (resulting in mechanical attachment of the vocal cords) to improve breathing. Diabetes treatment: Can help to improve a neuropathy of the vocal cords caused by the diabetes mellitus. Treatment of reflux: When the condition is caused by the gastroesophageal reflux. Treatment of the eventual scarring of the arytenoid cartilages. Several surgical procedures depending on whether one or both of the vocal cords are paralyzed. The most common procedures change the position of the vocal fold. These may involve inserting a structural implant or stitches to reposition the laryngeal cartilage and bring the vocal folds closer together. These procedures usually result in a stronger voice. Surgery is followed by additional voice therapy to help fine-tune the voice: Functional procedures as microflap, laryngectomy (similar to tracheostomy) with subsequent cricoidotomia (removal of the cricoid cartilage) and cartilage graft and stent (or stent placement only) or reconstruction of the local mucosa with scar removal. Tracheotomy: May be required to help breathing. In a tracheotomy, an incision is made in the front of the neck and a breathing tube is inserted through an opening, called a stoma, into the trachea. Rather than occurring through the nose and mouth, breathing now happens through the tube. Following surgery, therapy with a speech-language pathologist helps you learn how to use the voice and how to properly care for the breathing tube Permanent treatments with removal of the vocal cords (unilateral or bilateral) or the arytenoid cartilage (endoscopic or external, partial or complete) or changing the position of the vocal cords. Other treatment may include: Reinnervation techniques (experimental) Electrical stimulation (experimental). Most cases of unilateral vocal cord paralysis do not need any treatment. Adopting a vertical position is sometimes enough to relieve breathing problems but in some patients it may require an intubation."},{"instruction":"What is (are) Renal oncocytoma ?","output":"Renal oncocytoma is a benign (noncancerous) growth of the kidney. They generally do not cause any signs or symptoms and are often discovered incidentally (by chance) while a person is undergoing diagnostic imaging for other conditions. Some people with renal oncocytoma will have abdominal or flank pain; blood in the urine; and/or an abdominal mass. Although these tumors can occur in people of all ages, they most commonly develop in men who are over age 50. The exact underlying cause of most isolated (single tumor affecting one kidney) renal oncocytomas is unknown; however, multiple and bilateral (affecting both kidneys) renal oncocytomas sometimes occur in people with certain genetic syndromes such as tuberous sclerosis complex and Birt-Hogg-Dube syndrome. Although many benign tumors do not require treatment unless they are causing unpleasant symptoms, it can be difficult to confidently differentiate a renal oncocytoma from renal cell carcinoma. Most affected people are, therefore, treated with surgery which allows for confirmation of the diagnosis."},{"instruction":"What are the symptoms of Renal oncocytoma ?","output":"What are the signs and symptoms of Renal oncocytoma? Most people with a renal oncocytoma do not have any signs or symptoms. In fact, these tumors are often discovered incidentally (by chance) while a person is undergoing diagnostic imaging for other conditions. In about a third of cases, people with renal oncocytoma will present with abdominal or flank pain; blood in the urine; and/or an abdominal mass. Affected people usually have a single, unilateral (only affecting one kidney) renal oncocytoma. However, multiple, bilateral (affecting both kidneys) tumors have rarely been reported in people with tuberous sclerosis complex and Birt-Hogg-Dube syndrome. The Human Phenotype Ontology provides the following list of signs and symptoms for Renal oncocytoma. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of metabolism/homeostasis - Mitochondrial inheritance - Neoplasm - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Renal oncocytoma ?","output":"What causes a renal oncocytoma? The exact underlying cause of most renal oncocytomas is unknown. However, researchers suspect that acquired (not present at birth) changes in mitochondrial DNA may play a role in the development of some of these tumors. Renal oncocytomas sometimes occur in people with certain genetic syndromes such as tuberous sclerosis complex and Birt-Hogg-Dube syndrome. In these cases, affected people often have multiple and bilateral (affecting both kidneys) oncocytomas and may also have family members with these tumors. When renal oncocytomas are part of a genetic syndrome, they are caused by changes (mutations) in a specific gene. Tuberous sclerosis complex is caused by mutations in the TSC1 gene or TSC2 gene, while Birt-Hogg-Dube syndrome is caused by mutations in the FLCN gene."},{"instruction":"Renal oncocytoma inherited ?","output":"Is a renal oncocytoma inherited? Most renal oncocytomas are not inherited. They usually occur sporadically in people with no family history of tumors. However, in rare cases, they can occur in people with certain genetic syndromes such as tuberous sclerosis complex and Birt-Hogg-Dube syndrome. Both of these conditions are inherited in an autosomal dominant manner."},{"instruction":"w to diagnose Renal oncocytoma ?","output":"How is renal oncocytoma diagnosed? A diagnosis of renal oncocytoma is often suspected based on imaging studies such as computed tomography (CT scan) and/or magnetic resonance imaging (MRI scan). However, it can be difficult to differentiate a renal oncocytoma from renal cell carcinoma based on imaging studies alone. Although researchers are currently studying several new techniques for the diagnosis of renal oncocytoma, a biopsy and surgery are typically necessary to confirm the diagnosis. Is genetic testing available for renal oncocytoma? Genetic testing is not available for many people with renal oncocytoma since most of these tumors occur sporadically (by chance) and are not caused by a genetic mutation. However, genetic testing is an option for people with an inherited condition that predisposes to renal oncocytoma such as tuberous sclerosis complex and Birt-Hogg-Dube syndrome. Carrier testing for at-risk relatives and prenatal testing are possible if the disease-causing mutation in the family is known. The Genetic Testing Registry (GTR) is a centralized online resource for information about genetic tests. It provides a list of laboratories performing genetic testing for tuberous sclerosis complex and Birt-Hogg-Dube syndrome. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional."},{"instruction":"What are the treatments for Renal oncocytoma ?","output":"How might renal oncocytoma be treated? Most renal oncocytomas are benign (non-cancerous) and metastasis is very rare. Although many benign tumors do not require treatment unless they are causing unpleasant symptoms, it can be difficult to confidently differentiate a renal oncocytoma from renal cell carcinoma based on diagnostic imaging tests alone. Most people are, therefore, treated with surgery which allows for confirmation of the diagnosis. If a renal oncocytoma is strongly suspected prior to surgery, a more conservative procedure such as a partial nephrectomy, may be performed."},{"instruction":"What is (are) Shapiro syndrome ?","output":"Shapiro syndrome is a rare disease affecting about 50 people worldwide that is typically characterized by recurrent episodes of excessive sweating and hypothermia and the agenesis of the corpus callosum. The duration and frequency of the episodes vary from person to person, with some episodes lasting hours to weeks and occurring from hours to years; the reason for the variations in the episodes is not yet known. The cause of the condition is currently unknown; however, a \\"resetting\\" of the temperature of the body to a lower level has been suggested. Although different treatment options have been attempted in some patients, the treatments have been unsuccessful or of doubtful efficacy because of the small number of individuals that have been documented as having this condition."},{"instruction":"What are the symptoms of Shapiro syndrome ?","output":"What are the signs and symptoms of Shapiro syndrome? Shapiro syndrome generally consists of three findings: spontaneous periodic hypothermia, excessive sweating, and agenesis of the corpus callosum. However, there has been a documented case of a 4-year-old girl with Shapiro syndrome who did not have agenesis of the corpus callosum. Additionally, there have been some patients who also produce excessive amounts of urine (polyuria) and have experienced excessive thirst (polydipsia). Given that some people with Shapiro syndrome do not respond well to the various treatment options available for the condition, the symptoms may worsen with time for some people. The Human Phenotype Ontology provides the following list of signs and symptoms for Shapiro syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Gait disturbance 90% Hyperhidrosis 90% Hypothermia 90% Incoordination 90% Nausea and vomiting 90% Pallor 90% Arrhythmia 50% Reduced consciousness/confusion 50% Seizures 50% Sleep disturbance 50% Tremor 50% Abnormal pattern of respiration 7.5% Aplasia/Hypoplasia of the corpus callosum 7.5% Diarrhea 7.5% Skin rash 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the treatments for Shapiro syndrome ?","output":"What treatment options have been attempted for Shapiro syndrome? Evaluating effective treatment options for Shapiro syndrome can be difficult because of the limited number of diagnosed cases, the periodic nature of the disease, and other factors. Nonetheless, the following have been attempted and have resulted in varying responses: anticonvulsants, clonidine, cyproheptadine, glycopyrrolate, bromocriptine, chlorpromazine, or sympathectomy. It is recommended that treatment options be discussed with a health care provider. Only a patient's health care provider can determine the appropriate course of treatment."},{"instruction":"What is (are) Poland syndrome ?","output":"Poland syndrome is characterized by an underdeveloped or absent chest muscle on one side of the body, absence of the breastbone portion (sternal) of the chest muscle, and webbing of the fingers of the hand on the same side. The cause of Poland syndrome is not known. This syndrome is nearly always sporadic. It tends to occur on the right side and is more common in boys than girls. Treatment typically involves surgical correction of the chest wall deformities."},{"instruction":"What are the symptoms of Poland syndrome ?","output":"What are the signs and symptoms of Poland syndrome? Signs and symptoms of Poland syndrome may be slight to severe. Some people with Poland syndrome have only absence of the breast tissue, while others may be missing all or part of the chest muscle and underlying ribs. Symptoms tend to occur on one side of the body. Below we have listed symptoms that can be found in this condition: Absence of some of the chest muscles. The end of the main chest muscle, where it attaches to the breastbone, is usually missing. The nipple, including the darkened area around it (areola) is underdeveloped or missing; in females, this may extend to the breast and underlying tissues. Abnormally short and slightly webbed fingers. Often, the armpit (axillary) hair is missing. The skin in the area is underdeveloped (hypoplastic) with a thinned subcutaneous fat layer. The upper rib cage can be underdeveloped or missing, Sometimes the shoulder blade or bones of the arm are also involved, Rarely, spine or kidney problems are present. The Human Phenotype Ontology provides the following list of signs and symptoms for Poland syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Aplasia of the pectoralis major muscle 90% Aplasia/Hypoplasia of the nipples 90% Asymmetry of the thorax 90% Breast aplasia 90% Brachydactyly syndrome 50% Finger syndactyly 50% Split hand 50% Abnormal dermatoglyphics 7.5% Abnormality of the humerus 7.5% Abnormality of the liver 7.5% Abnormality of the lower limb 7.5% Abnormality of the ribs 7.5% Abnormality of the sternum 7.5% Abnormality of the ulna 7.5% Absent hand 7.5% Acute leukemia 7.5% Aplasia/Hypoplasia of the radius 7.5% Aplasia/Hypoplasia of the thumb 7.5% Cone-shaped epiphysis 7.5% Congenital diaphragmatic hernia 7.5% Low posterior hairline 7.5% Microcephaly 7.5% Neoplasm of the breast 7.5% Reduced bone mineral density 7.5% Renal hypoplasia/aplasia 7.5% Retinal hamartoma 7.5% Scoliosis 7.5% Short neck 7.5% Situs inversus totalis 7.5% Abnormality of the breast - Absence of pectoralis minor muscle - Autosomal dominant inheritance - Dextrocardia - Hemivertebrae - Hypoplasia of deltoid muscle - Hypoplasia of latissimus dorsi muscle - Hypoplasia of serratus anterior muscle - Rib fusion - Short ribs - Sprengel anomaly - Syndactyly - Unilateral absence of pectoralis major muscle - Unilateral brachydactyly - Unilateral hypoplasia of pectoralis major muscle - Unilateral oligodactyly - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Poland syndrome ?","output":"What causes Poland syndrome? The cause of Poland syndrome is unknown. Most evidence supports the idea that something abnormal happens during the sixth week of fetal development. This event most likely involves the vascular (blood and lymph) system. Speculations include: An interruption of the embryonic blood supply of the arteries that lie under the collarbone (subclavian arteries). This could be caused by the forward growth of the ribs reducing the flow of blood. A malformation of the subclavian arteries causes a reduced amount of blood delivered to the developing tissues on one side of the body."},{"instruction":"Poland syndrome inherited ?","output":"Is Poland syndrome inherited? Poland syndrome is rarely inherited and generally sporadic. Sporadic refers to the chance occurrence of a non-genetic disorder or abnormality that is not likely to recur in a family. In the few reported familial cases, researchers suggest that the condition may have stemmed from an inherited susceptibility to events such as interruption of blood flow that may predispose a person to the anomaly (i.e., make a person more likely to develop the anomaly)."},{"instruction":"w to diagnose Poland syndrome ?","output":"When is Poland syndrome typically first diagnosed? The severity of Poland syndrome differs from person to person. As a result it is not often diagnosed or reported. Sometimes, a person does not realize they have the condition until puberty, when lopsided (asymmetrical) growth makes it more obvious."},{"instruction":"What are the treatments for Poland syndrome ?","output":"How might Poland syndrome be treated? Management of Poland syndrome may include surgical correction of the chest wall deformities. Surgical options are available to improve appearance in both males and females. In females, breast reconstruction is typically performed at the time of normal full breast development and can be planned in conjunction with or following reconstruction of the chest wall. In males reconstruction of the chest may not be necessary if there is no underlying chest wall deformity. The optimal surgical approach will vary from patient to patient. Surgical options should be discussed with a surgeon familiar with reconstructive surgery in people with Poland syndrome."},{"instruction":"What is (are) Anaplastic astrocytoma ?","output":"Anaplastic astrocytoma is a rare, cancerous (malignant) type of brain tumor that arises from star-shaped brain cells called astrocytes. These cells surround and protect nerve cells in the brain and spinal cord. An anaplastic astrocytoma usually develops slowly over time, but may develop rapidly. Signs and symptoms vary depending on the location and size of the tumor and may include headaches, drowsiness, vomiting, and changes in personality or mental status. Some affected people have seizures, vision problems, weakness of the limbs, and/or coordination problems. Anaplastic astroctyomas usually occur sporadically but can be associated with a few rare, genetic disorders. Treatment may include surgery, radiation, and/or chemotherapy."},{"instruction":"Anaplastic astrocytoma inherited ?","output":"Are anaplastic astrocytomas inherited? Anaplastic astrocytomas are usually not inherited. These tumors typically occur sporadically, in people with no family history of astrocytomas. In most cases, the exact cause is unknown. Familial cases of isolated astrocytomas have been reported but are very rare. Astrocytomas can have a genetic link when they are associated with a few rare, inherited disorders. These include neurofibromatosis type I, Li-Fraumeni syndrome, Turcot syndrome, and tuberous sclerosis. Astrosytomas occur more frequently in people with one of these disorders. Like many other cancers, it is believed that isolated astrocytomas may occur due to a combination of genetic and environmental factors. This means that a person may carry a gene (or a combination of genes) that predisposes them to developing an astrocytoma, but it may not develop unless it is \\"triggered\\" by an environmental factor."},{"instruction":"w to diagnose Anaplastic astrocytoma ?","output":"Is genetic testing available for anaplastic astrocytomas? When anaplastic astrocytomas are not associated with an inherited condition, the cause typically remains unknown. In these cases, genetic testing is not available. However, genetic testing is available for the few genetic disorders that are associated with an increased risk for developing an astrocytoma. These include neurofibromatosis type I, Li-Fraumeni syndrome, Turcot syndrome, and tuberous sclerosis. The Genetic Testing Registry (GTR) provides information about the labs that offer genetic testing for these conditions. On the GTR Web site, search for a disorder to find out about the genetic tests that are available. The intended audience for the GTR is health care providers and researchers. Therefore, patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional."},{"instruction":"What are the symptoms of Perry syndrome ?","output":"What are the signs and symptoms of Perry syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Perry syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of extrapyramidal motor function 90% Respiratory insufficiency 90% Sleep disturbance 90% Tremor 90% Weight loss 90% Developmental regression 7.5% Hallucinations 7.5% Hypotension 7.5% Abnormality of metabolism/homeostasis - Apathy - Autosomal dominant inheritance - Bradykinesia - Central hypoventilation - Dysarthria - Hypoventilation - Inappropriate behavior - Insomnia - Mask-like facies - Parkinsonism - Rapidly progressive - Rigidity - Short stepped shuffling gait - Vertical supranuclear gaze palsy - Weak voice - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Pulmonary arterial hypertension ?","output":"Pulmonary arterial hypertension (PAH) is a progressive condition that affects the heart and lungs. It is characterized by abnormally high blood pressure (hypertension) in the pulmonary artery, the blood vessel that carries blood from the heart to the lungs. The most common signs and symptoms are shortness of breath (dyspnea) during exertion and fainting spells. As the condition worsens, people can experience dizziness, swelling (edema) of the ankles or legs, chest pain, and a racing pulse. Most cases of PAH occur in individuals with no family history of the disorder. Although some cases are due to mutations in the BMPR2 gene and inherited in an autosomal dominant pattern, a gene mutation has not yet been identified in most individuals. When PAH is inherited from an affected relative it is called \\"familial\\" PAH. Cases with no identifiable cause may be referred to as \\"idiopathic\\" PAH. PAH can also occur secondary to an underlying disorder such as connective tissue diseases, HIV infection, chronic hemolytic anemia, and congenital heart disease, to name a few. PAH can also be induced by certain drugs and toxins, for example fenfluramine and dexfenfluramine (appetite suppressants now banned by the FDA), toxic rapeseed oil, and amphetamines."},{"instruction":"What are the symptoms of Pulmonary arterial hypertension ?","output":"What are the signs and symptoms of Pulmonary arterial hypertension? The Human Phenotype Ontology provides the following list of signs and symptoms for Pulmonary arterial hypertension. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Pulmonary hypertension 100% Chest pain 90% Elevated right atrial pressure 90% Increased pulmonary vascular resistance 90% Respiratory insufficiency 90% Right ventricular failure 90% Right ventricular hypertrophy 90% Edema of the lower limbs 50% Hepatomegaly 50% Vertigo 50% Abnormal thrombosis 33% Dyspnea 33% Pulmonary arterial medial hypertrophy 33% Pulmonary artery vasoconstriction 33% Pulmonary aterial intimal fibrosis 33% Abnormality of the tricuspid valve 7.5% Acrocyanosis 7.5% Ascites 7.5% Congestive heart failure 7.5% Hemoptysis 7.5% Recurrent respiratory infections 7.5% Sudden cardiac death 7.5% Arterial intimal fibrosis - Autosomal dominant inheritance - Hypertension - Incomplete penetrance - Telangiectasia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the treatments for Pulmonary arterial hypertension ?","output":"How might pulmonary arterial hypertension be treated? People with pulmonary arterial hypertension (PAH) benefit from receiving treatment at specialized centers. The Pulmonary Hypertension Association offers a Find a Doctor tool which may aid you in locating your nearest center. Treatment of serious or life threatening PAH may involve continuous IV epoprostenol. Other treatment options, include treprostinil, iloprost, bosentan, ambrisentan, sildenafil, and tadalafil. Many of these treatments can be administered in various forms, such as by shot, IV, or inhalation. A small number of people with PAH respond well to long term oral calcium channel blockers. Blood thinners, diuretics, and supplemental oxygen may be prescribed as needed. Many drugs can be harmful to people with PAH. The following should be avoided: appetite suppressants, cocaine, amphetamines (and related compounds), low oxygen environments (such as high altitudes), and possibly estrogen compounds (oral contraceptives and hormone replacement therapy)."},{"instruction":"What is (are) GuillainBarre syndrome ?","output":"Guillain-Barr syndrome is a rare disorder in which the body's immune system attacks part of the peripheral nervous system. Symptoms include muscle weakness, numbness, and tingling sensations, which can increase in intensity until the muscles cannot be used at all. Usually Guillain-Barr syndrome occurs a few days or weeks after symptoms of a viral infection. Occasionally, surgery or vaccinations will trigger the syndrome. It remains unclear why only some people develop Guillain-Barr syndrome but there may be a genetic predisposition in some cases. Diagnosed patients should be admitted to a hospital for early treatment. There is no cure for Guillain-Barr syndrome, but treatments such as plasma exchange (plasmapheresis) and high dose immunoglobulins may reduce the severity and duration of symptoms. Recovery can take as little as a few days to as long as a few years. About 30% of those with Guillain-Barr syndrome have residual weakness. A small number may suffer a relapse many years after the initial attack."},{"instruction":"What are the symptoms of GuillainBarre syndrome ?","output":"What are the signs and symptoms of Guillain-Barre syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Guillain-Barre syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Acute demyelinating polyneuropathy - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Blastomycosis ?","output":"Blastomycosis is a rare infection that may develop when people inhale a fungus called Blastomyces dermatitidis, a fungus that is found in moist soil, particularly where there is rotting vegetation. The fungus enters the body through the lungs, infecting them. The fungus then spreads to other areas of the body. The infection may affect the skin, bones and joints, and other areas. The disease usually affects people with weakened immune systems, such as those with HIV or who have had an organ transplant."},{"instruction":"What is (are) Exogenous ochronosis ?","output":"Exogenous ochronosis refers to the bluish-black discoloration of certain tissues, such as the ear cartilage, the ocular (eye) tissue, and other body locations when it is due to exposure to various substances. It has been reported most commonly with topical application of hydroquinones to the skin. The discoloration may be caused by an effect on tyrosinase (an enzyme located in melanocytes, which are skin cells that produce pigment), or by inhibiting homogentisic acid oxidase, resulting in the accumulation and deposition of homogentisic acid (HGA) in cartilage. The discoloration is often permanent, but when exogenous ochronosis is caused by topical hydroquinones, carbon dioxide lasers and dermabrasion have been reported to be helpful. Exogenous ochronosis is different from hereditary ochronosis, which is an inherited condition that occurs with alkaptonuria."},{"instruction":"What is (are) Fanconi anemia ?","output":"Fanconi anemia is an inherited condition that affects the bone marrow, resulting in decreased production of all types of blood cells. People with this condition have lower-than-normal numbers of white blood cells, red blood cells, and platelets (cells that help the blood clot). Not enough white blood cells can lead to infections; a lack of red blood cells may result in anemia; and a decreased amount of platelets may lead to excess bleeding. Fanconi anemia can be caused by mutations in various genes; it can either be inherited in an autosomal recessive or X-linked recessive fashion."},{"instruction":"What are the symptoms of Fanconi anemia ?","output":"What are the signs and symptoms of Fanconi anemia? The Human Phenotype Ontology provides the following list of signs and symptoms for Fanconi anemia. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of chromosome stability 90% Anemia 90% Aplasia/Hypoplasia of the radius 90% Bone marrow hypocellularity 90% Hypopigmented skin patches 90% Irregular hyperpigmentation 90% Leukopenia 90% Short stature 90% Thrombocytopenia 90% Blepharophimosis 50% Cognitive impairment 50% Microcephaly 50% Scoliosis 50% Abnormal localization of kidney 7.5% Abnormality of female internal genitalia 7.5% Abnormality of the aorta 7.5% Abnormality of the aortic valve 7.5% Abnormality of the carotid arteries 7.5% Abnormality of the femur 7.5% Abnormality of the hip bone 7.5% Abnormality of the hypothalamus-pituitary axis 7.5% Abnormality of the liver 7.5% Abnormality of the preputium 7.5% Abnormality of the ulna 7.5% Aganglionic megacolon 7.5% Aplasia/Hypoplasia of the iris 7.5% Aplasia/Hypoplasia of the uvula 7.5% Arteriovenous malformation 7.5% Astigmatism 7.5% Atria septal defect 7.5% Cafe-au-lait spot 7.5% Cataract 7.5% Choanal atresia 7.5% Cleft palate 7.5% Clinodactyly of the 5th finger 7.5% Clubbing of toes 7.5% Cranial nerve paralysis 7.5% Cryptorchidism 7.5% Displacement of the external urethral meatus 7.5% Dolichocephaly 7.5% Duodenal stenosis 7.5% Epicanthus 7.5% External ear malformation 7.5% Facial asymmetry 7.5% Finger syndactyly 7.5% Frontal bossing 7.5% Functional abnormality of male internal genitalia 7.5% Hearing impairment 7.5% Hydrocephalus 7.5% Hyperreflexia 7.5% Hypertelorism 7.5% Hypertrophic cardiomyopathy 7.5% Intrauterine growth retardation 7.5% Meckel diverticulum 7.5% Myelodysplasia 7.5% Nystagmus 7.5% Oligohydramnios 7.5% Patent ductus arteriosus 7.5% Pes planus 7.5% Proptosis 7.5% Ptosis 7.5% Recurrent urinary tract infections 7.5% Reduced bone mineral density 7.5% Renal hypoplasia/aplasia 7.5% Renal insufficiency 7.5% Sloping forehead 7.5% Spina bifida 7.5% Strabismus 7.5% Tetralogy of Fallot 7.5% Toe syndactyly 7.5% Tracheoesophageal fistula 7.5% Triphalangeal thumb 7.5% Umbilical hernia 7.5% Upslanted palpebral fissure 7.5% Urogenital fistula 7.5% Ventriculomegaly 7.5% Visual impairment 7.5% Weight loss 7.5% Abnormality of cardiovascular system morphology - Abnormality of skin pigmentation - Absent radius - Absent thumb - Anemic pallor - Bruising susceptibility - Chromosomal breakage induced by crosslinking agents - Complete duplication of thumb phalanx - Deficient excision of UV-induced pyrimidine dimers in DNA - Duplicated collecting system - Ectopic kidney - Horseshoe kidney - Hypergonadotropic hypogonadism - Intellectual disability - Leukemia - Microphthalmia - Neutropenia - Pancytopenia - Prolonged G2 phase of cell cycle - Renal agenesis - Reticulocytopenia - Short thumb - Small for gestational age - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Microphthalmia syndromic 5 ?","output":"What are the signs and symptoms of Microphthalmia syndromic 5? The Human Phenotype Ontology provides the following list of signs and symptoms for Microphthalmia syndromic 5. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Cleft palate 5% Cryptorchidism 5% Ectopic posterior pituitary 5% Micropenis 5% Short stature 5% Autosomal dominant inheritance - Cataract - Coloboma - Joint laxity - Microcornea - Microphthalmia - Muscular hypotonia - Retinal dystrophy - Seizures - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) DyggveMelchiorClausen syndrome ?","output":"Dyggve-Melchior-Clausen (DMC) syndrome is a rare, progressive genetic condition characterized by abnormal skeletal development, microcephaly, and intellectual disability. Only about 100 cases have been reported to date. Skeletal abnormalities may include a barrel-shaped chest with a short truck, partial dislocation of the hips, knock knees, bowlegs, and decreased joint mobility. A small number of affected individuals experience instability in the upper neck vertebrae that can lead to spinal cord compression, weakness and paralysis. Normally, there is growth deficiency resulting in short stature. DMC is caused by mutations in the DYM gene and is inherited in an autosomal recessive manner. Some researchers have described an X-linked pattern of inheritance, which has not been confirmed to date."},{"instruction":"What are the symptoms of DyggveMelchiorClausen syndrome ?","output":"What are the signs and symptoms of Dyggve-Melchior-Clausen syndrome? Affected newborns may be small at birth, but otherwise appear normal. Skeletal findings are often recognized first between 1 and 18 months. With age, other characteristics begin to develop. Chest deformities, feeding difficulties, and developmental delay usually occur before 18 months. Disproportionate short stature usually occurs after 18 months. Additional features may include a long skull, distinctive facial appearance, a protruding jaw, microcephaly, and claw-like hands. Intellectual disability occurs in most cases, ranging from moderate to severe. Affected individuals can also develop a protruding breastbone; spinal abnormalities; abnormal bones in the hands, fingers, toes, wrists, and long bones of the arms and legs; and joint contractures, especially of the elbows and hips. Secondary problems resulting from the skeletal abnormalities may include spinal compression, dislocated hips, and restricted joint mobility. These problems may in turn cause a waddling gait. The Human Phenotype Ontology provides the following list of signs and symptoms for Dyggve-Melchior-Clausen syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of epiphysis morphology 90% Abnormality of the hip bone 90% Abnormality of the metaphyses 90% Cognitive impairment 90% Limb undergrowth 90% Pectus carinatum 90% Short stature 90% Short thorax 90% Skeletal dysplasia 90% Abnormality of the metacarpal bones 50% Abnormality of the wrist 50% Hyperlordosis 50% Hypoplasia of the odontoid process 50% Kyphosis 50% Limitation of joint mobility 50% Microcephaly 50% Neurological speech impairment 50% Sloping forehead 50% Spinal canal stenosis 50% Attention deficit hyperactivity disorder 7.5% Autism 7.5% Shoulder dislocation 7.5% Abnormality of the nervous system - Autosomal recessive inheritance - Avascular necrosis of the capital femoral epiphysis - Barrel-shaped chest - Beaking of vertebral bodies - Brachycephaly - Broad foot - Broad palm - Camptodactyly - Carpal bone hypoplasia - Coarse facial features - Cone-shaped epiphyses of the phalanges of the hand - Coxa vara - Deformed sella turcica - Disproportionate short-trunk short stature - Distal ulnar hypoplasia - Enlargement of the costochondral junction - Flat acetabular roof - Flat glenoid fossa - Genu valgum - Hallux valgus - Hypoplastic facial bones - Hypoplastic iliac wing - Hypoplastic ischia - Hypoplastic pelvis - Hypoplastic sacrum - Hypoplastic scapulae - Iliac crest serration - Irregular iliac crest - Lumbar hyperlordosis - Mandibular prognathia - Multicentric ossification of proximal femoral epiphyses - Multicentric ossification of proximal humeral epiphyses - Narrow greater sacrosciatic notches - Platyspondyly - Postnatal growth retardation - Prominent sternum - Rhizomelia - Scoliosis - Severe global developmental delay - Shield chest - Short femoral neck - Short metacarpal - Short metatarsal - Short neck - Spondyloepimetaphyseal dysplasia - Thickened calvaria - Thoracic kyphosis - Waddling gait - Wide pubic symphysis - X-linked recessive inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"w to diagnose DyggveMelchiorClausen syndrome ?","output":"How is Dyggve-Melchior-Clausen syndrome diagnosed? DMC syndrome may be suspected following a thorough clinical evaluation, a detailed patient history, and identification of characteristic findings (e.g., barrel chest, and disproportionate short stature). Radiographs may confirm specific skeletal abnormalities and findings consistent with DMC syndrome. Genetic testing can also confirm a diagnosis. Is genetic testing available for Dyggve-Melchior-Clausen syndrome? GeneTests lists the name of the laboratory that performs clinical genetic testing for Dyggve-Melchior-Clausen syndrome. To view the contact information for this laboratory, click here. Please note: Most of the laboratories listed through GeneTests do not accept direct contact from patients and their families; therefore, if you are interested in learning more, you will need to work with a health care provider or a genetics professional. Below, we provide a list of online resources that can assist you in locating a genetics professional near you."},{"instruction":"What are the treatments for DyggveMelchiorClausen syndrome ?","output":"How might Dyggve-Melchior-Clausen syndrome be treated? Treatment of individuals with DMC syndrome depends on the affected person's symptoms and is usually supportive. There is no cure for this condition. Treatments might include spinal fusion of the segments of the spinal column at the top of the spine or other means of vertebral stabilization. Additional surgical techniques may be used to correct various skeletal abnormalities such as dislocation of the shoulder and hip joints. In some cases, hip replacement is required. Children with DMC syndrome may benefit from early intervention and special educational programs."},{"instruction":"What are the symptoms of Genitopatellar syndrome ?","output":"What are the signs and symptoms of Genitopatellar syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Genitopatellar syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal nasal morphology 90% Abnormality of female external genitalia 90% Abnormality of pelvic girdle bone morphology 90% Brachydactyly syndrome 90% Cognitive impairment 90% Cryptorchidism 90% Microcephaly 90% Patellar aplasia 90% Polycystic kidney dysplasia 90% Prominent nasal bridge 90% Scrotal hypoplasia 90% Abnormal hair quantity 50% Aplasia/Hypoplasia of the corpus callosum 50% Delayed eruption of teeth 50% Fine hair 50% Hypertelorism 50% Long philtrum 50% Low-set, posteriorly rotated ears 50% Neurological speech impairment 50% Seizures 50% Talipes 50% Aplasia/Hypoplasia of the lungs 7.5% Apnea 7.5% Atria septal defect 7.5% Hearing impairment 7.5% Radioulnar synostosis 7.5% Short stature 7.5% Agenesis of corpus callosum - Autosomal recessive inheritance - Clitoral hypertrophy - Coarse facial features - Colpocephaly - Congenital hip dislocation - Dysphagia - Hip contracture - Hydronephrosis - Hypertrophic labia minora - Hypoplastic inferior pubic rami - Hypoplastic ischia - Intellectual disability, progressive - Knee flexion contracture - Laryngomalacia - Micropenis - Multicystic kidney dysplasia - Muscular hypotonia - Patellar dislocation - Periventricular gray matter heterotopia - Polyhydramnios - Prominent nose - Pulmonary hypoplasia - Short phalanx of finger - Sparse scalp hair - Talipes equinovarus - Ventricular septal defect - Wide nose - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Lowry Wood syndrome ?","output":"What are the signs and symptoms of Lowry Wood syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Lowry Wood syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Microcephaly 90% Short stature 90% Abnormality of retinal pigmentation 50% Arthralgia 50% Cognitive impairment 50% Nystagmus 50% Abnormality of nail color 7.5% Aplasia/Hypoplasia of the corpus callosum 7.5% Aplasia/Hypoplasia of the radius 7.5% Astigmatism 7.5% Brachydactyly syndrome 7.5% Delayed skeletal maturation 7.5% Elbow dislocation 7.5% Limitation of joint mobility 7.5% Patellar dislocation 7.5% Platyspondyly 7.5% Visual impairment 7.5% Autosomal recessive inheritance - Epiphyseal dysplasia - Intellectual disability, mild - Irregular epiphyses - Shallow acetabular fossae - Small epiphyses - Small for gestational age - Squared iliac bones - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Acanthosis nigricans muscle cramps acral enlargement ?","output":"What are the signs and symptoms of Acanthosis nigricans muscle cramps acral enlargement? The Human Phenotype Ontology provides the following list of signs and symptoms for Acanthosis nigricans muscle cramps acral enlargement. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Acanthosis nigricans - Autosomal recessive inheritance - Insulin resistance - Muscle cramps - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Escobar syndrome, type B ?","output":"What are the signs and symptoms of Escobar syndrome, type B? The Human Phenotype Ontology provides the following list of signs and symptoms for Escobar syndrome, type B. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Amniotic constriction ring 90% Finger syndactyly 90% Limitation of joint mobility 90% Pectus excavatum 90% Scoliosis 90% Symphalangism affecting the phalanges of the hand 90% Webbed neck 90% Abnormality of the foot 50% Aplasia/Hypoplasia of the abdominal wall musculature 50% Aplasia/Hypoplasia of the skin 50% Camptodactyly of finger 50% Epicanthus 50% Facial asymmetry 50% Hypertelorism 50% Intrauterine growth retardation 50% Long face 50% Low-set, posteriorly rotated ears 50% Microcephaly 50% Pointed chin 50% Popliteal pterygium 50% Ptosis 50% Respiratory insufficiency 50% Short stature 50% Telecanthus 50% Umbilical hernia 50% Vertebral segmentation defect 50% Abnormality of female external genitalia 7.5% Abnormality of the abdominal organs 7.5% Abnormality of the aortic valve 7.5% Abnormality of the ribs 7.5% Aortic dilatation 7.5% Aplasia/Hypoplasia of the lungs 7.5% Cleft palate 7.5% Cognitive impairment 7.5% Conductive hearing impairment 7.5% Cryptorchidism 7.5% Dolichocephaly 7.5% Gait disturbance 7.5% Hypoplasia of penis 7.5% Long philtrum 7.5% Low posterior hairline 7.5% Scrotal hypoplasia 7.5% Skeletal muscle atrophy 7.5% Spina bifida occulta 7.5% Strabismus 7.5% Abnormality of the neck - Absence of labia majora - Antecubital pterygium - Anterior clefting of vertebral bodies - Arachnodactyly - Autosomal recessive inheritance - Axillary pterygia - Bilateral camptodactyly - Camptodactyly of toe - Congenital diaphragmatic hernia - Decreased fetal movement - Diaphragmatic eventration - Dislocated radial head - Downturned corners of mouth - Dysplastic patella - Exostosis of the external auditory canal - Fused cervical vertebrae - High palate - Hip dislocation - Hypoplastic nipples - Hypospadias - Inguinal hernia - Intercrural pterygium - Kyphosis - Long clavicles - Low-set ears - Narrow mouth - Neck pterygia - Neonatal respiratory distress - Patellar aplasia - Pulmonary hypoplasia - Rib fusion - Rocker bottom foot - Syndactyly - Talipes calcaneovalgus - Talipes equinovarus - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Chitayat Meunier Hodgkinson syndrome ?","output":"What are the signs and symptoms of Chitayat Meunier Hodgkinson syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Chitayat Meunier Hodgkinson syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the fingernails 90% Abnormality of the nose 90% Clinodactyly of the 5th finger 90% Delayed skeletal maturation 90% Epicanthus 90% Frontal bossing 90% Glossoptosis 90% High forehead 90% Hypoplasia of the zygomatic bone 90% Long philtrum 90% Oral cleft 90% Proptosis 90% Proximal placement of thumb 90% Sandal gap 90% Short distal phalanx of finger 90% Triphalangeal thumb 90% Underdeveloped supraorbital ridges 90% Abnormal hair quantity 50% Abnormality of dental color 50% Carious teeth 50% Microdontia 50% Cleft palate - Easily subluxated first metacarpophalangeal joints - Hyperconvex nail - Pierre-Robin sequence - Tapered finger - X-linked inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Childhood ovarian cancer ?","output":"Childhood ovarian cancer is a rare type of cancer that occurs due to abnormal and uncontrolled cell growth in the ovaries. The childhood form, specifically, is extremely rare and accounts for less than 5% of all ovarian cancer cases. The most common types of ovarian cancers diagnosed in children and adolescents include germ cell tumors, followed by epithelial tumors, stromal tumors, and then other tumors (such as Burkitt lymphoma and small cell carcinoma of the ovary). Many people with early ovarian cancer have no signs or symptoms of the condition. When present, symptoms may include painful menstrual periods; an abdominal lump; pain or swelling in the abdomen; having male sex traits (i.e. body hair or a deep voice); and/or early signs of puberty. The underlying cause of childhood ovarian cancer is often unknown. Certain inherited conditions, such as Ollier disease, Maffucci syndrome and Peutz-Jeghers syndrome are associated with an increased risk of developing childhood ovarian cancer. Treatment varies based on many factors including the type of ovarian tumor and the severity of the condition. It may include surgery, radiation therapy, and/or chemotherapy."},{"instruction":"What is (are) Progressive deafness with stapes fixation ?","output":"Progressive deafness with stapes fixation, also known as Thies Reis syndrome, is a form of conductive or mixed hearing loss caused by fixation of the stapes. The stapes is one of the tiny bones in the middle ear. It rests in the entrance to the inner ear, allowing sounds to pass to the inner ear. If it becomes fixated, sound waves cannot pass through to the inner ear, resulting in loss of hearing. This condition may be associated with a number of conditions, including ostosclerosis, Paget's disease and osteogenesis imperfecta, or it may be found in isolation. It may also result from chronic ear infections (otitis media with tympanosclerosis). The progression of hearing loss is generally slow, rarely profound, and usually resolves following treatment. Conductive hearing loss can be restored through surgery or hearing aids. Sensorineural hearing loss can be managed with hearing aids or cochlear implants."},{"instruction":"What are the symptoms of Progressive deafness with stapes fixation ?","output":"What are the signs and symptoms of Progressive deafness with stapes fixation? Deafness, progressive with stapes fixation is characterized by bilateral hearing loss - either conductive or mixed - and stapes fixation. Hearing loss typically begins between ages 8 and 24. The Human Phenotype Ontology provides the following list of signs and symptoms for Progressive deafness with stapes fixation. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal recessive inheritance - Bilateral conductive hearing impairment - Stapes ankylosis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Progressive deafness with stapes fixation ?","output":"What causes deafness, progressive with stapes fixation? The exact cause of deafness, progressive with stapes fixation depends on whether it is associated with an underlying condition or infection. Isolated cases may be inherited. Autosomal dominant, autosomal recessive, and X-linked cases have been reported. In some cases, no underlying cause can be identified."},{"instruction":"What are the treatments for Progressive deafness with stapes fixation ?","output":"How might deafness, progressive with stapes fixation be treated? Treatment for deafness, progressive with stapes fixation typically involves surgery. The conductive component of the hearing loss can be restored by surgery or hearing aids. The associated sensorineural component is managed by hearing aids or cochlear implants, depending on its severity. Stapedotomy (a procedure where a laser is used to make a hole in the stapes) or partial stapedectomy (removal of the stapes) with stapes replacement using a prostheses most commonly achieves satisfactory results with minimal complications."},{"instruction":"What are the symptoms of Progeroid syndrome Petty type ?","output":"What are the signs and symptoms of Progeroid syndrome Petty type? The Human Phenotype Ontology provides the following list of signs and symptoms for Progeroid syndrome Petty type. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal dermatoglyphics 90% Abnormality of hair texture 90% Abnormality of the eyelashes 90% Abnormality of the fontanelles or cranial sutures 90% Anonychia 90% Broad forehead 90% Cutis laxa 90% Decreased skull ossification 90% Epicanthus 90% Hypertrichosis 90% Intrauterine growth retardation 90% Lipoatrophy 90% Low-set, posteriorly rotated ears 90% Mandibular prognathia 90% Prematurely aged appearance 90% Reduced number of teeth 90% Sacrococcygeal pilonidal abnormality 90% Shagreen patch 90% Short distal phalanx of finger 90% Short stature 90% Strabismus 90% Thick eyebrow 90% Umbilical hernia 90% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Hantavirus pulmonary syndrome ?","output":"Hantavirus pulmonary syndrome (HPS) is a severe, respiratory disease caused by infection with a hantavirus. People can become infected with a hantavirus through contact with hantavirus-infected rodents or their saliva, urine and/or droppings. Early symptoms universally include fatigue, fever and muscle aches (especially in the thighs, hips, and/or back), and sometimes include headaches, dizziness, chills, and abdominal problems such as nausea, vomiting, diarrhea, and pain. Later symptoms of the syndrome occur 4 to 10 days after initial onset and include coughing and shortness of breath. HPS can be fatal; approximately 38% of individuals with HPS do not survive. There is no cure or specific treatment for HPS, but early diagnosis and treatment in intensive care may increase the chance of recovery."},{"instruction":"What is (are) Mycobacterium Malmoense ?","output":"Mycobacterium malmoense (M. malmoense) is a bacterium naturally found in the environment, such as in wet soil, house dust, water, dairy products, domestic and wild animals, food, and human waste. M. malmoense infections most often occur in adults with lung disease, and manifests as a lung infection. Skin and tissue infections with M. malmoense have also been described. In young children, M. Malmoense may cause an infection of lymphnodes in the neck (i.e., cervical lymphadenitis)."},{"instruction":"What are the symptoms of Mycobacterium Malmoense ?","output":"What are the signs and symptoms of mycobacterium malmoense infection? Many cases of M. malmoense infection cause no symptoms, and as a result go unrecognized. M. malmoense infections in adults often present as lung infections with or without fever. In children, M. malmoense infections can present as a single sided, non-tender, enlarging, neck mass. The mass may be violet in color and often does not respond to conventional antibiotic therapy. M. malmoense infection can also cause skin lesions or abscesses."},{"instruction":"What causes Mycobacterium Malmoense ?","output":"How are mycobacterium malmoense infections contracted? M. Malmoense infection may be acquired by breathing in or ingesting the bacteria, or through trauma, such as an injury or surgical incision. People who have suppressed immune systems are at an increased risk for developing signs and symptoms from these infections."},{"instruction":"What is (are) HoltOram syndrome ?","output":"Holt-Oram syndrome is a genetic condition characterized by skeletal abnormalities of the hands and arms (upper limbs) and heart problems. Affected people have at least one bone abnormality in the wrist, many of which can be detected only by X-ray. Additional skeletal abnormalities may also be present. About 75% of affected people have heart problems, including congenital heart defects and/or cardiac conduction disease (an abnormality in the electrical system that coordinates contractions of the heart chambers). Holt-Oram syndrome is caused by mutations in the TBX5 gene and is inherited in an autosomal dominant manner. Most cases result from new mutations in the gene and occur in people with no family history of the condition."},{"instruction":"What are the symptoms of HoltOram syndrome ?","output":"What are the signs and symptoms of Holt-Oram syndrome? People with Holt-Oram syndrome have abnormally developed bones in their upper limbs. At least one abnormality in the bones of the wrist (carpal bones) is present. Additional bone abnormalities may also be present, such as a missing thumb, a long thumb that looks like a finger, partial or complete absence of bones in the forearm, an underdeveloped bone of the upper arm, and abnormalities of the collar bone or shoulder blades. About 75% of affected people have heart problems, which can be life-threatening. The most common problems are an atrial septal defect (ASD) and a ventricular septal defect (VSD). Some people have cardiac conduction disease, which is caused by abnormalities in the electrical system that coordinates contractions of the heart chambers. Cardiac conduction disease can lead to problems such as a slower-than-normal heart rate (bradycardia) or a rapid and uncoordinated contraction of the heart muscle (fibrillation). The features of Holt-Oram syndrome are similar to those of a condition called Duane-radial ray syndrome but these two disorders are caused by mutations in different genes. The Human Phenotype Ontology provides the following list of signs and symptoms for Holt-Oram syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the wrist 90% Abnormality of the metacarpal bones 50% Aplasia/Hypoplasia of the radius 50% Aplasia/Hypoplasia of the thumb 50% Arrhythmia 50% Atria septal defect 50% Triphalangeal thumb 50% Ventricular septal defect 50% Hypoplasia of the radius 37.8% Phocomelia 11% Abnormality of the aorta 7.5% Abnormality of the humerus 7.5% Abnormality of the ribs 7.5% Abnormality of the shoulder 7.5% Abnormality of the sternum 7.5% Anomalous pulmonary venous return 7.5% Aplasia of the pectoralis major muscle 7.5% Complete atrioventricular canal defect 7.5% Finger syndactyly 7.5% Hypoplastic left heart 7.5% Patent ductus arteriosus 7.5% Pectus excavatum 7.5% Radioulnar synostosis 7.5% Scoliosis 7.5% Sprengel anomaly 7.5% Thoracic scoliosis 7.5% Abnormality of the carpal bones - Abnormality of the vertebrae - Absent thumb - Autosomal dominant inheritance - Partial duplication of thumb phalanx - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes HoltOram syndrome ?","output":"What causes Holt-Oram syndrome? Holt-Oram syndrome is caused by changes (mutations) in the TBX5 gene. This gene gives the body instructions for making a protein involved in the development of the heart and upper limbs before birth. In particular, this gene seems important for dividing the developing heart into four chambers, and in regulating the development of bones in the arms and hands. When the TBX5 gene doesn't function properly, the features of Holt-Oram syndrome result. In some cases the mutation occurs for the first time in an affected person, while in other cases the mutation is inherited from a parent. However, in both of these cases, there is nothing a parent can do to cause this mutation or condition in a child."},{"instruction":"HoltOram syndrome inherited ?","output":"How is Holt-Oram syndrome inherited? Holt-Oram syndrome (HOS) is inherited in an autosomal dominant manner. This means that having only one changed (mutated) copy of the responsible gene in each cell is enough to cause signs and symptoms of the condition. In most cases, the mutation in the gene occurs for the first time in the affected person and is not inherited from a parent. When a mutation occurs for the first time, it is called a de novo mutation. This is what typically occurs when there is no family history of the condition. A de novo mutation is due to a random change in the DNA in an egg or sperm cell, or right after conception. In some cases, an affected person inherits the mutated copy of the gene from an affected parent. In these cases, the symptoms and severity can differ from those of the affected parent. When a person with an autosomal dominant condition has children, each child has a 50% (1 in 2) risk to inherit the condition."},{"instruction":"w to diagnose HoltOram syndrome ?","output":"How is Holt-Oram syndrome diagnosed? The diagnosis of Holt-Oram syndrome can be established based on physical features and family history. It can be confirmed through genetic testing looking for mutations in the TBX5 gene. Hand x-rays are usually performed for upper-limb malformations. A family history of this condition and/or cogenital heart malformations is also used as a diagnostic tool as a congenital heart malformation is present in 75% of individuals with Holt-Oram syndrome. An echocardiogram and electrocardiogram can be used to determine the presence and severity of heart defects and/or cardiac conduction disease. Holt-Oram syndrome can be excluded in individuals with congenital malformations involving the following structures or organ systems: ulnar ray only, kidney, vertebra, head and face region, auditory system (hearing loss or ear malformations), lower limb, anus, or eye."},{"instruction":"What are the treatments for HoltOram syndrome ?","output":"How might Holt-Oram syndrome be treated? The treatment of Holt-Oram syndrome is directed toward the specific symptoms that are apparent in each individual. Treatment may require the coordinated efforts of a team of specialists such as pediatricians, surgeons, cardiologists, orthopedists, and/or other health care professionals. Depending upon the severity of any upper limb abnormalities, treatment may consist of corrective or reconstructive surgery, the use of artificial replacements for portions of the forearms and hands (limb prosthetics), and/or physical therapy to help individuals enhance their motor skills. In those with mild cardiac conduction abnormalities, treatment may not be required. In more severe cases, an artificial pacemaker may be used. An artificial pacemaker overrides the heart's impaired electrical conducting system by sending electrical impulses to the heart that keep the heartbeat at a regular rate. Heart abnormalities may also be treated with certain medications, surgery, and/or other techniques. In such cases, the surgical procedures performed will depend upon the location and severity of the abnormalities and their associated symptoms. Affected individuals with heart defects may also be at risk for bacterial infection and inflammation of the lining of the heart's chambers and valves (endocarditis). So antibiotics should be prescribed before any surgical procedure, including dental procedures such as tooth extractions. In addition, because some individuals with certain heart defects may be susceptible to repeated respiratory infections, physicians may closely monitor such individuals to take preventive steps and to institute antibiotic and/or other appropriate therapies should such infections occur. Early intervention is important to ensure that children with Holt-Oram syndrome reach their potential. Special services that may be beneficial to affected children may include physical therapy and/or other medical, social, and/or vocational services."},{"instruction":"What are the symptoms of Corneal dystrophy crystalline of Schnyder ?","output":"What are the signs and symptoms of Corneal dystrophy crystalline of Schnyder? The Human Phenotype Ontology provides the following list of signs and symptoms for Corneal dystrophy crystalline of Schnyder. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal dominant inheritance - Corneal dystrophy - Crystalline corneal dystrophy - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Chromosome 17q11.2 deletion syndrome ?","output":"What are the signs and symptoms of Chromosome 17q11.2 deletion syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Chromosome 17q11.2 deletion syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of chromosome segregation 90% Abnormality of dental enamel 50% Alopecia 50% Cognitive impairment 50% Microcephaly 50% Short stature 50% Long foot 46% Intellectual disability 38% Abnormality of the eyelashes 7.5% Abnormality of the nasal alae 7.5% Aplasia/Hypoplasia of the eyebrow 7.5% Deviated nasal septum 7.5% Hypoplasia of the zygomatic bone 7.5% Long face 7.5% Macroorchidism 7.5% Midline defect of the nose 7.5% Neurological speech impairment 7.5% Seizures 7.5% Thin vermilion border 7.5% Axillary freckling 28/29 Cafe-au-lait spot 27/29 Cognitive impairment 27/29 Lisch nodules 27/29 Hypertelorism 25/29 Plexiform neurofibroma 22/29 Subcutaneous neurofibromas 22/29 Joint hypermobility 21/29 Spinal neurofibromas 9/14 Coarse facial features 17/29 Bone cyst 8/16 Delayed speech and language development 14/29 Large hands 13/28 Tall stature 13/28 Focal T2 hyperintense basal ganglia lesion 13/29 Muscular hypotonia 13/29 Specific learning disability 13/29 Scoliosis 12/28 Macrocephaly 9/23 Attention deficit hyperactivity disorder 8/24 Broad neck 9/29 Pectus excavatum 9/29 Abnormality of cardiovascular system morphology 8/28 Facial asymmetry 8/29 Neurofibrosarcoma 6/29 Optic glioma 5/27 Pes cavus 5/29 Low-set ears 4/29 Strabismus 4/29 Hearing impairment 3/29 Seizures 2/29 Autosomal dominant inheritance - Inguinal freckling - Overgrowth - Sporadic - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Neuhauser Daly Magnelli syndrome ?","output":"What are the signs and symptoms of Neuhauser Daly Magnelli syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Neuhauser Daly Magnelli syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the gastric mucosa 90% Nystagmus 90% Incoordination 50% Abnormality of the cerebellum - Autosomal dominant inheritance - Duodenal ulcer - Tremor - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Amyotrophic lateral sclerosisparkinsonism/dementia complex 1 ?","output":"What are the signs and symptoms of Amyotrophic lateral sclerosis-parkinsonism/dementia complex 1? The Human Phenotype Ontology provides the following list of signs and symptoms for Amyotrophic lateral sclerosis-parkinsonism/dementia complex 1. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal lower motor neuron morphology - Amyotrophic lateral sclerosis - Bulbar palsy - Dementia - Muscle cramps - Muscle weakness - Parkinsonism - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Mucopolysaccharidosis type VII ?","output":"What are the signs and symptoms of Mucopolysaccharidosis type VII? The Human Phenotype Ontology provides the following list of signs and symptoms for Mucopolysaccharidosis type VII. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the pleura 90% Ascites 90% Coarse facial features 90% Cognitive impairment 90% Lymphedema 90% Malar flattening 90% Opacification of the corneal stroma 90% Recurrent respiratory infections 90% Scoliosis 90% Short stature 90% Umbilical hernia 90% Abnormality of the hip bone 50% Abnormality of the liver 50% Epiphyseal stippling 50% Hydrops fetalis 50% Limitation of joint mobility 50% Muscular hypotonia 50% Splenomegaly 50% Talipes 50% Arteriovenous malformation 7.5% Enlarged thorax 7.5% Short neck 7.5% Abnormality of the heart valves - Acetabular dysplasia - Anterior beaking of lower thoracic vertebrae - Anterior beaking of lumbar vertebrae - Autosomal recessive inheritance - Corneal opacity - Dermatan sulfate excretion in urine - Dysostosis multiplex - Flexion contracture - Hearing impairment - Hepatomegaly - Hirsutism - Hydrocephalus - Hypoplasia of the odontoid process - Inguinal hernia - Intellectual disability - J-shaped sella turcica - Macrocephaly - Narrow greater sacrosciatic notches - Neurodegeneration - Pectus carinatum - Platyspondyly - Postnatal growth retardation - Proximal tapering of metacarpals - Thoracolumbar kyphosis - Urinary glycosaminoglycan excretion - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Ankylosis of teeth ?","output":"What are the signs and symptoms of Ankylosis of teeth? The Human Phenotype Ontology provides the following list of signs and symptoms for Ankylosis of teeth. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Reduced number of teeth 90% Abnormality of dental enamel 50% Clinodactyly of the 5th finger 7.5% Mandibular prognathia 7.5% Abnormality of the teeth - Autosomal dominant inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Cataractmicrocephalyfailure to thrivekyphoscoliosis ?","output":"What are the signs and symptoms of Cataract-microcephaly-failure to thrive-kyphoscoliosis? The Human Phenotype Ontology provides the following list of signs and symptoms for Cataract-microcephaly-failure to thrive-kyphoscoliosis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the face - Autosomal recessive inheritance - Cataract - Failure to thrive - Hip dislocation - Intellectual disability, progressive - Intellectual disability, severe - Kyphoscoliosis - Microcephaly - Small for gestational age - Spasticity - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Odontoma dysphagia syndrome ?","output":"What are the signs and symptoms of Odontoma dysphagia syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Odontoma dysphagia syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Atherosclerosis 90% Hepatic failure 90% Tracheoesophageal fistula 90% Autosomal dominant inheritance - Dysphagia - Odontoma - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Myoepithelial carcinoma ?","output":"Myoepithelial carcinoma is a rare malignant tumor that usually occurs in the salivary glands but can also occur in skin and soft tissues. The name of this cancer comes from the appearance of the tumor cells under the microscope. Approximately 66% of these tumors occur in the parotid gland. The average age of patients is reported to be 55 years."},{"instruction":"What are the treatments for Myoepithelial carcinoma ?","output":"How might myoepithelial carcinoma be treated? The treatment for metastatic myoepithelial carcinoma usually begins with surgery to remove the main tumor. Radiation therapy can be used to reduce the chance that the tumor could return in the same location. Recent studies have shown that neutron-based radiation therapy may be more effective than proton-based radiation therapy for treating myoepithelial cancers. There is limited evidence about the usefulness of chemotherapy in treating metastatic myoepithelial cancer, and there are no standard treatment guidelines. However, there are three reports of individuals with metastatic myoepithelial cancer who responded to chemotherapy. In one individual, the metastatic tumors stopped growing during chemotherapy. In the other two individuals, there was no evidence of the metastatic tumors after 14 months for one person and after three years for the other person."},{"instruction":"What are the symptoms of Hairy nose tip ?","output":"What are the signs and symptoms of Hairy nose tip? The Human Phenotype Ontology provides the following list of signs and symptoms for Hairy nose tip. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the hair - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Spondylocostal dysostosis 1 ?","output":"Spondylocostal dysostosis is a group of conditions characterized by abnormal development of the bones in the spine and ribs. In the spine, the vertebrae are misshapen and fused. Many people with this condition have an abnormal side-to-side curvature of the spine (scoliosis). The ribs may be fused together or missing. These bone malformations lead to short, rigid necks and short midsections. Infants with spondylocostal dysostosis have small, narrow chests that cannot fully expand. This can lead to life-threatening breathing problems. Males with this condition are at an increased risk for inguinal hernia, where the diaphragm is pushed down, causing the abdomen to bulge out. There are several types of spondylocostal dysostosis. These types have similar features and are distinguished by their genetic cause and how they are inherited. Spondylocostal dysostosis 1 is caused by mutations in the DLL3 gene. It is inherited in an autosomal recessive manner. Treatment is symptomatic and supportive and may include respiratory support and surgery to correct inguinal hernia and scoliosis."},{"instruction":"What are the symptoms of Spondylocostal dysostosis 1 ?","output":"What are the signs and symptoms of Spondylocostal dysostosis 1? The Human Phenotype Ontology provides the following list of signs and symptoms for Spondylocostal dysostosis 1. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal form of the vertebral bodies 90% Abnormality of immune system physiology 90% Abnormality of the intervertebral disk 90% Abnormality of the ribs 90% Intrauterine growth retardation 90% Respiratory insufficiency 90% Scoliosis 90% Short neck 90% Short stature 90% Short thorax 90% Vertebral segmentation defect 90% Kyphosis 50% Abnormality of female internal genitalia 7.5% Abnormality of the ureter 7.5% Anomalous pulmonary venous return 7.5% Anteverted nares 7.5% Broad forehead 7.5% Camptodactyly of finger 7.5% Cleft palate 7.5% Cognitive impairment 7.5% Congenital diaphragmatic hernia 7.5% Cryptorchidism 7.5% Depressed nasal bridge 7.5% Displacement of the external urethral meatus 7.5% Finger syndactyly 7.5% Long philtrum 7.5% Low-set, posteriorly rotated ears 7.5% Macrocephaly 7.5% Meningocele 7.5% Microcephaly 7.5% Prominent occiput 7.5% Spina bifida occulta 7.5% Umbilical hernia 7.5% Urogenital fistula 7.5% Abnormality of the odontoid process - Autosomal recessive inheritance - Block vertebrae - Death in infancy - Disproportionate short-trunk short stature - Hemivertebrae - Recurrent respiratory infections - Rib fusion - Severe short stature - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Hepatic encephalopathy ?","output":"Hepatic encephalopathy is a syndrome observed in some patients with cirrhosis. It is defined as a spectrum of neuropsychiatric abnormalities in patients with liver dysfunction, when other known brain disease has been excluded. Signs and symptoms may be debilitating, and they can begin mildly and gradually, or occur suddenly and severely. They may include personality or mood changes, intellectual impairment, abnormal movements, a depressed level of consciousness, and other symptoms. There are several theories regarding the exact cause, but development of the condition is probably at least partially due to the effect of substances that are toxic to nerve tissue (neurotoxic), which are typically present with liver damage and/or liver disease. Treatment depends upon the severity of mental status changes and upon the certainty of the diagnosis."},{"instruction":"Hepatic encephalopathy inherited ?","output":"Is hepatic encephalopathy inherited? Hepatic encephalopathy is not an inherited condition, so an individual who has it cannot pass it on to his/her children. It is brought on by chronic liver failure, particularly in alcoholics with cirrhosis. Although there are many theories and possibilities regarding what exactly causes HE, it is thought that one of the main causes is the accumulation of ammonia in the blood, which the liver, damaged by alcoholic liver disease, cannot remove. Researchers have found that ammonia alters the expression of certain genes; the genes that may be affected carry instructions for brain proteins. When the instructions in these genes are not \\"followed\\" correctly by the body due to the altered expression of the genes, the cells in the brain can no longer function normally, which may contribute to the signs and symptoms of HE. However, the genes themselves are not changed in such a way that these changes are passed down to an individual's children."},{"instruction":"What is (are) Fibrodysplasia ossificans progressiva ?","output":"Fibrodysplasia ossificans progressiva (FOP) is a disorder in which skeletal muscle and connective tissue, such as tendons and ligaments, are gradually replaced by bone (ossified). This condition leads to bone formation outside the skeleton (extra-skeletal or heterotopic bone) that restricts movement. This process generally becomes noticeable in early childhood, starting with the neck and shoulders and moving down the body and into the limbs. People with FOP are born with abnormal big toes (hallux valgus) which can be helpful in making the diagnosis. Trauma, such as a fall or invasive medical procedure, or a viral illness may trigger episodes of muscle swelling and inflammation (myositis). These flareups lasts for several days to months and often result in permanent bone growth in the injured area. FOP is almost always caused by a mutation at the same place in the ACVR1 gene and is inherited in an autosomal dominant manner. This condition occurs in about 1 in 1,600,000 newborns and about 800 people worldwide are known to have FOP."},{"instruction":"What are the symptoms of Fibrodysplasia ossificans progressiva ?","output":"What are the signs and symptoms of Fibrodysplasia ossificans progressiva? Fibrodysplasia ossificans progressiva (FOP) is characterized by the gradual replacement of muscle tissue and connective tissue (such as tendons and ligaments) by bone, restricting movement. This process generally becomes noticeable in early childhood, starting with the neck and shoulders and proceeding down the body and into the limbs. The formation of extra-skeletal bone causes progressive loss of mobility as the joints become affected. Speaking and eating may also become difficult as the mouth becomes affected. Over time, people with FOP may become malnourished because of the inability to eat. They may also develop breathing difficulties as a result of extra bone formation around the rib cage that restricts expansion of the lungs. Any trauma to the muscles of an individual with FOP (a fall or an invasive medical procedure) may trigger episodes of muscle swelling and inflammation followed by more rapid ossification in the injured area. Flare-ups may also be caused by viral illnesses such as the flu. People with FOP are generally born with malformed big toes. This abnormality of the big toes is a characteristic feature that helps to distinguish this disorder from other bone and muscle problems. Affected individuals may also have short thumbs and other skeletal abnormalities. The Human Phenotype Ontology provides the following list of signs and symptoms for Fibrodysplasia ossificans progressiva. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the skin 90% Ectopic calcification 90% Limitation of joint mobility 90% Short hallux 90% Spinal rigidity 90% Clinodactyly of the 5th finger 50% Respiratory insufficiency 50% Anemia 7.5% Cognitive impairment 7.5% Glaucoma 7.5% Hallux valgus 7.5% Seizures 7.5% Intellectual disability 6% Abnormality of the first metatarsal bone - Alopecia - Autosomal dominant inheritance - Broad femoral neck - Conductive hearing impairment - Ectopic ossification in ligament tissue - Ectopic ossification in muscle tissue - Ectopic ossification in tendon tissue - Metaphyseal widening - Progressive cervical vertebral spine fusion - Respiratory failure - Scoliosis - Sensorineural hearing impairment - Short 1st metacarpal - Small cervical vertebral bodies - Widely spaced teeth - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"Fibrodysplasia ossificans progressiva inherited ?","output":"How is fibrodysplasia ossificans progressiva inherited? Fibrodysplasia ossificans progressiva is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. Most cases of fibrodysplasia ossificans progressiva result from new mutations in the gene. These cases occur in people with no history of the disorder in their family. In only a small number of cases, an affected person has inherited the mutation from one affected parent."},{"instruction":"What are the treatments for Fibrodysplasia ossificans progressiva ?","output":"How might fibrodysplasia ossificans progressiva be treated? There is currently no definitive treatment. However, a brief course of high-dose corticosteroids, such as Prednisone, started within the first 24 hours of a flare-up, may help reduce the intense inflammation and tissue swelling seen in the early stages of fibrodysplasia ossificans progressiva. Other medications, such as muscle relaxants, mast cell inhibitors, and aminobisphosphonates, if appropriate, should be closely monitored by a physician. Surgery to remove heterotopic and extra-skeletal bone is risky and can potentially cause painful new bone growth."},{"instruction":"What are the symptoms of Oculodentoosseous dysplasia recessive ?","output":"What are the signs and symptoms of Oculodentoosseous dysplasia recessive? The Human Phenotype Ontology provides the following list of signs and symptoms for Oculodentoosseous dysplasia recessive. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) 2-4 toe cutaneous syndactyly - 4-5 finger syndactyly - Abnormality of dental enamel - Abnormality of dental morphology - Autosomal recessive inheritance - Brachycephaly - Broad long bones - Cataract - Delayed eruption of teeth - Delayed skeletal maturation - Dental crowding - Dental malocclusion - Failure to thrive - Fifth finger distal phalanx clinodactyly - Frontal bossing - Hypoplasia of teeth - Hypoplasia of the maxilla - Large earlobe - Long nose - Long philtrum - Low-set ears - Macrodontia of permanent maxillary central incisor - Microcornea - Microphthalmia - Myopia - Narrow mouth - Narrow nose - Persistent pupillary membrane - Prominent epicanthal folds - Short foot - Short palpebral fissure - Short stature - Small hand - Sparse eyelashes - Telecanthus - Thin vermilion border - Underdeveloped nasal alae - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Progressive bulbar palsy ?","output":"Progressive bulbar palsy involves the brain stem. The brain stem is the part of the brain needed for swallowing, speaking, chewing, and other functions. Signs and symptoms of progressive bulbar palsy include difficulty swallowing, weak jaw and facial muscles, progressive loss of speech, and weakening of the tongue. Additional symptoms include less prominent weakness in the arms and legs, and outbursts of laughing or crying (called emotional lability). Progressive bulbar palsy is considered a variant form of amyotrophic lateral sclerosis (ALS). Many people with progressive bulbar palsy later develop ALS. While there is no cure for progressive bulbar palsy or for ALS, doctors can treat symptoms."},{"instruction":"w to diagnose Progressive bulbar palsy ?","output":"How is progressive bulbar palsy diagnosed? What tests aid in the diagnosis of progressive bulbar palsy? Progressive bulbar palsy is a difficult to diagnose condition. No one test or procedure offers a definitive diagnosis. Diagnosis is largely based upon the person's symptoms, tests that show how well their nerves are working (e.g., an EMG or electromyography), and ruling out other causes for the symptoms. Particularly, stroke and a condition called myasthenia gravis, may have certain symptoms that are similar to those of progressive bulbar palsy and must be ruled out prior to diagnosing this disorder. Testing for acetylcholine receptor-binding antibodies may be helpful in ruling out myasthenia gravis. Because of the lack of definitive tests, you may find it helpful to consult with a doctor who is experienced in diagnosing ALS. The ALS Association lists experts and specialty centers through their Web site at: http://www.alsa.org/community/als-clinics"},{"instruction":"What are the treatments for Progressive bulbar palsy ?","output":"How is progressive bulbar palsy treated? Treatments aim to help people cope with the symptoms of progressive bulbar palsy, such as feeding tubes, devices to help with talking, and medicines to treat muscle spasms, weakness, drooling, sleep problems, pain, and depression. The Robert Packard Center for ALS Research at John Hopkins offers further general information on treatment: http://www.alscenter.org/living_with_als/treatment.html The Mayo Clinic provides information on treatment of ALS in general, which may be helpful: http://www.mayoclinic.org/diseases-conditions/amyotrophic-lateral-sclerosis/basics/treatment/con-20024397 If you are interested in learning about clinical trials, we recommend that you call the Patient Recruitment and Public Liaison (PRPL) Office at the National Institutes of Health (NIH) at 1-800-411-1222. Organizations, such as the ALS Association and Muscular Dystrophy Association are great sources for information on clinical trial opportunities and research. You can find information about participating in a clinical trial as well as learn about resources for travel and lodging assistance, through the Get Involved in Research section of our Web site."},{"instruction":"What is (are) Congenital porphyria ?","output":"Congenital erythropoietic porphyria (CEP) is the rarest porphyria and is commonly seen in infancy, although it may begin in adulthood. It is characterized by severe skin photosensitivity that may lead to scarring, blistering, and increased hair growth at the face and back of the hands. Photosensitivity and infection may cause the loss of fingers and facial features. Symptoms of CEP range from mild to severe and may include hypertrichosis, reddish discoloration of the teeth, anemia, and reddish-colored urine. In CEP, there is a defect in the synthesis of heme within the red blood cells of bone marrow. This defect leads to an increase in the buildup and, therefore, waste of porphyrin and its precursors, which leads to the signs and symptoms. Treatment for CEP may include activated charcoal or a bone marrow transplant, which can improve the anemia and future blister or scar formations from photosensitivity. Blood transfusions or spleen removal may also reduce the amount of porphyrin produced from bone marrow. This condition is inherited in an autosomal recessive fashion and is caused by mutations in the UROS gene."},{"instruction":"What are the symptoms of Congenital porphyria ?","output":"What are the signs and symptoms of Congenital porphyria? The Human Phenotype Ontology provides the following list of signs and symptoms for Congenital porphyria. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal blistering of the skin 90% Abnormality of dental color 90% Abnormality of the heme biosynthetic pathway 90% Abnormality of urine homeostasis 90% Cutaneous photosensitivity 90% Hemolytic anemia 90% Hypertrichosis 90% Self-injurious behavior 90% Splenomegaly 90% Abnormality of immune system physiology 50% Recurrent fractures 50% Reduced bone mineral density 50% Thrombocytopenia 7.5% Abnormality of the mouth - Alopecia - Atypical scarring of skin - Autosomal recessive inheritance - Cholelithiasis - Congenital onset - Conjunctivitis - Corneal scarring - Hyperpigmentation of the skin - Hypopigmentation of the skin - Joint contracture of the hand - Loss of eyelashes - Osteolysis - Osteopenia - Pathologic fracture - Scleroderma - Short stature - Thickened skin - Vertebral compression fractures - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) RussellSilver syndrome ?","output":"Russell-Silver syndrome (RSS) is a congenital disorder that causes poor growth; low birth weight; short height; and size differences (asymmetry) of parts of the body. Other signs and symptoms may include poor appetite; low blood sugar (hypoglycemia) due to feeding difficulties; a small, triangular face with distinctive facial features; clinodactyly (curved finger); digestive system abnormalities; delayed development; and/or learning disabilities. The genetic causes of RSS are complex and relate to certain genes that control growth. Most cases are not inherited from a parent and occur sporadically. In rare cases, it may be inherited in an autosomal dominant or autosomal recessive manner."},{"instruction":"What are the symptoms of RussellSilver syndrome ?","output":"What are the signs and symptoms of Russell-Silver syndrome? Signs and symptoms of Russell-Silver syndrome (RSS) can vary and may include: intrauterine growth restriction low birth weight poor growth short stature curving of the pinky finger (clinodactyly) characteristic facial features (wide forehead; small, triangular face; and small, narrow chin) arms and legs of different lengths cafe-au-lait spots (birth marks) delayed bone age gastroesophageal reflux disease kidney problems \\"stubby\\" fingers and toes developmental delay learning disabilities The Human Phenotype Ontology provides the following list of signs and symptoms for Russell-Silver syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Blue sclerae 90% Clinodactyly of the 5th finger 90% Decreased body weight 90% Downturned corners of mouth 90% Intrauterine growth retardation 90% Short stature 90% Triangular face 90% Asymmetric growth 50% Delayed skeletal maturation 50% Hypoglycemia 50% Thin vermilion border 50% Abnormality of the cardiovascular system 7.5% Abnormality of the urinary system 7.5% Cognitive impairment 7.5% Precocious puberty 7.5% Abnormality of the foot - Abnormality of the ureter - Cafe-au-lait spot - Congenital posterior urethral valve - Craniofacial disproportion - Craniopharyngioma - Delayed cranial suture closure - Fasting hypoglycemia - Frontal bossing - Growth hormone deficiency - Hepatocellular carcinoma - Hypospadias - Nephroblastoma (Wilms tumor) - Short distal phalanx of the 5th finger - Short middle phalanx of the 5th finger - Small for gestational age - Sporadic - Syndactyly - Testicular seminoma - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes RussellSilver syndrome ?","output":"What causes Russell-Silver syndrome? Russell-Silver syndrome (RSS) is a genetic disorder that usually results from the abnormal regulation of certain genes that control growth. Two genetic causes have been found to result in the majority of cases: abnormalities at an imprinted region on chromosome 11p15 - for some genes, only the copy inherited from a person's father (paternal copy) or mother (maternal copy) is \\"turned on,\\" or expressed. These parent-specific differences in gene expression are caused by a phenomenon called genomic imprinting. Abnormalities involving genes that undergo imprinting are responsible for many cases of RSS. maternal disomy of chromosome 7 (written as matUPD7) - this occurs when a child inherits both copies of chromosome 7 from the mother, instead of one copy from the mother and one copy from the father. Other chromosome abnormalities involving any of several chromosomes have also been described as causing RSS, or RSS-like syndromes. In some people with RSS, the underlying cause remains unknown."},{"instruction":"RussellSilver syndrome inherited ?","output":"Is Russell-Silver syndrome inherited? Most cases of Russell-Silver syndrome (RSS) are sporadic (not inherited), which means they occur in people with no family history of RSS. Less commonly, Russell-Silver syndrome is inherited. In some families, it appears to be inherited in an autosomal dominant manner. This means that having one \\"copy\\" of a genetic change in each cell is enough to cause the disorder. In some cases, an affected person inherits the genetic change from a parent. In other cases, the change occurs for the first time in an affected person. When a person with a genetic change that causes an autosomal dominant condition has children, each child has a 50% (1 in 2) chance to inherit the genetic change. In other families, the condition is inherited in an autosomal recessive manner. This means that to be affected, a person must have a change in both copies of the responsible gene in each cell. Affected people inherit one copy from each parent, who is referred to as a carrier. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a: 25% (1 in 4) chance to be affected 50% (1 in 2) chance to be an unaffected carrier like each parent 25% chance to be unaffected and not be a carrier"},{"instruction":"What is (are) Carbamoyl phosphate synthetase 1 deficiency ?","output":"Carbamoyl phosphate synthetase I deficiency is type of urea cycle disorder. It causes toxic levels of ammonia to accumulate in the blood. Signs and symptoms in newborns may include a lack of energy, unwillingness to eat, seizures, unusual body movements, and poorly controlled breathing or body temperature. Complications may include coma, developmental delay, and learning disability. Some individuals have a less severe form of the deficiency, and have milder symptoms that may not appear until later in life. Carbamoyl phosphate synthetase I deficiency is caused by mutations in the CPS1 gene and is inherited in an autosomal recessive fashion."},{"instruction":"What are the symptoms of Carbamoyl phosphate synthetase 1 deficiency ?","output":"What are the signs and symptoms of Carbamoyl phosphate synthetase 1 deficiency? The Human Phenotype Ontology provides the following list of signs and symptoms for Carbamoyl phosphate synthetase 1 deficiency. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Aminoaciduria 90% Hyperammonemia 90% Muscular hypotonia 90% Respiratory insufficiency 90% Seizures 90% Stroke 5% Ataxia - Autosomal recessive inheritance - Cerebral edema - Coma - Episodic ammonia intoxication - Failure to thrive - Hypoargininemia - Intellectual disability - Irritability - Lethargy - Low plasma citrulline - Protein avoidance - Respiratory alkalosis - Vomiting - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Osteopenia and sparse hair ?","output":"What are the signs and symptoms of Osteopenia and sparse hair? The Human Phenotype Ontology provides the following list of signs and symptoms for Osteopenia and sparse hair. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal hair quantity 90% Abnormal nasal morphology 90% Cognitive impairment 90% Frontal bossing 90% Hypertelorism 90% Increased bone mineral density 90% Macrocephaly 90% Malar flattening 90% Reduced bone mineral density 90% Joint hypermobility 50% Low-set, posteriorly rotated ears 50% Mandibular prognathia 50% Abnormality of the face - Autosomal recessive inheritance - Intellectual disability - Joint laxity - Muscular hypotonia - Osteopenia - Sparse hair - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Pontocerebellar hypoplasia type 6 ?","output":"What are the signs and symptoms of Pontocerebellar hypoplasia type 6? The Human Phenotype Ontology provides the following list of signs and symptoms for Pontocerebellar hypoplasia type 6. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Apnea - Autosomal recessive inheritance - Cerebellar atrophy - Cerebellar hypoplasia - Cerebral atrophy - Congenital onset - Death in childhood - Deeply set eye - Failure to thrive - Hyperreflexia - Increased CSF lactate - Increased serum lactate - Lower limb spasticity - Muscular hypotonia - Narrow forehead - Narrow palate - Poor head control - Poor suck - Progressive - Progressive microcephaly - Prominent nasal bridge - Seizures - Upper limb spasticity - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of CharcotMarieTooth disease type 4B2 ?","output":"What are the signs and symptoms of Charcot-Marie-Tooth disease type 4B2? The Human Phenotype Ontology provides the following list of signs and symptoms for Charcot-Marie-Tooth disease type 4B2. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Areflexia - Autosomal recessive inheritance - Decreased motor nerve conduction velocity - Decreased number of peripheral myelinated nerve fibers - Difficulty walking - Distal amyotrophy - Distal muscle weakness - Distal sensory impairment - Foot dorsiflexor weakness - Glaucoma - Hammertoe - Hyporeflexia - Juvenile onset - Kyphoscoliosis - Onion bulb formation - Pes cavus - Segmental peripheral demyelination/remyelination - Sensorineural hearing impairment - Steppage gait - Talipes equinovarus - Ulnar claw - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Spinal intradural arachnoid cysts ?","output":"What are the signs and symptoms of Spinal intradural arachnoid cysts? The Human Phenotype Ontology provides the following list of signs and symptoms for Spinal intradural arachnoid cysts. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the vertebral column - Arachnoid cyst - Autosomal dominant inheritance - Paraplegia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Palmoplantar keratoderma, epidermolytic ?","output":"What are the signs and symptoms of Palmoplantar keratoderma, epidermolytic? The Human Phenotype Ontology provides the following list of signs and symptoms for Palmoplantar keratoderma, epidermolytic. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Palmoplantar keratoderma 90% Verrucae 90% Abnormality of the fingernails 50% Eczema 50% Hyperhidrosis 50% Autosomal dominant inheritance - Increased IgE level - Localized epidermolytic hyperkeratosis - Palmoplantar hyperkeratosis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of BardetBiedl syndrome 12 ?","output":"What are the signs and symptoms of Bardet-Biedl syndrome 12? The Human Phenotype Ontology provides the following list of signs and symptoms for Bardet-Biedl syndrome 12. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the kidney 95% Abnormal electroretinogram 90% Abnormality of retinal pigmentation 90% Cognitive impairment 90% Multicystic kidney dysplasia 90% Obesity 90% Postaxial hand polydactyly 90% Micropenis 88% Myopia 75% Astigmatism 63% Hypertension 50% Hypoplasia of penis 50% Nystagmus 50% Polycystic ovaries 50% Short stature 50% Cataract 30% Glaucoma 22% Rod-cone dystrophy 8% Abnormality of the ovary 7.5% Cryptorchidism 7.5% Finger syndactyly 7.5% Hearing impairment 7.5% Hepatic failure 7.5% Hypertrichosis 7.5% Low-set, posteriorly rotated ears 7.5% Macrocephaly 7.5% Medial flaring of the eyebrow 7.5% Nephrotic syndrome 7.5% Neurological speech impairment 7.5% Prominent nasal bridge 7.5% Short neck 7.5% Vaginal atresia 7.5% Aganglionic megacolon 5% Asthma - Ataxia - Autosomal recessive inheritance - Biliary tract abnormality - Brachydactyly syndrome - Broad foot - Congenital primary aphakia - Decreased testicular size - Delayed speech and language development - Dental crowding - Diabetes mellitus - Foot polydactyly - Gait imbalance - Hepatic fibrosis - High palate - Hirsutism - Hypodontia - Hypogonadism - Intellectual disability - Left ventricular hypertrophy - Nephrogenic diabetes insipidus - Poor coordination - Radial deviation of finger - Retinal degeneration - Short foot - Specific learning disability - Strabismus - Syndactyly - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Familial dilated cardiomyopathy ?","output":"What are the signs and symptoms of Familial dilated cardiomyopathy? The Human Phenotype Ontology provides the following list of signs and symptoms for Familial dilated cardiomyopathy. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Hypertrophic cardiomyopathy 90% Abnormality of neutrophils 7.5% EMG abnormality 7.5% Lipoatrophy 7.5% Myopathy 7.5% Palmoplantar keratoderma 7.5% Sensorineural hearing impairment 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Cerebellar hypoplasia tapetoretinal degeneration ?","output":"What are the signs and symptoms of Cerebellar hypoplasia tapetoretinal degeneration? The Human Phenotype Ontology provides the following list of signs and symptoms for Cerebellar hypoplasia tapetoretinal degeneration. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal electroretinogram 90% Abnormality of retinal pigmentation 90% Aplasia/Hypoplasia of the cerebellum 90% Cognitive impairment 90% Incoordination 90% Muscular hypotonia 90% Nystagmus 90% Optic atrophy 90% Visual impairment 90% Ataxia - Autosomal recessive inheritance - Cerebellar hypoplasia - Tremor - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Branchiootorenal syndrome ?","output":"Branchiootorenal syndrome is characterized by birth defects or anomalies of tissues in the neck, malformations of the external ear, hearing loss, and kidney malformations. Symptom and symptom severity can vary greatly from person to person. It can be caused by mutations in the EYA1, SIX1, or SIX5 genes. It is passed through families in an autosomal dominant fashion. Treatment may include surgery to remove the anomalies of the neck (i.e., branchial fistulae or cysts), careful assessment and management of hearing loss, and follow-up by a kidney specialist (nephrologist). In some cases dialysis or kidney transplant may be required."},{"instruction":"What are the symptoms of Branchiootorenal syndrome ?","output":"What are the signs and symptoms of Branchiootorenal syndrome? Signs and symptoms of branchiootorenal syndrome can vary greatly from person to person and even between people within the same family. Hearing loss is the most common symptom and is shared by approximately 90% of people with this syndrome. Hearing loss may be conductive, sensorineural, or a combination of both. Other common signs and symptoms include branchial cleft cysts, branchial fistulae, outer, middle, and inner ear malformations, and kidney malformations. Specifically mutations in the EYA1 or SIX1 genes can be associated with kidney malformations. You can find more details regarding the signs and symptoms of branchiootorenal syndrome by visiting the Genetic Home Reference Web site at the following link: http://ghr.nlm.nih.gov/condition=branchiootorenalsyndrome The Human Phenotype Ontology provides the following list of signs and symptoms for Branchiootorenal syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Hearing impairment 90% Preauricular pit 75% Abnormality of the inner ear 50% Abnormality of the middle ear 50% External ear malformation 50% Mixed hearing impairment 50% Preauricular skin tag 50% Renal hypoplasia/aplasia 50% Cupped ear 45% Microtia 45% Stenosis of the external auditory canal 30% Lacrimal duct aplasia 25% Lacrimal duct stenosis 25% Facial palsy 10% Atresia of the external auditory canal 7.5% Cleft palate 7.5% Lacrimation abnormality 7.5% Multicystic kidney dysplasia 7.5% Renal insufficiency 7.5% Vesicoureteral reflux 7.5% Abnormality of the cerebrum - Abnormality of the renal collecting system - Autosomal dominant inheritance - Bifid uvula - Branchial cyst - Branchial fistula - Cholesteatoma - Congenital hip dislocation - Dilatated internal auditory canal - Euthyroid goiter - Gustatory lacrimation - Heterogeneous - High palate - Hypoplasia of the cochlea - Incomplete partition of the cochlea type II - Incomplete penetrance - Intestinal malrotation - Long face - Microdontia - Narrow face - Overbite - Polycystic kidney dysplasia - Renal agenesis - Renal dysplasia - Renal malrotation - Renal steatosis - Variable expressivity - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Branchiootorenal syndrome ?","output":"What causes branchiootorenal syndrome? Mutations in the genes, EYA1, SIX1, and SIX5, are known to cause branchiootorenal syndrome. About 40 percent of people with this condition have a mutation in the EYA1 gene. SIX1 and SIX5 mutations are much less common causes of the disorder. There are likely other genes that have not yet been identified that when mutated can cause this syndrome as well."},{"instruction":"Branchiootorenal syndrome inherited ?","output":"Is branchiootorenal syndrome inherited? Branchiootorenal syndrome may be inherited or occur sporadically. The inheritance pattern of branchiootorenal syndrome is autosomal dominant. Autosomal dominant inheritance is when one mutated copy of the gene that causes a disorder in each cell is needed for a person to be affected. Autosomal dominant conditions may occur for the first time in a person in a family due to a spontaneous gene mutation, or these conditions may be inherited from an affected parent. When a person with an autosomal dominant disorder has a child, there is a 50% chance that their child will inherit the condition."},{"instruction":"What are the treatments for Branchiootorenal syndrome ?","output":"How might branchiootorenal syndrome be treated? Hereditary hearing loss conditions, in general, tend to be managed by a team that includes an otolaryngologist, an audiologist, a clinical geneticist, a pediatrician, sometimes an educator of the Deaf, a neurologist, and in case of branchiootorenal syndrome, a nephrologist (kidney doctor). Treatment of hearing loss may include determining which aids would be most helpful, for example hearing aids or vibrotactile devices; cochlear implantation may be considered in children over age 12 months with severe-to-profound hearing loss. Early hearing intervention through amplification, surgery, or cochlear implantation may be recommended for children who are at risk to lose their hearing before they learn to speak. People with hereditary hearing loss often require regular follow-up with a hearing specialist such as an audiologist to monitor stability or progression of the hearing loss. Treatment of branchial fistulae or cysts may require surgery. For people with branchiootorenal syndrome and severe kidney malformations or complications, dialysis or kidney transplant may be required."},{"instruction":"What is (are) Leukodystrophy ?","output":"A leukodystrophy is a type of rare genetic disorder that affects the brain, spinal cord, and other nerves in the body. It is caused by destruction of the white matter of the brain. The white matter degrades due to defects of the myelin, which is a fatty covering that insulates nerves in the brain. Myelin is needed to protect the nerves and the nerves can't function normally without it. These disorders are progressive, meaning they tend to get worse with time. The leukodystrophies are a group of disorders caused by spelling mistakes (mutations) in the genes involved in making myelin. Specific leukodystrophies include metachromatic leukodystrophy, Krabbe leukodystrophy, X-linked adrenoleukodystrophy, Pelizaeus-Merzbacher disease, Canavan disease, and Alexander disease. The most common symptom of a leukodystrophy is a decline in functioning of an infant or child who previously appeared healthy. This gradual loss may be seen with issues in body tone, movements, gait, speech, ability to eat, vision, hearing, and behavior."},{"instruction":"What are the symptoms of Xlinked magnesium deficiency with EpsteinBarr virus infection and neoplasia ?","output":"What are the signs and symptoms of X-linked magnesium deficiency with Epstein-Barr virus infection and neoplasia? The Human Phenotype Ontology provides the following list of signs and symptoms for X-linked magnesium deficiency with Epstein-Barr virus infection and neoplasia. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Decreased number of CD4+ T cells - Decreased T cell activation - Immunodeficiency - Lymphoma - Recurrent viral infections - X-linked inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Blount disease ?","output":"Blount disease is characterized by progressive bowing of the legs in infancy, early childhood, or adolescence. While it is not uncommon for young children to have bowed legs, typically the bowing improves with age. Blount disease is a condition that results from abnormal growth in the upper part of the shin bone (tibia) and requires treatment for improvement to occur. Treatment may involve bracing and/or surgery. Other causes for Blount disease in young children includes metabolic disease and rickets. Blount disease in teens typically occurs in youth who are overweight. In teens surgery is often required to correct the problem."},{"instruction":"What are the symptoms of Blount disease ?","output":"What are the signs and symptoms of Blount disease? The Human Phenotype Ontology provides the following list of signs and symptoms for Blount disease. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the metaphyses 90% Abnormality of the tibia 90% Abnormality of the proximal tibial epiphysis - Autosomal dominant inheritance - Genu varum - Osteochondrosis dissecans - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Optic atrophy 1 ?","output":"Optic atrophy 1 is a condition that mainly affects vision, but may include other features. Vision loss typically begins within the first decade of life; severity varies widely among affected people (from nearly normal vision to complete blindness), even among members of the same family. Vision problems may include difficulty distinguishing colors, progressive narrowing of the field of vision (tunnel vision) and an abnormally pale appearance (pallor) of the optic nerve. Additional, less common abnormalities may include sensorineural hearing loss, ataxia, myopathy (muscle disease) and other neurological findings. It is usually caused by mutations in the OPA1 gene, although some individuals with optic atrophy 1 do not have identified mutations in this gene, in which case the cause of the condition is unknown. This condition is inherited in an autosomal dominant pattern but some cases result from a new mutation in the gene and occur in people with no history of the disorder in their family. Treatment focuses on individual symptoms when possible."},{"instruction":"What are the symptoms of Optic atrophy 1 ?","output":"What are the signs and symptoms of Optic atrophy 1? The Human Phenotype Ontology provides the following list of signs and symptoms for Optic atrophy 1. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Strabismus 10% Horizontal nystagmus 5% Progressive external ophthalmoplegia 48/104 Proximal muscle weakness 37/104 Ataxia 31/104 Abnormal amplitude of pattern reversal visual evoked potentials - Autosomal dominant inheritance - Central scotoma - Centrocecal scotoma - Incomplete penetrance - Insidious onset - Optic atrophy - Red-green dyschromatopsia - Reduced visual acuity - Tritanomaly - Visual impairment - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Epidermolysis bullosa ?","output":"Epidermolysis bullosa (EB) is a group of genetic skin diseases that cause the skin to blister very easily. Blisters form in response to minor injuries or friction, such as rubbing or scratching. There are four main types of epidermolysis bullosa: Dystrophic epidermolysis bullosa Epidermolysis bullosa simplex Junctional epidermolysis bullosa Kindler Syndrome Identifying the exact type can be hard because there are many subtypes of EB. Within each type or subtype, a person may be mildly or severely affected. The disease can range from being a minor inconvenience to completely disabling, and fatal in some cases. Most types of EB are inherited. The inheritance pattern may be autosomal dominant or autosomal recessive. Management involves protecting the skin, reducing friction against the skin, and keeping the skin cool."},{"instruction":"Epidermolysis bullosa inherited ?","output":"How is epidermolysis bullosa inherited? Inherited epidermolysis bullosa (EB) may follow either an autosomal dominant or autosomal recessive inheritance pattern, depending on the type and subtype of inherited EB in the affected person. Epidermolysis bullosa simplex (the most common type of EB) is mainly autosomal dominant, except for a few rare autosomal recessive subtypes. Dystrophic epidermolysis bullosa (DEB) can be inherited in an autosomal dominant or autosomal recessive manner, depending on the subtype present. However, dominant DEB is the second most common major type of EB. Junctional epidermolysis bullosa is autosomal recessive, although one article stated that an autosomal dominant form has recently been reported. Kindler syndrome is only inherited in an autosomal recessive manner. A condition is autosomal dominant if having only one changed (mutated) copy of the responsible gene in each cell is enough to cause symptoms of the condition. When a person with an autosomal dominant condition has children, each child has a 50% (1 in 2) risk to inherit the mutated copy of the gene from the affected parent. Many people with an autosomal dominant form of EB have an affected parent, but in some cases a mutation in the responsible gene occurs for the first time in a person with no family history of EB (called a de novo mutation). A person with a de novo mutation still has a 50% chance to pass the mutation on to each of his/her children. In autosomal recessive inheritance, a person must have a mutation in both copies of the responsible gene in each cell to be affected. Typically, an affected person inherits one changed (mutated) copy of the responsible gene from each parent, who are referred to as carriers. Carriers usually do not have symptoms of the condition. When two carriers of an autosomal recessive condition have children, each child has a 25% (1 in 4) risk to be affected, a 50% (1 in 2) risk to be an unaffected carrier like each parent, and a 25% risk to not be a carrier and not be affected. Epidermolysis bullosa acquisita (acquired EB) is a rare autoimmune disorder and is not inherited."},{"instruction":"What are the treatments for Epidermolysis bullosa ?","output":"How might infections in individuals with epidermolysis bullosa be treated? The chance of contracting a skin infection can be reduced by good nutrition, which builds the bodys defenses and promotes healing, and by careful skin care with clean hands and use of sterile materials. For added protection, a doctor may recommend antibiotic ointments and soaks. However, even in the presence of good care, it is possible for infection to develop. Signs of infection are redness and heat around an open area of skin, pus or a yellow drainage, excessive crusting on the wound surface, a red line or streak under the skin that spreads away from the blistered area, a wound that does not heal, and/or fever or chills. A doctor may prescribe a specific soaking solution, an antibiotic ointment, or an oral antibiotic to reduce the growth of bacteria. Wounds that are not healing may be treated by a special wound covering or biologically developed skin. More details about treatment, wound care and infection control can be obtained from the eMedicine and DEBRA web sites."},{"instruction":"What are the symptoms of Spinal muscular atrophy Ryukyuan type ?","output":"What are the signs and symptoms of Spinal muscular atrophy Ryukyuan type? The Human Phenotype Ontology provides the following list of signs and symptoms for Spinal muscular atrophy Ryukyuan type. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal recessive inheritance - Fasciculations - Infantile onset - Kyphoscoliosis - Pes cavus - Proximal amyotrophy - Spinal muscular atrophy - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Partial atrioventricular canal ?","output":"What are the signs and symptoms of Partial atrioventricular canal? The Human Phenotype Ontology provides the following list of signs and symptoms for Partial atrioventricular canal. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal dominant inheritance - Congestive heart failure - Cyanosis - First degree atrioventricular block - Inlet ventricular septal defect - Primum atrial septal defect - Pulmonary hypertension - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Intellectual disability, epileptic seizures, hypogonadism and hypogenitalism, microcephaly, and obesity ?","output":"What are the signs and symptoms of Intellectual disability, epileptic seizures, hypogonadism and hypogenitalism, microcephaly, and obesity? The Human Phenotype Ontology provides the following list of signs and symptoms for Intellectual disability, epileptic seizures, hypogonadism and hypogenitalism, microcephaly, and obesity. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the eyelashes 90% Cognitive impairment 90% Cryptorchidism 90% EEG abnormality 90% Hypoplasia of penis 90% Microcephaly 90% Obesity 90% Sloping forehead 90% Thick lower lip vermilion 90% Attention deficit hyperactivity disorder 50% Downturned corners of mouth 50% Full cheeks 50% Hyperreflexia 50% Hypertonia 50% Muscular hypotonia 50% Nystagmus 50% Reduced number of teeth 50% Seizures 50% Talipes 50% Tapered finger 50% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Spinocerebellar ataxia 10 ?","output":"What are the signs and symptoms of Spinocerebellar ataxia 10? The Human Phenotype Ontology provides the following list of signs and symptoms for Spinocerebellar ataxia 10. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal pyramidal signs - Abnormality of extrapyramidal motor function - Autosomal dominant inheritance - Cerebellar atrophy - Decreased nerve conduction velocity - Dementia - Depression - Dysarthria - Dysdiadochokinesis - Dysmetria - Dysphagia - Gait ataxia - Genetic anticipation - Hyperreflexia - Incomplete penetrance - Incoordination - Limb ataxia - Morphological abnormality of the pyramidal tract - Nystagmus - Progressive cerebellar ataxia - Scanning speech - Seizures - Urinary incontinence - Urinary urgency - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Thalamic degeneration, symmetric infantile ?","output":"What are the signs and symptoms of Thalamic degeneration, symmetric infantile? The Human Phenotype Ontology provides the following list of signs and symptoms for Thalamic degeneration, symmetric infantile. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Hypertonia 90% Incoordination 90% Respiratory insufficiency 90% Abnormality of neuronal migration 50% Abnormality of the voice 50% Arrhythmia 50% Seizures 50% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Schimke Xlinked mental retardation syndrome ?","output":"What are the signs and symptoms of Schimke X-linked mental retardation syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Schimke X-linked mental retardation syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Choreoathetosis - External ophthalmoplegia - Growth delay - Hearing impairment - Intellectual disability - Postnatal microcephaly - Spasticity - X-linked inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Arthrogryposis like disorder ?","output":"What are the signs and symptoms of Arthrogryposis like disorder? The Human Phenotype Ontology provides the following list of signs and symptoms for Arthrogryposis like disorder. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Gait disturbance 90% Limitation of joint mobility 90% Patellar aplasia 90% Talipes 50% Abnormal form of the vertebral bodies 7.5% Abnormality of the clavicle 7.5% Aplasia/Hypoplasia of the radius 7.5% Melanocytic nevus 7.5% Scoliosis 7.5% Autosomal recessive inheritance - Skeletal muscle atrophy - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Hoyeraal Hreidarsson syndrome ?","output":"What are the signs and symptoms of Hoyeraal Hreidarsson syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Hoyeraal Hreidarsson syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of immune system physiology 90% Aplasia/Hypoplasia of the cerebellum 90% Cognitive impairment 90% Intrauterine growth retardation 90% Microcephaly 90% Short stature 90% Subcutaneous hemorrhage 90% Thrombocytopenia 90% Abnormal hair quantity 50% Abnormality of coagulation 50% Abnormality of the nail 50% Abnormality of the oral cavity 50% Anemia 50% Cerebral cortical atrophy 50% Generalized hyperpigmentation 50% Hypertonia 50% Hypopigmentation of hair 50% Ventriculomegaly 50% Abnormality of leukocytes 7.5% Bone marrow hypocellularity 7.5% Cerebral calcification 7.5% Incoordination 7.5% Neoplasm 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Primary orthostatic hypotension ?","output":"Primary orthostatic hypotension is a rare type of orthostatic hypotension. It is not a disease per se, but a condition caused by several disorders that affect a specific part of the autonomic nervous system, such as multiple system atrophy, young-onset Parkinsons disease, pure autonomic failure, dopamine beta-hydroxylase deficiency, familial dysautonomia, and pure autonomic failure among others. The autonomic nervous system is the part of the nervous system that regulates certain involuntary body functions such as heart rate, blood pressure, sweating, and bowel and bladder control. Orthostatic hypotension is a form of low blood pressure that happens when standing-up from sitting or lying down. Common symptoms may include dizziness, lightheadedness, generalized weakness, leg buckling, nausea, blurry vision, fatigue, and headaches. Additional symptoms can include chest pain (angina), head and neck pain (often affecting neck and shoulders with a coat hanger distribution), decline in cognitive functioning such as difficulty concentrating, temporary loss of consciousness or blackout. Some people with primary orthostatic hypotension may also have high blood pressure when lying down. The treatment depends upon several factors including the specific underlying cause including The treatment depends upon several factors including the specific underlying cause and may include physical counter-maneuvers like lying down, sitting down, squatting clenching buttocks, leg crossing, and support garment and medication."},{"instruction":"What are the symptoms of Mental retardation Xlinked syndromic 7 ?","output":"What are the signs and symptoms of Mental retardation X-linked syndromic 7? The Human Phenotype Ontology provides the following list of signs and symptoms for Mental retardation X-linked syndromic 7. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Cognitive impairment 90% Obesity 90% Tapered finger 90% Abnormal hair quantity 50% Abnormality of dental morphology 50% Hypoplasia of penis 50% Muscle weakness 50% Neurological speech impairment 50% Short stature 50% Cryptorchidism 7.5% Visual impairment 7.5% Intellectual disability - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) GallowayMowat syndrome ?","output":"Galloway-Mowat syndrome is a rare, neurodegenerative disorder characterized by various developmental and physical abnormalities. Signs and symptoms may include small head size (microcephaly); developmental delay; seizures; nephrotic syndrome; hiatal hernia; optic atrophy; movement disorders; and intellectual disability. Other physical abnormalities may also be present. Galloway-Mowat syndrome may be caused by changes (mutations) in the WDR73 gene and is inherited in an autosomal recessive manner. Other, unknown genes may also be responsible. Affected children often do not survive beyond the first few years of life. Treatment is aimed at the specific signs and symptoms present."},{"instruction":"What are the symptoms of GallowayMowat syndrome ?","output":"What are the signs and symptoms of Galloway-Mowat syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Galloway-Mowat syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Cognitive impairment 90% Hypoplasia of the ear cartilage 90% Microcephaly 90% Nephropathy 90% Nephrotic syndrome 90% Proteinuria 90% Abnormality of neuronal migration 50% EEG abnormality 50% Intrauterine growth retardation 50% Macrotia 50% Premature birth 50% Seizures 50% Short stature 50% Abnormality of immune system physiology 7.5% Abnormality of the intervertebral disk 7.5% Abnormality of the teeth 7.5% Adducted thumb 7.5% Aqueductal stenosis 7.5% Camptodactyly of finger 7.5% Hemiplegia/hemiparesis 7.5% Hypertelorism 7.5% Hypertonia 7.5% Hypotelorism 7.5% Muscular hypotonia 7.5% Ataxia 5% Dandy-Walker malformation 5% Dystonia 5% Feeding difficulties 5% Spastic tetraplegia 5% Autosomal recessive inheritance - Camptodactyly - Cataract - Cerebellar atrophy - Cerebral atrophy - Diffuse mesangial sclerosis - Epicanthus - Flat occiput - Focal segmental glomerulosclerosis - Hand clenching - Hiatus hernia - High palate - Hyperreflexia - Hypoalbuminemia - Hypopigmentation of the skin - Hypoplasia of midface - Hypoplasia of the brainstem - Hypoplasia of the corpus callosum - Hypoplasia of the iris - Infantile onset - Intellectual disability - Joint contracture of the hand - Low-set ears - Microphthalmia - Narrow nasal ridge - Nystagmus - Oligohydramnios - Opacification of the corneal stroma - Optic atrophy - Pachygyria - Pes cavus - Prominent nose - Ptosis - Slender finger - Sloping forehead - Small for gestational age - Small nail - Strabismus - Talipes equinovarus - Wide mouth - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"GallowayMowat syndrome inherited ?","output":"How is Galloway-Mowat syndrome inherited? Galloway-Mowat syndrome is inherited in an autosomal recessive manner. This means that to be affected, a person must have a mutation in both copies of the responsible gene in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a carrier. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a: 25% (1 in 4) chance to be affected 50% (1 in 2) chance to be an unaffected carrier like each parent 25% chance to be unaffected and not be a carrier"},{"instruction":"w to diagnose GallowayMowat syndrome ?","output":"Is genetic testing available for Galloway-Mowat syndrome? Yes. The Genetic Testing Registry (GTR) provides information about the labs that offer clinical genetic testing for Galloway-Mowat syndrome. While it is known to be caused by mutations in the WDR73 gene, it has been suggested that other, unidentified genes may also be responsible. In some cases, carrier testing for unaffected relatives may only be available if the specific mutation in the affected family member is known. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional."},{"instruction":"What is (are) Emanuel syndrome ?","output":"Emanuel syndrome is a chromosome disorder that causes problems with physical and intellectual development. Signs and symptoms can vary but may include severe intellectual disability; small head size (microcephaly); failure to thrive; cleft palate or high-arched palate; small jaw (micrognathia); congenital heart defects; and abnormalities of the ears, kidneys, and/or male genitals. It is caused by having extra material from chromosomes 11 and 22 in each cell. Almost all people with Emanuel syndrome inherit the extra chromosome material from an unaffected parent with a balanced translocation. Treatment focuses on the specific signs and symptoms in each person."},{"instruction":"What are the symptoms of Emanuel syndrome ?","output":"What are the signs and symptoms of Emanuel syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Emanuel syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of metabolism/homeostasis - Anal atresia - Aortic valve stenosis - Atria septal defect - Broad jaw - Cerebral atrophy - Cleft palate - Congenital diaphragmatic hernia - Congenital hip dislocation - Constipation - Cryptorchidism - Deeply set eye - Delayed eruption of primary teeth - Delayed speech and language development - Dental crowding - Facial asymmetry - Feeding difficulties - Gastroesophageal reflux - Hearing impairment - High palate - Hypoplasia of the corpus callosum - Inguinal hernia - Intellectual disability - Intrauterine growth retardation - Kyphosis - Long philtrum - Low hanging columella - Low-set ears - Low-set nipples - Macrotia - Microcephaly - Micropenis - Muscular hypotonia - Myopia - Patent ductus arteriosus - Preauricular pit - Preauricular skin tag - Pulmonic stenosis - Recurrent otitis media - Recurrent respiratory infections - Renal agenesis - Renal hypoplasia - Scoliosis - Seizures - Single umbilical artery - Strabismus - Thickened nuchal skin fold - Truncus arteriosus - Upslanted palpebral fissure - Ventricular septal defect - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Hypomagnesemia 6 ?","output":"What are the signs and symptoms of Hypomagnesemia 6? The Human Phenotype Ontology provides the following list of signs and symptoms for Hypomagnesemia 6. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal dominant inheritance - Headache - Hypomagnesemia - Muscle weakness - Vertigo - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Carnitineacylcarnitine translocase deficiency ?","output":"Carnitine-acylcarnitine translocase deficiency is a condition that prevents the body from converting certain fats called long-chain fatty acids into energy, particularly during periods without food (fasting). Carnitine, a natural substance acquired mostly through the diet, is used by cells to process fats and produce energy. People with this disorder have a faulty transporter that disrupts carnitine's role in processing long-chain fatty acids. Carnitine-acylcarnitine translocase deficiency is a type of fatty acid oxidation disorder. There are two forms of carnitine-acylcarnitine translocase deficiency. The most common type happens in newborns. A milder, less common type happens in older infants and children."},{"instruction":"What are the symptoms of Carnitineacylcarnitine translocase deficiency ?","output":"What are the signs and symptoms of Carnitine-acylcarnitine translocase deficiency? The signs of carnitine-acylcarnitine translocase deficiency usually begin within the first few hours after birth. Seizures, an irregular heartbeat (arrhythmia), and breathing problems are often the first signs of this disorder. This disorder may also result in an extremely low level of ketones, which are products of fat breakdown that are used for energy. Low blood sugar (hypoglycemia) is another major feature. Together these signs are called hypoketotic hypoglycemia, which can result in unconsciousness and seizures. Other signs that are often present include excess ammonia in the blood (hyperammonemia), an enlarged liver (hepatomegaly), heart abnormalities (cardiomyopathy), and muscle weakness. This disorder can cause sudden infant death. Children with the mild type of carnitine-acylcarnitine translocase deficiency usually start having symptoms before age three. They are at risk to have episodes of metabolic crisis, but usually do not have heart problems. The Human Phenotype Ontology provides the following list of signs and symptoms for Carnitine-acylcarnitine translocase deficiency. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Atrioventricular block - Autosomal recessive inheritance - Bradycardia - Cardiomyopathy - Cardiorespiratory arrest - Coma - Dicarboxylic aciduria - Elevated hepatic transaminases - Elevated serum creatine phosphokinase - Hepatomegaly - Hyperammonemia - Hypoglycemia - Hypotension - Irritability - Lethargy - Muscle weakness - Muscular hypotonia - Rhabdomyolysis - Seizures - Ventricular extrasystoles - Ventricular hypertrophy - Ventricular tachycardia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Carnitineacylcarnitine translocase deficiency ?","output":"What causes carnitine-acylcarnitine translocase deficiency? Carnitine-acylcarnitine translocase deficiency occurs when an enzyme, called \\"carnitine-acylcarnitine translocase\\" (CAT), is either missing or not working properly. This enzyme's job is to help change certain fats in the food we eat into energy. It also helps to break down fat already stored in the body. Energy from fat keeps us going whenever our bodies run low of their main source of energy, a type of sugar called glucose. Our bodies rely on fat for energy when we don't eat for a stretch of time - like when we miss a meal or when we sleep. When the CAT normal enzyme is missing or not working well, the body cannot use fat for energy, and must rely solely on glucose. Although glucose is a good source of energy, there is a limited amount available. Once the glucose has been used up, the body tries to use fat without success. This leads to low blood sugar, called hypoglycemia, and to the build up of harmful substances in the blood."},{"instruction":"Carnitineacylcarnitine translocase deficiency inherited ?","output":"How is carnitine-acylcarnitine inherited? Carnitine-acylcarnitine translocase deficiency is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition."},{"instruction":"w to diagnose Carnitineacylcarnitine translocase deficiency ?","output":"Is there genetic testing available for carnitine-acylcarnitine translocase deficiency? Genetic testing for carnitine-acylcarnitine translocase deficiency can be done on a blood sample. Genetic testing, also called DNA testing, looks for changes in the pair of genes that cause carnitine-acylcarnitine translocase deficiency. In some affected children, both gene changes can be found. However, in other children, neither or only one of the two gene changes can be found, even though we know they are present. DNA testing is not necessary to diagnose carnitine-acylcarnitine translocase deficiency, however, it can be helpful for carrier testing or prenatal diagnosis."},{"instruction":"What are the treatments for Carnitineacylcarnitine translocase deficiency ?","output":"How might carnitine-acylcarnitine translocase deficiency be treated? Although there is no standard treatment plan for carnitine-acylcarnitine translocase deficiency, there are treatments that have been found to be helpful in the management of this condition. Certain treatments may be helpful for some children but not others. When necessary, treatment are usually needed throughout life. Children with carnitine-acylcarnitine translocase deficiency should be followed by a metabolic doctor and a dietician in addition to their primary doctor. Aggressive treatment of hypoglycemia, hyperammonemia and prevention of lipolysis (the breakdown of fat stored in fat cells) in the newborn may be lifesaving. Infants and young children with carnitine-acylcarnitine translocase deficiency need to eat frequently to prevent a metabolic crisis. In general, it is often suggested that infants be fed every four to six hours, although some babies need to eat even more frequently than this. It is important that infants be fed during the night. They may need to be woken up to eat if they do not wake up on their own. Sometimes a low-fat, high carbohydrate diet is advised. Carbohydrates give the body many types of sugar that can be used as energy. In fact, for children needing this treatment, most food in the diet should be carbohydrates (bread, pasta, fruit, vegetables, etc.) and protein (lean meat and low-fat dairy food). Some children may be helped by taking L-carnitine. This is a safe and natural substance that helps body cells make energy. It also helps the body get rid of harmful wastes. However, supplementation with carnitine remains controversial, as its efficacy remains unknown. Medium Chain Triglyceride oil (MCT oil) is sometimes used as part of the food plan for people with carnitine-acylcarnitine translocase deficiency. This special oil has medium chain fatty acids that people with carnitine-acylcarnitine translocase deficiency can use in small amounts for energy. You may be instructed to call your child's doctor at the start of any illness. Children with carnitine-acylcarnitine translocase deficiency need to eat extra starchy food and drink more fluids during any illness (even if they may not feel hungry) or they could develop a metabolic crisis."},{"instruction":"What is (are) Limbgirdle muscular dystrophy type 2I ?","output":"Limb-girdle muscular dystrophy type 2I (LGMD2I) is a form of limb-girdle muscular dystrophy, which refers to a group of conditions that cause weakness and wasting of the muscles in the arms and legs. The proximal muscles (those closest to the body such as the upper arms and thighs) are generally most affected by the condition. In LGMD2I, specifically, signs and symptoms often develop in late childhood (average age 11.5 years) and may include difficulty running and walking. The symptoms gradually worsen overtime and affected people generally rely on a wheelchair for mobility approximately 23-26 years after onset. LGMD2I is caused by changes (mutations) in the FKRP gene and is inherited in an autosomal recessive manner. There is, unfortunately, no cure for LGMD2I and treatment is based on the signs and symptoms present in each person."},{"instruction":"What are the symptoms of Limbgirdle muscular dystrophy type 2I ?","output":"What are the signs and symptoms of Limb-girdle muscular dystrophy type 2I? The Human Phenotype Ontology provides the following list of signs and symptoms for Limb-girdle muscular dystrophy type 2I. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Exercise-induced myoglobinuria 25% Achilles tendon contracture - Autosomal recessive inheritance - Calf muscle hypertrophy - Congenital muscular dystrophy - Difficulty climbing stairs - Difficulty walking - Dilated cardiomyopathy - Elevated serum creatine phosphokinase - Frequent falls - Hyperlordosis - Impaired left ventricular function - Kyphosis - Macroglossia - Muscle cramps - Myalgia - Nocturnal hypoventilation - Pelvic girdle muscle weakness - Proximal muscle weakness - Restrictive respiratory insufficiency - Scoliosis - Shoulder girdle muscle weakness - Thigh hypertrophy - Toe walking - Variable expressivity - Vertebral fusion - Waddling gait - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Spondylometaphyseal dysplasia type A4 ?","output":"What are the signs and symptoms of Spondylometaphyseal dysplasia type A4? The Human Phenotype Ontology provides the following list of signs and symptoms for Spondylometaphyseal dysplasia type A4. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the hip bone 90% Micromelia 90% Platyspondyly 90% Short stature 90% Brachydactyly syndrome 50% Enlarged thorax 7.5% Limitation of joint mobility 7.5% Autosomal recessive inheritance - Broad ischia - Costochondral joint sclerosis - Coxa valga - Disproportionate short-limb short stature - Dolichocephaly - Enlargement of the costochondral junction - Flat acetabular roof - Hypoplasia of the capital femoral epiphysis - Irregular capital femoral epiphysis - Irregular patellae - Metaphyseal irregularity - Metaphyseal sclerosis - Metaphyseal widening - Narrow greater sacrosciatic notches - Osteoporotic metatarsal - Osteoporotic tarsals - Ovoid vertebral bodies - Pectus carinatum - Sclerotic humeral metaphysis - Severe short stature - Spondylometaphyseal dysplasia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Hypertelorism and tetralogy of Fallot ?","output":"What are the signs and symptoms of Hypertelorism and tetralogy of Fallot? The Human Phenotype Ontology provides the following list of signs and symptoms for Hypertelorism and tetralogy of Fallot. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal recessive inheritance - Blepharophimosis - Depressed nasal bridge - Epicanthus - Hypertelorism - Hypospadias - Intellectual disability, mild - Long philtrum - Low-set ears - Patent ductus arteriosus - Patent foramen ovale - Posteriorly rotated ears - Spina bifida occulta - Talipes equinovarus - Tetralogy of Fallot - Tetralogy of Fallot with absent pulmonary valve - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Spondylometaphyseal dysplasia Xlinked ?","output":"What are the signs and symptoms of Spondylometaphyseal dysplasia X-linked? The Human Phenotype Ontology provides the following list of signs and symptoms for Spondylometaphyseal dysplasia X-linked. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the nail - Anteverted nares - Coarse facial features - Depressed nasal bridge - Enlarged joints - Hip contracture - Hyperextensibility of the finger joints - Hypertelorism - Intellectual disability, mild - Knee flexion contracture - Kyphosis - Neurological speech impairment - Nystagmus - Pectus carinatum - Platyspondyly - Respiratory failure - Sclerosis of skull base - Severe short stature - Spondylometaphyseal dysplasia - Strabismus - Tapered finger - Thoracolumbar scoliosis - Wide nasal bridge - X-linked inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Glomerulopathy with fibronectin deposits 2 ?","output":"What are the signs and symptoms of Glomerulopathy with fibronectin deposits 2? The Human Phenotype Ontology provides the following list of signs and symptoms for Glomerulopathy with fibronectin deposits 2. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Edema of the lower limbs 90% Glomerulopathy 90% Hematuria 90% Hypertension 90% Nephrotic syndrome 90% Proteinuria 90% Renal insufficiency 90% Intracranial hemorrhage 7.5% Autosomal dominant inheritance - Generalized distal tubular acidosis - Microscopic hematuria - Renal cell carcinoma - Slow progression - Stage 5 chronic kidney disease - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) CREST syndrome ?","output":"CREST syndrome, also known as limited scleroderma, is a widespread connective tissue disease characterized by changes in the skin, blood vessels, skeletal muscles, and internal organs. The symptoms involved in CREST syndrome are associated with the generalized form of the disease systemic sclerosis (scleroderma). CREST is an acronym for the clinical features that are seen in a patient with this disease. (C) - Calcinosis (KAL-sin-OH-sis): the formation of calcium deposits in the connective tissues, which can be detected by X ray. They are typically found on the fingers, hands, face, trunk, and on the skin above the elbows and knees. When the deposits break through the skin, painful ulcers can result. (R) - Raynaud's (ray-NOHZ) phenomenon: a condition in which the small blood vessels of the hands and/or feet contract in response to cold or anxiety. As the vessels contract, the hands or feet turn white and cold, then blue. As blood flow returns, they become red. Fingertip tissues may suffer damage, leading to ulcers, scars, or gangrene. (E) - Esophageal (eh-SOFF-uh-GEE-ul) dysfunction: impaired function of the esophagus (the tube connecting the throat and the stomach) that occurs when smooth muscles in the esophagus lose normal movement. In the upper esophagus, the result can be swallowing difficulties; in the lower esophagus, the problem can cause chronic heartburn or inflammation. (S) - Sclerodactyly (SKLER-oh-DAK-till-ee): thick and tight skin on the fingers, resulting from deposits of excess collagen within skin layers. The condition makes it harder to bend or straighten the fingers. The skin may also appear shiny and darkened, with hair loss. (T) - Telangiectasia (tel-AN-jee-ek-TAY-zee-uhs): small red spots on the hands and face that are caused by the swelling of tiny blood vessels. While not painful, these red spots can create cosmetic problems. It is not necessary to have all five symptoms of CREST syndrome to be diagnosed with the disease. Some doctors believe only two of the five are necessary for a diagnosis."},{"instruction":"What are the symptoms of CREST syndrome ?","output":"What are the signs and symptoms of CREST syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for CREST syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the gastric mucosa 90% Acrocyanosis 90% Arthralgia 90% Arthritis 90% Atypical scarring of skin 90% Autoimmunity 90% Chest pain 90% Chondrocalcinosis 90% Edema 90% Hyperkeratosis 90% Lack of skin elasticity 90% Myalgia 90% Nausea and vomiting 90% Skeletal muscle atrophy 90% Weight loss 90% Abnormality of the myocardium 50% Abnormality of the pericardium 50% Carious teeth 50% Feeding difficulties in infancy 50% Gangrene 50% Malabsorption 50% Mucosal telangiectasiae 50% Myositis 50% Pulmonary fibrosis 50% Pulmonary infiltrates 50% Respiratory insufficiency 50% Skin ulcer 50% Telangiectasia of the skin 50% Trismus 50% Xerostomia 50% Abnormal renal physiology 7.5% Abnormal tendon morphology 7.5% Arrhythmia 7.5% Bowel incontinence 7.5% Coronary artery disease 7.5% Erectile abnormalities 7.5% Hypertensive crisis 7.5% Irregular hyperpigmentation 7.5% Migraine 7.5% Narrow mouth 7.5% Osteolysis 7.5% Osteomyelitis 7.5% Peripheral neuropathy 7.5% Pulmonary hypertension 7.5% Seizures 7.5% Abnormality of chromosome stability - Abnormality of the abdomen - Autosomal dominant inheritance - Calcinosis - Sclerodactyly - Scleroderma - Telangiectasia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes CREST syndrome ?","output":"What causes CREST syndrome? In people with CREST syndrome, the immune system appears to stimulate cells called fibroblasts to produce excess amounts of collagen. Normally, fibroblasts synthesize collagen to help heal wounds, but in this case, the protein is produced even when it's not needed, forming thick bands of connective tissue around the cells of the skin, blood vessels and in some cases, the internal organs. Although an abnormal immune system response and the resulting production of excess collagen appears to be the main cause of limited scleroderma, researchers suspect that other factors may play a role, including: genetic factors, pregnancy, hormones, and environmental factors."},{"instruction":"w to diagnose CREST syndrome ?","output":"How is CREST syndrome diagnosed? CREST syndrome can be difficult to diagnose. Signs and symptoms vary widely and often resemble those of other connective tissue and autoimmune diseases. Further complicating matters is that limited scleroderma sometimes occurs with other autoimmune conditions such as polymyositis, lupus and rheumatoid arthritis. A blood sample can be tested for antibodies that are frequently found in the blood of people with limited scleroderma. But this isn't a definitive test because not everyone with limited scleroderma has these antibodies. Sometimes doctors take a small sample of skin that's then examined under a microscope in a laboratory. Biopsies can be helpful, but they can't definitively diagnose limited scleroderma either. Along with a blood test and skin biopsy, additional tests to identify lung, heart or gastrointestinal complications may also be conducted."},{"instruction":"What are the symptoms of Radio renal syndrome ?","output":"What are the signs and symptoms of Radio renal syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Radio renal syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal form of the vertebral bodies 90% Abnormality of the elbow 90% Abnormality of the palate 90% Abnormality of the pleura 90% Abnormality of the ribs 90% Brachydactyly syndrome 90% Convex nasal ridge 90% Depressed nasal bridge 90% Downturned corners of mouth 90% Micromelia 90% Multicystic kidney dysplasia 90% Renal hypoplasia/aplasia 90% Respiratory insufficiency 90% Short neck 90% Short stature 90% Abnormality of chromosome stability - Absent radius - Absent thumb - Autosomal dominant inheritance - Ectopic kidney - External ear malformation - Renal agenesis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Deafness oligodontia syndrome ?","output":"What are the signs and symptoms of Deafness oligodontia syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Deafness oligodontia syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Reduced number of teeth 90% Sensorineural hearing impairment 90% Vertigo 50% Autosomal recessive inheritance - Congenital sensorineural hearing impairment - Diastema - Oligodontia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Brittle diabetes ?","output":"Brittle diabetes is characterized by severe instability of blood glucose levels with frequent and unpredictable episodes of hypoglycemia and/or ketoacidosis that disrupt quality of life, often requiring frequent or prolonged hospitalizations. These unpredictable episodes are due to an absolute insulin dependency, affecting type 1 diabetics almost exclusively. Brittle diabetes is most common in women in their twenties or thirties, but can occur at any age and in either gender. The condition may be caused by stress and hormonal inbalance, neglect of self-care (noncompliance), or underlying medical conditions such as malabsorption, delayed gastric emptying due to autonomic neuropathy, drug or alcohol use or abnormal insulin absorption or degradation. Treatment is difficult and dependent upon the underlying cause."},{"instruction":"What are the symptoms of Brittle diabetes ?","output":"What are the symptoms of brittle diabetes? The main symptom of brittle diabetes is severe instability of blood glucose levels with frequent and unpredictable episodes of hypoglycemia and/or ketoacidosis that cause a disruption of daily activities. Three clinical presentations have been described: Predominant hyperglycemia with recurrent ketoacidosis, Predominant hypoglycemia, and Mixed hyper- and hypoglycemia. Patients with brittle diabetes have wide swings in their blood sugar levels and often experience differing blood sugar responses to the same dose and type of insulin. Complications such as neuropathy, nephropathy, and retinopathy are common. Most patients are females in their twenties of thirties, though any age or gender can be affected."},{"instruction":"What causes Brittle diabetes ?","output":"What causes brittle diabetes? There are multiple causes of brittle diabetes. Emotional stress seems to play an important role, in some cases leading to hormonal inbalances which can lead to brittle diabetes. Emotional stress can also lead to a shift in the behavior of an individual, leading them to neglect their self-care. Other cases can be traced to physiological causes, including malabsorption, delayed gastric emptying due to autonomic neuropathy (gastroparesis), celiac disease, impaired glucose counterregulation (which doesn't allow the patient's body to react as it should when blood glucose levels drop), hypothyroidism and adrenal insufficiency, drug or alcohol use, systemic insulin resistance, and abnormal insulin absorption or degradation."},{"instruction":"What are the treatments for Brittle diabetes ?","output":"How might brittle diabetes be treated? The approach to management depends upon the underlying cause. General management strategies include diabetes education, frequent self-monitoring of blood glucose, the use of a continuous subcutaneous insulin pump in conjunction with a continuous glucose monitoring device, and, in rare cases, pancreas transplantation. Psychotherapy or working with a psychiatrist or psychologist is recommended for many people with brittle diabetes. Referral to a specialty center may be warranted in certain situations."},{"instruction":"What are the symptoms of Nodular regenerative hyperplasia ?","output":"What are the signs and symptoms of Nodular regenerative hyperplasia? The Human Phenotype Ontology provides the following list of signs and symptoms for Nodular regenerative hyperplasia. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Hepatic failure 90% Hypertension 90% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Intestinal pseudoobstruction ?","output":"Intestinal pseudo-obstruction is a digestive disorder in which the intestinal walls are unable to contract normally (called hypomotility); the condition resembles a true obstruction, but no actual blockage exists. Signs and symptoms may include abdominal pain; vomiting; diarrhea; constipation; malabsorption of nutrients leading to weight loss and/or failure to thrive; and other symptoms. It may be classified as neuropathic (from lack of nerve function) or myopathic (from lack of muscle function), depending on the source of the abnormality. The condition is sometimes inherited (in an X-linked recessive or autosomal dominant manner) and may be caused by mutations in the FLNA gene; it may also be acquired after certain illnesses. The goal of treatment is to provide relief from symptoms and ensure that nutritional support is adequate."},{"instruction":"What is (are) Congenital bilateral absence of the vas deferens ?","output":"Congenital bilateral absence of the vas deferens (CBAVD) occurs in males when the tubes that carry sperm out of the testes (vas deferens) fail to develop properly. Although the testes usually develop and function normally, sperm cannot be transported through the vas deferens to become part of semen. As a result, men with this condition are unable to father children (infertile) unless they use assisted reproductive technologies. This condition has not been reported to affect sex drive or sexual performance. This condition can occur alone or as a sign of cystic fibrosis, an inherited disease of the mucus glands. Many men with CBAVD do not have the other characteristic features of cystic fibrosis; however, some men with this condition may experience mild respiratory or digestive problems."},{"instruction":"What are the symptoms of Congenital bilateral absence of the vas deferens ?","output":"What are the signs and symptoms of Congenital bilateral absence of the vas deferens? The Human Phenotype Ontology provides the following list of signs and symptoms for Congenital bilateral absence of the vas deferens. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal recessive inheritance - Azoospermia - Heterogeneous - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Congenital bilateral absence of the vas deferens ?","output":"What causes congenital bilateral absence of the vas deferens (CBAVD)? More than half of all men with CBAVD have mutations in the CFTR gene. Mutations in this gene also cause cystic fibrosis. When CBAVD occurs with CFTR mutations, it is considered a form of atypical cystic fibrosis. In instances of CBAVD without a mutation in the CFTR gene, the cause of this condition is often unknown. Some cases are associated with other structural problems of the urinary tract."},{"instruction":"Congenital bilateral absence of the vas deferens inherited ?","output":"How is congenital bilateral absence of the vas deferens (CBAVD) inherited? When this condition is caused by mutations in the CFTR gene, it is inherited in an autosomal recessive pattern. This pattern of inheritance means that both copies of the gene in each cell have a mutation. Parents of a person with CBAVD each carry one CFTR mutation, but are usually unaffected (carriers). Men with CBAVD who choose to father children through assisted reproduction have an increased risk of having a child with cystic fibrosis. If congenital absence of the vas deferens is not caused by mutations in CFTR, the risk of having children with cystic fibrosis is not increased. The risk to siblings of a person with CBAVD depends on the affected person's CFTR gene mutation(s) and cannot readily be predicted without this information. Genetic testing is most informative when the CBAVD-causing mutations have been identified in the affected individual. Men with CBAVD sometimes have only one identifiable CFTR mutation, complicating the testing and interpretation of results in their family members. We recommend speaking with a genetics professional about risk to other family members as well as any appropriate genetic testing."},{"instruction":"w to diagnose Congenital bilateral absence of the vas deferens ?","output":"Is genetic testing available for congenital bilateral absence of the vas deferens (CBAVD)? GeneTests lists the names of laboratories that are performing genetic testing for CBAVD. To view the contact information for the clinical laboratories conducting testing, click here. Please note: Most of the laboratories listed through GeneTests do not accept direct contact from patients and their families; therefore, if you are interested in learning more, you will need to work with a health care provider or a genetics professional. Below, we have provided a list of online resources that can assist you in locating a genetics professional near you."},{"instruction":"What are the symptoms of Olivopontocerebellar atrophy deafness ?","output":"What are the signs and symptoms of Olivopontocerebellar atrophy deafness? The Human Phenotype Ontology provides the following list of signs and symptoms for Olivopontocerebellar atrophy deafness. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Cerebral cortical atrophy 90% Hearing impairment 90% Hyperreflexia 90% Incoordination 90% Ventriculomegaly 90% Aplasia/Hypoplasia of the cerebellum 50% Nystagmus 50% Chorioretinal coloboma 7.5% EEG abnormality 7.5% Hypertonia 7.5% Neurological speech impairment 7.5% Optic atrophy 7.5% Seizures 7.5% Strabismus 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Odontomicronychial dysplasia ?","output":"What are the signs and symptoms of Odontomicronychial dysplasia? The Human Phenotype Ontology provides the following list of signs and symptoms for Odontomicronychial dysplasia. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the fingernails 90% Advanced eruption of teeth 90% Premature loss of primary teeth 90% Autosomal recessive inheritance - Premature eruption of permanent teeth - Short nail - Slow-growing nails - Thin nail - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Dwarfism, lowbirthweight type with unresponsiveness to growth hormone ?","output":"What are the signs and symptoms of Dwarfism, low-birth-weight type with unresponsiveness to growth hormone? The Human Phenotype Ontology provides the following list of signs and symptoms for Dwarfism, low-birth-weight type with unresponsiveness to growth hormone. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Hearing impairment - Hypoglycemia - Intellectual disability - Intrauterine growth retardation - Severe short stature - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Autosomal recessive nonsyndromic congenital nuclear cataract ?","output":"What are the signs and symptoms of Autosomal recessive nonsyndromic congenital nuclear cataract? The Human Phenotype Ontology provides the following list of signs and symptoms for Autosomal recessive nonsyndromic congenital nuclear cataract. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal recessive inheritance - Cataract - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Progressive supranuclear palsy atypical ?","output":"What are the signs and symptoms of Progressive supranuclear palsy atypical? The Human Phenotype Ontology provides the following list of signs and symptoms for Progressive supranuclear palsy atypical. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal pyramidal signs - Adult onset - Dementia - Kyphoscoliosis - Morphological abnormality of the pyramidal tract - Ophthalmoparesis - Parkinsonism - Rigidity - Tremor - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Acrofacial dysostosis Catania type ?","output":"What are the signs and symptoms of Acrofacial dysostosis Catania type? The Human Phenotype Ontology provides the following list of signs and symptoms for Acrofacial dysostosis Catania type. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the palate 90% Abnormality of the philtrum 90% Brachydactyly syndrome 90% Cognitive impairment 90% Finger syndactyly 90% High forehead 90% Hypoplasia of the zygomatic bone 90% Microcephaly 90% Short nose 90% Short palm 90% Short stature 90% Abnormality of periauricular region 50% Cryptorchidism 50% Delayed skeletal maturation 50% Intrauterine growth retardation 50% Low-set, posteriorly rotated ears 50% Single transverse palmar crease 50% Clinodactyly of the 5th finger 7.5% Coarse hair 7.5% Displacement of the external urethral meatus 7.5% Facial cleft 7.5% Hernia of the abdominal wall 7.5% Pectus excavatum 7.5% Premature birth 7.5% Reduced number of teeth 7.5% Spina bifida occulta 7.5% Webbed neck 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Poikiloderma with neutropenia ?","output":"What are the signs and symptoms of Poikiloderma with neutropenia? The Human Phenotype Ontology provides the following list of signs and symptoms for Poikiloderma with neutropenia. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Hypertelorism 5% Hypoplasia of midface 5% Malar flattening 5% Autosomal recessive inheritance - Blepharitis - Conjunctivitis - Neutropenia - Poikiloderma - Recurrent otitis media - Recurrent pneumonia - Short stature - Splenomegaly - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Pallister W syndrome ?","output":"What are the signs and symptoms of Pallister W syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Pallister W syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Acne 90% Broad forehead 90% Cognitive impairment 90% Eczema 90% Hypertonia 90% Macrotia 90% Mandibular prognathia 90% Narrow face 90% Short philtrum 90% Short stature 90% Strabismus 90% Wide nasal bridge 90% Camptodactyly of finger 50% Camptodactyly of toe 50% Cleft palate 50% Clinodactyly of the 5th finger 50% Cubitus valgus 50% Elbow dislocation 50% Hearing impairment 50% Hypertelorism 50% Median cleft lip 50% Non-midline cleft lip 50% Pes cavus 50% Seizures 50% Displacement of the external urethral meatus 7.5% Agenesis of central incisor - Agenesis of maxillary central incisor - Alternating esotropia - Broad nasal tip - Broad uvula - Camptodactyly - Clinodactyly - Depressed nasal bridge - Frontal bossing - Frontal upsweep of hair - Hypoplasia of the ulna - Intellectual disability - Joint contracture of the hand - Pes planus - Radial bowing - Radial deviation of finger - Spasticity - Submucous cleft hard palate - Telecanthus - X-linked inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Accessory navicular bone ?","output":"An accessory navicular bone is a small bone located in the middle of the foot. It is near the navicular bone, the bone that goes across the foot near the instep. It is a common trait, estimated to be in approximately 2 to 12% of the general population and up to 14% of children. This bone may develop a bump that can cause irritation, swelling, and pain. Click here to view a diagram of the foot."},{"instruction":"What are the symptoms of Accessory navicular bone ?","output":"What are the signs and symptoms of Accessory navicular bone? Accessory navicular bone may cause no symptoms, but in some cases causes pain, tenderness, or irritation on or around the top of the instep. It may also cause the foot to be abnormally positioned, and may limit the normal motion of the foot. Symptoms may worsen with increased activity or tight shoes. The Human Phenotype Ontology provides the following list of signs and symptoms for Accessory navicular bone. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the skeletal system - Autosomal dominant inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Accessory navicular bone ?","output":"What causes of accessory navicular bone? The cause of accessory navicular bone is unknown. In some cases, the condition may be related to the development of flatfoot also known as pes planus, in other cases it may be related to repeated foot and ankle sprains."},{"instruction":"What are the treatments for Accessory navicular bone ?","output":"How might accessory navicular bone be treated? If the accessory navicular bone is causing symptoms, activities may be restricted and a softer shoe may be recommended until the symptoms go away. If the symptoms persist a specially and carefully made shoe support may be tried. In children the condition usually resolves once the child stops growing. For people with accessory navicular bone who experience severe symptoms surgery may be considered to remove the bony growth. Other treatments may include non-steroidal anti-inflammatories (NSAIDs) such as ibuprofen, placing a doughnut-shaped piece of moleskin around the affected area to relieve pain and tenderness, or immobilizing the area with a cast for six weeks."},{"instruction":"What is (are) HTLV1 associated myelopathy/tropical spastic paraparesis ?","output":"HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic, progressive disease of the nervous system that affects less than 2 percent of people with HTLV-1 infection. Signs and symptoms vary but may include progressive weakness, stiff muscles, muscle spasms, backache, a 'weak' bladder, and constipation. The HTLV-1 virus can be transmitted from mother to child via breastfeeding or childbirth, from person to person through sexual contact and through blood contact, either by transfusion or by reuse of injection equipment. HTLV infection is not passed from person to person by coughing, sneezing, kissing, cuddling or daily social contact. Screening of donated blood for HTLV-1 has been done in the United States since 1988."},{"instruction":"What are the symptoms of HTLV1 associated myelopathy/tropical spastic paraparesis ?","output":"What are the signs and symptoms of HTLV-1 associated myelopathy/tropical spastic paraparesis? Signs and symptoms of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) vary but may include: Progressive weakness Stiff muscles Muscle spasms Backache A 'weak' bladder Constipation Rarely HAM/TSP may cause: Uveitis Arthritis Inflammation of the lung Polymyositis Dry eyes (keratoconjunctivitis sicca) Skin inflammation (infectious dermatitis)"},{"instruction":"What are the treatments for HTLV1 associated myelopathy/tropical spastic paraparesis ?","output":"How might HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) be treated? There is no established treatment program for HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). Corticosteroids may relieve some symptoms, but arent likely to change the course of the disorder. Clinical studies suggest that interferon alpha provides benefits over short periods and some aspects of disease activity may be improved favorably using interferon beta. Stiff and spastic muscles may be treated with lioresal or tizanidine. Urinary dysfunction may be treated with oxybutynin."},{"instruction":"What are the symptoms of Pillay syndrome ?","output":"What are the signs and symptoms of Pillay syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Pillay syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of bone mineral density 90% Abnormality of the humerus 90% Aplasia/Hypoplasia of the radius 90% Camptodactyly of finger 90% Elbow dislocation 90% Limitation of joint mobility 90% Micromelia 90% Opacification of the corneal stroma 90% Radioulnar synostosis 90% Symphalangism affecting the phalanges of the hand 90% Synostosis of carpal bones 90% Visual impairment 90% Glaucoma 7.5% Megalocornea 7.5% Abnormality of the thorax - Autosomal dominant inheritance - Blindness - Coxa valga - Decreased mobility 3rd-5th fingers - Fibular hypoplasia - Lateral humeral condyle aplasia - Mesomelia - Radial bowing - Radioulnar dislocation - Temporomandibular joint ankylosis - Ulnar deviated club hands - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Familial hemiplegic migraine type 3 ?","output":"Familial hemiplegic migraine (FHM) is a form of migraine headache that runs in families. Migraines usually cause intense, throbbing pain in one area of the head, often accompanied by nausea, vomiting, and extreme sensitivity to light and sound. These recurrent headaches typically begin in childhood or adolescence and may last from a few hours to a few days. People with familial hemiplegic migraine experience an aura that comes before the headache. The most common symptoms associated with an aura are temporary visual changes such as blind spots (scotomas), flashing lights, zig-zagging lines, and double vision. In people with familial hemiplegic migraine, auras are also characterized by temporary numbness or weakness, often affecting one side of the body (hemiparesis). An aura typically develops gradually over a few minutes and lasts about an hour. Researchers have identified three forms of familial hemiplegic migraine known as FHM1, FHM2, and FHM3. Each of the three types is caused by mutations in a different gene."},{"instruction":"What are the symptoms of Familial hemiplegic migraine type 3 ?","output":"What are the signs and symptoms of Familial hemiplegic migraine type 3? The Human Phenotype Ontology provides the following list of signs and symptoms for Familial hemiplegic migraine type 3. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of movement 90% Hemiplegia/hemiparesis 90% Incoordination 50% Nystagmus 50% Abnormality of retinal pigmentation 7.5% EEG abnormality 7.5% Neurological speech impairment 7.5% Sensorineural hearing impairment 7.5% Autosomal dominant inheritance - Blindness - Hemiparesis - Hemiplegia - Migraine with aura - Photophobia - Seizures - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Linear scleroderma ?","output":"Linear scleroderma is one sub-type of localized scleroderma, most commonly occurring in childhood. It is characterized by abnormalities of the skin and subcutaneous tissues that often follow a dermatomal distribution and that are found on one side of the body. Besides the lesion in the face or scalp there are also abnormalities of the muscles, fat tissue and skull. When the face is affected, some strips located on the forehead may be hollow and lead to an appearance termed \\"en coup de sabre\\". In most cases, Raynaud's phenomenon is absent. The exact cause is still unknown but may be related to an autoimmune reaction resulting in too much collagen. Management is symptomatic and includes immunosupressant medication. Physical therapy is helpful for the muscle retraction problems."},{"instruction":"What is (are) Osteopathia striata cranial sclerosis ?","output":"Osteopathia striata cranial sclerosis is a type of skeletal dysplasia, which refers to a group of genetic conditions that affect the bones and hinder growth and development. The severity of the condition and the associated symptoms vary significantly from person to person, even within a single family. Features of the condition are generally present at birth and may include skeletal abnormalities (particularly at the ends of long bones), sclerosis (hardening) of the craniofacial bones, macrocephaly (unusually large head size), and characteristic facial features. Some affected people may also have developmental delay, hearing loss, heart defects and/or ophthalmoplegia (paralysis of the muscles surrounding the eyes). Osteopathia striata cranial sclerosis is caused by changes (mutations) in the WTX gene and is inherited in an X-linked dominant manner. Treatment is based on the signs and symptoms present in each person."},{"instruction":"What are the symptoms of Osteopathia striata cranial sclerosis ?","output":"What are the signs and symptoms of Osteopathia striata cranial sclerosis? The Human Phenotype Ontology provides the following list of signs and symptoms for Osteopathia striata cranial sclerosis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of pelvic girdle bone morphology 90% Craniofacial hyperostosis 90% Rough bone trabeculation 90% Cleft palate 50% Conductive hearing impairment 50% Delayed eruption of teeth 50% Frontal bossing 50% Macrocephaly 50% Malar flattening 50% Scoliosis 50% Wide nasal bridge 50% Intellectual disability, mild 33% High palate 15% Abnormality of the aorta 7.5% Asymmetry of the thorax 7.5% Cataract 7.5% Cerebral calcification 7.5% Cognitive impairment 7.5% Delayed speech and language development 7.5% Epicanthus 7.5% Facial palsy 7.5% Headache 7.5% Hyperlordosis 7.5% Low-set, posteriorly rotated ears 7.5% Neurological speech impairment 7.5% Short stature 7.5% Spina bifida occulta 7.5% Anal atresia 5% Anal stenosis 5% Multicystic kidney dysplasia 5% Omphalocele 5% Apnea - Arachnodactyly - Atria septal defect - Bifid uvula - Broad ribs - Camptodactyly - Cleft upper lip - Clinodactyly of the 5th finger - Craniofacial osteosclerosis - Delayed closure of the anterior fontanelle - Dental crowding - Dental malocclusion - Failure to thrive - Fibular aplasia - Fibular hypoplasia - Flexion contracture of toe - Gastroesophageal reflux - Hydrocephalus - Hypertelorism - Intestinal malrotation - Joint contracture of the hand - Large fontanelles - Laryngeal web - Microtia - Muscular hypotonia - Narrow forehead - Nasal speech - Natal tooth - Oligohydramnios - Osteopathia striata - Overfolded helix - Paranasal sinus hypoplasia - Partial agenesis of the corpus callosum - Patent ductus arteriosus - Pectus excavatum - Pierre-Robin sequence - Polyhydramnios - Sclerosis of skull base - Seizures - Straight clavicles - Talipes equinovarus - Thick lower lip vermilion - Thickened calvaria - Thoracolumbar kyphosis - Tracheomalacia - Ventricular septal defect - Webbed neck - Wide intermamillary distance - X-linked dominant inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What are the symptoms of Pelvic dysplasia arthrogryposis of lower limbs ?","output":"What are the signs and symptoms of Pelvic dysplasia arthrogryposis of lower limbs? The Human Phenotype Ontology provides the following list of signs and symptoms for Pelvic dysplasia arthrogryposis of lower limbs. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Depressed nasal bridge 90% Gait disturbance 90% Limitation of joint mobility 90% Skeletal muscle atrophy 90% Slender long bone 90% Abnormality of the hip bone 50% Blue sclerae 50% Sacrococcygeal pilonidal abnormality 50% Spina bifida occulta 50% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What is (are) Glycogen storage disease type 4 ?","output":"Glycogen storage disease type 4 (GSD 4) is part of a group of disorders which lead to abnormal accumulation of glycogen (a storage form of glucose) in various parts of the body. Symptoms of GSD 4 usually begin in infancy and typically include failure to thrive; enlarged liver and spleen (hepatosplenomegaly); and in many cases, progressive liver cirrhosis and liver failure. In rare cases individuals may have a form with non-progressive liver disease, or a severe neuromuscular form. GSD 4 is caused by mutations in the GBE1 gene and is inherited in an autosomal recessive manner. Treatment typically focuses on the specific symptoms that are present in each individual."},{"instruction":"What are the symptoms of Glycogen storage disease type 4 ?","output":"What are the signs and symptoms of Glycogen storage disease type 4? The signs and symptoms of glycogen storage disease type 4 (GSD 4) can vary greatly between affected individuals, and several forms of GSD 4 have been described. Most affected individuals have a \\"classic\\" form characterized by progressive cirrhosis of the liver, eventually leading to liver failure. In these individuals, signs and symptoms typically begin in infancy and include failure to grow and gain weight appropriately (failure to thrive); enlargement of the liver and spleen (hepatosplenomegaly); abnormal fluid build-up in the abdomen (ascites); and enlargement of veins in the wall of the esophagus (esophageal varices) which may rupture and cause coughing up of blood. Progressive liver disease in affected children can lead to the need for a liver transplant or life-threatening complications by approximately 5 years of age. There have been some reports of affected individuals having nonprogressive liver disease; very mildly affected individuals may not show signs and symptoms of the disease. There have also been reports of neuromuscular forms of GSD 4, most of which become apparent in late childhood. These may be characterized by skeletal muscle or heart muscle disease (myopathy or cardiomyopathy) caused by the accumulation of glycogen in the muscle tissue. Signs and symptoms in these cases may include muscle weakness or fatigue, exercise intolerance, and muscle wasting (atrophy). Complications with these forms may include heart failure. A more severe neuromuscular form that is apparent at birth has also been reported; this form may be characterized by generalized edema (swelling cause by fluid); decreased muscle tone (hypotonia); muscle weakness and wasting; joints having fixed positions (contractures); and neurologic involvement, which can cause life-threatening complications early in life. The Human Phenotype Ontology provides the following list of signs and symptoms for Glycogen storage disease type 4. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of metabolism/homeostasis 90% Abnormality of movement 90% Ascites 90% Hepatic failure 90% Muscular hypotonia 90% Hypertrophic cardiomyopathy 7.5% Autosomal recessive inheritance - Cardiomyopathy - Cirrhosis - Decreased fetal movement - Edema - Esophageal varix - Failure to thrive - Hepatosplenomegaly - Hydrops fetalis - Muscle weakness - Polyhydramnios - Portal hypertension - Skeletal muscle atrophy - Tubulointerstitial fibrosis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common."},{"instruction":"What causes Glycogen storage disease type 4 ?","output":"What causes glycogen storage disease type 4? Glycogen storage disease type 4 (GSD 4) is caused by mutations in the GBE1 gene. The GBE1 gene normally provides instructions for making the glycogen branching enzyme. This enzyme is necessary for making glycogen, a major source of stored energy in the body. Glycogen is formed by assembling many molecules of glucose. The glycogen branching enzyme is involved in the formation of \\"branches\\" of glucose chains, which help to make glycogen more compact for storage and allows it to break down more easily when it is needed for energy. The GBE1 gene mutations that cause GSD 4 lead to a decrease in the amount or functionality of the glycogen branching enzyme. Glycogen is then not formed properly, and substances called polyglucosan bodies build up in cells throughout the body, causing the signs and symptoms of the condition."},{"instruction":"Evaluate the infinite sum sum_{n=2}^{infty} log_{2}left(frac{1frac{1}{n}}{1frac{1}{n+1}}right).","output":"1. **Rewrite the Logarithmic Expression:**    We start by using the identity for logarithms:    [    log_2 left( frac{a}{b} right) = log_2 a - log_2 b    ]    Applying this identity to the given sum:    [    log_2 left( frac{1 - frac{1}{n}}{1 - frac{1}{n+1}} right) = log_2left(1 - frac{1}{n}right) - log_2left(1 - frac{1}{n+1}right)    ] 2. **Express the Sum:**    Now, we can rewrite the entire series as follows:    [    sum_{n=2}^{infty} log_2left( frac{1 - frac{1}{n}}{1 - frac{1}{n+1}} right) = sum_{n=2}^{infty} log_2left( 1 - frac{1}{n} right) - sum_{n=2}^{infty} log_2left( 1 - frac{1}{n+1} right)    ] 3. **Rewrite Individual Logarithms:**    For (log_2 left(1 - frac{1}{n}right)):    [    log_2 left(1 - frac{1}{n}right) = log_2 left(frac{n-1}{n}right)    ]    For (log_2 left(1 - frac{1}{n+1}right)):    [    log_2 left(1 - frac{1}{n+1}right) = log_2 left(frac{n}{n+1}right)    ] 4. **Combine the Series:**    Substitute back into the series:    [    sum_{n=2}^{infty} log_2 left(frac{n-1}{n}right) - sum_{n=2}^{infty} log_2 left(frac{n}{n+1}right)    ] 5. **Partial Cancellation of the Series:**    The series is telescoping. Most terms will cancel out, but let's write out the first few terms to see the pattern:    begin{align*}    & left(log_2 frac{1}{2} + log_2 frac{2}{3} + log_2 frac{3}{4} + cdots right) - left( log_2 frac{2}{3} + log_2 frac{3}{4} + log_2 frac{4}{5} + cdots right)     = & , log_2 frac{1}{2} + cancel{log_2 frac{2}{3}} + cancel{log_2 frac{3}{4}} + cdots - left(cancel{log_2 frac{2}{3}} + cancel{log_2 frac{3}{4}} + cdotsright)    end{align*} 6. **Finding the Remaining Term:**    All terms apart from (log_2 frac{1}{2}) cancel out. Hence, the series simplifies to:    [    sum_{n=2}^{infty} log_2left( frac{n-1}{n} right) - sum_{n=2}^{infty} log_2left( frac{n}{n+1} right) = log_2 frac{1}{2}    ] 7. **Calculate the Remaining Term:**    [    log_2 frac{1}{2} = -log_2 2 = -1    ] # Conclusion: The value of the given infinite sum is: [ boxed{-1} ]"},{"instruction":"a competitive examination in state A, 6% candidates got selected from the total appeared candidates. State B had an equal number of candidates appeared and 7% candidates got selected with 80 more candidates got selected than A. What was the number of candidates appeared from each state?","output":"Let's denote the number of candidates appeared from each state as x. From state A, 6% of the candidates got selected. So, the number of candidates selected from state A is 0.06x. From state B, 7% of the candidates got selected. So, the number of candidates selected from state B is 0.07x. According to the problem, state B had 80 more candidates selected than state A. So we can set up the following equation: 0.07x = 0.06x + 80 Now, let's solve for x: 0.07x - 0.06x = 80 0.01x = 80 x = 80 / 0.01 x = 8000 So, the number of candidates appeared from each state is boxed{8000} ."},{"instruction":"A train traveling 48 km/h takes 2 hours longer than the ship traveling at a certain speed to reach a distance of 480 km. What is the speed of the ship?","output":"Let's denote the speed of the ship as ( v ) km/h. The time it takes for the train to cover 480 km at 48 km/h is: [ text{Time}_{text{train}} = frac{text{Distance}}{text{Speed}} = frac{480 text{ km}}{48 text{ km/h}} = 10 text{ hours} ] The time it takes for the ship to cover the same distance at speed ( v ) is: [ text{Time}_{text{ship}} = frac{480 text{ km}}{v text{ km/h}} ] According to the problem, the train takes 2 hours longer than the ship to cover the same distance, so we can write: [ text{Time}_{text{train}} = text{Time}_{text{ship}} + 2 text{ hours} ] Substituting the values we have: [ 10 text{ hours} = frac{480}{v} + 2 ] Now, we solve for ( v ): [ 10 = frac{480}{v} + 2 ] [ 10 - 2 = frac{480}{v} ] [ 8 = frac{480}{v} ] [ v = frac{480}{8} ] [ v = 60 text{ km/h} ] So, the speed of the ship is boxed{60}  km/h."},{"instruction":"A cricketer scored some runs which included 12 boundaries and 2 sixes. He made 56.52% of his total score by running between the wickets. What was his total score?","output":"Let's denote the total score of the cricketer as T. From the information given, we know that the cricketer scored 12 boundaries (4 runs each) and 2 sixes (6 runs each). So the runs from boundaries and sixes are: Runs from boundaries = 12 boundaries * 4 runs/boundary = 48 runs Runs from sixes = 2 sixes * 6 runs/six = 12 runs Total runs from boundaries and sixes = 48 runs + 12 runs = 60 runs We also know that 56.52% of his total score was made by running between the wickets. Therefore, the runs made by running between the wickets are 56.52% of T: Runs by running = 56.52% of T = 0.5652 * T Now, the total score (T) is the sum of the runs from boundaries, sixes, and running between the wickets: T = Runs from boundaries + Runs from sixes + Runs by running T = 60 runs + 0.5652 * T To find T, we need to solve for T in the equation above: T - 0.5652 * T = 60 runs 0.4348 * T = 60 runs Now, divide both sides by 0.4348 to isolate T: T = 60 runs / 0.4348 T  138 runs Therefore, the cricketer's total score was approximately boxed{138}  runs."},{"instruction":"Blake wants to spend his Friday making milkshakes for his family. He knows that he needs a certain amount of milk and 12 ounces of ice cream for each milkshake. He has 72 ounces of milk and 192 ounces of ice cream. When he is done, he has 8 ounces of milk left over. How many ounces of milk does he need for each milkshake?","output":"Let's denote the amount of milk needed for each milkshake as M ounces. Blake starts with 72 ounces of milk and ends up with 8 ounces left after making the milkshakes. This means he used 72 - 8 = 64 ounces of milk in total for the milkshakes. We also know that Blake has 192 ounces of ice cream, and he uses 12 ounces of ice cream for each milkshake. To find out how many milkshakes he can make with the ice cream, we divide the total amount of ice cream by the amount used per milkshake: 192 ounces of ice cream / 12 ounces per milkshake = 16 milkshakes Since Blake can make 16 milkshakes with the ice cream and he used 64 ounces of milk in total, we can find the amount of milk needed for each milkshake by dividing the total amount of milk used by the number of milkshakes: 64 ounces of milk / 16 milkshakes = 4 ounces of milk per milkshake Therefore, Blake needs boxed{4}  ounces of milk for each milkshake."},{"instruction":"triangle ( triangle ABC ), the angle bisector of ( angle A ) intersects the circumcircle of ( triangle ABC ) at point ( D ), and ( I ) is the incenter of ( triangle ABC ). Let ( M ) be the midpoint of side ( BC ), and ( P ) be the reflection of ( I ) with respect to ( M ) (assuming ( P ) is inside the circle). Extending ( DP ) intersects the circumcircle again at point ( N ). Prove that among the three line segments ( AN ), ( BN ), and ( CN ), at least one of them is the sum of the other two.","output":"Let's denote points and relevant distances and angles for clarity. 1. **Denote the given points and line segments:**    - Let triangle ABC.    - Let AD be the angle bisector of angle A intersecting the circumcircle of triangle ABC at point D.    - Let I be the incenter of triangle ABC.    - Let M be the midpoint of side BC.    - Let P be the reflection of I with respect to M such that PI=IM.    - Let DP be extended to intersect the circumcircle again at point N. 2. **Assume point N is on the arc overarc{BC} of the circumcircle:**        We need to prove that BN + CN = AN. 3. **Consider the areas of triangles involving N:**    - Calculate the areas of triangle BND and triangle CND.          Given that D lies on the angle bisector, we have:      [      angle BND = angle CND = theta      ]      The area expressions are:            [      S_{triangle BND} = frac{1}{2} BD cdot BN sin theta       ]            [      S_{triangle CND} = frac{1}{2} CD cdot CN sin theta       ]            Since D is on the angle bisector,      [      BD = CD = ID      ] 4. **Connecting areas with point M:**    Notice that     [    S_{triangle BND} + S_{triangle CND} = 2S_{triangle MND}    ]    This follows from P being on ND and IM = MP implying that the area expression holds true considering reflections over M and symmetry properties. 5. **Utilizing angle and area relationships:**    Since I and D are unique points based on angle bisectors and equality:        [    2S_{triangle MND} = S_{triangle IND}    ]        Here, S_{triangle IND} is the same area as S_{triangle BND} + S_{triangle CND} due to the reflection properties and symmetry around M,        which can be derived from area correspondences:        [    S_{triangle BND} = S_{triangle CND}    ] 6. **Therefore, by summing and symmetry:**    [    S_{triangle BND} + S_{triangle CND} = frac{1}{2} ID cdot AN sin theta    ]    Which translates, by relationship of angles, since:        [    BN sin theta + CN sin theta = AN sin theta    ]    Simplifying this, we clearly derive:        [    BN + CN = AN    ] # Conclusion: Thus, we conclude that among AN, BN, and CN, at least one of the segments must necessarily be the sum of the other two. We explicitly derive that: [ boxed{BN + CN = AN} ]  as per the given configurations and derived properties  the angle bisectors and reflections around M."},{"instruction":"Evaluate the expression sqrt{80}  3sqrt{20} + frac{sqrt{500}}{sqrt{5}} + 2sqrt{45}.","output":"First, let's simplify the terms individually: 1. sqrt{80} = sqrt{2^4 cdot 5} = 4sqrt{5} 2. sqrt{20} = sqrt{2^2 cdot 5} = 2sqrt{5} 3. Simplifying the term frac{sqrt{500}}{sqrt{5}}:    sqrt{500} = sqrt{2^2 cdot 5^3} = 10sqrt{5}    frac{sqrt{500}}{sqrt{5}} = frac{10sqrt{5}}{sqrt{5}} = 10 4. sqrt{45} = sqrt{3^2 cdot 5} = 3sqrt{5} Now, plug these simplifications into our original expression, yielding: sqrt{80} - 3sqrt{20} + frac{sqrt{500}}{sqrt{5}} + 2sqrt{45} = 4sqrt{5} - 3(2sqrt{5}) + 10 + 2(3sqrt{5})  = 4sqrt{5} - 6sqrt{5} + 10 + 6sqrt{5}  = 4sqrt{5} - 6sqrt{5} + 6sqrt{5} + 10  = 4sqrt{5} + 10 To find an expression of type sqrt{N} for 4sqrt{5} + 10, note that such a form as sqrt{a} + sqrt{b} or sqrt{a} + b (where b is a rational number) generally isn't reducible to sqrt{N} unless a and b undergo adjustments which are not feasible here with given terms. Since looking for sqrt{N} for explicit sqrt{a} + b doesn't fit directly into a clean radical form, the expression simplifies only up to the addition of a rational number and a radical: boxed{4sqrt{5} + 10}"},{"instruction":"enry decides one morning to do a workout, and he walks tfrac{2}{3} of the way from his home to his gym. The gym is 3 kilometers away from Henry's home. At that point, he changes his mind and walks tfrac{2}{3} of the way from where he is back toward home. When he reaches that point, he changes his mind again and walks tfrac{2}{3} of the distance from there back toward the gym. If Henry continues this pattern indefinitely, alternating his decisions each time and walking tfrac{2}{3} of the remaining distance to his destination, he will oscillate between two points, C and D. Calculate the absolute difference |CD|. A) 1 km B) 1.5 km C) 2 km D) 2.5 km E) 3 km","output":"1. **Sequence of distances**:    - After the first segment of walking to the gym, Henry covers frac{2}{3} times 3 = 2 km.    - Then, he walks back frac{2}{3} of the remaining 1 km towards home, thus moving frac{2}{3} times 1 = frac{2}{3} km back. So, he is at 2 - frac{2}{3} = frac{4}{3} km from home.    - For the third segment, he walks frac{2}{3} of the remaining distance to the gym, which is now 3 - frac{4}{3} = frac{5}{3} km, covering frac{2}{3} times frac{5}{3} = frac{10}{9} km. Thus, he is frac{4}{3} + frac{10}{9} = frac{22}{9} km from home. 2. **Recursive relationship and limiting position calculations**:    - Define c_n for positions after walking back towards home (even steps) and d_n after walking towards the gym (odd steps). Recursive relation for d_n could be calculated as c_{n-1} + frac{2}{3}(3 - c_{n-1}), and for c_n as d_{n-1} - frac{2}{3}(d_{n-1}).    - Substituting and simplifying these recursively, determine limit values. Lets solve:      - c_infty = 2 - frac{2}{3}c_infty Rightarrow c_infty = 1.5      - d_infty = 1.5 + frac{2}{3}(3 - 1.5) = 1.5 + 1 = 2.5     3. **Compute the distance |C-D|**:    - |C-D| = |1.5 - 2.5| = 1. The final answer is boxed{A) 1 km}"},{"instruction":"Given the function f(x)=cos(2x+frac{}{3}).   (1) Find the center of symmetry of the graph of the function f(x) and the interval where the function is monotonically decreasing.   (2) If beta in (0,pi) and f(frac{beta}{2})=frac{1}{2}, find the value of angle beta.","output":"# Solution:  Part (1): Center of Symmetry and Monotonically Decreasing Interval - **Center of Symmetry**:   Given f(x) = cos(2x + frac{pi}{3}), we set 2x + frac{pi}{3} = kpi + frac{pi}{2} to find the center of symmetry.   Rearranging, we get x = frac{kpi}{2} + frac{pi}{12}.   Thus, the center of symmetry is at left(frac{kpi}{2} + frac{pi}{12}, 0right), where k in mathbb{Z}.   boxed{text{Center of Symmetry: } left(frac{kpi}{2} + frac{pi}{12}, 0right), k in mathbb{Z}} - **Monotonically Decreasing Interval**:   We consider 2kpi leq 2x + frac{pi}{3} leq 2kpi + pi, where k in mathbb{Z}.   Rearranging, we find kpi - frac{pi}{6} leq x leq kpi + frac{pi}{3}.   Therefore, the function is monotonically decreasing in the interval left[kpi - frac{pi}{6}, kpi + frac{pi}{3}right] for any integer k.   boxed{text{Monotonically Decreasing Interval: } left[kpi - frac{pi}{6}, kpi + frac{pi}{3}right], k in mathbb{Z}}  Part (2): Finding the Value of beta Given fleft(frac{beta}{2}right) = cosleft(beta + frac{pi}{3}right) = -frac{1}{2} and beta in (0,pi), we have beta + frac{pi}{3} in left(frac{pi}{3}, frac{4pi}{3}right).   To satisfy the equation, beta + frac{pi}{3} = frac{2pi}{3}.   Solving for beta, we get beta = frac{2pi}{3} - frac{pi}{3} = frac{pi}{3}.   boxed{beta = frac{pi}{3}}"},{"instruction":"2016, the price of a certain small commodity was 15 yuan/piece, and the sales volume was a pieces. The distributor plans to reduce the price of this commodity to between 10 yuan/piece and 14 yuan/piece in 2017. After investigation, the expected price by customers is 7 yuan/piece. According to market research, the increase in sales volume after the price reduction is inversely proportional to the difference between the set price and the customer's expected price, with a proportionality constant k. The cost price of the commodity is 5 yuan/piece.   (1) Write the function relationship between the distributor's annual income y and the set price x after the price reduction;   (2) Let k=3a. When the set price is how much, the distributor's income in 2017 is exactly 1.2 times the income of 2016?","output":"Solution:   (1) Let the price of the commodity after the reduction be x yuan/piece, where 10 leq x leq 14, and the sales volume increases to left(a+ frac{k}{x-7}right) pieces,   The annual income y is left(a+ frac{k}{x-7}right)(x-5) (where 10 leq x leq 14),   (2) When k=3a, according to the problem, we have left(a+ frac{3a}{x-7}right)(x-5) = (15-5)a times 1.2,   Solving this equation, we get x=13 or x=8,   Since 10 leq x leq 14,   Thus, x=13,   Therefore, when the set price is 13 yuan, the distributor's income in 2017 is exactly 1.2 times the income of 2016.   So, the final answers are:   (1) y=left(a+ frac{k}{x-7}right)(x-5)   (2) boxed{x=13}"},{"instruction":"Circle omega has a radius of 6 and is centered at O. Point A lies outside omega such that OA=15. The two tangents to omega passing through A are drawn, and points B and C are chosen on them (one on each tangent), such that line BC is tangent to omega and omega lies outside triangle ABC. Compute AB+AC given that BC=9.","output":"Let T_1, T_2, and T_3 denote the points of tangency of AB, AC, and BC with omega, respectively. 1. **Calculate lengths of tangents from A to omega**:    - By the Pythagorean theorem in triangle OAT_1 (or OAT_2 since AT_1 = AT_2), where OA = 15 and radius OT_1 = 6,    [    AT_1 = AT_2 = sqrt{15^2 - 6^2} = sqrt{225 - 36} = sqrt{189} = 3sqrt{21}.    ] 2. **Relate AB, AC, and BC**:    - Since BC = BT_3 + T_3C = BT_1 + CT_2 = 9, and using the property that AB + AC = AT_1 + AT_2 + BT_1 + CT_2,    [    AB + AC = AT_1 + AT_2 + BC = 2 times 3sqrt{21} + 9.    ] 3. **Calculate total sum**:    [    AB + AC = 6sqrt{21} + 9.    ] Conclusion: Therefore, the sum of AB and AC is boxed{6sqrt{21} + 9}."},{"instruction":"it possible to partition the set of all natural numbers into disjoint finite subsets ( A_{1}, A_{2}, A_{3}, ldots ) such that for any natural number ( k ), the sum of all numbers in the subset ( A_{k} ) equals ( k + 2013 )?","output":":  1. Let us assume the contrary, that it is possible to partition the set of all natural numbers into disjoint finite subsets (A_1, A_2, A_3, ldots) such that the sum of all numbers in (A_k) equals (k+2013) for any natural number (k). 2. Define a set (A_k) as **large** if it contains more than one element. We will show that for any (n), we can find (n) large sets using induction on (n). 3. **Base Case** ((n=1)): Consider the set (A_{k_1}), which contains the number 1; the sum of all numbers in it must be (k_1 + 2013 > 1). Therefore, (A_{k_1}) must contain at least one more number, making it large. 4. **Induction Step**: Assume we have already found (n) large sets (A_{k_1}, A_{k_2}, ldots, A_{k_n}) where (k_1 < k_2 < ldots < k_n). The number (k_n+2013) cannot be in (A_{k_n}) because if it were, the set (A_{k_n}) would not remain large. Hence, (k_n + 2013) belongs to some other set (A_{k_{n+1}}), and the sum of all numbers in (A_{k_{n+1}}) is (k_{n+1} + 2013 > k_n + 2013). Therefore, (A_{k_{n+1}}) is also large and (k_{n+1} > k_n). 5. By induction, for any (n), there exist (n) large sets (A_{k_1}, A_{k_2}, ldots, A_{k_n}). 6. Consider 2014 large sets with indices (k_1 < k_2 < ldots < k_{2014}). Let's examine the sets (A_1, A_2, ldots, A_{k_{2014}}). Their union contains at least (k_{2014} + 2014) distinct numbers. Consequently, there is a number (d geq k_{2014} + 2014) among these numbers. 7. However, this number (d) cannot belong to any of the sets (A_{k_1}, A_{k_2}, ldots, A_{k_{2014}}) because the sum of the elements in each of these sets is less than (d). This leads to a contradiction. 8. Therefore, it is impossible to partition the set of all natural numbers into disjoint finite subsets (A_1, A_2, A_3, ldots) where the sum of all numbers in (A_k) equals (k + 2013) for any natural number (k). 9. Hence, the solution to the problem is concluded with a contradiction proving the assumption is false. [ boxed{text{textbf{Answer:} No, it is not possible.}} ]"},{"instruction":"Evaluate leftlceilsqrt{frac{16}{9}}rightlceil + leftlceilfrac{16}{5}rightrceil + leftlceilleft(frac{16}{5}right)^2rightrceil.","output":"The equation can be rewritten as leftlceilfrac{4}{3}rightrceil + leftlceilfrac{16}{5}rightrceil + leftlceilleft(frac{16}{5}right)^2rightrceil.  - The smallest integer greater than frac{4}{3} is 2. - The smallest integer greater than frac{16}{5} is 4 because frac{16}{5} = 3.2. - Calculating left(frac{16}{5}right)^2 = frac{256}{25} = 10.24, the smallest integer greater than 10.24 is 11. Thus, 2+4+11=boxed{17}."},{"instruction":"Given that  in [frac{}{4}, frac{}{2}] and sin 2 = frac{3sqrt{7}}{8}, find the value of sin .","output":"Since  in [frac{}{4}, frac{}{2}], we have 2 in [frac{}{2}, ]. Using the identity cos^2 2 + sin^2 2 = 1, we find: cos 2 = -sqrt{1 - sin^2 2} = -sqrt{1 - frac{9 cdot 7}{64}} = -frac{1}{8} Now, using the double angle identity cos 2 = 1 - 2sin^2  and the fact that sin  > 0 (since  is in the first quadrant), we get: sin  = sqrt{frac{1 - cos 2}{2}} = sqrt{frac{1 - (-frac{1}{8})}{2}} = frac{3}{4} Therefore, the answer is: boxed{sin  = frac{3}{4}}. This problem tests our understanding of trigonometric identities and double angle formulas. It's important to consider the range of the angle to determine the sign of the trigonometric functions."},{"instruction":"Part of an npointed regular star is depicted. It is a simple closed polygon in which all 2n edges are congruent, angles A_1, A_2, dots, A_n are congruent, and angles B_1, B_2, dots, B_n are congruent. If the acute angle at A_1 is 15^circ less than the acute angle at B_1, then determine the value of n. A) 12   B) 18   C) 24   D) 36   E) 60","output":"1. **Star Polygon Setup**: A regular star polygon with n points has congruent angles A_i and B_i, where A_i is 15^circ less than B_i. 2. **Angle Relationships**: Denote the angle at each B_i as theta, thus each A_i is theta - 15^circ. 3. **Sum of Exterior Angles**: The exterior angles of any polygon sum to 360^circ. For our star polygon, this can be expressed as:    [    n(theta - (theta - 15^circ)) = 360^circ    ]    Simplifying, we get:    [    n cdot 15^circ = 360^circ    ]    [    n = frac{360^circ}{15^circ} = 24    ] 4. **Conclusion**: The number of points n in the star polygon is 24. The final answer is boxed{24} (Choice C)."},{"instruction":"Find all real numbers (x) such that [frac{x^3 + 3x^2  x}{x^2 + 4x + 3} + x = 7.]","output":"First, factorize the denominator: [x^2 + 4x + 3 = (x+1)(x+3).] Check the simplification of the fraction: [frac{x^3 + 3x^2 - x}{x^2 + 4x + 3} = frac{x(x^2 + 3x - 1)}{(x+1)(x+3)}.] Since (x^2 + 3x - 1) does not share common factors with (x^2 + 4x + 3), we simplify: [frac{x^3 + 3x^2 - x}{x^2 + 4x + 3} = frac{x(x^2 + 3x - 1)}{(x+1)(x+3)} = frac{x^2 + 3x - 1}{x+3},] provided (x neq -1) and (x neq -3). Next, substitute and simplify: [frac{x^2 + 3x - 1}{x+3} + x = -7.] Multiply through by (x+3): [x^2 + 3x - 1 + x(x+3) = -7(x+3).] This expands to: [2x^2 + 6x - 1 = -7x - 21.] Combine like terms: [2x^2 + 13x + 20 = 0.] Factor the quadratic: [(2x + 5)(x + 4) = 0.] Thus, solutions are: [x = -tfrac{5}{2} text{ or } x = -4.] However, we must discard (x = -3) as it invalidates the original fraction's denominator. (boxed{x = -tfrac{5}{2} text{ and } x = -4})."},{"instruction":"Given that plane alpha intersects plane beta at line l, and line m is contained in plane alpha with m intersecting l at point P, then () A: There must exist a line within plane beta that is parallel to m, and there exists a line perpendicular to m. B: There must not exist a line within plane beta that is parallel to m, but there must exist a line perpendicular to m. C: There must not exist a line within plane beta that is parallel to m, and there does not exist a line perpendicular to m. D: There must exist a line within plane beta that is parallel to m, and there does not exist a line perpendicular to m.","output":"Since plane alpha intersects plane beta at line l, and line m is contained in plane alpha with m intersecting l at point P,   it is certain that within the plane, there exists a line perpendicular to m, but it is not certain that there exists a line parallel to m.   Therefore, only option B is correct.   Hence, the answer is B.   This problem utilizes the properties of the intersection of planes, combined with the positional relationship of line m for discussion and judgment.   The main focus of this problem is on the judgment of parallelism and perpendicularity between spatial lines, testing the student's spatial imagination ability. Therefore, the correct answer is boxed{text{B}}."},{"instruction":"how many seconds will a train 2500 feet long pass an oak tree, if the speed of the train is 120 mph?","output":"First, we need to convert the speed of the train from miles per hour (mph) to feet per second (fps), because the length of the train is given in feet. 1 mile = 5280 feet 1 hour = 3600 seconds So, to convert 120 mph to fps: 120 miles/hour * (5280 feet/mile) / (3600 seconds/hour) = fps 120 * 5280 / 3600 = fps 633600 / 3600 = fps 176 fps Now that we have the speed of the train in feet per second, we can calculate the time it takes for the train to pass the oak tree. The length of the train is 2500 feet, and the speed of the train is 176 fps. To find the time (t) it takes for the train to pass the oak tree, we use the formula: distance = speed * time 2500 feet = 176 fps * t Now, solve for t: t = 2500 feet / 176 fps t  14.2045 seconds So, it will take approximately boxed{14.2045}  seconds for the train to pass the oak tree."},{"instruction":"Five friends sat in a movie theater in a row containing 5 seats, numbered 1 to 5 from left to right. (The directions left and right are from the point of view of the people as they sit in the seats.) During the movie Ada went to the lobby to get some popcorn. When she returned, she found that Bea had moved two seats to the right, Ceci had moved one seat to the left, and Dee and Edie had switched seats, leaving an end seat for Ada. In which seat had Ada been sitting before she got up? textbf{(A) }1 qquad textbf{(B) } 2 qquad textbf{(C) } 3 qquad textbf{(D) } 4qquad textbf{(E) } 5","output":"To solve this problem, we need to analyze the movements of each friend and determine the original seating arrangement based on the given movements. 1. **Initial Setup**: There are 5 seats, and each friend occupies one seat. Ada leaves, creating one empty seat. 2. **Movements**:    - **Bea** moves two seats to the right.    - **Ceci** moves one seat to the left.    - **Dee** and **Edie** switch seats. 3. **Final Position**: Ada returns to an end seat. 4. **Analyzing Movements**:    - Since Bea moves two seats to the right, she increases the rightward displacement by 2.    - Ceci moves one seat to the left, contributing -1 to the rightward displacement.    - Dee and Edie switching seats does not change the net displacement as they simply exchange positions. 5. **Net Displacement Calculation**:    - The total net displacement for Bea and Ceci is (2 + (-1) = 1).    - Dee and Edie's switch does not affect the net displacement, so it remains 1. 6. **Ada's Movement**:    - The net displacement of all movements except Ada's must be balanced by Ada's movement for the total displacement to be zero (since they end up occupying all original seats).    - Since the net displacement from Bea, Ceci, Dee, and Edie is 1 to the right, Ada must have moved 1 seat to the left to balance this (net displacement of -1). 7. **Determining Ada's Original Seat**:    - Ada returns to an end seat. The end seats are seat 1 and seat 5.    - Since Ada moved 1 seat to the left and ended up in an end seat, she must have originally been in seat 2 (moving from seat 2 to seat 1). Thus, Ada was originally sitting in seat 2 before she got up to get popcorn. boxed{textbf{(B) } 2}"},{"instruction":"wo employees a and b are paid a total of rs . 560 per week by their employer . if a is paid 150 percent of the sum paid to b , how much is b paid per week ?","output":"Let's call the amount paid to employee B \\"x\\". Since employee A is paid 150 percent of the sum paid to B, we can express the amount paid to A as 1.5x. The total amount paid to both employees is Rs. 560, so we can set up the following equation: A + B = Total 1.5x + x = 560 Now we combine like terms: 2.5x = 560 To find the value of x, we divide both sides of the equation by 2.5: x = 560 / 2.5 x = 224 So, employee B is paid Rs. boxed{224}  per week."},{"instruction":"Simplify the expression y = sqrt{x^2  4x + 4} + sqrt{x^2 + 4x + 4}. A) |,x3,| + |,x+3,| B) |,x2,| + |,x+2,| C) |,x1,| + |,x+1,| D) |,x,| + 4","output":"To simplify the expression for y, we follow a similar approach: 1. **Recognize Perfect Squares**:    The terms inside the square roots can be rewritten as squares of binomials:    [ x^2 - 4x + 4 = (x-2)^2 ]    [ x^2 + 4x + 4 = (x+2)^2 ]    This reformulation is based on the binomial square formula: (a pm b)^2 = a^2 pm 2ab + b^2. 2. **Simplify Using Square Roots**:    Substituting the perfect squares back into the expression for y, we get:    [ y = sqrt{(x-2)^2} + sqrt{(x+2)^2} ] 3. **Apply the Property of Square Roots**:    Since the square root of a square is the absolute value of the base:    [ y = |,x-2,| + |,x+2,| ] Conclusion with boxed answer: Thus, the simplified form of ( y ) is: [ |,x-2,| + |,x+2,| ] The final answer is boxed{B}"},{"instruction":"When positive integer k is divided by 5, the remainder is 2. When k is divided by 6, the remainder is 5. If k is less than 39, what is the remainder when k is divided by 7?","output":"Let's solve the problem step by step. 1. When k is divided by 5, the remainder is 2. This means that k can be written as 5n + 2, where n is a non-negative integer. 2. When k is divided by 6, the remainder is 5. This means that k can be written as 6m + 5, where m is a non-negative integer. We need to find a number k that satisfies both conditions and is less than 39. Let's find the common numbers that satisfy both conditions by listing multiples of 5 with a remainder of 2 and multiples of 6 with a remainder of 5 up to 39: Multiples of 5 with remainder 2: 7, 12, 17, 22, 27, 32, 37 Multiples of 6 with remainder 5: 11, 17, 23, 29, 35 The common number from both lists that is less than 39 is 17. Now, we need to find the remainder when k (which is 17) is divided by 7. 17 divided by 7 gives us 2 with a remainder of 3. Therefore, the remainder when k is divided by 7 is boxed{3} ."},{"instruction":"Every year, an amount increases by a varying percentage rate. In the first year, it increases by 12% and in the second year, it increases by 8%. How much will it be after two years if its present value is Rs. 65,000?","output":"To calculate the amount after two years with varying percentage rates of increase, we will apply the percentage increase to the amount for each year consecutively. Let's start with the first year: The initial amount is Rs. 65,000. The increase in the first year is 12%. The increased amount after the first year = Initial amount + (Initial amount * Percentage increase) = Rs. 65,000 + (Rs. 65,000 * 12/100) = Rs. 65,000 + (Rs. 65,000 * 0.12) = Rs. 65,000 + Rs. 7,800 = Rs. 72,800 Now, for the second year: The amount at the beginning of the second year is Rs. 72,800. The increase in the second year is 8%. The increased amount after the second year = Amount at the beginning of the second year + (Amount at the beginning of the second year * Percentage increase) = Rs. 72,800 + (Rs. 72,800 * 8/100) = Rs. 72,800 + (Rs. 72,800 * 0.08) = Rs. 72,800 + Rs. 5,824 = Rs. 78,624 Therefore, after two years, the amount will be Rs. boxed{78,624} ."},{"instruction":"Determine the largest possible threedigit sum for: \`\`\`    YXX  + YX  + ZY   \`\`\` where X, Y, and Z are different digits.  (A) 1156  (B) 1121  (C) 1099  (D) 997","output":"1. **Expand and express in decimal form**:    - YXX = 100Y + 10X + X = 100Y + 11X    - YX = 10Y + X    - ZY = 10Z + Y 2. **Combine for total sum**:    [    (100Y + 11X) + (10Y + X) + (10Z + Y) = 111Y + 12X + 10Z    ] 3. **Objective to maximize sum under constraints**:    - The digits X, Y, and Z must be different and within the range of 0-9. Start by maximizing Y, the most influential in terms of place value. 4. **Determine maximum Y**:    - Set Y = 9. Then we proceed to maximize X and Z, both different from 9 and each other. 5. **Maximize X and set Z**:    - Let X = 8 (maximization under distinct constraint).     - Let Z = 7 (next maximum under distinct constraint). 6. **Calculate the sum**:    [    111 cdot 9 + 12 cdot 8 + 10 cdot 7 = 999 + 96 + 70 = 1165    ]    Since 1165 is a four-digit number and the problem constraints desire a three-digit number, adjustments are needed:    - Set X = 7 and Z = 8:    [    111 cdot 9 + 12 cdot 7 + 10 cdot 8 = 999 + 84 + 80 = 1163    ]    This remains a four-digit number. Readjust to X=6, Z=5, then calculate:    [    111 cdot 9 + 12 cdot 6 + 10 cdot 5 = 999 + 72 + 50 = 1121    ]    We need to further reduce to maintain a three-digit solution.    - Set X = 5 and Z = 4:    [    111 cdot 9 + 12 cdot 5 + 10 cdot 4 = 999 + 60 + 40 = 1099    ]    Finally, we achieve a valid three-digit result. Adjust smaller adjustments might optimize this further within the three-digit limit. 7. **Conclusion with boxed answer**:    [    1099    ] boxed{The final answer is (C) 1099}"},{"instruction":"Given that the terminal side of angle alpha lies on the line y = 3x where x < 0, calculate sinalpha  cosalpha = _____.","output":"In order to determine sinalpha and cosalpha, we need to find a right triangle whose hypotenuse extends from the origin to a point on the line y = -3x where x < 0. Since y = -3x and x < 0, we choose a point on the line with coordinates (-1, 3) due to convenience. This point provides a simple, whole-number ratio for the sides of the triangle. Now, consider the right triangle with vertices at the origin (0,0), the point on the line (-1, 3), and a vertical projection onto the x-axis at (-1, 0). The lengths of the sides adjacent and opposite to alpha in this triangle are as follows: - Length of opposite side (along the y-axis): 3 - Length of adjacent side (along the x-axis): -1 (because x < 0) The hypotenuse of the triangle can be found using the Pythagorean theorem: [ sqrt{(-1)^2 + 3^2} = sqrt{1 + 9} = sqrt{10} ] Therefore, the sine and cosine of angle alpha can be computed using: *  sinalpha = frac{text{opposite}}{text{hypotenuse}} = frac{3}{sqrt{10}} = frac{3sqrt{10}}{10}  *  cosalpha = frac{text{adjacent}}{text{hypotenuse}} = frac{-1}{sqrt{10}} = frac{-sqrt{10}}{10}  Now, calculate sinalpha - cosalpha: [ sinalpha - cosalpha = frac{3sqrt{10}}{10} - frac{-sqrt{10}}{10} = frac{3sqrt{10} + sqrt{10}}{10} = frac{4sqrt{10}}{10} = frac{2sqrt{10}}{5} ] Thus, the final answer is: [ boxed{sinalpha - cosalpha = frac{2sqrt{10}}{5}} ]"},{"instruction":"Let x, y, z be nonnegative real numbers. Define: begin{align*} A &= sqrt{x + 3} + sqrt{y + 4} + sqrt{z + 7},  B &= sqrt{x + 2} + sqrt{y + 2} + sqrt{z + 2}. end{align*} Find the minimum value of A^2  B^2.","output":"First, express A^2 - B^2 as: begin{align*} A^2 - B^2 &= (A + B)(A - B)  &= (sqrt{x + 3} + sqrt{x + 2} + sqrt{y + 4} + sqrt{y + 2} + sqrt{z + 7} + sqrt{z + 2})  &quad times (sqrt{x + 3} - sqrt{x + 2} + sqrt{y + 4} - sqrt{y + 2} + sqrt{z + 7} - sqrt{z + 2}). end{align*} Let begin{align*} a_1 &= sqrt{x + 3} + sqrt{x + 2},  b_1 &= sqrt{y + 4} + sqrt{y + 2},  c_1 &= sqrt{z + 7} + sqrt{z + 2},  a_2 &= sqrt{x + 3} - sqrt{x + 2},  b_2 &= sqrt{y + 4} - sqrt{y + 2},  c_2 &= sqrt{z + 7} - sqrt{z + 2}. end{align*} By Cauchy-Schwarz inequality, begin{align*} A^2 - B^2 &= (a_1 + b_1 + c_1)(a_2 + b_2 + c_2)  &ge (sqrt{a_1 a_2} + sqrt{b_1 b_2} + sqrt{c_1 c_2})^2  &= (1 + 2 + 3)^2  &= 36. end{align*} Equality is achieved when [frac{a_1}{a_2} = frac{b_1}{b_2} = frac{c_1}{c_2},] which implies [frac{x + 3}{x + 2} = frac{y + 4}{y + 2} = frac{z + 7}{z + 2}.] Setting each fraction to 2, we find x = 1, y = 2, and z = 5. Thus, the minimum value is boxed{36}."},{"instruction":"Given the sets A={1,2,4}, B={2,4}, then the union of sets A cup B=    ","output":"**Analysis** This question tests the concept of union and its operation. We can conclude by using the operation of union. **Solution** By the definition of union, we can get A cup B = {1,2,4} Therefore, the answer is boxed{{1,2,4}}."},{"instruction":"Let triangle ABC be a triangle with angles alpha = 59^circ, beta = 60^circ, and gamma = 61^circ. For each positive integer n, define alpha_n = 59^circ + ncdot 0.02^circ, beta_n = beta, and gamma_n = 61^circ  ncdot 0.02^circ. What is the least positive integer n for which triangle ABC with angles alpha_n, beta_n, and gamma_n is obtuse?  **(A)** 1550  **(B)** 1551  **(C)** 1600  **(D)** 1650  **(E)** 1700","output":"1. **Definition of obtuse triangle**: A triangle is obtuse if one of its angles is greater than 90^circ. 2. **Evaluate alpha_n and gamma_n**:     - alpha_n = 59^circ + ncdot 0.02^circ    - gamma_n = 61^circ - ncdot 0.02^circ    We need to find when alpha_n > 90^circ or gamma_n > 90^circ. 3. **Solve for n in alpha_n > 90^circ**:    [    59^circ + ncdot 0.02^circ > 90^circ implies ncdot 0.02^circ > 31^circ implies n > frac{31}{0.02} = 1550    ] 4. **Solve for n in gamma_n > 90^circ**:    Since gamma_n decreases as n increases, gamma_n cannot exceed 90^circ from its initial value of 61^circ. 5. **Conclusion**: The least positive integer n for which triangle ABC is obtuse due to alpha_n is 1551, as it's the smallest integer greater than 1550. The final answer is boxed{textbf{(B) } 1551}"},{"instruction":"w many sets A satisfy A cup {1, 1} = {1, 0, 1}?","output":"**Answer:** According to the problem, we can analyze that the set A must contain the element 0, and it may contain 1 or -1. By listing all possible sets A, we can find the answer. Therefore, the possible sets A are as follows: - {0} - {0, 1} - {0, -1} - {0, 1, -1} Hence, there are boxed{4} sets A that satisfy the given condition."},{"instruction":"a certain school, the ratio of boys to girls is some number to 13. There are 128 more girls than boys, and there are 80 boys. What is the ratio of boys to girls?","output":"Let's denote the number of boys as B and the number of girls as G. We are given that B = 80 and G = B + 128. Since there are 128 more girls than boys, we can write: G = 80 + 128 G = 208 Now we have the number of boys and girls, we can find the ratio of boys to girls. The ratio is B:G, which is 80:208. To simplify the ratio, we can divide both numbers by the greatest common divisor. The greatest common divisor of 80 and 208 is 16. Dividing both numbers by 16, we get: 80  16 = 5 208  16 = 13 Therefore, the simplified ratio of boys to girls is boxed{5:13} ."},{"instruction":"A metallic sheet is of rectangular shape with a certain length and width of 36 m. From each of its corners, a square is cut off so as to make an open box. If the length of the square is 8 m, the volume of the box is 5120 m. What is the length of the metallic sheet?","output":"Let's denote the length of the metallic sheet as L and the width as W. We are given that W = 36 m and the length of the square cut from each corner is 8 m. When the squares are cut from each corner and the sides are folded up to form the open box, the new length and width of the box will be reduced by twice the length of the square cut from each corner (since a square is cut from both sides). Therefore, the new dimensions of the box will be: New length (L') = L - 2 * 8 m New width (W') = W - 2 * 8 m We are also given that the volume of the box is 5120 m. The volume of a box is calculated by multiplying its length, width, and height. Since the height of the box is equal to the length of the square cut from the corners, the height (H) is 8 m. So, the volume (V) of the box can be expressed as: V = L' * W' * H Substituting the values we have: 5120 m = (L - 16 m) * (W - 16 m) * 8 m We know W = 36 m, so: 5120 m = (L - 16 m) * (36 m - 16 m) * 8 m 5120 m = (L - 16 m) * (20 m) * 8 m Now, let's solve for L: 5120 m = (L - 16 m) * 160 m 5120 m / 160 m = L - 16 m 32 m = L - 16 m L = 32 m + 16 m L = 48 m Therefore, the length of the metallic sheet is boxed{48}  meters."},{"instruction":"Random variables ( X_{1} ) and ( X_{2} ) have distribution functions ( F_{1}(x) ) and ( F_{2}(x) ), respectively. Prove that the function [  F(x)=C_{1} F_{1}(x) + C_{2} F_{2}(x)  ] is a distribution function of some random variable ( X ), where ( C_{1} ) and ( C_{2} ) are nonnegative numbers whose sum equals one.","output":"Given: We have two random variables (X_1) and (X_2) with distribution functions (F_1(x)) and (F_2(x)) respectively. We need to prove that the function  [F(x) = C_1 F_1(x) + C_2 F_2(x)] is a distribution function of some random variable (X), where (C_1) and (C_2) are non-negative numbers such that (C_1 + C_2 = 1). Let's proceed with the proof by verifying that (F(x)) satisfies the conditions of distribution functions. 1. **Non-negativity and Monotonicity**:     - Since (F_1(x)) and (F_2(x)) are distribution functions, we have:       [       0 leq F_1(x) leq 1 quad text{and} quad 0 leq F_2(x) leq 1       ]     - Therefore,       [       0 leq C_1 F_1(x) leq C_1 quad text{and} quad 0 leq C_2 F_2(x) leq C_2       ]     - Adding these, since (C_1 + C_2 = 1):       [       0 leq C_1 F_1(x) + C_2 F_2(x) leq C_1 + C_2 = 1       ]     - Hence,       [       0 leq F(x) = C_1 F_1(x) + C_2 F_2(x) leq 1       ] 2. **Right-continuity**:     - Distribution functions are right-continuous by definition. If (F_1(x)) and (F_2(x)) are right-continuous, then a linear combination of these functions is also right-continuous. Therefore, (F(x)) is right-continuous. 3. **Non-decreasing**:     - Distribution functions are non-decreasing. Therefore, for (x_1 leq x_2),       [       F_1(x_1) leq F_1(x_2) quad text{and} quad F_2(x_1) leq F_2(x_2)       ]     - Given that (C_1) and (C_2) are non-negative, we have:       [       C_1 F_1(x_1) + C_2 F_2(x_1) leq C_1 F_1(x_2) + C_2 F_2(x_2)       ]     - Thus,       [       F(x_1) leq F(x_2)       ] 4. **Limit as (x to -infty) and (x to +infty)**:     - For the limit as (x to -infty):       [       lim_{x to -infty} F(x) = lim_{x to -infty} (C_1 F_1(x) + C_2 F_2(x))       ]     - Since (lim_{x to -infty} F_1(x) = 0) and (lim_{x to -infty} F_2(x) = 0),       [       = C_1 cdot 0 + C_2 cdot 0 = 0       ]     - Therefore,       [       lim_{x to -infty} F(x) = 0       ]     - For the limit as (x to +infty):       [       lim_{x to +infty} F(x) = lim_{x to +infty} (C_1 F_1(x) + C_2 F_2(x))       ]     - Since (lim_{x to +infty} F_1(x) = 1) and (lim_{x to +infty} F_2(x) = 1),       [       = C_1 cdot 1 + C_2 cdot 1 = C_1 + C_2 = 1       ]     - Therefore,       [       lim_{x to +infty} F(x) = 1       ] Since (F(x)) satisfies all the conditions (non-negativity, right-continuity, non-decreasing, and correct limits at (-infty) and (+infty)), it is a valid distribution function. # Conclusion: [ boxed{F(x) = C_1 F_1(x) + C_2 F_2(x) ,, text{is a distribution function}} ]"},{"instruction":"Find all functions  f,g : N to N  such that for all  m ,n in  N  the following relation holds:    f(m )  f(n) = (m  n)(g(m) + g(n))   .  Note:  N = {0,1,2,...}","output":"To find all functions ( f, g : mathbb{N} to mathbb{N} ) such that for all ( m, n in mathbb{N} ), the following relation holds: [ f(m) - f(n) = (m - n)(g(m) + g(n)), ] we will proceed step-by-step. 1. **Substitute ( n = 0 ) into the given equation:**    [ f(m) - f(0) = m(g(m) + g(0)). ]    This can be rewritten as:    [ f(m) = f(0) + m(g(m) + g(0)). ] 2. **Substitute ( n = 1 ) into the given equation:**    [ f(m) - f(1) = (m - 1)(g(m) + g(1)). ]    Using the expression for ( f(m) ) from step 1, we get:    [ f(0) + m(g(m) + g(0)) - f(1) = (m - 1)(g(m) + g(1)). ] 3. **Simplify the equation from step 2:**    [ f(0) + m(g(m) + g(0)) - f(1) = mg(m) + mg(1) - g(m) - g(1). ]    Rearrange terms to isolate ( g(m) ):    [ f(0) - f(1) + mg(0) + mg(1) - g(1) = mg(m) - g(m). ]    [ f(0) - f(1) + mg(0) + mg(1) - g(1) = (m - 1)g(m). ] 4. **Assume ( g(m) ) is a linear function:**    Let ( g(m) = am + b ), where ( a ) and ( b ) are constants. Substitute this into the equation:    [ f(0) - f(1) + m(g(0) + g(1)) - g(1) = (m - 1)(am + b). ]    Simplify:    [ f(0) - f(1) + m(g(0) + g(1)) - g(1) = am^2 + bm - am - b. ] 5. **Determine the form of ( f(m) ):**    From step 1, we have:    [ f(m) = f(0) + m(g(m) + g(0)). ]    Substitute ( g(m) = am + b ):    [ f(m) = f(0) + m(am + b + g(0)). ]    [ f(m) = f(0) + am^2 + m(b + g(0)). ]    Let ( c = f(0) ) and ( d = b + g(0) ):    [ f(m) = am^2 + dm + c. ] 6. **Verify the solution:**    Substitute ( f(m) = am^2 + dm + c ) and ( g(m) = am + b ) back into the original equation:    [ f(m) - f(n) = (am^2 + dm + c) - (an^2 + dn + c) = a(m^2 - n^2) + d(m - n). ]    [ (m - n)(g(m) + g(n)) = (m - n)(am + b + an + b) = (m - n)(a(m + n) + 2b). ]    Both sides are equal, confirming the solution. The final answer is ( boxed{ (f(n), g(n)) = (an^2 + 2bn + c, an + b) } )."},{"instruction":"The coefficient of x^5 in the expansion of (x+1)^8 is.","output":"The general term of the binomial expansion is T_{r+1} = C_8^r x^{8-r}.   To find the term containing x^5, let 8-r=5, then r=3.   Therefore, T_4 = C_8^3 x^5 = 56x^5.   Hence, the answer is boxed{56}."},{"instruction":"Given acute angles (alpha) and (beta) satisfying (sin alpha =dfrac{sqrt{5}}{5}) and (cos beta =dfrac{3sqrt{10}}{10}), then (alpha +beta) equals () A: (dfrac{3pi}{4}) B: (dfrac{pi}{4}) or (dfrac{3pi}{4}) C: (dfrac{pi}{4}) D: (2kpi+ dfrac{3pi}{4} (kinmathbb{Z}))","output":"**Analysis** This question tests the problem-solving skills related to trigonometric functions, focusing on calculation abilities, and is considered a basic question. First, we calculate (cos alpha) and (sin beta), then we find the value of (cos (alpha+beta)). Based on the fact that (alpha) and (beta) are acute angles, we determine the value of (alpha+beta). **Solution** Given that (alpha) and (beta) are acute angles and satisfy (sin alpha= dfrac{ sqrt{5}}{5} ) and (cos beta= dfrac{3 sqrt{10}}{10} ), we have (cos alpha= dfrac{2 sqrt{5}}{5} ) and (sin beta= dfrac{ sqrt{10}}{10} ), (cos (alpha+beta)=cos alphacos beta-sin alphasin beta= dfrac{ sqrt{2}}{2} )   The value of (alpha+beta) equals ( dfrac{pi}{4} )   Therefore, the correct choice is boxed{text{C}}."},{"instruction":"Let the set M={x|2^{x}1 > 3}, and P={x|log_{2}x < 2}. Then, x belongs to M or x belongs to P is a(n) __________ for x belongs to M cap P. A: Sufficient but not necessary condition B: Necessary but not sufficient condition C: Necessary and sufficient condition D: Neither sufficient nor necessary conditio","output":"Solve 2^{x}-1 > 3, which gives 2^{x} > 4=2^{2}, and we get x > 2.   Therefore, the set M={x|2^{x}-1 > 3}=(2,+infty),   Similarly, we can get P={x|log_{2}x < 2}=(0,4),   Mcup P=(0,+infty), Mcap P=(2,4),   Thus, \\"x belongs to M or x belongs to P\\" is a necessary but not sufficient condition for \\"x belongs to M cap P\\".   Hence, the answer is: boxed{B}.   By utilizing the monotonicity of functions to simplify the sets M, P, and using the relationship between Mcup P and Mcap P, we can derive the conclusion.   This question examines the monotonicity of functions, the operational properties of sets and their relationships, simple logic determination methods, and tests reasoning and computational abilities, making it a basic question."},{"instruction":"The common ratio of an arithmetic sequence {a_{n}} is frac{1}{2}, and the sum of the first n terms is S_{n}. Calculate the value of frac{S_{4}}{a_{4}}=(    ). A: 31 B: 15 C: 7 D: 1","output":"Let a_{1} be the first term of the arithmetic sequence {a_{n}}. Given the common ratio is q = frac{1}{2}, We can express the sum of the first four terms, S_4, and the fourth term, a_4, using the first term a_1: S_4 = a_1 cdot frac{1 - (frac{1}{2})^4}{1 - frac{1}{2}} = a_1 cdot frac{1 - frac{1}{16}}{frac{1}{2}} a_4 = a_1 cdot (frac{1}{2})^3 = a_1 cdot frac{1}{8} Now, let's find the value of frac{S_{4}}{a_{4}}: frac{S_{4}}{a_{4}} = frac{a_1 cdot frac{1 - frac{1}{16}}{frac{1}{2}}}{a_1 cdot frac{1}{8}} = frac{15}{1} = 15 Thus, the correct answer is boxed{B}. The problem requires the understanding of an arithmetic sequence with a given common ratio, focusing on the sum of terms and the expression of a specific term in the sequence. Utilizing the formulas accurately is crucial to solving the problem."},{"instruction":"ABC, the sides opposite to angles A, B, C are a, b, c respectively. Given that B=45, C=60, c=1, find the value of b. A: frac{sqrt{6}}{3} B: frac{sqrt{6}}{2} C: frac{1}{2} D: frac{sqrt{3}}{2}","output":"Given: B=45, C=60, c=1, According to the law of sines, frac{b}{sin B} = frac{c}{sin C}, we can derive: b = frac{c cdot sin B}{sin C} = frac{1 times frac{sqrt{2}}{2}}{frac{sqrt{3}}{2}} = frac{sqrt{6}}{3}. Hence, the answer is: boxed{text{A}}. By using the law of sines and the values of trigonometric functions for special angles, we can calculate the solution. This question primarily tests the application of the law of sines and the values of trigonometric functions for special angles in solving triangles, requiring the ability to transform thinking, and is a basic question."},{"instruction":"Find the mass of the body Omega with density mu=z, bounded by the surfaces  x^{2} + y^{2} = 4, quad z=0, quad z=frac{x^{2} + y^{2}}{2}","output":"1. We need to find the mass of the body Omega with density mu = z bounded by the surfaces:    [    x^2 + y^2 = 4, quad z = 0, quad z = frac{x^2 + y^2}{2}    ]    The mass m is determined by the formula:    [    m = iiint_{Omega} z , dx , dy , dz    ] 2. Since Omega is a body of revolution around the OZ axis, it's convenient to switch to cylindrical coordinates:    [    left{    begin{array}{l}    x = varrho cos varphi     y = varrho sin varphi     z = z    end{array}    right.    ]    In cylindrical coordinates, the volume element dV becomes varrho , dvarrho , dvarphi , dz. Thus, the mass integral becomes:    [    V = iiint_{Omega'} z varrho , dvarrho , dvarphi , dz    ] 3. Substitute x and y with varrho cos varphi and varrho sin varphi in the equations of the bounding surfaces:    [    varrho = 2, quad z = 0, quad z = frac{varrho^2}{2}    ]    The region Omega' can therefore be defined by:    [    Omega' = left{    begin{array}{ll}    0 leq varrho leq 2     0 leq z leq frac{varrho^2}{2}     0 leq varphi leq 2pi    end{array}    right.    ] 4. Now we compute the mass m by evaluating the triple integral, breaking it into iterated integrals:    [    m = int_{0}^{2pi} , dvarphi int_{0}^{2} varrho , dvarrho int_{0}^{varrho^2 / 2} z , dz    ]    Let's solve the integral step-by-step:    - Evaluate the innermost integral with respect to z:      [      int_{0}^{varrho^2 / 2} z , dz = left[ frac{z^2}{2} right]_{0}^{varrho^2/2} = frac{(varrho^2 / 2)^2}{2} = frac{varrho^4}{8}      ]    - Substitute this result into the next integral with respect to varrho:      [      int_{0}^{2} varrho cdot frac{varrho^4}{8} , dvarrho = frac{1}{8} int_{0}^{2} varrho^5 , dvarrho = frac{1}{8} left[ frac{varrho^6}{6} right]_{0}^{2} = frac{1}{8} cdot frac{64}{6} = frac{8}{3}      ]    - Finally, integrate with respect to varphi:      [      int_{0}^{2pi} , dvarphi cdot frac{8}{3} = frac{8}{3} cdot 2pi = frac{16pi}{3}      ] 5. Conclusion:    [    boxed{frac{16pi}{3}}    ]"},{"instruction":"akshi can do a piece of work in 10 days . tanya is 25 % more efficient than sakshi . the number of days taken by tanya to do the same piece of work","output":"If Sakshi can do a piece of work in 10 days, then her work rate is 1/10 of the work per day. Tanya is 25% more efficient than Sakshi. This means Tanya's work rate is 1.25 times Sakshi's work rate. So, Tanya's work rate is 1.25 * (1/10) = 1/8 of the work per day. Therefore, Tanya can complete the same piece of work in boxed{8}  days."},{"instruction":"Under the guidance of the national big data strategy, China has made significant achievements in the field of artificial intelligence. The independently developed artificial intelligence Jueyi has won the championship in the world's most cuttingedge artificial intelligence competition. This success is attributed to the scale and data storage capacity of the established big data centers, which determine the quality and speed of artificial intelligence deep learning. One of the big data centers can store 58000000000 books. Expressing 58000000000 in scientific notation should be ( ). A: 5.8times 10^{10} B: 5.8times 10^{11} C: 58times 10^{9} D: 0.58times 10^{11}","output":"To express 58000000000 in scientific notation, we follow the standard procedure of converting a large number into a form where it is represented as a number between 1 and 10 multiplied by a power of 10.  Starting with 58000000000, we notice that the decimal point needs to be moved 10 places to the left to place it right after the first non-zero digit, which is 5. This movement of the decimal point is equivalent to dividing the number by 10^{10}. Therefore, we can rewrite 58000000000 as 5.8 times 10^{10}. To verify this, we can break it down as follows: - 58 becomes 5.8 when we want to express it in a form that is between 1 and 10. - Since we moved the decimal point 10 places to the left, we multiply 5.8 by 10^{10} to maintain the value of the original number. Thus, the scientific notation for 58000000000 is 5.8 times 10^{10}. Comparing this with the given options, we find that it matches option A: 5.8times 10^{10}. Therefore, the correct answer is boxed{A}."},{"instruction":"Consider a triangle with vertices ((3, 4)), ((5, 2)), and ((7, 2)). This triangle is reflected about the line (x = 5) to create a second triangle. Determine the area of the union of these two triangles. (textbf{(A)} 18 qquadtextbf{(B)} 20 qquadtextbf{(C)} 22 qquadtextbf{(D)} 24 qquadtextbf{(E)} 26)","output":"1. **Identify vertices and their reflections**:    (triangle ABC) with vertices (A = (3, 4)), (B = (5, -2)), and (C = (7, 2)).    - Reflecting (A) over (x=5): It moves 2 units left to (x=5), and thus 2 units right to (x=5) gives (A' = (7, 4)).    - (B' = B = (5, -2)) since (B) is on the line of reflection.    - Reflecting (C) over (x=5): It moves 2 units right to (x=5), and thus 2 units left to (x=5) gives (C' = (3, 2)). 2. **Calculate the area of original and reflected triangles**:    Area of (triangle ABC) using formula (text{Area} = frac{1}{2} |x_1(y_2-y_3) + x_2(y_3-y_1) + x_3(y_1-y_2)|):    [    text{Area}_{ABC} = frac{1}{2} |3(-2-2) + 5(2-4) + 7(4+2)| = frac{1}{2} |3(-4) + 5(-2) + 7(6)| = frac{1}{2} |-12 - 10 + 42| = frac{1}{2} |20| = 10    ]    Similarly, (triangle A'B'C'= triangle CBA) (mirror image), so:    [    text{Area}_{A'B'C'} = 10    ] 3. **Area of the union of two triangles**:    Since (triangle A'B'C') is a reflection and does not overlap with (triangle ABC), the union area is simply the sum of the areas of the two individual triangles:    [    text{Union Area} = 10 + 10 = 20    ] Conclusion: The area of the union of the two triangles is (20). boxed{The final answer is (boxed{textbf{(B)} 20})}"},{"instruction":"Tommy's mother lets him ride his bike some blocks north of his block, 3 blocks east, 2 blocks west, and 2 blocks south. His friend's father lets his friend ride his bike 80 square blocks. The area his friend can ride in is 4 times greater than Tommy's. How many blocks north can Tommy ride his bike?","output":"First, let's calculate the area that Tommy is allowed to ride his bike. Since Tommy can ride some blocks north (let's call this number \\"n\\"), 3 blocks east, 2 blocks west, and 2 blocks south, we can calculate the total distance he can ride east-west and north-south. For east-west, Tommy can ride 3 blocks east and 2 blocks west, which is a total of 3 + 2 = 5 blocks. For north-south, Tommy can ride \\"n\\" blocks north and 2 blocks south, which is a total of n + 2 blocks. The area Tommy can ride is the product of these two distances: Area = 5 * (n + 2). Now, Tommy's friend can ride in an area of 80 square blocks, which is 4 times greater than the area Tommy can ride. So, we can set up the equation: 4 * Area(Tommy) = Area(Friend) 4 * (5 * (n + 2)) = 80 Now, let's solve for \\"n\\": 20 * (n + 2) = 80 n + 2 = 80 / 20 n + 2 = 4 n = 4 - 2 n = 2 Tommy can ride his bike boxed{2}  blocks north."},{"instruction":"Real numbers (x) and (y) satisfy the equation (x^2 + y^2 = 8x  4y  20). What is (x+y)?","output":"Start by rewriting the given equation: [ x^2 - 8x + y^2 + 4y = -20. ] Now, complete the square for both (x) and (y). For (x), we add and subtract ((frac{8}{2})^2 = 16), and for (y), we add and subtract ((frac{4}{2})^2 = 4): [ x^2 - 8x + 16 + y^2 + 4y + 4 = -20 + 16 + 4. ] [ (x-4)^2 + (y+2)^2 = 0. ] Since the sum of squares equals zero, both squares must be zero: [ (x-4)^2 = 0 quad text{and} quad (y+2)^2 = 0. ] Thus, we find (x = 4) and (y = -2). Therefore, (x + y = 4 - 2 = boxed{2})."},{"instruction":"Let ( M ) be any point inside ( triangle ABC ). The lines ( AM, BM, CM ) intersect ( BC, CA, AB ) at ( D, E, F ) respectively. Prove that (frac{MD}{AD} + frac{ME}{BE} + frac{MF}{CF} = 1).","output":"Given: Let M be any point inside triangle ABC. AM, BM, CM intersect BC, CA, AB at D, E, F respectively. We need to prove: [ frac{MD}{AD} + frac{ME}{BE} + frac{MF}{CF} = 1 ] 1. Let us denote the ratios of segments as follows:    [    frac{BD}{DC} = m, quad frac{CE}{EA} = n, quad frac{AF}{FB} = l    ] 2. Apply the **Ceva's Theorem** in triangle ABC with concurrent lines AM, BM, CM:    [    frac{BD}{DC} cdot frac{CE}{EA} cdot frac{AF}{FB} = m cdot n cdot l = 1    ] 3. Consider triangle triangle ADC and the transversal line EMB. Using the **Menelaus' Theorem**:    [    frac{AM}{MD} cdot frac{DB}{BC} cdot frac{CE}{EA} = frac{AM}{MD} cdot frac{m}{1+m} cdot n = 1    ]    Solving for frac{AM}{MD}:    [    frac{AM}{MD} = frac{(1+m)n}{m} = (1+m)l quad text{(from mnl = 1 Rightarrow nl = frac{1}{m})}    ] 4. Using the ratio frac{AM}{MD}, we apply the **sum of ratios theory**:    [    frac{AD}{MD} = 1 + (1+m)l quad Rightarrow quad frac{MD}{AD} = frac{1}{1 + (1+m)l}    ] 5. Similarly for the other segments using the frac{MD}{AD} formula structure considering individual segment relationships:    - For ME and frac{ME}{BE}:      [      frac{ME}{BE} = frac{1}{1+n+l} = frac{l}{1+l+m}      ]    - For MF and frac{MF}{CF}:      [      frac{MF}{CF} = frac{1}{1+m+n} = frac{ml}{ml+1+l}      ] 6. Sum up the results derived:    [    frac{MD}{AD} + frac{ME}{BE} + frac{MF}{CF} = frac{1}{1+(1+m)l} + frac{l}{1+l+m} + frac{ml}{ml+1+l} = 1    ] Conclusion: [ boxed{1} ]"},{"instruction":"The numbers in the sequence 105, 112, 121, 132, ldots are of the form a_n=100+2n^2, where n=1,2,3,ldots For each n, let d_n be the greatest common divisor of a_n and a_{n+1}. Find the maximum value of d_n as n ranges through the positive integers.","output":"Let a_n = 100 + 2n^2. This gives a_{n+1} = 100 + 2(n+1)^2 = 100 + 2(n^2 + 2n + 1) = 100 + 2n^2 + 4n + 2.  To find d_n, we evaluate (a_n, a_{n+1}), which is (100 + 2n^2, 100 + 2n^2 + 4n + 2). We observe that if d_n divides 100 + 2n^2, it must also divide the difference a_{n+1} - a_n = 4n + 2: [ d_n = (100 + 2n^2, 4n + 2). ] Since 4n + 2 = 2(2n + 1), which is always even, we can remove a factor of 2 from both sides: [ d_n = (50 + n^2, 2n + 1). ] Now, the greatest common divisor (50 + n^2, 2n + 1) can be simplified further using the Euclidean algorithm: [ (50 + n^2, 2n + 1) = (50 + n^2 - (2n+1)lfloorfrac{n^2}{2n+1}rfloor, 2n + 1). ] Approximating lfloorfrac{n^2}{2n+1}rfloor approx n/2, we get: [ (50 + n^2 - n(n+1), 2n + 1) = (50 - n, 2n + 1). ] Since 50 - n and 2n + 1 are generally odd, we explore for specific n values and find that it is possible for d_n to be 1 in general as n varies. The values depend on the specific integers, with no maximum value greater than potentially small numbers consistently given the terms' nature.  Thus, d_n = boxed{1} since no larger consistent divisor is possible for arbitrary n."},{"instruction":"A man buys three items: a cycle for Rs. 2300, a scooter for Rs. 12,000, and a motorbike for Rs. 25,000. He sells the cycle at a loss of 30%, the scooter at a profit of 25%, and the motorbike at a profit of 15%. After calculating the individual selling prices of the items, he offers an additional 10% discount on the total combined selling price and also has to pay a 5% tax on the final amount. What is the final selling price, including the discount and tax, for all these three items?","output":"First, let's calculate the individual selling prices of the items: 1. Cycle: Bought for Rs. 2300, sold at a loss of 30%. Loss amount = 30% of 2300 = 0.30 * 2300 = Rs. 690 Selling price of cycle = Cost price - Loss amount = 2300 - 690 = Rs. 1610 2. Scooter: Bought for Rs. 12,000, sold at a profit of 25%. Profit amount = 25% of 12,000 = 0.25 * 12,000 = Rs. 3000 Selling price of scooter = Cost price + Profit amount = 12,000 + 3000 = Rs. 15,000 3. Motorbike: Bought for Rs. 25,000, sold at a profit of 15%. Profit amount = 15% of 25,000 = 0.15 * 25,000 = Rs. 3750 Selling price of motorbike = Cost price + Profit amount = 25,000 + 3750 = Rs. 28,750 Now, let's calculate the total combined selling price before any additional discount or tax: Total combined selling price = Selling price of cycle + Selling price of scooter + Selling price of motorbike Total combined selling price = 1610 + 15,000 + 28,750 = Rs. 45,360 Next, we apply the additional 10% discount on the total combined selling price: Discount amount = 10% of 45,360 = 0.10 * 45,360 = Rs. 4536 Discounted selling price = Total combined selling price - Discount amount = 45,360 - 4536 = Rs. 39,824 Finally, we calculate the 5% tax on the discounted selling price: Tax amount = 5% of 39,824 = 0.05 * 39,824 = Rs. 1991.2 The final selling price, including the discount and tax, is: Final selling price = Discounted selling price + Tax amount = 39,824 + 1991.2 = Rs. 41,815.20 Therefore, the final selling price for all three items, including the discount and tax, is Rs. boxed{41,815.20} ."},{"instruction":"f a, b in mathbb{R}, and frac{a}{1i} + frac{b}{12i} = frac{1+3i}{4}, then a+b= ______.","output":"Given a, b in mathbb{R}, and frac{a}{1-i} + frac{b}{1-2i} = frac{1+3i}{4}, therefore frac{a(1+i)}{(1-i)(1+i)} + frac{b(1+2i)}{(1-2i)(1+2i)} = frac{a(1+i)}{2} + frac{b(1+2i)}{5} = frac{1+3i}{4}, This simplifies to: 10a+10ai+4b+8bi=5+15i, therefore 10a+4b=5, 10a+8b=15, Solving these equations, we get a= -frac{1}{2}, b= frac{5}{2}. Therefore, a+b=2. Hence, the answer is: boxed{2}. This problem involves the use of complex number operations and the principle that two complex numbers are equal. It tests reasoning and computational skills and is considered a basic question."},{"instruction":"Given the hyperbola C: frac{x^{2}}{a^{2}}  frac{y^{2}}{b^{2}} = 1 (b > a > 0), the symmetric point of the left focus of the hyperbola C about one of its asymptotes lies on the other asymptote. Determine the eccentricity of hyperbola C.","output":"By the symmetry of the hyperbola, the slope of the asymptotes is frac{pi}{3}, therefore frac{b}{a} = sqrt{3}, therefore e = frac{c}{a} = sqrt{1+3} = 2, Hence, the eccentricity is boxed{2}. By the symmetry of the hyperbola, the slope of the asymptotes is frac{pi}{3}, which implies that frac{b}{a} = sqrt{3}. Substituting this value into the formula for the eccentricity, we obtain e = frac{c}{a} = sqrt{1+(sqrt{3})^2} = 2. Therefore, the eccentricity of the given hyperbola is boxed{2}."},{"instruction":"As shown in the figure, there are 21 points. Every three adjacent points can form an equilateral triangle with an area of 1. What is the area of triangle ABC?","output":":  1. Given that there are 21 points and every set of three adjacent points form an equilateral triangle of area 1. 2. We note that the equilateral triangles can be grouped into a larger triangular arrangement such that all smaller triangles contribute to a bigger triangle. 3. Visualize or draw the larger triangle formed by these equilateral triangles. If we label this larger triangle as triangle ABC, we want to find the total area of this larger triangle. 4. Breakdown:    - The triangle has 21 equilateral triangles each with an area of 1. But the way the problem states \\"3+3+3+4\\":        - The precise steps highly suggest we adopt this sum with a logical grouping:            - Three three's contribute 3+3+3 = 9.            - Adding the remaining 4 completes the total number of these chilling equilateral triangles forming the area = 9 + 4 = 13. 5. Thus, using intuition and visualization, combined with the area considerations provided by group adjustments, the final area deduction: [ text{Area of } triangle ABC = 3 + 3 + 3 + 4 = 13 text{ (area units)} ] # Conclusion The area of triangle ABC is therefore: [ boxed{13} ]"},{"instruction":"Six bottles of 2 liters of water cost 12. What is the price of 1 liter of water?","output":"To find the price of 1 liter of water, we first determine the cost of each 2-liter bottle, and then divide that cost by 2 to find the cost per liter. 1. Calculate the cost of each 2-liter bottle: [ frac{12}{6 text{ bottles}} = 2 text{ per 2-liter bottle} ] 2. Determine the cost of 1 liter of water: [ frac{2}{2 text{ liters}} = 1 text{ per liter} ] Therefore, the price of 1 liter of water is boxed{1}."},{"instruction":"Find the equation of the tangent line to the curve y=4x+x^{2} at the point (1,3). A: y=7x+4 B: y=7x+2 C: y=x4 D: y=2x1","output":"First, find the derivative of the given curve, y=4x+x^{2}. The derivative is y'=4+2x. Next, find the slope of the tangent line at the point (-1,-3). Substitute x=-1 into the derivative equation: y'=4+2(-1)=4-2=2. Now that we have the slope of the tangent line, we can use the point-slope form of the linear equation to find the equation of the tangent line: y - y_1 = m(x - x_1), where m is the slope and (x_1, y_1) is the point through which the line passes. Substitute the slope m=2 and the point (-1,-3) into the equation: y - (-3) = 2(x - (-1)) Simplify the equation to get y = 2x - 1. Therefore, the equation of the tangent line to the curve y=4x+x^{2} at the point (-1,-3) is boxed{y = 2x - 1}. The answer is (D)."},{"instruction":"a triangle, two sides are 3cm and 7cm respectively, then the possible length of the third side is: A: 3cm B: 7cm C: 10cm D: 12cm","output":"To solve this problem, we start by letting the length of the third side of the triangle be x cm. According to the triangle inequality theorem, the sum of the lengths of any two sides of a triangle must be greater than the length of the third side. This gives us two inequalities based on the given side lengths of 3 cm and 7 cm: 1. 3 + 7 > x 2. x + 3 > 7 3. x + 7 > 3 From the first inequality, we simplify to get: - 10 > x From the second inequality, rearranging terms gives: - x > 7 - 3 - x > 4 Combining these inequalities, we have: - 4 < x < 10 This means the length of the third side must be greater than 4 cm but less than 10 cm. Looking at the options provided: A: 3 cm (This is less than 4 cm, so it cannot be the length of the third side.) B: 7 cm (This is within the range 4 < x < 10, so it could be the length of the third side.) C: 10 cm (This is equal to the upper limit, so it cannot be the length of the third side because the inequality is strict.) D: 12 cm (This is greater than 10 cm, so it cannot be the length of the third side.) Therefore, the only option that satisfies the condition 4 < x < 10 is option B: 7 cm. So, the possible length of the third side is boxed{B}."},{"instruction":"The maximum distance from a point on the circle x^{2}+y^{2}2x2y+1=0 to the line xy=2 is boxed{text{answer}}. A: 2+ sqrt {2} B: 1+ sqrt {2} C: sqrt {2}1 D: 1+2 sqrt {2}","output":"First, we convert the equation of the circle into the standard form: (x-1)^{2}+(y-1)^{2}=1. Thus, the coordinates of the circle's center are (1,1), and its radius r=1. Next, we calculate the distance d from the circle's center to the line x-y=2 using the formula for the distance between a point and a line: d= frac {|1-1-2|}{ sqrt {2}}= sqrt {2}. The maximum distance from a point on the circle to the line is the sum of the radius and the distance from the center to the line: d+r= sqrt {2}+1. Therefore, the answer is boxed{B}. After converting the equation of the circle into the standard form, we find the coordinates of the center and the radius r. Then, we use the formula for the distance between a point and a line to find the distance d from the center to the given line. The sum of d and r gives us the required maximum distance. This problem primarily tests the understanding of the relationship between a line and a circle. When dealing with problems about the distance from a point on a circle to a line, the basic approach is: first, find the distance from the circle's center to the line; when seeking the maximum value, add the radius; when seeking the minimum value, subtract the radius."},{"instruction":"**H**orizontal parallel segments  AB=10  and  CD=15  are the bases of trapezoid  ABCD . Circle  gamma  of radius  6  has center within the trapezoid and is tangent to sides  AB ,  BC , and  DA . If side  CD  cuts out an arc of  gamma  measuring  120^{circ} , find the area of  ABCD .","output":"1. **Identify the center and radius of the circle:**    Let ( O ) be the center of the circle ( gamma ) with radius ( 6 ). The circle is tangent to sides ( AB ), ( BC ), and ( DA ). 2. **Determine the geometry of the circle and the trapezoid:**    Since the circle is tangent to ( AB ), the distance from ( O ) to ( AB ) is ( 6 ). Similarly, since the circle is tangent to ( BC ) and ( DA ), the distance from ( O ) to these sides is also ( 6 ). 3. **Analyze the arc cut by ( CD ):**    The problem states that side ( CD ) cuts out an arc of ( gamma ) measuring ( 120^circ ). Let ( E ) and ( F ) be the points where ( CD ) intersects the circle ( gamma ). The central angle ( angle EOF ) corresponding to this arc is ( 120^circ ). 4. **Determine the triangle formed by the center and the arc endpoints:**    The triangle ( OEF ) is an isosceles triangle with ( angle EOF = 120^circ ) and ( OE = OF = 6 ). This makes ( triangle OEF ) a ( 30^circ-120^circ-30^circ ) triangle. 5. **Calculate the height from ( O ) to ( EF ):**    The height from ( O ) to ( EF ) can be found using the sine function:    [    text{Height} = 6 cdot sin(30^circ) = 6 cdot frac{1}{2} = 3    ] 6. **Determine the total height of the trapezoid:**    The total height of the trapezoid ( ABCD ) is the sum of the distance from ( O ) to ( AB ) and the height from ( O ) to ( EF ):    [    text{Total height} = 6 + 3 = 9    ] 7. **Calculate the area of the trapezoid:**    The area ( A ) of trapezoid ( ABCD ) is given by the formula for the area of a trapezoid:    [    A = frac{1}{2} times (text{Base}_1 + text{Base}_2) times text{Height}    ]    Here, ( text{Base}_1 = AB = 10 ), ( text{Base}_2 = CD = 15 ), and the height is ( 9 ):    [    A = frac{1}{2} times (10 + 15) times 9 = frac{1}{2} times 25 times 9 = frac{225}{2}    ] The final answer is (boxed{frac{225}{2}})"},{"instruction":"A shopkeeper has three items in his store: Item A, Item B, and Item C. He marks Item A's price 20% above the cost price and offers a 15% discount on it. For Item B, he marks up the price by 30% and offers a 10% discount. Lastly, for Item C, the shopkeeper marks up the price by 40% and offers a 25% discount. Calculate the combined net profit for all three items, given the cost prices of Item A as 80, Item B as 120, and Item C as 200.","output":"To calculate the combined net profit for all three items, we need to find the selling price for each item after the discount and then subtract the cost price from the selling price to find the profit for each item. Finally, we will add up the profits from all three items to get the combined net profit. Let's start with Item A: - Cost price of Item A = 80 - Marked price after 20% markup = 80 + (20/100 * 80) = 80 + 16 = 96 - Selling price after 15% discount = 96 - (15/100 * 96) = 96 - 14.40 = 81.60 - Profit for Item A = Selling price - Cost price = 81.60 - 80 = 1.60 Now, let's calculate for Item B: - Cost price of Item B = 120 - Marked price after 30% markup = 120 + (30/100 * 120) = 120 + 36 = 156 - Selling price after 10% discount = 156 - (10/100 * 156) = 156 - 15.60 = 140.40 - Profit for Item B = Selling price - Cost price = 140.40 - 120 = 20.40 Finally, let's calculate for Item C: - Cost price of Item C = 200 - Marked price after 40% markup = 200 + (40/100 * 200) = 200 + 80 = 280 - Selling price after 25% discount = 280 - (25/100 * 280) = 280 - 70 = 210 - Profit for Item C = Selling price - Cost price = 210 - 200 = 10 Now, let's add up the profits from all three items to get the combined net profit: Combined net profit = Profit for Item A + Profit for Item B + Profit for Item C Combined net profit = 1.60 + 20.40 + 10 = 32 The combined net profit for all three items is boxed{32} ."},{"instruction":"a geometric arrangement, one large regular hexagon with a side length of 2 is surrounded by six smaller regular hexagons each with a side length of 1. Three of these smaller hexagons are selected such that they are adjacent to each other and each shares a side with the large hexagon. If a triangle is formed by connecting the centers of these three smaller hexagons, what is the area of this triangle? textbf{(A)}  frac{sqrt{3}}{2} qquad textbf{(B)}  2sqrt{3} qquad textbf{(C)}  sqrt{3} qquad textbf{(D)}  3sqrt{3} qquad textbf{(E)}  4sqrt{3}","output":"1. **Properties of Hexagons**:     - Large hexagon side length = 2, area formula: (text{Area} = frac{3sqrt{3}}{2} s^2 = 6sqrt{3}).    - Small hexagon side length = 1, area formula: (text{Area} = frac{3sqrt{3}}{2} times 1^2 = frac{3sqrt{3}}{2}). 2. **Circumradius Calculation**:    - Circumradius of small hexagon = 1.    - Distance between the center of the large hexagon and any small hexagon center = large hexagon side length + small hexagon circumradius = 2 + 1 = 3. 3. **Triangle Formation and Side Length**:    - Centers of the adjacent small hexagons form an equilateral triangle, each side being twice the circumradius of a small hexagon = 2.     4. **Area of Triangle**:    - Area of an equilateral triangle is given by (text{Area} = frac{sqrt{3}}{4} s^2).    - Substituting (s = 2): (text{Area} = frac{sqrt{3}}{4} times 2^2 = sqrt{3}). Thus, the area of triangle formed by connecting the centers of the three adjacent smaller hexagons is sqrt{3}. The final answer is boxed{textbf{(C)}  sqrt{3}}"},{"instruction":"the polar coordinate system, the equation of circle C is given by =2sqrt{2}sin(+frac{}{4}). Establish a Cartesian coordinate system with the pole as the origin and the positive half of the xaxis as the polar axis. The parametric equations of line l are given by begin{cases} x=t  y=1+2t end{cases} (where t is the parameter). Determine the relationship between line l and circle C.","output":"Eliminate the parameter t to obtain the Cartesian equation of line l, which is y=2x+1. The equation of circle C is =2sqrt{2}sin(+frac{}{4}), which can be rewritten as =2(sin +cos ). Multiply both sides by  to get ^2=2(sin +cos ). Thus, the Cartesian equation of circle C is (x-1)^2+(y-1)^2=2. The distance d between the center of circle C and line l is given by d=frac{|2-1+1|}{sqrt{2^2+1^2}}=frac{2sqrt{5}}{5}<sqrt{2}. Therefore, since the distance between the center of the circle and the line is less than the radius of the circle, boxed{text{line } l text{ intersects circle } C}."},{"instruction":"Jo adds up all the positive integers from 1 to 100. Kate does a similar thing with the first 100 positive integers; however, she first rounds every integer to its nearest multiple of 10 (rounding 5s up) and then adds the 100 values. What is the positive difference between Jo's sum and Kate's sum?","output":"To solve this problem, let's break down the process step by step, closely following the logic provided in the standard solution. 1. **Understanding Jo's Sum**: Jo adds up all the positive integers from 1 to 100 directly. This is a straightforward sum of an arithmetic series. 2. **Understanding Kate's Sum**: Kate rounds each number to its nearest multiple of 10 before adding. This means:    - Numbers 1 to 4 are rounded down to 0.    - Number 5 to 10 are rounded up to 10.    - This pattern repeats for each set of ten numbers up to 100. 3. **Calculating the Difference for the First Ten Numbers**:    - **Decrease in Sum**: The sum decreases by 1+2+3+4=10 due to rounding down.    - **Increase in Sum**: The sum increases by 5+4+3+2+1+0=15 due to rounding up.    - **Net Change**: The net change for the first ten numbers is -10 + 15 = 5. 4. **Applying the Logic to All Sets of Ten Numbers**:    - There are 10 sets of ten numbers from 1 to 100.    - Since each set contributes a net change of 5 to Kate's sum compared to Jo's, the total difference is 10 times 5. 5. **Conclusion**:    - The positive difference between Jo's sum and Kate's sum is 10 times 5 = boxed{50}."},{"instruction":"Given the true statement: If a quadrilateral is a rhombus, then it is a parallelogram. Determine the truth of the converse and the inverse of this statement. textbf{(A)} text{only the converse is true} qquad textbf{(B)} text{only the inverse is true} qquad textbf{(C)} text{both are true} qquad textbf{(D)} text{neither is true} qquad textbf{(E)} text{the inverse is true, but the converse is sometimes true}","output":"1. **Identify the original statement and its components:**    - Original statement: \\"If a quadrilateral is a rhombus, then it is a parallelogram.\\"    - Let p: \\"a quadrilateral is a rhombus\\"    - Let q: \\"it is a parallelogram\\" 2. **Formulate the converse and the inverse:**    - **Converse:** \\"If q, then p\\"      - Restated: \\"If a quadrilateral is a parallelogram, then it is a rhombus.\\"    - **Inverse:** \\"If not p, then not q\\"      - Restated: \\"If a quadrilateral is not a rhombus, then it is not a parallelogram.\\" 3. **Evaluate the truth of the converse:**    - The converse states that if a quadrilateral is a parallelogram, then it must be a rhombus. This is false because a parallelogram only requires that opposite sides be parallel, but does not require all sides to be of equal length as a rhombus does. 4. **Evaluate the truth of the inverse:**    - The inverse states that if a quadrilateral is not a rhombus, then it is not a parallelogram. This is false because there are many parallelograms that are not rhombuses (e.g., rectangles). 5. **Conclusion:**    - Both the converse and the inverse of the original statement are false. The correct solution is therefore text{neither is true}. The final answer is boxed{textbf{D}}"},{"instruction":"Let ABCD and BCFG be two faces of a cube with AB=10. A beam of light emanates from vertex A and reflects off face BCFG at point P, which is 6 units from overline{BG} and 3 units from overline{BC}. The beam continues to be reflected off the faces of the cube. The length of the light path from the time it leaves point A until it next reaches a vertex of the cube is given by msqrt{n}, where m and n are integers and n is not divisible by the square of any prime. Find m+n.","output":"1. Set up the cube with vertices having coordinates involving 0 and 10. 2. Since the light changes by 3 in the Y direction and 6 in the X direction (and 10 in the Z direction), and considering 3 and 6 are factors of 10, the light must make 10 reflections onto the XY plane or the face parallel to the XY plane. 3. Calculate the distance for one reflection using sqrt{(10^2) + (3^2) + (6^2)} = sqrt{145}. The total path length after 10 reflections is 10sqrt{145}. Thus, m=10 and n=145, giving m+n=boxed{155}."},{"instruction":"Find all functions ( f:(0,+infty) rightarrow mathbf{R} ) such that for all ( x, y > 0 ), left(x+frac{1}{x}right) f(y)=f(x y)+fleft(frac{y}{x}right).","output":"Let us consider the given functional equation: [ left(x+frac{1}{x}right) f(y) = f(xy) + fleft(frac{y}{x}right) ] We need to find all functions ( f : (0, infty) to mathbb{R} ) that satisfy this equation. We'll begin by introducing new variables and substituting them appropriately. 1. First, fix some ( a > 1 ) and a new variable ( t ). 2. Substitute ( x = y = t ):    [    left(t + frac{1}{t}right) f(t) = f(t^2) + f(1) quad text{(Equation (1))}    ] 3. Substitute ( x = frac{t}{a} ) and ( y = at ):    [    left(frac{t}{a} + frac{a}{t}right) f(at) = f(t^2) + f(a^2) quad text{(Equation (2))}    ] 4. Substitute ( x = a^2t ) and ( y = t ):    [    left(a^2 t + frac{1}{a^2 t}right) f(t) = f(a^2 t^2) + fleft(frac{1}{a^2}right) quad text{(Equation (3))}    ] 5. Substitute ( x = y = at ):    [    left(at + frac{1}{at}right) f(at) = f(a^2 t^2) + f(1) quad text{(Equation (4))}    ] Next, let's eliminate ( f(t^2) ) from equations (1) and (2). Subtract Equation (2) from Equation (1): [ left(t + frac{1}{t}right) f(t) - left(frac{t}{a} + frac{a}{t}right) f(at) = f(1) - f(a^2) quad text{(Equation (5))} ] Now, let's eliminate ( f(a^2 t^2) ) from equations (3) and (4). Subtract Equation (4) from Equation (3): [ left(a^2 t + frac{1}{a^2 t}right) f(t) - left(at + frac{1}{at}right) f(at) = fleft(frac{1}{a^2}right) - f(1) quad text{(Equation (6))} ] Next, we'll eliminate ( f(at) ) by combining equations (5) and (6). Multiply Equation (5) by (left(a t + frac{1}{a t}right)): [ left(a t + frac{1}{a t}right)left(t + frac{1}{t}right) f(t) - left(a t + frac{1}{a t}right)left(frac{t}{a} + frac{a}{t}right) f(at) = left(a t + frac{1}{a t}right)left(f(1) - f(a^2)right) ] Substitute the left-hand sides from above equations into this expression: [ left(a t + frac{1}{a t}right)left(t + frac{1}{t}right) f(t) - left(frac{t}{a} + frac{a}{t}right)left(a^2 t + frac{1}{a^2 t}right) f(t) = left(a t + frac{1}{a t}right)left(f(1) - f(a^2)right) - left(frac{t}{a} + frac{a}{t}right)left(fleft(frac{1}{a^2}right) - f(1)right) ] Since the equation  [ left(a t + frac{1}{a t}right)left(t + frac{1}{t}right) - left(frac{t}{a} + frac{a}{t}right)left(a^2 t + frac{1}{a^2 t}right) = a + frac{1}{a} - left(a^3 + frac{1}{a^3}right) < 0 ] for all ( a neq 1 ), then ( f(t) ) is of the form: [ f(t) = c_1 t + frac{c_2}{t} ] where ( c_1, c_2 ) are constants which depend on values such as ( a, f(1), f(a^2), fleft(frac{1}{a^2}right) ), and not the variable ( t ). Finally, substituting ( f(x) = c_1 x + frac{c_2}{x} ) into the original functional equation: [ left(x + frac{1}{x}right) f(y) = left(x + frac{1}{x}right)left(c_1 y + frac{c_2}{y}right) = c_1 x y + frac{c_2}{x y} + c_1 frac{y}{x} + c_2 frac{x}{y} = f(x y) + fleft(frac{y}{x}right) ] Thus, the proposed form satisfies the given functional equation. Therefore, the solution is: [ boxed{f(x) = c_1 x + frac{c_2}{x}} ]"},{"instruction":"Jairus read 20 pages of the newspaper. Arniel read 2 more than twice the number of pages Jairus read. Carlos read the product of the number of pages Jairus and Arniel read, minus 17. Daniella read half the sum of the number of pages Carlos and Jairus read. How many pages have they read altogether?","output":"Let's calculate the number of pages each person read step by step: 1. Jairus read 20 pages. 2. Arniel read 2 more than twice the number of pages Jairus read. So, Arniel read:    2 * 20 (Jairus' pages) + 2 = 40 + 2 = 42 pages. 3. Carlos read the product of the number of pages Jairus and Arniel read, minus 17. So, Carlos read:    (20 * 42) - 17 = 840 - 17 = 823 pages. 4. Daniella read half the sum of the number of pages Carlos and Jairus read. So, Daniella read:    (823 (Carlos' pages) + 20 (Jairus' pages)) / 2 = (843) / 2 = 421.5 pages. Now, let's add up the total number of pages they all read: Jairus: 20 pages Arniel: 42 pages Carlos: 823 pages Daniella: 421.5 pages Total = 20 + 42 + 823 + 421.5 = 1306.5 pages So, they have read boxed{1306.5}  pages altogether."},{"instruction":"Given an arithmetic sequence {a_n} satisfying a_2=4 and a_6+a_8=28, the sum of the first n terms of the sequence left{frac{1}{a_n^21}right} equals ______.","output":"Let's consider an arithmetic sequence {a_n} with the common difference d and the first term a_1, satisfying a_2=4 and a_6+a_8=28, Then, we have the system of equations:  begin{cases} a_1 + d = 4  2a_1 + 12 = 18 end{cases}  Solving this system, we get a_1=d=2. Therefore, a_n=2+2(n-1)=2n. Thus, frac{1}{a_n^2-1} = frac{1}{4n^2-1} = frac{1}{2}left(frac{1}{2n-1} - frac{1}{2n+1}right), Then, T_n = frac{1}{2}left(1 - frac{1}{3} + frac{1}{3} - frac{1}{5} + ldots + frac{1}{2n-1} - frac{1}{2n+1}right), = frac{1}{2}left(1 - frac{1}{2n+1}right), = frac{n}{2n+1}. Therefore, the answer is: boxed{frac{n}{2n+1}}. This solution involves finding the general formula of the sequence and further applying the method of splitting terms for summation. The problem tests the knowledge point of finding and applying the general formula of a sequence. The application of the method of splitting terms in sequence summation mainly examines the students' computational ability and transformation ability, belonging to the basic question type."},{"instruction":"Given that F is the focus of the parabola C: x^{2}=4y, O is the origin, and point M lies on the parabola C with |MF|=5, then the perimeter of triangle OMF is ( ) A: 6+4sqrt{2} B: 7+4sqrt{2} C: 10 D: 11","output":"Given that F is the focus of the parabola C: x^{2}=4y, and O is the origin, with point M lying on the parabola C such that |MF|=5, we aim to find the perimeter of triangle OMF. 1. **Determine the coordinates of M**: Let the coordinates of point M be (x_{0}, y_{0}). Since M lies on the parabola, it satisfies the equation x^{2}=4y.  2. **Use the distance MF**: Given |MF|=5, and knowing that the focus of the parabola x^{2}=4y is at (0,1), we can express the distance MF in terms of y_{0} as |MF|=y_{0}+1=5. Solving this gives us y_{0}=4. 3. **Substitute y_{0} into the parabola's equation**: With y_{0}=4, we substitute into the parabola's equation to find x_{0}:     [x_{0}^{2}=4y_{0}=16]    Thus, x_{0}=pm4. However, the exact value of x_{0} (positive or negative) does not affect the distance calculations in this context. 4. **Calculate |OM|**: The distance from O to M can be found using the Pythagorean theorem:    [|OM|=sqrt{x_{0}^{2}+y_{0}^{2}}=sqrt{16+16}=sqrt{32}=4sqrt{2}] 5. **Calculate the perimeter of triangle OMF**: The perimeter is the sum of the lengths of its sides, which are |OM|, |MF|, and |OF| (the distance from O to F, which is the focus at (0,1), hence |OF|=1):    [|OM|+|MF|+|OF|=4sqrt{2}+5+1=4sqrt{2}+6] Therefore, the perimeter of triangle OMF is boxed{6+4sqrt{2}}, which corresponds to choice boxed{text{A}}."},{"instruction":"Compute dbinom{8}{4}.","output":"The solution starts by applying the definition of a binomial coefficient: [ dbinom{8}{4} = frac{8!}{4!(8-4)!} = frac{8!}{4!4!} ] Breaking down the factorials: [ 8! = 8 times 7 times 6 times 5 times 4 times 3 times 2 times 1 ] and since 4! = 4 times 3 times 2 times 1, the equation simplifies to: [ dbinom{8}{4} = frac{8 times 7 times 6 times 5}{4 times 3 times 2 times 1} ] Calculate the fraction step-by-step: [ = frac{8}{4} times frac{7}{1} times frac{6}{3} times frac{5}{2} = 2 times 7 times 2 times 2.5 = 28 times 5 = boxed{70} ]"},{"instruction":"Given a function f(x) = 2^{|xm|}  1 (where m is a real number) defined on mathbb{R} is an even function. Let a = f(log_{0.5}3), b = f(log_{2}5), and c = f(2m). Then, the relationship among a, b, and c is (   ) A: a < b < c B: a < c < b C: c < a < b D: c < b < a","output":"Since f(x) is an even function; Then f(-x) = f(x); Thus, 2^{|-x-m|} - 1 = 2^{|x-m|} - 1; Therefore, |-x-m| = |x-m|; (-x-m)^2 = (x-m)^2; Hence, mx = 0; Therefore, m = 0; Thus, f(x) = 2^{|x|} - 1; Therefore, f(x) is monotonically increasing on [0, +infty), and a = f(|log_{0.5}3|) = f(log_{2}3), b = f(log_{2}5), c = f(0); Since 0 < log_{2}3 < log_{2}5; Therefore, c < a < b. Hence, the correct answer is boxed{C}. **Analysis:** By knowing that f(x) is an even function, we can deduce that m = 0, thus f(x) = 2^{|x|} - 1. Knowing that f(x) is monotonically increasing on [0, +infty), and by the property of the even function, we can convert the variable to the interval [0, +infty): a = f(|log_{0.5}3|), b = f(log_{2}5), c = f(0). Then, by comparing the values of the variables and the monotonicity of f(x) on [0, +infty), we can determine the relationship among a, b, and c."},{"instruction":"Given sets A = {x mid x geq 0} and B = {x mid x < 1}, then A cup B = ______.","output":"As we have A = {x mid x geq 0} and B = {x mid x < 1}, to find the union of the two sets, we need to consider all elements that are in at least one of the sets. The set A contains all non-negative numbers including 0 and all positive numbers. On the other hand, the set B contains all numbers less than 1, which includes all negative numbers as well as non-negative numbers that are less than 1. Combining both sets in the union A cup B, we have: - All non-negative numbers from set A. - All negative numbers from set B, since they are not included in set A. - Numbers between 0 and 1 are in both A and B. Hence, A cup B contains all real numbers since there are no numbers left out between the two sets. Therefore, we have A cup B = mathbb{R}. To conclude,  A cup B = boxed{mathbb{R}}"},{"instruction":"the given diagram, semicircles are constructed on diameters overline{AB}, overline{AC}, and overline{CB} where point C is no longer halfway between A and B. Instead, let overline{AC} = 2x and overline{CB} = 6x such that overline{AB} = 8x. All semicircles are mutually tangent, and overline{CD} perp overline{AB}. The radius of the first semicircle (overline{AB}) is therefore 4x, for overline{AC} it is x, and for overline{CB}, it is 3x. Calculate the ratio of the shaded area to the area of a circle with overline{CD} as radius.","output":"First, compute the total shaded area: - Area of the largest semicircle (on overline{AB}): frac{1}{2} pi (4x)^2 = 8pi x^2. - Area of the semicircle on overline{AC}: frac{1}{2} pi x^2 = frac{1}{2} pi x^2. - Area of the semicircle on overline{CB}: frac{1}{2} pi (3x)^2 = frac{9}{2} pi x^2. - Total shaded area in semicircles = 8pi x^2 - frac{1}{2} pi x^2 - frac{9}{2} pi x^2 = 7pi x^2. The radius overline{CD} equals 3x since overline{CB} = 6x and it is the diameter of the respective semicircle. The area of the circle with radius overline{CD}: - pi (3x)^2 = 9pi x^2. The ratio of the shaded area to the area of the circle given overline{CD} as radius is: [ frac{7pi x^2}{9pi x^2} = frac{7}{9} ] Thus, the answer is boxed{frac{7}{9}}."},{"instruction":"From the first 539 positive integers, we select some such that their sum is at least onethird of the sum of the original numbers. What is the minimum number of integers we need to select for this condition to be satisfied?","output":"1. **Calculate the sum of the first 539 positive integers:**    The sum ( S_{539} ) of the first 539 positive integers can be found using the formula for the sum of an arithmetic series:    [    S_{539} = frac{n(n+1)}{2}    ]    Here ( n = 539 ), so:    [    S_{539} = frac{539 cdot 540}{2} = 145530    ] 2. **Determine one-third of this sum:**    To find one-third of ( S_{539} ):    [    frac{S_{539}}{3} = frac{145530}{3} = 48510    ] 3. **Set up the selection of large numbers:**    We aim to select the smallest number ( x ) and subsequent numbers ( x+1, x+2, ldots, 539 ) such that their sum ( S' ) is at least 48510. 4. **Sum of the selected numbers:**    The sum ( S' ) of these ( n ) numbers (from ( x ) to 539) can be given by the sum formula of an arithmetic series:    [    S' = frac{n}{2}(2x + (n-1))    ]    Where, the smallest number is ( x ) and the largest number is 539, so:    [    539 = x + (n-1) Rightarrow n = 540 - x    ]    Substituting ( n ) into the sum formula:    [    S' = frac{(540 - x)}{2}(x + 539)    ]    We want ( S' geq 48510 ):    [    frac{(540 - x)}{2}(x + 539) geq 48510    ] 5. **Formulate and solve the inequality:**    Simplifying the inequality:    [    (540 - x)(x + 539) geq 97020    ]    [    540x + 539 cdot 540 - x^2 - 539x geq 97020    ]    [    x^2 - x - 194040 leq 0    ] 6. **Finding the roots of the quadratic equation:**    To solve ( x^2 - x - 194040 = 0 ), use the quadratic formula ( x = frac{-b pm sqrt{b^2 - 4ac}}{2a} ), where ( a = 1 ), ( b = -1 ), and ( c = -194040 ):    [    x = frac{1 pm sqrt{1 + 4 cdot 194040}}{2} = frac{1 pm sqrt{776161}}{2}    ]    Calculate the square root:    [    x = frac{1 pm 881}{2}    ]    This gives two solutions:    [    x = frac{1 + 881}{2} = 441 quad text{and} quad x = frac{1 - 881}{2} approx -440 quad (text{Not valid})    ] 7. **Determine the number of selections:**    Since ( x = 441 ), the number of selected integers is:    [    n = 540 - x = 540 - 441 = 99    ] # Conclusion: To ensure the sum of the selected numbers is at least one-third of the sum of the first 539 positive integers, we need to select at least ( boxed{99} ) numbers."},{"instruction":"quadrilateral ABCD, angle B is a right angle, diagonal overline{BD} is perpendicular to overline{CD}, AB=15, BC=20, and CD=9. Find the perimeter of ABCD.","output":"Given the properties: 1. Right angle at B implies triangle ABC is a right triangle. 2. Since overline{BD} is perpendicular to overline{CD}, triangle BCD is a right triangle. Using the Pythagorean Theorem for triangle ABC: [ (AC)^2 = (AB)^2 + (BC)^2 ] Plugging in the values: [ (AC)^2 = 15^2 + 20^2 = 225 + 400 = 625 ] Thus, AC = 25. For triangle BCD: [ (BD)^2 = (BC)^2 + (CD)^2 ] [ (BD)^2 = 20^2 + 9^2 = 400 + 81 = 481 ] Thus, BD = sqrt{481}. The perimeter of quadrilateral ABCD is: [ AB + BC + CD + BD = 15 + 20 + 9 + sqrt{481} ] Therefore, the perimeter is boxed{44 + sqrt{481}}."},{"instruction":"There are five different dinosaur dolls. Find the number of possible ways to give one each to two friends.","output":"To find the number of possible ways to give one dinosaur doll each to two friends, we can use the concept of permutations since the order in which we give the dolls matters (giving friend A the first doll and friend B the second doll is different from giving friend B the first doll and friend A the second doll). There are 5 choices for the first friend and, once that doll is given, there are 4 remaining choices for the second friend. So the number of possible ways to give one each to two friends is: 5 (choices for the first friend) * 4 (choices for the second friend) = boxed{20}  possible ways."},{"instruction":"Of the diplomats attending a summit conference, 17 speak French, some do not speak Russian, and 20% of the diplomats speak neither French nor Russian. If 10% of the diplomats speak both languages, and there are 150 diplomats in total, how many diplomats do not speak Russian?","output":"Let's denote the total number of diplomats as D. According to the problem, D = 150. Let's denote the number of diplomats who speak French as F, the number of diplomats who speak Russian as R, and the number of diplomats who speak both French and Russian as B. According to the problem, F = 17 and B = 10% of D. B = 0.10 * D B = 0.10 * 150 B = 15 The problem also states that 20% of the diplomats speak neither French nor Russian. Let's denote this number as N. N = 0.20 * D N = 0.20 * 150 N = 30 Now, we need to find the number of diplomats who do not speak Russian. Let's denote this number as NR. We know that the total number of diplomats is the sum of those who speak only French, those who speak only Russian, those who speak both, and those who speak neither language. D = (F - B) + (R - B) + B + N We can rearrange this to solve for R - B (the number of diplomats who speak only Russian): R - B = D - (F - B) - B - N We already know D, F, B, and N, so we can plug in those values: R - B = 150 - (17 - 15) - 15 - 30 R - B = 150 - 2 - 15 - 30 R - B = 150 - 47 R - B = 103 This is the number of diplomats who speak only Russian. However, we want to find the number of diplomats who do not speak Russian, which includes those who speak only French and those who speak neither language. NR = (F - B) + N NR = (17 - 15) + 30 NR = 2 + 30 NR = 32 Therefore, boxed{32}  diplomats do not speak Russian."},{"instruction":"Cara is sitting at a circular table with her six friends, including her friend Alex. How many different pairs of people could Cara be sitting between where one of the pairs must always be Alex?","output":"Since the table is circular and Cara has six friends, if one of the neighbors must always be Alex, then we need to choose the other neighbor from the remaining five friends. The choices for the other neighbor are independent of the choice of Alex being one of the neighbors. We can calculate the number of possible pairs of neighbors, where one neighbor is always Alex, as follows: 1. Alex is fixed as one neighbor. 2. Select one friend from the remaining five to be the other neighbor. The number of ways to select one friend from five is given by: [ {5 choose 1} = 5 ] Hence, the number of different pairs of people Cara could be sitting between, where one of the pairs must be Alex, is boxed{5}."},{"instruction":"f p, q, and r are positive integers such that gcd(p,q) = 240 and gcd(p,r) = 540, what is the smallest possible value of gcd(q,r)?","output":"Step 1: Determine gcd(240, 540).  - gcd(240, 540) can be calculated by finding the prime factorization of both numbers. - 240 = 2^4 times 3 times 5 and 540 = 2^2 times 3^3 times 5. - gcd(240, 540) = 2^2 times 3 times 5 = 60. Step 2: Check if gcd(q,r) = 60 is attainable. - Choose p = 4320 (which is 60 times 4 times 18). - Choose q = 240 and r = 540 so that gcd(p,q) = 240 and gcd(p,r) = 540. - Confirm using gcd(q,r) = gcd(240, 540) = 60. Conclusion: Thus, the smallest possible value of gcd(q,r) is boxed{60}."},{"instruction":"Given a function y=f(x) defined on mathbb{R} whose graph passes through the point (1,1), identify the fixed point through which the graph of the function y=f(x+2) must pass.","output":"Since the graph of the function y=f(x) passes through the point (1,1), we can deduce the following relationship:  f(1) = 1  To find the corresponding point on the graph of y=f(x+2), we need to determine the input to the function f that will give us the same output as when x=1 in the original function f(x). Therefore, we set x+2=1 so that we can substitute x=1 into f(x+2) to get the same output. Solving for x, we get:  x+2=1  x=1-2  x=-1  Thus, for y=f(x+2), the input x=-1 will yield the same output as f(1)=1. When x=-1, the output is:  y = f(-1+2)  y = f(1)  y = 1  Therefore, the graph of the function y=f(x+2) must pass through the point (-1,1).  boxed{(-1,1)}"},{"instruction":"Among the following general formulas, the corresponding sequences that are increasing sequences are: A: a_{n}=1n B: {a_n}=frac{1}{{{4^n}}} C: {a_n}=2{n^2}5n+1 D: {a_n}=left{{begin{array}{l}{n+3n2}{{2^{n1}}n2}end{array}}right.","output":"To determine which of the given sequences are increasing, we analyze each option step by step. **Option A: a_{n}=1-n** To check if the sequence is increasing, we look at the difference between consecutive terms: - a_{n+1} - a_{n} = (1-(n+1)) - (1-n) = -1 < 0 This shows that the sequence is decreasing, not increasing. **Option B: a_{n}=frac{1}{{4^n}}** Similarly, we check the difference between consecutive terms: - a_{n+1} - a_{n} = frac{1}{{4^{n+1}}} - frac{1}{{4^n}} = frac{1}{{4^n}}(frac{1}{4} - 1) < 0 This indicates that the sequence is decreasing. **Option C: a_{n}=2n^2-5n+1** For this sequence, we calculate the difference between consecutive terms to determine if it's increasing: - a_{n+1} - a_{n} = 2(n+1)^2 - 5(n+1) + 1 - (2n^2 - 5n + 1) = 4n - 3 Since 4n - 3 > 0 for all n geq 1, the sequence is increasing. **Option D: a_{n}=left{{begin{array}{l}{n+3nleq2}{{2^{n-1}}n>2}end{array}}right.** For this sequence, we specifically look at the transition point from the first formula to the second: - a_{2} = 2 + 3 = 5 - a_{3} = 2^{3-1} = 4 Since a_{2} > a_{3}, the sequence is not continuously increasing. Therefore, based on the analysis, the correct answer is boxed{text{C}}."},{"instruction":"w many ways are there to put 6 balls into 4 boxes if the balls are indistinguishable but the boxes are distinguishable, with the condition that no box remains empty?","output":"We need to count the distributions where each box gets at least one ball. The total number of ways to distribute n indistinguishable balls into k distinguishable boxes such that no box is empty can be calculated by the Stirling numbers of the second kind and then multiplied by k! to consider the distinguishability of boxes. However, since we have a small number of balls and boxes, we can approach this by enumeration: 1. **Case (1,1,1,3)**: Choose 1 box to get 3 balls (4 ways), and the rest get 1 ball each. No further choice is needed. 2. **Case (1,1,2,2)**: Choose 2 boxes to get 2 balls each ({4 choose 2} = 6 ways). 3. **Case (1,2,1,2)**: This is identical to the case above due to symmetry, so still 6 ways. 4. **Case (2,1,2,1)**: Also the same as case (1,1,2,2) due to symmetry, so 6 ways. Adding these, we get 4 + 6 + 6 + 6 = boxed{22} ways."},{"instruction":"triangle ABC, the side lengths opposite to internal angles A, B, and C are denoted as a, b, and c respectively. It is known that the function f(x) = sin(2x  frac {pi}{6}) satisfies the following condition: for any x in mathbb{R}, f(x) leq f(A) always holds.    (1) Determine the size of angle A.    (2) If a = sqrt{3}, find the range of values for the length of the median AM from vertex A to side BC.","output":"(1) Based on the given information, f(A) represents the maximum value of the function f(x). Therefore, we have that sin(2A - frac {pi}{6}) = 1. It follows that 2A - frac {pi}{6} = frac {pi}{2} or 2A - frac {pi}{6} = frac {3pi}{2}. Considering that 0 < A < pi (since A is an internal angle of the triangle), we get A = boxed{frac {pi}{3}}. (2) Given a = sqrt{3}, the semi-length BM of the median AM is frac {sqrt{3}}{2}. In triangle ABM, by the law of cosines, we have:  c^2 = left(frac{sqrt{3}}{2}right)^2 + AM^2 - 2 cdot frac{sqrt{3}}{2} cdot AM cdot cos(angle AMB) quad text{(3)}  Similarly, in triangle ACM:  b^2 = left(frac{sqrt{3}}{2}right)^2 + AM^2 + 2 cdot frac{sqrt{3}}{2} cdot AM cdot cos(angle AMB) quad text{(4)}  Adding equations (3) and (4), we get:  AM^2 = frac{b^2 + c^2}{2} - frac{3}{4} quad text{(5)}  Furthermore, applying the law of cosines to triangle ABC, we have:  3 = b^2 + c^2 - 2bc cdot cos A = b^2 + c^2 - bc, quad text{since } cos A = frac{1}{2}  Hence, b^2 + c^2 = 3 + bc > 3 and 3 geq b^2 + c^2 - frac{b^2 + c^2}{2}. Simplifying, we find:  3 < b^2 + c^2 leq 6  Therefore, from equation (5), AM^2 > frac{3}{2} - frac{3}{4} = frac{3}{4} and AM^2 leq frac{6}{2} - frac{3}{4} = 3 - frac{3}{4} = frac{9}{4}. Taking square roots, we get:  frac{sqrt{3}}{2} < AM leq frac{3}{2}  Thus, the range for the length of median AM is boxed{left(frac{sqrt{3}}{2}, frac{3}{2}right]}."},{"instruction":"A candy store uses food colouring in various candies. Each lollipop uses 5ml of food colouring, and each hard candy also needs food colouring. In one day, the candy store makes 100 lollipops and 5 hard candies. They do not use food colouring in anything else. The store has used 600ml of food colouring by the end of the day. How much food colouring, in millilitres, does each hard candy need?","output":"To find out how much food colouring each hard candy needs, we first calculate the total amount of food colouring used for the lollipops. Since each lollipop uses 5ml of food colouring, and there are 100 lollipops made, the total food colouring used for lollipops is: [5, text{ml/lollipop} times 100, text{lollipops} = 500, text{ml}.] Given that the store used a total of 600ml of food colouring by the end of the day, and knowing that 500ml was used for lollipops, we can find the amount of food colouring used for the hard candies by subtracting the amount used for lollipops from the total amount used: [600, text{ml} - 500, text{ml} = 100, text{ml}.] Since this 100ml of food colouring was used for 5 hard candies, the amount of food colouring needed for each hard candy is: [100, text{ml} / 5, text{hard candies} = 20, text{ml/hard candy}.] Therefore, each hard candy needs boxed{20, text{ml}} of food colouring."},{"instruction":"Two terms are in a 3:4 ratio. If 10 is added to each of the terms, they will be in a certain ratio. The second term is 40. What is the new ratio of the two terms after adding 10 to each?","output":"Let's denote the first term as x and the second term as y. We are given that y = 40 and the original ratio of the two terms is 3:4. This means that: x/y = 3/4 Now, we can substitute y with 40: x/40 = 3/4 To find the value of x, we cross-multiply: 4x = 3 * 40 4x = 120 Now, we divide both sides by 4 to solve for x: x = 120 / 4 x = 30 So the first term is 30 and the second term is 40. Now, we are asked to find the new ratio after adding 10 to each term: New first term = x + 10 = 30 + 10 = 40 New second term = y + 10 = 40 + 10 = 50 The new ratio of the two terms is: New first term : New second term = 40 : 50 This ratio can be simplified by dividing both terms by their greatest common divisor, which is 10: 40/10 : 50/10 = 4 : 5 Therefore, the new ratio of the two terms after adding 10 to each is boxed{4:5} ."},{"instruction":"The function y=3sin(2x+phi+frac{pi}{3}) is an even function, and |phi|leqslantfrac{pi}{2}. Determine the value of phi.","output":"Since y=3sin(2x+phi+frac{pi}{3}) is an even function, we have phi+frac{pi}{3}=frac{pi}{2}+kpi, where kinmathbb{Z}. Solving for phi, we get phi=frac{pi}{6}+kpi, where kinmathbb{Z}. Given that |phi|leqslantfrac{pi}{2}, we have phi=frac{pi}{6}. Hence, the answer is boxed{frac{pi}{6}}. By using the induced formula and the even-odd identities of trigonometric functions, we can obtain phi+frac{pi}{3}=frac{pi}{2}+kpi. Solving for phi will yield the answer. This question tests the properties of trigonometric functions and the application of the induced formula, making it a basic-level problem."},{"instruction":"A new telephone pole is supported by a steel cable which extends from the top of the pole to a point on the ground 5 meters from its base. If Leah walks 3 meters from the base of the pole towards the point where the cable is anchored on the ground, and her head just touches the cable at that point, knowing Leah's height is now 1.75 meters. How tall is the pole?","output":"Firstly, let's outline the problem visually and symbolically as right triangles: - Denote by A the base of the pole, B the top of the pole, and C the anchoring point of the cable on the ground. - Let D be Leah's position when her head touches the cable, that cable point being E.    Given: - Distance from pole base to cable anchor (AC) is 5 m. - Distance Leah walks towards the cable anchor (AD) is 3 m. - Leah's height (DE), where her head touches the cable, is 1.75 m. Find: - Height of the pole (AB). We know triangle ABC is a right triangle (as the pole stands upright), and similarly triangle DEC. Since AD = 3text{ m}, the distance from D to C (DC) is the remainder of AC, i.e., DC = AC - AD = 5text{ m} - 3text{ m} = 2text{ m}. Employing triangle similarity (AA similarity between triangle ABC and triangle DEC): [ frac{AB}{AC} = frac{DE}{DC} ] Plugging in the known values: [ frac{AB}{5text{ m}} = frac{1.75text{ m}}{2text{ m}} ] [ AB = 5text{ m} times frac{1.75text{ m}}{2text{ m}} = 4.375text{ m} ] Hence, the pole's height is boxed{4.375text{ meters}}."},{"instruction":"The distance from the focus of the parabola x^2=8y to its directrix is ______.","output":"Given the parabola x^2=8y, we have p=4. Therefore, the distance from the focus of the parabola x^2=8y to its directrix is 4. Hence, the answer is boxed{4}. This solution directly utilizes the properties of a parabola to derive the result. This question tests the application of simple properties of a parabola and computational skills."},{"instruction":"On a twodimensional coordinate plane, the line q = x^2  x^3 touches the xaxis in 2 places. What is the cubic term in the equation of the line?","output":"The equation of the line is given as q = boxed{x^2}  - x^3. The cubic term in this equation is -x^3."},{"instruction":"Find the number of moles of H2 formed on combining 3 moles of NaH and 3 moles of H2O","output":"When sodium hydride (NaH) reacts with water (H2O), the following chemical reaction occurs: [ text{NaH} + text{H}_2text{O} rightarrow text{NaOH} + text{H}_2 ] This reaction shows that one mole of NaH reacts with one mole of H2O to produce one mole of sodium hydroxide (NaOH) and one mole of hydrogen gas (H2). Given that we have 3 moles of NaH and 3 moles of H2O, the reaction will proceed with a 1:1 molar ratio, as indicated by the balanced equation. Therefore, 3 moles of NaH will react with 3 moles of H2O to produce 3 moles of H2. So, the number of moles of H2 formed is boxed{3}  moles."},{"instruction":"Given the hyperbola frac{x^2}{4}  frac{y^2}{b^2} = 1 with b > 0, and its asymptotes are y = pm frac{1}{2}x, find the value of b.","output":"The general equation of the asymptotes for a hyperbola frac{x^2}{a^2} - frac{y^2}{b^2} = 1 is y = pm frac{b}{a}x. Since the given asymptotes are y = pm frac{1}{2}x, that means the slope of the asymptote, which is frac{b}{a}, must be equal to frac{1}{2}. For the given hyperbola, we have a = 2 because a^2, which is the denominator of the x^2 term, equals 4. So we have: frac{b}{a} = frac{1}{2}  frac{b}{2} = frac{1}{2}  By solving for b, we get: b = 1  Thus, the value of b is boxed{1}."},{"instruction":"A train station has 8 tracks. If each track can only accommodate 1 train, and 4 different trains need to be parked, then the number of different parking methods is: A: 70 B: 256 C: 1680 D: 4096","output":"To tackle this problem, let's break down the solution into detailed steps, following the formula for permutations, which is denoted by {A}_{n}^{r} where n is the total number of items to choose from (in this case, tracks), and r is the number of items to choose (in this case, trains).  Given there are 8 tracks and 4 different trains, the formula we use is {A}_{8}^{4}, which represents the number of ways to arrange 4 trains on 8 tracks.  The calculation of {A}_{8}^{4} can be broken down as follows: [ {A}_{8}^{4} = 8 times 7 times 6 times 5 ] This is because for the first train, there are 8 tracks to choose from. Once the first train is placed, there are only 7 choices left for the second train, then 6 choices for the third, and finally, 5 choices for the fourth train.  Calculating this gives: [ {A}_{8}^{4} = 8 times 7 times 6 times 5 = 56 times 30 = 1680 ] Therefore, the number of different parking methods for 4 different trains is 1680.  So, the answer is boxed{C}."},{"instruction":"f a and b are positive integers with a > b, what is the smallest possible value of frac{2a+b}{a2b} + frac{a2b}{2a+b}?","output":"Let x = frac{2a+b}{a-2b}. Thus frac{a-2b}{2a+b} = frac{1}{x}. The expression simplifies to x + frac{1}{x}, which can be rewritten as frac{x^2 + 1}{x}. Assume frac{x^2 + 1}{x} = k. Rearranging gives, x^2 - kx + 1 = 0. The discriminant of this quadratic must be non-negative for real solutions: k^2 - 4 geq 0, k geq 2 text{ or } k leq -2. Minimum positive k could be 2 when Delta = 0 (i.e., the equation has double roots). Solving for x when k=2: x^2 - 2x + 1 = 0, x = 1.  Setting x = frac{2a+b}{a-2b} = 1 leads to: 2a+b = a-2b, a + 3b = 0, which for positive integers is impossible. Thus, to satisfy the equation, let's examine the next possible solution or suitable a, b values by example or further tightening the conditions. For x = frac{2a+b}{a-2b} > 1, try a = 3, b = 1, x = frac{2(3)+1}{3-2(1)} = frac{7}{1} = 7, frac{1}{x} = frac{1}{7},  x + frac{1}{x} = 7 + frac{1}{7} = frac{50}{7}.  Minimum occurs when x = 7, so smallest value is boxed{frac{50}{7}}."},{"instruction":"Let  s(n)  be the sum of all positive divisors of  n , so  s(6) = 12 . We say  n  is almost perfect if  s(n) = 2n  1 . Let  mod(n, k)  denote the residue of  n  modulo  k  (in other words, the remainder of dividing  n  by  k ). Put  t(n) = mod(n, 1) + mod(n, 2) + cdots + mod(n, n) . \\r \\r Show that  n  is almost perfect if and only if  t(n) = t(n1) .","output":"To show that ( n ) is almost perfect if and only if ( t(n) = t(n-1) ), we will analyze the behavior of the function ( t(n) ) and the sum of divisors function ( s(n) ). 1. **Definitions and Initial Setup:**    - ( s(n) ) is the sum of all positive divisors of ( n ).    - ( n ) is almost perfect if ( s(n) = 2n - 1 ).    - ( mod(n, k) ) denotes the remainder when ( n ) is divided by ( k ).    - ( t(n) = sum_{k=1}^{n} mod(n, k) ). 2. **Behavior of ( t(n) ) and ( t(n-1) ):**    - We need to compare ( t(n) ) and ( t(n-1) ).    - Consider the numbers ( 1, 2, ldots, n-1 ). Each number ( k leq n-1 ) falls into one of the following categories:      1. ( k ) divides ( n ) but not ( n-1 ).      2. ( k ) divides ( n-1 ) but not ( n ).      3. ( k ) divides neither ( n ) nor ( n-1 ). 3. **Case Analysis:**    - **Case 1:** ( k ) divides ( n ) but not ( n-1 ). Let these numbers be ( b_k ). Then:      [      mod(n, b_k) = 0 quad text{and} quad mod(n-1, b_k) = b_k - 1      ]    - **Case 2:** ( k ) divides ( n-1 ) but not ( n ). Let these numbers be ( a_k ). Then:      [      mod(n-1, a_k) = 0 quad text{and} quad mod(n, a_k) = 1      ]    - **Case 3:** ( k ) divides neither ( n ) nor ( n-1 ). Let these numbers be ( p_k ) and the remainder when divided by ( n-1 ) be ( c_k ). Then:      [      mod(n-1, p_k) = c_k quad text{and} quad mod(n, p_k) = c_k + 1      ] 4. **Summing the Contributions:**    - The total difference ( t(n) - t(n-1) ) can be written as:      [      t(n) - t(n-1) = sum_{k=1}^{n} mod(n, k) - sum_{k=1}^{n-1} mod(n-1, k)      ]    - Breaking it down by cases:      [      t(n) - t(n-1) = sum_{k text{ divides } n-1} 1 + sum_{k text{ neither divides } n text{ nor } n-1} (c_k + 1 - c_k) - sum_{k text{ divides } n} (b_k - 1)      ]    - Simplifying:      [      t(n) - t(n-1) = sum_{k text{ divides } n-1} 1 + sum_{k text{ neither divides } n text{ nor } n-1} 1 - sum_{k text{ divides } n} (b_k - 1)      ]    - Since the sum of the divisors of ( n-1 ) is ( s(n-1) ) and the sum of the divisors of ( n ) is ( s(n) ):      [      t(n) - t(n-1) = (n-1) + (n - text{number of divisors of } n) - (s(n) - text{number of divisors of } n)      ] 5. **Conclusion:**    - For ( t(n) = t(n-1) ), we need:      [      0 = (n-1) + (n - text{number of divisors of } n) - (s(n) - text{number of divisors of } n)      ]    - Simplifying, we get:      [      s(n) = 2n - 1      ]    - Therefore, ( n ) is almost perfect if and only if ( t(n) = t(n-1) ). (blacksquare)"},{"instruction":"Given the function f(x)= sqrt{3}sin^2x+sin xcos x, where xinmathbb{R}; (1) Find the smallest positive period and the extremum of f(x); (2) Find the intervals of monotonic increase for f(x);","output":"Solution: (1) We have f(x)= sqrt{3}sin^2x+sin xcos x= frac{sqrt{3}}{2}- frac{sqrt{3}}{2}cos 2x+ frac{1}{2}sin 2x=sin left(2x- frac{pi}{3}right)+ frac{sqrt{3}}{2}, Therefore, the smallest positive period of f(x) is T= frac{2pi}{2}=pi, The maximum value is 1+ frac{sqrt{3}}{2}, and the minimum value is -1+ frac{sqrt{3}}{2}; (2) From - frac{pi}{2}+2kpileqslant 2x- frac{pi}{3}leqslant frac{pi}{2}+2kpi (kinmathbb{Z}), We get - frac{pi}{12}+kpileqslant xleqslant frac{5pi}{12}+kpi (kinmathbb{Z}), Therefore, the intervals of monotonic increase for the function are left[- frac{pi}{12}+kpi, frac{5pi}{12}+kpiright] (kinmathbb{Z}). Thus, the smallest positive period is boxed{pi}, the maximum value is boxed{1+ frac{sqrt{3}}{2}}, the minimum value is boxed{-1+ frac{sqrt{3}}{2}}, and the intervals of monotonic increase are boxed{left[- frac{pi}{12}+kpi, frac{5pi}{12}+kpiright]} (kinmathbb{Z})."},{"instruction":"Suppose that ( g(x) ) is a function such that [ g(xy) + x^2 = xg(y) + g(x) ] for all real numbers ( x ) and ( y ). If ( g(1) = 7 ), then compute ( g(1001) ).","output":"Setting ( y = 0 ) in the given functional equation, we get [ g(0) + x^2 = xg(0) + g(x), ] which implies ( g(x) = (1 - g(0))x^2 + g(0) ). This tells us that ( g(x) ) is a quadratic function of the form ( g(x) = ax^2 + b ). Since ( g(-1) = 7 ), [ 7 = a(-1)^2 + b = a + b, ] so ( b = 7 - a ), [ g(x) = ax^2 + 7 - a. ] Substituting this back into the functional equation, we get: [ a(xy)^2 + 7 - a + x^2 = x(ay^2 + 7 - a) + ax^2 + 7 - a. ] Simplifying, we find: [ ax^2y^2 + 7 - a + x^2 = ax^2y^2 + 7x - ax + ax^2 + 7 - a. ] This simplifies to ( x^2 = 7x - ax ). For this to hold for all ( x ), we must have ( a = -6 ). Then ( g(x) = -6x^2 + 13 ). In particular, ( g(-1001) = boxed{6006013} )."},{"instruction":"Javier is having an eating contest with his brother. It's ravioli night and there is meat ravioli, pumpkin ravioli, and cheese ravioli. The meat ravioli weighs 1.5 ounces each. The pumpkin ravioli is 1.25 ounces each. The cheese ravioli is one ounce. Javier eats 5 meat ravioli, 2 pumpkin ravioli, and 4 cheese ravioli. His brother just ate pumpkin ravioli and had 12 of them. What is the total amount of ounces eaten by the winner?","output":"To calculate the total amount of ounces eaten by Javier and his brother, and determine the winner, we follow these steps: 1. Calculate the total ounces of meat ravioli Javier ate:    - Javier ate 5 meat ravioli, each weighing 1.5 ounces.    - Total meat ravioli = 5 times 1.5 = 7.5 ounces. 2. Calculate the total ounces of pumpkin ravioli Javier ate:    - Javier ate 2 pumpkin ravioli, each weighing 1.25 ounces.    - Total pumpkin ravioli = 2 times 1.25 = 2.5 ounces. 3. Calculate the total ounces of cheese ravioli Javier ate:    - Javier ate 4 cheese ravioli, each weighing 1 ounce.    - Total cheese ravioli = 4 times 1 = 4 ounces. 4. Calculate the total ounces Javier ate:    - Total ounces = meat ravioli + pumpkin ravioli + cheese ravioli.    - Total ounces = 7.5 + 2.5 + 4 = 14 ounces. 5. Calculate the total ounces of pumpkin ravioli Javier's brother ate:    - His brother ate 12 pumpkin ravioli, each weighing 1.25 ounces.    - Total pumpkin ravioli = 12 times 1.25 = 15 ounces. 6. Determine the winner by comparing the total ounces eaten:    - Javier ate 14 ounces, and his brother ate 15 ounces.    - The winner ate 15 ounces because 15 > 14. Therefore, the total amount of ounces eaten by the winner is boxed{15} ounces."},{"instruction":"Joshua is reading a 396page book. He has read the first third of the book only. How many pages does he have left to read to finish the rest of the book? (A) 264 (B) 124 (C) 250 (D) 199 (E) 244","output":"To determine how many pages Joshua has left to read in his 396-page book, we can follow these detailed steps: 1. **Calculate the number of pages Joshua has read:**    Joshua has read the first third of the book.    [    text{Pages read} = frac{396}{3}    ]        Perform the division:    [    frac{396}{3} = 132    ]    Hence, Joshua has read 132 pages. 2. **Calculate the number of pages remaining:**    Subtract the pages Joshua has read from the total number of pages to find the number of pages he has left to read:    [    text{Pages left} = 396 - 132    ]    Perform the subtraction:    [    396 - 132 = 264    ]    Thus, Joshua has 264 pages left to read. Alternatively, you can calculate the remaining pages using the fraction of the book left to read: 1. **Determine the fraction of the book remaining:**    Since Joshua has read (frac{1}{3}) of the book, he has (frac{2}{3}) of the book left to read. 2. **Calculate the remaining pages:**    Multiply the total number of pages by (frac{2}{3}):    [    text{Pages left} = 396 times frac{2}{3}    ]    First, multiply 396 by 2:    [    396 times 2 = 792    ]    Then divide by 3:    [    frac{792}{3} = 264    ]    Hence, Joshua has 264 pages left to read. # Conclusion: Joshua has 264 pages left to read. Therefore, the correct answer is: [ boxed{text{(A) 264}} ]"},{"instruction":"a semicircle, square ABCD is drawn with its side AB aligned along the diameter of the semicircle. The semicircle and square ABCD are coplanar. The length of line segment AB is 8 centimeters. If point M is located onequarter of the way along the arc from A to B, what is the length of segment MC? Express your answer in simplest radical form.","output":"We begin by noting that since AB is the diameter of the semicircle and also a side of the square ABCD, each side of the square has a length of 8 cm. Therefore, the radius of the semicircle, which is half of the diameter, is 4 cm. Since point M is one-quarter of the way along the arc from A to B, angle AMB in the semicircle is a quarter of 180 degrees, so angle AMB = 45 degrees. We note that line CD parallels AB and shares the same length. Let F be the midpoint of CD. Since ABCD is a square, F aligns directly below the midpoint E of AB. As M lies on the semicircle, and E is directly beneath M (vertical projection), segment ME is vertical and equals the radius of the semicircle (4 cm). Segment EF (same as AB/2 because F is the midpoint of CD) is 4 cm. Thus, in right triangle MFC, we have: - MF = ME + EF = 4 + 4 = 8 cm - FC = 4 cm (half of CD, as F is the midpoint) Using Pythagoras' theorem in triangle MFC: [ MC^2 = MF^2 + FC^2 = 8^2 + 4^2 = 64 + 16 = 80 ] So, [ MC = sqrt{80} = 4sqrt{5} ] Thus, the length of segment MC is boxed{4sqrt{5}} cm."},{"instruction":"What is the greatest common divisor of 2^{1030}1 and 2^{1040}1?","output":"Applying the Euclidean algorithm, start by finding: [ text{gcd}(2^{1040}-1, 2^{1030}-1) ] We proceed via the identity: [ text{gcd}(a, b) = text{gcd}(a - b, b) ] Plug in a = 2^{1040}-1 and b = 2^{1030}-1: [ text{gcd}(2^{1040}-1, 2^{1030}-1) = text{gcd}(2^{1040}-1 - 2^{10}(2^{1030}-1), 2^{1030}-1) ] Simplifying the difference: [ 2^{1040}-1 - (2^{10} cdot (2^{1030}-1)) = 2^{1040}-1 - 2^{1040} + 2^{10} = 2^{10} - 1 = 1023 ] So, we can express: [ text{gcd}(2^{1040}-1, 2^{1030}-1) = text{gcd}(1023, 2^{1030}-1) ] Checking divisibility, since 2^{1030} = (2^{10})^{103} and both 1023 and 2^{10}-1 are each 1023, we form: [ 2^{1030}-1 = (2^{10}-1)left( (2^{10})^{102} + (2^{10})^{101} + ldots + 2^{10} + 1 right) ] Thus, it follows that 2^{1030}-1 is divisible by 1023, so the greatest common divisor is boxed{1023}."},{"instruction":"Given that angle 1 is an acute angle, the supplement of angle 1 is greater than the complement of angle 1 ( ). A: 30^{circ} B: 45^{circ} C: 60^{circ} D: 90^{circ}","output":"To solve the problem, we start by understanding what is meant by the supplement and complement of an angle. The supplement of an angle is what, when added to the angle, equals 180^{circ}. The complement of an angle, on the other hand, is what, when added to the angle, equals 90^{circ}.  Given that angle 1 is an acute angle, we are told that the supplement of angle 1 is greater than the complement of angle 1. Mathematically, this can be expressed as: [ left(180^{circ}-angle 1right) > left(90^{circ}-angle 1right) ] To find out by how much the supplement exceeds the complement, we subtract the complement from the supplement: [ left(180^{circ}-angle 1right) - left(90^{circ}-angle 1right) ] Simplifying this expression, we distribute the subtraction across the terms: [ = 180^{circ} - angle 1 - 90^{circ} + angle 1 ] Notice that the -angle 1 and +angle 1 cancel each other out, leaving us with: [ = 180^{circ} - 90^{circ} ] [ = 90^{circ} ] Therefore, the supplement of angle 1 is greater than the complement of angle 1 by 90^{circ}. This means the correct answer is: [ boxed{D} ]"},{"instruction":"A certain manufacturer of cake, muffin, and bread mixes has 100 buyers, of whom 50 purchase cake mix, 40 purchase muffin mix, and some purchase both cake mix and muffin mix. If a buyer is to be selected at random, the probability that the buyer selected will be one who purchases neither cake mix nor muffin mix is 0.28. How many buyers purchase both cake mix and muffin mix?","output":"Let's denote the number of buyers who purchase both cake mix and muffin mix as ( x ). According to the problem, we have 50 buyers who purchase cake mix and 40 who purchase muffin mix. However, since some buyers purchase both, they are being counted twice when we add these two numbers together. To correct for this, we subtract ( x ) (the number of buyers who purchase both) from the total of 50 + 40 to avoid double-counting those buyers. So, the total number of buyers who purchase either cake mix or muffin mix (or both) is ( 50 + 40 - x ). The problem also states that the probability of selecting a buyer who purchases neither cake mix nor muffin mix is 0.28. Since there are 100 buyers in total, this means that the number of buyers who purchase neither is ( 0.28 times 100 = 28 ). Now, we can set up an equation to find ( x ). The total number of buyers is the sum of those who purchase cake mix, muffin mix, both, and neither. This gives us: [ 50 + 40 - x + 28 = 100 ] Solving for ( x ): [ 90 - x + 28 = 100 ] [ 118 - x = 100 ] [ x = 118 - 100 ] [ x = 18 ] Therefore, boxed{18}  buyers purchase both cake mix and muffin mix."},{"instruction":"Let ( P(x) = 1 + 8x + 4x^2 + 8x^3 + 4x^4 + cdots ) for values of ( x ) for which this sum has finite value. Find ( Pleft(frac{1}{7}right) ).","output":"We start by expressing the polynomial ( P(x) ) in a recognizable form: [ P(x) = 1 + 8x + 4x^2 + 8x^3 + 4x^4 + cdots ] Notice that the terms seem to alternate in their coefficients, switching between coefficients involving 8 and 4. Given the pattern: [ a_{n} =  begin{cases}  8x^n & text{if } n text{ is odd}  4x^n & text{if } n text{ is even } end{cases}  ] We need to rewrite the series in the form of sums of geometric series. 1. **Separate the series based on coefficients**:    Let's separate ( P(x) ) into odd and even power series.    [    P(x) = 1 + 8x + 4x^2 + 8x^3 + 4x^4 + ...    ]    We can group it as follows:    [    P(x) = (1 + 4x^2 + 4x^4 + cdots) + (8x + 8x^3 + 8x^5 + cdots)    ] 2. **Recognize each as a geometric series**:    Each group in parentheses forms a geometric series.    Let's handle the even-power series first:    [    1 + 4x^2 + 4x^4 + 4x^6 + cdots    ]    This is a geometric series with first term (a_1 = 1) and common ratio (r = 4x^2).    Sum of an infinite geometric series is given by:    [    frac{a_1}{1-r}    ]    Applying this formula:    [    frac{1}{1-4x^2}    ]        Now, for the odd-power series:    [    8x + 8x^3 + 8x^5 + cdots    ]    This has first term (a_1 = 8x) and common ratio (r = (8x^2)).    Sum of this infinite geometric series is:    [    frac{8x}{1-4x^2}    ] 3. **Combine the sums**:    Adding both geometric series together:    [    P(x) = frac{1}{1-4x^2} + frac{8x}{1-4x^2}    ] 4. **Simplify**:    Combine the fractions into a single fraction:    [    P(x) = frac{1 + 8x}{1 - 4x^2}    ] 5. **Evaluate ( P left( frac{1}{7} right) )**:    Substitute ( x = frac{1}{7} ) into the simplified expression:    [    Pleft(frac{1}{7}right) = frac{1 + 8 left(frac{1}{7}right)}{1 - 4 left(frac{1}{7}right)^2}    ]    [    Pleft(frac{1}{7}right) = frac{1 + frac{8}{7}}{1 - frac{4}{49}}    ]    Simplify the numerator and the denominator:    [    Pleft(frac{1}{7}right) = frac{frac{7+8}{7}}{frac{49 - 4}{49}}    ]    [    Pleft(frac{1}{7}right) = frac{frac{15}{7}}{frac{45}{49}}    ]    Simplify further:    [    Pleft(frac{1}{7}right) = frac{15}{7} times frac{49}{45} = frac{15 cdot 49}{7 cdot 45} = frac{15 cdot 7}{7 cdot 9} = frac{15}{9} = frac{5}{3}    ]    Thus:    [    Pleft(frac{1}{7}right) = frac{5}{3}    ] # Conclusion: [ boxed{frac{5}{3}} ]"},{"instruction":"There are ______ prime numbers within 20, and their sum is ______.","output":"To find the number of prime numbers within 20 and their sum, we first list all the prime numbers less than or equal to 20: - The prime numbers are: 2, 3, 5, 7, 11, 13, 17, 19. Counting these, we find there are a total of 8 prime numbers within 20. Next, to find their sum, we add them together: [ 2 + 3 + 5 + 7 + 11 + 13 + 17 + 19 = 77. ] Therefore, the number of prime numbers within 20 is 8, and their sum is 77. So, the answer is: boxed{8, 77}."},{"instruction":"Star lists the whole numbers 1 through 40 once. Emilio copies Star's numbers, replacing each occurrence of the digit '3' with the digit '2'. Star adds her numbers and Emilio adds his numbers. How much larger is Star's sum than Emilio's? A) 100 B) 102 C) 104 D) 110 E) 120","output":"1. **Identify the numbers affected by the digit change**: The numbers from 1 to 40 are listed. Emilio replaces each occurrence of the digit '3' with '2'.     2. **Count occurrences of the digit '3'**:    - **As a tens digit**: The numbers 30 through 39 have the digit '3' as the tens digit. There are 10 such numbers.    - **As a units digit**: The numbers 3, 13, 23, and 33 have the digit '3' as the units digit. There are 4 such numbers. 3. **Calculate the difference in sums due to each digit change**:    - **Tens digit change**: Changing the tens digit from '3' to '2' in numbers 30 through 39 decreases each number by 10. Since there are 10 such numbers, the total decrease is 10 times 10 = 100.    - **Units digit change**: Changing the units digit from '3' to '2' in numbers 3, 13, 23, and 33 decreases each number by 1. Since there are 4 such numbers, the total decrease is 1 times 4 = 4. 4. **Sum the total decrease**: The total decrease in Emilio's sum compared to Star's sum is 100 + 4 = 104. 5. **Conclusion**: Star's total sum is 104 larger than Emilio's after the digit replacement. The final answer is boxed{C) 104}"},{"instruction":"A lady grows cauliflower in her garden that is in the shape of a square. Each cauliflower takes a certain amount of area in her garden. This year, she has increased her output by 223 cauliflower when compared to last year. The shape of the area used for growing the cauliflower has remained a square in both these years. She produced 12544 cauliflowers this year. How many square feet of area does each cauliflower take in her garden?","output":"Let's denote the side length of the square area used for growing cauliflower last year as ( x ) and the side length of the square area used for growing cauliflower this year as ( y ). Since the number of cauliflowers grown is equal to the area of the square (assuming one cauliflower per square unit), we have: Last year: ( x^2 ) cauliflowers This year: ( y^2 ) cauliflowers According to the information given, this year she produced 12544 cauliflowers, so: ( y^2 = 12544 ) To find the side length of the square this year, we take the square root of 12544: ( y = sqrt{12544} ) ( y = 112 ) (since the side length cannot be negative) Now, we know that she increased her output by 223 cauliflowers compared to last year, so: ( y^2 = x^2 + 223 ) Substituting the value of ( y^2 ) we found: ( 12544 = x^2 + 223 ) Now, let's solve for ( x^2 ): ( x^2 = 12544 - 223 ) ( x^2 = 12321 ) Taking the square root of 12321 to find ( x ): ( x = sqrt{12321} ) ( x = 111 ) (since the side length cannot be negative) Now, we know that each cauliflower takes up a certain amount of area in her garden. Since the garden is a square and each cauliflower corresponds to a unit of area in that square, the area taken by each cauliflower is 1 square unit. Therefore, each cauliflower takes boxed{1}  square foot of area in her garden."},{"instruction":"Teams A and B are playing a volleyball match. The first team to win 3 sets will be declared the winner, and the match will end immediately. Except for the fifth set, where Team A has a probability of frac{1}{2} to win, Team A has a probability of frac{2}{3} to win in all other sets. Assume that the results of each set are independent. The probability that Team A will win is _______.","output":"There are three scenarios in which Team A can win: 1. Winning 3 sets without losing any (3:0): The probability is P_1 = (frac{2}{3})^3 = frac{8}{27}. 2. Winning 3 sets after losing 1 (3:1): The probability is P_2 = C_3^2 (frac{2}{3})^2 times (1 - frac{2}{3}) times frac{2}{3} = frac{8}{27}. 3. Winning 3 sets after losing 2 (3:2): The probability is P_3 = C_4^2 (frac{2}{3})^2 times (1 - frac{2}{3})^2 times frac{1}{2} = frac{4}{27}. Thus, the probabilities of Team A winning with scores 3:0, 3:1, and 3:2 are frac{8}{27}, frac{8}{27}, and frac{4}{27}, respectively. Therefore, the probability of Team A winning is: frac{8}{27} + frac{8}{27} + frac{4}{27} = boxed{frac{20}{27}}. Team A can win in three scenarios: 3:0, 3:1, and 3:2. Calculate the probability for each scenario and then use the formula for the probability of mutually exclusive events to find the probability of Team A winning the match. Add these probabilities together to get the final answer. This problem tests your understanding of the multiplication rule for independent events and is a basic question."},{"instruction":"What will be the length of the strip if a cubic kilometer is cut into cubic meters and laid out in a single line?","output":"1. First, understand that a cubic kilometer ((km^3)) is a unit of volume measurement, whereas a cubic meter ((m^3)) is another, smaller unit of volume measurement. 2. To consider how many cubic meters are in one cubic kilometer, recognize the following conversion:    [    1 text{ km} = 1000 text{ m}    ]     3. Since the kilometer and meter units are three-dimensional measurements, a cubic kilometer ((km^3)) can be visualized as a cube with each side of length (1000) meters. 4. As a result, the volume in cubic meters can be calculated as:    [    1 text{ km}^3 = (1000 text{ m})^3 = 1000^3 text{ m}^3    ] 5. Calculate the cube of (1000):    [    1000^3 = 1000 times 1000 times 1000 = 1,000,000,000 text{ m}^3    ]    Therefore:    [    1 text{ km}^3 = 1,000,000,000 text{ m}^3    ] 6. Now, consider the question stating that if all the cubic meters from a cubic kilometer are placed end-to-end in a line, we need to determine the total length of the line. 7. Since each unit of (1 text{ m}^3) is placed one after another in a straight line:    [    text{Total length of the line} = 1,000,000,000 text{ m}    ] 8. Convert the total length from meters to kilometers:    [    1,000,000,000 text{ m} = 1,000,000 text{ km}    ] # Conclusion: Thus, the total length of the line of cubic meters obtained from one cubic kilometer is: [ boxed{1,000,000 text{ km}} ]"},{"instruction":"Let S be the area of a given triangle, R the radius of its circumscribed circle, and d the distance from the circumcenter to a certain point. Let S_{1} be the area of the triangle formed by the feet of the perpendiculars dropped from this point to the sides of the given triangle. Prove that [ S_{1} = frac{S}{4} left| 1  frac{d^{2}}{R^{2}} right|. ]","output":"1. Let ABC be the given triangle, and O be the center of the circumcircle of triangle ABC with radius R.  2. Let M be a point such that the distance OM = d. 3. The perpendiculars from M to the sides BC, CA, and AB intersect these sides at points A_1, B_1, and C_1, respectively. These points form the triangle A_1B_1C_1. 4. We aim to prove that the area S_{1} of triangle A_1B_1C_1 is given by:    [    S_{1} = frac{S}{4} left|1 - frac{d^2}{R^2}right|    ]    where S is the area of triangle ABC. 5. Note that the sides of triangle A_1B_1C_1 are given in terms of the projections of the sides of triangle ABC. For example, the length a_1 = |AM|sin A = |AM| frac{a}{2R}. 6. Similarly, we have:    [    b_1 = |BM|sin B = |BM| frac{b}{2R}    ]    [    c_1 = |CM|sin C = |CM| frac{c}{2R}    ] 7. Next, consider the triangle triangle B_2MC_2, where B_2 and C_2 are the points where the lines AM, BM, and CM (extended) intersect the circumcircle again. We have similar relationships:    [    frac{a_2}{a} = frac{|B_2M|}{|CM|} = frac{|C_2M|}{|BM|}    ]    Analogous ratios hold for b_2 and c_2.  8. Hence, the areas of the triangles are related as follows:    [    S_{A_1B_1C_1} = frac{1}{4R^2} cdot |AM|^2 cdot |BM|^2 cdot |CM|^2     ] 9. Considering the similarity relationships and the properties of projections, we can also write:    [    frac{S_{1}}{S} = left(frac{|AM||BM||CM|}{a cdot b cdot c cdot 4R^2}right)^{3/2} cdot left( frac{a^3 b^3 c^3}{a cdot b cdot c} right) = frac{S_{1}^3}{S_{2}^3} cdot frac{S_{2}^3}{S^3}    ] 10. Danile by considering a simplified form, we obtain:    [    S_{1} = frac{S}{4} left|1 - frac{d^2}{R^2}right|    ] # Conclusion: Thus, the area of the triangle triangle A_1B_1C_1, formed by the feet of the perpendiculars from the point M onto the sides of triangle ABC, where M is a distance d from the center O of the circumcircle of triangle ABC with radius R, is given by: [ boxed{S_{1} = frac{S}{4} left| 1 - frac{d^2}{R^2} right|} ]"},{"instruction":"Given vectors overrightarrow {a}=( sqrt {3},1), overrightarrow {b}=(0,1), overrightarrow {c}=(k, sqrt {3}). If overrightarrow {a}+2overrightarrow {b} is perpendicular to overrightarrow {c}, then k=  A: 3 B: 2 C: 1 D: 1","output":"Since overrightarrow {a}+2 overrightarrow {b}=( sqrt {3},3), and overrightarrow {c}=(k, sqrt {3}),   and since ( overrightarrow {a}+2 overrightarrow {b}) is perpendicular to overrightarrow {c},   then ( overrightarrow {a}+2 overrightarrow {b})cdot overrightarrow {c}=sqrt {3}k+3sqrt {3}=0.   Therefore, k=-3.   Hence, the correct choice is boxed{A}.   By using the coordinate representation of the dot product of vectors, we can substitute the values to solve for k.   This question mainly examines the coordinate representation of the dot product of vectors, which is a basic problem."},{"instruction":"A stock's monthly price changes during the first half of a year are recorded as follows:  January: The stock increased by 1.50.  February: The stock decreased by 2.25.  March: The stock increased by 0.75.  April: The stock decreased by 3.00.  May: The stock increased by 1.00.  June: The stock decreased by 4.00. Which month experienced the greatest drop in the stock's price? (A) February (B) March (C) April (D) May (E) June","output":"To solve this problem, we look at the months with negative changes, which indicate a drop in stock price: - February: -2.25 - April: -3.00 - June: -4.00 The largest drop is seen in June with a decrease of 4.00. Conclusion: The greatest monthly drop in the stock's price occurred in June, with a decrease of text{June}. The final answer is boxed{text{(E)} text{June}}"},{"instruction":"Janice can type 6 sentences per minute. Today at work, Janice continued working on a paper she started typing yesterday. She typed for 20 minutes, took a break, and typed 15 minutes longer. She then had to erase 40 sentences she had typed incorrectly. After a meeting, she typed for 18 minutes more. In all, the paper had some sentences by the end of today. How many sentences did she start with today if the paper had 536 sentences by the end of today?","output":"Let's calculate the total number of sentences Janice typed today. First, she typed for 20 minutes at a rate of 6 sentences per minute: 20 minutes * 6 sentences/minute = 120 sentences Then, she typed for another 15 minutes at the same rate: 15 minutes * 6 sentences/minute = 90 sentences After erasing 40 sentences, the number of sentences she added to the paper is reduced by 40: 120 sentences + 90 sentences - 40 sentences = 170 sentences Finally, she typed for another 18 minutes: 18 minutes * 6 sentences/minute = 108 sentences Adding all the sentences she typed today: 170 sentences + 108 sentences = 278 sentences The paper had 536 sentences by the end of today, and we know she added 278 sentences today. So, to find out how many sentences she started with today, we subtract the sentences she added from the total number of sentences by the end of today: 536 sentences - 278 sentences = 258 sentences Janice started with boxed{258}  sentences today."},{"instruction":"Suppose you have 7 blue shirts, 6 green shirts, 7 pairs of pants, 10 blue hats, and 9 green hats, all distinct. How many different outfits can you create consisting of one shirt, one pair of pants, and one hat, where the shirt and hat are not the same color?","output":"Consider two cases: bullet **Case 1**: Wearing a blue shirt and a green hat.    - Number of blue shirts = 7    - Number of green hats = 9    - Number of pairs of pants = 7    - Total outfits for Case 1 = 7 times 9 times 7 = 441. bullet **Case 2**: Wearing a green shirt and a blue hat.    - Number of green shirts = 6    - Number of blue hats = 10    - Number of pairs of pants = 7    - Total outfits for Case 2 = 6 times 10 times 7 = 420. Summing up the two cases gives us 441 + 420 = boxed{861} outfits."},{"instruction":"The quadratic ( x^2  6x + 5 = 2x  8 ) has two solutions. What is the sum of these solutions?","output":"First, bring all the terms to one side to form a standard quadratic equation: [ x^2 - 6x + 5 - 2x + 8 = 0 ] [ x^2 - 8x + 13 = 0 ] We can use the formula for the sum of the roots of a quadratic equation, (-b/a), where (a) is the coefficient of (x^2) and (b) is the coefficient of (x). Thus, the sum of the solutions for (x^2 - 8x + 13 = 0) is: [ frac{-(-8)}{1} = 8 ] Therefore, the sum of the solutions is: [ boxed{8} ]"},{"instruction":"The sum of three different numbers is 100. The two larger numbers differ by 10, and the two smaller numbers differ by 5. What is the value of the largest number?","output":"Let's denote the three numbers as a leq b leq c. The conditions given are: [ a + b + c = 100, quad c - b = 10, quad b - a = 5. ] From the second equation, we can express c as c = b + 10. From the third equation, we express a as a = b - 5. Substituting these into the first equation: [ (b - 5) + b + (b + 10) = 100. ] Simplifying this equation: [ 3b + 5 = 100 quad Rightarrow quad 3b = 95 quad Rightarrow quad b = frac{95}{3} approx 31.67. ] Now, calculating c = b + 10 = 31.67 + 10 = 41.67. Thus, the value of the largest number is boxed{41.67}."},{"instruction":"Jake has 3 snakes. Each of them lays 2 eggs. Most of the baby snakes sell for 250 but one super rare one costs a certain multiple of that. He got 2250 from selling the snakes. How many times more expensive is the super rare snake compared to the regular ones?","output":"First, let's calculate the total number of snake eggs. Jake has 3 snakes, and each lays 2 eggs, so that's 3 * 2 = 6 eggs. Assuming each of these eggs hatches into a baby snake, Jake would have 6 baby snakes to sell. Since he got 2250 from selling them, we need to figure out how many of these were regular snakes and how many were the super rare one. Let's assume that there is only one super rare snake, and the rest are regular. Let x be the price of the super rare snake. Then the total money made from the regular snakes would be (6 - 1) * 250, because there are 5 regular snakes. So the equation to represent this situation would be: 5 * 250 + x = 2250 Solving for x: 1250 + x = 2250 x = 2250 - 1250 x = 1000 The super rare snake sold for 1000, which is 1000 / 250 = boxed{4}  times more expensive than the regular ones."},{"instruction":"man can swim in still water at 4.5 km / h , but takes twice as long to swim upstream than downstream . the speed of the stream is ?","output":"Let's denote the speed of the stream as ( v ) km/h. When the man swims downstream, his effective speed is the sum of his swimming speed and the speed of the stream, which is ( 4.5 + v ) km/h. When he swims upstream, his effective speed is his swimming speed minus the speed of the stream, which is ( 4.5 - v ) km/h. According to the problem, it takes him twice as long to swim upstream as it does to swim downstream. This means that the ratio of his upstream speed to his downstream speed is 1:2. So we can set up the following equation: [ frac{4.5 - v}{4.5 + v} = frac{1}{2} ] Now we can solve for ( v ): [ 2(4.5 - v) = 4.5 + v ] [ 9 - 2v = 4.5 + v ] [ 9 - 4.5 = 2v + v ] [ 4.5 = 3v ] [ v = frac{4.5}{3} ] [ v = 1.5 ] Therefore, the speed of the stream is boxed{1.5}  km/h."},{"instruction":"A laser is placed at the point (4,6). The laser beam travels in a straight line. Larry wants the beam to hit and bounce off the yaxis, then hit and bounce off the xaxis, then hit and bounce off the yaxis again before hitting the point (8,6). What is the total distance the beam will travel along this path? textbf{(A) }10 qquad textbf{(B) }12 qquad textbf{(C) }14 qquad textbf{(D) }16 qquad textbf{(E) }18","output":"1. **Identify Points and Reflections**:    Let A = (4,6) and final point F = (8,6). Identify points B on the y-axis, C on the x-axis, and E again on the y-axis where the laser beam bounces off. 2. **Reflecting the Path**:    - Reflect overline{BC} about the y-axis to get overline{BC'}.    - Reflect overline{CD} about the x-axis to get overline{C'D'}.    - Reflect overline{DE} about the y-axis to get overline{D'E'} with E' = (-8, 6). 3. **Diagram Analysis**:    The path A rightarrow B rightarrow C rightarrow D rightarrow E rightarrow F can be transformed into a straight line from A to E' by the series of reflections. This transformation simplifies calculation of the total distance traveled by the beam. 4. **Calculate Total Distance**:    [    AE' = sqrt{(4 - (-8))^2 + (6 - 6)^2} = sqrt{(4 + 8)^2} = sqrt{12^2} = 12.    ] 5. **Conclusion**:    The total distance the beam will travel along this path is 12. The final answer is boxed{textbf{(B) }12}"},{"instruction":"Given vectors overrightarrow{a}=(2,1,3) and overrightarrow{b}=(4,2,k), and it is known that overrightarrow{a} perp overrightarrow{b}, then k equals to ( ). A: 6 B: 6 C: dfrac{10}{3} D: 2","output":"Since overrightarrow{a} perp overrightarrow{b}, we have 2 times 4 + (-1) times (-2) + 3k = 0, Solving this, we get k = -dfrac{10}{3}. Therefore, the correct choice is boxed{C}. By using the property that overrightarrow{a} perp overrightarrow{b} Leftrightarrow overrightarrow{a} cdot overrightarrow{b} = 0, we can easily solve this problem. This question tests the property of perpendicular vectors and can be solved by substitution, making it a basic question."},{"instruction":"f t = 5 / 9 * ( k  32 ) , and if t = 105 , then what is the value of k ?","output":"To find the value of k when t = 105, we can substitute t with 105 in the given equation and solve for k. The equation is: t = 5/9 * (k - 32) Substitute t with 105: 105 = 5/9 * (k - 32) To solve for k, we first need to get rid of the fraction by multiplying both sides of the equation by 9/5: (9/5) * 105 = k - 32 Now, calculate the left side: 9/5 * 105 = 189 So we have: 189 = k - 32 Now, add 32 to both sides to solve for k: 189 + 32 = k k = 221 Therefore, the value of k is boxed{221} ."},{"instruction":"Given x=3^{n} and y=2+9^{n}, express y in terms of x as y=2+x^{2}.","output":"To express y in terms of x, we start with the given expressions for x and y: 1. We are given x=3^{n} and y=2+9^{n}. 2. We know that 9^{n} = (3^{2})^{n}, which simplifies to 3^{2n}. 3. Therefore, we can rewrite y as y=2+3^{2n}. 4. Recognizing that 3^{2n} = (3^{n})^{2}, we substitute x=3^{n} into the equation. 5. This gives us y=2+x^{2}. Hence, the expression for y in terms of x is boxed{y=2+x^{2}}."},{"instruction":"The ellipse frac{x^{2}}{a^{2}}+frac{y^{2}}{b^{2}}=1 has a focal distance of 2c. If the numbers a, b, and c form a geometric sequence in that order, what is its eccentricity?","output":"Given the ellipse equation  [ frac{x^{2}}{a^{2}} + frac{y^{2}}{b^{2}} = 1 ] The foci of the ellipse are at pm c where ( c = sqrt{a^2 - b^2} ). Let's proceed with the given information and conditions. 1. **Step 1 (Relating the given terms in an arithmetic sequence):**    It is given that the numbers ( a, b, ) and ( c ) form an arithmetic progression (AP). That means:        [    b^2 = ac    ] 2. **Step 2 (Relating the ellipse and the arithmetic progression):**    From the properties of ellipses, we know:        [    c^2 = a^2 - b^2    ]        Since ( b^2 = ac ):    [    c^2 = a^2 - ac    ] 3. **Step 3 (Expressing c in terms of a):**    As ( b ) is the mean term in the arithmetic sequence,        [    c = sqrt{a^2 - ac}    ] 4. **Step 4 (Relating eccentricity e):**    The eccentricity ( e ) of the ellipse is given by:    [    e = frac{c}{a}    ]        Now using ( c = sqrt{a^2 - ac} ):        [    e = frac{sqrt{a^2 - ac}}{a}    ]        Squaring both sides, we get:        [    e^2 = frac{a^2 - ac}{a^2}    ]        Simplifying further:        [    e^2 = 1 - frac{ac}{a^2}    ]        [    e^2 = 1 - frac{c}{a}    ]        Since ( e = frac{c}{a} ):        [    e^2 = 1 - e    ] 5. **Step 5 (Solving the quadratic equation):**    To find ( e ), we solve the quadratic equation:        [    e^2 + e - 1 = 0    ]    Using the quadratic formula ( e = frac{-b pm sqrt{b^2 - 4ac}}{2a} ):        Here ( a = 1, b = 1, c = -1 ):        [    e = frac{-1 pm sqrt{1^2 - 4 cdot 1 cdot (-1)}}{2 cdot 1}    ]        [    e = frac{-1 pm sqrt{1 + 4}}{2}    ]        [    e = frac{-1 pm sqrt{5}}{2}    ]        Therefore, the eccentricity ( e ) has the two possible solutions:        [    e = frac{-1 + sqrt{5}}{2} quad text{or} quad e = frac{-1 - sqrt{5}}{2}    ]        Since eccentricity ( e ) must be non-negative:        [    e = frac{sqrt{5} - 1}{2}    ] # Conclusion: [ boxed{frac{sqrt{5} - 1}{2}} ]"},{"instruction":"Evaluate the product [ (a9) cdot (a8) cdot dotsm cdot (a1) cdot a, ] where ( a = 3 ).","output":"In this case, we examine the factors:  [ (3-9) cdot (3-8) cdot dotsm cdot (3-1) cdot 3 = (-6) cdot (-5) cdot dotsm cdot 2 cdot 3. ] This sequence can be viewed as: [ (-6) cdot (-5) cdot (-4) cdot (-3) cdot (-2) cdot (-1) cdot 0 cdot 1 cdot 2 cdot 3. ] However, the product includes the term ((3-3)) which is zero: [ dotsm cdot 0 cdot dotsm ] Thus, the product is (boxed{0})."},{"instruction":"A decorative window is composed of a rectangle and semicircles on both ends. The ratio of the rectangle's length AD to its width AB is 3:2, with AB measuring 40 inches. Calculate the ratio of the rectangle's area to the combined area of the semicircles. textbf{(A)} 2:3qquadtextbf{(B)} 3:2qquadtextbf{(C)} 6:piqquadtextbf{(D)} 9:piqquadtextbf{(E)} 30:pi","output":"1. **Set up the proportion for AD and AB:**    [    frac{AD}{AB} = frac{3}{2}    ]    With AB = 40 inches, we have:    [    frac{AD}{40} = frac{3}{2}    ] 2. **Solve for AD:**    [    AD = 40 times frac{3}{2} = 60 text{ inches}    ] 3. **Calculate the radius of the semicircles:**    The diameter of the semicircles equals AB = 40 inches, so the radius r is:    [    r = frac{40}{2} = 20 text{ inches}    ] 4. **Calculate the area of the combined semicircles:**    Since two semicircles make a full circle, the area A_{text{circle}} is:    [    A_{text{circle}} = pi times (20)^2 = 400pi text{ square inches}    ] 5. **Calculate the area of the rectangle:**    The area A_{text{rectangle}} with AD = 60 inches and AB = 40 inches is:    [    A_{text{rectangle}} = 60 times 40 = 2400 text{ square inches}    ] 6. **Calculate the ratio of the area of the rectangle to the combined area of the semicircles:**    [    text{Ratio} = frac{A_{text{rectangle}}}{A_{text{circle}}} = frac{2400}{400pi} = frac{6}{pi}    ] 7. **Conclusion:**    The ratio of the area of the rectangle to the combined area of the semicircles remains frac{6}{pi}, so the answer is:    [    frac{6{pi}}    ] The final answer is boxed{textbf{(C)} 6:pi}"},{"instruction":"Class A and Class B have a total of 85 students. The sum of frac{3}{8} of the number of students in Class A and frac{3}{5} of the number of students in Class B is 42 students. How many students are in Class A? How many students are in Class B?","output":"1. Let ( A ) be the number of students in class  and ( B ) be the number of students in class . We can set up our equations based on the problem statement as follows: [ A + B = 85 ] 2. The second piece of information tells us that the sum of (frac{3}{8}) of class  and (frac{3}{5}) of class  is 42. This gives us another equation: [ frac{3}{8}A + frac{3}{5}B = 42 ] 3. To remove the fractions, we can multiply through by the least common multiple (LCM) of 8 and 5, which is 40: [ 40 left( frac{3}{8}A right) + 40 left( frac{3}{5}B right) = 40 cdot 42 ] 4. Simplifying the equation: [ 5 cdot 3A + 8 cdot 3B = 1680 ] [ 15A + 24B = 1680 ] 5. Now we have a system of linear equations: [ begin{cases} A + B = 85  15A + 24B = 1680 end{cases} ] 6. We can solve this system using substitution or elimination. Let's use the substitution method first. From the first equation: [ A = 85 - B ] 7. Substitute ( A ) in the second equation: [ 15(85 - B) + 24B = 1680 ] [ 1275 - 15B + 24B = 1680 ] [ 1275 + 9B = 1680 ] [ 9B = 1680 - 1275 ] [ 9B = 405 ] [ B = frac{405}{9} = 45 ] 8. Now that we have ( B ), we can find ( A ): [ A = 85 - 45 = 40 ] Conclusion: [ boxed{40, 45} ]"},{"instruction":"**6.** Prove or disprove the following two propositions:**(i)** If  a  and  b  are positive integers such that  a<b , then in any set of  b  consecutive integers there are two whose product is divisible by  ab **(ii)** If  a,b  and  c  are positive integers such that  a<b<c , then in any set of  c  consecutive integers there are three whose product is divisible by  abc . **(N.8)**","output":"**(i)** We need to prove that if ( a ) and ( b ) are positive integers such that ( a < b ), then in any set of ( b ) consecutive integers, there are two whose product is divisible by ( ab ). 1. Consider any set of ( b ) consecutive integers: ( n, n+1, n+2, ldots, n+b-1 ). 2. By the Pigeonhole Principle, in any set of ( b ) consecutive integers, there must be at least one integer divisible by ( a ) and at least one integer divisible by ( b ). This is because the integers ( n, n+1, ldots, n+b-1 ) cover all possible remainders modulo ( a ) and modulo ( b ). 3. Let ( n_1 ) be an integer in the set that is divisible by ( a ) and ( n_2 ) be an integer in the set that is divisible by ( b ). If ( n_1 ) and ( n_2 ) are different, then ( n_1 cdot n_2 ) is divisible by ( ab ). 4. The only issue arises if ( n_1 = n_2 ), meaning there is a single integer ( n ) in the set that is divisible by both ( a ) and ( b ). In this case, ( n ) must be divisible by the least common multiple of ( a ) and ( b ), denoted as ([a, b]). 5. We need to find another integer in the set whose product with ( n ) is divisible by ( ab ). Consider the greatest common divisor of ( a ) and ( b ), denoted as ((a, b)). We have:    [    frac{ab}{[a, b]} = (a, b)    ] 6. Since ((a, b) leq frac{max(a, b)}{2} = frac{b}{2}) (this inequality holds for ( a neq b ) because ((a, b)) must lack at least one of ( b )'s divisors, which is at least 2), there must be an integer in the set ( n pm (a, b) ) that lies within the range of ( b ) consecutive numbers. 7. Therefore, there exists another integer ( m ) in the set such that ( n cdot m ) is divisible by ( ab ). (blacksquare)"},{"instruction":"A high school has a total of 720 students, including 480 science students and 240 humanities students. If stratified sampling is used to select 90 students for a survey, how many science students should be included in the sample?","output":"To solve this problem, we must use the principle of stratified sampling, which involves sampling in proportion to the size of each stratum (group) within the population. The total population is 720 students, with 480 being science students. We want to select a sample of 90 students. To determine how many science students should be included in the sample, we calculate the fraction of the total population that are science students and apply that fraction to the size of the sample. The fraction of science students in the total population is: frac{480}{720} Therefore, the number of science students to be included in the sample is: frac{480}{720} times 90 = frac{2}{3} times 90 = 60 So, we should include boxed{60} science students in the sample."},{"instruction":"Given the function f(x) = sin(2x  frac{pi}{2}), determine the nature of f(x): A: An odd function with the smallest positive period of pi B: An even function with the smallest positive period of pi C: An odd function with the smallest positive period of frac{pi}{2} D: An even function with the smallest positive period of frac{pi}{2}","output":"To determine the properties of the given function f(x), we use trigonometric identities and the definitions of even and odd functions. First, we rewrite the function using a trigonometric identity: f(x) = sin(2x - frac{pi}{2}) = -cos(2x). Next, to check for even or odd symmetry, we evaluate f(-x): f(-x) = -cos(-2x) = -cos(2x) = f(x). Since f(-x) = f(x), we conclude that f(x) is an even function. Now, to find the smallest positive period T of f(x), we look at the coefficient of x in the argument of the cosine function. Since the coefficient is 2, the smallest positive period is frac{2pi}{2} = pi. Therefore, the function f(x) is an even function with the smallest positive period of pi. Hence, the answer is boxed{text{B: An even function with the smallest positive period of } pi}."},{"instruction":"For a geometric sequence g_1, g_2, g_3, dots, let [S_n = g_1 + g_2 + g_3 + dots + g_n,]and let [T_n = S_1 + S_2 + S_3 + dots + S_n.]If S_{2019} is known, for which smallest integer n can you determine T_n uniquely?","output":"Let g = g_1 and r be the common ratio. For a geometric sequence, the sum of the first n terms is: [S_n = g frac{r^n - 1}{r - 1}.] Then, [T_n = sum_{k=1}^n S_k = sum_{k=1}^n g frac{r^k - 1}{r - 1} = frac{g}{r - 1} left( sum_{k=1}^n r^k - n right).] We manipulate the sum of the geometric series: [sum_{k=1}^n r^k = frac{r(r^n - 1)}{r - 1},] so, [T_n = frac{g}{r - 1} left( frac{r(r^n - 1)}{r - 1} - n right).] Considering the known S_{2019}: [S_{2019} = g frac{r^{2019} - 1}{r - 1},] which uniquely determines g frac{r^{2019}-1}{r-1}. We need their sums (T_n) and particularly look for the point where we can uniquely define T_n with minimum n. Since S_{2019} is known and gives r^{2019} in terms of g, the expression for T_n can be uniquely defined once we know r^{n} for each n depending on the powers of r exceeding 2019. Thus, n = 2019 ensures that T_{2019} can be uniquely determined. boxed{n = 2019}."},{"instruction":"A zoo has six pairs of different animals, each consisting of one male and one female. The zookeeper decides to feed the animals, ensuring that each time he feeds a single animal, the next one he feeds must be of the opposite gender. He begins by feeding the male lion. How many ways can he feed all the animals?","output":"Starting with the male lion, there are 6 females available for the next feeding turn. Once a female is chosen, there are 5 remaining males to choose from for the successive turn. This pattern continues, alternating between the remaining number of females and males until all are fed. The number of ways to choose the first female is 6. After that, 5 males are available, then 5 females, then 4 males, and so on. The sequence of choices looks like this: - 6 choices for the first female - 5 choices for the next male - 5 choices for the next female - 4 choices for the next male - 4 choices for the next female - 3 choices for the next male  - 3 choices for the next female - 2 choices for the next male - 2 choices for the next female - 1 choice for the last male - 1 choice for the last female The total number of feeding sequences is calculated by multiplying these choices together: [ 6 times 5 times 5 times 4 times 4 times 3 times 3 times 2 times 2 times 1 times 1 = 6 times 5^2 times 4^2 times 3^2 times 2^2 times 1^2 ] Calculating this product: [ 6 times 25 times 16 times 9 times 4 times 1 = 86400 ] Thus, there are boxed{86400} ways for the zookeeper to feed all the animals following the specified pattern."},{"instruction":"After grandmother had drunk 0.4 of the total milk, the remaining milk was 0.69 liters (L). Find how many liters (L) of milk were there in the beginning.","output":"If grandmother drank 0.4 of the total milk, that means she drank 40% of it, leaving 60% of the milk remaining. The remaining milk is 0.69 liters, which represents 60% of the original amount. To find the original amount of milk, we can set up a proportion where the remaining milk (0.69 liters) is to 60% as the total original milk (which we'll call T) is to 100%. So, we have: 0.69 L / 60% = T / 100% To solve for T, we can cross-multiply and divide: 0.69 L * 100% = T * 60% 69 L = T * 60 Now, divide both sides by 60 to solve for T: T = 69 L / 60 T = 1.15 L Therefore, there were originally boxed{1.15}  liters of milk before grandmother drank any."},{"instruction":"Let  ABC  be a right triangle with  angle A=90^circ.  The bisectors of the angles  B  and  C  meet each other in  I  and meet the sides  AC  and  AB  in  D  and  E , respectively. Prove that  S_{BCDE}=2S_{BIC},  where  S  is the area function. [asy] import graph; size(200); real lsf = 0.5; pen dp = linewidth(0.7) + fontsize(10); defaultpen(dp); pen ds = black; pen ttqqcc = rgb(0.2,0,0.8); pen qqwuqq = rgb(0,0.39,0); pen xdxdff = rgb(0.49,0.49,1); pen fftttt = rgb(1,0.2,0.2); pen ccccff = rgb(0.8,0.8,1); draw((1.89,4.08)(1.89,4.55)(1.42,4.55)(1.42,4.08)cycle,qqwuqq); draw((1.42,4.08)(7.42,4.1),ttqqcc+linewidth(1.6pt)); draw((1.4,10.08)(1.42,4.08),ttqqcc+linewidth(1.6pt)); draw((1.4,10.08)(7.42,4.1),ttqqcc+linewidth(1.6pt)); draw((1.4,10.08)(4,4.09),fftttt+linewidth(1.2pt)); draw((7.42,4.1)(1.41,6.24),fftttt+linewidth(1.2pt)); draw((1.41,6.24)(4,4.09),ccccff+linetype(5pt 5pt)); dot((1.42,4.08),ds); label( A , (1.1,3.66),NE*lsf); dot((7.42,4.1),ds); label( B , (7.15,3.75),NE*lsf); dot((1.4,10.08),ds); label( C , (1.49,10.22),NE*lsf); dot((4,4.09),ds); label( E , (3.96,3.46),NE*lsf); dot((1.41,6.24),ds); label( D , (0.9,6.17),NE*lsf); dot((3.37,5.54),ds); label( I , (3.45,5.69),NE*lsf); clip((6.47,7.49)(6.47,11.47)(16.06,11.47)(16.06,7.49)cycle); [/asy]","output":"1. **Identify the incenter and inradius:**    - Let I be the incenter of triangle ABC. Since angle A = 90^circ, triangle ABC is a right triangle.    - The inradius r of triangle ABC can be found using the formula for the area of a right triangle:      [      [ABC] = frac{1}{2} AB cdot AC      ]      The area can also be expressed in terms of the inradius:      [      [ABC] = frac{1}{2} r (AB + BC + CA)      ]      Solving for r, we get:      [      r = frac{2[ABC]}{AB + BC + CA} = frac{AB cdot AC}{AB + BC + CA}      ] 2. **Calculate the area of triangle BIC:**    - The area of triangle BIC can be expressed as:      [      [BIC] = frac{1}{2} r cdot BC      ]    - Substituting the value of r:      [      [BIC] = frac{1}{2} left( frac{AB cdot AC}{AB + BC + CA} right) cdot BC = frac{1}{2} frac{AB cdot AC cdot BC}{AB + BC + CA}      ] 3. **Calculate the area of quadrilateral BCDE:**    - The area of BCDE can be found by subtracting the area of triangle ADE from the area of triangle ABC:      [      [BCDE] = [ABC] - [ADE]      ]    - Using the angle bisector theorem, we find:      [      AD = AC left( frac{AB}{AB + BC} right) quad text{and} quad AE = AB left( frac{AC}{AC + BC} right)      ]    - The area of triangle ADE is:      [      [ADE] = frac{1}{2} AD cdot AE = frac{1}{2} left( AC frac{AB}{AB + BC} right) left( AB frac{AC}{AC + BC} right) = frac{1}{2} frac{AB^2 cdot AC^2}{(AB + BC)(AC + BC)}      ]    - Therefore:      [      [BCDE] = frac{1}{2} AB cdot AC - frac{1}{2} frac{AB^2 cdot AC^2}{(AB + BC)(AC + BC)}      ] 4. **Simplify and compare areas:**    - We need to show that [BCDE] = 2[BIC]:      [      [BCDE] = frac{1}{2} AB cdot AC - frac{1}{2} frac{AB^2 cdot AC^2}{(AB + BC)(AC + BC)}      ]      [      2[BIC] = 2 left( frac{1}{2} frac{AB cdot AC cdot BC}{AB + BC + CA} right) = frac{AB cdot AC cdot BC}{AB + BC + CA}      ]    - By the Pythagorean theorem, AB^2 + AC^2 = BC^2, which simplifies the expression:      [      [BCDE] = frac{1}{2} AB cdot AC - frac{1}{2} frac{AB^2 cdot AC^2}{(AB + BC)(AC + BC)} = frac{AB cdot AC cdot BC}{AB + BC + CA}      ]    - Therefore, we have:      [      [BCDE] = 2[BIC]      ] (blacksquare)"},{"instruction":"Points A, B, C, D, E, and F are located in 3dimensional space with AB= BC= CD= DE= EF= FA= 3 and angle ABC = angle CDE = angle DEF = 90^circ.  The plane of triangle ABC is parallel to overline{DE}, and the line overline{DE} is perpendicular to overline{EF}. What is the area of triangle DEF?","output":"Given that the points form a spatial polygon with each segment equal to 3 and three right angles: 1. Place D = (0,0,1) and E = (0,0,-1) to maintain the perpendicular distance between D and E as 2. Since DE = 3, adjust E = (0,0,-sqrt{5}). 2. Now, F should lie at a distance of 3 from E with angle DEF = 90^circ. Hence, F could be on the circle centered at E with radius 3 in the x-y plane. 3. The plane of triangle ABC is parallel to overline{DE}. Assuming triangle ABC lies in the plane x = k (for some constant k), and using the symmetry and constraints, let F = (k,3,-sqrt{5}) where k^2 + 3^2 = 3^2, yielding k = 0. 4. Placing F = (0,3,-sqrt{5}), we have triangle DEF with vertices at D = (0,0,1), E = (0,0,-sqrt{5}), and F = (0,3,-sqrt{5}). 5. The sides DE and EF are perpendicular, and their lengths are 3 and 3 respectively. Thus, the area of triangle DEF is frac{1}{2} times 3 times 3 = frac{9}{2}. Conclusion: The area of triangle DEF is boxed{4.5}."},{"instruction":"A hotel arranges for five people, labeled (A), (B), (C), (D), and (E), to stay in three rooms, with each room housing at least one person. Given that (A) and (B) cannot stay in the same room, there are ______ different arrangements possible (Answer with a number).","output":"To solve this problem, we consider the distribution of 5 people into three rooms, with each room housing at least one person. There are two possible distributions: ((3,1,1)) and ((2,2,1)). - For the ((3,1,1)) distribution, there are (C_{5}^{3} cdot A_{3}^{3} = 60) ways to arrange the people. However, if (A) and (B) are in the same room, there are (C_{3}^{1} cdot A_{3}^{3} = 18) arrangements. Therefore, there are (60 - 18 = 42) valid arrangements for this distribution. - For the ((2,2,1)) distribution, there are (dfrac{C_{5}^{2} cdot C_{3}^{2}}{A_{2}^{2}} cdot A_{3}^{3} = 90) ways to arrange the people. If (A) and (B) are in the same room, there are (C_{3}^{1} cdot C_{3}^{2} cdot A_{2}^{2} = 18) arrangements. Thus, there are (90 - 18 = 72) valid arrangements for this distribution. By applying the principle of counting by categories, the total number of different arrangements is (42 + 72 = 114). Therefore, the answer is: boxed{114}. This problem examines the issue of group allocation, focusing on how to divide the groups, and is considered a medium-level question."},{"instruction":"er team played 280 games and won 65 percent of them . how many games did it win ?","output":"To find out how many games the soccer team won, you need to calculate 65 percent of 280 games. 65% of 280 = (65/100) * 280 Now, calculate the value: = 0.65 * 280 = 182 So, the soccer team won boxed{182}  games."},{"instruction":"Let the function f(x)=2sin left( frac{pi}{2}x+ frac{pi}{5} right). If for any xinmathbb{R}, f(x_{1})leqslant f(x)leqslant f(x_{2}) holds, then the minimum value of |x_{1}x_{2}| is ____.   A: 4   B: 2   C: 1   D: frac{1}{2}","output":"**Analysis** This question examines the graph of the function. We can only solve such problems by being familiar with the graph of trigonometric functions. Additionally, other properties also need to be solved with the help of the graph of trigonometric functions. This chapter is a typical example of integrating mathematics and figures. From the given information, we know that f(x_{1}) is the minimum value of f(x), and f(x_{2}) is the maximum value in the range. They are obtained at the highest and lowest points, respectively. Their abscissas differ by at least half a period. From the trigonometric function, the result is half the value of the period. **Solution** Given that for any xinmathbb{R}, f(x_{1})leqslant f(x)leqslant f(x_{2}),   Therefore, f(x_{1}) is the minimum value, and f(x_{2}) is the maximum value;   Therefore, the minimum value of |x_{1}-x_{2}| is half the period of the function,   Since T=4,   Therefore, the minimum value of |x_{1}-x_{2}| is 2,   Hence, the correct choice is boxed{B}."},{"instruction":"Let left{a_{n}right} be a sequence of positive numbers with the partial sum of the first n terms denoted as b_{n}. Let left{b_{n}right} be a sequence where the product of the first n terms is denoted as c_{n}, and given that b_{n} + c_{n} = 1, the number in the sequence left{frac{1}{a_{n}}right} that is closest to 2011 is: (A) 1980   (B) 2010   (C) 2040   (D) 2070","output":"1. Given that the sequence of positive numbers (left{a_nright}) has a sum of the first (n) terms denoted by (b_n), and the product of the first (n) terms of (b_n) is (c_n), and given the equation (b_n + c_n = 1). 2. It is mentioned that:    [    b_{n} = frac{c_{n}}{c_{n-1}} quad text{for } n geq 2 quad text{and} quad c_{1}=b_{1}    ]     3. Therefore:    [    frac{c_{n}}{c_{n-1}} + c_n = 1     ] 4. From this, we get:    [    frac{c_n}{c_{n-1}} + c_n = 1    ] 5. Dividing both sides by (c_n):    [    frac{1}{c_{n-1}} + 1 = frac{1}{c_n}    ] 6. Rearranging gives:    [    frac{1}{c_n} - frac{1}{c_{n-1}} = 1    ] 7. This equation implies (left{frac{1}{c_n}right}) forms an arithmetic sequence with the first term (2) and a common difference of (1). 8. So we can write:    [    frac{1}{c_n} = 2 + (n-1) cdot 1 = n + 1    ] 9. Hence:    [    c_n = frac{1}{n+1}    ] 10. And given that (b_n + c_n = 1), we substitute (c_n):     [     b_n = 1 - c_n = 1 - frac{1}{n+1} = frac{n}{n+1}     ] 11. Now, let's find (a_n). We know (a_n = b_n - b_{n-1}):     [     a_n = frac{n}{n+1} - frac{n-1}{n} = frac{n^2 - (n^2 - 1)}{n(n+1)} = frac{1}{n(n+1)}     ] 12. Let us find (frac{1}{a_n}):     [     frac{1}{a_n} = n(n+1)     ] 13. We need to find the number closest to (2011) in the form (n(n+1)). Checking nearby values:     [     44 times 45 = 1980 quad text{and} quad 45 times 46 = 2070     ] 14. Since (2011) is closer to (1980) than (2070), the number in the sequence (left{frac{1}{a_n}right}) closest to (2011) is: [ boxed{text{1980}} ]"},{"instruction":"A store had 40 oranges in a bin. They threw away some of the old ones and put 7 new ones in the bin. There are now 10 oranges in the bin. How many old oranges did they throw away?","output":"Let's call the number of old oranges thrown away \\"x.\\" Originally, there were 40 oranges in the bin. After throwing away x oranges and adding 7 new ones, there are now 10 oranges in the bin. So the equation to represent this situation is: 40 - x + 7 = 10 Now, let's solve for x: 40 - x + 7 = 10 40 + 7 = 10 + x 47 = 10 + x 47 - 10 = x 37 = x Therefore, they threw away boxed{37}  old oranges."},{"instruction":"The condition The coordinates of point (A) are ((kpi,0), k in mathbb{Z}) is a ____ condition for The graph of (y = tan x) is symmetric about point (A). (Fill in the blank with either unnecessary and sufficient condition, necessary but not sufficient condition, sufficient and necessary condition, or neither sufficient nor necessary condition).","output":"**Analysis** This question mainly examines the judgment of sufficient and necessary conditions. **Solution** Given that \\"The coordinates of point (A) are ((kpi,0), k in mathbb{Z})\\", then \\"The graph of (y = tan x) is symmetric about point (A)\\"; If \\"The graph of (y = tan x) is symmetric about point (A)\\", then the coordinates of point (A) would be (left( frac{kpi}{2},0right)), Therefore, the answer is a sufficient but not necessary condition. boxed{text{Sufficient but not necessary condition}}"},{"instruction":"Compute [sum_{n=1}^{100} frac{1}{n^3 + n^2}.]","output":"First, we note that [frac{1}{n^3 + n^2} = frac{1}{n^2(n+1)}.] We can decompose this further using partial fractions: [frac{1}{n^2(n+1)} = frac{A}{n} + frac{B}{n^2} + frac{C}{n+1}.] To find A, B, and C, we equate: [1 = A cdot n(n+1) + B cdot (n+1) + C cdot n^2.] Setting n=0, we get B = 1. Setting n=-1, we get C = -1. For A, by substituting in B=1 and C=-1: [1 = A cdot n^2 + A cdot n + n + 1 - n^2,] [0 = (A-1) cdot n^2 + (A+1) cdot n + 1,] Fixing A, (A-1) = 0 and (A+1) = 0 indicates A=1.  This simplifies the fraction to: [frac{1}{n^2(n+1)} = frac{1}{n} - frac{1}{n^2} - frac{1}{n+1}.] Now, we compute the sum: [sum_{n=1}^{100} left(frac{1}{n} - frac{1}{n^2} - frac{1}{n+1}right).] This breaks down into three parts: [left(sum_{n=1}^{100} frac{1}{n}right) - left(sum_{n=1}^{100} frac{1}{n^2}right) - left(sum_{n=2}^{101} frac{1}{n}right).] Since the sum from 2 to 101 is simply (sum_{n=1}^{100} frac{1}{n}) - 1 + frac{1}{101}, this simplifies to: [1 - left(sum_{n=1}^{100} frac{1}{n^2}right) - frac{1}{101}.] Now, sum_{n=1}^{100} frac{1}{n^2} is best left as is unless a specific numerical approximation is needed. Thus, the final result is: [boxed{1 - sum_{n=1}^{100} frac{1}{n^2} - frac{1}{101}}.]"},{"instruction":"Given that the equation of circle A is (x+3)^{2}+y^{2}=9, and the equation of circle B is (x1)^{2}+y^{2}=1, find the external common tangent lines of circle A and circle B.","output":"Let the external common tangent lines intersect the x-axis at (t,0). Then, according to the property of external common tangents, we have: frac{t-1}{t+3}=frac{R_A-R_B}{d}=frac{3-1}{3}=frac{1}{3} Solving for t, we get t=3. Now, let the equation of the external common tangent lines be y=k(x-3) (or kx-y-3k=0). Since the distance from the center of circle A to the tangent line equals the radius of circle A, we have: frac{|-6k|}{sqrt{k^{2}+1}}=3 Solving for k, we get k=pmfrac{sqrt{3}}{3}. Therefore, the equations of the external common tangent lines of circle A and circle B are: boxed{y=pmfrac{sqrt{3}}{3}(x-3)}"},{"instruction":"Given proposition p: f(x) = frac {1}{x} is a decreasing function on its domain; proposition q: g(x) = cos(x + frac {}{2}) is an odd function. The true proposition among the following options is (   ): A: p  q B: (p)  (q) C: (p)  q D: p  (q)","output":"f(x) = frac {1}{x} is not a decreasing function on its domain, so proposition p is false. q: g(x) = cos(x + frac {}{2}) = -sin(x) is an odd function, so proposition q is true. Therefore, (p)  q is the true proposition, and the rest are false propositions. Hence, the answer is boxed{text{C}}. According to the given conditions, judge the truth or falsity of propositions p and q, and determine the truth or falsity of compound propositions. This question mainly examines the judgment of the truth or falsity of compound propositions, and finding out the truth or falsity of propositions p and q is the key to solving this question."},{"instruction":"Given that the point left(4a,2bright)left(a gt 0,b gt 0right) lies on the common chord of circles C:x^{2}+y^{2}=4 and M:left(x2right)^{2}+left(y2right)^{2}=4, then the minimum value of frac{1}{a}+frac{2}{b} is ______.","output":"To solve the given problem, we start by understanding the equations of the circles C and M: 1. Circle C has the equation x^{2}+y^{2}=4. 2. Circle M has the equation left(x-2right)^{2}+left(y-2right)^{2}=4. The common chord of these circles lies on the line that is the geometric place of their intersection points. To find this line, we solve the system of equations given by the two circles: [ left{begin{array}{l} x^{2}+y^{2}=4  (x-2)^{2}+(y-2)^{2}=4 end{array}right. ] Expanding and simplifying the second equation gives us: [ x^2 - 4x + 4 + y^2 - 4y + 4 = 4 ] Subtracting the first equation from this, we get: [ -4x - 4y + 8 = 0 implies x + y = 2 ] Thus, the equation of the line containing the common chord is x + y = 2. Given a point (4a, 2b) lies on this line, we substitute x = 4a and y = 2b into the line's equation: [ 4a + 2b = 2 ] We are interested in finding the minimum value of frac{1}{a} + frac{2}{b}. Multiplying both sides of the equation 4a + 2b = 2 by frac{1}{2}, we get: [ 2a + b = 1 ] Using the AM-GM inequality, we have: [ frac{1}{2}left(frac{1}{a} + frac{2}{b}right)(2a + b) geqslant sqrt{frac{1}{a} cdot frac{2}{b}} cdot sqrt{2a cdot b} = 2sqrt{2} ] Simplifying further, we find: [ frac{1}{a} + frac{2}{b} geqslant 4sqrt{2} cdot sqrt{2} = 8 ] Equality holds when b = 4a, which means the minimum value of frac{1}{a} + frac{2}{b} is indeed 8. Therefore, the answer is boxed{8}."},{"instruction":"Paul got a box of some crayons for his birthday. By the end of the school year, he had either lost or given away 70 of them. He had 183 crayons left by the end of the school year. How many crayons did he get for his birthday?","output":"To find out how many crayons Paul got for his birthday, we need to add the number of crayons he lost or gave away to the number of crayons he had left at the end of the school year. Number of crayons lost or given away: 70 Number of crayons left: 183 Total number of crayons Paul got for his birthday = Number of crayons lost or given away + Number of crayons left Total number of crayons = 70 + 183 Total number of crayons = 253 Paul got boxed{253}  crayons for his birthday."},{"instruction":"The least common multiple (LCM) of ( x ), ( 15 ), and ( 21 ) is ( 105 ). What is the greatest possible value of ( x )?","output":"First, we need to find the prime factorization of ( 15 ) and ( 21 ), and compare it with ( 105 ): [ 15 = 3 cdot 5, quad 21 = 3 cdot 7, quad 105 = 3 cdot 5 cdot 7. ] Since the LCM of ( 15 ) and ( 21 ) is already ( 105 ) (coinciding with ( 3 cdot 5 cdot 7 )), and this LCM should also cover ( x ), we can set ( x ) to be a factor of ( 105 ) that wont introduce any new prime factors. To retain the same LCM of ( 105 ), ( x ) must be a product of the primes ( 3 ), ( 5 ), and ( 7 ) in any multiplicities that do not exceed those in ( 105 ). The candidates for ( x ) can thus be any of ( 1, 3, 5, 7, 15, 21, 35, 105 ). The greatest possible ( x ) that still ensures the LCM of ( x ), ( 15 ), and ( 21 ) remains ( 105 ) is ( boxed{105} )."},{"instruction":"Find the point on the plane 5x  3y + 2z = 40 that is closest to the point (3,1,4).","output":"Let ( A = (3,1,4) ), and let ( P ) be the point on the plane which is closest to ( A ). We need to find ( P ) such that the distance from ( A ) to ( P ) is minimized. This occurs when the vector ( overrightarrow{AP} ) is parallel to the normal vector of the plane. For the plane ( 5x - 3y + 2z = 40 ), the normal vector is ( begin{pmatrix} 5  -3  2 end{pmatrix} ). Thus, [ overrightarrow{AP} = t begin{pmatrix} 5  -3  2 end{pmatrix} ] for some scalar ( t ). Representing ( P ) in terms of ( t ), we get  [ P = (3 + 5t, 1 - 3t, 4 + 2t). ] Substituting these into the plane equation, we calculate [ 5(3 + 5t) - 3(1 - 3t) + 2(4 + 2t) = 40. ] This simplifies to: [ 15 + 25t - 3 + 9t + 8 + 4t = 40, ] [ 25t + 9t + 4t = 40 - 15 - 3 - 8, ] [ 38t = 14, ] [ t = frac{14}{38} = frac{7}{19}. ] Thus, the coordinates of ( P ) are: [ P = left( 3 + 5 times frac{7}{19}, 1 - 3 times frac{7}{19}, 4 + 2 times frac{7}{19} right) = left( 3 + frac{35}{19}, 1 - frac{21}{19}, 4 + frac{14}{19} right). ] Simplifying the above coordinates, we get [ P = left( frac{92}{19}, frac{-2}{19}, frac{90}{19} right). ] Thus, the closest point on the plane to ( A ) is [ P = boxed{left( frac{92}{19}, frac{-2}{19}, frac{90}{19} right)}. ]"},{"instruction":"A sufficient condition for a gt b is: A: e^{ab} gt 0 B: lnfrac{a}{b}0 C: a^{a} gt b^{b} D: frac{1}{a}frac{1}{b}0","output":"Let's analyze each option step by step: **Option A: e^{a-b} gt 0** For any real number x, e^x gt 0. Thus, e^{a-b} gt 0 for any real values of a and b, which means a-b can be positive, zero, or negative. Therefore, this condition does not necessarily imply a gt b. **Option B: lnfrac{a}{b}0** Given lnfrac{a}{b}0, we can rewrite this as lnfrac{a}{b}ln1 because ln1 = 0. This implies frac{a}{b}1, which means a gt b when both a and b are positive. However, if a lt 0 and b lt 0, then frac{a}{b}1 would imply a lt b, which contradicts the condition a gt b. Therefore, option B is incorrect. **Option C: a^{a} gt b^{b}** Considering two cases:  - Case 1: Let a=2 and b=1, we find that 2^2 gt 1^1, which satisfies a gt b. - Case 2: Let a=-frac{2}{3} and b=1, we find that (-frac{2}{3})^{-frac{2}{3}} gt 1^1, which satisfies a^{a} gt b^{b} but a lt b. Thus, a^{a} gt b^{b} does not necessarily imply a gt b, making option C incorrect. **Option D: frac{1}{a}frac{1}{b}0** Given frac{1}{a}frac{1}{b}0, it implies that both frac{1}{a} and frac{1}{b} are negative, which means both a and b are negative. Since frac{1}{a}frac{1}{b}, by inverting both sides, we get b lt a. Given that both a and b are negative, this condition correctly implies a gt b. Therefore, the correct answer is boxed{text{D}}."},{"instruction":"There are two numbers with a difference of 1375. On dividing the larger number by the smaller, we get 6 as quotient and a certain remainder. The larger number is 1632. What is the remainder when the larger number is divided by the smaller number?","output":"Let's denote the smaller number as ( S ) and the larger number as ( L ). Given that the difference between the two numbers is 1375, we can write: [ L - S = 1375 ] We are also given that the larger number is 1632, so: [ L = 1632 ] Now, we can substitute the value of ( L ) into the first equation: [ 1632 - S = 1375 ] Solving for ( S ), we get: [ S = 1632 - 1375 ] [ S = 257 ] Now, we are told that when the larger number is divided by the smaller number, the quotient is 6 and there is a certain remainder. Let's denote the remainder as ( R ). The division can be represented as: [ L = 6S + R ] Substituting the known values of ( L ) and ( S ) into this equation, we get: [ 1632 = 6 times 257 + R ] [ 1632 = 1542 + R ] Solving for ( R ), we get: [ R = 1632 - 1542 ] [ R = 90 ] Therefore, the remainder when the larger number (1632) is divided by the smaller number (257) is boxed{90} ."},{"instruction":"Point ( E ) lies on the extension of side ( AC ) of equilateral triangle ( ABC ) beyond point ( C ). Point ( K ) is the midpoint of segment ( CE ). The line passing through point ( A ) perpendicular to ( AB ) and the line passing through point ( E ) perpendicular to ( BC ) intersect at point ( D ). Find the angles of triangle ( BKD ).","output":"1. **Identify Key Points and Angles:**     Given a regular triangle ( triangle ABC ) with point ( E ) on the extension of side ( AC ) beyond point ( C ). Point ( K ) is the midpoint of segment ( CE ). A line passing through point ( A ) perpendicular to ( AB ) intersects with a line passing through ( E ) perpendicular to ( BC ) at point ( D ). We need to find the angles of ( triangle BKD ). 2. **Determine Configuration and Proven Points:**     Let's denote ( M ) as the point of intersection of lines ( BC ) and ( ED ). Notice that both ( angle BAD ) and ( angle BMD ) are ( 90^circ ). By these properties, points ( A ) and ( M ) would lie on a circle with diameter ( BD ). 3. **Evaluate Right Triangles and Symmetric Properties:**     Since ( MK ) is the median to the hypotenuse in right triangle ( triangle CME ), it follows that ( CK = KM) and both are thus half of ( CE ):     [     CK = KM     ] 4. **Equality of Angles:**     From the properties of the equilateral triangle ( triangle ABC ), we know:     [     angle BAC = angle BCA = angle CKB = 60^circ     ]     [     angle BKD = angle CKM = 60^circ     ]     5. **Concluding the Full Solution:**     Given that ( triangle BKD ) contains the ( 90^circ ) angle due to ( angle BKD = 90^circ ), and that the median ( MK ) divides ( triangle CME ) symmetrically leading to triangles of ( 60^circ ):     [     angle BDK = angle BAK = 60^circ     ]     Finally, by angle sum property of triangle ( triangle BDK ), the remaining angle:     [     theta = 180^circ - 90^circ - 60^circ = 30^circ     ] # Conclusion: Thus, the angles of ( triangle BKD ) are ( 90^circ, 60^circ, ) and ( 30^circ ). [ boxed{90^circ, 60^circ, 30^circ} ]"},{"instruction":"Sarah is trying to fence a rectangular area containing at least 100 sq. ft while using the least amount of material to build the fence. The length of the rectangular area should be 15 ft longer than the width. What should the width, in ft, be?","output":"To solve the problem, we start by setting up an equation based on the information given. We know that the area of the rectangle must be at least 100 square feet, and the length is 15 feet longer than the width. Let's denote the width as w. Therefore, the length can be represented as w + 15. The area of a rectangle is given by the product of its length and width, so we have: 1. The inequality representing the area requirement: w(w + 15) ge 100. 2. Distributing the left-hand side and moving all terms to one side gives us a quadratic inequality:  begin{align*} w^2 + 15w &ge 100  w^2 + 15w - 100 &ge 0. end{align*} 3. To solve this inequality, we factor the quadratic expression: begin{align*} w^2 + 15w - 100 &= 0  (w - 5)(w + 20) &= 0. end{align*} 4. The factored form gives us two possible solutions for w: w = 5 and w = -20. However, since a width of -20 feet does not make sense in this context (as dimensions cannot be negative), we discard this solution. 5. Therefore, the smallest width that satisfies the condition of having an area of at least 100 square feet, while using the least amount of material for the fence, is boxed{5} feet."},{"instruction":"A waiter had 7 tables he was waiting on, with 7 women and some men at each table. The waiter had a total of 63 customers. How many men were at each table?","output":"Let's denote the number of men at each table as M. Since there are 7 women at each table, the total number of women across all 7 tables is 7 tables * 7 women/table = 49 women. The total number of customers is 63, which includes both men and women. If we subtract the total number of women (49) from the total number of customers (63), we get the total number of men: 63 customers - 49 women = 14 men Now, we need to find out how many men were at each table. Since there are 7 tables, we divide the total number of men by the number of tables: 14 men / 7 tables = 2 men/table So, there were boxed{2}  men at each table."},{"instruction":"Let  n  be a positive integer. For a permutation  a_1, a_2, dots, a_n  of the numbers  1, 2, dots, n  we define   b_k = min_{1 leq i leq k} a_i + max_{1 leq j leq k} a_j   We say that the permutation  a_1, a_2, dots, a_n  is *guadiana* if the sequence  b_1, b_2, dots, b_n  does not contain two consecutive equal terms. How many guadiana permutations exist?","output":"**    - We biject guadiana permutations with (0-1) sequences of length (n-1).    - By the same argument as in the first solution, we must have either (a_k = M_k) or (a_k = m_k) for each (k geq 2). Thus, we can assign to each guadiana permutation the (0-1) sequence (x_1, x_2, dots, x_{n-1}) where (x_i = 1) if and only if (a_{i+1} = M_{i+1}).    - We now reconstruct a guadiana permutation from its (0-1) sequence. Assume that there are exactly (m) zeroes in the sequence, so (a_k = m_k) for (k geq 2) exactly (m) times.    - Notice that if (a_k = m_k), then (a_k < a_1), so there exist at least (m) values in the permutation that are less than (a_1). Similarly, there are at least (n-1-m) values in the permutation that are greater than (1). This clearly implies that (a_1 = m+1).    - Furthermore, the values less than (a_1) must form a decreasing subsequence in the permutation, as (a_1 > a_i > a_j) implies (m_j = a_j < a_i = m_i), and because ((m_i)) is clearly a decreasing sequence, this implies (j > i). Similarly, the values greater than (a_1) must form an increasing subsequence. Because their positions are given by the (0-1) string, this allows us to reconstruct the permutation uniquely.    - So the number of guadiana permutations is equal to the number of (0-1) sequences of length (n-1), which is clearly (2^{n-1}). The final answer is (boxed{2^{n-1}})"},{"instruction":"(1) sqrt {18}  sqrt {8} + sqrt { frac {1}{8}} (2) (1+ sqrt {3})(2 sqrt {3}) (3) frac { sqrt {15}+ sqrt {60}}{ sqrt {3}}3 sqrt {5} (4) ( sqrt {7}+ sqrt {3})( sqrt {7} sqrt {3}) sqrt {36}","output":"(1) The original expression =3 sqrt {2} - 2 sqrt {2} + frac { sqrt {2}}{4} = frac {5 sqrt {2}}{4} boxed{frac {5 sqrt {2}}{4}} (2) The original expression =2- sqrt {3}+2 sqrt {3}-3 = sqrt {3}-1 boxed{sqrt {3}-1} (3) The original expression = sqrt { frac {15}{3}}- sqrt { frac {60}{3}}-3 sqrt {5} = sqrt {5}-2 sqrt {5}-3 sqrt {5} =-5 sqrt {5} boxed{-5 sqrt {5}} (4) The original expression =7-3-6 =-2 boxed{-2}"},{"instruction":"the diagram, if points   A ,   B  and   C  are points of tangency, then   x  equals:\\r [asy]unitsize(5cm); defaultpen(linewidth(.8pt)+fontsize(8pt)); dotfactor=3; pair A=(3*sqrt(3)/32,9/32), B=(3*sqrt(3)/32, 9/32), C=(0,9/16); pair O=(0,3/8); draw((2/3,9/16)(2/3,9/16)); draw((2/3,1/2)(sqrt(3)/6,1/2)(0,0)(sqrt(3)/6,1/2)(2/3,1/2)); draw(Circle(O,3/16)); draw((2/3,0)(2/3,0)); label( A ,A,SW); label( B ,B,SE); label( C ,C,N); label( frac{3}{8} ,O); draw(O+.07*dir(60)O+3/16*dir(60),EndArrow(3)); draw(O+.07*dir(240)O+3/16*dir(240),EndArrow(3)); label( frac{1}{2} ,(.5,.25)); draw((.5,.33)(.5,.5),EndArrow(3)); draw((.5,.17)(.5,0),EndArrow(3)); label( x ,midpoint((.5,.5)(.5,9/16))); draw((.5,5/8)(.5,9/16),EndArrow(3)); label( 60^{circ} ,(0.01,0.12)); dot(A); dot(B); dot(C);[/asy]  textbf{(A)} frac {3}{16} qquad textbf{(B)} frac {1}{8} qquad textbf{(C)} frac {1}{32} qquad textbf{(D)} frac {3}{32} qquad textbf{(E)} frac {1}{16}","output":"1. Identify the given information:    - The distance from the center of the circle to the intersection point of the tangents is frac{3}{8}.    - The radius of the circle is frac{3}{16}.    - The distance from the center of the circle to the line segment CD is frac{1}{2}. 2. Calculate the total distance from the center of the circle to the point C:    [    CD = frac{3}{8} + frac{3}{16}    ] 3. Convert the fractions to a common denominator to add them:    [    frac{3}{8} = frac{6}{16}    ]    [    CD = frac{6}{16} + frac{3}{16} = frac{9}{16}    ] 4. Set up the equation for the total distance from the center of the circle to the point C:    [    CD = x + frac{1}{2}    ] 5. Substitute the known value of CD:    [    frac{9}{16} = x + frac{1}{2}    ] 6. Convert frac{1}{2} to a fraction with a denominator of 16:    [    frac{1}{2} = frac{8}{16}    ] 7. Substitute and solve for x:    [    frac{9}{16} = x + frac{8}{16}    ]    [    x = frac{9}{16} - frac{8}{16}    ]    [    x = frac{1}{16}    ] 8. Therefore, the value of x is:    [    boxed{frac{1}{16}}    ]"},{"instruction":"Given m, n in mathbb{R}, and the sets A = {2, log_{7}m}, B = {m, n}. If A cap B = {0}, then m + n =   A: 1   B: 2   C: 4   D: 8","output":"According to A = {2, log_{7}m}, B = {m, n}, and A cap B = {0}, we get log_{7}m = 0. Solving this gives m = 1;   Therefore, n = 0,   Therefore, m + n = 1 + 0 = 1.   Hence, the correct choice is: boxed{A}.   **Analysis:** Based on A cap B = {0}, we determine log_{7}m = 0, calculate the value of m, thereby finding the value of n, and then calculate the value of m + n."},{"instruction":"Given a triangle ( triangle ABC ) and a point ( M ) on segment ( AC ) (distinct from its endpoints), construct points ( P ) and ( Q ) on the sides ( AB ) and ( BC ) respectively such that ( PQ parallel AC ) and ( angle PMQ = 90^circ ) using only a compass and straightedge.","output":"To solve the problem of constructing points P and Q on the sides AB and BC of triangle ABC such that PQ parallel AC and angle PMQ = 90^circ, follow these steps: 1. **Draw Triangle and Point M:**    Draw the triangle triangle ABC and identify the point M on the segment AC. 2. **Construct Line Parallel to AC:**    From point M, construct a line l parallel to AC. This can be achieved using a compass and straightedge.    - Place the compass point on A and draw an arc that intersects AC and extends beyond M.    - Without changing the compass width, draw a similar arc from point C.    - Use a straightedge to draw a line tangent to both arcs which will be parallel to AC. 3. **Identify Intersection Points:**    Let this parallel line intersect AB and BC at points P and Q respectively. 4. **Ensure Right Angle at PMQ:**    Verify that angle PMQ = 90^circ. This can be done by checking the slopes of lines MP and MQ or utilizing the construction tools directly if the right-angle is ensured in the construction step. Let us detail the verification:    - Calculate the slope of PQ, which is parallel to AC, indicating both slopes are equal.    - Ensure PM and MQ form a right angle at M by constructing a perpendicular line from M to the line PQ. By these precise steps, we have constructed the required points P and Q such that PQ parallel AC and angle PMQ = 90^circ. Thus, the solution is complete.  blacksquare"},{"instruction":"parallelogram ABCD, a circle passing through vertex A intersects the extended lines of sides AB and AD at points F and H, respectively, and intersects the extended line of diagonal AC at point G. Prove that AB cdot AF + AD cdot AH = AC cdot AG.","output":"We are given a parallelogram (ABCD) with a circle passing through the vertex (A). This circle intersects the line extensions of sides (AB) and (AD) at points (F) and (H) respectively, and intersects the diagonal (AC) at point (G). We need to show that: [ AB cdot AF + AD cdot AH = AC cdot AG. ] 1. **Reflection and Intersection**:         Let (F') be the reflection of (F) across the perpendicular bisector of (AG). Consider the intersection point (M) where lines (AG) and (F'H) meet. 2. **Case Analysis**: Begin with the scenario where (F), (G), and (H) lie respectively on the rays from (A) towards (B), (C), and (D).        - Here, the line (AC) separates points (B) and (D), as well as (F) and (H). Consequently, (F) and (H) lie on different arcs of the circle divided by the chord (AG). 3. **Similar Triangles**:    We will prove the similarity of the triangles:        [    triangle AHM, quad triangle ACD, quad triangle F'GM, quad triangle CAB.    ]         - Considering angle congruences:        [    begin{aligned}    angle ACB = angle CAD &= angle HAM,     angle HAG &= angle HF'G = angle MF'G,    end{aligned}    ]         where the last two angles are inscribed angles subtended by the same arc.         - Also,        [    begin{aligned}    angle AHM &= angle AHF' = angle AGF',     angle MGF' &= angle FAG = angle CAB = angle ACD.    end{aligned}    ]     4. **Proportional Segments**:        From the similarity criteria, we obtain the following relationships:        [    frac{AH}{AM} = frac{AC}{AD}, quad frac{GF'}{GM} = frac{AC}{AB}.    ]        Noting that (GF' = AF) by the mirroring property, these ratios yield:        [    AD cdot AH = AC cdot AM, quad AB cdot AF = AC cdot GM.    ]     5. **Summation and Conclusion**:    By summing the equations and recognizing that (AM + MG = AG), we find:        [    AD cdot AH + AB cdot AF = AC cdot (AM + MG) = AC cdot AG.    ]        Thus, the desired relation is shown:    [    boxed{AB cdot AF + AD cdot AH = AC cdot AG}.    ] 6. **Verification for General Circle Positions**:    - We verify the equality holds for any position of the circle around (A), including when the circle is tangent to the rays opposite (AB) or (AD). Using reflection and symmetry arguments and considering segments with negative lengths when necessary, we ensure the equality remains valid across all circle positions.       This analysis confirms the correctness of the statement under varying geometrical configurations, ensuring its completeness and rigor.   boxed{AB cdot AF + AD cdot AH = AC cdot AG}"},{"instruction":"The graph shows the distribution of the number of children in the families of the students in Ms. Jordan's English class. The median number of children in the family for this distribution is text{(A)} 1qquadtext{(B)} 2qquadtext{(C)} 3qquadtext{(D)} 4qquadtext{(E)} 5","output":"To find the median number of children in the families of the students in Ms. Jordan's English class, we follow these steps: 1. **Identify the Total Number of Data Points**: The total number of families (data points) is given as thirteen. 2. **Determine the Position of the Median**: The median is the middle value in a data set that has been arranged in order of magnitude. Since there are 13 data points, the median will be the value at position:    [    frac{13 + 1}{2} = 7    ]    This means the median is the 7th value when the data is arranged in ascending order. 3. **Locate the Median Value**: Since the problem statement does not provide the detailed list of the number of children per family, but mentions that it is \\"easy to see from the right side that this number is 4,\\" we assume the data has been arranged, and the 7th value in this ordered list is 4. 4. **Conclusion**: The median number of children in the families of the students in Ms. Jordan's English class is 4. Thus, the correct answer is boxed{text{(D)} 4}."},{"instruction":"the interval [0, 2pi), the angle that has the same terminal side as  frac {3pi}{4} is ______.","output":"Solution: - frac {3pi}{4} = -2pi + frac {5pi}{4}, Therefore, in the interval [0, 2pi), the angle that has the same terminal side as - frac {3pi}{4} is frac {5pi}{4}, So, the answer is: boxed{frac {5pi}{4}} From - frac {3pi}{4} = -2pi + frac {5pi}{4}, we can directly write out the answer. This question examines the concept of angles with the same terminal side, which is a basic question."},{"instruction":"f 100^a = 7 and 100^b = 11, then find 20^{(1  a  b)/(2(1  b))}.","output":"Given: [ a = log_{100} 7 ] [ b = log_{100} 11 ] First, evaluate 1 - a - b: [ 1 - a - b = log_{100} 100 - log_{100} 7 - log_{100} 11 = log_{100} left( frac{100}{7 cdot 11} right) = log_{100} left( frac{100}{77} right) = log_{100} left( frac{100}{77} right) ] Next, evaluate 2(1 - b): [ 2 (1 - b) = 2 (log_{100} 100 - log_{100} 11) = 2 log_{100} left( frac{100}{11} right) ] Then, calculate frac{1 - a - b}{2(1 - b)}: [ frac{1 - a - b}{2(1 - b)} = frac{log_{100} left( frac{100}{77} right)}{2 log_{100} left( frac{100}{11} right)} = log_{frac{100}{11}} left( frac{100}{77} right) ] Finally, find 20^{(1 - a - b)/(2(1 - b))}: [ 20^{(1 - a - b)/(2(1 - b))} = 20^{log_{frac{100}{11}} left( frac{100}{77} right)} = left( frac{100}{11} right)^{log_{frac{100}{11}} left( frac{100}{77} right)} = frac{100}{77} ] Thus, [ 20^{(1 - a - b)/(2(1 - b))} = boxed{frac{100}{77}}. ]"},{"instruction":"A batsman scores 100 runs in the 11th inning, hitting 12 boundaries (fours) and 2 sixes, with a strike rate of 130. He also takes 1 wicket in the same inning. This performance increases his batting average by 5 runs per inning and his bowling average reduces by 3 runs per wicket. Calculate his new overall career batting and bowling averages after the 11th inning, considering his performances in the mentioned categories.","output":"To calculate the new overall career batting and bowling averages, we need to know the batsman's batting and bowling averages before the 11th inning. However, since that information is not provided, we can only calculate the changes in the averages based on the performance in the 11th inning. Let's start with the batting average: Before the 11th inning, let's assume the batsman's batting average was ( A ) runs per inning. After scoring 100 runs in the 11th inning, his batting average increases by 5 runs per inning. Therefore, his new batting average after the 11th inning would be ( A + 5 ). Now, let's calculate the bowling average: Similarly, before the 11th inning, let's assume the bowler's bowling average was ( B ) runs per wicket. After taking 1 wicket in the 11th inning, his bowling average reduces by 3 runs per wicket. Therefore, his new bowling average after the 11th inning would be ( B - 3 ). Without the initial averages before the boxed{11th}  inning, we cannot calculate the exact new overall career averages. If you can provide the initial averages, I can calculate the new averages for you."},{"instruction":"Given a circle odot O and points A and B in the plane. If the radius of circle odot O is 2 cm, the length of segment OA is 3 cm, and the length of segment OB is 2 cm, then the relationship between line AB and circle odot O is ( ). A: Do not intersect B: Intersect C: Tangent D: Intersect or Tange","output":"Given the information, we start by analyzing the positions of points A and B relative to circle odot O with radius 2 cm. 1. The radius of circle odot O is 2 cm. 2. The length of segment OA is 3 cm, which is greater than the radius of the circle. This implies that point A is outside circle odot O. 3. The length of segment OB is 2 cm, which is equal to the radius of the circle. This implies that point B is on circle odot O. From these observations, we can conclude the relationship between line AB and circle odot O. Since point A is outside the circle and point B is on the circle, line AB could either intersect the circle at another point apart from B or be tangent to the circle at point B.  Therefore, the correct relationship between line AB and circle odot O is either intersect or tangent. Thus, the answer is boxed{D}."},{"instruction":"Consider two concentric circles in the same plane with radii ( R ) and ( r ) where ( R > r ). Let ( P ) be a fixed point on the circumference of the smaller circle, and ( B ) be a moving point on the circumference of the larger circle. The line ( BP ) intersects the circumference of the larger circle at another point ( C ). A line passing through point ( P ) and perpendicular to ( BP ) intersects the circumference of the smaller circle at another point ( A ) (if the line is tangent to the smaller circle at ( P ), then ( A = P )). (1) Find the set of values for the expression ( BC^2 + CA^2 + AB^2 ). (2) Find the trajectory of the midpoint of the line segment ( AB ).","output":"# Part (1) Consider two concentric circles lying on the same plane, with radii R and r where R > r. Let P be a fixed point on the circumference of the smaller circle, and B be a variable point on the circumference of the larger circle. The line BP intersects the larger circle at another point C.  Suppose we draw a line through point P that is perpendicular to BP. This line intersects the circumference of the smaller circle at another point A (if A coincides with P, then A = P). To find the expression for BC^2 + CA^2 + AB^2: 1. Draw perpendiculars BC and CC' forming a rectangle with BP = B'C'. Note that B'C' passes through point A. 2. Suppose B'C' meets the smaller circle again at A'. The distance from the center O to line BC is equal to the distance from O to AA'. Let z_{B}, z_{C}, z_{A} represent the complex coordinates of points B, C, A, respectively. Similarly, let z_{A'} be the complex coordinate of point A'.    Using the geometric relationship:    [    z_B + z_r + z_A + z_A = 0 implies z_A + z_B + z_C = -z_{A'}    ] 3. Calculate BC^2 + CA^2 + AB^2 using the complex conjugate properties:    [    begin{aligned}    BC^2 + CA^2 + AB^2 &= (z_C - z_B)(overline{z_C} - overline{z_B}) + (z_A - z_C)(overline{z_A} - overline{z_C}) + (z_B - z_A)(overline{z_B} - overline{z_A})    &= 4R^2 + 2r^2 - (z_B cdot overline{z_A} + z_A cdot overline{z_B} + z_C cdot overline{z_B} + z_B cdot overline{z_C} + z_A cdot overline{z_C} + z_C cdot overline{z_A})    &= 6R^2 + 3r^2 - (z_A + z_B + z_C)(overline{z_A} + overline{z_B} + overline{z_C})    &= 6R^2 + 2r^2 quad (text{since } z_A + z_B + z_C text{ equal fixed value})    end{aligned}    ] Therefore, ( BC^2 + CA^2 + AB^2 = 6R^2 + 2r^2 ) as a constant value. The set of values for the expression is  {6R^2 + 2r^2}. # Part (2) To determine the trajectory of the midpoint of segment AB: 1. Since PBBA forms a rectangle, the midpoint Q of segment AB is also the midpoint of segment PB'. Given the complex coordinates, we have:    [    z_{B'} + z_P = 2z_Q implies z_{Q} = frac{z_{B'} + z_P}{2}    ] 2. Since B' lies on the circumference of the larger circle, we have |z_{B'}| = R. Hence,    [    |2z_Q - z_P| = R implies left|z_Q - frac{z_{P}}{2}right| = frac{R}{2}    ] This implies that Q traces a circle with center at the midpoint of segment OP and radius frac{R}{2}. Thus, the geometric locus of the midpoint of AB is a circle with radius frac{R}{2} centered at the midpoint of OP. # Conclusion 1. The set of values for {BC^2 + CA^2 + AB^2} is:    [    boxed{{6R^2 + 2r^2}}    ] 2. The trajectory of the midpoint of segment AB is:    [    boxed{text{a circle of radius } frac{R}{2} text{ centered at the midpoint of segment } OP}    ]"},{"instruction":"an isosceles triangle, one of the angles opposite an equal side measures 50^{circ}. Calculate the measure of the triangle's largest angle.","output":"Since it is given that the triangle is isosceles, the angles opposite the equal sides must be congruent. Therefore, the two base angles in this triangle each measure 50^{circ}. The sum of the angles in any triangle must be 180^{circ}. Hence, the measure of the third angle, which is the vertex angle, can be calculated as follows: [ 180^circ - (50^circ + 50^circ) = 180^circ - 100^circ = boxed{80^circ} ]"},{"instruction":"Let  f: mathbb {R} to mathbb {R}  be a concave function and   g: mathbb {R} to mathbb {R}  be a continuous function . If     f (x + y) + f (xy) 2f (x) = g (x) y^2    for all  x, y in mathbb {R},   prove that  f   is a second degree polynomial.","output":"1. **Given Assertion**: Let ( P(x, y) ) denote the given assertion:    [    f(x + y) + f(x - y) - 2f(x) = g(x) y^2 quad forall x, y in mathbb{R}    ] 2. **Claim 1: ( g ) is linear**:    - Consider the expressions:      [      2 cdot P(x, y) - P(x, 2y) + P(x + y, y) + P(x - y, -y)      ]    - Substituting the given assertion into these expressions, we get:      [      2[f(x + y) + f(x - y) - 2f(x)] - [f(x + 2y) + f(x - 2y) - 2f(x)] + [f(x + 2y) + f(x) - 2f(x + y)] + [f(x) + f(x - 2y) - 2f(x - y)]      ]    - Simplifying, we obtain:      [      2g(x) y^2 - g(x) (2y)^2 + g(x + y) y^2 + g(x - y) y^2 = 0      ]      [      2g(x) y^2 - 4g(x) y^2 + g(x + y) y^2 + g(x - y) y^2 = 0      ]      [      -2g(x) y^2 + g(x + y) y^2 + g(x - y) y^2 = 0      ]      [      -2g(x) + g(x + y) + g(x - y) = 0      ]      [      2g(x) = g(x + y) + g(x - y) quad forall x, y in mathbb{R}      ]    - This is the Cauchy functional equation for ( g ). Since ( g ) is continuous, it follows that ( g ) must be a linear function. Therefore, we can write:      [      g(x) = Mx + N      ] 3. **Claim 2: ( g ) is constant**:    - Substitute ( g(x) = Mx + N ) into the original assertion:      [      f(x + y) + f(x - y) - 2f(x) = (Mx + N) y^2      ]    - Consider ( P(x, x) ):      [      f(2x) + f(0) - 2f(x) = (Mx + N) x^2      ]    - Since ( f ) is concave, ( f(0) leq 0 ). Let ( f(0) = C ):      [      f(2x) + C - 2f(x) = (Mx + N) x^2      ]    - For ( x = 0 ):      [      C = N cdot 0^2 = 0      ]    - Therefore, ( f(0) = 0 ). Now, consider the behavior of ( f ) for large ( x ):      [      f(2x) - 2f(x) = Mx^3 + Nx^2      ]    - Since ( f ) is concave, the term ( Mx^3 ) must be zero for all ( x ), implying ( M = 0 ). Thus, ( g(x) = N ), a constant function. 4. **Conclusion**:    - Let ( g(x) = 2B ) (a constant). The original assertion becomes:      [      f(x + y) + f(x - y) - 2f(x) = 2B y^2      ]    - Define ( h(x) = f(x) - Bx^2 ). Then:      [      h(x + y) + h(x - y) - 2h(x) = 0      ]    - This implies ( h ) satisfies the Jensen's functional equation, which means ( h ) is linear. Therefore, ( h(x) = Ax + C ).    - Hence, ( f(x) = Ax + Bx^2 + C ), a second-degree polynomial. The final answer is ( boxed{ f(x) = Ax + Bx^2 + C } )."},{"instruction":"f 3 cats can kill 3 rats in a certain amount of time, how long will it take a larger number of cats to kill the same number of rats, given that it takes 3 minutes for 100 cats to kill 100 rats?","output":"If 3 cats can kill 3 rats in a certain amount of time, it implies that each cat is killing one rat in that time frame. Therefore, the number of cats and the number of rats killed are directly proportional. Given that it takes 3 minutes for 100 cats to kill 100 rats, we can see that the ratio of cats to rats remains the same (1:1), and each cat is still killing one rat. Since the number of cats and rats is equal, and each cat kills one rat, the time it takes for any number of cats to kill the same number of rats will be the same, as long as the ratio remains 1:1. Therefore, regardless of the number of cats, as long as it's the same as the number of rats, it will take boxed{3}  minutes for that number of cats to kill the same number of rats."},{"instruction":"Which of the following equations has a curve that is symmetric about the yaxis?   A: x^2  x + y^2 = 1   B: x^2y + xy^2 = 1   C: x^2  y^2 = 1   D: x  y = 1","output":"**Answer:** To determine if a curve is symmetric about the y-axis, we substitute -x for x in the equation. If the equation remains unchanged, then the curve is symmetric about the y-axis. Therefore, the correct answer is boxed{text{C}}. **Analysis:** This is a straightforward problem. By substituting -x for x, if the equation remains unchanged, then the curve is symmetric about the y-axis."},{"instruction":"Beka flew some miles to visit her aunt. Jackson flew 563 miles to visit his aunt. Beka flew 310 more miles than Jackson. How many miles did Beka fly?","output":"If Beka flew 310 more miles than Jackson, and Jackson flew 563 miles, then Beka flew: 563 miles + 310 miles = 873 miles Beka flew boxed{873}  miles to visit her aunt."},{"instruction":"a mixture of milk and water, the quantity of water is 10%. To make the new mixture have 25% water, 14 liters of water should be added. What is the initial volume of the mixture?","output":"Let's denote the initial volume of the mixture as V liters. Since the quantity of water is 10% of the initial mixture, the volume of water in the initial mixture is 0.10V liters. When we add 14 liters of water to the mixture, the total volume of the mixture becomes V + 14 liters. We want the new mixture to have 25% water. Therefore, the volume of water in the new mixture should be 0.25(V + 14) liters. The volume of water in the new mixture is the sum of the initial volume of water (0.10V liters) and the added water (14 liters). So we can set up the following equation: 0.10V + 14 = 0.25(V + 14) Now, let's solve for V: 0.10V + 14 = 0.25V + 0.25 * 14 0.10V + 14 = 0.25V + 3.5 14 - 3.5 = 0.25V - 0.10V 10.5 = 0.15V V = 10.5 / 0.15 V = 70 The initial volume of the mixture is boxed{70}  liters."},{"instruction":"The two foci of the hyperbola frac{x^2}{a^2}frac{y^2}{b^2}=1 (a > 0,b > 0) are F_1 and F_2. If P is a point on it, and |PF_1|=3|PF_2|, then the range of the eccentricity of the hyperbola is (quad) A: (1,2) B: left( 1,2 right] C: (3,+infty ) D: left[ 3,+infty right)","output":"**Analysis** This question mainly examines the geometric meaning and properties of the hyperbola, and the relationship between the sides of a triangle. When solving the problem, pay attention to special positions to avoid missing the answer. **Solution** According to the hyperbola, we know that |PF_2|-|PF_1|=2a. Therefore, 3|PF_1|-|PF_1|=2a, therefore a=|PF_1|, |PF_2|=3a, In triangle PF_1F_2, |F_1F_2| < |PF_1|+|PF_2|, 2c < 4|PF_1|, c < 2|PF_1|=2a, therefore frac{c}{a} < 2 When p is the vertex of the hyperbola, frac{c}{a}=2, And since the eccentricity e > 1, therefore 1 < e leqslant 2, Hence, the correct choice is boxed{text{B}}."},{"instruction":"The solution set of the inequality system left{begin{array}{l}x30 2x51end{array}right. is ______.","output":"To solve the given system of inequalities, we proceed step by step: 1. **First Inequality: x - 3 geq 0** Starting with the first inequality, we isolate x: begin{align*} x - 3 &geq 0  x &geq 3 end{align*} 2. **Second Inequality: 2x - 5 < 1** For the second inequality, we again isolate x: begin{align*} 2x - 5 &< 1  2x &< 6  x &< 3 end{align*} 3. **Combining the Inequalities** We have found that x geq 3 from the first inequality and x < 3 from the second. These two conditions cannot be true at the same time for any real number x. Therefore, there is no value of x that satisfies both inequalities simultaneously. 4. **Conclusion** Given the analysis above, we conclude that the system of inequalities has boxed{text{no solution}}."},{"instruction":"Given the equation of the circle ( C ) as ( x^{2} + y^{2}  8x + 15 = 0 ), if there is at least one point on the line ( y = kx  2 ) (where ( k in mathbf{R} )) such that a circle with this point as its center and radius 1 intersects circle ( C ), then the maximum value of ( k ) is equal to ______.","output":"Given:  - Equation of the circle C is (x^{2} + y^{2} - 8x + 15 = 0). - Line (y = kx - 2) where (k in mathbb{R}). We need to find the maximum value of (k) such that a point (A) on the line can be the center of a circle of radius 1 that intersects the circle (C). 1. **Transform the circle equation:**    [    x^{2} + y^{2} - 8x + 15 = 0    ]    Complete the square for the (x) terms:    [    x^{2} - 8x = (x - 4)^{2} - 16    ]    Rewrite the equation:    [    (x - 4)^{2} + y^{2} = 1    ]    Therefore, the circle (C) has its center at ((4, 0)) and radius 1. 2. **Circle and line intersection condition:**    Point (A(x_0, kx_0 - 2)) lies on the line (y = kx - 2) and must be at most 2 units away from the center of circle (C):        The distance from point (A(x_0, kx_0 - 2)) to the center of the circle (C(4, 0)):    [    left| A C right| leq 2    ] 3. **Calculate the distance AC:**    The minimum distance from C(4, 0) to the line (y = kx - 2) is given by:    [    d = frac{| k cdot 4 - 0 - 2 |}{sqrt{k^{2} + 1}} = frac{|4k - 2|}{sqrt{k^{2} + 1}}    ]    Set the distance (d) to be less than or equal to 2:    [    frac{|4k - 2|}{sqrt{k^{2} + 1}} leq 2    ] 4. **Solve the inequality:**    [    frac{|4k - 2|}{sqrt{k^{2} + 1}} leq 2    ]    Squaring both sides:    [    left(frac{|4k - 2|}{sqrt{k^{2} + 1}}right)^2 leq 2^2     ]    [    frac{(4k - 2)^2}{k^{2} + 1} leq 4    ]    [    (4k - 2)^2 leq 4(k^{2} + 1)    ]    Expand and simplify:    [    16k^2 - 16k + 4 leq 4k^2 + 4    ]    [    12k^2 - 16k leq 0    ]    Factor the quadratic inequality:    [    4k(3k - 4) leq 0    ] 5. **Solve for (k):**    From the inequality (4k(3k - 4) leq 0), note the roots:    [    k = 0 quad text{or} quad k = frac{4}{3}    ]    and the parabola opens upwards ((a > 0)), testing intervals in ((-infty, 0]), (left[0, frac{4}{3}right]) and (left[frac{4}{3},infty):    [    0 leq k leq frac{4}{3}    ] Conclusion: The maximum value of (k) is: [ boxed{frac{4}{3}} ]"},{"instruction":"Given the function fleft(xright)=cos 2xcdot ln x, then the derivative of fleft(xright) is: A: sin 2xln x+frac{cos2x}{x} B: sin 2xln x+frac{cos2x}{x} C: 2sin 2xln x+frac{cos2x}{x} D: 2cos 2xln x+frac{sin2x}{x}","output":"Given the function fleft(xright)=cos 2xcdot ln x, we are asked to find the derivative of fleft(xright). To find the derivative, we apply the product rule of differentiation, which states that if we have a function g(x) = u(x)v(x), then the derivative of g(x), denoted as g'(x), is given by g'(x) = u'(x)v(x) + u(x)v'(x). In our case, u(x) = cos 2x and v(x) = ln x. First, we find the derivatives of u(x) and v(x) separately: 1. The derivative of u(x) = cos 2x with respect to x is given by the chain rule as u'(x) = -2sin 2x. 2. The derivative of v(x) = ln x with respect to x is v'(x) = frac{1}{x}. Applying the product rule: [ {f'}left(xright) = u'(x)v(x) + u(x)v'(x) = (-2sin 2x)cdot (ln x) + (cos 2x)cdot left(frac{1}{x}right) ] Simplifying: [ {f'}left(xright) = -2sin 2xcdot ln x + frac{cos 2x}{x} ] Therefore, the correct answer is boxed{C}."},{"instruction":"Camila and Maverick started watching an hour long movie. They paused the movie at a certain point and have 30 more minutes to watch the rest of the movie. At what point did they pause the movie in terms of the movie's length?","output":"If Camila and Maverick have 30 more minutes to watch the rest of the movie, and the movie is an hour long (which is 60 minutes), they paused the movie at the halfway point.  60 minutes (total length) - 30 minutes (remaining) = 30 minutes They paused the movie at the boxed{30-minute}  mark, which is halfway through the movie's length."},{"instruction":"There are three numbers 10, 11 and 12. What is the sum of the largest number and the next largest number?","output":"The largest number is 12 and the next largest number is 11.  The sum of these two numbers is: 12 + 11 = boxed{23} ."},{"instruction":"the year 1275, the Chinese mathematician Yang Hui of the Southern Song Dynasty posed the following problem: a rectangular field measures 650 paces in area, with the width being 1 pace less than the length. The question is, what are the width and length of the field? If we let the length be x paces, then the equation based on the problem can be written as ______.","output":"To solve the problem posed by Yang Hui, we start by letting the length of the rectangular field be x paces. Given that the width is 1 pace less than the length, we can express the width as x - 1 paces. The area of the rectangle is given as the product of its length and width, which is 650 paces squared. Therefore, we can set up the equation based on these relationships: [ begin{align*} text{Area} &= text{Length} times text{Width}  650 &= x times (x - 1) end{align*} ] This simplifies to the equation: [ x(x - 1) = 650 ] Thus, the equation based on the problem, which represents the relationship between the length and width of the field and its area, is: [ boxed{x(x - 1) = 650} ]"},{"instruction":"John drinks 2 energy drinks. 1 of them is a 12ounce drink with a certain amount of caffeine. The second drink is 3 times more caffeinated per ounce but only 2 ounces. He then takes a caffeine pill that has as much caffeine as his 2 drinks combined. He consumed 750 grams of caffeine. How much caffeine is in the first drink?","output":"Let's denote the amount of caffeine per ounce in the first drink as ( c ) grams. Since the first drink is 12 ounces, the total caffeine in the first drink is ( 12c ) grams. The second drink is 3 times more caffeinated per ounce, so it has ( 3c ) grams of caffeine per ounce. Since the second drink is only 2 ounces, the total caffeine in the second drink is ( 2 times 3c = 6c ) grams. The caffeine pill has as much caffeine as the two drinks combined, so the caffeine in the pill is ( 12c + 6c = 18c ) grams. The total caffeine consumed from the two drinks and the pill is ( 12c + 6c + 18c = 36c ) grams. We are told that John consumed 750 grams of caffeine in total, so we can set up the equation: [ 36c = 750 ] To find the value of ( c ), we divide both sides of the equation by 36: [ c = frac{750}{36} ] [ c = 20.8333... ] Since we are looking for the amount of caffeine in the first drink, we multiply ( c ) by 12 (the number of ounces in the first drink): [ 12 times c = 12 times 20.8333... ] [ 12 times c approx 250 ] Therefore, the first drink contains approximately boxed{250}  grams of caffeine."},{"instruction":"Let a=log_{7}3, b=log_{frac{1}{3}}7, c=3^{0.7}, then the relationship among a, b, c is (). A: a < b < c B: c < b < a C: b < c < a D: b < a < c","output":"To determine the relationship among a, b, c, we analyze each: - a=log_{7}3 represents the exponent to which the base 7 must be raised to produce 3. Since 3<7, it's clear that 0<a<1. - b=log_{frac{1}{3}}7 represents the exponent to which the base frac{1}{3} must be raised to produce 7. Since raising a fraction to a positive power results in a smaller fraction, and we want to get a larger number (7), b must be negative. Thus, b<0. - c=3^{0.7} is slightly less than 3^{1}=3 but greater than 1, so 1<c<3. From the above analysis, we can conclude that b<0, 0<a<1, and 1<c<3. Therefore, the correct relationship is b<a<c. The correct answer is boxed{text{D}}."},{"instruction":"Given that the diagonals of a rhombus are always perpendicular bisectors of each other, what is the area of a rhombus with side length sqrt{113} units and diagonals that differ by 10 units?","output":"Let x be half the length of the shorter diagonal, and x+5 be half the length of the longer diagonal. These form the legs of the right triangles created by the diagonals of the rhombus. By the Pythagorean theorem: [ x^2 + (x + 5)^2 = (sqrt{113})^2 ] Expanding and simplifying: [ x^2 + x^2 + 10x + 25 = 113 ] [ 2x^2 + 10x - 88 = 0 ] Dividing through by 2: [ x^2 + 5x - 44 = 0 ] Factoring, we find: [ (x - 4)(x + 11) = 0 ] So, x = 4 or x = -11. Discarding the negative solution, we use x = 4. The diagonals are 2x = 8 units and 2(x+5) = 18 units. The area of the rhombus is: [ text{Area} = frac{1}{2} times 8 times 18 = 72 text{ square units} ] Thus, the area of the rhombus is boxed{72} square units."},{"instruction":"Among all solutions of the system  begin{aligned} & x^{2}+y^{2}=4  & z^{2}+t^{2}=9  & x t+y z=6 end{aligned}  select those for which the value of x+z is the maximum.","output":"1. **Definition of Vectors:**    Define vectors (boldsymbol{a}) and (boldsymbol{b}) as follows:    [    boldsymbol{a} = (x, y), quad boldsymbol{b} = (t, z).    ] 2. **Magnitudes of Vectors:**    Based on the given system of equations, find the magnitudes of these vectors:    [    |boldsymbol{a}| = sqrt{x^2 + y^2} = 2, quad |boldsymbol{b}| = sqrt{z^2 + t^2} = 3.    ] 3. **Dot Product:**    The third equation in the system gives the dot product of vectors (boldsymbol{a}) and (boldsymbol{b}):    [    (boldsymbol{a}, boldsymbol{b}) = x t + y z = 6.    ] 4. **Equal Magnitude Condition:**    Given that ((boldsymbol{a}, boldsymbol{b}) = | boldsymbol{a}| cdot | boldsymbol{b}| = 6), and    [    | boldsymbol{a} | = 2, quad | boldsymbol{b} | = 3,    ]    it follows that:    [    6 = | boldsymbol{a}| cdot | boldsymbol{b}| = 2 cdot 3.    ]    This means that the angle between vectors (boldsymbol{a}) and (boldsymbol{b}) is zero, and they are parallel. 5. **Directional Vectors Relationship:**    Since (boldsymbol{a}) and (boldsymbol{b}) are parallel, we can express them as:    [    boldsymbol{a} = 2 (u, v), quad boldsymbol{b} = 3 (u, v),    ]    where (u) and (v) are directional cosines. 6. **Directional Cosines:**    Let (u = cos varphi) and (v = sin varphi), then:    [    boldsymbol{a} = 2 (cos varphi, sin varphi), quad boldsymbol{b} = 3 (cos varphi, sin varphi).    ] 7. **Expression for (x + z):**    Using these representations, we can write:    [    x + z = 2 cos varphi + 3 sin varphi.    ] 8. **Maximizing (x + z):**    Recognize the expression (2 cos varphi + 3 sin varphi) as the projection of a vector onto a rotated coordinate system. This has a maximum value given by the Euclidean norm of the coefficients:    [    x + z = 2 cos varphi + 3 sin varphi = sqrt{2^2 + 3^2} sin (varphi + alpha) = sqrt{13} sin (varphi + alpha) leq sqrt{13}.    ]    The maximum value (sqrt{13}) is achieved when (sin (varphi + alpha) = 1). 9. **Optimal Values of (varphi):**    The maximum occurs when:    [    cos varphi = frac{2}{sqrt{13}}, quad sin varphi = frac{3}{sqrt{13}}.    ] 10. **Find (x, y, z, t):**     Using these values, we compute:     [     x = 2 cos varphi = 2 left( frac{2}{sqrt{13}} right) = frac{4}{sqrt{13}},     ]     [     y = 2 sin varphi = 2 left( frac{3}{sqrt{13}} right) = frac{6}{sqrt{13}},     ]     [     z = 3 cos varphi = 3 left( frac{2}{sqrt{13}} right) = frac{6}{sqrt{13}},     ]     [     t = 3 sin varphi = 3 left( frac{3}{sqrt{13}} right) = frac{9}{sqrt{13}}.     ] # Conclusion: [ boxed{x = frac{4}{sqrt{13}},  y = frac{6}{sqrt{13}},  z = frac{6}{sqrt{13}},  t = frac{9}{sqrt{13}}} ]"},{"instruction":"Solve the system of equations left{begin{array}{l}x^{2} y+x y^{2}2 x2 y+10=0,  x^{3} yx y^{3}2 x^{2}+2 y^{2}30=0 .end{array}right.","output":"To solve the given system of equations: [ left{ begin{array}{l} x^{2} y + x y^{2} - 2 x - 2 y + 10 = 0,  x^{3} y - x y^{3} - 2 x^{2} + 2 y^{2} - 30 = 0. end{array} right. ] we start by rewriting them in a simpler form.  1. **Simplify the Given Equations:**    Rewrite the first equation:    [    x^2y + xy^2 - 2x - 2y + 10 = 0    ]    Factor out the common terms and group them:    [    xy(x + y) - 2(x + y) + 10 = 0    ]    Rewrite the second equation:    [    x^3y - xy^3 - 2x^2 + 2y^2 - 30 = 0    ]    Again, factor out and group the common terms:    [    xy(x^2 - y^2) - 2(x^2 - y^2) - 30 = 0    ] 2. **Apply Factored Form:**    The system is now equivalent to:    [left{    begin{array}{l}    (xy - 2)(x + y) = -10     (xy - 2)(x - y)(x + y) = 30    end{array}    right.] 3. **Relate the Two Equations:**    Divide the second equation by the first:    [    frac{(xy-2)(x-y)(x+y)}{(xy-2)(x+y)} = frac{30}{-10}    ]    This simplifies to:    [    x - y = -3    ]    Therefore, we get:    [    y = x + 3    ] 4. **Substitute Back and Solve:**    Substitute ( y = x + 3 ) into the first simplified equation:    [    (x^2 + 3x - 2)(2x + 3) = -10    ]    Expand and simplify:    [    (x^2 + 3x - 2)(2x + 3) = -10    ]    [    (2x^3 + 6x^2 - 4x + 3x^2 + 9x - 6) = -10    ]    Combine like terms:    [    2x^3 + 9x^2 + 5x - 6  = -10    ]    Move all terms to one side:    [    2x^3 + 9x^2 + 5x + 4 = 0    ] 5. **Find Integer Roots:**    Test potential integer roots like ( x = -4 ):    [    2(-4)^3 + 9(-4)^2 + 5(-4) + 4 = 0     ]    [    2(-64) + 9(16) - 20 + 4 = 0     ]    [    -128 + 144 - 20 + 4 = 0     ]    [    0 = 0    ]    Thus, ( x = -4 ) is a root. 6. **Factoring:**    Factor ( (x + 4) ) from ( 2x^3 + 9x^2 + 5x + 4 = 0 ):    [    2x^3 + 9x^2 + 5x + 4 = (x + 4)(2x^2 + x + 1) = 0    ]    Since (2x^2 + x + 1) has complex roots, the only real root is ( x = -4 ). 7. **Determine ( y ):**    Substitute ( x = -4 ) into ( y = x + 3 ):    [    y = -4 + 3 = -1    ] 8. **Conclusion:**    The solution to the system of equations is:    [    boxed{(-4, -1)}    ]"},{"instruction":"Given an ellipse with its foci on the xaxis, dfrac{x^2}{m} + dfrac{y^2}{6} = 1, and its eccentricity is dfrac{1}{2}, then m=. A: 8 B: 9 C: 3 D: 16","output":"According to the problem, the ellipse dfrac{x^2}{m} + dfrac{y^2}{6} = 1 has its foci on the x-axis,   which means m > 6,   then a= sqrt{m}, b= sqrt{6}, and thus c= sqrt{m-6},   Given the eccentricity of the ellipse e= dfrac{c}{a}= dfrac{1}{2}, we have dfrac{sqrt{m-6}}{sqrt{m}}= dfrac{1}{2},   Solving this equation yields m=8;   Therefore, the answer is: boxed{A}.   By analyzing the equation of the ellipse, we can determine the values of a and b, and then calculate the value of c. Using the formula for the eccentricity of an ellipse, we can solve for the value of m and thus find the answer.   This problem tests the standard equation of an ellipse, paying attention to the position of the foci of the ellipse."},{"instruction":"Let x in mathbb{R}. Among all constants M for which x^2  2x geq M always holds, we call the maximum value of M minus 1 the infimum of x^2  2x. If a, b in mathbb{R}, and a + b = 1, then the infimum of frac{1}{2a} + frac{2}{b} is A: 5   B: 4   C: sqrt{2}   D: frac{9}{2}","output":"Since a + b = 1, we have frac{1}{2a} + frac{2}{b} = (a + b) left( frac{1}{2a} + frac{2}{b} right) = frac{5}{2} + frac{b}{2a} + frac{2a}{b} geq frac{9}{2}; equality holds if and only if a = b. Therefore, the correct choice is: boxed{text{D}}. The essence of the problem is to find the minimum value of frac{1}{2a} + frac{2}{b} when a + b = 1, which can be solved using the basic inequality principle. This question tests the ability to find the maximum value, and using the basic inequality principle is key to solving this problem. It is important to accumulate problem-solving techniques, and this is considered a medium-level problem."},{"instruction":"Al, Bill, and Cal will each randomly be assigned a whole number from 1 to 12, inclusive, with no two of them getting the same number. Additionally, Al's number must be a perfect square. What is the probability that Als number will be a multiple of both Bill's and Cal's numbers? textbf{(A)} frac{1}{330} qquad textbf{(B)} frac{1}{400} qquad textbf{(C)} frac{1}{500} qquad textbf{(D)} frac{1}{600}","output":"1. **Total number of ways to assign numbers**: Since no two people can have the same number and there are 12 choices for the first person, 11 for the second, and 10 for the third, there are 12 times 11 times 10 = 1320 total possible assignments. 2. **Counting valid assignments**:    - **Valid choices for Al (square numbers within 1 to 12)**: 1, 4, 9.    - **Cal's number and subsequent Bills number for each Als number**:      - **Al = 1**: Not possible as 1 is not a multiple of any other number apart from itself.      - **Al = 4**: Cal's number can be 1 or 2.         - If Cal = 1, Bill can be 2 (1 choice).        - If Cal = 2, Bill can only be 1 (1 choice).      - **Al = 9**: Cal's number can be 1 or 3.        - If Cal = 1, Bill can be 3 (1 choice).        - If Cal = 3, Bill can only be 1 (1 choice). 3. **Summing valid cases**:    - For Al = 4: 2 valid assignments.    - For Al = 9: 2 valid assignments. 4. **Calculating the probability**:    - Total valid assignments are 2 + 2 = 4.    - The probability is therefore frac{4}{1320}. 5. **Simplifying the probability**:    - frac{4}{1320} = frac{1}{330}. Thus, the probability that Al's number will be a multiple of both Bill's and Cal's numbers, and Al's number is a perfect square is frac{1{330}}. The final answer is boxed{frac{1}{330}}"},{"instruction":"the cartesian coordinate system (xOy), an ellipse {{C}_{1}} :frac{{{x}^{2}}}{{{a}^{2}}}+frac{{{y}^{2}}}{{{b}^{2}}}=1 (a > b > 0 ) has its left focus at {{F}_{1}}left( 1,0 right) and the point Pleft( 0,1 right) is on {{C}_{1}}. (1) Find the equation of the ellipse {{C}_{1}}. (2) Suppose a line l is tangent to both the ellipse {{C}_{1}} and the parabola {{C}_{2}} :{{y}^{2}}=4x. Find the equation of the line l.","output":"(1) Since the left focus of the ellipse {C}_{1} is at {F}_{1}(-1,0), we have c=1. Substituting the point P(0,1) into the equation of the ellipse frac{{x}^{2}}{{a}^{2}}+frac{{y}^{2}}{{b}^{2}}=1, we obtain frac{1}{{b}^{2}}=1, which implies b=1. Hence, {a}^{2}={b}^{2}+{c}^{2}=2. Therefore, the equation of the ellipse {C}_{1} is frac{{x}^{2}}{2}+{y}^{2}=1. (2) The slope of the line l obviously exists. Let's denote the equation of line l as y=kx+m. Solving the system of equations begin{cases} frac{{x}^{2}}{2}+{y}^{2}=1  y=kx+mend{cases} and eliminating y, we obtain (1+2k^{2})x^{2}+4kmx+2m^{2}-2=0. Since line l is tangent to the ellipse {{C}_{1}}, the discriminant of this quadratic equation must be zero, i.e., 16k^{2}m^{2}-4(1+2k^{2})(2m^{2}-2)=0. Simplifying this expression, we get 2k^{2}-m^{2}+1=0. Next, solving the system of equations begin{cases}{y}^{2}=4x  y=kx+mend{cases} and eliminating y, we obtain k^{2}x^{2}+(2km-4)x+m^{2}=0. Since line l is also tangent to the parabola {{C}_{2}}, the discriminant of this quadratic equation must also be zero, i.e., (2km-4)^{2}-4k^{2}m^{2}=0. Simplifying this expression, we get km=1. Combining equations  and , we find two possible solutions: begin{cases}k= frac{ sqrt{2}}{2}  m= sqrt{2}end{cases} or begin{cases}k=- frac{ sqrt{2}}{2}  m=- sqrt{2}end{cases}. Therefore, the equation of the line l is either boxed{y= frac{ sqrt{2}}{2}x+ sqrt{2}} or boxed{y=- frac{ sqrt{2}}{2}x - sqrt{2}}."},{"instruction":"Let  a  be a positive integer. For all positive integer n, we define   a_n=1+a+a^2+ldots+a^{n1}.  Let  s,t  be two different positive integers with the following property:  If  p  is prime divisor of  st , then   p  divides   a1 .  Prove that number  frac{a_{s}a_{t}}{st}  is an integer. (FYROM)","output":"1. We start by considering the given sequence ( a_n = 1 + a + a^2 + ldots + a^{n-1} ). This is a geometric series with the sum formula:    [    a_n = frac{a^n - 1}{a - 1}    ] 2. We need to prove that the expression (frac{a_s - a_t}{s - t}) is an integer. Using the sum formula for (a_s) and (a_t), we have:    [    a_s = frac{a^s - 1}{a - 1} quad text{and} quad a_t = frac{a^t - 1}{a - 1}    ] 3. Subtracting these two expressions, we get:    [    a_s - a_t = frac{a^s - 1}{a - 1} - frac{a^t - 1}{a - 1} = frac{a^s - 1 - (a^t - 1)}{a - 1} = frac{a^s - a^t}{a - 1}    ] 4. Therefore, the expression we need to prove is an integer becomes:    [    frac{a_s - a_t}{s - t} = frac{frac{a^s - a^t}{a - 1}}{s - t} = frac{a^s - a^t}{(a - 1)(s - t)}    ] 5. We can factor (a^s - a^t) as:    [    a^s - a^t = a^t(a^{s-t} - 1)    ]    Thus, the expression becomes:    [    frac{a^s - a^t}{(a - 1)(s - t)} = frac{a^t(a^{s-t} - 1)}{(a - 1)(s - t)}    ] 6. Given that if (p) is a prime divisor of (s - t), then (p) divides (a - 1), we know that (a equiv 1 pmod{p}). By Lifting The Exponent (LTE) lemma, we have:    [    v_p(a^{s-t} - 1) = v_p(a - 1) + v_p(s - t)    ] 7. This implies that (a^{s-t} - 1) is divisible by ((a - 1)(s - t)). Therefore, the expression:    [    frac{a^t(a^{s-t} - 1)}{(a - 1)(s - t)}    ]    is an integer because the numerator (a^t(a^{s-t} - 1)) is divisible by the denominator ((a - 1)(s - t)). Thus, we have shown that (frac{a_s - a_t}{s - t}) is an integer. (blacksquare)"},{"instruction":"a candy store, a salesperson placed 91 candies of several kinds in a row on the counter. It turned out that between any two candies of the same kind, there is an even number of candies. What is the minimum number of kinds of candies that could be?","output":"1. **Understanding the Problem:**    - There are 91 candies of different sorts laid out in a row.    - Each pair of candies of the same sort has an even number of candies between them.    - We need to determine the minimum number of sorts that could achieve this arrangement. 2. **Proof by Contradiction:**    - Assume there are three or more candies of the same sort.    - Lets denote these candies as (A), (B), and (C).     3. **Analyzing the Distances Between Same Sort Candies:**    - Suppose the number of candies between (A) and (B) is (2x) (even).    - Suppose the number of candies between (B) and (C) is (2y) (even).    - Therefore, the total number of candies between (A) and (C) would be:      [      2x + 2y + 1      ]    - This total is:      [      2(x + y) + 1      ] 4. **Contradiction:**    - The number (2(x + y) + 1) is clearly odd.    - This contradicts the condition that the number of candies between any two candies of the same sort must be even.       5. **Conclusion From the Contradiction:**    - Therefore, we cannot have three or more candies of the same sort and satisfy the problems even-number condition. 6. **Determining Minimum Number of Sorts:**    - Since each sort can have no more than 2 candies:    - Let (n) be the number of sorts.    - Each sort contributes at most 2 candies, and we have 91 candies in total.      [      2n geq 91      ]    - Solving for (n):      [      n geq leftlceil frac{91}{2} rightrceil = 46      ] 7. **Example Arrangement:**    - For example, assume we have 46 sorts, each sort having a pair, except for one sort which will have only 1 candy.    - Candy pairs can be laid out in the format: sort 1, sort 2, ..., up to sort 45, and the last candy can be the 46th sort. # Conclusion: [ boxed{46} ]"},{"instruction":"There are positive integers with leading digits being 6, and upon removing this leading digit, the resulting integer is (frac{1}{25}) of the original value. Determine the least of such positive integers.","output":"Let's denote the original number as ( x ). Given the information in the problem, we can express ( x ) as follows: 1. The leading digit of ( x ) is 6, which means we can write ( x ) in the form:    [    x = 6 times 10^n + y    ]    where ( y ) is the remainder when the leading digit 6 is removed from ( x ). Clearly, ( 0 leq y < 10^n ). 2. According to the problem, when the leading digit is removed, the resulting number ( y ) is (frac{1}{25}) of the original number ( x ):    [    y = frac{1}{25}x    ] 3. Substituting this back into the expression for ( x ), we get:    [    x = 6 times 10^n + frac{1}{25}x    ] 4. To eliminate the fraction, multiply both sides by 25:    [    25x = 25 cdot 6 times 10^n + x    ] 5. Simplify and solve for ( x ):    [    25x - x = 25 cdot 6 times 10^n implies 24x = 150 times 10^n implies x = frac{150 times 10^n}{24}    ] 6. Simplify the fraction:    [    x = frac{150 times 10^n}{24} = frac{150 times 10^n}{24} = frac{150 times 10^n}{4 times 6} = frac{25 times 10^n}{4}    ] 7. For ( x ) to be an integer, (frac{25 times 10^n}{4}) must be an integer. Therefore, (4) must be a factor of (10^n).    - (10^n) is composed of factors 2 and 5:      - For (4) to divide (10^n), we need (2^2) to be a part of (10^n).      - Thus, (n) must be at least 2, as (10^n) must have 2 factors of 2 (i.e., (2^2)). 8. Let's determine the smallest ( n ):    [    n = 2 text{ (the least value where (10^2) contains (2^2))}    ] So, substituting ( n = 2 ) back into the expression for (frac{25 times 10^n}{4}): 9. Compute the value:    [    x = frac{25 times 10^2}{4} = frac{25 times 100}{4} = frac{2500}{4} = 625    ] # Conclusion: Hence, the least positive integer satisfying the given conditions is  [ boxed{625} ]"},{"instruction":"Given a geometric sequence {a_n} with a_1=1, 0<q<frac{1}{2}, and for any positive integer k, a_k  (a_{k+1}+a_{k+2}) is still an element of the sequence, find the common ratio q.","output":"Consider the given geometric sequence {a_n} where a_1=1 and the common ratio 0<q<frac{1}{2}. For any positive integer k, a_k - (a_{k+1}+a_{k+2}) = q^{k-1} - (q^k+q^{k+1}) = q^{k-1}(1 - q - q^2). Since a_n is an element of the sequence and all elements are of the form q raised to a power, 1 - q - q^2 should also be q raised to a power. Given 0<q<frac{1}{2}, we can infer that frac{1}{4}<1-q-q^2<1. Therefore, 1-q-q^2 can only be equal to q. Setting 1-q-q^2 equal to q, we have 1-2q-q^2=0 or q^2 + 2q - 1 = 0. Solving this quadratic equation, we find that q = sqrt{2} - 1 (since q must be positive and less than frac{1}{2}). Hence, the common ratio q is boxed{sqrt{2} - 1}."},{"instruction":"Given the wins of five baseball teams as displayed in the graph, identify the number of games won by the Patriots. The clues are as follows: 1. The Tigers won more than the Eagles. 2. The Patriots won more than the Cubs, but fewer than the Mounties. 3. The Cubs won more than 15 games. 4. The Falcons won more games than the Eagles but fewer than the Mounties. How many games did the Patriots win?  Graph data: Teams (in unknown order): 10, 18, 22, 27, 33 games.","output":"The three teams that won more than 15 games are those with 22, 27, and 33 wins. Since the Patriots and the Mounties won more games than the Cubs, and the Falcons won more than the Eagles but fewer than the Mounties: - The Cubs are limited to winning 22 games (they won more than 15 but are the lowest among the three who won more than 15). - The Falcons cannot have the lowest wins among those who won more than 15 games, which limits Falcons to winning 27 games (more than Eagles and Cubs but fewer than the Mounties). - The remaining 33 games must be the Mounties, as they won the most. - The Patriots, who won more than the Cubs but fewer than the Mounties, are left to have won 27 games. The Tigers would therefore have 18 games since they won more than the Eagles, who then necessarily have 10 games. Thus, the Patriots won boxed{27} games."},{"instruction":"Given the sets M={1, 1}, N={1}, the number of all nonempty subsets of the set M cup N is ( ) A: 1 B: 2 C: 3 D: 4","output":"Since M={1, -1}, N={1},   then M cup N={-1, 1}.   Therefore, the number of all non-empty subsets of the set M cup N is 2^2 - 1 = 3, which are {-1}, {1}, {-1, 1}.   Hence, the correct option is boxed{C}."},{"instruction":"w many 4digit positive integers exist that satisfy the following conditions:  (A) Each of the first two digits must be 2, 3, or 6. (B) The last two digits cannot be the same and they must come from the sets {5, 7, 8} or {0, 1, 9}. (C) The sum of all four digits must be divisible by 3.","output":"1. The first two digits: There are 3 choices for each digit, leading to (3 times 3 = 9) combinations. 2. For the last two digits:    - If using the set {5, 7, 8}, there are 3 choices for the first and 2 remaining choices for the second: (3 times 2 = 6) combinations.    - If using the set {0, 1, 9}, there are again 3 choices for the first and 2 remaining choices for the second: (3 times 2 = 6) combinations.    - Hence, combining both sets, the total combinations for the last two digits is (6 + 6 = 12). 3. Each possible number (from the (9 times 12 = 108) initial combinations) will be considered to check divisibility by 3. Each combination needs careful evaluation, but if uniformly distributed, statistically, one-third should meet the criterion. Predicting exact distribution without specific instance testing is difficult, but let's assume a uniform distribution across these choices for simplicity, resulting in approximately (frac{108}{3} = 36) valid numbers. Conclusion:  The final possible count of four-digit integers meeting all conditions is boxed{36}."},{"instruction":"The sum of six integers is 20. What is the maximum number of the six integers that can be larger than 15? textbf{(A)} 3qquadtextbf{(B)} 4qquadtextbf{(C)} 5qquadtextbf{(D)} 6qquadtextbf{(E)} 2","output":"To solve this problem, we need to determine the maximum number of integers among the six that can exceed 15 while still achieving a total sum of 20. 1. **Assume the maximum number of integers greater than 15**: Denote these integers as x_1, x_2, ldots, x_k where k is the number we want to maximize. Each of these integers is at least 16. 2. **Calculate the minimum sum of these k integers**: The minimum sum of these k integers, each being at least 16, is 16k. 3. **Consider the remaining integers**: There are 6-k integers left. Denote these integers as y_1, y_2, ldots, y_{6-k}. 4. **Sum of all six integers**: The total sum of all six integers is given by:    [    sum_{i=1}^k x_i + sum_{j=1}^{6-k} y_j = 20    ]    With sum_{i=1}^k x_i geq 16k, we need sum_{j=1}^{6-k} y_j to balance this out so that the total is 20. 5. **Finding the maximum k**: We find the maximum k such that there exists a set of 6-k integers whose sum complements 16k to make the overall sum 20. 6. **Example with k = 4**: If k = 4, then the integers x_1, x_2, ldots, x_4 are each at least 16, so their sum is at least 16 times 4 = 64. The remaining two integers must sum to:    [    64 + sum_{j=1}^{2} y_j = 20 implies sum_{j=1}^{2} y_j = 20 - 64 = -44    ]    Even if we assume y_1 = y_2 = -22, this sum is achievable, making it possible to have 4 integers greater than 15. 7. **Example with k = 5**: If k = 5, then the minimum sum of the five integers is 16 times 5 = 80. The remaining integer must be:    [    80 + y_1 = 20 implies y_1 = 20 - 80 = -60    ]    This is a valid integer, so having 5 integers greater than 15 is possible. 8. **Example with k = 6**: If k = 6, then the sum is 16 times 6 = 96. Achieving a total of 20 is impossible with all integers greater than 15. **Conclusion**: The maximum number of integers that can be larger than 15 is 5. The final answer is boxed{C}"},{"instruction":"Define the sequence (b_i) by b_{n+2} = frac{b_n + 2011}{1 + b_{n+1}} for n geq 1 with all terms being positive integers. Determine the minimum possible value of b_1 + b_2.","output":"Given the recurrence relation b_3(b_2+1) = b_1 + 2011, quad b_4(b_3+1) = b_2 + 2011, quad b_5(b_4+1) = b_3 + 2011. Subtracting consecutive equations, we get b_3 - b_1 = (b_3+1)(b_4-b_2) and b_4 - b_2 = (b_4+1)(b_5-b_3). Assuming b_3 - b_1 neq 0, then also b_4 - b_2 neq 0, and so on.  From the inequality |b_{n+3} - b_{n+1}| < |b_{n+2} - b_n| and assuming strict positivity, the sequence differences decrease and approach zero, implying the terms converge or become a stationary sequence. Hence, b_3 = b_1 and b_2 = b_4. Hence, from b_3(b_2+1) = b_1 + 2011, setting b_3 = b_1, then b_1(b_2+1) = b_1 + 2011. This further simplifies to b_1b_2 = 2011. Since 2011 is prime, the only integer solutions for (b_1, b_2) with the smallest sum are (1, 2011) and (2011, 1). The minimum value of b_1 + b_2 = 2012. Conclusion with boxed answer: The minimum possible value of b_1 + b_2 given b_{n+2} = frac{b_n + 2011}{1 + b_{n+1}} for all positive integer terms is boxed{2012}."},{"instruction":"Find the derivative of the function f(x)=xcos x+sin x, denoted as f(x)= ______.","output":"To find the derivative of f(x)=xcos x+sin x, we will apply the product rule and sum rule of differentiation. 1. First, identify the components of the function: u=x and v=cos x. 2. Apply the product rule for the first term: (uv)' = u'v + uv'. Here, u'=1 and v'=-sin x. 3. Differentiate the second term: the derivative of sin x is cos x. 4. Combine the results from steps 2 and 3: f'(x) = cos x + x(-sin x) + cos x. 5. Simplify the expression: f'(x) = 2cos x - xsin x. Thus, the derivative of the function is boxed{f'(x) = 2cos x - xsin x}. This problem evaluates your understanding of differentiation rules, specifically the product rule and sum rule, as well as your computational skills. It is considered a basic question in calculus."},{"instruction":"Given that ( F_{1} ) and ( F_{2} ) are the foci of the hyperbola ( x^{2}  y^{2} = 1 ), ( M ) is a point on the right branch of the hyperbola, and ( O ) is the origin of the coordinate system. If ( frac{left|M F_{1}right| + left|M F_{2}right|}{|M O|} = sqrt{6} ), then the coordinates of point ( M ) are ____.","output":"1. Let us denote the points by their given locations. Given that ( F_1 ) and ( F_2 ) are the foci of the hyperbola ( x^2 - y^2 = 1 ), we know that the coordinates of these foci can be calculated based on the standard form of the hyperbola equation.        For the hyperbola ( x^2 - y^2 = 1 ), the distance (c) from the center (0, 0) to each focus can be computed using (c = sqrt{a^2 + b^2}). Here, ( a = 1 ) (the distance from the center to each vertex on the x-axis) and ( b = 1 ) (though not needed for the calculation of the foci). Thus,    [    c = sqrt{1^2 + 1^2} = sqrt{2}.    ]    So, the coordinates of the foci are ( F_1(-sqrt{2}, 0) ) and ( F_2(sqrt{2}, 0) ). 2. Let point ( M ) be ( (x, y) ) where ( x geq 1 ) since ( M ) is on the right branch of the hyperbola. We are given:    [    frac{|MF_1| + |MF_2|}{|MO|} = sqrt{6}.    ] 3. Calculate the distances:    [    left| M F_1 right| = sqrt{(x + sqrt{2})^2 + y^2},    ]    [    left| M F_2 right| = sqrt{(x - sqrt{2})^2 + y^2},    ]    [    |M O| = sqrt{x^2 + y^2}.    ] 4. Substitute these into the given ratio and square both sides to eliminate the square roots:    [    left( frac{sqrt{(x + sqrt{2})^2 + y^2} + sqrt{(x - sqrt{2})^2 + y^2}}{sqrt{x^2 + y^2}} right)^2 = 6.    ]    Simplify this expression,    [    frac{(x + sqrt{2})^2 + y^2 + (x - sqrt{2})^2 + y^2 + 2sqrt{left((x^2 + y^2) + 2xsqrt{2} + 2right)left((x^2 + y^2) - 2xsqrt{2} + 2right)}}{x^2 + y^2} = 6.    ] 5. Let's simplify the components step by step. First, simplify the sum of the squared terms:    [    (x+sqrt{2})^2 + (x-sqrt{2})^2 = (x^2 + 2xsqrt{2} + 2) + (x^2 - 2xsqrt{2} + 2) = 2x^2 + 4.    ] 6. Observe the form of the cross-term inside the square root, ( left((x^2 + y^2) + 2right)^2 - left(2x sqrt{2}right)^2 = (x^2 + y^2 + 2)^2 - 8x^2 ):    [    sqrt{left(x^2 + y^2 + 2right)^2 - 8x^2} = sqrt{left(x^2 + y^2right)^2 + 4(x^2 + y^2) + 4 - 8x^2}.    ]    Assume this reduces nicely to workable form; for simplification, we substitute back because there's symmetry:    [    frac{2x^2 + 2 + 2sqrt{left( x^2 + y^2 + 2right)^2 - 8x^2}}{x^2 + y^2} = 6    ]    yields:    [    frac{4x^2 + 4}{x^2 + y^2} = 6.    ] 7. From this,    [    4(x^2 + y^2) + 4 = 6 (x^2 + y^2),    ]    solving gives:    [    4 = 2(x^2 + y^2),    ]    [    x^2 + y^2 = 2.    ] 8. Since (xgeq 1), assume equality and solve for (x):    [    x^2 = 1 + y^2.    ] 9. Also given is ( sqrt{6}), thus solve (6x^2 = 4 (x^2 + y^2)):    [    y^2 = x^2 - 1,    ]    [    x = frac{sqrt{6}}{2}, , y = pm frac{sqrt{2}}{2}.    ]    Hence, coordinates are  ( M = left( frac{sqrt{6}}{2}, pm frac{sqrt{2}}{2} right) ). # Conclusion: [ boxed{left( frac{sqrt{6}}{2}, pm frac{sqrt{2}}{2} right)} ]"},{"instruction":"Find the value of C_{6}^{1} + C_{6}^{2} + C_{6}^{3} + C_{6}^{4} + C_{6}^{5} (A) 61   (B) 62   (C) 63   (D) 64","output":"To find the value of C_{6}^{1} + C_{6}^{2} + C_{6}^{3} + C_{6}^{4} + C_{6}^{5}, we can make use of the binomial theorem. Recall that the binomial theorem states that for any positive integer n, the expansion of (1 + x)^n is given by: (1 + x)^n = C_{n}^{0} + C_{n}^{1}x + C_{n}^{2}x^2 + cdots + C_{n}^{n}x^n. When x = 1, this simplifies to: (1 + 1)^n = C_{n}^{0} + C_{n}^{1} + C_{n}^{2} + cdots + C_{n}^{n}. For our case, where n = 6, we have: (1 + 1)^6 = C_{6}^{0} + C_{6}^{1} + C_{6}^{2} + C_{6}^{3} + C_{6}^{4} + C_{6}^{5} + C_{6}^{6}. The left-hand side simplifies to 2^6 = 64. We are given that we need to find the sum without the C_{6}^{0} and C_{6}^{6} terms. Since C_{6}^{0} = C_{6}^{6} = 1, we can subtract these from our total to get the required sum: C_{6}^{1} + C_{6}^{2} + C_{6}^{3} + C_{6}^{4} + C_{6}^{5} = 64 - 2 = 62. Hence, the value is boxed{62}."},{"instruction":"The slope of the line x sqrt {3}y+3=0 is ()   A:  frac { sqrt {3}}{3}   B:  sqrt {3}   C: frac { sqrt {3}}{3}   D: sqrt {3}","output":"Solution: From x- sqrt {3}y+3=0, we get sqrt {3}y=x+3, which can be rewritten as y= frac { sqrt {3}}{3}x+ sqrt {3}.   Therefore, the slope of the line x- sqrt {3}y+3=0 is frac { sqrt {3}}{3}.   Hence, the correct option is: boxed{A}.   By converting the general form of the line equation to slope-intercept form, the slope of the line can be determined.   This question tests the concept of the slope of a line and the conversion from general form to slope-intercept form, making it a basic question."},{"instruction":"Grandma told her grandchildren: Today I am 60 years and 50 months and 40 weeks and 30 days old. How old was Grandma on her last birthday?","output":"1. Convert the given units of time to full years where necessary:    - Note that 50 months can be converted to years and additional months. Since there are 12 months in a year, we have:    [    50 text{ months} = 4 text{ years and } 2 text{ months} quad (text{since } 50 div 12 = 4 text{ remainder } 2)    ] 2. Calculate the total years based on the age given by Babika:    [    60 text{ years} + 4 text{ years} = 64 text{ years}    ] 3. Convert the additional time (2 months, 40 weeks, and 30 days) into days to determine how much it contributes to the age in terms of years:    - **Days in 2 months:** Depending on the specific months, the number of days can vary:      [      text{The number of days in 2 months can range from } 59 text{ days (shortest) to } 62 text{ days (longest)}       ]    - **Days in 40 weeks:**      [      40 text{ weeks} = 40 times 7 = 280 text{ days}      ]    - **Days in 30 days:**      [      30 text{ days} = 30 text{ days}      ] 4. Sum the days to find the total:    [    text{Total days} = text{Days in 2 months} + text{Days in 40 weeks} + text{Days in 30 days}    ]    - Minimum total:      [      text{Minimum Number of Days} = 59 text{ days} + 280 text{ days} + 30 text{ days} = 369 text{ days}      ]    - Maximum total:      [      text{Maximum Number of Days} = 62 text{ days} + 280 text{ days} + 30 text{ days} = 372 text{ days}      ] 5. Determine if this exceeds one year:    - Since:      [      369 text{ days} leq text{age in additional time} leq 372 text{ days}      ]    - And knowing:      [      365 text{ days} < 369 text{ days} leq text{age in additional time} leq 372 text{ days} < 730 text{ days} quad text{(2 years)}      ]    - This indicates that all calculations fall above 1 year but less than 2 years. 6. Add these extra days to the initial calculated age in years:    [    64 text{ years} + 1 text{ year (since 369 to 372 is a bit more than a year)}    ]    [    = 65 text{ years}    ] Conclusion: Therefore, the last birthday Babika celebrated was her: [ boxed{65 text{th}} ]"},{"instruction":"A train 140 m long, running with a speed of 63 km/hr, will pass a tree in how many seconds?","output":"First, we need to convert the speed from km/hr to m/s because the length of the train is given in meters.  To convert km/hr to m/s, we use the conversion factor: 1 km/hr = 5/18 m/s. So, the speed of the train in m/s is: 63 km/hr * (5/18) m/s per km/hr = 35/3 m/s Now, we need to calculate the time it takes for the train to pass the tree. Since the train is 140 m long, we can use the formula: Time = Distance / Speed The distance the train needs to cover to pass the tree is equal to the length of the train, which is 140 m. The speed is 35/3 m/s. So, the time taken to pass the tree is: Time = 140 m / (35/3) m/s = 140 m * (3/35) s/m = 4 * 3 s = 12 s Therefore, the train will pass the tree in boxed{12}  seconds."},{"instruction":"a vast lake, 500 fish were caught, tagged, and returned to the lake. A few weeks later, 300 fish were caught again, of which 45 were found to have been tagged. If the percent of tagged fish in the second catch approximates the percent of tagged fish in the lake, what is the approximate number of fish in the lake?","output":"Let's denote the total number of fish in the lake as N. From the first catch, we know that 500 fish were tagged and returned to the lake. This means that out of the total N fish in the lake, 500 are tagged. In the second catch, 300 fish were caught, and 45 of these were tagged. This gives us a ratio of tagged to caught fish in the second catch: 45 tagged / 300 caught = 500 tagged / N total We can set up a proportion to solve for N: 45/N = 500/300 Cross-multiply to solve for N: 45 * 300 = 500 * N 13500 = 500N Now, divide both sides by 500 to solve for N: N = 13500 / 500 N = 27 So, the approximate number of fish in the lake is 27 times the number of fish caught in the second catch, which is 300. Therefore: N = 27 * 300 N = 8100 The approximate number of fish in the lake is boxed{8100} ."},{"instruction":"The product of a number M and eight less than M is 7. What is the sum of all possible values of M?","output":"To set up the equation based on the problem statement, we have M(M-8) = -7. Rearranging this yields: [ M^2 - 8M + 7 = 0 ] To find the sum of all possible values of M, we apply Vieta's formula for quadratic equations, which states that the sum of the roots (solutions for M) of the equation ax^2 + bx + c = 0 is -b/a. Here, a = 1, b = -8, and c = 7. Thus, the sum of the roots is: [ -frac{-8}{1} = boxed{8} ] Conclusion: The sum of all possible values of M for the equation M^2 - 8M + 7 = 0 is boxed{8}."},{"instruction":"Given that the asymptotes of the hyperbola frac{x^{2}}{9}  frac{y^{2}}{4} = 1 coincide with the tangents of the curve y=ax^{2}+ frac{ {1}}{3}, find the value of a.","output":"First, find the equations of the asymptotes of the hyperbola frac{x^{2}}{9} - frac{y^{2}}{4} = 1, which are y= frac{2}{3}x. Since these lines are tangents to the curve y=ax^{2}+ frac{ {1}}{3}, we can form a system of equations: ax^{2} frac{2}{3}x+ frac{ {1}}{3}=0. The discriminant triangle of this quadratic equation is given by triangle = frac{4}{9}-4 cdot frac{1}{3}a = 0. Solving for a, we get a = boxed{frac{1}{3}}. To solve this problem, we first determine the equations of the asymptotes of the hyperbola. Then, we establish a system of equations with the curve's equation and solve for a by setting the discriminant of the resulting quadratic equation to zero. When finding the asymptotes of a hyperbola, always consider whether the foci lie on the X-axis or the Y-axis."},{"instruction":"Calculate the sum of 2213_4 + 2703_4 + 1531_4. Convert the sum from base 4 to base 10 and express the final answer in base 10.","output":"Let's start by adding in base 4: 1. Add the least significant digits (rightmost column): 3_4 + 3_4 + 1_4 = 11_4 (since 6_{10} is 12_4, we need to carry over 1_4 and write down 1_4) 2. Add the next digits with the carry over: 1_4 + 1_4 + 0_4 + 3_4 = 5_4 (which is already within a single digit in base 4). 3. Proceed with the next column: 2_4 + 7_4 + 5_4 = 16_4. Since 14_{10} is 32_4, write down 2_4 and carry over 3_4 (or 12_{10}). 4. Lastly, add the leftmost digits along with the carry from the previous step: 2_4 + 2_4 + 1_4 + 3_4 = 10_4 (which in decimal is 8_{10}, perfectly fitting in base 4). So, we get in base 4:   begin{array}{c@{}c@{;}c@{}c@{}c@{}c}  & & _{3}  &_{1}&  & & 2& 2 & 1 & 3_4  & & 2& 7 & 0 & 3_4 +& & 1 & 5 & 3 & 1_4 cline{1-6}  &1& 0 & 2 & 5 & 1_4 end{array}  Therefore, the sum in base 4 is 10251_4. Convert this to base 10:  1 times 4^4 + 0 times 4^3 + 2 times 4^2 + 5 times 4^1 + 1 times 4^0 = 256 + 0 + 32 + 20 + 1 = 309_{10}  Therefore, the final answer remains boxed{309}."},{"instruction":"a plane, there is a point set ( M ) and seven distinct circles ( C_{1}, C_{2}, ldots, C_{7} ). Circle ( C_{7} ) passes through exactly 7 points in ( M ), circle ( C_{6} ) passes through exactly 6 points in ( M ), and so on, until circle ( C_{1} ) passes through exactly 1 point in ( M ). What is the minimum number of points in ( M )? (A) 11 ; (B) 12 ; (C) 21 ; (D) 28 .","output":"To solve the problem, we will find the minimum number of points in the set ( M ) that satisfies the given conditions for the circles ( C_1, C_2, ldots, C_7 ). 1. **Understanding the problem setup:**    - There are seven circles ( C_1, C_2, ldots, C_7 ) each uniquely passing through a different number of points in ( M ).    - Specifically, ( C_1 ) passes through 1 point, ( C_2 ) passes through 2 points, up to ( C_7 ) which passes through 7 points. 2. **Determine the intersection possibilities:**    - Each pair of distinct circles can intersect at most at 2 points.    - Starting from ( C_7 ), which passes through 7 unique points, and ensure other circles share these points as efficiently as possible. 3. **Analyzing step-by-step overlapping:**    - **Circle ( C_7 ):** Passes through 7 unique points.    - **Circle ( C_6 ):** Needs to pass through 6 points. Since each circle can intersect another circle in at most 2 points:      - Let (C_6) share 2 points with (C_7), then it needs 4 new points.    - **Circle ( C_5 ):** Needs to pass through 5 points. It can share points with (C_7) and (C_6):      - Let (C_5) share 2 points each with (C_7) and (C_6), then it needs 1 more point.    - **Circle ( C_4 ):** Needs to pass through 4 points. It can share points with (C_7) and (C_6):      - ( C_4 ) can share 2 points each with (C_7) and (C_6), then no new points are needed.          Continue this pattern:    - **Circle ( C_3 ):** Needs to pass through 3 points. It can share points with ( C_7 ):      - ( C_3 ) can share all 3 points with (C_7).    - **Circle ( C_2 ):** Needs to pass through 2 points. It can share points with ( C_7 ):      - ( C_2 ) can share both points with (C_7).    - **Circle ( C_1 ):** Needs to pass through 1 point. It can share a point with ( C_7 ):      - ( C_1 ) can share its point with (C_7). 4. **Summarizing and calculating the minimum points required:**    - Since the maximum number of unique points is pushed to later circles, we see:      - ( C_7 ) covers 7 points.      - ( C_6 ) needs at least 4 new points.      - ( C_5 ) needs 1 new point.    - Combining, we observe there are no more than 12 unique points if the intersections follow correctly. Thus, by carefully overlaying the circles such that each successive circle takes advantage of maximal shared points with previous circles, the minimum number of unique points in ( M ) required to satisfy all the circle conditions is 12. [ boxed{12} ]"},{"instruction":"Before the World Cup soccer tournament, the coach of country F wants to evaluate players A_{1}, A_{2}, cdots, A_{7} by having them participate in three training matches (each match lasting 90 minutes). Suppose that at any moment during the games, exactly one of these players is on the field, and the total playing time (in minutes) for A_{1}, A_{2}, A_{3}, A_{4} is divisible by 7, and the total playing time (in minutes) for A_{5}, A_{6},  and A_{7} is divisible by 13. If there is no restriction on the number of substitutions, how many different possible distributions of total playing time are there for each player?","output":"1. Let the playing time of the i-th player be denoted as x_i (in minutes), for i = 1, 2, ldots, 7.    [    x_1 + x_2 + cdots + x_7 = 270    ]     2. Given that x_{1}, x_{2}, x_{3}, x_{4} are each divisible by 7, and x_{5}, x_{6}, x_{7} are each divisible by 13, we can express:    [    sum_{i=1}^{4} x_{i}= 7m, quad sum_{j=5}^{7} x_{j} = 13n    ]    where (m geq 4) and (n geq 3). Thus, we have:    [    7m + 13n = 270    ] 3. To simplify this equation, we subtract 28 from 7m and 39 from 13n by setting m' = m-4 and n' = n-3:    [    7(m' + 4) + 13(n' + 3) = 270 Rightarrow 7m' + 13n' = 270 - 28 - 39 = 203    ] 4. Solving the Diophantine equation (7m' + 13n' = 203), we consider the known particular solution:    [    m' = 406 - 13t, quad n' = -203 + 7t    ] 5. Enforcing the non-negativity constraints:    [    begin{cases}    406 - 13t geq 0     -203 + 7t geq 0    end{cases}    ]    Solving these inequalities:    [    t leq 31 quad text{and} quad t geq 29    ] 6. Therefore, (t) can be 29, 30, or 31:    [    begin{aligned}    &t = 29: & (m', n') = (406 - 13times 29, -203 + 7times 29) = (29, 0)     &t = 30: & (m', n') = (406 - 13times 30, -203 + 7times 30) = (16, 7)     &t = 31: & (m', n') = (406 - 13times 31, -203 + 7times 31) = (3, 14)    end{aligned}    ] 7. Converting back to (m) and (n):    [    begin{aligned}    &t = 29: & (m, n) = (29 + 4, 0 + 3) = (33, 3)     &t = 30: & (m, n) = (16 + 4, 7 + 3) = (20, 10)     &t = 31: & (m, n) = (3 + 4, 14 + 3) = (7, 17)    end{aligned}    ] 8. Calculate the number of solutions satisfying the constraints for each ((m, n)):    - **Case m = 33, n = 3:**      [      x_{i} = 7y_{i} quad text{for} quad i = 1,2,3,4      ]      Hence,      [      y_1 + y_2 + y_3 + y_4 = 33      ]      The number of positive integer solutions is given by:      [      binom{33-1}{4-1} = binom{32}{3} = 4960      ]    - **Case m = 20, n = 10:**      [      x_{i} = 7y_{i} quad text{for} quad i = 1,2,3,4      ]      and      [      x_{j} = 13y_{j} quad text{for} quad j = 5,6,7      ]      Hence,      [      y_1 + y_2 + y_3 + y_4 = 20, quad y_5 + y_6 + y_7 = 10      ]      The number of positive integer solutions is:      [      binom{20-1}{4-1} = binom{19}{3} = 969, quad binom{10-1}{3-1} = binom{9}{2} = 36      ]      Therefore, the total number of solutions is:      [      969 times 36 = 34884      ]    - **Case m = 7, n = 17:**      [      x_{i} = 7y_{i} quad text{for} quad i = 1,2,3,4      ]      and      [      x_{j} = 13y_{j} quad text{for} quad j = 5,6,7      ]      Hence,      [      y_1 + y_2 + y_3 + y_4 = 7, quad y_5 + y_6 + y_7 = 17      ]      The number of positive integer solutions is:      [      binom{7-1}{4-1} = binom{6}{3} = 20, quad binom{17-1}{3-1} = binom{16}{2} = 120      ]      Therefore, the total number of solutions is:      [      20 times 120 = 2400      ] 9. Summing all the solutions:    [    4960 + 34884 + 2400 = 42244    ] Conclusion: [ boxed{42244} ]"},{"instruction":"f (frac{x}{x3} = frac{y^2 + 3y + 1}{y^2 + 3y  4},) then find the expression for ( x ) in terms of ( y ). A) ( frac{3y^2 + 5y + 3}{5} )   B) ( frac{3y^2 + 9y + 3}{5} )   C) ( frac{y^2 + 3y + 4}{5} )   D) ( frac{y^2 + 3y + 9}{5} )   E) ( 3y^2 + 9y + 3 )","output":"1. Start with the given equation:    [    frac{x}{x-3} = frac{y^2 + 3y + 1}{y^2 + 3y - 4}    ] 2. Cross multiply to remove fractions:    [    x(y^2 + 3y - 4) = (x-3)(y^2 + 3y + 1)    ] 3. Expand both sides:    [    xy^2 + 3xy - 4x = xy^2 + 3xy + x - 3y^2 - 9y - 3    ] 4. Rearrange to isolate terms with ( x ):    [    xy^2 + 3xy - 4x - xy^2 - 3xy - x = -3y^2 - 9y - 3    ]    Simplifying, we find:    [    -5x = -3y^2 - 9y - 3    ] 5. Solve for ( x ):    [    x = frac{3y^2 + 9y + 3}{5}    ] Thus, ( x ) can be expressed as (frac{3y^2 + 9y + 3{5}}). Conclusion: The solution checks out under the assumption and manipulation performed, making the problem valid. The final answer is boxed{The final answer, given the choices, is **(B) ( frac{3y^2 + 9y + 3}{5} )**.}"},{"instruction":"Let  p  be a prime divisor of  x^3 + x^2  4x + 1 . Prove that  p  is a cubic residue modulo  13 .","output":"To prove that any prime divisor ( p ) of ( x^3 + x^2 - 4x + 1 ) is a cubic residue modulo ( 13 ), we will follow these steps: 1. **Simplify the polynomial modulo ( 13 ):**    [    x^3 + x^2 - 4x + 1 equiv (x-4)^3 pmod{13}    ]    This simplification is based on the polynomial identity and properties of congruences. 2. **Check the values of the polynomial modulo small primes:**    We need to show that ( x^3 + x^2 - 4x + 1 ) is not divisible by ( 2, 3, 7, ) or ( 11 ).    - For ( p = 2 ):      [      x^3 + x^2 - 4x + 1 equiv x^3 + x^2 + 1 pmod{2}      ]      Since ( x^3 + x^2 + 1 ) is always odd, it is never ( 0 pmod{2} ).    - For ( p = 3 ):      [      x^3 + x^2 - 4x + 1 equiv x^3 + x^2 - x + 1 pmod{3}      ]      Evaluating for ( x = 0, 1, 2 ):      [      begin{aligned}      &x = 0: quad 0^3 + 0^2 - 0 + 1 equiv 1 pmod{3}       &x = 1: quad 1^3 + 1^2 - 1 + 1 equiv 2 pmod{3}       &x = 2: quad 2^3 + 2^2 - 2 + 1 equiv 8 + 4 - 2 + 1 equiv 11 equiv 2 pmod{3}      end{aligned}      ]      Thus, ( x^3 + x^2 - 4x + 1 ) is never ( 0 pmod{3} ).    - For ( p = 7 ):      [      x^3 + x^2 - 4x + 1 equiv x^3 + x^2 - 4x + 1 pmod{7}      ]      Evaluating for ( x = 0, 1, 2, 3, 4, 5, 6 ):      [      begin{aligned}      &x = 0: quad 0^3 + 0^2 - 0 + 1 equiv 1 pmod{7}       &x = 1: quad 1^3 + 1^2 - 4 cdot 1 + 1 equiv -1 equiv 6 pmod{7}       &x = 2: quad 2^3 + 2^2 - 4 cdot 2 + 1 equiv 8 + 4 - 8 + 1 equiv 5 pmod{7}       &x = 3: quad 3^3 + 3^2 - 4 cdot 3 + 1 equiv 27 + 9 - 12 + 1 equiv 25 equiv 4 pmod{7}       &x = 4: quad 4^3 + 4^2 - 4 cdot 4 + 1 equiv 64 + 16 - 16 + 1 equiv 65 equiv 2 pmod{7}       &x = 5: quad 5^3 + 5^2 - 4 cdot 5 + 1 equiv 125 + 25 - 20 + 1 equiv 131 equiv 5 pmod{7}       &x = 6: quad 6^3 + 6^2 - 4 cdot 6 + 1 equiv 216 + 36 - 24 + 1 equiv 229 equiv 6 pmod{7}      end{aligned}      ]      Thus, ( x^3 + x^2 - 4x + 1 ) is never ( 0 pmod{7} ).    - For ( p = 11 ):      [      x^3 + x^2 - 4x + 1 equiv x^3 + x^2 - 4x + 1 pmod{11}      ]      Evaluating for ( x = 0, 1, 2, ldots, 10 ):      [      begin{aligned}      &x = 0: quad 0^3 + 0^2 - 0 + 1 equiv 1 pmod{11}       &x = 1: quad 1^3 + 1^2 - 4 cdot 1 + 1 equiv -1 equiv 10 pmod{11}       &x = 2: quad 2^3 + 2^2 - 4 cdot 2 + 1 equiv 8 + 4 - 8 + 1 equiv 5 pmod{11}       &x = 3: quad 3^3 + 3^2 - 4 cdot 3 + 1 equiv 27 + 9 - 12 + 1 equiv 25 equiv 3 pmod{11}       &x = 4: quad 4^3 + 4^2 - 4 cdot 4 + 1 equiv 64 + 16 - 16 + 1 equiv 65 equiv 10 pmod{11}       &x = 5: quad 5^3 + 5^2 - 4 cdot 5 + 1 equiv 125 + 25 - 20 + 1 equiv 131 equiv 10 pmod{11}       &x = 6: quad 6^3 + 6^2 - 4 cdot 6 + 1 equiv 216 + 36 - 24 + 1 equiv 229 equiv 9 pmod{11}       &x = 7: quad 7^3 + 7^2 - 4 cdot 7 + 1 equiv 343 + 49 - 28 + 1 equiv 365 equiv 2 pmod{11}       &x = 8: quad 8^3 + 8^2 - 4 cdot 8 + 1 equiv 512 + 64 - 32 + 1 equiv 545 equiv 6 pmod{11}       &x = 9: quad 9^3 + 9^2 - 4 cdot 9 + 1 equiv 729 + 81 - 36 + 1 equiv 775 equiv 4 pmod{11}       &x = 10: quad 10^3 + 10^2 - 4 cdot 10 + 1 equiv 1000 + 100 - 40 + 1 equiv 1061 equiv 5 pmod{11}      end{aligned}      ]      Thus, ( x^3 + x^2 - 4x + 1 ) is never ( 0 pmod{11} ). 3. **Conclusion:**    Since ( x^3 + x^2 - 4x + 1 ) is not divisible by ( 2, 3, 7, ) or ( 11 ), any prime divisor ( p ) of ( x^3 + x^2 - 4x + 1 ) must be a cubic residue modulo ( 13 ). (blacksquare)"},{"instruction":"James binges on Cheezits and eats 3 bags that are 2 ounces each. There are 150 calories in an ounce of Cheezits. He then goes for a run and burns 12 calories per minute. He ate 420 excess calories. How long was his run in minutes?","output":"First, we need to calculate the total number of calories James consumed from the Cheezits. Since each bag is 2 ounces and he ate 3 bags, he consumed a total of 2 * 3 = 6 ounces of Cheezits. Next, we calculate the total number of calories from the 6 ounces of Cheezits. Since there are 150 calories in an ounce, the total calories consumed from Cheezits is 6 * 150 = 900 calories. James ate 420 excess calories, which means he needed to burn 900 - 420 = 480 calories during his run to offset the excess. Finally, we calculate the duration of his run. Since he burns 12 calories per minute, we divide the total calories he needed to burn by the calories burned per minute to find the duration of his run in minutes. 480 calories / 12 calories per minute = 40 minutes James ran for boxed{40}  minutes."},{"instruction":"The gummy bear factory has three separate production lines. Line A manufactures 300 gummy bears a minute, and each packet for this line contains 50 gummy bears. Line B manufactures 400 gummy bears a minute, and each packet for this line contains 75 gummy bears. Line C manufactures 500 gummy bears a minute, and each packet for this line contains 100 gummy bears. The factory needs to produce enough gummy bears to fill 240 packets for Line A, 180 packets for Line B, and 150 packets for Line C. Given that all three lines run simultaneously but Line A must stop production after 180 minutes due to maintenance, how long would it take for the factory to complete this task for all three lines, in minutes?","output":"First, let's calculate how many gummy bears are needed for each line to fill the required number of packets. For Line A: 240 packets * 50 gummy bears per packet = 12,000 gummy bears For Line B: 180 packets * 75 gummy bears per packet = 13,500 gummy bears For Line C: 150 packets * 100 gummy bears per packet = 15,000 gummy bears Now, let's calculate how many minutes it would take for each line to produce the required number of gummy bears if they were running independently. For Line A: 12,000 gummy bears / 300 gummy bears per minute = 40 minutes For Line B: 13,500 gummy bears / 400 gummy bears per minute = 33.75 minutes For Line C: 15,000 gummy bears / 500 gummy bears per minute = 30 minutes However, Line A must stop after 180 minutes due to maintenance. Since 40 minutes (the time needed for Line A to complete its task) is less than 180 minutes, Line A will be able to complete its production without interruption. Now, we need to find out how long it will take for Line B and Line C to complete their tasks. Since Line A will finish in 40 minutes, we need to check if Line B and Line C can finish their tasks in the same time or if they will take longer. For Line B, we already calculated that it would take 33.75 minutes, which is less than 40 minutes, so Line B will also be able to complete its production without any issues. For Line C, it would take 30 minutes, which is also less than 40 minutes, so Line C will complete its production without any issues as well. Since all lines will finish their tasks in less than 40 minutes, the total time for the factory to complete the task for all three lines is boxed{40}  minutes."},{"instruction":"A certain school organized a fire safety knowledge competition with two types of questions, A and B. Each student participating in the competition first chooses one type of question and randomly selects one question to answer from it. If the answer is incorrect, the student's competition ends; if the answer is correct, another question is randomly selected from the other type of question to answer, and regardless of the correctness of the answer, the student's competition ends. Each correct answer in type A questions earns 40 points, otherwise 0 points; each correct answer in type B questions earns 60 points, otherwise 0 points. It is known that Xiao Ming has a probability of 0.7 of correctly answering type A questions, a probability of 0.5 of correctly answering type B questions, and the probability of answering questions correctly is independent of the order of answering.   (1) If Xiao Ming first answers type A questions, let X be Xiao Ming's cumulative score, find the distribution of X;   (2) To maximize the expected cumulative score, which type of question should Xiao Ming choose to answer first? Explain the reason.","output":"# Solution:  Part 1: Distribution of X Given that Xiao Ming first answers type A questions, we can determine the possible outcomes and their probabilities. - **Case 1:** Xiao Ming answers the type A question incorrectly. This results in a score of 0 points.   - Probability: P(X=0) = 1 - P(text{correct on A}) = 1 - 0.7 = 0.3. - **Case 2:** Xiao Ming answers the type A question correctly (earning 40 points) but answers the type B question incorrectly. This results in a cumulative score of 40 points.   - Probability: P(X=40) = P(text{correct on A}) times P(text{incorrect on B}) = 0.7 times (1 - 0.5) = 0.35. - **Case 3:** Xiao Ming answers both questions correctly, first the type A question (earning 40 points) and then the type B question (earning 60 points), resulting in a cumulative score of 100 points.   - Probability: P(X=100) = P(text{correct on A}) times P(text{correct on B}) = 0.7 times 0.5 = 0.35. Therefore, the distribution of X is as follows: | X   | 0   | 40  | 100 | |-------|-------|-------|-------| | P   | 0.3 | 0.35| 0.35|  Part 2: Maximizing Expected Cumulative Score - **Expected score for choosing type A first:**   - E(X) = 0 times 0.3 + 40 times 0.35 + 100 times 0.35 = 49. - **Expected score for choosing type B first:**   - For type B questions first, the outcomes are 0, 60, and 100 points.   - P(Y=0) = 1 - P(text{correct on B}) = 1 - 0.5 = 0.5.   - P(Y=60) = P(text{correct on B}) times P(text{incorrect on A}) = 0.5 times (1 - 0.7) = 0.15.   - P(Y=100) = P(text{correct on B}) times P(text{correct on A}) = 0.5 times 0.7 = 0.35.   - Therefore, E(Y) = 0 times 0.5 + 60 times 0.15 + 100 times 0.35 = 44. Comparing the expected scores: - E(X) = 49. - E(Y) = 44. Since E(X) > E(Y), to maximize the expected cumulative score, Xiao Ming should choose to answer type A questions first. boxed{text{Xiao Ming should choose type A questions first to maximize the expected cumulative score.}}"},{"instruction":"A standard sixsided fair die is rolled six times. Determine the probability that the product of all six numbers rolled is a cube. Express your answer as a reduced fraction frac{m}{n}, where m and n are coprime integers, and find m+n.","output":"First, consider the prime factors from the possible outcomes when a six-sided die is rolled: 1, 2, 3, 4 (which is 2^2), 5, and 6 (which is 2 times 3). A product being a cube requires each prime factor's exponent to be a multiple of 3. We use recursive thinking and cases based on the count of 5's rolled, since 5 must appear in multiples of 3 (or not at all) for the product to be a cube: - **Case 1**: No 5's are rolled. - **Case 2**: Three 5's are rolled. - **Case 3**: Six 5's are rolled (impossible in six rolls). For each case, consider a 5-sided die (excluding 5) with faces 1, 2, 3, 4, 6. Define b_n as the number of outcomes such that the product of n rolls is a cube: - b_1 = 2 (1 and 4 are cubes). - For b_{n+1}, if the product of the first n rolls is a cube, then the next roll must also result in a cube (possible outcomes are 1 and 4), giving 2b_n outcomes. - Otherwise, if the product is not a cube, the next roll is determined uniquely to adjust the exponents to multiples of 3 (either 2, 3, or 6). Using this recursive method: - b_2 = 7, b_3 = 32, b_4 = 157, b_5 = 772, b_6 = 3797. In Case 1, we have b_6 = 3797 outcomes where no 5's are rolled. In Case 2, using binom{6}{3} ways to choose positions for three 5's: - The probability is frac{1 cdot binom{6}{3} cdot 32}{6^6} = frac{320}{46656}. Summing the probabilities and simplifying: [ frac{3797 + 320}{46656} = frac{4117}{46656} = frac{137}{15552} ] Thus, m+n = 137+15552 = boxed{15689}."},{"instruction":"The scores on a 120point test were organized in the stemandleaf plot shown. 10 | 2 represents 102 points. What is the mode of the scores? begin{tabular}{c|lllllll} multicolumn{8}{c}{underline{Points on the Test}} 6 &5 & 5 & & & & & 7 &3 & & & & & & 8 &2 & 8 & & & & & 9 &1 & 6 & 6 & 6 & 6 & & 10 &2 & 4 & 4 & 4 & 4 & & 11 &0 & 0 & 0 & & & & end{tabular}","output":"- The row for 96 has four instances of 6, so the score 96 appears four times. - The row for 104 also shows four instances of 4, so the score 104 appears four times. - Both scores 96 and 104 appear four times, which is the highest frequency in the data. Thus, there are two modes. Conclusion: The modes of the scores are boxed{96 text{ and } 104}."},{"instruction":"Given the parabola C: y^2 = 4x and the point M(0, 2), a line passing through the focus of C with a slope of k intersects C at points A and B. If overrightarrow{MA} cdot overrightarrow{MB} = 0, then k = boxed{text{______}}.","output":"The focus of the parabola C: y^2 = 4x is F(1, 0). Therefore, the equation of line AB is y = k(x - 1). Let A(x_1, y_1) and B(x_2, y_2), By solving the system of equations begin{cases} y^2 = 4x  y = k(x - 1) end{cases}, we get k^2x^2 - (2k^2 + 4)x + k^2 = 0, Thus, x_1 + x_2 = frac{2k^2 + 4}{k^2} = 2 + frac{4}{k^2}. And x_1x_2 = 1. Therefore, y_1 + y_2 = k(x_1 + x_2) - 2k = frac{4}{k}, and y_1y_2 = k^2(x_1 - 1)(x_2 - 1) = k^2[x_1x_2 - (x_1 + x_2) + 1] = -4, Since overrightarrow{MA} cdot overrightarrow{MB} = 0, we have (x_1, y_1 - 2) cdot (x_2, y_2 - 2) = 0, which means x_1x_2 + y_1y_2 - 2(y_1 + y_2) + 4 = 0. Solving this, we find k = 8. Hence, the answer is boxed{1}. By setting the equation of line AB, substituting into the equation of the parabola, and using Vieta's formulas along with the operation of the dot product of vectors (x_1, y_1 - 2) cdot (x_2, y_2 - 2) = 0, we can find the value of k. This problem examines the relationship between a line and a parabola, Vieta's formulas, the operation of the dot product of vectors, and computational skills. It is considered a medium-level question."},{"instruction":"Two trains of equal length are running on parallel lines in the same direction at 42 km/hr and 36 km/hr. The faster train passes the slower train in a certain amount of time. The length of each train is 30 meters. How long does it take for the faster train to pass the slower train?","output":"To find out how long it takes for the faster train to pass the slower train, we need to calculate the relative speed between the two trains and then use that to determine the time it takes for the faster train to cover the entire length of the slower train. The relative speed is the difference in speed between the two trains since they are moving in the same direction. The faster train is moving at 42 km/hr and the slower train at 36 km/hr. The relative speed is: 42 km/hr - 36 km/hr = 6 km/hr To calculate the time, we need to convert the relative speed into meters per second because the length of the trains is given in meters. 1 km/hr = 1000 meters / 3600 seconds 6 km/hr = 6 * (1000 / 3600) m/s 6 km/hr = 6000 / 3600 m/s 6 km/hr = 5/3 m/s Now, since the length of each train is 30 meters, the faster train needs to cover the length of both trains to completely pass the slower train, which is a total distance of: 30 meters + 30 meters = 60 meters The time it takes to pass the slower train is the total distance divided by the relative speed: Time = Total Distance / Relative Speed Time = 60 meters / (5/3 m/s) Time = 60 * (3/5) seconds Time = 180/5 seconds Time = 36 seconds Therefore, it takes boxed{36}  seconds for the faster train to pass the slower train."},{"instruction":"Given that the terminal side of angle  passes through (2, 3), find the value of cos( + frac{3}{2}) = ______.","output":"Since the terminal side of angle  passes through (-2, 3), we have x = -2, y = 3, and r = sqrt{4 + 9} = sqrt{13}. Thus, sin = frac{y}{r} = frac{3sqrt{13}}{13}. Hence, cos( + frac{3}{2}) = sin = boxed{frac{3sqrt{13}}{13}}. The solution involves using the definition of trigonometric functions for any angle and the cofunction identities to find the value of the given expression. This problem primarily tests the understanding of trigonometric functions for any angle and cofunction identities, making it a basic-level question."},{"instruction":"the following statement true: if the sequences left{a_{n}right} and left{b_{n}right} are both positive and the series sum_{n=1}^{infty} a_{n} and sum_{n=1}^{infty} b_{n} are divergent, then the series sum_{n=1}^{infty} frac{2 a_{n} b_{n}}{a_{n}+b_{n}} is also divergent?","output":"1. We need to determine whether the series sum_{n=1}^{infty} frac{2a_nb_n}{a_n + b_n} converges if the series sum_{n=1}^{infty} a_n and sum_{n=1}^{infty} b_n are both divergent and each term in these sequences is positive.    2. To show that the statement is false, we can construct a counterexample.  Counterexample 1: 3. Consider the sequences defined as follows:    [    a_n =    begin{cases}    n^2 & text{if } n text{ is even},     frac{1}{n^2} & text{if } n text{ is odd}.    end{cases}    ]    [    b_n =    begin{cases}    frac{1}{n^2} & text{if } n text{ is even},     n^2 & text{if } n text{ is odd}.    end{cases}    ] 4. It is evident that left{a_nright} and left{b_nright} are positive sequences. We now show that both sum_{n=1}^{infty} a_n and sum_{n=1}^{infty} b_n diverge.    [    sum_{n=1}^{k} a_n geq (k-1)^2 quad text{and} quad sum_{n=1}^{k} b_n geq (k-1)^2    ]    for all positive integers k. 5. Next, we evaluate sum_{n=1}^{infty} frac{2a_nb_n}{a_n + b_n}:    [    sum_{n=1}^{infty} frac{2a_nb_n}{a_n + b_n} = sum_{n=1}^{infty} frac{2}{n^2 + frac{1}{n^2}}.    ]    This can be simplified as:    [    frac{2}{n^2 + frac{1}{n^2}} < 2cdot frac{1}{n^2}.    ]    Therefore,    [    sum_{n=1}^{infty} frac{2a_nb_n}{a_n + b_n} < 2 sum_{n=1}^{infty} frac{1}{n^2}.    ]    We know that sum_{n=1}^{infty} frac{1}{n^2} is a convergent p-series (since p>1). Let S be its sum.    [    sum_{n=1}^{infty} frac{1}{n^2} = S < infty.    ]    Hence,    [    sum_{n=1}^{infty} frac{2a_nb_n}{a_n + b_n} < 2S < infty.    ]    Thus sum_{n=1}^{infty} frac{2a_nb_n}{a_n + b_n} converges.  Counterexample 2: 6. Define a series left{c_nright} of positive terms such that sum_{n=1}^{infty} c_n converges. For example, let c_n be a geometric series with a ratio between 0 and 1. Specifically, choose:    [    a_{2n} = 1, quad a_{2n-1} = c_n,    ]    [    b_{2n-1} = 1, quad b_{2n} = c_n    ]    for all natural numbers n. 7. Verify that both left{a_nright} and left{b_nright} are positive and that neither sum_{n=1}^{infty} a_n nor sum_{n=1}^{infty} b_n converges, as both sequences have an infinite number of terms equal to 1. 8. Examine the behavior of sum_{n=1}^{infty} frac{2a_nb_n}{a_n + b_n}:    [    0< frac{2a_{2n-1}b_{2n-1}}{a_{2n-1} + b_{2n-1}} = frac{2a_{2n}b_{2n}}{a_{2n} + b_{2n}} = frac{2c_n}{c_n +1} <2c_n.    ]    Therefore,    [    sum_{n=1}^{infty} frac{2a_nb_n}{a_n + b_n} = 2 sum_{n=1}^{infty} frac{2c_n}{c_n+1} < 4 sum_{n=1}^{infty} c_n.    ]    Since sum_{n=1}^{infty} c_n is assumed to converge, it follows that sum_{n=1}^{infty} frac{2a_nb_n}{a_n + b_n} converges as well. # Conclusion: The statement given in the problem is false. Therefore, the series sum_{n=1}^{infty} frac{2a_nb_n}{a_n + b_n} can converge even if both sum_{n=1}^{infty} a_n and sum_{n=1}^{infty} b_n do not converge. blacksquare"},{"instruction":"Given the function f(x)=ln x frac {3}{e}, determine the approximate interval where its zero point is located. The options are: A: (frac {1}{e}, 1) B: (1, e) C: (e, e^2) D: (e^2, e^3)","output":"The function f(x)=ln x- frac {3}{e} is a monotonically increasing and continuous function. Let's calculate f(e) and f(e^2): 1. f(e) = ln e - frac{3}{e} = 1 - frac{3}{e} < 0 2. f(e^2) = ln e^2 - frac{3}{e} = 2 - frac{3}{e} > 0 Since f(e) and f(e^2) have opposite signs, the zero point of the function lies between e and e^2 according to the Intermediate Value Theorem. Therefore, the zero point of the given function f(x) is in the interval (e, e^2). So, the answer is: boxed{C} This problem tests the application of the Intermediate Value Theorem and understanding of the basic properties of logarithmic functions."},{"instruction":"Given a linear function y=kx+b (k and b are constants, and kneq 0), some corresponding values of x and y are shown in the table below: | x | 2 | 1 | 0 | 1 | 2 | 3 | |||||||| | y | 3  | 2  | 1| 0| 1| 2| Then the solution set of the inequality kx+b lt 0 is ______.","output":"Given the linear function y=kx+b where k and b are constants and kneq 0, we observe the values of x and y from the table provided.  Step 1: Identify a specific point from the table.   - When x=1, we have y=0. This gives us a specific point on the graph of the linear function. Step 2: Analyze the trend in the table.   - As x increases from -2 to 3, the corresponding y values decrease from 3 to -2. This indicates that the slope k of the linear function is negative, and thus, the function is decreasing. Step 3: Determine the solution set of the inequality kx+b < 0.   - Since the function decreases and reaches y=0 at x=1, for any x value greater than 1, the function value y will be less than 0.   - Therefore, the solution set for kx+b < 0 is all x values greater than 1. Final Step: State the solution set.   - The solution set of the inequality kx+b < 0 is boxed{x > 1}."},{"instruction":"The opposite number of 2 is () A: 2 B: 1 C:  frac {1}{2} D:  frac {1}{2}","output":"The opposite of -2 is 2. - According to the definition, the opposite number of a given number is that which, when added to the original number, yields zero. - Hence, the opposite number of -2 is such number that -2 added to it equals zero. - To find the opposite of -2, we can set up the equation:    -2 + x = 0  - Solving for x, we add 2 to both sides of the equation:    x = 0 + 2     x = 2  - Therefore, x is 2, which means the opposite number of -2 is 2. - The correct answer is A. boxed{text{A}}"},{"instruction":"Among the following statements about regression analysis of two variables, the incorrect one is () A: The regression equation obtained from sample data overset{land }{y} = overset{land }{b}x + overset{land }{a} must pass through the sample center (overset{ .}{x}, overset{ .}{y}) B: The larger the sum of squared residuals, the better the model fit C: The regression effect is described using R^2, the larger the R^2, the better the model fit D: If the scatter plot of the samples is stripshaped, then there is a linear correlation between variable y and x","output":"The sample center point is on the line, so A is correct.   A model with a smaller sum of squared residuals has a better fit, so B is incorrect.   A larger R^2 indicates a better fit, so C is correct.   When the scatter plot of the samples is strip-shaped, it indicates that the two variables have a linear correlation, which is correct.   Therefore, the answer is: boxed{text{B}}.   A linear regression equation must pass through the sample center point. Among a set of models, the one with the smaller sum of squared residuals has a better fit. The correlation index indicates the quality of the fit; the smaller the index, the stronger the correlation.   This question examines the methods of measuring the correlation between two variables. To accurately and reliably determine whether two variables are related or unrelated, calculations related to independence tests must be utilized for judgment."},{"instruction":"Given that line l passes through P(2, 4) and its angle of inclination is 45^circ, the equation of line l is __________.","output":"Since the angle of inclination of the line is 45^circ, the slope of the line is tan 45^circ = 1.   Given that line l passes through P(2, 4), using the point-slope form, the equation of line l is y - 4 = 1 times (x - 2),   Simplifying, we get x - y + 2 = 0,   Therefore, the answer is boxed{x - y + 2 = 0}."},{"instruction":"The right triangles (MDC) and (ADK) have a common right angle at (D). Point (K) lies on (CD) and divides it in the ratio (2:3) from point (C). Point (M) is the midpoint of side (AD). Find the sum of the degree measures of angles (AKD) and (MCD), given that (AD : CD = 2:5).","output":"Consider two right triangles triangle MDC and triangle ADK that share a common right angle at point D. We are given that point K lies on CD and divides it in the ratio 2:3, starting from C. Moreover, point M is the midpoint of side AD. We need to find the sum of the degree measures of angles angle AKD and angle MCD, given that AD : CD = 2 : 5. 1. **Completing the Triangle**:    We extend triangle ADC to form a square LJCD, where:    - Point L is an extension of A,    - Point J completes the square. 2. **Identifying Points**:    - We choose point H on side LJ such that LH : HJ = 2:3.    - We also place point N on side CJ such that CN : NJ = 3:2 and similarly, point B on side CJ such that CB : BJ = 2:3. 3. **Identifying Equal Triangles**:    Since AD : CD = 2 : 5 and K divides CD into CK : KD = 2:3, triangle AKD and triangle MDC are indeed similar. Given that:    - triangle AKD cong triangle ALH,    - triangle ALH cong triangle HJN. 4. **Right Angles and Isosceles Triangle**:    - From the given, AH = HN and angle AHN = 90^circ.    - Consequently, angle HAN = 45^circ. 5. **Equal Angles and Conclusion**:    Given the similarity triangle MDC cong triangle NAB, it follows:    - angle NAB = angle MCD.    - Additionally, angle LAH + angle HAN + angle NAB = 90^circ. 6. **Final Sum**:    - Thus, angle LAH + angle NAB = angle AKD + angle MCD = 45^circ. Conclusion: [ boxed{45} ]"},{"instruction":"Evaluate the expression 3000(3000^{1500} + 3000^{1500}). textbf{(A)}  6000^{1501} qquad textbf{(B)}  2 cdot 3000^{1501} qquad textbf{(C)}  6000^{3000} qquad textbf{(D)}  3000^{3002} qquad textbf{(E)}  2 cdot 3000^{3000}","output":"1. **Identify and rewrite the expression**: The given expression is 3000(3000^{1500} + 3000^{1500}). 2. **Simplify the inside of the parentheses**: Since 3000^{1500} + 3000^{1500} are two identical terms, it simplifies to 2 times 3000^{1500}.     3. **Apply distributive property**:    [    3000 cdot (2 times 3000^{1500}) = 2 cdot (3000 cdot 3000^{1500}) = 2 cdot 3000^{1501}    ]    Here, 3000 cdot 3000^{1500} also follows the law of exponents a^m cdot a^n = a^{m+n}, leading to:    [    3000^{1} cdot 3000^{1500} = 3000^{1501}    ]     4. **Combine into final form**:    [    2 cdot 3000^{1501}    ] 5. **Conclusion**: The expression simplifies to 2 cdot 3000^{1501}. The correct answer is boxed{textbf{(B)}  2 cdot 3000^{1501}}."},{"instruction":"f 40 lemons are required to make 50 gallons of lemonade, how many lemons are needed to make 20 gallons of lemonade assuming each gallon of lemonade made in a larger batch also requires an additional 1 lemon for every 10 gallons due to increased handling?","output":"1. Start by understanding the base proportion of lemons to gallons without considering additional lemons. We have frac{40}{50} = frac{4}{5} lemons per gallon initially. 2. For 20 gallons, the basic number of lemons required is frac{4}{5} times 20 = 16 lemons. 3. Considering the additional lemons for larger batches, since every 10 gallons require an additional lemon and we are preparing 20 gallons, we need 20 div 10 = 2 extra lemons. 4. Total lemons required = Base lemons + Additional lemons = 16 + 2 = 18 lemons. Therefore, boxed{18} lemons are needed to make 20 gallons of lemonade under the new constraints."},{"instruction":"For how many ordered pairs (b,c) of positive integers does neither x^2bx+c=0 nor x^2cx+b=0 have two distinct real solutions? A) 4 B) 5 C) 6 D) 8 E) 12","output":"To solve for the number of ordered pairs (b,c) where neither x^2 - bx + c = 0 nor x^2 - cx + b = 0 have two distinct real solutions, we analyze their discriminants: 1. For x^2 - bx + c = 0, the discriminant is Delta_1 = b^2 - 4c. For there to be no two distinct real solutions, this must be non-positive:    [    b^2 - 4c leq 0 implies c geq frac{b^2}{4}    ] 2. For x^2 - cx + b = 0, the discriminant is Delta_2 = c^2 - 4b. For there to be no two distinct real solutions, this too must be non-positive:    [    c^2 - 4b leq 0 implies b geq frac{c^2}{4}    ] Next, examine the system of inequalities: [ left{ begin{array}{l} c geq frac{b^2}{4}  b geq frac{c^2}{4} end{array} right. ] For small values of b and c: - For b=1: c geq 0.25. Since c is a positive integer, c=1. Check second equation: 1 geq frac{1^2}{4} = 0.25. True. - For b=2: c geq 1. Valid c are 1, 2. For both values, check b geq frac{c^2}{4} holds. - For b=3 and c=3: Both conditions hold. - For b=4 and c=4: Both conditions hold. - For b>4, check that no feasible c applies because frac{b^2}{4} > b. Count pairs: - Valid pairs (b,c) are: (1,1), (2,1), (2,2), (3,3), (4,4). Conclusion: There are 5 feasible ordered pairs that satisfy the modified conditions. Therefore, the answer is 5. The final answer is boxed{B) 5}"},{"instruction":"Given sin alpha = 2cos alpha, then sin left( frac {pi}{2}+2alpha right)=() A:  frac {3}{5} B:  frac {4}{5} C: frac {3}{5} D: frac {4}{5}","output":"From sin alpha = 2cos alpha, we get tan alpha = 2.   Therefore, sin left( frac {pi}{2}+2alpha right) = cos 2alpha = frac {1-tan ^{2}alpha}{1+tan ^{2}alpha} = frac {1-4}{1+4} = - frac {3}{5}.   Hence, the correct option is boxed{A}.   From the given information, we can find tan alpha, and then use the trigonometric identities and the universal substitution formula to convert it into a function to find the value of sin left( frac {pi}{2}+2alpha right).   This problem tests the simplification and evaluation of trigonometric functions, including the application of trigonometric identities and the universal substitution formula, making it a basic question."},{"instruction":"Gabriel is looking at her marble sets. In the first set, 10% of her marbles are broken. In the second set, 20% of the marbles are broken. The first set contains some marbles. The second set contains 60 marbles. In total, 17 marbles are broken. How many marbles are in the first set?","output":"Let's denote the number of marbles in the first set as ( x ). From the second set, we know that 20% of the 60 marbles are broken. So, the number of broken marbles from the second set is: ( 0.20 times 60 = 12 ) broken marbles. Since there are 17 broken marbles in total, the number of broken marbles from the first set is: ( 17 - 12 = 5 ) broken marbles. We know that these 5 broken marbles represent 10% of the first set. Therefore, to find the total number of marbles in the first set, we can set up the equation: ( 0.10 times x = 5 ). To solve for ( x ), we divide both sides of the equation by 0.10: ( x = frac{5}{0.10} ). ( x = 50 ). So, there are boxed{50}  marbles in the first set."},{"instruction":"A student chose a number, multiplied it by 2, then subtracted 138 from the result. The number he chose was 120. What was the final result after subtracting 138?","output":"To find the final result, we need to follow the steps the student took with the number 120. First, the student multiplied the number by 2: 120 * 2 = 240 Then, the student subtracted 138 from the result: 240 - 138 = 102 So, the final result after subtracting 138 is boxed{102} ."},{"instruction":"Vitya has five math lessons per week, one on each day from Monday to Friday. Vitya knows that with a probability of (1 / 2), the teacher will not check his homework at all during the week, and with a probability of (1 / 2), the teacher will check it, but only once on any of the math lessons, with equal chances on any day. By the end of the math lesson on Thursday, Vitya realized that the teacher has not checked his homework so far this week. What is the probability that the homework will be checked on Friday?","output":"1. We need to find the probability that Vitya's homework will be checked on Friday, given that it has not been checked by the end of Thursday. 2. Let ( A ) be the event \\"homework has not been checked up until the end of Thursday.\\"      Let ( B ) be the event \\"homework will be checked on Friday.\\" 3. From the problem, the total probability consists of:    - The probability that no homework check will occur at all during the week    - The probability that homework is checked specifically on Friday 4. Probability that no homework check will occur at all is denoted by ( S ) which happened with probability ( frac{1}{2} ). 5. To find the probability ( mathrm{P}(B mid A) ), we need to use Bayes' theorem:    [    mathrm{P}(B mid A) = frac{mathrm{P}(A mid B) cdot mathrm{P}(B)}{mathrm{P}(A)}    ] 6. Calculate ( mathrm{P}(A mid B) ):    - This is the probability that homework has not been checked up until the end of Thursday, given that it will be checked on Friday.    - This is equal to ( frac{4}{5} ) (i.e., no check on Monday, Tuesday, Wednesday, or Thursday). 7. Calculating ( mathrm{P}(A) ):    - This includes two scenarios:      1. No check throughout the week: ( mathrm{P}(S) = frac{1}{2} )      2. Check happens on Friday: ( mathrm{P}(A mid B) times mathrm{P}(B) = frac{4}{5} times frac{1}{2 times 5} = frac{4}{10 times 5} = frac{1}{10} ) 8. Hence,    [    mathrm{P}(A) = mathrm{P}(S) + mathrm{P}(A mid B) cdot mathrm{P}(B) = frac{1}{2} + frac{1}{10} = frac{6}{10} = frac{3}{5}    ] 9. We proceed to apply Bayes theorem:    [    mathrm{P}(B mid A) = frac{mathrm{P}(A mid B) cdot mathrm{P}(B)}{mathrm{P}(A)} = frac{frac{4}{5} times frac{1}{10}}{frac{1}{2}} = frac{frac{4}{10 times 5}}{frac{3}{5}} = frac{1}{6}    ] # Conclusion: The calculated probability that the homework will be checked on Friday given that it has not been checked up to Thursday is: [ boxed{frac{1}{6}} ]"},{"instruction":"Compute tanleft(frac{pi}{8}right)tanleft(frac{3pi}{8}right)tanleft(frac{5pi}{8}right)tanleft(frac{7pi}{8}right).","output":"By DeMoivre's Theorem, we have: [ operatorname{cis} n theta = (cos theta + i sin theta)^n = cos ntheta + i sin ntheta. ] For n = 8, matching real and imaginary parts, we get: [ sin 8theta = binom{8}{1} cos^{7} theta sin theta - binom{8}{3} cos^{5} theta sin^3 theta + binom{8}{5} cos^{3} theta sin^5 theta - binom{8}{7} cos theta sin^7 theta. ] Thus, [ tan 8theta = frac{sin 8theta}{cos 8theta}. ] For theta = frac{pi}{8}, frac{3pi}{8}, frac{5pi}{8}, frac{7pi}{8}, tan 8theta = 0. Hence, tan frac{pi}{8}, tan frac{3pi}{8}, tan frac{5pi}{8}, tan frac{7pi}{8} are roots of [ 8t - 56t^3 + 56t^5 - 8t^7 = 0, ] or [ t^7 - 7t^5 + 7t^3 - t = 0. ] Factoring out t, we get: [ t(t^6 - 7t^4 + 7t^2 - 1) = 0. ] The roots are tan frac{pi}{8}, tan frac{3pi}{8}, tan frac{5pi}{8}, tan frac{7pi}{8}, and their negatives. By Vieta's formulas, [ left( tan frac{pi}{8} right) left( tan frac{3pi}{8} right) left( tan frac{5pi}{8} right) left( tan frac{7pi}{8} right) = 1. ] All tangents are positive since all angles are within the first and second quadrants. Therefore, [ tan frac{pi}{8} tan frac{3pi}{8} tan frac{5pi}{8} tan frac{7pi}{8} = boxed{1}. ]"},{"instruction":"Given the sets M={1,2,5} and N={x|xleqslant 2}, then Mcap N equals to (). A: {1}   B: {5}   C: {1,2}   D: {2,5}","output":"Solution: Since M={1,2,5} and N={x|xleqslant 2}, then Mcap N={1,2}.   Therefore, the correct choice is boxed{C}.   This problem can be directly solved by finding the intersection of the two sets.   It tests the method of finding the intersection of sets, a basic knowledge point."},{"instruction":"A circle with a circumference of 24 is divided into 24 equal segments. Select eight points from these 24 points in such a way that the arc length between any two selected points is not equal to 3 or 8. Find the number of different ways to choose these eight points that meet the requirements.","output":"# Problem: 24242438 1. **Data Analysis and Structure:**    - First, label the 24 points on the circle clockwise as 1, 2, 3, ldots, 24.    - Arrange these points into a 3 times 8 table format:      [      begin{array}{cccccccc}      1 & 4 & 7 & 10 & 13 & 16 & 19 & 22       9 & 12 & 15 & 18 & 21 & 24 & 3 & 6       17 & 20 & 23 & 2 & 5 & 8 & 11 & 14      end{array}      ] 2. **Row and Column Analysis:**    - In the table, any two adjacent numbers in the same column represent points where the chord between them results in an arc length of 3.    - Similarly, any two adjacent numbers in the same row represent points where the chord between them results in an arc length of 8. 3. **Selection Strategy:**    - From the above analysis, it's clear that any two adjacent numbers in the same column or row cannot be chosen simultaneously. Therefore, choose exactly one number from each column, ensuring no two numbers selected from adjacent columns are in the same row. 4. **Generalization and Recurrence Relation:**    - To generalize, let's consider a 3 times n table where we pick exactly one number from each column and ensure no two chosen numbers from adjacent columns are in the same row.    - Let the number of ways to choose the numbers satisfying these conditions from a 3 times n table be denoted by a_n.    - For n geq 4, the recursive relation is derived as:      [      a_n = 3 times 2^{n-1} - a_{n-1}      ]      Simplifying, we find:      [      a_n = 2^n + 2(-1)^n      ] 5. **Base Case and Calculation:**    - For the base case n=3, the table configuration allows precisely 6 valid selections:      [      a_3 = 6      ] 6. **Solving for a_8:**    [    a_8 = 2^8 + 2(-1)^8 = 256 + 2 cdot 1 = 258    ] # Conclusion: Thus, the number of valid ways to choose eight points from the 24-point circle, such that the chord between any two points doesn't correspond to arc lengths of 3 or 8, is: [ boxed{258} ]"},{"instruction":"f k is a non  negative integer and 18 ^ k is a divisor of 624,938 then 6 ^ k  k ^ 6 =","output":"To find the value of (6^k - k^6), we first need to determine the value of (k) such that (18^k) is a divisor of 624,938. Let's factorize 624,938 into its prime factors to see if (18^k) can be a divisor. 624,938 = 2  312,469 312,469 is not divisible by 2, so we check for divisibility by the next prime number, which is 3. 312,469 = 3  104,156 + 1 Since there is a remainder, 312,469 is not divisible by 3. However, we know that 18 is a power of 2 and 3 (since 18 = 2  3^2), so if 18^k is a divisor of 624,938, then 624,938 must be divisible by both 2 and 3 to some power. Since 624,938 is only divisible by 2 once, the highest power of 18 that can divide 624,938 is 18^0, because 18^1 would already have a factor of 2^1 and 3^2, which is not possible here. Therefore, (k = 0). Now we can calculate (6^k - k^6): (6^0 - 0^6 = 1 - 0 = 1). So, (6^k - k^6 = boxed{1)} ."},{"instruction":"Let ABCD be a rectangle with overline{AB} parallel to overline{CD} and longer than overline{BC}. The diagonals of the rectangle have length 20sqrt{5}. Point E is inside the rectangle at distances 8sqrt{5} from vertex A and 12sqrt{5} from vertex B. Let F be the midpoint of overline{CD}. Compute the distance EF, which can be expressed as xsqrt{y}, where x and y are positive integers with y not divisible by the square of any prime. Find x + y.","output":"To solve this, consider the rectangle ABCD where overline{AB} > overline{BC}. The diagonal AC = BD = 20sqrt{5}, so by the Pythagorean theorem in triangles ABC and BCD, if AB = a and BC = b, then: [ a^2 + b^2 = (20sqrt{5})^2 = 2000 ] Given E is 8sqrt{5} from A and 12sqrt{5} from B, we can place A at (0, 0), B at (a, 0), C at (a, b), and D at (0, b). With E's distances, its coordinates (x, y) must satisfy: [ x^2 + y^2 = (8sqrt{5})^2 = 320 ] [ (x-a)^2 + y^2 = (12sqrt{5})^2 = 720 ] Subtracting these two equations, we get: [ a^2 - 2ax = 400 ] [ a = 2x + 20 ] Substituting a = 2x + 20 back into a^2 + b^2 = 2000, we derive b as a function of x. To simplify, assume x = 20, so a = 60. Solve for b: [ 60^2 + b^2 = 2000 ] [ b^2 = 640 ] [ b = 8sqrt{10} ] Point F, being the midpoint of CD, has coordinates (0, b/2) = (0, 4sqrt{10}). Thus, EF is: [ EF = sqrt{x^2 + left(y-frac{b}{2}right)^2} ] [ EF = sqrt{20^2 + left(0 - 4sqrt{10}right)^2} ] [ EF = sqrt{400 + 160} = sqrt{560} = 2sqrt{140} = 2sqrt{35*4} = 4sqrt{35} ] Thus, x + y = 4 + 35 = boxed{39}."},{"instruction":"Let m and n satisfy mn=4 and m+n=5. What is |mn|?","output":"To solve for |m-n|, we start with the given equations: 1. mn = 4 2. m + n = 5 Instead of solving for m and n directly, we take a more strategic approach by manipulating these equations to find |m-n|.  First, we square the second equation to expand it: (m + n)^2 = 5^2 This leads to: m^2 + 2mn + n^2 = 25 Given that mn = 4, we can substitute 2mn with 2(4) = 8 in the equation: m^2 + 8 + n^2 = 25 To isolate (m-n)^2, we subtract 4mn (which is 16) from both sides of the equation: m^2 - 2mn + n^2 = 25 - 16 Simplifying this gives us: (m-n)^2 = 9 Taking the square root of both sides, we find that m-n can be either 3 or -3. However, since we are interested in the absolute value of m-n, we have: |m-n| = boxed{3}"},{"instruction":"Solve the equation ( 1 + cos 3x = 2 cos 2x ).","output":"We are given the trigonometric equation: [1+cos 3x = 2 cos 2x.] To solve this equation, we'll utilize some known trigonometric identities. Rewriting ( cos 3x ) using the triple angle identity and ( cos 2x ) using the double angle identity, we get: [cos 3x = 4 cos^3 x - 3 cos x,] and [cos 2x = cos^2 x - sin^2 x = cos^2 x - (1 - cos^2 x) = 2 cos^2 x - 1.] Now, substituting these expressions into the original equation: [1 + (4 cos^3 x - 3 cos x) = 2 (2 cos^2 x - 1).] Let's expand and simplify this equation step-by-step: 1. Replace (cos 3x) and (cos 2x) with the identities: [ 1 + 4 cos^3 x - 3 cos x = 2(2 cos^2 x - 1) ] 2. Distribute the 2 on the right-hand side: [ 1 + 4 cos^3 x - 3 cos x = 4 cos^2 x - 2 ] 3. Move all terms to one side to set the equation to zero: [ 1 + 4 cos^3 x - 3 cos x - 4 cos^2 x + 2 = 0 ] 4. Combine like terms: [ 4 cos^3 x - 4 cos^2 x - 3 cos x + 3 = 0 ] 5. Notice that we can factor out common terms: [ 4 cos^2 x (cos x - 1) - 3 (cos x - 1) = 0 ] 6. Factor out (cos x - 1): [ (cos x - 1)(4 cos^2 x - 3) = 0 ] This gives us a product of factors equal to zero, which means: 1. Either (cos x - 1 = 0), hence (cos x = 1), 2. Or (4 cos^2 x - 3 = 0), hence (cos^2 x = frac{3}{4}) and (cos x = pm frac{sqrt{3}}{2}). Now, let's find the solutions for ( x ): # Case 1: (cos x = 1) [ cos x = 1 implies x = 2lpi text{ where } l in mathbb{Z} ] # Case 2: (cos x = pm frac{sqrt{3}}{2}) - When (cos x = frac{sqrt{3}}{2}): [ x = frac{pi}{6} + 2kpi quad text{or} quad x = frac{11pi}{6} + 2kpi quad text{where } k in mathbb{Z} ] - When (cos x = -frac{sqrt{3}}{2}): [ x = frac{5pi}{6} + 2kpi quad text{or} quad x = frac{7pi}{6} + 2kpi quad text{where } k in mathbb{Z} ] # Conclusion: The complete set of solutions to the equation [1 + cos 3x = 2 cos 2x] is: [ boxed{x = 2kpi, quad x = frac{pi}{6} + kpi, quad x = frac{5pi}{6} + kpi text{ where } k in mathbb{Z}} ]"},{"instruction":"f ( N=2^{5} times 3^{2} times 7 times square ) and 100 divides evenly into ( N ), which of the following numbers could be placed in the box? (A) 5 (B) 20 (C) 75 (D) 36 (E) 120","output":"To solve for the correct number that can be placed in the box for N=2^5 times 3^2 times 7 times square such that 100 divides evenly into N, let's follow these detailed steps: 1. **Initial Analysis**:     - We know 100 can be factored as 100 = 2^2 times 5^2.     - This means for 100 to divide evenly into N, N must have at least 2 prime factors of 2 and 2 prime factos of 5. 2. **Factors of N Present**:     - From N = 2^5 times 3^2 times 7 times square, the component 2^5 times 3^2 times 7 already provides 2^5, plenty of factors of 2 (more than 2 but sufficient), as well as 3^2 and 7.    - However, N does not currently have any factors of 5. 3. **Requirement for Factors of 5**:     - Since we need N to be divisible by 100 = 2^2 times 5^2, the box must contain factors of 5 sufficient to provide 5^2 (i.e., 25). 4. **Check Choices for Required Factorization**:    - We need a number whose prime factorization includes exactly 5^2 = 25 to place in the box.    Let's analyze each choice:    - (A) 5: Prime factorization is 5, which includes only 5 (not enough, needs 5^2).    - (B) 20: Prime factorization is 2^2 times 5, which includes only 5 (not enough, needs 5^2).    - (C) 75: Prime factorization is 3 times 5^2, which includes 5^2 (this is sufficient).    - (D) 36: Prime factorization is 2^2 times 3^2, which includes no 5 factors (not enough, needs 5^2).    - (E) 120: Prime factorization is 2^3 times 3 times 5, which includes only 5 (not enough, needs 5^2). 5. **Verification**:    - Use multiplication to ensure that the chosen option results in N being divisible by 100:      [      N = 2^5 times 3^2 times 7 times 75 = 32 times 9 times 7 times 75      ]      Calculate step-by-step:      [      32 times 9 = 288      ]      [      288 times 7 = 2016      ]      [      2016 times 75 = 151200      ]      Verify:      [      151200 div 100 = 1512       ]      151200 is divisible by 100. Therefore, the only possible correct answer is  [ boxed{C} ]"},{"instruction":"The planet Zircon orbits its sun in an elliptical path with the sun at one of the foci. The nearest point of Zircon to its sun (perigee) is 3 astronomical units (AU) and its farthest point (apogee) is 15 AU. Determine how far Zircon is from its sun when it is onefourth way from the perigee towards the apogee along its orbital path.","output":"Let A be the perigee, B be the apogee, F the focus where the sun is, O the center of the ellipse, and P the position of Zircon when it is one-fourth way along the orbit from A to B. 1. **Ellipse major axis and distance properties:**    The major axis length of the ellipse, which passes through A, O, and B, equals the sum of the perigee and apogee distances. So, AB = 3 + 15 = 18 AU. Hence, center O of the ellipse, which is the midpoint of line segment AB, is at a distance of frac{18}{2} = 9 AU from both A and B. 2. **Place of the planet Zircon (Point P):**    As point P is one-fourth way from A towards B, it is located at frac{1}{4}th of the distance from A to B along the semi-major axis. This placement is on the major axis stretching from 3 AU at A to 9 AU at O. Thus, P is at 3 + frac{1}{4}(18 - 3) = 3 + frac{15}{4} = 3 + 3.75 = 6.75 AU from one focus F. 3. **Verification to ensure P is actually frac{1}{4} way along the path from A:**    The distance from A to P would be 6.75 - 3 = 3.75 AU which is indeed frac{1}{4} of the total length 15 AU from A to B. boxed{6.75} AU is the distance from the sun at focus F to planet Zircon at position P."},{"instruction":"Mr. John used to purchase a certain number of mangoes for a certain amount. Since the price of mangoes is reduced by 10%, he got 12 more mangoes today. The original price of 135 mangoes was 450. How much did Mr. John spend on mangoes before the price reduction?","output":"Let's denote the original price per mango as P and the number of mangoes Mr. John used to purchase as N. From the information given, we know that the original price of 135 mangoes was 450. Therefore, we can calculate the original price per mango (P) as follows: [ P = frac{Total Cost}{Number of Mangoes} ] [ P = frac{450}{135} ] [ P = frac{50}{15} ] [ P = frac{10}{3} ] [ P = 3.33 (recurring) ] Now, since the price of mangoes is reduced by 10%, the new price per mango (P_new) is: [ P_{new} = P - (0.10 times P) ] [ P_{new} = P - (0.10 times 3.33) ] [ P_{new} = 3.33 - 0.333 ] [ P_{new} = 3 ] With the reduced price, Mr. John got 12 more mangoes than he used to. Let's denote the new number of mangoes as N_new: [ N_{new} = N + 12 ] We know that the amount of money Mr. John spends remains the same, so we can set up the equation: [ P times N = P_{new} times N_{new} ] [ 3.33 times N = 3 times (N + 12) ] Now we need to solve for N: [ 3.33N = 3N + 36 ] [ 3.33N - 3N = 36 ] [ 0.33N = 36 ] [ N = frac{36}{0.33} ] [ N = 109.09 (recurring) ] Since the number of mangoes must be a whole number, we round N to the nearest whole number, which is 109. Now we can calculate how much Mr. John spent on mangoes before the price reduction: [ Total Cost = P times N ] [ Total Cost = 3.33 times 109 ] [ Total Cost = 362.97 ] Since we are dealing with money, we round to the nearest cent, so Mr. John spent approximately boxed{363}  on mangoes before the price reduction."},{"instruction":"After paying 6 dollars for the pie, Mary has some amount left, her friend has 43 dollars. Mary had 58 dollars before buying the pie. How much money does Mary have now?","output":"Mary had 58 before buying the pie. She spent 6 on the pie. To find out how much money she has left, we subtract the cost of the pie from the amount she had originally: 58 - 6 = 52 So, Mary now has boxed{52}  left after buying the pie."},{"instruction":"40 % of x is greater than 1 / 3 rd of x by 110 . what is x ?","output":"Let's denote x as the unknown value we are trying to find. According to the problem, 40% of x is greater than 1/3 of x by 110. We can write this as an equation: 0.40x = (1/3)x + 110 To solve for x, we first need to get all the x terms on one side of the equation. We can do this by subtracting (1/3)x from both sides: 0.40x - (1/3)x = 110 To combine the x terms, we need a common denominator. The common denominator for 0.40 (which is the same as 2/5) and 1/3 is 15. So we convert both fractions to have the denominator of 15: (6/15)x - (5/15)x = 110 Now we can subtract the fractions: (1/15)x = 110 To solve for x, we multiply both sides of the equation by 15: x = 110 * 15 x = 1650 Therefore, x is boxed{1650} ."},{"instruction":"Find a nonzero value of q such that the quadratic equation qx^2  18x + 8 = 0 has only one solution.","output":"For a quadratic equation to have only one solution, its discriminant must be zero. The discriminant Delta for the equation qx^2 - 18x + 8 = 0 is given by: [ Delta = (-18)^2 - 4 cdot q cdot 8 = 324 - 32q ] Setting the discriminant to zero to find the condition for q: [ 324 - 32q = 0 ] Solving for q, we have: [ 32q = 324 quad Rightarrow quad q = frac{324}{32} = frac{81}{8} ] Thus, the required value of q is boxed{frac{81}{8}}."},{"instruction":"The distance between two parallel lines l<sub>1</sub>: 2x + y + 1 = 0, l<sub>2</sub>: 4x + 2y + 3 = 0 is (   ) A: frac { sqrt {5}}{10} B: frac {2 sqrt {5}}{5} C: frac { sqrt {5}}{5} D: 2","output":"**Analysis:** This problem tests the formula for the distance between two parallel lines. When using the formula, pay attention to first convert the equations of the two lines into equations with equal coefficients of x and y, then find the corresponding C<sub>1</sub> and C<sub>2</sub>, and substitute them into the formula. This is a basic problem. First, convert the two lines into equations with the same coefficients of x and y, find C<sub>1</sub> and C<sub>2</sub>, and then substitute them into the formula for the distance between parallel lines. **Answer:** The equations of the two parallel lines l<sub>1</sub>: 2x + y + 1 = 0, l<sub>2</sub>: 4x + 2y + 3 = 0 can be converted into: two parallel lines l<sub>1</sub>: 4x + 2y + 2 = 0, l<sub>2</sub>: 4x + 2y + 3 = 0, So the distance d between the two parallel lines l<sub>1</sub>: 2x + y + 1 = 0, l<sub>2</sub>: 4x + 2y + 3 = 0 is d = frac {|3-2|}{ sqrt {4^{2}+2^{2}}} = frac { sqrt {5}}{10}. Therefore, the answer is: boxed{text{A}}."},{"instruction":"Determine the minimum value of  [ frac{x^2}{x  9} ] for (x > 9).","output":"Rewriting the expression, we have: [ frac{x^2}{x - 9} = frac{x^2 - 81 + 81}{x - 9} = frac{(x - 9)(x + 9) + 81}{x - 9} = x + 9 + frac{81}{x - 9}. ] It is useful to simplify and minimize: [ frac{x^2}{x - 9} = x - 9 + frac{81}{x - 9} + 18. ] Applying the AM-GM inequality to the terms (x - 9) and (frac{81}{x - 9}), we get: [ x - 9 + frac{81}{x - 9} geq 2 sqrt{(x - 9) cdot frac{81}{x - 9}} = 18. ] Thus, the whole expression becomes: [ frac{x^2}{x - 9} geq 18 + 18 = 36. ] Equality is achieved when (x - 9 = frac{81}{x - 9}), leading to: [ x - 9 = 9 implies x = 18. ] Checking at (x = 18): [ frac{18^2}{18 - 9} = frac{324}{9} = 36. ] Therefore, the minimum value is (boxed{36})."},{"instruction":"Dalton wants to buy 3 jump ropes that cost 7 each, 2 board games that cost 12 each and 4 playground balls that cost 4 each. Each jump rope has a discount of 2, and each ball has a 1 discount. He has saved 30 from his allowance, his uncle gave him 25, and his grandma gave him an additional 10. Sales tax in his location is 8%. How much more money does Dalton need to buy the items including the discounts and tax?","output":"First, let's calculate the total cost of the items before the discounts: - Jump ropes: 3 jump ropes * 7 each = 21 - Board games: 2 board games * 12 each = 24 - Playground balls: 4 balls * 4 each = 16 Total cost before discounts = 21 + 24 + 16 = 61 Now, let's apply the discounts: - Jump rope discount: 3 jump ropes * 2 discount each = 6 discount - Playground ball discount: 4 balls * 1 discount each = 4 discount Total discounts = 6 + 4 = 10 Subtract the total discounts from the total cost before discounts to get the total cost after discounts: Total cost after discounts = 61 - 10 = 51 Now, let's calculate the sales tax: Sales tax = Total cost after discounts * Sales tax rate Sales tax = 51 * 8% = 51 * 0.08 = 4.08 Add the sales tax to the total cost after discounts to get the final total cost: Final total cost = Total cost after discounts + Sales tax Final total cost = 51 + 4.08 = 55.08 Finally, let's calculate how much money Dalton has: Total money Dalton has = Money from allowance + Money from uncle + Money from grandma Total money Dalton has = 30 + 25 + 10 = 65 Now, let's see if Dalton has enough money or if he needs more: If Dalton's total money is greater than or equal to the final total cost, he has enough. If not, he needs more. 65 (Dalton's total money) - 55.08 (Final total cost) = 9.92 Dalton has boxed{9.92}  more than he needs, so he does not need any additional money to buy the items including the discounts and tax."},{"instruction":"Given the function f(x) = begin{cases} (3a1)x+4a & (x < 1)  log_{a}x & (x geq 1)end{cases} is not a monotonic function on mathbb{R}, then the range of real number a is ______","output":"When the function f(x) is a decreasing function on mathbb{R}, we have 3a-1<0 and 0<a<1 and (3a-1) cdot 1 + 4a geq log_{a}1. Solving this, we get frac{1}{7} leq a < frac{1}{3}. When the function f(x) is an increasing function on mathbb{R}, we have 3a-1>0 and a>1 and (3a-1) cdot 1 + 4a leq log_{a}1. Solving this, we find that there is no solution for a. Therefore, when the function f(x) is a monotonic function on mathbb{R}, we have frac{1}{7} leq a < frac{1}{3}. Therefore, when the function f(x) is not a monotonic function on mathbb{R}, we have a>0 and a neq 1 and a < frac{1}{7} or a geq frac{1}{3}. That is, 0 < a < frac{1}{7} or frac{1}{3} leq a < 1 or a > 1. Hence, the answer is: (0, frac{1}{7}) cup [frac{1}{3}, 1) cup (1, +infty). This problem can be approached using the complement concept, by first determining the range for which f(x) is a monotonic function on mathbb{R}, and then taking its complement. This problem tests the concept of complements and the idea of discussing cases, which requires a certain level of thinking from students. Therefore, the range of real number a for which the function f(x) is not a monotonic function on mathbb{R} is boxed{(0, frac{1}{7}) cup [frac{1}{3}, 1) cup (1, +infty)}."},{"instruction":"f ( |x| + x + 5y = 2 ) and ( |y|  y + x = 7 ), find the value of ( x + y + 2009 ).","output":"**Step 1:** Consider the given system of equations: [ |x| + x + 5y = 2  quad text{(1)} ] [ |y| - y + x = 7  quad text{(2)} ] **Step 2:** Analyze cases based on the sign of (y): - **Case 1:** Suppose (y geq 0)   In this case:   [   |y| = y   ]   Substituting into equation (2):   [   y - y + x = 7   ]   Simplifies to:   [   x = 7   ]   Substituting (x = 7) into equation (1):   [   |7| + 7 + 5y = 2   ]   Simplifies to:   [   7 + 7 + 5y = 2   ]   [   14 + 5y = 2   ]   Solving for (y):   [   5y = 2 - 14   ]   [   5y = -12   ]   [   y = -frac{12}{5}   ]   Since (y = -frac{12}{5} < 0), this contradicts the assumption (y geq 0). Therefore, (y < 0). **Step 3:** Consider the system with (y < 0): - **Case 2:** Suppose (x leq 0)   In this case:   [   |x| = -x   ]   Substituting into equation (1):   [   -x + x + 5y = 2   ]   Simplifies to:   [   5y = 2   ]   Solving for (y):   [   y = frac{2}{5}   ]   Since (y = frac{2}{5} > 0), this contradicts the assumption (y < 0). Therefore, (x > 0) and (y < 0). **Step 4:** Taking into account the correct signs for (x) and (y): [ |x| = x quad text{and} quad |y| = -y ] Substitute these into the original equations: [ -x - y + x = 7 implies -2y + x = 7 quad text{(3)} ] [ x + x + 5y = 2 implies 2x + 5y = 2 quad text{(4)} ] **Step 5:** Solving the system of linear equations: 1. From equation (3): [ -2y + x = 7 implies x = 7 + 2y ] 2. Substitute ( x = 7 + 2y ) into equation (4): [ 2(7 + 2y) + 5y = 2 ] [ 14 + 4y + 5y = 2 ] [ 14 + 9y = 2 ] Solving for (y): [ 9y = 2 - 14 ] [ 9y = -12 ] [ y = -frac{4}{3} ] 3. Substitute (y = -frac{4}{3}) back into ( x = 7 + 2y ): [ x = 7 + 2left(-frac{4}{3}right) ] [ x = 7 - frac{8}{3} ] [ x = frac{21}{3} - frac{8}{3} ] [ x = frac{13}{3} ] **Conclusion:** [ x + y + 2009 = frac{13}{3} - frac{4}{3} + 2009 ] [ = frac{13 - 4}{3} + 2009 ] [ = frac{9}{3} + 2009 ] [ = 3 + 2009 ] [ = 2012 ] [ boxed{2012} ]"},{"instruction":"Find all angles theta, 0 le theta le 2pi, with the following property: For all real numbers x, 0 le x le 1, [ x^3 cos theta + x(1  x)  (1  x)^3 sin theta < 0. ]","output":"- **Step 1**: Evaluate boundary conditions x = 0 and x = 1.   - For x = 0, the expression simplifies to -sin theta < 0, thus sin theta > 0.   - For x = 1, the expression simplifies to cos theta < 0, so cos theta > 0 is invalid; instead, it confirms cos theta < 0. - **Step 2**: Analyze and solve for theta considering both conditions:   - sin theta > 0 and cos theta < 0 implies theta is in the second quadrant, i.e., frac{pi}{2} < theta < pi.   - For such theta, we need to check if the inequality holds across 0 le x le 1. - **Step 3**: Check for the entire range of x in [0,1] using trigonometric identities:   - The expression is x^3 cos theta + x(1 - x) - (1 - x)^3 sin theta < 0.   - Simplifying and factoring, none of the real roots of this cubic equation in x should lie in [0,1] for frac{pi}{2} < theta < pi. - **Conclusion**: The solution holds true within the second quadrant where sin theta > 0 and cos theta < 0, hence the range of theta where the condition is satisfied is boxed{left(frac{pi}{2}, piright)}."},{"instruction":"Two chords, EF and GH, meet inside a circle at Q. If EQ = 5 and GQ = 7, then what is frac{FQ}{HQ}?","output":"By using the Power of a Point theorem, we know that: [ EQ cdot FQ = GQ cdot HQ ] Given that EQ = 5 and GQ = 7, we substitute these values into the equation: [ 5 cdot FQ = 7 cdot HQ ] We need to find the ratio frac{FQ}{HQ}. Solving the equation for this ratio, we get: [ frac{FQ}{HQ} = frac{7}{5} ] Hence, the ratio of FQ to HQ is boxed{frac{7}{5}}."},{"instruction":"Let the universal set be {R}, set {A= {xmathrel{|} 0lt xlt 2}}, {B= {xmathrel{|} xgeq 1}}, then {Acap (complement _{R}B)= (}{)} A: {{xmathrel{|} 0lt xleq 1}} C: {{xmathrel{|} 1leq xlt 2}} B: {{xmathrel{|} 0lt xlt 1}} D: {{xmathrel{|} 0lt xlt 2}}","output":"Given: - The universal set is R. - Set A = {x | 0 < x < 2}. - Set B = {x | x geq 1}. To find A cap (complement_{R}B), follow these steps: 1. Identify Set A: A = {x | 0 < x < 2}, which means A includes all real numbers between 0 and 2, not including 0 and 2 themselves. 2. Identify Set B: B = {x | x geq 1}, which means B includes all real numbers equal to 1 and greater than 1. 3. Determine complement_{R}B: complement_{R}B = {x | x < 1}, since the complement of B in the universal set R consists of all numbers that are not in B. Therefore, it includes all numbers less than 1. 4. Calculate A cap (complement_{R}B): Since A includes numbers from 0 to 2 and complement_{R}B includes numbers less than 1, the intersection of these two sets will include all numbers that are greater than 0 and less than 1. Hence, A cap (complement_{R}B) = {x | 0 < x < 1}. Therefore, the correct answer is boxed{B}."},{"instruction":"The interval in which the function f(x)=sqrt{2}sinleft(x+frac{pi}{4}right) is decreasing, given xin[0,pi], is ________.","output":"[Analysis] This problem examines the monotonicity of the sine function. By utilizing the overall method combined with the monotonicity of the sine function, we find the decreasing interval of f(x)=sqrt{2}sinleft(x+frac{pi}{4}right). Then, considering xin[0,pi], we obtain the result. [Solution] The function f(x) is decreasing when 2kpi+frac{pi}{2}leq x+frac{pi}{4}leq 2kpi+frac{3pi}{2}, kinmathbb{Z}, i.e., 2kpi+frac{pi}{4}leq xleq 2kpi+frac{5pi}{4}, kinmathbb{Z}. Given xin[0,pi], the decreasing interval of f(x) is left[frac{pi}{4},piright]. Therefore, the answer is boxed{left[frac{pi}{4},piright]}."},{"instruction":"Viggo's age was 10 years more than twice his younger brother's age when his brother was a certain age. If his younger brother is currently 10 years old, what was his brother's age when Viggo's age was 10 years more than twice his brother's age?","output":"Let's denote Viggo's younger brother's age at the time in question as B. According to the information given, Viggo's age at that time was 10 years more than twice his younger brother's age. So, we can write this as: Viggo's age at that time = 2B + 10 Now, we know that the younger brother is currently 10 years old. Let's assume that the time in question was X years ago. That means, at that time, the younger brother's age was: B = 10 - X Since Viggo's age was 10 years more than twice his brother's age at that time, we can substitute B in the first equation with (10 - X): Viggo's age at that time = 2(10 - X) + 10 Now, we need to find the value of X that satisfies the equation. However, we don't have information about Viggo's current age or his age at the time in question, so we cannot determine the exact value of X with the information given. To solve this problem, we need additional information about Viggo's current age or the difference in age between Viggo and his brother at the present time. Without this information, we cannot determine the brother's age when Viggo's age was boxed{10}  years more than twice his brother's age."},{"instruction":"f sin theta =frac{4}{5}, and theta is an angle in the second quadrant, then sin 2theta = ______________.","output":"**Analysis** This question tests the application of basic trigonometric relationships and the double angle formula. It is a basic problem. **Solution** Given sin theta =frac{4}{5}, and theta is an angle in the second quadrant, we can find cos theta= -sqrt{1-sin^2theta}=-frac{3}{5}, thus, sin 2theta =2sin thetacos theta=2times frac{4}{5}times(-frac{3}{5})=-frac{24}{25}. Therefore, the answer is boxed{-frac{24}{25}}."},{"instruction":"Find the probability that if the digits 0,1,2, ldots, 9 are placed in random order into the empty places in the row of digits  538382936582039376  the resulting number will be divisible by 396.","output":"We need to determine the probability that a random arrangement of the digits (0, 1, 2, ldots, 9) in the sequence below will form a number divisible by 396: [ 5-383-8-2-936-5-8-203-9-3-76 ] To solve this, we'll check the criteria for the number formed being divisible by 396. Since 396 can be factored into its prime components: [ 396 = 4 times 9 times 11 ] A number must meet the criteria for divisibility by 4, 9, and 11 simultaneously to be divisible by 396. 1. **Divisibility by 4**:    - A number is divisible by 4 if the last two digits of the number form a number that is divisible by 4.    - In this case, the last two digits are fixed as (76).    - (76 div 4 = 19), hence it is divisible by 4. 2. **Divisibility by 9**:    - A number is divisible by 9 if the sum of its digits is divisible by 9.    - The digits in our number sequence are (0, 1, 2, 3, 4, 5, 6, 7, 8, 9).    - The sum of these digits is:      [      0 + 1 + 2 + 3 + 4 + 5 + 6 + 7 + 8 + 9 = 45      ]    - Since (45 div 9 = 5), the sum 45 is divisible by 9. 3. **Divisibility by 11**:    - A number is divisible by 11 if the alternating sum of its digits is divisible by 11.    - Lets label positions as even and odd. For this sequence, alternating positions are defined as:      - **Odd positions:** 5, 3, 3, 3, 2, 6, 5, 8, 3, 9, 7      - **Even positions:** 8, 8, 2, 9, 6, 8, 2, 0, 9, 7, 6    - Calculating the sum of digits in odd and even positions:      - Sum (Odd positions):       [      5 + 3 + 3 + 2 + 5 + 3 + 7 = 28      ]      - Sum (Even positions):      [      8 + 2 + 9 + 6 + 8 + 2 + 0 + 9 + 7 + 6 = 57      ]      - Difference (Odd sum - Even sum):      [      57 - 17 = 17      ]    - The number (17 - 45) depends on the digit placements and thus might differ depending on placements of individual digits.  Given the constraints of the problem, provided digits, and placement, it covers the full trial variation proving divisibility constraints are met at probability 1 under ordered digit mechanism. **Conclusion:** The resulting number is always divisible by (396) thus the probability is: [ boxed{1} ]"},{"instruction":"The cafeteria had 47 apples. For lunch they handed out 27 to students and decided to use the rest to make pies. If each pie takes 4 apples, how many pies could they make?","output":"After handing out 27 apples to students, the cafeteria had 47 - 27 = 20 apples left. Since each pie takes 4 apples, the number of pies they could make with 20 apples is 20 / 4 = boxed{5}  pies."},{"instruction":"f the graph of the quadratic function fleft(xright)=ax^{2}+2ax2 is always below the xaxis, then the range of real number a is () A: (2,0) B: (infty ,0) C: (infty ,2) D: (infty ,2)cup left(0,+infty right)","output":"To determine the range of real numbers for (a) such that the graph of the quadratic function (fleft(xright)=ax^{2}+2ax-2) is always below the (x)-axis, we first recognize that (f(x)) being always below the (x)-axis implies it never touches or crosses the (x)-axis. This situation occurs under two conditions: 1. The quadratic function opens downwards. 2. The discriminant ((Delta)) is negative, ensuring no real roots. The quadratic function opens downwards when the coefficient of (x^{2}), which is (a), is less than (0). Therefore, we have: [a < 0] Next, we calculate the discriminant ((Delta)) of the quadratic equation, which is given by (Delta=b^{2}-4ac). Using the coefficients from (f(x)=ax^{2}+2ax-2), we have (b=2a) and (c=-2). This gives us: [Delta = (2a)^{2} - 4(a)(-2) = 4a^{2} + 8a] For the graph of the function to be always below the (x)-axis, (Delta) must be less than (0): [4a^{2} + 8a < 0] To solve this inequality, we factor it: [4a(a + 2) < 0] The inequality (4a(a + 2) < 0) holds when (a) is between the roots of the equation (4a(a + 2) = 0), namely (a = 0) and (a = -2), without including the endpoints because the discriminant must be strictly less than (0) for no real roots. This implies: [-2 < a < 0] Therefore, the range of real numbers for (a) that ensures the graph of (f(x)) is always below the (x)-axis is (a in (-2, 0)). The correct answer is: [boxed{A}]"},{"instruction":"the diagram, if angle XYZ = 72^circ, what is the measure of angle XWZ? \`\`\` [asy] size(6cm); pair x = (0, 0); pair w = dir(180  36); pair z = dir(180 + 36); pair y = 1.3 * dir(36); pair v = 2 * 1.3 * Cos(72) * dir(36); draw(wvyzcycle); label(W, w, N); label(Y, y, N); label(X, x, 1.5 * S); label(Z, z, S); label(V, v, SE); add(pathticks(wx, s=4)); add(pathticks(zx, s=4)); add(pathticks(yx, 2, spacing=0.9, s=4)); add(pathticks(yv, 2, spacing=0.9, s=4)); [/asy] \`\`\`","output":"In the triangle XYZ, given XY = YZ, the internal angles opposite these sides are equal, so angle YXZ = angle YZX = 72^circ (as angle XYZ is given). Since angle XWZ and angle YXZ are vertically opposite, angle XWZ = angle YXZ = 72^circ. In triangle XWZ, given that XW = XZ, it follows that angle XWZ = angle XZW. Thus, angle XWZ = frac{1}{2}(180^circ - angle XWZ) = frac{1}{2}(180^circ - 72^circ) = frac{1}{2}(108^circ) = boxed{54^circ}."},{"instruction":"When x in mathbb{R}, the quadratic inequality x^2  kx + 1 > 0 always holds. Find the range of k.","output":"Since x in mathbb{R} and the quadratic inequality x^2 - kx + 1 > 0 always holds, we have k^2 - 4 < 0. Therefore, -2 < k < 2. Hence, the answer is boxed{-2 < k < 2}. **Analysis:** According to the problem, we get k^2 - 4 < 0. Solving this inequality gives us the range of k."},{"instruction":"triangle ABC, a, b, c are the sides opposite to angles A, B, C, respectively. If dfrac{2cb}{a} = dfrac{cos B}{cos A},   (1) find the size of angle A;   (2) given a=2sqrt{5}, find the maximum area of triangle ABC.","output":"Solution:   (1) Since dfrac{2c-b}{a} = dfrac{cos B}{cos A}, we have (2c-b)cos A=acos B. By the sine theorem,   we get (2sin C-sin B)cos A=sin Asin B, which simplifies to 2sin Ccos A-sin Bcos A=sin Acos B.   Therefore, 2sin C-cos A=sin (A+B)=sin C.   In triangle ABC, sin Cneq 0, so cos A= dfrac{1}{2}, angle A= dfrac{pi}{3}. Thus, boxed{angle A = dfrac{pi}{3}}.   (2) By the cosine theorem, cos A= dfrac{b^{2}+c^{2}-a^{2}}{2bc}= dfrac{1}{2}, and a=2sqrt{5}.   therefore b^{2}+c^{2}-20=bcgeqslant 2bc-20   therefore bcleqslant 20, equality holds when and only when b=c.   therefore The area of the triangle S= dfrac{1}{2}bcsin Aleqslant 5sqrt{3}.   therefore The maximum area of the triangle is boxed{5sqrt{3}}."},{"instruction":"Adva van egy ferde helyzet sk s egy az els kpskra merleges egyenes. Keressk ezen egyenes hajlsszgt a megadott skkal.","output":"To solve the problem, we need to determine the inclination angle between a line perpendicular to the horizontal plane and an oblique plane. **First Solution:** 1. **Consider any point on the line**:    - Lets say a point ( P ) is on the given line ( l ). 2. **Draw a perpendicular from point ( P ) to the plane**:    - Draw the perpendicular ( PQ ) from point ( P ) to the given oblique plane ( pi ).  3. **Construct a plane containing the line and the perpendicular**:    - This will be called the first projection plane, denoted as ( Pi_1 ). The plane ( Pi_1 ) will contain both the given line ( l ) and the line segment ( PQ ). 4. **Find the intersection of the planes**:    - Determine the line of intersection of the first projection plane ( Pi_1 ) with the given oblique plane ( pi ). Let this line of intersection be ( m ). 5. **Angle between the line and the intersection line**:    - The angle between the given line ( l ) and the line of intersection ( m ) is the required angle of inclination. Thus, the inclination angle between the given line and the oblique plane can be found by this method. **Second Solution:** 1. **One segment of the angle is the given line**:    - Lets denote the given line as ( l ). 2. **Project the intersection point to the horizontal plane**:    - Find the intersection point of the line ( l ) with the plane ( pi ). Let this intersection point be ( A ). 3. **Draw a perpendicular from the intersection point to the horizontal plane**:    - Draw a perpendicular from point ( A ) to the first trace (horizontal trace) of the plane ( pi ). This perpendicular is the projection of the line ( l ) on the plane ( pi ). 4. **Angle between the original and projected lines**:    - The required inclination angle is the angle between the line ( l ) and its projection on the plane ( pi ). By these steps, we can determine the inclination angle effectively. **Third Solution:** 1. **Given the first angle**:    - Let the first angle of the plane ( pi ) be ( alpha ). 2. **Calculate the inclination angle**:    - Since the given line is perpendicular to the horizontal plane, the inclination angle ( theta ) of the line with the plane ( pi ) will be ( 90^circ - alpha ).    [    theta = 90^circ - alpha    ] 3. **Determine the first angle of the plane**:    - Only the first angle ( alpha ) of the plane ( pi ) needs to be calculated. By following these steps, we get the inclination angle of the line with respect to the oblique plane. The correct inclination angle is thus found by each method, and should match accordingly with the context of the problem. [ boxed{90^circ - alpha} ]"},{"instruction":"Define the function  f(x) = lfloor x rfloor + lfloor sqrt{x} rfloor + lfloor sqrt{sqrt{x}} rfloor  for all positive real numbers  x . How many integers from  1  to  2023  inclusive are in the range of  f(x) ? Note that  lfloor xrfloor  is known as the  textit{floor}  function, which returns the greatest integer less than or equal to  x . *Proposed by Harry Kim*","output":"To determine how many integers from 1 to 2023 inclusive are in the range of the function f(x) = lfloor x rfloor + lfloor sqrt{x} rfloor + lfloor sqrt{sqrt{x}} rfloor, we need to analyze the behavior of the function and find the range of values it can produce. 1. **Analyze the function components:**    - lfloor x rfloor: This is the greatest integer less than or equal to x.    - lfloor sqrt{x} rfloor: This is the greatest integer less than or equal to sqrt{x}.    - lfloor sqrt{sqrt{x}} rfloor: This is the greatest integer less than or equal to sqrt{sqrt{x}}. 2. **Determine the range of each component:**    - For x in [1, 2023], lfloor x rfloor ranges from 1 to 2023.    - For x in [1, 2023], lfloor sqrt{x} rfloor ranges from lfloor sqrt{1} rfloor = 1 to lfloor sqrt{2023} rfloor = lfloor 44.94 rfloor = 44.    - For x in [1, 2023], lfloor sqrt{sqrt{x}} rfloor ranges from lfloor sqrt{sqrt{1}} rfloor = 1 to lfloor sqrt{sqrt{2023}} rfloor = lfloor sqrt{44.94} rfloor = lfloor 6.70 rfloor = 6. 3. **Combine the components:**    - The function f(x) can be written as f(x) = lfloor x rfloor + lfloor sqrt{x} rfloor + lfloor sqrt{sqrt{x}} rfloor.    - The minimum value of f(x) occurs when x = 1: f(1) = lfloor 1 rfloor + lfloor sqrt{1} rfloor + lfloor sqrt{sqrt{1}} rfloor = 1 + 1 + 1 = 3.    - The maximum value of f(x) occurs when x = 2023: f(2023) = lfloor 2023 rfloor + lfloor sqrt{2023} rfloor + lfloor sqrt{sqrt{2023}} rfloor = 2023 + 44 + 6 = 2073. 4. **Determine the range of f(x):**    - We need to find how many integers from 3 to 2073 are in the range of f(x).    - Since f(x) is a sum of three non-decreasing functions, it will cover all integers from its minimum value to its maximum value without gaps. 5. **Count the integers in the range:**    - The number of integers from 3 to 2073 inclusive is 2073 - 3 + 1 = 2071. The final answer is boxed{2071}."},{"instruction":"f h(x) = 4x  5 and k(x) = 2x + 6, what is the value of k(h(10))?","output":"First, compute the value of h(10): [ h(10) = 4(10) - 5 = 40 - 5 = 35. ] Next, use this result as the input for k(x): [ k(35) = 2(35) + 6 = 70 + 6 = 76. ] So, the value of k(h(10)) is boxed{76}."},{"instruction":"Express 2.overline{35} as a common fraction in lowest terms.","output":"Let x = 2.overline{35}. Then: 100x = 235.overline{35} By subtracting the original x from 100x, we get: 100x - x = 235.overline{35} - 2.overline{35} = 233 99x = 233 This simplifies to: x = frac{233}{99} To reduce this to lowest terms, compute the GCD of 233 and 99. Since 233 is a prime number, the only common factor of 233 and 99 is 1. Therefore, the fraction is already in lowest terms: boxed{frac{233}{99}}"},{"instruction":"After dividing one pair of opposite sides of a rectangle into p segments and another pair into q segments, a triangle X is formed by joining the endpoints of one segment from each divided pair to the nearest vertex of the rectangle. Calculate the ratio of the area of this triangle X to the area of the entire rectangle if p = 12 and q = 8. text{(A)} frac{1}{96}qquadtext{(B)} frac{1}{100}qquadtext{(C)} 0.01qquadtext{(D)} frac{1}{192}","output":"1. **Setting the Scenario**:    - Consider rectangle with 12 segments along its length and 8 segments along its width.    - Rectangle total dimensions: length L and width W. 2. **Calculating Segment Sizes**:    - Length of each length-segment: frac{L}{12},    - Length of each width-segment: frac{W}{8}. 3. **Forming Triangle X**:    - Take segments bordering the nearest vertex, corners of triangle are: A (vertex), B (end of one segment on length side), and C (end of one segment on width side).    - Coordinates: A(0,0), B(frac{L}{12},0), C(0,frac{W}{8}). 4. **Area of Triangle X**:    - Using formula text{Area} = frac{1}{2}|x_1(y_2-y_3) + x_2(y_3-y_1) + x_3(y_1-y_2)|,    - Plugging coordinates into the area formula gives: text{Area} = frac{1}{2}left|0(0-frac{W}{8}) + frac{L}{12}(0-0) + 0(0-0)right| = frac{1}{2} cdot frac{LW}{96} = frac{LW}{192}. 5. **Area of Rectangle**:    - Total area is LW. 6. **Ratio**:    - Ratio of area of triangle X to the rectangle: frac{frac{LW}{192}}{LW} = frac{1}{192}.    - The ratio of the area of triangle X to the entire rectangle is frac{1{192}}. Conclusion: The calculation validates that the problem and the derived ratio is correctly established, considering the new condition of using a rectangle's vertex instead of the center makes this approach unique and the solution applicable. The final answer is boxed{text{(D)} frac{1}{192}}"},{"instruction":"Let ( P ) be a point inside a triangle ( ABC ). A line through ( P ) parallel to ( AB ) meets ( BC ) and ( CA ) at points ( L ) and ( F ), respectively. A line through ( P ) parallel to ( BC ) meets ( CA ) and ( AB ) at points ( M ) and ( D ) respectively, and a line through ( P ) parallel to ( CA ) meets ( AB ) and ( BC ) at points ( N ) and ( E ) respectively. Prove [ (PDBL) cdot (PEC M) cdot (PFAN) = 8 cdot (PFM) cdot (PEL) cdot (PDN), ] where ((XYZ)) and ((XYZW)) denote the area of the triangle (XYZ) and the area of the quadrilateral (XYZW).","output":"We start by observing that ( P ) is a point inside the triangle ( ABC ), and we introduce three lines through ( P ) that are parallel to the sides of the triangle ( ABC ): 1. ( overline{P L} parallel overline{AB} ), 2. ( overline{PM} parallel overline{BC} ), 3. ( overline{PN} parallel overline{CA} ). These parallels generate intersections ( L, F, M, D, E, ) and ( N ) on the sides of ( ABC ). We aim to prove the area relationship: [ (P D B L) cdot (P E C M) cdot (P F A N) = 8 cdot (P F M) cdot (P E L) cdot (P D N). ] We denote the relevant areas as follows: [ U = text{Area of } (B I D), quad V = text{Area of } (E M C), quad W = text{Area of } (F A N), ] [ X = text{Area of } (P E D), quad Y = text{Area of } (P F M), quad Z = text{Area of } (P I H). ]  Step 1: Relate the Area of Triangles and Quadrilaterals Consider the triangle ( triangle BID ): [ X = frac{1}{2} a y frac{BC}{BA}, quad Z = frac{1}{2} b x frac{BA}{BC}, ] [ U = frac{1}{2} a x = frac{1}{2} b y. ] This implies: [ U^2 = X cdot Z. ] Using the same reasoning for other triangles, we get: [ V^2 = X cdot Y, quad W^2 = Y cdot Z. ]  Step 2: Multiply All Three Equalities Multipling ( U^2, V^2, ) and ( W^2 ): [ (U cdot V cdot W)^2 = (X cdot Y cdot Z)^2. ] Taking the square root: [ U cdot V cdot W = X cdot Y cdot Z. ]  Alternative Solution Let: [ P_A = text{area of } (PEL), quad P_B = text{area of } (PFM), quad P_C = text{area of } (PDN), ] [ Q_A = text{area of } (PFAN), quad Q_B = text{area of } (PDBL), quad Q_C = text{area of } (PECM). ] We must show: [ Q_A Q_B Q_C = 8 P_A P_B P_C. ] Since triangles ( PEL, PFM, PDN ) are similar to ( triangle ABC ), we denote the similarity coefficients as ( k_A, k_B ), and ( k_C ) respectively. The similarity coefficient of ( triangle ENB ) to ( triangle ABC ): [ frac{EN}{AC} = frac{EF + FN}{AC} = frac{EF}{AC} + frac{FN}{AC} = k_A + k_C implies (k_A + k_C)^2. ] Comparing the areas: [ P_A : P_B = left(frac{k_A}{k_B}right)^2 implies P_A = left(frac{k_A}{k_B}right)^2 P_B, ] [ P_C : P_B = left(frac{k_C}{k_B}right)^2 implies P_C = left(frac{k_C}{k_B}right)^2 P_B. ] Adding the areas of ( PEL, PFN, ) and their quadrilateral counterpart: [ (P_A + P_C + Q_B) : P_B = (ENB) : (PFM) = left(frac{k_A + k_C}{k_B}right)^2, ] [ P_A + P_C + Q_B = frac{k_A^2 + 2k_A k_C + k_C^2}{k_B^2} P_B = P_A + P_C + frac{2k_A k_C}{k_B^2} P_B, ] [ implies Q_B = frac{2k_A k_C}{k_B^2} P_B. ] Similarly, [ Q_C = frac{2k_B k_A}{k_C^2} P_C text{ and } Q_A = frac{2k_C k_B}{k_A^2} P_A. ] Multiplying these: [ Q_A Q_B Q_C = frac{2k_C k_B}{k_A^2} P_A cdot frac{2k_A k_C}{k_B^2} P_B cdot frac{2k_B k_A}{k_C^2} P_C, ] [ = 8 cdot frac{k_A^2 k_B^2 k_C^2}{k_A^2 k_B^2 k_C^2} P_A P_B P_C, ] [ = 8 P_A P_B P_C. ] Thus: [ (PDBL) cdot (PECM) cdot (PFAN) = 8 cdot (PFM) cdot (PEL) cdot (PDN), ] [ boxed{8 cdot (PFM) cdot (PEL) cdot (PDN)}. ]"},{"instruction":"Let astar b = a^b+ab. If a and b are positive integers greater than or equal to 2 and astar b =15, find a+b.","output":"Given astar b = a^b + ab and astar b = 15 with a, b geq 2 being positive integers, we need to find a+b. 1. **Considering the maximum value of a:** Since b geq 2, we can test the value of a starting from 2 upwards. However, we quickly realize that for a=4, 4^2 + 4cdot2 = 24 > 15, which is too large. Therefore, the maximum possible value for a is 3. 2. **Testing a=2:**     - We substitute a=2 into the equation, getting 2^b + 2b = 15.     - Simplifying, we get 2(2^{b-1} + b) = 15, leading to 2^{b-1} + b = 7.5.     - However, since b is a positive integer, 2^{b-1} + b must also be an integer, which contradicts our result of 7.5. Thus, a neq 2. 3. **Testing a=3:**    - Substituting a=3 into the equation, we get 3^b + 3b = 15.    - By trial, we find that for b=2, 3^2 + 3cdot2 = 9 + 6 = 15, which satisfies the equation. 4. **Conclusion:** The only solution that satisfies astar b = 15 with a, b geq 2 is a=3 and b=2. Therefore, the sum a+b = 3+2 = boxed{5}."},{"instruction":"A decimal number is converted into a vulgar fraction, which is 9/25. What is the decimal number?","output":"To convert the vulgar fraction 9/25 into a decimal number, you divide the numerator by the denominator: 9  25 = 0.36 So, the decimal number equivalent to the vulgar fraction 9/25 is boxed{0.36} ."},{"instruction":"ain is moving at 6 / 7 of its usual speed . the train is 10 minutes too late . what is the usual time ( in hours ) for the train to complete the journey ?","output":"Let's denote the usual speed of the train as ( S ) and the usual time it takes to complete the journey as ( T ).  When the train is moving at ( frac{6}{7} ) of its usual speed, its new speed is ( frac{6}{7}S ). Since speed and time are inversely proportional (when one increases, the other decreases to cover the same distance), we can set up the following relationship: ( frac{New Speed}{Usual Speed} = frac{Usual Time}{New Time} ) Substituting the given values, we get: ( frac{frac{6}{7}S}{S} = frac{T}{T + frac{10}{60}} ) ( frac{6}{7} = frac{T}{T + frac{1}{6}} ) Now, we solve for ( T ): ( frac{6}{7}T + frac{6}{7} cdot frac{1}{6} = T ) ( frac{6}{7}T + frac{1}{7} = T ) ( T - frac{6}{7}T = frac{1}{7} ) ( frac{1}{7}T = frac{1}{7} ) ( T = 1 ) hour So, the usual time for the train to complete the journey is boxed{1}  hour."},{"instruction":"Given x>0, y>0, z>0, and xyz=1, prove that x^3+y^3+z^3 geq xy+yz+xz.","output":"Proof: Since x>0, y>0, z>0, we have 1. x^3+y^3+z^3 geq 3xyz 2. x^3+y^3+1 geq 3xy 3. y^3+z^3+1 geq 3yz 4. x^3+z^3+1 geq 3xz Adding the above inequalities, we get 3x^3+3y^3+3z^3+3 geq 3xyz+3xy+3yz+3xz. Since xyz=1, it follows that x^3+y^3+z^3 geq xy+yz+xz. Therefore, the proof is complete, and the final answer is boxed{x^3+y^3+z^3 geq xy+yz+xz}."},{"instruction":"Given a geometric sequence {a_n} with the first term a_1=1 and common ratio q, discuss the conditions under which the system of linear equations  begin{cases}  a_{1}x + a_{3}y = 3   a_{2}x + a_{4}y = 2  end{cases} has no solution or infinitely many solutions based on different values of q.","output":"Let's solve the system of equations: begin{cases}  a_{1}x + a_{3}y = 3   a_{2}x + a_{4}y = -2  end{cases} To eliminate y, we multiply the first equation by a_4 and the second by a_3, and then subtract the second from the first to get: (a_1a_4 - a_2a_3)x = 3a_4 + 2a_3 Since {a_n} is a geometric sequence with common ratio q, we know that: a_2 = a_1q, quad a_3 = a_1q^2, quad a_4 = a_1q^3 Substituting these values, we obtain the equation: (a_1^2q^3 - a_1^2q^3)x = 3a_1q^3 + 2a_1q^2 Since a_1 = 1, this simplifies to: (q^3 - q^3)x = 3q^3 + 2q^2 0x = 3q^3 + 2q^2 For a normal system of equations, the determinant (also known as the coefficient of x) should not be zero to have a unique solution. In our case, the determinant is always zero, which means that we either have no solution or infinitely many solutions depending on the right-hand side of the equation. If 3q^3 + 2q^2 = 0, the system will have infinitely many solutions as the equations are dependent. Factoring out q^2, we get: q^2(3q + 2) = 0 This has solutions q = 0 or q = -frac{2}{3}. Since q = 0 is not valid for a geometric sequence (as it would not progress beyond the first term), the only meaningful solution is q = -frac{2}{3}. Thus, when q = -frac{2}{3}, the system of equations will have infinitely many solutions. [boxed{text{For } q = -frac{2}{3}, text{the system has infinitely many solutions.}}] If q neq -frac{2}{3}, 3q^3 + 2q^2 neq 0, and with a determinant of zero and a nonzero right-hand side, the system has no solution. [boxed{text{For } q neq -frac{2}{3}, text{the system has no solution.}}]"},{"instruction":"Calculate the value of frac{3c}{a+b} when a = 5, b = 3, and c = 2.  **(A)** 3  **(B)** 6  **(C)** 2  **(D)** 1","output":"1. **Identify the values of (a), (b), and (c):**    Given (a = 5), (b = -3), and (c = 2). 2. **Calculate the denominator (a + b):**    [    a + b = 5 + (-3) = 5 - 3 = 2    ] 3. **Evaluate the expression (frac{3c}{a+b}):**    Substitute (c = 2) and (a+b = 2) into the expression:    [    frac{3c}{a+b} = frac{3 times 2}{2} = frac{6}{2} = 3    ] 4. **Conclusion:**    The expression (frac{3c}{a+b}) simplifies to 3 when substituting the given values. Therefore, the answer is:        (3) The final answer is boxed{- **(A)** 3}"},{"instruction":"Prove the criteria for the congruence of rightangled triangles: a) By two legs b) By a leg and the adjacent acute angle c) By a leg and the hypotenuse d) By the hypotenuse and an acute angle","output":"(a) By the Two Legs  **Step 1:** Let us consider two right-angled triangles ( triangle ABC ) and ( triangle DEF ) with right angles at ( C ) and ( F ) respectively.  Assume: [ AB = DE quad text{and} quad AC = DF ] **Step 2:** According to the Pythagorean theorem, the hypotenuses ( BC ) in ( triangle ABC ) and ( EF ) in ( triangle DEF ) can be calculated: [ BC = sqrt{AB^2 - AC^2} ] [ EF = sqrt{DE^2 - DF^2} ] **Step 3:** Since ( AB = DE ) and ( AC = DF ), it follows that: [ BC = EF ] **Step 4:** By the Converse of the Pythagorean Theorem, if the hypotenuses of two right triangles are equal and the corresponding legs are equal, then the triangles are congruent by the RHS (Right angle-Hypotenuse-Side) theorem. **Conclusion:** [ triangle ABC cong triangle DEF ] (blacksquare) ----  (b) By a Leg and an Adjacent Acute Angle **Step 1:** Let us consider two right-angled triangles ( triangle ABC ) and ( triangle DEF ) with right angles at ( C ) and ( F ) respectively. Assume: [ AC = DF quad text{and} quad angle BAC = angle EDF ] **Step 2:** The triangles share an acute angle ((angle BAC = angle EDF)) and the right angle ((angle ACB = angle DFE)).  **Step 3:** By the Angle-Angle-Side (AAS) theorem, if two angles and a non-included side of one triangle are equal to two angles and a corresponding non-included side of another triangle, then the triangles are congruent. **Conclusion:** [ triangle ABC cong triangle DEF ] (blacksquare) ----  (c) By a Leg and the Hypotenuse **Step 1:** Let us consider two right-angled triangles ( triangle ABC ) and ( triangle DEF ) with right angles at ( C ) and ( F ) respectively.  Assume: [ AC = DF quad text{and} quad BC = EF ] **Step 2:** According to the Pythagorean theorem, the hypotenuses ( AB ) in ( triangle ABC ) and ( DE ) in ( triangle DEF ) can be calculated: [ AB = sqrt{AC^2 + BC^2} ] [ DE = sqrt{DF^2 + EF^2} ] **Step 3:** Since ( AC = DF ) and ( BC = EF ), it follows that: [ AB = DE ] **Step 4:** By the RHS (Right angle-Hypotenuse-Side) theorem, if the hypotenuses and one corresponding leg of two right triangles are equal, then the triangles are congruent. **Conclusion:** [ triangle ABC cong triangle DEF ] (blacksquare) ----  (d) By the Hypotenuse and an Acute Angle **Step 1:** Let us consider two right-angled triangles ( triangle ABC ) and ( triangle DEF ) with right angles at ( C ) and ( F ) respectively.  Assume: [ AB = DE quad text{and} quad angle BAC = angle EDF ] **Step 2:** The triangles share an acute angle ((angle BAC = angle EDF)) and the right angle ((angle ACB = angle DFE)). **Step 3:** By the Angle-Angle-Side (AAS) theorem, if two angles and a non-included side of one triangle are equal to two angles and a corresponding non-included side of another triangle, then the triangles are congruent. **Conclusion:** [ triangle ABC cong triangle DEF ] (blacksquare)"},{"instruction":"Let triangle ABC be a triangle in a plane, and let D be a point outside the plane of triangle ABC, forming a pyramid DABC. Each edge of pyramid DABC has a length of either 13 or 24, but no face of DABC is equilateral. What is the surface area of DABC?","output":"Since all edges of pyramid DABC have lengths 13 or 24, each triangular face must be isosceles: either 13-13-24 or 13-24-24. The first of these sets of side lengths satisfies the triangle inequality: 13 + 13 > 24, hence the face could either be isosceles triangles with sides 13-13-24 or 13-24-24. First, consider a triangle with sides 13, 13, 24. Calculate its area: - The altitude divides the base of 24 into two equal parts, each of length 12. - By the Pythagorean theorem: 12^2 + h^2 = 13^2 implies h^2 = 169 - 144 = 25 implies h = 5. - Area = frac{1}{2} times 24 times 5 = 60. Now consider a triangle with sides 13, 24, 24: - With the altitude falling on the 13, base of 13 splits into two parts of 6.5 each. - By the Pythagorean theorem: 6.5^2 + h^2 = 24^2 implies h^2 = 576 - 42.25 implies h approx 23.07. - Area = frac{1}{2} times 13 times 23.07 approx 149.95 approx 150. The surface area of pyramid DABC consists of one triangle with sides 13, 13, 24, and three triangles with sides 13, 24, 24: 60 + 3 times 150 = 510. Thus, the surface area of the pyramid DABC is boxed{510}."},{"instruction":"406 is divided among a , b , and c so that a receives half as much as b , and b receives half as much as c . how much money is c ' s share ?","output":"Let's denote the amount of money received by a, b, and c as A, B, and C respectively. According to the problem, we have the following relationships: 1. A = 1/2 * B 2. B = 1/2 * C We also know that the total amount of money is 406, so: A + B + C = 406 Using the relationships above, we can express A and B in terms of C: A = 1/2 * (1/2 * C) = 1/4 * C B = 1/2 * C Now, let's substitute A and B in the total amount equation: 1/4 * C + 1/2 * C + C = 406 To combine like terms, we need to find a common denominator, which is 4 in this case: (1/4 * C) + (2/4 * C) + (4/4 * C) = 406 (1 + 2 + 4)/4 * C = 406 7/4 * C = 406 Now, we solve for C: C = 406 * (4/7) C = 1624/7 C = 232 Therefore, c's share is boxed{232} ."},{"instruction":"the disaster relief donation, frac{1}{10} of the people in a company each donated 200 yuan, frac{3}{4} of the people each donated 100 yuan, and the remaining people each donated 50 yuan. Find the average donation per person in the company.","output":"1. Calculate the proportion of people who donated 50 yuan:    [    text{Proportion} = 1 - frac{1}{10} - frac{3}{4}    ] 2. Simplifying the expression:    [    1 = frac{10}{10}    ]    [    frac{10}{10} - frac{1}{10} = frac{9}{10}    ]    [    frac{9}{10} - frac{3}{4}     ] 3. To subtract these fractions, find a common denominator (LCM of 10 and 4 is 20):    [    frac{9}{10} = frac{18}{20}    ]    [    frac{3}{4} = frac{15}{20}    ]    [    frac{18}{20} - frac{15}{20} = frac{3}{20}    ]    Thus, the proportion of people who donated 50 yuan is (frac{3}{20}). 4. Calculate the total donation in yuan using the given proportions and individual amounts:    [    text{Total Contribution} = left(200 times frac{1}{10} + 100 times frac{3}{4} + 50 times frac{3}{20}right)    ] 5. Compute each term separately:    [    200 times frac{1}{10} = 20    ]    [    100 times frac{3}{4} = 75    ]    [    50 times frac{3}{20} = frac{150}{20} = 7.5    ] 6. Add these contributions together:    [    20 + 75 + 7.5 = 102.5 text{ yuan}    ] # Conclusion: [ boxed{102.5} ] Thus, the average donation amount per person by the company is 102.5 yuan."},{"instruction":"The product of positive numbers ( x, y, ) and ( z ) equals 1. Prove that ((2+x)(2+y)(2+z) geq 27).","output":"1. The given problem asks us to prove that ((2+x)(2+y)(2+z) geq 27) given that (x, y,) and (z) are positive numbers, and their product is equal to 1, i.e., (xyz = 1). 2. We will use the AM-GM (Arithmetic Mean - Geometric Mean) Inequality to help us prove this inequality. The AM-GM Inequality states that for any non-negative real numbers (a_1, a_2, ldots, a_n), we have:    [    frac{a_1 + a_2 + cdots + a_n}{n} geq sqrt[n]{a_1 a_2 cdots a_n}    ] 3. First, let's apply the AM-GM Inequality to each term (2+x), (2+y), and (2+z):    [    2 + x = 1 + 1 + x implies frac{1 + 1 + x}{3} geq sqrt[3]{1 cdot 1 cdot x} implies 2 + x geq 3sqrt[3]{x}    ] 4. Similarly, for the other two terms:    [    2 + y geq 3sqrt[3]{y}    ]    [    2 + z geq 3sqrt[3]{z}    ] 5. Now, we multiply the three inequalities:    [    (2+x)(2+y)(2+z) geq (3sqrt[3]{x})(3sqrt[3]{y})(3sqrt[3]{z})    ] 6. Simplify the right-hand side:    [    3sqrt[3]{x} cdot 3sqrt[3]{y} cdot 3sqrt[3]{z} = 27 sqrt[3]{x cdot y cdot z}    ] 7. Since (x, y, text{ and } z) are positive numbers and their product is 1 ((xyz = 1)), we have:    [    sqrt[3]{x cdot y cdot z} = sqrt[3]{1} = 1    ] 8. Therefore:    [    27 sqrt[3]{x cdot y cdot z} = 27 cdot 1 = 27    ] 9. Putting it all together, we get:    [    (2+x)(2+y)(2+z) geq 27    ] # Conclusion: [ boxed{(2+x)(2+y)(2+z) geq 27} ]"},{"instruction":"Let [g(x) = left{ begin{aligned} 4x + 8 & quad text{ if } x < 0  3x  15 & quad text{ if } x ge 0 end{aligned} right.]Find all solutions to the equation g(x) = 5.","output":"Analyzing g(x) in its piecewise form: 1. **For x < 0:**    [4x + 8 = 5]    [4x = 5 - 8]    [4x = -3]    [x = -frac{3}{4}]    Since -frac{3}{4} < 0, this solution is valid for x < 0. 2. **For x ge 0:**    [3x - 15 = 5]    [3x = 5 + 15]    [3x = 20]    [x = frac{20}{3}]    Since frac{20}{3} > 0, this solution is valid for x ge 0. **Conclusion**: The valid solutions for the equation g(x) = 5 are x = boxed{-frac{3}{4}, frac{20}{3}}."},{"instruction":"Read the following material and answer the questions: Solve the equation x^45x^2+4=0, which is a fourthdegree equation. Based on the characteristics of this equation, the solution method is usually as follows: Let x^2=y, then x^4=y^2. Therefore, the original equation can be transformed into y^25y+4=0 (1). Solve to get y_1=1 and y_2=4. When y=1, x^2=1, so x=pm1; when y=4, x^2=4, so x=pm2; Therefore, the original equation has four roots: x_1=1, x_2=1, x_3=2, x_4=2. Answer the questions: (1) In the process of obtaining equation (1) from the original equation, the method of substitution was used to achieve the purpose of solving the equation, reflecting the mathematical idea of transformation; (2) Please solve the equation (x^2+1)^24(x^2+1)12=0 using the above knowledge.","output":"# Solution:  Part 1: Understanding the Method of Substitution In the process of solving the given fourth-degree equation, we utilized the method of substitution to simplify the equation and make it solvable. This was done by introducing a new variable y to replace x^2, transforming the original equation into a quadratic form that is easier to solve. This reflects the mathematical idea of transformation, which is a powerful tool in solving complex equations. - **Answer for Question (1):** The method used is boxed{text{substitution}}.  Part 2: Solving the Given Equation Given the equation (x^2+1)^2-4(x^2+1)-12=0, we apply the knowledge from the previous problem to solve it. 1. **Step 1:** Let y = x^2 + 1. This transforms the original equation into a quadratic equation in terms of y:    [y^2 - 4y - 12 = 0] 2. **Step 2:** Factor the quadratic equation:    [(y - 6)(y + 2) = 0] 3. **Step 3:** Solve for y:    - For y - 6 = 0, we get y_1 = 6.    - For y + 2 = 0, we get y_2 = -2. 4. **Step 4:** Substitute back y = x^2 + 1 to find x:    - When y = 6, x^2 + 1 = 6 Rightarrow x^2 = 5 Rightarrow x = pmsqrt{5}.    - When y = -2, x^2 + 1 = -2, which is not possible since x^2 + 1 is always positive. Therefore, the solutions to the original equation are x_1 = sqrt{5} and x_2 = -sqrt{5}. - **Answer for Question (2):** The solutions are boxed{x_1 = sqrt{5}} and boxed{x_2 = -sqrt{5}}."},{"instruction":"On his first journey, Dylan traveled 80 miles. On a subsequent trip, he covered 160 miles but increased his speed by a factor of four compared to the first journey. How does the new time compare to the old time? A) Three times as much B) Twice as much C) The same D) Half as much E) A third as much","output":"Let the speed of Dylan on his first trip be ( v ) miles per hour. Thus, the time taken for his first trip, ( t_1 ), to cover 80 miles is: [ t_1 = frac{text{distance}}{text{speed}} = frac{80}{v} text{ hours} ] On his later trip, Dylan traveled at four times his original speed, so the speed during the second trip, ( v_2 ), is: [ v_2 = 4v text{ miles per hour} ] The distance covered on the second trip is 160 miles. Therefore, the time taken for his second trip, ( t_2 ), is: [ t_2 = frac{text{distance}}{text{speed}} = frac{160}{4v} = frac{40}{v} text{ hours} ] Comparing ( t_1 ) and ( t_2 ): [ t_1 = frac{80}{v} text{ hours} ] [ t_2 = frac{40}{v} text{ hours} ] Clearly, ( t_2 ) is half of ( t_1 ): [ t_2 = frac{1}{2} times t_1 ] Thus, the new time compared with the old time was half as much. The correct answer is: [ text{half as much} ] The final answer is boxed{textbf{(D)} text{half as much}}"},{"instruction":"Find the value of y that satisfies frac{sqrt{8y}}{sqrt{2(y2)}} = 3. Express your answer in simplest fractional form.","output":"Start with the given equation: [ frac{sqrt{8y}}{sqrt{2(y-2)}} = 3 ] Isolate the square root term: [ sqrt{8y} = 3sqrt{2(y-2)} ] Square both sides of the equation to eliminate the square roots: [ 8y = 9 times 2(y-2) ] [ 8y = 18(y-2) ] Expand and simplify: [ 8y = 18y - 36 ] [ 10y = 36 ] [ y = frac{36}{10} = frac{18}{5} ] Thus, we have: [ y = boxed{frac{18}{5}} ] Conclusion: By substituting y = frac{18}{5} back into the original equation, we can verify that it satisfies the equation: [ frac{sqrt{8 times frac{18}{5}}}{sqrt{2(frac{18}{5}-2)}} = 3 ] [ frac{sqrt{frac{144}{5}}}{sqrt{frac{16}{5}}} = 3 ] [ frac{12/sqrt{5}}{4/sqrt{5}} = 3 ] [ 3 = 3 ]"},{"instruction":"There are 180 students in ninth grade. 1/4 of them bombed their finals because they were going through difficult breakups. 1/3rd of the rest didn't show up to take the test, and some students got less than a D. 70 students passed their finals. How many students got less than a D?","output":"Let's break down the problem step by step: 1. There are 180 students in ninth grade. 2. 1/4 of them bombed their finals due to breakups. So, the number of students who bombed their finals is 1/4 * 180 = 45 students. 3. This leaves us with 180 - 45 = 135 students who did not bomb their finals due to breakups. 4. 1/3 of the remaining students did not show up to take the test. So, the number of students who did not show up is 1/3 * 135 = 45 students. 5. This leaves us with 135 - 45 = 90 students who showed up and did not bomb their finals due to breakups. 6. Out of these 90 students, 70 passed their finals. 7. This means that the number of students who got less than a D is 90 - 70 = 20 students. So, boxed{20}  students got less than a D on their finals."},{"instruction":"There are five students: A, B, C, D, and E. 1. In how many different ways can they line up in a row such that A and B must be adjacent, and C and D cannot be adjacent? 2. In how many different ways can these five students be distributed into three classes, with each class having at least one student?","output":"1. To solve this problem, we first treat A and B as a single unit since they must be adjacent. We now have 4 units to arrange: AB, C, D, and E. These can be arranged in A_4^4 = 4! = 24 ways. However, since C and D cannot be adjacent, we need to subtract the cases where they are together. Treating C and D as a single unit, we have 4 units to arrange: AB, CD, and E. These can be arranged in A_3^3 = 3! = 6 ways. But C and D can swap places within their unit, giving us 2! = 2 ways. So, there are 6 cdot 2 = 12 cases where C and D are adjacent. Therefore, the total number of ways to arrange the students is 24 - 12 = boxed{12}. 2. To distribute the students into three classes, we first consider the case where one class has 3 students and the other two classes have 1 student each. There are C_5^3 = 10 ways to choose the 3 students for the larger class, and A_3^3 = 3! = 6 ways to arrange these students within their class. So, there are 10 cdot 6 = 60 ways for this case. Next, we consider the case where two classes have 2 students each and the third class has 1 student. There are C_5^2 = 10 ways to choose the 2 students for the first class, C_3^2 = 3 ways to choose the 2 students for the second class, and A_2^2 = 2! = 2 ways to arrange the students within each of these classes. However, since the two classes with 2 students each are identical, we need to divide by A_2^2 = 2! = 2 to avoid double-counting. So, there are frac{10 cdot 3 cdot 2 cdot 2}{2} = 90 ways for this case. Therefore, the total number of ways to distribute the students is 60 + 90 = boxed{150}."},{"instruction":"triangle ABC, if b cos C + c sin B = 0, then angle C = ______.","output":"Since b cos C + c sin B = 0, By the law of sines, we know that sin B cos C + sin C sin B = 0, Given that 0 < B < pi, Then sin B > 0, thus cos C + sin C = 0, which implies tan C = -1, Given that 0 < C < pi, Then C = boxed{frac{3pi}{4}}. The answer is directly obtained by utilizing the law of sines and the basic trigonometric identities, further calculating the value of C. This question primarily tests the comprehensive application of the law of sines and basic trigonometric identities, as well as the ability to transform and simplify expressions. It is considered a basic problem."},{"instruction":"A person walks from one end to the other of a 90meter long moving walkway at a constant rate in 30 seconds, assisted by the walkway. When this person reaches the end, they reverse direction and continue walking with the same speed, but this time it takes 120 seconds because the person is traveling against the direction of the moving walkway. If the walkway were to stop moving, how many seconds would it take this person to walk from one end of the walkway to the other?","output":"Let's denote the person's walking speed as ( v_p ) (in meters per second) and the speed of the walkway as ( v_w ) (also in meters per second). When the person is walking with the walkway, their effective speed is ( v_p + v_w ), and it takes them 30 seconds to cover the 90 meters. So we have the equation: [ (v_p + v_w) cdot 30 = 90 ] [ v_p + v_w = frac{90}{30} ] [ v_p + v_w = 3 quad text{(1)} ] When the person is walking against the walkway, their effective speed is ( v_p - v_w ), and it takes them 120 seconds to cover the same distance. So we have the equation: [ (v_p - v_w) cdot 120 = 90 ] [ v_p - v_w = frac{90}{120} ] [ v_p - v_w = frac{3}{4} quad text{(2)} ] Now we have a system of two equations with two unknowns. We can solve for ( v_p ) and ( v_w ) by adding equations (1) and (2) together: [ (v_p + v_w) + (v_p - v_w) = 3 + frac{3}{4} ] [ 2v_p = 3 + frac{3}{4} ] [ 2v_p = frac{12}{4} + frac{3}{4} ] [ 2v_p = frac{15}{4} ] [ v_p = frac{15}{8} ] [ v_p = frac{15}{8} text{ m/s} ] Now that we have the person's walking speed, we can find out how long it would take them to walk the 90 meters if the walkway were not moving. The time ( t ) it would take is given by the distance divided by the person's walking speed: [ t = frac{90}{v_p} ] [ t = frac{90}{frac{15}{8}} ] [ t = 90 cdot frac{8}{15} ] [ t = 6 cdot 8 ] [ t = 48 text{ seconds} ] So, if the walkway were to stop moving, it would take the person boxed{48}  seconds to walk from one end of the walkway to the other."},{"instruction":"Point ( P ) lies inside a square with side length ( a ). The distances from ( P ) to the two endpoints of one side and to the opposite side of the square are equal. If ( d ) represents this common distance, then ( d ) is equal to (A) (frac{3a}{5}). (B) (frac{5a}{8}). (C) (frac{3a}{8}). (D) (frac{sqrt{2}a}{2}). (E) (frac{a}{2}).","output":"Given: - (P) is a point inside a square with side length (a). - The point (P) is equidistant from two endpoints of one side of the square and the opposite side. - We need to find this common distance (d). Steps to solve the problem: 1. **Setup the Geometry:**     - Let the vertices of the square be labeled as (A, B, C, D) in a clockwise manner.     - Without loss of generality, assume (P) lies such that it is closest to side (CD) of the square. 2. **Reference Triangle:**     - Draw a perpendicular from (P) to side (CD), intersecting at (F). Hence, (PF perp CD).     - (F) must be the midpoint of (CD). Since (P) is equidistant from both (C) and (D), point (F) lies at (frac{a}{2}) from both endpoints (C) and (D).      3. **Right Triangle ( triangle PDF ):**     - In (triangle PDF), (DF = frac{a}{2}) (since (F) is the midpoint of (CD)).     - The height of the triangle (PF = a - d).     - The hypotenuse (PD = d). 4. **Apply the Pythagorean Theorem:**     - In (triangle PDF), apply the Pythagorean theorem:     [     (DF)^2 + (PF)^2 = (PD)^2      ]     - Using the given lengths:     [     left(frac{a}{2}right)^2 + (a - d)^2 = d^2      ]     - Simplify this equation step-by-step:     [     left(frac{a}{2}right)^2 = frac{a^2}{4}     ]     [     (a - d)^2 = a^2 - 2ad + d^2     ]     [     frac{a^2}{4} + a^2 - 2ad + d^2 = d^2     ] 5. **Combine and Simplify:**     [     frac{a^2}{4} + a^2 - 2ad = 0     ]     [     frac{a^2}{4} + a^2 - 2ad = 0     ]     [     frac{5a^2}{4} = 2ad     ] 6. **Solve for (d):**     [     frac{5a^2}{4} = 2ad     ]     [     5a^2 = 8ad     ]     [     d = frac{5a^2}{8a} = frac{5a}{8}     ] # Conclusion: The required distance (d) is therefore: [ boxed{frac{5a}{8}} ]"},{"instruction":"The greatest common divisor of 840 and 1764 is ( ) A. 84 B. 12 C. 168 D. 252","output":"**Answer** Choose boxed{A}. We have 1764 = 840 times 2 + 84 and 840 = 84 times 10."},{"instruction":"The proposition For any x in [1,2], x^2  a leq 0 is a true statement when a sufficient but not necessary condition is given by ( )  A: a geq 4 B: a > 4 C: a geq 1 D: a > 1","output":"For the proposition \\"For any x in [1,2], x^2 - a leq 0\\" to be true, it must hold that for any x in [1,2], we have x^2 leq a. Since when x in [1,2], x^2 in [1,4], the smallest value of a that satisfies this condition for every x in the interval is a = 4. Thus, a geq 4 is a necessary and sufficient condition for the proposition to be true. However, the question asks for a sufficient but not necessary condition. This means we need an a value that will ensure the proposition is true without being the smallest such a. Therefore, a > 4 will suffice, even though it is not the minimum value that makes the proposition true.  The correct answer is: [ boxed{B: a > 4}. ]"},{"instruction":"Rational numbers (a) and (b) are randomly selected from all rational numbers in the interval ([0, 3)) that can be represented as fractions (frac{n}{d}) where (n) and (d) are integers with (1 leq d leq 6). Calculate the probability that [(text{cos}(api)+itext{sin}(bpi))^8] is a real number.","output":"Let (S) be the set of possible values of (a) and (b) obtained from denominators (1) to (6) for the interval ([0, 3)). Then, [S = {0, 1, 2, frac{1}{2}, frac{3}{2}, frac{5}{2}, frac{1}{3}, frac{2}{3}, frac{4}{3}, frac{5}{3}, frac{7}{3}, frac{8}{3}, ldots, frac{11}{6}}.] We have (42) possible values of (a) and (b), total of (42 times 42 = 1764) possible pairs ((a, b)). The expression expands to [(x + yi)^8.] This equals to real if the coefficient of all imaginary components is zero. Solving for (x^7y - 7x^5y^3 + 7x^3y^5 - xy^7 = 0) gives us the cases (x = 0), (y = 0), (x = y), and (x = -y). 1. **(x = 0)** & **(y = 0)**: (x = 0) when (a = frac{1}{2}, frac{3}{2}, frac{5}{2}), and (y = 0) when (b = 1, 2). Total pairs: (9) from (x = 0) and (126) from (y = 0); adequately adjust for overcounts. 2. **(x = y)**: Solving (cos(api) = sin(bpi)), since (|cos| = |sin|) at particular known angles, can lead to (9) solutions similar to (x = 0) setups, if we check for each (a) based on the derived (b). 3. **(x = -y)**: Solving (cos(api) = -sin(bpi)), we expect (9) similar solutions as (x = 0). Adding these up, [9 + 126 + 9 + 9 = 153.] Probability: [frac{153}{1764} = frac{51}{588} = boxed{frac{17}{196}}.]"},{"instruction":"A train running at a certain speed crosses a pole in 8 seconds. The length of the train is 160 meters. What is the speed of the train in km/hr?","output":"To find the speed of the train, we can use the formula: Speed = Distance / Time We know the distance (length of the train) is 160 meters and the time taken to cross the pole is 8 seconds. Speed = 160 meters / 8 seconds Speed = 20 meters/second To convert the speed from meters/second to km/hr, we use the conversion factor: 1 meter/second = 3.6 km/hr So, the speed of the train in km/hr is: Speed = 20 meters/second * 3.6 km/hr per meter/second Speed = 72 km/hr Therefore, the speed of the train is boxed{72}  km/hr."},{"instruction":"Prove the following equation: begin{array}{l} frac{sin (xbeta) sin (xgamma)}{sin (alphabeta) sin (alphagamma)}+frac{sin (xgamma) sin (xalpha)}{sin (betagamma) sin (betaalpha)}  quad+frac{sin (xalpha) sin (xbeta)}{sin (gammaalpha) sin (gammabeta)}=1 . end{array}","output":"To prove that: [  begin{array}{l} frac{sin (x-beta) sin (x-gamma)}{sin (alpha-beta) sin (alpha-gamma)} + frac{sin (x-gamma) sin (x-alpha)}{sin (beta-gamma) sin (beta-alpha)}  quad + frac{sin (x-alpha) sin (x-beta)}{sin (gamma-alpha) sin (gamma-beta)} = 1. end{array} ] We need to prove the equivalent statement: [  begin{array}{l} sin (alpha-beta) sin (x-alpha) sin (x-beta)  quad + sin (beta-gamma) sin (x-beta) sin (x-gamma)  quad + sin (gamma-alpha) sin (x-gamma) sin (x-alpha)  = sin (alpha-gamma) sin (gamma-beta) sin (beta-alpha). end{array} ] Let's expand the left-hand side using product-to-sum formulas and trigonometric identities. First, consider the left-hand side of the identity from the problem in expanded form: [  begin{aligned} 4 times text{LHS} &= 2 sin (alpha-beta)[cos (alpha-beta) - cos (2x-alpha-beta)]  &quad + 2 sin (beta-gamma)[cos (beta-gamma) - cos (2x-beta-gamma)]  &quad + 2 sin (gamma-alpha)[cos (gamma-alpha) - cos (2x-gamma-alpha)]. end{aligned} ] Now, simplify term by term: [  begin{aligned} 2 sin (alpha-beta)&[cos (alpha-beta) - cos (2x-alpha-beta)]  &= 2 sin (alpha-beta) cos (alpha-beta) - 2 sin (alpha-beta) cos (2x-alpha-beta)  &= sin 2(alpha-beta) - [sin 2(alpha-x) + sin 2(x-beta)], end{aligned} ] [  begin{aligned} 2 sin (beta-gamma)&[cos (beta-gamma) - cos (2x-beta-gamma)]  &= 2 sin (beta-gamma) cos (beta-gamma) - 2 sin (beta-gamma) cos (2x-beta-gamma)  &= sin 2(beta-gamma) - [sin 2(beta-x) + sin 2(x-gamma)], end{aligned} ] [  begin{aligned} 2 sin (gamma-alpha)&[cos (gamma-alpha) - cos (2x-gamma-alpha)]  &= 2 sin (gamma-alpha) cos (gamma-alpha) - 2 sin (gamma-alpha) cos (2x-gamma-alpha)  &= sin 2(gamma-alpha) - [sin 2(gamma-x) + sin 2(x-alpha)]. end{aligned} ] Combining these results, we get: [  begin{aligned} 4 times text{LHS} &= sin 2(alpha-beta) + sin 2(beta-gamma) + sin 2(gamma-alpha)  &quad - [sin 2(alpha-x) + sin 2(x-beta) + sin 2(beta-x) + sin 2(x-gamma) + sin 2(gamma-x) + sin 2(x-alpha)]. end{aligned} ] We recognize that: [  begin{aligned} sin 2(alpha-x) + sin 2(x-beta) + sin 2(beta-x) + sin 2(x-gamma) + sin 2(gamma-x) + sin 2(x-alpha) &= 0, end{aligned} ] because each of these terms forms a symmetric pair which cancels out. Thus, we have, simplifying: [  begin{aligned} 4 times text{LHS} &= sin 2(alpha-beta) + sin 2(beta-gamma) + sin 2(gamma-alpha)  &= 2 sin (alpha-gamma) cos (alpha-2beta+gamma)  &quad + 2 sin (gamma-alpha) cos (gamma-alpha)  &= 2 sin (alpha-gamma)[cos (alpha-2beta+gamma) - cos (gamma-alpha)]. end{aligned} ] Hence,  [ 4 times text{LHS} = 4 times text{RHS}. ] Therefore, we conclude: [  begin{aligned} frac{sin (x-beta) sin (x-gamma)}{sin (alpha-beta) sin (alpha-gamma)} + frac{sin (x-gamma) sin (x-alpha)}{sin (beta-gamma) sin (beta-alpha)} + frac{sin (x-alpha) sin (x-beta)}{sin (gamma-alpha) sin (gamma-beta)} = 1. end{aligned} ] Conclusion:  [ boxed{1} ]"},{"instruction":"Given the sequence ( a_1, a_2, a_3, cdots ) where ( a_1 = 1 ) and ( a_{n} = a_{n1} + frac{1}{a_{n1}} ) for ( n geq 2 ), prove that ( 14 < a_{100} < 18 ).","output":"We are given the sequence ( a_1, a_2, a_3, ldots ) defined by ( a_1 = 1 ) and ( a_{n} = a_{n-1} + frac{1}{a_{n-1}} ) for ( n geq 2 ). The goal is to show that ( 14 < a_{100} < 18 ). 1. **Establishing the recurrence relation**:     [     a_n = a_{n-1} + frac{1}{a_{n-1}}     ] 2. **Square the recurrence relation to derive an inequality**:     [     a_n^2 = left( a_{n-1} + frac{1}{a_{n-1}} right)^2 = a_{n-1}^2 + 2 cdot frac{a_{n-1}}{a_{n-1}} + left( frac{1}{a_{n-1}} right)^2     ]     [     a_n^2 = a_{n-1}^2 + 2 + frac{1}{a_{n-1}^2}     ] 3. **Finding the bounds**: Since ( a_{n} > 1 ) for ( n geq 2 ), we use:     [     a_n^2 = a_{n-1}^2 + 2 + frac{1}{a_{n-1}^2} > a_{n-1}^2 + 2     ]     And also:     [     frac{1}{a_{n-1}^2} < 1     ]     Therefore:     [     a_n^2 < a_{n-1}^2 + 2 + 1 = a_{n-1}^2 + 3     ] 4. **Formulating a pair of inequalities**:     [     2 < a_n^2 - a_{n-1}^2 < 3     ] 5. **Applying the inequalities repeatedly**:     [     2 < a_{n-1}^2 - a_{n-2}^2 < 3     ]     [     2 < a_{n-2}^2 - a_{n-3}^2 < 3     ]     [     vdots     ]     [     2 < a_2^2 - a_1^2 < 3     ] 6. **Summing up the inequalities from **(a_2)** to **(a_n)** across all previous inequalities**:     [     sum_{k=2}^{n} 2 < a_n^2 - a_1^2 < sum_{k=2}^{n} 3     ]     [     2(n-1) < a_n^2 - a_1^2 < 3(n-1)     ] 7. **Simplify and solve for **(a_n)****:     [     2(n-1) + 1 < a_n^2 < 3(n-1) + 1     ]     [     2n - 2 + 1 < a_n^2 < 3n - 3 + 1     ]     [     2n - 1 < a_n^2 < 3n - 2     ] 8. **Take square root (for both sides of inequality)**:     [     sqrt{2n - 1} < a_n < sqrt{3n - 2}     ] 9. **Substitute ( n = 100 ) and simplify**:     [     sqrt{2 cdot 100 - 1} < a_{100} < sqrt{3 cdot 100 - 2}     ]     [     sqrt{199} < a_{100} < sqrt{298}     ] 10. **Evaluate numerical bounds**:     [     sqrt{199} approx 14.11, quad text{and} quad sqrt{298} approx 17.26     ]     Hence:     [     14 < a_{100} < 18     ] Thus, we have shown that ( 14 < a_{100} < 18 ). (boxed{14 < a_{100} < 18})"},{"instruction":"f a  b = 5 and a^2 + b^2 = some value, the value of ab is 2. What is the value of a^2 + b^2?","output":"Let's solve this step by step. We are given: 1) ( a - b = 5 ) 2) ( ab = 2 ) We want to find the value of ( a^2 + b^2 ). We know that ( (a - b)^2 = a^2 - 2ab + b^2 ). From 1), we can square both sides to get: ( (a - b)^2 = 5^2 ) ( a^2 - 2ab + b^2 = 25 ) Now, we can substitute the value of ( ab ) from 2) into this equation: ( a^2 - 2(2) + b^2 = 25 ) ( a^2 - 4 + b^2 = 25 ) Now, we add 4 to both sides to isolate ( a^2 + b^2 ): ( a^2 + b^2 = 25 + 4 ) ( a^2 + b^2 = 29 ) Therefore, the value of ( a^2 + b^2 ) is boxed{29} ."},{"instruction":"What is the greatest integer less than 200 for which the greatest common divisor of that integer and 18 is 6?","output":"- The prime factors of 18 are 2 and 3, 3. - The greatest common divisor (gcd) with 18 is required to be 6, implying the number must be a multiple of 6 but not a multiple of 18. - We start from 198 and check each integer downwards:   - 198 is a multiple of 18.   - 192 is not a multiple of 6.   - 186 is a multiple of 18.   - 180 is a multiple of 18.   - 174 is a multiple of 6 and not a multiple of 18. Thus, the greatest integer less than 200 that satisfies the conditions is boxed{174}."},{"instruction":"Let x and y be complex numbers such that [frac{x^3 + y^3}{x^3  y^3} + frac{x^3  y^3}{x^3 + y^3} = 1.]Find [frac{x^9 + y^9}{x^9  y^9} + frac{x^9  y^9}{x^9 + y^9}.]","output":"Start by calculating the given condition with a common denominator: [frac{(x^3 + y^3)^2 - (x^3 - y^3)^2}{(x^3 - y^3)(x^3 + y^3)} = frac{2x^3y^3}{x^6 - y^6} = 1.] Then, 2x^3y^3 = x^6 - y^6. Let's assume x^3 = a and y^3 = b. Then the equation becomes 2ab = a^2 - b^2. Solving for a in terms of b, we get a^2 - 2ab - b^2 = 0 Rightarrow (a-b)^2 = 3b^2 Rightarrow a = bsqrt{3} or a = -bsqrt{3}. Without loss of generality, choose a = bsqrt{3}. Now compute the desired expression: begin{align*} frac{x^9 + y^9}{x^9 - y^9} + frac{x^9 - y^9}{x^9 + y^9} &= frac{(bsqrt{3})^3 + b^3}{(bsqrt{3})^3 - b^3} + frac{(bsqrt{3})^3 - b^3}{(bsqrt{3})^3 + b^3}  &= frac{2b^3sqrt{3}}{b^3(sqrt{3}^3 - 1)} + frac{b^3(sqrt{3}^3 - 1)}{b^3(sqrt{3}^3 + 1)}  &= frac{2sqrt{3}}{2sqrt{3}} + frac{2sqrt{3}}{4sqrt{3}}  &= 1 + frac{1}{2}  &= boxed{frac{3}{2}}. end{align*}"},{"instruction":"(1) Calculate: 3(4)^{3} ( frac {1}{2})^{0}+0.25;^{ frac {1}{2}}( frac {1}{ sqrt {2}})^{4}; (2) Given x;^{ frac {1}{2}}+x;^{ frac {1}{2}}=3, find the value of frac {x^{2}+x^{2}2}{x+x^{1}3}.","output":"(1) 3(-4)^{3} -( frac {1}{2})^{0}+0.25;^{ frac {1}{2}}( frac {-1}{ sqrt {2}})^{-4}; The original expression =3 times (-4)^{3} - 1 + sqrt{0.25} times left(-frac{1}{sqrt{2}}right)^{-4} =-64 -1 + frac{1}{2} times frac{1}{(frac{-1}{sqrt{2}})^{4}} =-65 + frac{1}{2} times frac{1}{frac{1}{(sqrt{2})^{4}}} =-65 + frac{1}{2} times {(sqrt{2})^{4}} =-65 + frac{1}{2} times 4 =-65 + 2 =boxed{-63} (2) Given: x;^{ frac {1}{2}}+x;^{- frac {1}{2}}=3, Squaring both sides, we get: (x^{ frac {1}{2}}+x^{- frac {1}{2}})^{2}=3^{2} x+x^{-1}+2=9 x+x^{-1}=7 Now, squaring both sides again: (x+x^{-1})^{2}=7^{2} x^{2}+x^{-2}+2=49 x^{2}+x^{-2}=47 So, frac {x^{2}+x^{-2}-2}{x+x^{-1}-3} = frac {47-2}{7-3} =frac {45}{4} =boxed{11.25}"},{"instruction":"Given a sequence (a_0, a_1, ldots, a_n) satisfying (a_0 = a_n = 0) and (a_{k1}  2a_k + a_{k+1} geq 0) for (k = 1, 2, ldots, n1), prove that all the numbers in the sequence are nonpositive (negative or zero).","output":"Given the sequence ( a_0, a_1, ldots, a_n ) satisfying the conditions: 1. ( a_0 = 0 ) 2. ( a_n = 0 ) 3. ( a_{k-1} - 2a_k + a_{k+1} geq 0 ) for ( k = 1, 2, ldots, n-1 ) We need to show that all ( a_k leq 0 ). 1. **Define a difference sequence**: Lets define ( d_k = a_{k+1} - a_k ) for ( k = 0, 1, ldots, n-1 ). 2. **Rewrite the given inequality**: We can express the given inequality ( a_{k-1} - 2a_k + a_{k+1} geq 0 ) in terms of ( d_k ).    [    a_{k-1} - 2a_k + a_{k+1} = (a_{k+1} - a_k) - (a_k - a_{k-1}) = d_k - d_{k-1} geq 0    ]    Hence, we have:    [    d_k geq d_{k-1}    ]    This tells us that the sequence ( d_k ) is non-decreasing. 3. **Analyze the non-decreasing sequence**: Since ( d_k geq d_{k-1} ), it implies that if ( d_k ) becomes positive, it remains positive or increases for all subsequent ( k ). 4. **Initial conditions**:    - ( a_0 = 0 )    - ( d_0 = a_1 - a_0 = a_1 )    We need to analyze these initial conditions in the context of the entire sequence. 5. **Inductive Argument**: Suppose some ( a_s ) is positive and is the first positive term in the sequence:    - Let ( s ) be the smallest index such that ( a_s > 0 ).    - Hence ( a_{s-1} leq 0 ) (since ( a_s ) is the first positive). 6. **Induction on ( a_s )**:    - Since ( d_s = a_{s+1} - a_s geq d_{s-1} = a_s - a_{s-1} ), and ( a_{s-1} leq 0 ), so ( a_s - a_{s-1} > 0 ).    - This implies ( d_s > 0 ).    - Given ( d_k ) is non-decreasing, for ( k geq s ), ( d_k geq d_s > 0 ).    However, ( a_n = 0 ) and if ( d_k > 0 ) for some ( k ), then ( a_{k+1} > a_k ), leading to contradiction since ( a_n = 0 ). 7. **Conclusion**: If we assume ( a_s > 0 ) for some ( s ), we end up with a contradiction due to the non-decreasing nature of ( d_k ). Thus, no ( a_s ) can be positive, and therefore all ( a_k ) must be ( leq 0 ). [ boxed{ text{All } a_k leq 0. } ]"},{"instruction":"My aunt has 12 pieces of art, including 4 prints by Escher. If she arranges the pieces of art in a row in a random order, what is the probability that all four prints by Escher will be placed consecutively?","output":"To find the desired probability: 1. Treat the four Escher prints as one unit. This transformation leads to 9 units total (the 4 Escher prints as one unit + 8 other pieces of art). 2. The units can be arranged in 9! ways. Within the Escher unit, the 4 prints can be permuted among themselves in 4! ways. 3. Calculate the total number of arrangements considering the Escher unit as one block: 9! times 4!. 4. Calculate the total arrangements with no restrictions on the Escher prints: 12!. 5. Compute the probability: [ text{Probability} = frac{9! times 4!}{12!} = frac{362880 times 24}{479001600} = frac{8709120}{479001600} = boxed{frac{1}{55}} ] Conclusion: The probability that all four Escher prints will be placed consecutively is boxed{frac{1}{55}}."},{"instruction":"Positive integers a and b are such that the graphs of y=ax+7 and y=2x+b intersect the xaxis at the same point. What is the sum of all possible xcoordinates of these points of intersection? A) 9 B) 10 C) 11 D) 12 E) 13","output":"1. **Identify the points of intersection with the x-axis**:     Given y = ax+7 and y = 2x+b, the x-intercepts occur when y=0. 2. **Set up equations for x-intercepts**:    - For y = ax + 7, setting y = 0 gives:      [      0 = ax + 7 implies x = -frac{7}{a}      ]    - For y = 2x + b, setting y = 0 gives:      [      0 = 2x + b implies x = -frac{b}{2}      ] 3. **Equating the x-intercepts**:    Since the x-intercepts must be the same, equate the two expressions for x:    [    -frac{7}{a} = -frac{b}{2}    ]    Simplifying, we get:    [    frac{7}{a} = frac{b}{2} implies 2 cdot 7 = ab implies ab = 14    ] 4. **Finding possible values of a and b**:    The pairs (a, b) that satisfy ab = 14 are:    [    (1, 14), (2, 7), (7, 2), (14, 1)    ]    These are all the positive integer solutions. 5. **Calculate the corresponding x-values**:    Substituting each pair into x = -frac{7}{a}, we get:    - For (a, b) = (1, 14), x = -frac{7}{1} = -7    - For (a, b) = (2, 7), x = -frac{7}{2}    - For (a, b) = (7, 2), x = -frac{7}{7} = -1    - For (a, b) = (14, 1), x = -frac{7}{14} = -frac{1}{2} 6. **Sum the x-values**:    [    -7 + left(-frac{7}{2}right) + (-1) + left(-frac{1}{2}right) = -7 - frac{7}{2} - 1 - frac{1}{2} = -8 - frac{8}{2} = -8 - 4 = -12    ] 7. **Conclusion**:    The sum of all possible x-coordinates of these points of intersection is -12. The final answer is boxed{text{D}}"},{"instruction":"Let a, b, c, d be the four roots of X^{4}X^{3}X^{2}1. Calculate P(a)+P(b)+P(c)+P(d), where P(X) = X^{6}X^{5}X^{4}X^{3}X.","output":"1. Given the polynomial equations ( X^4 - X^3 - X^2 - 1 ) and another polynomial ( P(X) = X^6 - X^5 - X^4 - X^3 - X ). 2. We need to calculate ( P(a) + P(b) + P(c) + P(d) ), where ( a, b, c, d ) are the roots of the polynomial equation ( X^4 - X^3 - X^2 - 1 = 0 ). 3. First, let's factorize ( P(X) ):    [    P(X) = X^6 - X^5 - X^4 - X^3 - X     = X^2 cdot (X^4 - X^3 - X^2 - 1) - X^3 + X^2 - X     ]    This representation allows us to use the roots ( a, b, c, d ) of ( X^4 - X^3 - X^2 - 1 ). 4. Since ( a, b, c, d ) are the roots, we have:    [    a^4 - a^3 - a^2 - 1 = 0, quad b^4 - b^3 - b^2 - 1 = 0, quad c^4 - c^3 - c^2 - 1 = 0, quad d^4 - d^3 - d^2 - 1 = 0    ]    Hence,    [    a^4 = a^3 + a^2 + 1, quad b^4 = b^3 + b^2 + 1, quad c^4 = c^3 + c^2 + 1, quad d^4 = d^3 + d^2 + 1    ] 5. Using these identities in ( P(a), P(b), P(c), P(d) ):    For ( P(a) ):    [    P(a) = a^6 - a^5 - a^4 - a^3 - a     = a^2 cdot (a^4 - a^3 - a^2 - 1) - a^3 + a^2 - a     = a^2 cdot 0 - a^3 + a^2 - a     = -a^3 + a^2 - a     ]    Similarly,    [    P(b) = -b^3 + b^2 - b, quad P(c) = -c^3 + c^2 - c, quad P(d) = -d^3 + d^2 - d    ] 6. Therefore, we need to compute:    [    P(a) + P(b) + P(c) + P(d)     = (-a^3 + a^2 - a) + (-b^3 + b^2 - b) + (-c^3 + c^2 - c) + (-d^3 + d^2 - d)    ] 7. Using the polynomial ( X^4 - X^3 - X^2 - 1 ), we define the elementary symmetric sums:    [    sigma_1 = a + b + c + d, quad sigma_2 = ab + ac + ad + bc + bd + cd, quad sigma_3 = abc + abd + acd + bcd, quad sigma_4 = abcd    ]        From Vieta's formulas for ( X^4 - X^3 - X^2 - 1 ), we get:    [    sigma_1 = 1, quad sigma_2 = -1, quad sigma_3 = 0, quad sigma_4 = 1    ] 8. Now we will evaluate each symmetric polynomial sum:        [    S_1 = sigma_1 = 1    ]    [    S_2 = sigma_1 S_1 - 2sigma_2 = 1 cdot 1 - 2(-1) = 1 + 2 = 3    ]    [    S_3 = sigma_1 S_2 - sigma_2 S_1 + 3sigma_3 = 1 cdot 3 - (-1) cdot 1 + 3 cdot 0 = 3 + 1 = 4    ] 9. Combining these results, we get:    [    P(a) + P(b) + P(c) + P(d) = -S_3 + S_2 - S_1 = -4 + 3 - 1 = -2    ] Therefore, the final answer is ( boxed{-2} )."},{"instruction":"A cistern is filled by pipe A in 10 hours and the full cistern can be leaked out by an exhaust pipe B in 12 hours. If both the pipes are opened, in what time is the cistern full?","output":"Let's denote the capacity of the cistern as C liters. Pipe A fills the cistern in 10 hours, so the rate at which Pipe A fills the cistern is C/10 liters per hour. Pipe B empties the cistern in 12 hours, so the rate at which Pipe B empties the cistern is C/12 liters per hour. When both pipes are opened, the net rate at which the cistern is filled is the rate of filling by Pipe A minus the rate of emptying by Pipe B. Net rate = Rate of A - Rate of B Net rate = (C/10) - (C/12) To find a common denominator, we can use 60 (the least common multiple of 10 and 12): Net rate = (6C/60) - (5C/60) Net rate = (6C - 5C)/60 Net rate = C/60 This means that with both pipes open, the cistern is filled at a rate of C/60 liters per hour. To find the time it takes to fill the cistern at this net rate, we divide the capacity of the cistern by the net rate: Time = Capacity / Net rate Time = C / (C/60) Time = C * (60/C) Time = 60 hours So, with both pipes open, the cistern will be full in boxed{60}  hours."},{"instruction":"Let  x_n=2^{2^{n}}+1  and let  m  be the least common multiple of  x_2, x_3, ldots, x_{1971}.  Find the last digit of  m.","output":"1. **Understanding the problem**: We need to find the last digit of the least common multiple (LCM) of the sequence ( x_n = 2^{2^n} + 1 ) for ( n = 2, 3, ldots, 1971 ). 2. **Coprimality of Fermat numbers**: The numbers of the form ( 2^{2^n} + 1 ) are known as Fermat numbers. It is a well-known fact that any two Fermat numbers are coprime. This can be shown as follows:    - Suppose ( p ) is a common divisor of ( 2^{2^n} + 1 ) and ( 2^{2^m} + 1 ) with ( n > m ).    - Then ( 2^{2^m} equiv -1 pmod{p} ).    - Raising both sides to the power ( 2^{n-m} ), we get ( 2^{2^n} equiv (-1)^{2^{n-m}} equiv 1 pmod{p} ).    - Thus, ( p ) divides both ( 2^{2^n} + 1 ) and ( 2^{2^n} - 1 ), which is impossible since their difference is 2. 3. **LCM of coprime numbers**: Since the Fermat numbers are pairwise coprime, the LCM of ( x_2, x_3, ldots, x_{1971} ) is simply their product:    [    m = x_2 cdot x_3 cdot ldots cdot x_{1971}    ] 4. **Product of Fermat numbers**: The product of Fermat numbers can be expressed as:    [    x_2 cdot x_3 cdot ldots cdot x_{1971} = (2^{2^2} + 1)(2^{2^3} + 1) ldots (2^{2^{1971}} + 1)    ]    Using the identity for the product of Fermat numbers:    [    (2^{2^2} - 1)(2^{2^2} + 1)(2^{2^3} + 1) ldots (2^{2^{1971}} + 1) = 2^{2^{1972}} - 1    ]    Therefore,    [    m = frac{2^{2^{1972}} - 1}{2^{2^2} - 1} = frac{2^{2^{1972}} - 1}{15}    ] 5. **Finding the last digit**: To find the last digit of ( m ), we need to compute ( 2^{2^{1972}} - 1 ) modulo 10.    - Note that ( 2^{2^{1972}} ) is a very large power of 2. We can use the fact that the powers of 2 modulo 10 cycle every 4:      [      2^1 equiv 2 pmod{10}, quad 2^2 equiv 4 pmod{10}, quad 2^3 equiv 8 pmod{10}, quad 2^4 equiv 6 pmod{10}, quad 2^5 equiv 2 pmod{10}, ldots      ]    - Since ( 2^{1972} equiv 0 pmod{4} ), we have:      [      2^{2^{1972}} equiv 2^0 equiv 1 pmod{10}      ]    - Therefore,      [      2^{2^{1972}} - 1 equiv 1 - 1 equiv 0 pmod{10}      ] 6. **Conclusion**: The last digit of ( 2^{2^{1972}} - 1 ) is 0. Since we are dividing by 15, which does not affect the last digit modulo 10, the last digit of ( m ) is:    [    boxed{9}    ]"},{"instruction":"Excluding the stoppages, the speed of a bus is 48 km/hr, and including the stoppages, the speed of the bus is 12 km/hr. For how many minutes does the bus stop per hour?","output":"The speed of the bus excluding stoppages is 48 km/hr, and including stoppages, it is 12 km/hr. This means that due to stoppages, the bus covers 48 - 12 = 36 km/hr less. To find out how long the bus stops per hour, we need to calculate the time it would take to cover the 36 km at the original speed (without stoppages). Time = Distance / Speed The time taken to cover 36 km at a speed of 48 km/hr is: Time = 36 km / 48 km/hr = 0.75 hours Since we want to find out the stoppage time in minutes, we convert 0.75 hours to minutes: 0.75 hours * 60 minutes/hour = 45 minutes Therefore, the bus stops for boxed{45}  minutes per hour."},{"instruction":"Define a sequence   < a_n > _{ngeq0}  by   a_0 equal{} 0 ,   a_1 equal{} 1  and\\r [ a_n equal{} 2a_{n minus{} 1} plus{} a_{n minus{} 2},]\\r for   ngeq2. \\r \\r  (a)  For every   m > 0  and   0leq jleq m,  prove that   2a_m  divides\\r  a_{m plus{} j} plus{} ( minus{} 1)^ja_{m minus{} j} .\\r \\r  (b)  Suppose   2^k  divides   n  for some natural numbers   n  and   k . Prove that   2^k  divides   a_n.","output":"# Part (a) We need to prove that for every ( m > 0 ) and ( 0 leq j leq m ), ( 2a_m ) divides ( a_{m+j} + (-1)^j a_{m-j} ). 1. **Base Case:**    For ( j = 0 ):    [    a_{m+0} + (-1)^0 a_{m-0} = a_m + a_m = 2a_m    ]    Clearly, ( 2a_m ) divides ( 2a_m ). 2. **Inductive Step:**    Assume that for some ( k leq m ), ( 2a_m ) divides ( a_{m+k} + (-1)^k a_{m-k} ). We need to show that ( 2a_m ) divides ( a_{m+k+1} + (-1)^{k+1} a_{m-k-1} ).    Using the recurrence relation ( a_n = 2a_{n-1} + a_{n-2} ), we have:    [    a_{m+k+1} = 2a_{m+k} + a_{m+k-1}    ]    and    [    a_{m-k-1} = 2a_{m-k-2} + a_{m-k-3}    ]    Consider the expression:    [    a_{m+k+1} + (-1)^{k+1} a_{m-k-1}    ]    Substituting the recurrence relations, we get:    [    a_{m+k+1} + (-1)^{k+1} a_{m-k-1} = (2a_{m+k} + a_{m+k-1}) + (-1)^{k+1} (2a_{m-k-2} + a_{m-k-3})    ]    By the inductive hypothesis, ( 2a_m ) divides ( a_{m+k} + (-1)^k a_{m-k} ). Therefore, we can write:    [    2a_m mid (2a_{m+k} + a_{m+k-1}) + (-1)^{k+1} (2a_{m-k-2} + a_{m-k-3})    ]    Simplifying, we get:    [    2a_m mid (a_{m+k+1} + (-1)^{k+1} a_{m-k-1})    ]    Thus, by induction, ( 2a_m ) divides ( a_{m+j} + (-1)^j a_{m-j} ) for all ( 0 leq j leq m ). # Part (b) We need to prove that if ( 2^k ) divides ( n ) for some natural numbers ( n ) and ( k ), then ( 2^k ) divides ( a_n ). 1. **Base Case:**    For ( k = 1 ):    [    n = 2    ]    We have ( a_2 = 2a_1 + a_0 = 2 cdot 1 + 0 = 2 ), and clearly ( 2^1 = 2 ) divides ( a_2 ). 2. **Inductive Step:**    Assume that ( 2^k ) divides ( a_{2^k} ). We need to show that ( 2^{k+1} ) divides ( a_{2^{k+1}} ).    Using the recurrence relation and the result from part (a), we have:    [    a_{2^{k+1}} = 2a_{2^k} + a_{2^k-1}    ]    By the inductive hypothesis, ( 2^k ) divides ( a_{2^k} ). Therefore, ( a_{2^k} = 2^k cdot m ) for some integer ( m ).    Substituting this into the recurrence relation, we get:    [    a_{2^{k+1}} = 2(2^k cdot m) + a_{2^k-1} = 2^{k+1} cdot m + a_{2^k-1}    ]    Since ( 2^k ) divides ( a_{2^k-1} ) by the properties of the sequence, we can write ( a_{2^k-1} = 2^k cdot n ) for some integer ( n ).    Therefore:    [    a_{2^{k+1}} = 2^{k+1} cdot m + 2^k cdot n = 2^k (2m + n)    ]    Hence, ( 2^{k+1} ) divides ( a_{2^{k+1}} ).    By induction, ( 2^k ) divides ( a_n ) for all ( n ) such that ( 2^k ) divides ( n ). (blacksquare)"},{"instruction":"Given that ( A B CA_{1} B_{1} C_{1} ) is a regular triangular prism with ( A B = B C = C A = 2 ) and ( A A_{1} = sqrt{2} ), and ( D ) and ( E ) are the midpoints of ( A C ) and ( B C ), respectively, find the angle in degrees between ( A_{1} D ) and ( C_{1} E ).","output":"1. **Identify Important Segments and Points**:     Given that triangle ABC - triangle A_1B_1C_1 is a regular tetrahedron, the edges AB = BC = CA = 2 units, and the vertical height A A_{1} = sqrt{2} units. Points D and E are the midpoints of AC and BC respectively. 2. **Find Midpoints D and E**:    Calculate the coordinates and lengths involving the midpoints. Since D and E are midpoints:    [    D = left(frac{A + C}{2}right), quad E = left(frac{B + C}{2}right)    ]    Since AC = BC = 2, the lengths AD and BE are half of these, or 1 unit each. 3. **Calculate the Length A_1D and C_1E**:    The distances A_1D and C_1E will be calculated using the 3D distance formula. Since the lengths involved are right triangles' legs where hypotenuses are split, (sqrt{AC^2 + A_1A^2}):    [    A_1D = sqrt{(text{half of } AC)^2 + A_1A^2}    ]    [    A_1D = sqrt{1^2 + (sqrt{2})^2} = sqrt{1 + 2} = sqrt{3}    ]    Similarly,    [    C_1E = sqrt{1^2 + (sqrt{2})^2} = sqrt{1 + 2} = sqrt{3}    ] 4. **Identify the Median Relationship**:    Take the midpoint F of the segment A_1B_1. The relationship in the triangle can use midpoints:    [    F = (text{midpoint of } A_1B_1)    ]     5. **Calculate Lengths From Midpoints**:    The line E to F matches to the midpoint lengths:    [    EF = DA_1    ] 6. **Form Relationships: Triangles and Regularity**:    By considering triangle Delta C_1EF_1:    [    Delta C_1E = sqrt{3}    ] 7. **Angle Calculation**:    Noting Delta C_1EF forms a regular triangle,    [    text{Thus, angle } angle FEC_1 = 60^circ    ]    Hence, the angle between lines A_1D and C_1E is: 8. **Conclusion**:    [    boxed{60^circ}    ]"},{"instruction":"Find the value of ( k ) if ( (x^2  k)(x + k) = x^3  k(x^2 + x + 3) ) and ( k neq 0 ).","output":"We begin by expanding the left-hand side of the equation: [ (x^2 - k)(x + k) = x^3 + kx^2 - kx - k^2. ] Next, we rewrite the equation with both sides expanded: [ x^3 + kx^2 - kx - k^2 = x^3 - kx^2 - kx - 3k. ] Subtract ( x^3 ), ( -kx ), and ( kx^2 ) from both sides for simplification: [ -k^2 = -kx^2 - 3k. ] Since this must be true for all ( x ), compare the coefficients: [ -k^2 = -3k. ] It simplifies to: [ k^2 = 3k. ] [ k^2 - 3k = 0. ] [ k(k - 3) = 0. ] Since ( k neq 0 ), we find: [ k - 3 = 0. ] [ k = boxed{3}. ]"},{"instruction":"Each piece of candy in a store costs a whole number of cents. Pamela has exactly enough money to buy either 10 pieces of yellow candy, 16 pieces of orange candy, 18 pieces of black candy, or n pieces of white candy. A piece of white candy costs 15 cents. What is the smallest possible value of n? A) 45 B) 48 C) 50 D) 52 E) 54","output":"1. Let the cost of each type of candy be y, o, b, and w cents respectively, where w = 15 cents for white candy.    2. The equations for the total amount of money Pamela has can be expressed as:    - 10y for yellow candy    - 16o for orange candy    - 18b for black candy    - 15n for white candy. 3. To find the smallest value of n, 15n must be a common multiple of 10y, 16o, and 18b. We find the LCM of 10, 16, and 18:    - Prime factorization of 10 = 2 cdot 5    - Prime factorization of 16 = 2^4    - Prime factorization of 18 = 2 cdot 3^2        The highest power of each prime:    [    text{LCM} = 2^4 cdot 3^2 cdot 5 = 720    ] 4. Determine the smallest n such that 15n = 720:    [    15n = 720 implies n = frac{720}{15} = 48    ] 5. Verify that 15 cdot 48 is divisible by 10, 16, and 18:    - 720 div 10 = 72, which is an integer.    - 720 div 16 = 45, which is an integer.    - 720 div 18 = 40, which is an integer. Since 720 is divisible by 10, 16, and 18, and since 15 cdot 48 = 720, the smallest possible value of n is indeed 48. Thus, the smallest possible value of n for which Pamela can buy n pieces of white candy with her money is 48. The final answer is boxed{B) 48}"},{"instruction":"What is the simplified form of the following expression: [3  5x  7x^2 + 9  11x + 13x^2  15 + 17x + 19x^2] in terms of x?","output":"Start by grouping similar terms (constants, linear terms, and quadratic terms): - Constants: 3 + 9 - 15 = -3 - Linear terms: -5x - 11x + 17x = 1x - Quadratic terms: -7x^2 + 13x^2 + 19x^2 = 25x^2 Combining these grouped terms results in: [ (-3) + (1x) + (25x^2) = 25x^2 + x - 3 ] Thus, the expression simplifies to: [boxed{25x^2 + x - 3}]"},{"instruction":"Given the function f(x) = begin{cases} log_{2}x, & x>1  (frac{1}{2})^{x}, & xleq 1 end{cases}, then f(f(frac{1}{2})) equals to () A: frac{1}{2}   B: frac{1}{2}   C: 2   D: 2","output":"Since the function f(x) = begin{cases} log_{2}x, & x>1  (frac{1}{2})^{x}, & xleq 1 end{cases},   then f(-frac{1}{2}) = (frac{1}{2})^{-frac{1}{2}} = sqrt{2},   and f(f(-frac{1}{2})) = f(sqrt{2}) = log_{2}sqrt{2} = frac{1}{2}.   Therefore, the correct answer is: boxed{A}.   First, we find f(-frac{1}{2}) = (frac{1}{2})^{-frac{1}{2}} = sqrt{2}, thus f(f(-frac{1}{2})) = f(sqrt{2}), from which we can determine the result.   This question tests the method of finding function values, which is a basic problem. When solving, it is important to carefully read the problem and properly apply the properties of the function."},{"instruction":"a division sum, the remainder is 6 and the divisor is 5 times the quotient and is obtained by adding 2 to some multiple of the remainder. The dividend is 86. What is the multiple of the remainder used to calculate the divisor?","output":"Let's denote the following: - Divisor: D - Quotient: Q - Remainder: R - Dividend: V From the problem, we have: R = 6 V = 86 D = 5Q D = kR + 2, where k is the multiple of the remainder we are looking for. We know that in a division sum, the following relationship holds: V = D * Q + R Substituting the given values, we have: 86 = D * Q + 6 Since D = 5Q, we can substitute D in the equation: 86 = 5Q * Q + 6 Now, let's solve for Q: 86 - 6 = 5Q^2 80 = 5Q^2 Q^2 = 80 / 5 Q^2 = 16 Q = 16 Q = 4 Now that we have Q, we can find D: D = 5Q D = 5 * 4 D = 20 Now, we know that D is also obtained by adding 2 to some multiple of the remainder: D = kR + 2 20 = k * 6 + 2 20 - 2 = k * 6 18 = k * 6 k = 18 / 6 k = 3 Therefore, the multiple of the remainder used to calculate the divisor is boxed{3} ."},{"instruction":"Determine how many integers satisfy the following inequalities: [ begin{array}{cccc} (1) & 4x & geq & 2x + 13  (2) & 3x & leq & 15  (3) & 5x & geq & 3x + 23 end{array} ]","output":"We begin by solving each inequality: 1. For inequality (1):  [ -4x geq 2x + 13  Rightarrow -6x geq 13  Rightarrow x leq -frac{13}{6} ] 2. For inequality (2): [ -3x leq 15  Rightarrow x geq -5 ] 3. For inequality (3): [ -5x geq 3x + 23  Rightarrow -8x geq 23  Rightarrow x leq -frac{23}{8} ] When combining these, inequalities (1) and (3) provide upper bounds, with (3) being the more restrictive: (x leq -frac{23}{8} approx -2.875). Inequality (2) provides a lower bound: (x geq -5). Thus, the integers satisfying all three are -5, -4, -3. Therefore, there are boxed{3} integers that satisfy all the inequalities."},{"instruction":"There are 24 marbles in a jar. Some are blue. There are 6 red marbles. The rest of the marbles are orange. There are 6 orange marbles. What is the ratio of blue marbles to the total number of marbles?","output":"To find the ratio of blue marbles to the total number of marbles, we first need to determine how many blue marbles there are. We know there are 24 marbles in total, 6 of which are red and 6 of which are orange. To find the number of blue marbles, we subtract the number of red and orange marbles from the total number of marbles: Number of blue marbles = Total marbles - Red marbles - Orange marbles Number of blue marbles = 24 - 6 - 6 Number of blue marbles = 12 Now that we know there are 12 blue marbles, we can find the ratio of blue marbles to the total number of marbles: Ratio of blue marbles to total marbles = Number of blue marbles : Total marbles Ratio of blue marbles to total marbles = 12 : 24 To simplify the ratio, we can divide both sides by the greatest common divisor, which is 12 in this case: Ratio of blue marbles to total marbles = (12  12) : (24  12) Ratio of blue marbles to total marbles = 1 : 2 So the ratio of blue marbles to the total number of marbles is boxed{1:2} ."},{"instruction":"Given fleft(xright)=x^{2}+bx+cleft(b,cin Rright), where fleft(xright)x=0 has two distinct roots x_{1} and x_{2}, and (x_{1}1)(x_{2}1)=5.   (1) If x_{1}=x_{2}+4, find the value of b.   (2) Find the range of values for x_1^2+x_2^2.","output":"# Step-by-Step Solution  Part (1) Given f(x) = x^2 + bx + c, and f(x) - x = 0, we can rewrite the equation as: [x^2 + (b - 1)x + c = 0] From this, we know the sum and product of the roots are: [x_1 + x_2 = 1 - b] [x_1x_2 = c] Given (x_1 - 1)(x_2 - 1) = 5, we can expand and substitute the values of x_1 + x_2 and x_1x_2: [(x_1x_2) - (x_1 + x_2) + 1 = 5] [c - (1 - b) + 1 = 5] [c + b = 5] Given x_1 = x_2 + 4, we use the quadratic formula to express the difference between the roots: [x_1 - x_2 = sqrt{(b - 1)^2 - 4c} = 4] Substituting c = 5 - b into the equation: [sqrt{(b - 1)^2 - 4(5 - b)} = 4] Simplifying, we get: [b^2 + 2b - 35 = 0] Solving this quadratic equation, we find: [b = 5 text{ or } b = -7] Thus, the value of b is boxed{5 text{ or } -7}.  Part (2) For the range of x_1^2 + x_2^2, we first find the discriminant Delta: [Delta = (b - 1)^2 - 4c = b^2 + 2b - 19 > 0] This implies: [b < -1 - 2sqrt{5} text{ or } b > -1 + 2sqrt{5}] Next, we calculate x_1^2 + x_2^2 using the identity: [x_1^2 + x_2^2 = (x_1 + x_2)^2 - 2x_1x_2] Substituting the values of x_1 + x_2 and x_1x_2: [x_1^2 + x_2^2 = (1 - b)^2 - 2c = 1 - 2b + b^2 - 2(5 - b) = b^2 - 9] Given the conditions on b, we have: [b^2 > (2sqrt{5} - 1)^2 = 21 - 4sqrt{5}] Therefore, the range of x_1^2 + x_2^2 is greater than 12 - 4sqrt{5}, so the range is boxed{(12 - 4sqrt{5}, +infty)}."},{"instruction":"w many integers are solutions to the equation (x3)^{(30x^2)} = 1?","output":"To determine where (x-3)^{(30-x^2)} = 1, we consider cases similar to the original problem: 1. **(30 - x^2) = 0:** Solves to x^2 = 30, thus x = pmsqrt{30}. Since sqrt{30} is not an integer, we discard these solutions. 2. **x - 3 = 1:** Solves to x = 4. Plugging into the exponent gives 30 - 4^2 = 30 - 16 = 14. Since (1)^{14} = 1, x = 4 is a valid solution. 3. **x - 3 = -1:** Solves to x = 2. Plugging this into the exponent gives 30 - 2^2 = 30 - 4 = 26. Since (-1)^{26} = 1, x = 2 is also a valid solution. Conclusion: From these cases, only x = 4 and x = 2 satisfy the conditions for the equation to equal 1. Thus, there are boxed{2} integer solutions."},{"instruction":"A square piece of wood is sawn from an isosceles triangle wooden board with a base of 2m and a height of 3m. The square has one side coinciding with the base of the triangle. The area of this square piece of wood is ____ square meters.","output":"Let the side length of the square be x meters. Given that the base is 2m and the height is 3m, we have:  frac{x}{2} = frac{3-x}{3}  Solving this equation, we get:  x = frac{6}{5}  Therefore, the area of the square is:  left( frac{6}{5} right)^2 = frac{36}{25}  Hence, the answer is boxed{frac{36}{25}}."},{"instruction":"Compute: 2(ab) + 3b = ______.","output":"First, distribute the 2 to both terms inside the parentheses: 2(a-b) = 2a - 2b. Next, combine like terms 2b and 3b: 2a  2b + 3b = 2a + b. So the answer is: boxed{2a + b}. To solve this problem, we simply need to remove the parentheses and combine like terms following the basic arithmetic operations."},{"instruction":"Let the function f(x) be defined as follows: f(x) = begin{cases} (3a)x  3, & x leq 7  a^{x6}, & x > 7 end{cases} The sequence {a_n} satisfies a_n = f(n) for n in mathbb{N}^+, and the sequence {a_n} is increasing. The range of the real number a is ( ). A: (1, 3) B: (2, 3) C: left( frac{9}{4}, 3 right) D: (1, 2)","output":"To ensure that the sequence {a_n} is increasing, we must have a_7 < a_8 as it is the point where the piecewise definition of f(x) changes. We consider the two parts of f(x) at n=7 and n=8 to establish the inequalities that a must satisfy: 1. For n leq 7, f(n) = (3-a)n - 3. As n ranges over the positive integers, the expression (3-a)n - 3 must be less than f(8) for the sequence to be increasing. Thus, using n=7, we obtain the inequality        a_7 = (3-a)cdot 7 - 3 < a^{8-6}.     2. For n > 7, f(n) = a^{n-6}. Since a_8 = a^{8-6} = a^2, we need a_7 < a_8 = a^2. Plugging in the expression for a_7 using n=7 we get        (3-a)cdot 7 - 3 < a^2.     To find the range for a, we solve the system of inequalities from the two conditions above: begin{cases} 1 < a & text{(because a^{x-6} must be increasing for x > 7, requiring a > 1)}  3 - a > 0 & text{(to ensure f(x) is positive and increasing for x leq 7)}  a^2 > (3-a)cdot 7 - 3 end{cases} From this system, we can isolate the third inequality to find the range of a. begin{aligned} a^2 &> 21 - 7a - 3  a^2 &> 18 - 7a  a^2 + 7a - 18 &> 0 end{aligned} We can factor this quadratic inequality: (a - 2)(a + 9) > 0. To satisfy the inequality a^2 + 7a - 18 > 0, a must be greater than 2 or less than -9. However, since a also needs to be greater than 1 and less than 3 based on the other conditions, the intersection of all these conditions is 2 < a < 3. Thus, the range for the real number a is 2 < a < 3. boxed{B}"},{"instruction":"Seven positive consecutive integers starting with (a) have average (b). What is the average of 7 consecutive integers that start with (b)? A) (a + 3) B) (a + 4) C) (a + 5) D) (a + 6) E) (a + 7)","output":"1. **Define the sequence and calculate the average (b)**:    The seven consecutive integers starting with (a) are (a, a+1, a+2, a+3, a+4, a+5, a+6). The average of these integers, (b), is calculated as follows:    [    b = frac{a + (a+1) + (a+2) + (a+3) + (a+4) + (a+5) + (a+6)}{7} = frac{7a + 21}{7} = a + 3    ] 2. **Identify the new sequence starting with (b)**:      Since (b = a + 3), the next set of seven consecutive integers starting with (b) are (b, b+1, b+2, b+3, b+4, b+5, b+6). Substituting (b = a + 3), these integers are:    [    a+3, a+4, a+5, a+6, a+7, a+8, a+9    ] 3. **Calculate the average of the new sequence**:    The average of these integers is:    [    frac{(a+3) + (a+4) + (a+5) + (a+6) + (a+7) + (a+8) + (a+9)}{7} = frac{7a + 42}{7} = a + 6    ] 4. **Conclusion**:    The average of the seven consecutive integers that start with (b) is (a + 6). Therefore, the answer is a + 6. The final answer is boxed{D) a + 6}"},{"instruction":"Calculate the volumes of the solids formed by the rotation of figures bounded by the function graphs. The axis of rotation is the xaxis.  y = x e^x, quad y = 0, quad x = 1","output":"1. To find the volume of the solid obtained by rotating the region bounded by the curves about the x-axis, we use the formula for the volume of a solid of revolution: [ V = pi int_{a}^{b} y^2 , dx ] 2. Identify the region of integration. From the given problem, we have (y = x e^x), (y = 0), and (x = 1). We also need to find the lower bound for (x). Setting (y = 0): [ x e^x = 0 implies x = 0 ] Thus, the limits of integration are from (x = 0) to (x = 1). 3. Substitute (y = x e^x) into the volume formula: [ V = pi int_{0}^{1} (x e^x)^2 , dx = pi int_{0}^{1} x^2 e^{2x} , dx ] 4. To solve the integral, we will use integration by parts. Recall the formula for integration by parts: [ int u , dv = uv - int v , du ] Let (u = x^2) and (dv = e^{2x} , dx). 5. Compute (du) and (v): [ u = x^2 implies du = 2x , dx ] [ dv = e^{2x} , dx implies v = frac{e^{2x}}{2} ] 6. Apply integration by parts: [ int x^2 e^{2x} , dx = left. x^2 cdot frac{e^{2x}}{2} right|_0^1 - int_0^1 frac{e^{2x}}{2} cdot 2x , dx ] [ = left. frac{x^2 e^{2x}}{2} right|_0^1 - int_0^1 x e^{2x} , dx ] 7. Evaluate the first term at the bounds: [ left. frac{x^2 e^{2x}}{2} right|_0^1 = frac{1^2 e^{2 cdot 1}}{2} - frac{0^2 e^{2 cdot 0}}{2} = frac{e^2}{2} - 0 = frac{e^2}{2} ] 8. To evaluate ( int_0^1 x e^{2x} , dx ), we use integration by parts again, letting (u = x) and (dv = e^{2x} , dx): [ u = x implies du = dx ] [ dv = e^{2x} , dx implies v = frac{e^{2x}}{2} ] 9. Apply integration by parts again: [ int x e^{2x} , dx = left. x cdot frac{e^{2x}}{2} right|_0^1 - int_0^1 frac{e^{2x}}{2} , dx ] [ = left. frac{x e^{2x}}{2} right|_0^1 - int_0^1 frac{e^{2x}}{2} , dx ] 10. Evaluate the first term at the bounds: [ left. frac{x e^{2x}}{2} right|_0^1 = frac{1 cdot e^{2 cdot 1}}{2} - frac{0 cdot e^{2 cdot 0}}{2} = frac{e^2}{2} - 0 = frac{e^2}{2} ] 11. Evaluate the integral (int_0^1 frac{e^{2x}}{2} , dx): [ int_0^1 frac{e^{2x}}{2} , dx = frac{1}{2} int_0^1 e^{2x} , dx = frac{1}{2} cdot left. frac{e^{2x}}{2} right|_0^1 = frac{1}{2} cdot left( frac{e^2}{2} - frac{1}{2} right) = frac{1}{2} cdot frac{e^2 - 1}{2} = frac{e^2 - 1}{4} ] 12. Combine all the parts: [ int_0^1 x e^{2x} , dx = frac{e^2}{2} - frac{e^2 - 1}{4} = frac{2e^2}{4} - frac{e^2 - 1}{4} = frac{2e^2 - e^2 + 1}{4} = frac{e^2 + 1}{4} ] 13. Substitute this back into the original expression for the volume: [ V = pi left( frac{e^2}{2} - frac{e^2 + 1}{4} right) = pi left( frac{2e^2}{4} - frac{e^2 + 1}{4} right) = pi left( frac{2e^2 - e^2 - 1}{4} right) = pi cdot frac{e^2 - 1}{4} ] 14. Simplify: [ V = frac{pi (e^2 - 1)}{4} ] # Conclusion: The volume of the solid obtained by rotating the region bounded by the given curves about the x-axis is  [ boxed{frac{pi (e^2 - 1)}{4}} ]"},{"instruction":"There are some bicycles and 7 tricycles in the storage area at Braden's apartment building. Each bicycle has 2 wheels and each tricycle has 3 wheels. There are 53 wheels in all. How many bicycles are there?","output":"Let's use algebra to solve this problem. Let ( b ) represent the number of bicycles and ( t ) represent the number of tricycles. We know that there are 7 tricycles, so ( t = 7 ). Each bicycle has 2 wheels, so the total number of wheels for the bicycles is ( 2b ). Each tricycle has 3 wheels, so the total number of wheels for the tricycles is ( 3t ). The total number of wheels is given as 53. So we can write the equation: [ 2b + 3t = 53 ] Since we know ( t = 7 ), we can substitute that into the equation: [ 2b + 3(7) = 53 ] Now we solve for ( b ): [ 2b + 21 = 53 ] [ 2b = 53 - 21 ] [ 2b = 32 ] [ b = frac{32}{2} ] [ b = 16 ] So there are boxed{16}  bicycles."},{"instruction":"A nearsighted rook attacks all cells in its row and column that can be reached within 60 steps, moving from one cell to an adjacent cell. What is the maximum number of nonattacking nearsighted rooks that can be placed on a 100 times 100 grid?","output":"1. **Problem Understanding**:    - We are given a 100 times 100 chessboard.    - A \\"nearsighted rook\\" can move any number of steps within its row or column but can only move to a cell within 60 steps of its current position.    - The task is to find the maximum number of such rooks that can be placed on the chessboard such that no two rooks can attack each other. 2. **Breaking Down the Board**:    - We divide the 100 times 100 chessboard into one central 22 times 22 square.    - Additionally, we have four rectangular regions each of dimensions 1 times 61. This breakdown helps in optimal placement by ensuring coverage without overlap.    - The central square is chosen as 22 times 22 to accommodate the interaction of the nearsighted rook's movement constraint effectively within the board's restricted area. 3. **Placement Strategy in Central Square**:    - The total cells in the central 22 times 22 square is 22^2 = 484.    - Since rooks placed in each row and column need 60 empty cells apart to avoid mutual attacks, only one rook can be placed in each row and in each column within the 22 times 22 square without causing overlap. 4. **Placement of Rooks in Rectangular Strips**:    - Each 1 times 61 strip allows only one rook per strip to ensure they are not in attacking range of each other vertically.    - The multiplicity of such strips is 4 times 39 = 156. 5. **Combining the Counts**:    - Combining the rooks from the central square and the rectangular strips, we see:      - Central 22 times 22 square: 22 rooks (one per row/column without overlap).      - Four 1 times 61 strips: 156 rooks (one in each). 6. **Total Calculation**:    [    22 + 156 = 178    ] # Conclusion: [ boxed{178} ] Therefore, the maximum number of non-attacking nearsighted rooks that can be placed on a 100 times 100 board is ( boxed{178} )."},{"instruction":"N^{3} unit cubes are drilled diagonally and tightly strung on a thread, which is then tied into a loop (i.e., the vertex of the first cube is connected to the vertex of the last cube). For which N can such a necklace of cubes be packed into a cubic box with an edge length of N?","output":"1. **Number the Cubes:**    - Consider one of the cubes in the string and designate it as cube 1. Number the remaining cubes sequentially so that all N^3 cubes are numbered from 1 to N^3. 2. **Coordinate System Placement:**    - Place the entire structure within a coordinate system, aligning the origin (0,0,0) with one of the vertices of the enclosing cubic box whose edge length is N.    - The idea is to analyze how the vertices of the cubes, specifically the vertices connected by the thread, are positioned in this coordinate system.     3. **Vertex Abscissas Analysis:**    - Let's denote the vertex connected by the thread in cube n as A_n. Assume coordinates are integer points in the 3D grid. If the necklace (thread) is packed into the cubic box, the x-coordinates (abscissas) of these vertices should exhibit a specific pattern.    - Due to the threading pattern, each of A_n's coordinates (x, y, z) will differ in even-odd properties (e.g., (even, even, odd)).    - If we examine the sum of these coordinates for the entire thread, we should see various patterns based on whether N is odd or even. 4. **Odd versus Even N:**    - For an odd N, the sum of all coordinates in the cubic structure will be odd because each coordinate corresponding to any threaded vertex will appear twice (one start and one end at each pairwise connection).      Since N is odd, the iterative sequence (with repeated even/odd combinations) would yield an odd total, this conflicts with the requirement of double counting leading to an even sum. This contradiction implies it is impossible to fit the necklace into the box.    - For an even N, the sum of abscissas from the threaded pattern can be made symmetrical and the total sum would be even. Thereby each vertex participating in threading fits well within the grid constraints imposed by the cube. 5. **Moebius-like Edge Traversal:**    - Considering how the necklace threading can traverse vertices and sides of the box, we can think about a Moebius-like traversal where every cube vertex A_n connects to its appropriate diagonal counterparts without leaving connectivity gaps assuming N is even.    - Analyzing the 3D spatial properties and this connectivity ensures every cube can be precisely packed without overflow or misalignment. 6. **Boxed Conclusion:**    - Hence, such a threading construction can successfully pack into the box if and only if **N is even**.    [boxed{text{N is even}}]"},{"instruction":"Calculate 3^{4} + (3)^{3} + (3)^{2} + (3)^{1} + 3^{1} + 3^{2} + 3^{3}.","output":"Using the power rules for negative bases: - (-3)^{4} = 3^{4} because 4 is even. - (-3)^{3} = -3^{3} because 3 is odd. - (-3)^{2} = 3^{2} because 2 is even. - (-3)^{1} = -3^{1} because 1 is odd. Therefore, the expression simplifies to: [ 3^{4} + (-3)^{3} + (-3)^{2} + (-3)^{1} + 3^{1} + 3^{2} + 3^{3} = 3^{4} - 3^{3} + 3^{2} - 3^{1} + 3^{1} + 3^{2} + 3^{3} ] Simplifying the terms, we see that -3^{1} + 3^{1} = 0 and the remaining terms are: [ 3^{4} - 3^{3} + 3^{2} + 3^{2} + 3^{3} = 3^{4} + 2 cdot 3^{2} ] Calculating the values: - 3^{4} = 81 - 3^{2} = 9 Thus, the expression becomes: [ 81 + 2 cdot 9 = 81 + 18 = boxed{99} ]"},{"instruction":"Given the function fleft(xright)=x^{3}x^{2}xa. 1. Find the extreme values of fleft(xright); 2. If the function fleft(xright) has exactly one zero, find the range of real numbers for a.","output":"1. To find the extreme values of f(x) = x^3 - x^2 - x - a, we first find its derivative: [f'(x) = 3x^2 - 2x - 1.] Setting f'(x) = 0 to find critical points, we solve: [3x^2 - 2x - 1 = 0.] This quadratic equation can be solved using the quadratic formula, x = frac{-b pm sqrt{b^2 - 4ac}}{2a}, with a=3, b=-2, and c=-1, yielding: [x = frac{2 pm sqrt{(-2)^2 - 4cdot3cdot(-1)}}{2cdot3} = frac{2 pm sqrt{4 + 12}}{6} = frac{2 pm sqrt{16}}{6} = frac{2 pm 4}{6}.] Thus, we have two critical points: [x = -frac{1}{3} quad text{and} quad x = 1.] To determine the nature of these critical points and find the extreme values, we analyze the sign of f'(x) around these points. The sign analysis shows that f'(x) changes from positive to negative at x = -frac{1}{3}, indicating a maximum, and from negative to positive at x = 1, indicating a minimum. The maximum value of f(x) is at x = -frac{1}{3}: [fleft(-frac{1}{3}right) = left(-frac{1}{3}right)^3 - left(-frac{1}{3}right)^2 - left(-frac{1}{3}right) - a = -frac{1}{27} - frac{1}{9} + frac{1}{3} - a = frac{5}{27} - a.] The minimum value of f(x) is at x = 1: [f(1) = 1^3 - 1^2 - 1 - a = 1 - 1 - 1 - a = -1 - a.] Therefore, the extreme values of f(x) are a maximum of boxed{frac{5}{27} - a} and a minimum of boxed{-1 - a}. 2. For f(x) to have exactly one zero, the maximum value frac{5}{27} - a must be less than 0, or the minimum value -1 - a must be greater than 0. This gives us two inequalities: [frac{5}{27} - a < 0 quad text{and} quad -1 - a > 0.] Solving these inequalities for a, we find: [a > frac{5}{27} quad text{and} quad a < -1.] Therefore, the range of real numbers for a for which f(x) has exactly one zero is boxed{a < -1 text{ or } a > frac{5}{27}}."},{"instruction":"Sara and Jim both decided to save some money each week. Sara has already saved 4100 dollars, and she plans to save 10 dollars a week. Jim plans to save 15 dollars a week. In how many weeks will Jim and Sara have saved the same amount?","output":"Let's denote the number of weeks it will take for Jim and Sara to have saved the same amount as ( w ). Sara has already saved 4100, and she saves 10 each week. So, after ( w ) weeks, Sara will have saved: ( 4100 + 10w ) dollars. Jim starts from 0, and he saves 15 each week. So, after ( w ) weeks, Jim will have saved: ( 0 + 15w ) dollars. For them to have saved the same amount, we set these two expressions equal to each other: ( 4100 + 10w = 15w ). Now, we solve for ( w ): ( 4100 = 15w - 10w ) ( 4100 = 5w ) ( w = 4100 / 5 ) ( w = 820 ). So, it will take Jim boxed{820}  weeks to save the same amount as Sara."},{"instruction":"Find the derivative of the function ( z = x^2 + y^2 ) at the point ( M(3,1) ) in the direction of the point ( M_1(0,5) ).","output":"To find the derivative of the function ( z = x^2 + y^2 ) at the point ( M(3,1) ) in the direction towards the point ( M_1(0,5) ), follow these steps: 1. **Determine the direction vector (overrightarrow{MM_1})}:    [    overrightarrow{MM_1} = {0-3, 5-1} = {-3, 4}    ] 2. **Calculate the magnitude of (overrightarrow{MM_1})}:    [    |overrightarrow{MM_1}| = sqrt{(-3)^2 + 4^2} = sqrt{9 + 16} = sqrt{25} = 5    ] 3. **Find the direction cosines**:    [    cos alpha = -frac{3}{5}, quad sin alpha = frac{4}{5}    ] 4. **Define the unit direction vector**:    [    vec{l} = left{-frac{3}{5}, frac{4}{5}right}    ] 5. **Compute the partial derivatives of (z)}:    [    frac{partial z}{partial x} = 2x, quad frac{partial z}{partial y} = 2y    ]    At the point ( (3,1) ):    [    left(frac{partial z}{partial x}right)_{(3,1)} = 2 cdot 3 = 6, quad left(frac{partial z}{partial y}right)_{(3,1)} = 2 cdot 1 = 2    ] 6. **Determine the directional derivative (frac{partial z}{partial l})}:    Using the formula for the directional derivative:    [    frac{partial z}{partial l} = left( frac{partial z}{partial x} right)_{(3,1)} cdot cos alpha + left( frac{partial z}{partial y} right)_{(3,1)} cdot sin alpha    ]    Substitute the previously computed values:    [    frac{partial z}{partial l} = 6 left( -frac{3}{5} right) + 2 cdot frac{4}{5}    ] 7. **Simplifying the expression**:    [    frac{partial z}{partial l} = 6 left(-frac{3}{5}right) + 2 left(frac{4}{5}right)    ]    [    = - frac{18}{5} + frac{8}{5}    ]    [    = frac{-18 + 8}{5}    ]    [    = frac{-10}{5}    ]    [    = -2    ]     # Conclusion: The derivative of the function (z = x^2 + y^2) at the point (M(3,1)) in the direction toward the point (M_1(0,5)) is: [ boxed{-2} ] The negative sign of the value (frac{partial z(3,1)}{partial l}) indicates that the function decreases in the direction (vec{l})."},{"instruction":"Define a function y=f(x) on mathbb{R}, which is increasing on (infty, 2). If the axis of symmetry of the graph of y=f(x+2) is x=0, then ( ) A: f(1)<f(3) B: f(0)>f(3) C: f(1)=f(3) D: f(2)<f(3)","output":"The correct answer is A. Since the axis of symmetry of the graph of y=f(x+2) is x=0, it implies that f(-x+2)=f(x+2). Therefore, for x=-1, we have f(-1+2)=f(-1+2), which does not directly help in comparing the values of f at different points. However, knowing that the function is increasing on (-infty, 2), we can conclude that f(-1)<f(3) because -1<2<3, and the function is increasing up to x=2. Thus, the correct option is boxed{text{A}}."},{"instruction":"Given the following propositions: Proposition p: For all x in mathbb{R}, the inequality ax^2 + ax + 1 > 0 always holds. Proposition q: The function f(x) = 4x^2  ax is monotonically increasing on the interval [1, +infty). If the proposition p vee q is true and neg p is also true, find the range of values for the real number a.","output":"1. For all x in mathbb{R}, the inequality ax^2 + ax + 1 > 0 always holds. When a=0, it is clearly true. When a neq 0, we must have the following conditions: begin{cases} a > 0  Delta = a^2 - 4a < 0 end{cases} Solving the inequalities, we get 0 < a < 4. Thus, proposition p: 0 < a < 4. 2. The function f(x) = 4x^2 - ax is monotonically increasing on the interval [1, +infty). This implies that the axis of symmetry frac{a}{8} leq 1. Solving for a, we get a leq 8. Thus, proposition q: a leq 8. 3. If the proposition \\"p vee q\\" is true and \\"neg p\\" is also true, then p is false and q is true. Thus, we have the following conditions: begin{cases} a leq 8  a geq 4 text{ or } a leq 0 end{cases} Solving the system of inequalities, we get a leq 0 or 4 leq a leq 8. Therefore, the range of values for the real number a is boxed{a leq 0 text{ or } 4 leq a leq 8}."},{"instruction":"Let ( ABC ) be a triangle and ( D ) the foot of the angle bisector from ( A ). Denote ( O ) (resp. ( O_1 ), resp. ( O_2 )) as the circumcenter of ( triangle ABC ) (resp. ( triangle ABD ), resp. ( triangle ADC )). Show that ( OO_1 = OO_2 ).","output":":  1. Let us start by noting that we have a triangle ( triangle ABC ), and ( D ) is the foot of the angle bisector of ( angle BAC ).     2. Let ( O ) be the circumcenter of ( triangle ABC ), ( O_1 ) be the circumcenter of ( triangle ABD ), and ( O_2 ) be the circumcenter of ( triangle ACD ). 3. We begin by examining the angles ( widehat{BAO_1} ) and ( widehat{BAO_2} ). Since ( O_1 ) and ( O_2 ) are circumcenters, they lie on the perpendicular bisectors of segments ( BD ) and ( DC ) respectively. 4. Consequently, it follows that:    [    widehat{BAO_1} = widehat{BAO_2} = x    ] 5. Now, we consider the angles ( widehat{OO_1A} ) and ( widehat{OO_2A} ). Since ( O ) is the circumcenter of ( triangle ABC ), we have:    [    widehat{OO_1A} + widehat{OO_2A} = 180^circ    ] 6. Therefore, the quadrilateral ( O_1AOO_2 ) is cyclic. This is due to the supplementary angles formed at ( A ). 7. To further explore, let us focus on the angles at ( O ):    [    y = widehat{BAO} = x    ]    This step follows since ( O ) is the circumcenter and the angle subtended by ( BD ) or ( DC ) over ( triangle ABC ) splits evenly due to the angle bisector. 8. Continuing, since ( O_1 ) and ( O_2 ) both lie on the perpendicular bisectors of ( BD ) and ( DC ), respectively:    [    widehat{O_1AO} = widehat{O_2AO}    ] 9. By exploring the angle inscribed argument and considering that they are on the same circle from the cyclic quadrilateral:    [    OO_1 = OO_2    ] # Conclusion: [ boxed{OO_1 = OO_2} ]"},{"instruction":"Let ( n, b > 1 ) be integers. Suppose that for every integer ( k > 1 ), there exists an integer ( a_k ) such that ( k mid b  a_k^n ). Show that there exists an integer ( A ) such that ( b = A^n ).","output":"1. **Prime Factorization of ( b ):**    We start by writing ( b ) as a product of its prime factors:    [    b = p_{1}^{alpha_{1}} p_{2}^{alpha_{2}} cdots p_{m}^{alpha_{m}}    ]    where ( p_1, p_2, ldots, p_m ) are distinct primes, and ( alpha_1, alpha_2, ldots, alpha_m ) are positive integers. 2. **Property Provided:**    By the problem statement, for every integer ( k > 1 ), there exists an integer ( a_k ) such that:    [    k mid b - a_k^n    ]    We need to show that there exists an integer ( A ) such that:    [    b = A^n    ] 3. **Choosing ( k = b^2 ):**    Let us apply the given property for ( k = b^2 ). There exists an integer ( a ) such that:    [    b^2 mid b - a^n    ]    This implies:    [    b - a^n = b times q quad text{for some integer } q    ]    Therefore:    [    b^2 mid b - a^n implies b^2 mid b times q implies b^2 mid a^n    ] 4. **Analyzing the Modulo Condition:**    For each prime ( p_i ) dividing ( b ), we have:    [    p_i^{2alpha_i} mid a^n    ]    This also means:    [    a^n equiv b pmod{p_i^{alpha_i}}    ]    However, we need the precise power of ( p_i ) such that:    [    a^n equiv b pmod{p_i^{alpha_i} + 1}    ] 5. **Understanding ( v_{p_i}(a^n) ):**    We know:    [    a^n equiv b equiv 0 pmod{p_i^{alpha_i}}    ]    and:    [    a^n equiv b notequiv 0 pmod{p_i^{alpha_i + 1}}    ]    Therefore, the ( p_i )-adic valuation ( v_{p_i}(a^n) ) must be equal to ( alpha_i ):    [    v_{p_i}(a^n) = alpha_i    ] 6. **Divisibility Property:**    Since:    [    a^n = (a^*)^n times (whatever text{ irrelevant steps})    ]    and:    [    n mid v_{p_i}(a^n)    ]    it follows:    [    n mid alpha_i    ]    Thus, ( alpha_i ) is a multiple of ( n ) for each ( i ). 7. **Conclusion:**    Hence, we can write:    [    alpha_i = n beta_i quad text{for some integers} quad beta_i    ]    Therefore:    [    b = p_1^{nbeta_1} p_2^{nbeta_2} cdots p_m^{nbeta_m}    ]    Let:    [    A = p_1^{beta_1} p_2^{beta_2} cdots p_m^{beta_m}    ]    So:    [    b = A^n    ]    Thus, we have shown that there exists an integer ( A ) such that:    [    b = A^n    ]    (boxed{})"},{"instruction":"Given an arithmetic sequence left{a_nright} where all terms are distinct, satisfying a_{2n}=2a_n3, and a_6^2=a_1cdot a_{21}, the sum of the first n terms of left{a_nright} is S_n. Then, the maximum value among the terms of the sequence left{frac{S_n}{2^{n1}}right} is.","output":"**Analysis** First, we derive the general formula for left{a_nright} based on the given conditions. Then, by using the inequalities begin{cases} frac{S_n}{2^{n-1}}geqslant frac{S_{n-1}}{2^{n-2}}  frac{S_n}{2^{n-1}}geqslant frac{S_{n+1}}{2^n}end{cases}, we can solve the problem. **Solution** Let the first term of the arithmetic sequence left{a_nright} be a_1, and the common difference be d. From the given conditions, we have begin{cases}a_1+(2n-1)d=2a_1+2(n-1)d-3  (a_1+5d)^2=a_1cdot(a_1+20d)end{cases} Solving these, we get begin{cases}a_1=5  d=2end{cases}, (discard d=0), Therefore, S_n=5n+ frac{n(n-1)}{2}2=n(n+4), Thus, frac{S_n}{2^{n-1}}=2cdot frac{n(n+4)}{2^n}, By solving begin{cases} frac{S_n}{2^{n-1}}geqslant frac{S_{n-1}}{2^{n-2}}  frac{S_n}{2^{n-1}}geqslant frac{S_{n+1}}{2^n}end{cases}, We find that sqrt{6}-1 < n < sqrt{6}, Therefore, n=2, Hence, the maximum value among the terms of the sequence left{frac{S_n}{2^{n-1}}right} is frac{S_2}{2^{2-1}}=6, Thus, the answer is boxed{6}."},{"instruction":"f m is a real number and x^2 + mx + 9 has two distinct real roots, what are the possible values of m? Express your answer in interval notation.","output":"To find the values of m that allow the quadratic equation x^2 + mx + 9 to have two distinct real roots, the discriminant (Delta) must be positive. The discriminant for any quadratic equation ax^2 + bx + c is given by Delta = b^2 - 4ac. For the given equation: - a = 1 - b = m - c = 9 Substituting these into the discriminant formula, we get: [ Delta = m^2 - 4 cdot 1 cdot 9 = m^2 - 36 ] We need Delta > 0, so: [ m^2 - 36 > 0  ] [ m^2 > 36 ] Solving for m, we need: [  |m| > 6 ] This translates to m in (-infty, -6) cup (6, infty). Thus, the possible values of m are boxed{(-infty, -6) cup (6, infty)}."},{"instruction":"Find the smallest threedigit palindrome whose product with 103, minus 300, is not a fivedigit palindrome.","output":"**Step 1:** Represent a three-digit palindrome as aba (where a and b are digits from 0 to 9). **Step 2:** Multiply this palindrome by 103, considering potential carrying and adjustments.  103 cdot aba = (100 + 3) cdot aba = aba00 + 3aba  **Step 3:** Calculate the specified transformation.  103 cdot aba - 300 = aba00 + 3aba - 300  **Step 4:** Check the resulting number which should be:  ab0(2a)b(3a-3)  If 3a - 3 has a carry or results in an even number different from the other numbers to maintain palindrome structure, or if 2a has a carry. **Step 5:** The smallest possible value of a = 5, b = 0, then:  aba = 505   103 cdot 505 = 50500 + 1515 = 52015   52015 - 300 = 51715  Since 51715 is a palindrome and satisfies all constraints, we should try next:  aba = 606   103 cdot 606 = 60600 + 1818 = 62418   62418 - 300 = 62118  Here, 62118 is not a palindrome. Thus, boxed{606} is the smallest three-digit palindrome which gives a non-palindrome result of 62118 after computing 103 cdot 606 - 300."},{"instruction":"Let the universal set U=mathbb{R}, and let A=left{x middle| frac{1}{|x1|} < 1right}, B=left{x middle| x^{2}5x+4 > 0right}. Find A cap (complement_{U}B).","output":"Since the universal set U=mathbb{R}, we have A=left{x middle| frac{1}{|x-1|} < 1right}=left{x middle| |x-1| > 1right}=left{x middle| x < 0 text{ or } x > 2right};   B=left{x middle| x^{2}-5x+4 > 0right}=left{x middle| x < 1 text{ or } x > 4right},   Therefore, complement_{U}B=left{x middle| 1 leq x leq 4right},   Thus, A cap (complement_{U}B)=left{x middle| 2 < x leq 4right}.   So, the answer is boxed{left{x middle| 2 < x leq 4right}}.   This problem involves solving inequalities to find sets A and B, and then using the definitions of complement and intersection to find A cap (complement_{U}B). It tests the basic operations with inequalities and sets, making it a foundational question."},{"instruction":"Given a convex quadrilateral (ABCD). It is known that (angle ABD + angle ACD > angle BAC + angle BDC). Prove that the area of (triangle ABD) plus the area of (triangle ACD) is greater than the area of (triangle BAC) plus the area of (triangle BDC).","output":"1. **Understanding the Problem**:        We are given a convex quadrilateral (ABCD). We know that the sum of the angles (angle ABD + angle ACD) is greater than the sum of the angles (angle BAC + angle BDC). We need to prove that the sum of the areas of triangles (ABD) and (ACD) is greater than the sum of the areas of triangles (BAC) and (BDC).     2. **Geometrical Interpretation**:        First, observe that the given inequality (angle ABD + angle ACD > angle BAC + angle BDC) implies the configuration of the quadrilateral (ABCD). Specifically, it suggests that point (C) is closer to line (AB) than point (D), and point (B) is closer to line (CD) than point (A).    This can be visualized with a diagram:    [    begin{align*}    text{Let }ABCD text{ be the quadrilateral. Consider the lines } &overline{AB} text{ and } overline{CD}.     & text{If } overline{AB} text{ and } overline{CD} text{ intersect, it implies the relative positions of } B text{ and } D text{ with respect to } C text{ and } A.    end{align*}    ] 3. **Proof by Area Comparison**:        Recall that the area (S_{Delta}) of a triangle can be compared by looking at its base and corresponding height. Given the previous geometrical interpretation, we write:        [    angle ABD + angle ACD > angle BAC + angle BDC    ] 4. **Detailed Calculation**:        Compare the areas of the triangles two at a time considering the given inequality:    - Since point (C) is closer to line (AB) than point (D), the triangle (ACD) will have a larger height from (C) dropping perpendicular to (AB) when compared to (ABD). Thus,    [    S_{ACD} > S_{ABC}    ]    - Similarly, since point (B) is closer to line (CD) than point (A), the area of (ABD) will be larger than that of (BDC). Therefore,    [    S_{ABD} > S_{BDC}    ] 5. **Adding and Concluding**:        Adding these inequalities together, we get:    [    S_{ABD} + S_{ACD} > S_{ABC} + S_{BDC}    ] 6. **Conclusion**:        This confirms that the total area of triangles (ABD) and (ACD) is indeed greater than the total area of triangles (BAC) and (BDC). Thus,    [    boxed{S_{ABD} + S_{ACD} > S_{BAC} + S_{BDC}}.    ]"},{"instruction":"Which of the following operations is correct? A: 3x+4y=12xy B: x^{9}div x^{3}=x^{3} C: (x^{2})^{3}=x^{6} D: (xy)^{2}=x^{2}y^{2}","output":"To evaluate each option: **Option A: 3x+4y=12xy** This operation attempts to combine unlike terms, which is not a valid algebraic operation. Therefore, option A is incorrect. **Option B: x^{9}div x^{3}=x^{3}** Using the rule of exponents for division, x^{a} div x^{b} = x^{a-b}. Therefore, x^{9} div x^{3} = x^{9-3} = x^{6}. Hence, option B is incorrect as it claims the result is x^{3}. **Option C: (x^{2})^{3}=x^{6}** Applying the rule of exponents for powers raised to powers, (x^{a})^{b} = x^{ab}. Thus, (x^{2})^{3} = x^{2cdot3} = x^{6}. This matches the claim in option C, making it correct. **Option D: (x-y)^{2}=x^{2}-y^{2}** Expanding the square of a binomial, (x-y)^{2} = x^{2} - 2xy + y^{2}, not x^{2} - y^{2} as suggested. Therefore, option D is incorrect. Given the analysis, the correct operation is: boxed{C}"},{"instruction":"a rectangle, the base equals the product of the smaller side and 2, plus the difference between the larger side and a constant k. The altitude of this rectangle equals the sum of half of the diagonal and the constant k. If the smaller side is 6 units, the larger side is 10 units, and k = 3 units, what is the area of the rectangle? A) frac{17(sqrt{106} + 4)}{2} B) frac{19(sqrt{126} + 8)}{2} C) frac{19(sqrt{136} + 6)}{2} D) frac{25(sqrt{136} + 6)}{2} E) frac{19(sqrt{146} + 6)}{2}","output":"1. **Identify dimensions of the given rectangle:**    The smaller side x = 6 and the larger side y = 10. 2. **Calculate the diagonal of the rectangle:**    [    d = sqrt{x^2 + y^2} = sqrt{6^2 + 10^2} = sqrt{36 + 100} = sqrt{136}    ] 3. **Define the new rectangle dimensions:**    [    text{Base} = 2x + (y - k) = 2 times 6 + (10 - 3) = 12 + 7 = 19    ]    [    text{Altitude} = frac{d}{2} + k = frac{sqrt{136}}{2} + 3 = frac{sqrt{136}}{2} + 3    ] 4. **Calculate the area of the new rectangle:**    [    A_{text{new}} = text{Base} times text{Altitude} = 19 left(frac{sqrt{136}}{2} + 3right) = 19 times frac{sqrt{136} + 6}{2}    ]    [    A_{text{new}} = frac{19(sqrt{136} + 6)}{2}    ] 5. **Conclusion:**    The area of the rectangle can be given by frac{19(sqrt{136 + 6)}{2}} units squared. The correct answer is boxed{C}."},{"instruction":"Given the function f(x)=2^{x}+x5, the interval in which the solution to the equation f(x)=0 lies is (n,n+1). Find n.","output":"Let f(x)=2^{x}+x-5. Then, the interval in which the solution to the equation 2^{x}+x=5 lies is the same as the interval containing the zero of the function f(x)=2^{x}+x-5. We have f(1)=2+1-5=-2 < 0 and f(2)=4+2-5=1 > 0. By the Intermediate Value Theorem, the zero of the function f(x)=2^{x}+x-5 lies in the interval (1,2). The solution to the equation f(x)=0 lies in the interval (n,n+1). Therefore, n=1. So, the answer is boxed{1}. This problem primarily tests the application of the Intermediate Value Theorem, demonstrating a mathematical thought process of transformation and is considered a basic problem."},{"instruction":"f the range of the function ( f(x) = lg left[ (k^2  1)x^2  (k + 1)x + 1 right] ) is (mathbf{R}), then the range of the real number ( k ) is ______.","output":":  We are given the function ( f(x) = lg left[(k^2 - 1)x^2 - (k+1)x + 1 right] ) and we need to determine the range of the real number ( k ) such that the domain of ( f(x) ) is the set of all real numbers, (mathbf{R}). Here's the step-by-step solution: 1. For ( f(x) ) to be defined for all ( x in mathbf{R} ), the argument of the logarithm must be positive for all ( x ), that is,      [    (k^2 - 1)x^2 - (k+1)x + 1 > 0 quad forall x in mathbf{R}.    ]     2. Analyze the quadratic expression ((k^2 - 1)x^2 - (k+1)x + 1):     - This quadratic expression must be positive for all ( x ), which means that it does not intersect the x-axis (i.e., its discriminant must be non-positive and the leading coefficient must be positive). 3. Discriminant condition:     - The discriminant (Delta) of the quadratic expression ( ax^2 + bx + c ) is given by        [       Delta = b^2 - 4ac.       ]      - For the quadratic expression ((k^2 - 1)x^2 - (k+1)x + 1), the coefficients are ( a = k^2 - 1 ), ( b = -(k + 1) ), and ( c = 1 ). The discriminant (Delta) is        [       Delta = (-(k + 1))^2 - 4(k^2 - 1)(1) = (k + 1)^2 - 4(k^2 - 1).       ]      - Simplify the discriminant expression:       [       Delta = (k + 1)^2 - 4(k^2 - 1) = k^2 + 2k + 1 - 4k^2 + 4 = -3k^2 + 2k + 5.       ]     - For the quadratic to be positive for all ( x ), (Delta leq 0):       [       -3k^2 + 2k + 5 leq 0.       ]        4. Solve the inequality ( -3k^2 + 2k + 5 leq 0 ):     - Rewrite it as        [       3k^2 - 2k - 5 geq 0.       ]     - Factorizing the quadratic expression or using the quadratic formula to find roots:       [       k = frac{-b pm sqrt{b^2 - 4ac}}{2a},       ]       where ( a = 3 ), ( b = -2 ), and ( c = -5 ):       [       k = frac{2 pm sqrt{4 + 60}}{6} = frac{2 pm sqrt{64}}{6} = frac{2 pm 8}{6}.       ]     - The roots are:       [       k = frac{2 + 8}{6} = frac{10}{6} = frac{5}{3}, quad text{and} quad k = frac{2 - 8}{6} = frac{-6}{6} = -1.       ]     - The inequality (3k^2 - 2k - 5 geq 0) holds for the intervals:       [       (-infty, -1] cup left[ frac{5}{3}, infty right).       ] 5. However, there is the additional condition that the leading coefficient ( k^2 - 1 ) must be positive because we need the quadratic to open upwards:     - This implies ( k^2 - 1 > 0 ), i.e.,        [       k > 1 quad text{or} quad k < -1.       ] 6. Intersecting the solutions of both parts, the range of ( k ) that satisfies both conditions is:     [     k in [1, frac{5}{3}]     ] # Conclusion:  [ boxed{left[ 1, frac{5}{3} right]} ]"},{"instruction":"Solve for ( x ): ( frac{6x}{(x+4)}  frac{2}{(x+4)} = frac{3}{(x+4)} )","output":"First, combine the fractions on the left-hand side: [ frac{6x - 2}{x+4} = frac{3}{x+4} ] Next, multiply both sides by ( x+4 ) to clear the denominator: [ 6x - 2 = 3 ] Solve for ( x ): [ 6x - 2 = 3 ] [ 6x = 3 + 2 ] [ 6x = 5 ] [ x = frac{5}{6} ] Then, box the final answer: [ x = boxed{frac{5}{6}} ]"},{"instruction":"From a group of 2008 students, 50 are to be selected to form a delegation for a visit. First, 8 students are excluded via simple random sampling. Then, the remaining 2000 students are selected using systematic sampling. The probability of each student being selected is () A: Not all equal B: Equal to frac{25}{1004} C: All unequal D: Equal to frac{1}{40}","output":"Since the sampling method must be fair, the probability of each student being selected should be equal. Let's calculate the probability for each student: Initially, there are 2008 students. 8 students are excluded, leaving 2000 students. From these 2000 students, 50 will be selected. The probability for any student to be selected from the initial group of 2008 students is:  P = frac{text{Number of students to be selected}}{text{Total number of students}} = frac{50}{2008}  After simplifying the fraction, we obtain:  P = frac{50}{2008} = frac{25 times 2}{1004 times 2} = frac{25}{1004}  Therefore, the correct answer is:  boxed{B: text{Equal to}  frac{25}{1004}}"},{"instruction":"Nathan will roll two eightsided dice. What is the probability that he will roll a number less than 4 on the first die and a number greater than 2 on the second die? Express your answer as a common fraction.","output":"To solve for the first die rolling a number less than 4 (numbers 1, 2, 3), the probability is frac{3}{8}, as three favorable outcomes exist out of eight possible outcomes. For the second die to roll a number greater than 2 (numbers 3 through 8), the probability is frac{6}{8} = frac{3}{4}, because six favorable outcomes exist out of eight possible outcomes. Given that the rolls of the two dice are independent events, the joint probability of the first event (rolling < 4 on the first die) and the second event (rolling > 2 on the second die) is: P(text{first die < 4 and second die > 2}) = P(text{first die < 4}) cdot P(text{second die > 2}) = frac{3}{8} cdot frac{3}{4} = frac{9}{32}. Therefore, the probability that Nathan meets both conditions is boxed{frac{9}{32}}."},{"instruction":"Define an odd function f(x) on mathbb{R}, where for x geqslant 0, f(x)=begin{cases} & log_{2}(x+1), & xin [0,1)  & |x3|1, & xin [1,+infty ) end{cases}. Then, the sum of all zeros of the function F(x)=f(x)a(1 < a < 0) is A: 12^{a} B: 2^{a}1 C: 12^{a} D: 2^{a}1","output":"**Analysis** The zeros of the function F(x)=f(x)-a(-1 < a < 0) can be transformed into finding the x-coordinates of the intersection points of the graphs y=f(x) and y=a in the same coordinate system. By drawing the graphs of the two functions and examining the number of intersection points, combined with the idea of equations and the symmetry of zeros, we can simplify the calculation. **Solution**   When -1leqslant x < 0, it implies 1geqslant -x > 0; xleqslant -1 implies -xgeqslant 1. Since f(x) is an odd function,   for x < 0, f(x)=-f(-x)=begin{cases}-log_{2}(-x+1), & xin[-1,0)  1-|-x-3|, & xin(-infty,-1]end{cases}. Drawing the graphs of y=f(x) and y=a(-1 < a < 0),   there are 5 intersection points. Let their x-coordinates from left to right be x_{1}, x_{2}, x_{3}, x_{4}, x_{5}, then frac{x_{1}+x_{2}}{2}=-3, frac{x_{4}+x_{5}}{2}=3, and -log_{2}(-x_{3}+1)=-a Rightarrow log_{2}(1-x_{3})=-a Rightarrow x_{3}=1-2^{-a}, thus, x_{1}+x_{2}+x_{3}+x_{4}+x_{5}=1-2^{-a}.   Therefore, the correct choice is boxed{C}."},{"instruction":"f a gt b, which of the following expressions is correct? A: a1 lt b1 B: frac{1}{2}a lt frac{1}{2}b C: 2+a gt 2+b D: 3a gt 3b","output":"Given a > b, let's examine each option step by step: **Option A: a-1 < b-1** Given that a > b, subtracting 1 from both sides gives: [a - 1 > b - 1] This contradicts the statement of option A, so option A is not correct. **Option B: frac{1}{2}a < frac{1}{2}b** Given that a > b, multiplying both sides by frac{1}{2} gives: [frac{1}{2}a > frac{1}{2}b] This contradicts the statement of option B, so option B is not correct. **Option C: 2+a > 2+b** Given that a > b, adding 2 to both sides gives: [2 + a > 2 + b] This confirms the statement of option C, making option C correct. **Option D: -3a > -3b** Given that a > b, multiplying both sides by -3 (and remembering that multiplying by a negative number reverses the inequality) gives: [-3a < -3b] This contradicts the statement of option D, so option D is not correct. Therefore, the correct answer is (boxed{C})."},{"instruction":"Let p, q, r, s, t, u, v, and w be distinct elements in the set  [ {6, 4, 1, 0, 3, 5, 7, 10}. ] What is the minimum possible value of  [ (p+q+r+s)^{2} + (t+u+v+w)^{2}? ]","output":"Note that the sum of the elements in the set is 14. Let x = p+q+r+s, so t+u+v+w = 14 - x. Then, [ (p+q+r+s)^{2} + (t+u+v+w)^{2} = x^{2} + (14-x)^{2} ] [ = 2x^{2} - 28x + 196 = 2(x - 7)^{2} + 98 geq 98. ] The minimum value of 98 is achieved if and only if x = 7. This can occur if we distribute the numbers such that each subset sums up to 7. One possible distribution could be p, q, r, s = -6, -4, 3, 14 and t, u, v, w = -1, 0, 5, 10.  Thus, [ (p+q+r+s)^2 + (t+u+v+w)^2 = 7^2 + 7^2 = 49 + 49 = boxed{98}. ]"},{"instruction":"Consider the set of all points ((x,y)) in the coordinate plane for which one of the coordinates is three times the other. If these points are plotted, into how many regions would the resulting graph split up the plane?","output":"We analyze two cases: 1. ( y ) is three times ( x ), which gives the equation ( y=3x ). 2. ( x ) is three times ( y ), which leads to ( y=frac{1}{3}x ). These two lines are not parallel as their slopes (3 and (frac{1}{3})) are different and will therefore intersect. The intersection occurs when ( 3x = frac{1}{3}x ). Solving for ( x ) gives: [ 3x = frac{1}{3}x ] [ 9x = x ] [ 8x = 0 ] [ x = 0 ] Thus, at ( x=0 ), ( y = 0 ). By plotting lines ( y=3x ) and ( y=frac{1}{3}x ) on a coordinate plane, these lines will intersect perpendicularly at the origin. Hence, they will divide the plane into four quadrants: - Region 1: Above both lines - Region 2: Between the lines - Region 3: Below both lines - Region 4: Between the lines on the other side Thus, the number of regions formed by these intersecting lines is: [ boxed{4} ]"},{"instruction":"Let h(x) = 4x + 3, and let p(x) = h(h(h(h(x)))). If the domain of p is 1 leq x leq 3, compute the range of p.","output":"We iterate the function to find p: [ h(h(x)) = 4(4x + 3) + 3 = 16x + 15 ] [ h(h(h(x))) = 4(16x + 15) + 3 = 64x + 63 ] [ h(h(h(h(x)))) = 4(64x + 63) + 3 = 256x + 255 ] This is a linear function, which is both continuous and increasing. We then evaluate p(x) at the endpoints of the domain: - When x = -1, p(-1) = 256(-1) + 255 = -1. - When x = 3, p(3) = 256(3) + 255 = 768 + 255 = 1023. Thus, the function p(x) covers all values continuously from -1 to 1023, so the range of p is boxed{-1 leq p(x) leq 1023}."},{"instruction":"Given that the arithmetic sequence {a_{n}} has a common difference of 2, and a_{1}, a_{2}, a_{4} form a geometric sequence, find a_{1}= ________ and the sum of the first n terms of the sequence {a_{n}}, S_{n}= ________.","output":"Since the sequence {a_{n}} is an arithmetic sequence with a common difference of 2, and a_{1}, a_{2}, a_{4} form a geometric sequence, we have that a_{1}, a_{1}+2, a_{1}+6 form a geometric sequence. Thus, (a_{1}+2)^{2}=a_{1}(a_{1}+6). Solving this equation yields a_{1}=2. The sum of the first n terms of the sequence {a_{n}}, S_{n} can be calculated as follows: S_{n} = n times frac{a_{1} + a_{n}}{2} Since a_{n} = a_{1} + (n-1) times 2, we have: S_{n} = n times frac{2 + (2 + (n-1) times 2)}{2} Simplifying this expression gives us: S_{n} = n^{2} + n Therefore, the final answer is: a_{1} = boxed{2} S_{n} = boxed{n^{2} + n}"},{"instruction":"a population of 100 individuals, they are randomly numbered from 0, 1, 2, 3, , 99, and evenly divided into 10 groups according to the order of their numbers. The groups are sequentially numbered from 1 to 10. Now, using the systematic sampling method to draw a sample of size 10, it is stipulated that if the number drawn in the first group is m, then the number drawn in the k^{th} group should have the same units digit as the number m+k. If m=6, then the number drawn in the 7th group is ( ). A: 66   B: 76   C: 63   D: 73","output":"Since the number drawn in the first group is m=6, and we are looking for the number in the 7th group that has the same units digit as m+6=12, the correct answer is the number that has 2 as its units digit in the 7th group. The 7th group consists of numbers 60 to 69. Therefore, the number that fits the criteria is 62. However, since 62 is not among the options and considering the systematic sampling method's requirement for the units digit to match m+k, we realize there might have been a misunderstanding in the explanation. The correct approach is to add k=6 (since we are looking into the 7th group and started with m=6) to the initial m=6, resulting in m+k=12. The units digit is 2, and since the 7th group's numbers range from 60 to 69, the correct number with a unit digit of 2 in the 7th group is actually 72. Therefore, the correct answer is: boxed{text{D: 73}}"},{"instruction":"triangle PQR, side overline{PQ}, overline{QR}, and overline{RP} have lengths 15, 36, and 39, respectively. Let Omega be the circle circumscribed around triangle PQR and let S be the intersection of Omega and the perpendicular bisector of overline{PR} that is not on the same side of overline{PR} as Q. Find the length of overline{PS}, and express your answer in the form msqrt{n}, where m and n are positive integers.","output":"First, check if triangle PQR is a right triangle by Pythagoras' Theorem: [ PQ^2 + QR^2 = 15^2 + 36^2 = 225 + 1296 = 1521 = 39^2 = RP^2 ] triangle PQR is indeed a right triangle with angle PRQ as the right angle. Since Omega is the circumcircle of triangle PQR, PR is the diameter of Omega and Omega's center O is the midpoint of PR. Let M be the midpoint of overline{PR}. The length of overline{PM} is half of overline{PR}: [ PM = frac{PR}{2} = frac{39}{2} = 19.5 ] Since S is on the perpendicular bisector of overline{PR} and not on the same side as Q, S is the point where circle Omega intersects the perpendicular bisector again. Therefore, S is the reflection of P over line OM, thus PS = PR. Hence, the length of overline{PS} is: [ overline{PS} = overline{PR} = 39 ] Since 39 can be expressed as 39sqrt{1}: [ boxed{m=39, n=1} ]"},{"instruction":"the diagram, PQRS is a trapezoid with an area of 24. RS is three times the length of PQ. What is the area of triangle PQS? [asy] draw((0,0)(1,6)(10,6)(18,0)cycle); draw((10,6)(0,0)); label(S,(0,0),W); label(P,(1,6),NW); label(Q,(10,6),NE); label(R,(18,0),E); [/asy]","output":"- Since PQ parallel RS, both triangles triangle PQS and triangle SRQ share the same height (the vertical distance between PQ and RS). - Given that RS is three times the length of PQ, and using the same height for both triangles, the area of triangle SRQ is three times the area of triangle PQS. - Therefore, the area of triangle PQS is frac{1}{4} of the total area of the trapezoid, because text{Area of trapezoid} = text{Area of } triangle PQS + text{Area of } triangle SRQ = text{Area of } triangle PQS + 3 times text{Area of } triangle PQS = 4 times text{Area of } triangle PQS. - Calculating frac{1}{4} times 24 = boxed{6}."},{"instruction":"The ratio of the areas of two squares is frac{245}{125}. After rationalizing the denominator, the ratio of their side lengths can be expressed in the simplified form frac{psqrt{q}}{r} where p, q, and r are integers. What is the value of the sum p+q+r?","output":"First, simplify the given ratio frac{245}{125}:  frac{245}{125} = frac{49}{25}. Next, find the ratio of the side lengths by taking the square root of the ratio of areas:  sqrt{frac{49}{25}} = frac{sqrt{49}}{sqrt{25}} = frac{7}{5}.  However, to match the problem format and check the rationalization step, we can express it initially in a form that needs rationalizing:  sqrt{frac{245}{125}} = frac{sqrt{245}}{sqrt{125}} = frac{sqrt{49 times 5}}{sqrt{25 times 5}} = frac{7sqrt{5}}{5sqrt{5}} = frac{7sqrt{5}}{5}.  Rationalizing the denominator:  frac{7sqrt{5}}{5} cdot frac{sqrt{5}}{sqrt{5}} = frac{7 times 5}{5} = frac{7}{5}.  So, we have p = 7, q = 5, r = 5, and summing these gives:  7 + 5 + 5 = boxed{17}."},{"instruction":"Find the equation of the tangent to the conic (a x^{2} + b x y + c y^{2} + d x + e y + f = 0) at the point (left(x_{0}, y_{0}right)).","output":"1. Suppose the point ((x_0, y_0)) belongs to the conic. This implies:    [    ax_{0}^{2} + bx_{0}y_{0} + c y_{0}^{2} + d x_{0} + e y_{0} + f = 0    ] 2. Any straight line passing through the point ((x_0, y_0)) can be written either as (y - y_{0} = k(x - x_{0})) or as (x = x_{0}) (which corresponds to (k = infty)). 3. Let's find the second point of intersection of the straight line with the conic. Substitute the equation of the straight line (y = k(x - x_{0}) + y_{0}) into the conic equation and calculate the coefficients (A) and (B) for (x^2) and (x):        Substituting (y = k(x - x_{0}) + y_{0}) into (a x^{2} + b x y + c y^{2} + d x + e y + f = 0), we get:    [    a x^{2} + b x left[k(x - x_{0}) + y_{0}right] + c left[k(x - x_{0}) + y_{0}right]^{2} + d x + e left[k(x - x_{0}) + y_{0}right] + f = 0    ]        Simplifying:    [    a x^{2} + b x left[kx - kx_{0} + y_{0}right] + c left[k^2(x - x_{0})^2 + 2k(x - x_{0})y_{0} + y_{0}^{2}right] + d x + e (kx - kx_{0} + y_{0}) + f = 0    ] 4. Collecting terms of (x^{2}), (x), and the constant, we get:    - Coefficient of (x^{2}): (a + bk + ck^{2})    - Coefficient of (x): ((b(-kx_0 + y_0) + 2c k(-kx_0 + k y_{0}) + d + ke))    Denote these coefficients as:    [    A = a + bk + ck^{2}    ]    [    B = -b k x_{0} + b y_{0} - 2c k^{2} x_{0} + 2c k y_{0} + d + ke    ] 5. The line is tangent to the conic if and only if it intersects the conic at exactly one additional point other than ((x_{0}, y_{0})). This condition is met when the discriminant of the quadratic equation in (x) equals zero. That is:    [    2x_{0} = -frac{B}{A}    ] 6. Using the relationship:    [    k left(b x_{0} + 2 c y_{0} + eright) = - left(2 a x_{0} + b y_{0} + dright)    ]    Therefore, the equation of the tangent line is:    [    (x - x_{0}) left(2 a x_{0} + b y_{0} + dright) + (y - y_{0}) left(b x_{0} + 2 c y_{0} + eright) = 0    ] 7. Given that the point ((x_{0}, y_{0})) lies on the conic:    [    a x_{0}^{2} + b x_{0} y_{0} + c y_{0}^{2} + d x_{0} + e y_{0} + f = 0    ]        Using this, the tangent line equation can also be written in another form:    [    left(2 a x_{0} + b y_{0} + d right) x + left(b x_{0} + 2 c y_{0} + eright) y + d x_{0} + e y_{0} + 2 f = 0    ] # Conclusion: The equation of the tangent line to the conic at ((x_0, y_0)) is: [ boxed{left(2 a x_{0} + b y_{0} + dright) x + left(b x_{0} + 2 c y_{0} + eright) y + d x_{0} + e y_{0} + 2 f= 0} ]"},{"instruction":"You collect pens. You start out with 5 pens. Mike gives you another 20 pens. Since her father makes pens, Cindy decides to do something to your pens. Since you're nice, you give Sharon 19 pens. At the end, you have 31 pens. What did Cindy do to your pens?","output":"Let's calculate the number of pens you have after each event: 1. You start with 5 pens. 2. Mike gives you 20 pens, so you now have 5 + 20 = 25 pens. 3. You give Sharon 19 pens, so you now have 25 - 19 = 6 pens. However, at the end, you have 31 pens. This means that Cindy must have given you some pens. To find out how many pens Cindy gave you, we can subtract the number of pens you had after giving some to Sharon from the final number of pens: 31 (final number of pens) - 6 (after giving to Sharon) = 25 pens. So, Cindy gave you boxed{25}  pens."},{"instruction":"Given sets A={xinmathbb{N}|(x+4)(x5)leq0}, B={xinmathbb{N}|x<2}, and U=mathbb{N}, then Acap(C_{U}B)= ( ) A: {1,2,3,4,5} B: {2,3,4,5} C: {3,4,5} D: {x|1<xleq5}","output":"Since A={xinmathbb{N}|(x+4)(x-5)leq0}   ={xinmathbb{N}|-4leq xleq5}={0,1,2,3,4,5},   B={xinmathbb{N}|x<2}={0,1}, and U=mathbb{N},   Therefore, Acap(C_{U}B)={2,3,4,5},   Hence, the correct option is boxed{text{B}}."},{"instruction":"Two different integers are randomly chosen from the set { 5, 0, 8, 7, 4, 2, 3, 1 }. What is the probability that their product is negative?","output":"1. Identify the set of integers: {-5, 0, -8, 7, 4, -2, -3, 1}. 2. Count the negative integers: {-5, -8, -2, -3} rightarrow 4 text{ negatives}. 3. Count the positive integers: {7, 4, 1} rightarrow 3 text{ positives}. 4. Calculate the number of combinations where one is positive and the other is negative:    4 text{ negatives} times 3 text{ positives} = 12 text{ combinations}. 5. Total number of ways to choose any two different integers from a set of 8:    binom{8}{2} = frac{8 times 7}{2 times 1} = 28. 6. Probability that the product is negative:    frac{text{Number of negative product combinations}}{text{Total combinations}} = frac{12}{28} = frac{3}{7} rightarrow boxed{frac{3}{7}}. Conclusion: Given that zero exists in the set, but since a product of zero isn't negative, it does not affect our count of negative products."},{"instruction":"Let ( a, b, c, d ) be four nonnegative real numbers such that ( a + b + c + d = 1 ). Prove the inequality ( abcd + bcda + cdab + dabc leq frac{1}{27} + frac{176}{27} abcd ).","output":"Let ( a, b, c, d ) be four non-negative real numbers such that ( a + b + c + d = 1 ). We are to prove the inequality: [ a b c + b c d + c d a + d a b leq frac{1}{27} + frac{176}{27} a b c d. ] First, without loss of generality, assume ( a geq b geq c geq d ). Consequently, we have ( a geq frac{1}{4} geq d ). Define the function: [ F(a, b, c, d) = bc(a+d) + ad left( b+c - frac{176}{27} bc right) ]  Step 1: Check the inequality at ( a = b = c = d = frac{1}{4} ) When ( a = b = c = d = frac{1}{4} ), we have: [ F left( frac{1}{4}, frac{1}{4}, frac{1}{4}, frac{1}{4} right) = bc(a+d) + ad left( b+c-frac{176}{27}bc right) ] [ = left(frac{1}{4} cdot frac{1}{4}right) left(frac{1}{4}+frac{1}{4}right) + left(frac{1}{4} cdot frac{1}{4}right) left(frac{1}{4} + frac{1}{4} - frac{176}{27} cdot frac{1}{4} cdot frac{1}{4} right) ] [ = frac{1}{16} cdot frac{1}{2} + frac{1}{16} left(frac{1}{2} - frac{176}{27} cdot frac{1}{16} right) ] [ = frac{1}{32} + frac{1}{16} left( frac{1}{2} - frac{11}{27} right) ] [ = frac{1}{32} + frac{1}{16} left( frac{13}{54} right) ] [ = frac{1}{32} + frac{13}{864} = frac{27}{864} + frac{13}{864} = frac{40}{864} ] [ = frac{5}{108} = frac{1}{27} ] So, we have shown: [ F left(frac{1}{4}, frac{1}{4}, frac{1}{4}, frac{1}{4}right) = frac{1}{27} ]  Step 2: Consider the case ( a > frac{1}{4} > d ) (i) If ( b + c - frac{176}{27} bc leq 0 ), then: By the arithmetic mean-geometric mean inequality (AM-GM): [ F(a, b, c, d) = bc(a+d) leq left( frac{a+d+b+c}{3} right)^{3} = left( frac{1}{3} right)^{3} = frac{1}{27} ] Thus, the inequality holds true. (ii) If ( b + c - frac{176}{27} bc > 0 ), set: [ a' = frac{1}{4}, b' = b, c' = c, d' = a + d - a' ] Thus: [ a' + d' = a + d quad text{and} quad a'd' > ad ] Using the function ( F ): [ F(a, b, c, d) leq b'c' left( a' + d' right) + a'd' left( b' + c' - frac{176}{27} b'c' right) = F left( a', b', c', d' right) ] Re-arrange ( a', b', c', d' ) in descending order: [ a' = frac{1}{4} ] And repeat the transformation steps. Every transformation increases the number of quarters (( frac{1}{4} )). At most, we can repeat this process three times, resulting in: [ F left( frac{1}{4}, frac{1}{4}, frac{1}{4}, frac{1}{4} right) = frac{1}{27} ] Thus, we have shown: [ F(a, b, c, d) leq frac{1}{27} ] So, the desired inequality is proven: [ a b c + b c d + c d a + d a b leq frac{1}{27} + frac{176}{27} a b c d ] (blacksquare)"},{"instruction":"During the college entrance examination, in order to provide safe, convenient, fast, and comfortable transportation services for candidates, taxi driver Xiao Wang participated in volunteer service to provide free transportation for candidates. If it is stipulated that east is positive and west is negative, then the taxi driver Xiao Wang's morning itinerary (unit: kilometers) is as follows: 15, +4, 5, +10, 12, +5, +8, 7. (1) How many kilometers did the taxi drive in the morning? (2) If the taxi consumes 10 liters of gasoline for every 100 kilometers driven, and the price of gasoline is 8 yuan per liter, how much is the taxi driver's gasoline cost for the morning?","output":"To solve the given problem, we will tackle it in two parts as requested: # Part 1: Total Kilometers Driven Given the taxi's itinerary in the morning, we calculate the absolute value of each trip segment to find the total distance traveled, disregarding the direction: [ begin{align*} text{Total Distance} &= |-15| + |+4| + |-5| + |+10| + |-12| + |+5| + |+8| + |-7|  &= 15 + 4 + 5 + 10 + 12 + 5 + 8 + 7  &= 66 text{ kilometers} end{align*} ] Therefore, the taxi drove a total of boxed{66 text{ kilometers}} in the morning. # Part 2: Gasoline Cost for the Morning To find the gasoline cost, we first calculate the gasoline consumption based on the distance driven, and then multiply by the price per liter: [ begin{align*} text{Gasoline Cost} &= left(frac{66}{100} times 10right) times 8  &= (0.66 times 10) times 8  &= 6.6 times 8  &= 52.8 text{ yuan} end{align*} ] Thus, the taxi driver's gasoline cost for the morning is boxed{52.8 text{ yuan}}."},{"instruction":"The numbers ( a_1, a_2, ldots, a_{1985} ) are a permutation of the numbers ( 1, 2, ldots, 1985 ). Each number ( a_k ) is multiplied by its position ( k ), and then the largest of the 1985 products is selected. Prove that this largest product is not less than ( 993^2 ).","output":"Given a sequence ( a_1, a_2, ldots, a_{1985} ) which represents a permutation of the numbers ( 1, 2, ldots, 1985 ). Each number ( a_k ) is multiplied by its index ( k ), and among these products, the largest one is selected. We need to show that the largest such product is at least ( 993^2 ). To solve this, follow these steps: 1. **Identify Minimum Value Context**:     - There are exactly 993 numbers in the range from 993 to 1985. Thus, at least one of them will have an index (position in the sequence) of at least 993.  2. **Explain Why ( a_k cdot k geq 993^2 )**:    - Let ( a_k geq 993 ) and ( k geq 993 ). The product ( a_k cdot k ) will then be:      [      a_k cdot k geq 993 cdot 993 = 993^2      ] 3. **Conclude with Detailed Calculation**:    - To calculate ( 993^2 ):      [      993 times 993 = (1000 - 7)^2 = 1000^2 - 2 cdot 1000 cdot 7 + 7^2       ]      [      1000^2 - 2 cdot 1000 cdot 7 + 7^2 = 1000000 - 14000 + 49 = 985049      ]    - So, ( 993^2 = 985049 ). # Conclusion: The largest product ( a_k cdot k ) is at least 993^2, that is: [ a_k cdot k geq 993^2 = 985049 ] boxed{993^2}"},{"instruction":"The graph, G, of y=e^x is rotated 180^{circ} about the origin to obtain a new graph, G'. Which of the following is an equation for G'?  (A) y=e^{x}  (B) y=x^2  (C) y=e^{x}  (D) y=e^x  (E) y=e^{2x} (A) y=e^{x} (B) y=x^2 (C) y=e^{x} (D) y=e^x (E) y=e^{2x}","output":"1. **Understanding the rotation**:    Rotating a point (x, y) 180^circ about the origin converts the point (x, y) to (-x, -y). This transformation is based on the rotation matrix or by simply understanding that a half-circle rotation reverses both coordinates. 2. **Applying the rotation to the graph of y = e^x**:    Each point (x, e^x) on the graph G of y = e^x transforms to (-x, -e^x). Thus, for every original x, the new y value becomes -e^x. 3. **Deriving the new equation**:    In terms of the new coordinates, new x is -x, and new y is -e^x. Hence, the equation of the graph after rotation is    [    y = -e^x.    ]    Conclusion: The 180^circ rotation of the graph y = e^x is described by the equation y = -e^x. Therefore, the correct choice is D. The final answer is boxed{D}, boxed{y=-e^x}."},{"instruction":"1. a) A convex pentagon is divided into three triangles by nonintersecting diagonals. Can the points of intersection of the medians of these triangles lie on the same line? b) The same question for a nonconvex pentagon.","output":"Part (a) 1. Let's consider a convex pentagon ABCDE which is divided into three triangles by two non-intersecting diagonals that are drawn from a single vertex, say A. Thus, we have the diagonals AC and AD which create the triangles ABC, ACD, and ADE. 2. For each triangle formed, note that the median intersects at its centroid. In particular, the centroid of a triangle is found at the intersection of its medians and divides each median into a ratio of 2:1, with the longer segment being from the vertex to the centroid. 3. We will perform a homothety transformation centered at point A with a ratio of frac{2}{3}. This transformation maps the midpoints of the sides BC, CD, and DE to the centroids of triangles ABC, ACD, and ADE respectively. 4. Since these midpoints (M, N, and P for sides BC, CD, and DE respectively) are distinct points, and the straight line in planar geometry can intersect the convex pentagon boundary in no more than two points, it follows logically that no single straight line can pass through all three distinct centroids (which lie within the interior of the triangles and not on the boundary). **Conclusion**: The intersection points of the medians of the three triangles cannot lie on one straight line for a convex pentagon. [ boxed{text{cannot}} ]  Part (b) 1. Consider a non-convex pentagon where one or more of the vertices jut inward. We will again look at a specific example such that it is divided into three triangles by drawing two diagonals from a single vertex. 2. For simplicity, let's assign the pentagon as ABCDE with diagonals AC and AD drawn from vertex A. Suppose the geometry of the pentagon is such that it is a \\"simple star shape\\" non-convex pentagon with point D being inward. 3. This time, when considering the midpoints of the segments BC, CD, and DE, their respective centroids (points of intersection of medians in the triangles formed) can actually be aligned linearly if the structure and lengths are appropriate. 4. In the following diagram, the vertices and the relative positions of midpoints are showcased such that the centroids align along one line: [Here would be an appropriate diagram showing that for a suitable non-convex shape, the triangles centroids do lie on a single line.] **Conclusion**: For a non-convex pentagon, it is theoretically possible that the intersection points of the medians of the three triangles can lie on one straight line. [ boxed{text{can}} ]"},{"instruction":"On dividing 109 by a number, the quotient is some value and the remainder is 1. The divisor is 12. What is the quotient?","output":"To find the quotient, we can use the formula for division: Dividend = (Divisor  Quotient) + Remainder Given that the dividend is 109, the divisor is 12, and the remainder is 1, we can plug these values into the formula: 109 = (12  Quotient) + 1 Now, we need to solve for the Quotient: 109 - 1 = 12  Quotient 108 = 12  Quotient Divide both sides by 12 to find the Quotient: Quotient = 108 / 12 Quotient = 9 So, the quotient is boxed{9} ."},{"instruction":"A certain percentage of the population of a village is 32,000. The total population of the village is 40,000. What percentage of the population is 32,000?","output":"To find the percentage of the population that is 32,000, we can use the following formula: Percentage = (Part / Whole) * 100 In this case, the \\"Part\\" is 32,000 and the \\"Whole\\" is the total population of 40,000. Percentage = (32,000 / 40,000) * 100 Percentage = (0.8) * 100 Percentage = 80% Therefore, 32,000 is boxed{80%}  of the total population of the village."},{"instruction":"Let w_1 and w_2 denote the circles given by x^2+y^2+8x20y75=0 and x^2 +y^28x20y+175=0, respectively. Let n be the smallest positive value of b for which the line y=bx contains the center of a circle that is externally tangent to w_2 and internally tangent to w_1. Given that n^2=frac pq, where p and q are relatively prime integers, find p+q.","output":"First, convert the circle equations into standard form: 1. (x+4)^2 + (y-10)^2 = 100 for w_1 2. (x-4)^2 + (y-10)^2 = 36 for w_2 The centers are (-4, 10) and (4, 10), with radii 10 and 6, respectively. Let w_3 be the circle with center (x, y) and radius r. For tangency conditions: 1. r + 6 = sqrt{(x-4)^2 + (y-10)^2} (External tangency with w_2) 2. 10 - r = sqrt{(x+4)^2 + (y-10)^2} (Internal tangency with w_1) Setting these equal and simplifying gives: [ 16 = 2sqrt{(x+4)^2 + (y-10)^2} ] [ x = 4 ] Substituting y = bx: [ 16 = 2sqrt{(4+4)^2 + (b cdot 4 - 10)^2} ] [ 8 = sqrt{64 + (4b - 10)^2} ] [ 64 = 64 + (4b - 10)^2 ] [ (4b - 10)^2 = 0 ] [ b = frac{10}{4} = 2.5 ] Thus, n = 2.5 and n^2 = 6.25 = frac{25}{4}, so p+q = 25+4 = boxed{29}."},{"instruction":"Xiao Wen and Xiao Li drew a straight line on the paper, and played a game of rockpaperscissors, roll the dice, move the chess piece on this line. Each of them holds a chess piece (they move their own chess pieces and do not affect each other). The winner of the rockpaperscissors game rolls the dice first, and the number on the dice determines how many centimeters the chess piece moves eastward; the loser of the rockpaperscissors game rolls the dice afterwards, and the number on the dice determines how many centimeters the chess piece moves westward. Now, both of them start at point A on the line and play the game. It is defined that moving eastward is positive and moving westward is negative. Below is the record of five consecutive games played by Xiao Wen and Xiao Li (starting from the second game, the starting point of the chess piece is the endpoint of the previous game): (unit: centimeters) (In case of a tie in rockpaperscissors, they replay until a winner is determined) |         | 1st Game | 2nd Game | 3rd Game | 4th Game | 5th Game | ||||||| | Xiao Wen| +3     | 2     | 1     | +4     | 5     | | Xiao Li | 4     | +3     | +5     | 2     | a      | (1) At the end of the fifth game, in which direction is Xiao Wen's chess piece from point A? How far is it from point A?   (2) At the end of the fifth game, Xiao Li's chess piece is 5 centimeters east of point A. Find the value of a.   (3) Under the condition in (2), Xiao Wen scores 3 points for every centimeter moved eastward and loses 2 points for every centimeter moved westward. At the end of the fifth game, how many more points does the player with the higher score have compared to the player with the lower score?","output":"(1) To find the final position of Xiao Wen's chess piece relative to point A, we sum up all the movements: [ +3 + (-2) + (-1) + (+4) + (-5) = -1 , text{centimeters}. ] This means Xiao Wen's chess piece is 1 centimeter to the west of point A. Therefore, the answer is: [ boxed{text{West, 1 centimeter}} ] (2) To find the value of a for Xiao Li, we know that Xiao Li's final position is 5 centimeters east of point A. We can set up an equation based on Xiao Li's movements: [ -4 + 3 + 5 - 2 + a = 5. ] Simplifying the left side gives: [ 2 + a = 5. ] Solving for a gives: [ a = 5 - 2 = 3. ] Thus, the value of a is: [ boxed{+3} ] (3) To calculate the scores, we first calculate Xiao Wen's score: [ text{Xiao Wen's score} = (3 + 4) times 3 - |-2 - 1 - 5| times 2. ] This simplifies to: [ 7 times 3 - 8 times 2 = 21 - 16 = 5 , text{points}. ] Next, we calculate Xiao Li's score: [ text{Xiao Li's score} = (3 + 5 + 3) times 3 - |-4 - 2| times 2. ] This simplifies to: [ 11 times 3 - 6 times 2 = 33 - 12 = 21 , text{points}. ] The difference in scores between the higher and lower scorer is: [ 21 - 5 = 16 , text{points}. ] Therefore, the player with the higher score has: [ boxed{16 , text{more points}} ]"},{"instruction":"a game, Diana and Sam each have two fair sixsided dice and a third die that shows a number '1' with probability frac{5}{8} and a number '6' with probability frac{3}{8}. Diana throws all three dice, followed by Sam. Calculate the probability that both obtain the same sum from their dice throws. Let frac{m}{n} be this reduced fraction and find m + n.","output":"Begin with the generating functions for a fair die, which is (x^1 + x^2 + x^3 + x^4 + x^5 + x^6) because each outcome (1 to 6) has an equal probability. The generating function for the biased die is (frac{5}{8}x^1 + frac{3}{8}x^6). The total generating function, when all dice are thrown, is: [ (x^1 + x^2 + x^3 + x^4 + x^5 + x^6)^2 cdot (frac{5}{8}x^1 + frac{3}{8}x^6) ] Expanding and simplifying, [ (x^2 + 2x^3 + 3x^4 + 4x^5 + 5x^6 + 6x^7 + 5x^8 + 4x^9 + 3x^{10} + 2x^{11} + x^{12}) cdot (frac{5}{8}x^1 + frac{3}{8}x^6) ] [ = frac{5}{8}(x^3 + 2x^4 + 3x^5 + 4x^6 + 5x^7 + 6x^8 + 5x^9 + 4x^{10} + 3x^{11} + 2x^{12} + x^{13}) + frac{3}{8}(x^8 + 2x^9 + 3x^{10} + 4x^{11} + 5x^{12} + 6x^{13} + 5x^{14} + 4x^{15} + 3x^{16} + 2x^{17} + x^{18}) ] Compute the sum of coefficients squared [sum(scores) probabilities for both players]: [ sum (coefficient_{text{each score}}^2) ] The total sum of cases: [ sum (coefficient_{text{each score}}) = 2 cdot 6 + 2^2 cdot 5 + ... (summing over all coefficients) ] And their total as squared sum: [ 36^2 ] Compute the probability: [ frac{sum (coefficient_{text{each score}}^2)}{36^2} ] Simplify to find frac{m}{n}, ensuring m and n are relatively prime. Conclusion with boxed answer: [ boxed{text{final answer m+n}} ]"},{"instruction":"Given vectors overrightarrow{a} = (2, 1) and overrightarrow{b} = (3, lambda), and overrightarrow{a} is perpendicular to overrightarrow{b}, then lambda =  A: 6 B: 6 C: frac{3}{2} D: frac{3}{2}","output":"Solution: According to the necessary and sufficient condition for vectors to be perpendicular, we have 2 times 3 + 1 times lambda = 0,   Solving this, we get lambda = -6,   Therefore, the correct choice is boxed{text{A}}.   This problem tests the necessary and sufficient condition for vectors to be perpendicular, and it is a basic question."},{"instruction":"Melanie computes the mean mu, the median M, and the modes of the 365 values that are the dates in the months of 2019. Thus her data consist of 12 1text{s}, 12 2text{s}, . . . , 12 28text{s}, 11 29text{s}, 11 30text{s}, and 7 31text{s}. Let d be the median of the modes. Which of the following statements is true? textbf{(A) } mu < d < M qquadtextbf{(B) } M < d < mu qquadtextbf{(C) } d = M =mu qquadtextbf{(D) } d < M < mu qquadtextbf{(E) } d < mu < M","output":"1. **Identify the Data Set**: Melanie's data set consists of the dates in the months of 2019. This means there are:    - 12 occurrences each of 1, 2, ldots, 28 (since each of these dates appears in all 12 months),    - 11 occurrences each of 29 and 30 (since February does not have these dates),    - 7 occurrences of 31 (since only January, March, May, July, August, October, and December have a 31st). 2. **Calculate the Median (M)**: The median is the middle value in a data set when it is ordered. Since there are 365 values, the median is the frac{365+1}{2} = 183^text{rd} value.    - Counting up to 183, we have 12 times 15 = 180 values for the dates 1 through 15. The 183^text{rd} value falls into the next group, which is 16. Therefore, the median M = 16. 3. **Calculate the Mean (mu)**: The mean is the average of all values. We calculate it by summing all the values and dividing by the number of values.    - Sum of values: sum_{k=1}^{28} 12k + 11 times 29 + 11 times 30 + 7 times 31.    - This simplifies to 12 times frac{28 times 29}{2} + 11 times (29 + 30) + 7 times 31 (using the sum of the first n integers formula frac{n(n+1)}{2}).    - Calculate the sum: 12 times 406 + 11 times 59 + 7 times 31 = 4872 + 649 + 217 = 5738.    - Mean mu = frac{5738}{365} approx 15.72. 4. **Identify the Modes**: The modes are the values that appear most frequently. In this data set, the modes are 1 through 28, each appearing 12 times.    - Since all these modes appear with the same frequency, any of them could be considered a mode. However, since they are equally frequent, the median of these modes (d) is the median of the set {1, 2, ldots, 28}, which is frac{1+28}{2} = 14.5. 5. **Compare mu, d, and M**: We have calculated:    - Mean mu approx 15.72,    - Median of the modes d = 14.5,    - Median M = 16. 6. **Conclusion**: Since d < mu < M, the correct answer is boxed{textbf{(E) } d < mu < M}."},{"instruction":"Given that an interior angle of a regular ngon is 140^{circ}, then the number of sides of this regular ngon is ______.","output":"Given that an interior angle of a regular n-gon is 140^{circ}, we can find the number of sides of this regular n-gon by following these steps: 1. **Determine the measure of each exterior angle**: Since the interior and exterior angles are supplementary in a polygon, we calculate the exterior angle as follows:    [    text{Exterior angle} = 180^{circ} - text{Interior angle} = 180^{circ} - 140^{circ} = 40^{circ}.    ] 2. **Calculate the number of sides (n)**: Knowing that the sum of all exterior angles of a polygon is 360^{circ}, we can find the number of sides by dividing the total sum of exterior angles by the measure of one exterior angle:    [    n = frac{360^{circ}}{text{Exterior angle}} = frac{360^{circ}}{40^{circ}} = 9.    ] Therefore, the number of sides of this regular n-gon is boxed{9}."},{"instruction":"A high school has 400 male students and 300 female students in the first grade. To investigate the preferences of firstgrade students for liberal arts or sciences in the second grade, a random sample of 35 students will be selected. The number of male students to be sampled is ( ). A: 25 B: 20 C: 15 D: 10","output":"According to the problem, using stratified sampling, the sampling ratio in each stratum is: frac {35}{400+300} = frac {1}{20} Thus, the number of male students to be sampled is: 400 times frac {1}{20} = 20 Hence, the answer is: boxed{text{B}}. The stratified sampling ratio is calculated by dividing the sample size by the total population size. The number of male students to be sampled is then calculated by multiplying the total number of male students by this ratio. The focus of this problem is the stratified sampling method, which maintains consistency between the sample structure and the population structure. The sampling ratio is calculated first, and then the number of individuals to be sampled in each stratum is determined."},{"instruction":"f fleft(xright)=left(x+aright)lnfrac{2x1}{2x+1} is an even function, then a=left(  right) A: 1 B: 0 C: frac{1}{2} D: 1","output":"Given that f(x) = (x + a)lnfrac{2x - 1}{2x + 1} is an even function, we want to find the value of a. 1. For a function to be even, f(-x) = f(x) must hold for all x in the domain of f. 2. The domain of f is determined by the condition frac{2x - 1}{2x + 1} > 0, which gives x > frac{1}{2} or x < -frac{1}{2}. 3. Applying the even function property, we get:    [    f(-x) = (-x + a)lnfrac{-2x - 1}{-2x + 1} = (x + a)lnfrac{2x - 1}{2x + 1}    ] 4. Simplifying the logarithmic expression, we have:    [    (-x + a)lnfrac{2x + 1}{2x - 1} = (x + a)lnfrac{2x - 1}{2x + 1}    ] 5. Recognizing that lnfrac{2x + 1}{2x - 1} = -lnfrac{2x - 1}{2x + 1}, we can rewrite the equation as:    [    (-x + a)(-lnfrac{2x - 1}{2x + 1}) = (x + a)lnfrac{2x - 1}{2x + 1}    ] 6. This simplifies further to:    [    (x - a)lnfrac{2x - 1}{2x + 1} = (x + a)lnfrac{2x - 1}{2x + 1}    ] 7. For the equality to hold for all x in the domain, the coefficients of the logarithmic expressions must be equal, leading to:    [    x - a = x + a    ] 8. Solving for a, we find:    [    -a = a Rightarrow 2a = 0 Rightarrow a = 0    ] Therefore, the correct answer is boxed{B}."},{"instruction":"A cylindrical log has a diameter of 16 inches. Two planar cuts are made through the entire log. The first cut is perpendicular to the axis of the cylinder, and the second cut's plane forms a 60^circ angle with that of the first cut. The intersection of these two planes touches the log at exactly one point. Calculate the volume of the wedge formed, expressed as mpi, where m is a positive integer.","output":"1. **Determine the relevant dimensions of the cylinder**: The radius of the cylinder is half of the diameter, so r = 8 inches. 2. **Volume calculation based on geometry**: Since the wedge is formed by a perpendicular cut and another cut at a 60^circ angle to that, we can visualize this as cutting out a specific sector from a full circular cross-section. The volume of the wedge will be frac{1}{6} (since 60^circ is frac{1}{6} of 360^circ) of the total cylindrical volume (as opposed to frac{1}{4} in the original problem). 3. **Calculate the cylinder's volume and the wedge's portion**:    [    V_{text{cylinder}} = pi r^2 h = pi (8^2)(16) = 1024pi text{ cubic inches}    ]    [    V_{text{wedge}} = frac{1}{6} V_{text{cylinder}} = frac{1}{6}(1024pi) = frac{1024}{6}pi = 170.67pi text{ cubic inches}    ]     Since m must be an integer, round 170.67 to the nearest integer: [ m = 171 ] Thus, the volume of the wedge can be expressed as mpi where m = boxed{171}."},{"instruction":"Triangle triangle ABC has a right angle at C, angle A = 45^circ, and AC = 12. Find the radius of the incircle of triangle ABC.","output":"1. triangle ABC has measurements under the properties of a 45^circ-45^circ-90^circ triangle:    - Since angle A = 45^circ, angle B also becomes 45^circ.     - In a 45^circ-45^circ-90^circ triangle, the sides are in a ratio 1:1:sqrt{2}. Therefore, both AC and BC are 12 and AB = 12sqrt{2}. 2. Compute the semiperimeter s of triangle ABC:    [    s = frac{12 + 12 + 12sqrt{2}}{2} = 12 + 6sqrt{2}    ] 3. Compute the area [triangle ABC]:    [    [triangle ABC] = frac{1}{2} times text{base} times text{height} = frac{1}{2} times 12 times 12 = 72    ] 4. Let the inradius be r; we know the relation text{Area} = r s, hence:    [    72 = r(12 + 6sqrt{2})    ] 5. Solve for r:    [    r = frac{72}{12 + 6sqrt{2}} = frac{72}{12 + 6sqrt{2}} times frac{12 - 6sqrt{2}}{12 - 6sqrt{2}} = frac{72(12 - 6sqrt{2})}{144 - 72} = 72(12 - 6sqrt{2})/72    ]    [    r = 12 - 6sqrt{2}    ]    [    r = 12 - 6sqrt{2} = 6(2 - sqrt{2})    ]    Thus,    [    boxed{r = 6(2 - sqrt{2})}    ]"},{"instruction":"Given the complex number z that satisfies z(1+2i)=5i. (1) Find the complex number z and determine whether z is a root of the equation x^{2}4x+5=0; (2) Calculate the modulus of the complex number overset{ .}{z}+ frac {5}{z}.","output":"(1) To find z, we can solve the equation z(1+2i)=5i as shown below: z = frac{5i}{1+2i} = frac{5i(1-2i)}{(1+2i)(1-2i)} = i(1-2i) = 2+i. Now, let's check if z = 2+i is a root of the equation x^{2}-4x+5=0. The roots of this equation are 2 pm i. Since z=2+i, it is indeed one of the roots of the equation. (Alternatively, we can verify this by substituting z = 2+i into the equation: (2+i)^2 - 4(2+i) + 5 = 0.) (2) To calculate the modulus of overset{ .}{z}+ frac {5}{z}, we first find the value of this expression: overset{ .}{z}+ frac {5}{z}=(2-i)+ frac {5}{2+i}=4-2i. The modulus of a complex number a+bi is given by sqrt{a^2 + b^2}. So, the modulus of 4-2i is: sqrt{4^2 + (-2)^2} = boxed{2sqrt{5}}."},{"instruction":"Given that the function f(x) is an odd function, and when x > 0, f(x) = x^3 + 1, then f(2) = .","output":"Since the function f(x) is defined on mathbb{R} as an odd function, and when x > 0, f(x) = x^3 + 1, Therefore, f(-2) = -f(2) = -(2^3 + 1) = -9. Hence, the answer is boxed{-9}. **Analysis:** The property of odd functions can be utilized to find the solution."},{"instruction":"Fifteen families have an average of 3 children per family. If exactly three of these families are childless, what is the average number of children in the families with children? Express your answer as a decimal to the nearest tenth.","output":"1. Calculate the total number of children among all families:    [    15 times 3 = 45 text{ children total}    ] 2. Determine the number of families with children:    [    15 - 3 = 12 text{ families with children}    ] 3. Calculate the average number of children in the families that have children:    [    frac{45}{12} approx 3.75    ] Conclusion: The average number of children in families with children is boxed{3.8} when rounded to the nearest tenth."},{"instruction":"w many onethirds are in onesixth?","output":"To find how many one-thirds are in one-sixth, we follow the division of fractions rule, which involves flipping the divisor and changing the division sign to multiplication. Thus, we have: [ frac{1}{6} div frac{1}{3} = frac{1}{6} cdot frac{3}{1} ] Multiplying these fractions directly, we get: [ = frac{1 cdot 3}{6 cdot 1} = frac{3}{6} ] Simplifying the fraction by dividing both numerator and denominator by their greatest common divisor, which is 3, we get: [ = frac{1cdotcancel{3}}{2cdotcancel{3}} = boxed{frac{1}{2}} ]"},{"instruction":"A manufacturer has built a machine that can address 1000 envelopes in 12 minutes. He wishes to build another machine so that, when both are operating together, they can address 1000 envelopes in 4 minutes. To find the number of minutes x it would take for the second machine to address 1000 envelopes alone, which equation should be used? **A)** frac{1}{12} + frac{1}{x} = frac{1}{4} **B)** frac{1}{12}  frac{1}{x} = frac{1}{4} **C)** frac{12}{1000} + frac{x}{1000} = 1000 **D)** frac{x}{4} + frac{x}{12} = 1 **E)** None of these answer","output":"1. **Rate of the first machine**: It can address 1000 envelopes in 12 minutes, which is frac{1000}{12} approx 83.33 envelopes per minute. 2. **Combined rate required**: Together, the machines need to address 1000 envelopes in 4 minutes, which is frac{1000}{4} = 250 envelopes per minute. 3. **Rate of the second machine**: Let r represent the rate of the second machine in envelopes per minute. The combined rate is 83.33 + r = 250. Solving for r, we have r = 250 - 83.33 = 166.67 envelopes per minute. 4. **Finding x (time for second machine to address 1000 envelopes alone)**: The time x for the second machine, operating alone at 166.67 envelopes per minute to address 1000 envelopes, is x = frac{1000}{166.67} approx 6 minutes. 5. **Checking the options**: The correct equation that represents the relationship should be frac{1}{12} + frac{1}{x} = frac{1}{4}. Conclusion with boxed answer: frac{1{12} + frac{1}{x} = frac{1}{4}} The final answer is boxed{textbf{(A)} frac{1}{12} + frac{1}{x} = frac{1}{4}}"},{"instruction":"85 percent of Andrea's living room floor is covered by a carpet that is 6.5 feet by 12 feet. There is also a 10 square foot area in one corner that is not covered by the carpet. What is the area of her entire living room floor?","output":"Let's call the area of the entire living room floor A. We know that 85% of A is covered by the carpet, and there is also a 10 square foot area that is not covered by the carpet. First, let's find the area of the carpet: Area of carpet = length  width = 6.5 feet  12 feet = 78 square feet This area represents 85% of the total area of the living room floor, so: 0.85A = 78 square feet Now, let's solve for A: A = 78 square feet / 0.85 A = 91.7647 square feet (approximately) Since there is also a 10 square foot area that is not covered by the carpet, we need to add this to the total area: Total area of living room floor = A + 10 square feet Total area of living room floor  91.7647 square feet + 10 square feet Total area of living room floor  101.7647 square feet Therefore, the area of Andrea's entire living room floor is approximately boxed{101.7647}  square feet."}]`),_={name:"App",components:{PoemCard:H},data(){return{searchQuery:"",visibleCount:4,poemsData:M,isLoading:!1}},computed:{filteredPoems(){const i=this.searchQuery.trim().toLowerCase();return i?this.poemsData.filter(e=>e.instruction&&e.instruction.toLowerCase().includes(i)||e.output&&e.output.toLowerCase().includes(i)):this.poemsData},displayedPoems(){return this.searchQuery.trim()?this.filteredPoems:this.filteredPoems.slice(0,this.visibleCount)},hasMorePoems(){return!this.searchQuery.trim()&&this.visibleCount<this.poemsData.length}},methods:{async loadMore(){this.isLoading=!0,await new Promise(i=>setTimeout(i,1e3)),this.visibleCount+=4,this.isLoading=!1}}},B={class:"search-container"},D={class:"card-container"},O={key:0,class:"empty-state"},I=["disabled"],W={key:0},F={key:1};function E(i,e,h,u,n,s){const f=y("PoemCard");return a(),o("section",null,[e[4]||(e[4]=t("div",{class:"top-banner"},[t("div",{class:"top-banner-title"},[t("div",{class:"top-banner-title-text"},"prompts chat")])],-1)),t("div",B,[e[3]||(e[3]=t("span",{class:"search-icon"},"",-1)),g(t("input",{type:"text",class:"search-input","onUpdate:modelValue":e[0]||(e[0]=r=>n.searchQuery=r),placeholder:"Search..."},null,512),[[b,n.searchQuery]]),n.searchQuery?(a(),o("button",{key:0,class:"clear-search",onClick:e[1]||(e[1]=r=>n.searchQuery="")},"  ")):l("",!0)]),t("div",D,[(a(!0),o(w,null,v(s.displayedPoems,(r,p)=>(a(),x(f,{key:p,poem:r},null,8,["poem"]))),128)),s.displayedPoems.length===0?(a(),o("div",O,' No results found for "'+c(n.searchQuery)+'". ',1)):l("",!0)]),s.hasMorePoems?(a(),o("button",{key:0,class:"load-more-button",disabled:n.isLoading,onClick:e[2]||(e[2]=(...r)=>s.loadMore&&s.loadMore(...r))},[n.isLoading?(a(),o("span",F,"Loading...")):(a(),o("span",W,"See more"))],8,I)):l("",!0)])}const L=d(_,[["render",E],["__scopeId","data-v-d97f2b42"]]),N=JSON.parse('{"title":"","description":"","frontmatter":{"page":true},"headers":[],"relativePath":"library/64.md","filePath":"library/64.md"}'),R={name:"library/64.md"},G=Object.assign(R,{setup(i){return(e,h)=>(a(),o("div",null,[T(L)]))}});export{N as __pageData,G as default};
